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903 ATRIAL FIBRILLATION - RECENT THERAPEUTIC 
ADVANCES
Monday, March 15, 2010, 8:00 a.m. - 9:30 a.m.
Georgia World Congress Center, Room B404
CME/CE Hours: 1.5
8:00 Left Ventricular Hypertrophy and Antiarrhythmic 
Drugs in Atrial Fibrillation: Impact on Mortality
Roy Chung, Michael Tchou, Mark J. Niebauer, Patrick J. Tchou, 
Mina K. Chung, Department of Cardiovascular Medicine, Heart and 
Vascular Institute, Cleveland Clinic, Cleveland, OH
Learning Objective: To evaluate the safety of anti-arrhythmic drugs 
in patients with atrial fibrillation and left ventricular hypertrophy.
8:15 Dabigatran Versus Warfarin in Atrial Fibrillation 
Patients with Low, Moderate and High Chads2 
Score: A Re-ly Subgroup Analysis
Jonas Oldgren, Marco Alings, Harald Darius, John Eikelboom, 
Michael Ezekowitz, Amit Parekh, Janice Pogue, Paul Reilly, Salim 
Yusuf, Lars Wallentin, Stuart Connolly, Uppsala Clinical Research 
Center, Uppsala, Sweden, Population Health Research Institute, 
Hamilton, Canada
Learning Objective: Describe the benefit risk profile with dabigatran 
versus warfarin in low, moderate and high risk atrial fibrillation 
patients
8:30 Impact of Dronedarone Started Rapidly after 
Amiodarone Discontinuation
Peter R. Kowey, Bramah N. Singh, Stuart J. Connolly, Harry J. Crijns, 
Denis Roy, Alessandro Capucci, David Radzik, Etienne M. Aliot, 
Stefan H. Hohnloser, Lankenau Hospital, Wynnewood, PA
Learning Objective: undertand the effects of starting dronedarone 
after amiodarone discontinuation.
8:45 A Therapeutic Strategy for 2010 to Reduce the 
Incidence of Postoperative Atrial Fibrillation: A Pilot 
Study
Jennifer Shea, Amit Shah, Gurpreet Sodhi, Jennifer Price, 
Farzad Najam, Allen J. Solomon, George Washington University, 
Washington, DC
Learning Objective: Describe a new strategy to reduce postoperative 
atrial fibrillation
9:00 Catheter-Based Left Atrial Appendage (LAA) 
Ligation for the Prevention of Embolic Events 
Arising from the LAA
Randall J. Lee, Steven J. Yakubov, Krzysztof Bartus, Jacek Bednarek, 
Boguslaw Kapelak, Jerzy Sadowski, University of California, San 
Francisco, San Francisco, CA, Riverside Methodist Hospital, 
Columbus, OH
Learning Objective: Evaluate a novel catheter based approach for 
ligation of the left atrial appendage
906 NONINVASIVE PREDICTORS OF CARDIAC 
ARRHYTHMIAS
Monday, March 15, 2010, 10:30 a.m. - 12:00 p.m.
Georgia World Congress Center, Room B404
CME/CE Hours: 1.5
10:30 Right Ventricular Mechanical Dispersion 
Predicts Malignant Arrhythmias in Patients with 
Arrhythmogenic Right Ventricular Cardiomyopathy
Sebastian I. Sarvari, Kristina H. Haugaa, Ole-Gunnar Anﬁnsen, Otto 
A. Smiseth, Jan P. Amlie, Thor Edvardsen, Oslo University Hospital, 
Rikshospitalet, Oslo, Norway
Learning Objective: Identify ARVC pasients with increased risk for 
ventricular arrhythmias by assessing right ventricular dispersion by 
strain echocardiography.
10:45 Viral Load and CD4+ Cell Count as Risk Factors for 
Prolonged QTc Interval in HIV-infected Subjects: A 
Cohort-Nested Case-Control Study in an Outpatient 
Population
Ashraf Y. QaQa, Hamid S. Shaaban, Vincent A. DeBari, Susan 
Phung, Jihad Slim, George Perez, Fayez Shamoon, Saint Michael’s 
Medical Center /Seton Hall University, Newark, NJ
Learning Objective: Demonestrate that CD+ cell count and viral load 
are independent risk factors for QTc prolongation in HIV poistive 
outpatient population.
11:00 Fragmented QRS Predicts Mortality in Patients with 
Systolic Heart Failure
Vikas Kalra, Prem Konakondla, Julie M. Clary, Mithilesh K. Das, 
Indiana University, Indianapolis, IN
Learning Objective: Demonstrate that fragmented QRS complex 
predicts increased mortality in patients with systolic heart failure.
11:15 Can MRI Shed Insight into the Accuracy of EKG’s?
Wadih Nadour, Robert WW Biederman, The Center for CVMRI, The 
Gerald McGinnis Cardiovascular Institute at Allegheny General 
Hospital, Pittsburgh, PA
Learning Objective: To learn that the electrophysiologic basis of the 
Q-wave is variably accurate when depicted by CMR infarct imaging
11:30 Prevalence of QTc Interval Prolongation in Patients 
Admitted to Cardiac Critical Care Units and 
Frequency of Subsequent Administration of QT 
Interval Prolonging Drugs
Heather A. Wroblewski, James E. Tisdale, Joanna R. Kingery, Brian R. 
Overholser, Richard J. Kovacs, Purdue University, West Lafayette, IN
Learning Objective: Identify prevelance of administration of QTc 
prolonging medications in vulnerable populations 
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1023 CLINICAL ELECTROPHYSIOLOGY--
SUPRAVENTRICULAR ARRHYTHMIAS
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1023-120 Ranolazine Facilitates Electrical Cardioversion in 
Cardioversion Resistant Patients
David K. Murdock, Jeffrey W. Kaliebe, Mary Kersten, German 
Larrain, Cardiovascular Associates of Northern Wisconsin, S.C., 
Wausau, WI, CaRE Foundation, Inc., Wausau, WI
Learning Objective: Describe our use of ranolazine as an agent to 
facilitate electrical cardioversion in patients who were refractory to 
electrical cardioversion
1023-121 The Effect of Atrial Rhythm on the QTc Interval: 
Implications for Dofetilide Dose Titration
Dan Laurentiu Musat, Emad F. Aziz, Alexandre Benjo, Sonali Mantoo, 
Jonathan S. Steinberg, Suneet Mittal, St. Luke’s and Roosevelt 
Hospitals, Columbia University College of Physicians and Surgeons, 
New York, NY
Learning Objective: Demonstrate that QTc calculated in atrial 
fibrillation are longer than the ones calculated in sinus rhythm
1023-123 Modest Antiarrhythmic Efficacy of Dronedarone for 
Atrial Fibrillation: Results of a Meta-analysis.
Sanjay Kaul, Eugenio Cingolani, David Singh, George A. Diamond, 
Cedars-Sinai Medical Center, Los Angeles, CA, UCSF Medical Center, 
San Francisco, CA
Learning Objective: Evauate the antiarrhythmic efficacy of 
dronedarone compared to placebo in patients with atrial fibrillation 
or atrial flutter
1023-124 Use of n-3 Polyunsaturated Fatty Acids to Maintain 
Sinus Rhythm After Conversion from Persistent 
Atrial Fibrillation. A Prospective Randomized Study
Savina Nodari, Marco Triggiani, Anna Foresti, Giuseppe Milesi, 
Nicola Berlinghieri, Mihai Gheorghiade, Livio Dei Cas, Department 
of Experimental and Applied Medicine-University of Brescia, Brescia, 
Italy
Learning Objective: n-3 PUFAs are effective to reduce atrial 
fibrillation recurrences after cardioversion in patients with 
persistent AF treated with amiodarone and RAS inihibitors
1023-125 Increasing Trends in Hospitalization for Atrial 
Fibrillation in Australia: 1998-2008
Christopher X. Wong, Dennis H. Lau, Anthony G. Brooks, Darryl P. 
Leong, Nicholas J. Shipp, Muayad Alasady, Han S. Lim, Hany Abed, 
Julian Laborderie, Prashanthan Sanders, Cardiovascular Research 
Centre, Department of Cardiology, Royal Adelaide Hospital, 
Adelaide, Australia, Discipline of Medicine, University of Adelaide, 
Adelaide, Australia
Learning Objective: Describe recent trends in hospitalization for 
atrial fibrillation in Australia from 1998 to 2008.
1023-126 Intracellular Ca2+ (Cai) Oscillations and T-wave 
Lability (TWL) Precede Torsade De Pointes (TdP) In 
A Rabbit Model Of Long QT Type 2 (LQT2)
Jan Nemec, Jong Kim, Bethanny Gabris, Guy Salama, University of 
Pittsburgh, Pittsburgh, PA
Learning Objective: Describe the role of intracellular Ca oscillations 
in ventricular myocytes in trigerring torsade de pointes.
1023-127 Ouabain Increases Late Sodium Current by a 
Ca2+/Calmodulin Kinase-Mediated Mechanism
Yejia Song, John C. Shryock, Shen-Ling Xia, Luiz Belardinelli, 
University of Florida, Gainesville, FL, Gilead Sciences, Palo Alto, CA
Learning Objective: Identify a novel mechanism, i.e. a CaMKII-
mediated stimulation of late sodium current, that underlies cardiac 
glycosides-induced intracellular calcium overload and arrhythmic 
activity.
1024 EFFECT OF LEAD PLACEMENT ON CARDIAC 
PACING
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1024-129 Biventricular versus Left Ventricular Pacing for 
Cardiac Resynchrnoization Therapy: Comparison of 
the Acute Hemodynamic Response and Optimal AV 
Delay
Michael Robert Gold, Imran Niazi, Michael Giudici, Robert Leman, 
J Lacy Sturdivant, Michael Kim, Yinghong Yu, Medical University of 
South Carolina, Charleston, SC
Learning Objective: Evaluate Hemodynamic Effect and AV 
Optimization of LV and BV pacing
1024-130 The Relationship between the Proximity of Left 
Ventricular Lead Positions to the Latest Site of 
Activation and Response to Cardiac Resynchronization 
Therapy: How Close Do You Need to Be?
Fakhar Z. Khan, Munmohan S. Virdee, Philip A. Read, Peter J. Pugh, 
Simon P. Fynn, David P. Dutka, Addenbrooke’s Hospital, Cambridge, 
United Kingdom, Papworth Hospital, Cambridge, United Kingdom
Learning Objective: To understand the relationship of LV lead 
position and response to CRT
1024-131 Right Ventricular Pacing in Heart Failure Patients 
with RBBB: Effects on RV Hemodynamic Function 
and Optimization of the AV Delay
J. Lacy Sturdivant, Jiang Ding, Frank Cuoco, Robert B. Leman, J 
Marcus Wharton, Yinghong Yu, Michael R. Gold, Medical University 
of South Carolina, Charleston, SC
Learning Objective: Evaluate Hemodynamic Effect and AV 
Optimization of RV pacing in RBBB patients
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1025-140 Survival Benefit from Cardiac Resynchronization 
Therapy in Patients with Borderline QRS Duration
Olusegun Oyenuga, Phillip Habib, Hidekazu Tanaka, Stephanie 
C. Haberman, Evan C. Adelstein, Samir Saba, John Gorcsan, III, 
University Of Pittsburgh, Pittsburgh, PA
Learning Objective: Demonstrate that survival following CRT 
implantation may be similar in patients with wide QRS duration 
and borderline QRS patients selected by echocardiographic 
dyssynchrony indices.
1025-141 Persistence Of A Vasodepressor Etiology In Patients 
With Bradycardia And Permanent Pacemakers. 
Mechanism Of The Response And Role Of The ClS 
Sensor In Improving Outcome
Atul Prakash, Pranesh Thirukkonda, St Marys Hospital, Passaic, NJ
Learning Objective: Understand the role of contractility in 
Neurocardiogenic Syncope
1025-142 The Absence of Left Bundle Branch Block On 12-
lead ECG Predicts Poor Response and Increased 
Mortality in Patients Undergoing Resynchronization 
Therapy
Hicham Z. El Masry, Julie M. Clary, Ahmad Alqaqa’a, Mithilesh K. 
Das, Indiana University, Indianapolis, IN
Learning Objective: The abscence of LBBB on baseline ECG in 
patients who are candidates to cardiac resynchronization therapy is 
a predictor of worse prognosis and poor response to CRT.
1025-143 Effect of Left Axis Deviation on Cardiac 
Resynchronization Therapy Response in Patients 
With Left Bundle Branch Block
Madhu Reddy, Xuedong Shen, Siva Soma, Chandra N. Nair, Aryan N. 
Mooss, Creighton University, Omaha, NE
Learning Objective: Identify the effect of left axis deviation on 
cardiac resynchronization therapy response in patients with left 
bundle brach block.
1026 CARDIAC RESYNCHRONIZATION THERAPY
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1026-146 Cardiac Resynchronization Therapy for Patients with 
Heart Failure and Chronic Atrial fibrillation.
MAMORU HAYANO, Satoshi Shizuta, Tetsushi Nakao, Takahiro Doi, 
Takeshi Kimura, Kenji Andou, Takeshi Arita, Masakiyo Nobuyoshi, 
Satoki Fujii, Koichi Inoue, Takaaki Isshiki, Kyoto University Graduate 
School of Medicine, Kyoto, Japan
1024-132 Alterations In The Expression Of Genes Related To 
Contractile Function And Hypertrophy Of The Left 
Ventricle In Chronically Paced Patients From The 
Right Ventricular Apex (preliminary Results)
Emmanuel N. Simantirakis, Joanna E. Kontaraki, Eva G. 
Arkolaki, Stavros I. Chrysostomakis, Eva G. Nyktari, Alexandros 
P. Patrianakos, Panos E. Vardas, Heraklion University Hospital, 
Heraklion, Greece
Learning Objective: to comprehend that alterations in the 
expression of genes regulating left ventricular contractile function 
and hypertrophy are evident at an earlier stage, even before 
impairment of ventricular functi
1024-133 The Impact of Right Ventricular Lead Position on 
Response to Cardiac Resynchronisation Therapy 
in Patients with Concordant and Discordant Left 
Ventricular Leads
Fakhar Z. Khan, Pegah Salahshouri, Munmohan S. Virdee, Peter J. 
Pugh, Philip A. Read, Simon P. Fynn, David P. Dutka, Addenbrooke’s 
Hospital, Cambridge, United Kingdom, Papworth Hospital, 
Cambridge, United Kingdom
Learning Objective: to undestand the impact of th RV lead position 
on CRT response
1024-135 Effect of Biventricular and Right Ventricular Pacing 
on Coronary Flow Reserve in Responders and Non-
Responders to Cardiac Resynchronization Therapy
Spyridon Deftereos, Georgios Giannopoulos, Charalambos 
Kossyvakis, Konstantinos Raisakis, Vasiliki Panagopoulou, Olga 
Ntzouvara, Andreas Theodorakis, Vlasios Pyrgakis, Athens General 
Hospital “G. Gennimatas”, Athens, Greece
Learning Objective: evaluata the effect of CRT on coronary flow 
reserve
1024-136 Right Ventricular Outflow Tract Pacing Brings 
Favorable Cardiac Output in comparison with Mid-
ventricular or Apical Pacing
Yasutaka Hirayama, Hokkaido Cardiovascular Hospital, Sapporo, 
Japan, Asahikawa Medical College, Asahikawa, Japan
Learning Objective: know the beneficial effect of RVOT in 
comparison with RVAP and RVMS.
1025 ELECTROCARDIOGRAPHIC PARAMETERS EFFECT 
ON CARDIAC PACING
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1025-138 Recovery of Atrioventricular Nodal Function 
After Pacemaker Placement for High Grade 
Atrioventricular Block After Valve Surgery
Ashwani Sastry, A. Garvey Rene, James Horowitz, George Thomas, 
Christopher F. Liu, Bruce B. Lerman, Steven M. Markowitz, Weill 
Medical College of Cornell University, New York, NY
Learning Objective: Describe the prevalence of long-term AV block in 
patients undergoing PPM implantation for AV dysfunction after valve 
surgery.
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1078 CLINICAL ELECTROPHYSIOLOGY--
SUPRAVENTRICULAR ARRHYTHMIAS
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1078-120 Effect of Age and Renal Function on the Risks 
of Stroke and Major Bleeding with Dabigatran 
Compared to Warfarin: An Analysis from the RE-LY 
Study
Jeff S. Healey, John Eikelboom, Lars Wallentin, Michael D. 
Ezekowitz, Stuart J. Connolly, Paul Reilly, Cameron D. Joyner, Basil 
S. Lewis, Ellison Themeles, Salim Yusuf, McMaster University, 
Hamilton, ON, Canada
Learning Objective: Understand the impact of age and renal function 
on the effectiveness of Dabigatran
1078-121 Efficiency of CHADS2 Scoring System in Prediction 
of Thromboembolic Risk: 10-Year Survey of Over 
3000 Studies
Hirad Yarmohammadi, Tristan Klosterman, Brandon Varr, Bruce 
Lindsey, Andrew Zurick, Kevin Shrestha, Wai Hong Wilson Tang, Allan 
L. Klein, Cleveland Clinic Foundation, Cleveland, OH
Learning Objective: Describe the limitation of CHADS2 scoring 
system in assessing thromboembolic risk in patient with atrial 
fibrillation
1078-123 How Does Left Atrial Appendage Occlusion Using 
the WATCHMAN Device Compare to Dabigatran for 
Reducing Thromboembolic Events in Patients with 
Nonvalvular Atrial Fibrillation?
Sanjay Kaul, Eugenio Cingolani, Michael Shehata, George A. 
Diamond, Cedars-Sinai Medical Center, Los Angeles, CA
Learning Objective: Indirectly compare the effect of left atrial 
appendage occlusion by WATCHMAN device versus dabigatran, 
an oral direct thrombin inhibitor, on thromboembolic events in 
nonvalvular atrial fibrillation
1078-124 Dabigatran Versus Warfarin In Patients With Atrial 
Fibrillation - An Analysis Of Patients Undergoing 
Cardioversion
Meghashyam J. Koti, Amit Parekh, Stuart J. Connolly, Lars Wallentin, 
Paul A. Reilly, Salim Yusuf, Rangadham Nagarakanti, Janice Pogue, 
Gregory C. Flaker, Michael D. Ezekowitz, Lankenau Institute for 
Medical Research, Wynnewood, PA, Population Health Research 
Institute, McMaster University and Hamilton Health Sciences, 
Hamilton, ON, Canada
Learning Objective: Evaluate the safety and efficacy of dabigatran 
compared to warfarin in patients undergoing cardioversion for atrial 
fibrillation
1026-147 The Effect of Cardiac Resynchronization Therapy on 
Cerebral Blood Flow
Rutger van Bommel, Nina Ajmone Marsan, Hille Koppen, Victoria 
Delgado, Carel JW Borleffs, Claudia Ypenburg, Matteo Bertini, 
Martin J. Schalij, Jeroen J. Bax, Leiden University Medical Center, 
Leiden, The Netherlands
Learning Objective: define changes in cerebral blood flow in relation 
to changes in LV function after CRT
1026-148 Pre-Implant Left Ventricular Dilation Is an Important 
Predictor of Response in Patients Undergoing 
Cardiac Resynchronization Therapy
Jack Rickard, Eiran Z. Gorodeski, Bryan Baranowski, Daniel Sraow, 
Richard Grimm, Wilson H. Tang, David O. Martin, Bruce L. Wilkoff, 
Eileen Hsich, Cleveland Clinic, Cleveland, OH
Learning Objective: Identify patients likely to derive the most 
response from cardiac resynchronization therapy.
1026-149 Gender Differences in Surface Electrocardiographic 
Characteristics and Left Ventricular Remodeling 
in Heart Failure Patients With Cardiac 
Resynchronization Therapy
Dat Nguyen, Mahesh Manne, Niraj Varma, Patrick Tchou, Cleveland 
Clinic, Cleveland, OH
Learning Objective: Identify gender differences in 
electrocardiographic parameters in patients with CRT
1026-150 The Impact of Improvement of Mitral Regurgitation 
on Long Term Clinical Outcomes in Patients 
Undergoing Cardiac Resynchronization Therapy.
Kenji Ando, Satoshi Shizuta, Takeshi Arita, Riki Fujii, Kouichi Inoue, 
Takeshi Kimura, Takaaki Isshiki, Masakiyo Nobuyoshi, Cubic 
Investigators, Kokura Memorial Hospital, Kitakyushu, Japan
Learning Objective: Understand patients with improvement of mitral 
regurgitation after cardiac resynchronization therapy had better long 
term clinical outcomes than patients without improvement of MR.
1026-152 Gender Similarities in Survival Following Cardiac 
Resynchronization Therapy Despite Differences in 
Patient Characteristics
Stephanie C. Haberman, Evan C. Adelstein, Hidekazu Tanaka, 
Olusegun Oyenuga, Phillip Habib, John Gorcsan, III, University of 
Pittsburgh, Pittsburgh, PA
Learning Objective: demonstrate that gender does not affect the 
long term survival of patients after CRT
1026-153 Left Ventricular Dyssynchrony, Left Ventricular Lead 
Position and Myocardial Scar: Long-term Survival 
Predictors of Ischemic Heart Failure Patients After 
Cardiac Resynchronization Therapy
Victoria Delgado, Rutger J. van Bommel, Matteo Bertini, CT Arnold 
Ng, C.Jan Willem Borleffs, Nina Ajmone Marsan, Gaetano Nucifora, 
Nico RL van de Veire, Claudia Ypenburg, Eduard R. Holman, Ernst 
E. van der Wall, Martin J. Schalij, Jeroen J. Bax, Leiden University 
Medical Center, Leiden, The Netherlands
Learning Objective: demonstrate
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1079-131 Mechanistic Insights, Results of Catheter Ablation, 
and Risk Factors for Atrial Tachycardia after 
Ablation of Atrial Fibrillation: Ostial Pulmonary 
Veins Ablation, Circumferential Pulmonary Veins 
Ablation and Ganglionated Plexi Ablation
Evgeny Pokushalov, Alexander Romanov, Sergey Artemenko, Pavel 
Shugaev, Nataliya Shirokova, Alex Turov, State Research Institute of 
Circulation Pathology, Novosibirsk, Russian Federation
Learning Objective: These discoveries allow us to assume that the 
location of the AT gap may be related with the complex anatomy 
of the LA and most cases of AT can be prevented by linear lesions 
limitation
1079-132 The Impact of Electrical and Structural Remodeling 
on Outcomes in Patients Undergoing Catheter 
Ablation of Persistent Atrial Fibrillation
Kentaro Yoshida, Amir B. Rabbani, Hakan Oral, Eric Good, Matthew 
Ebinger, Thomas Crawford, Srikar Veerareddy, Sreedhar Billakanty, 
Wai S. Wong, Krit Jongnarangsin, Frank Pelosi, Frank Bogun, Fred 
Morady, Aman Chugh, University of Michigan, Ann Arbor, MI
Learning Objective: demonstrate that AF frequency is a more robust 
predictor of long-term outcome after catheter ablation of persistent 
AF as compared to LA volume.
1079-133 Atrial Fibrillation Ablation-Induced Scar with Left 
Atrial Debulking Does Not Hinder the Reverse 
Remodeling of Left Atrium
Suman Kuppahally, Troy Badger, Nazem Akoum, Nathan Burgon, 
Eugene Kholmovski, Nassir F. Marrouche, University of Utah, Salt 
Lake City, UT
Learning Objective: Demonstrate that atrial fibrillation ablation scar 
does not hinder the reverse remodeling of left atrium
1079-135 Reverse Remodeling of Left Atrium After Catheter 
Ablation of Atrial Fibrillation in Early and Advanced 
Stages of Left Atrial Structural Remodeling by 
Delayed Enhancement-MRI
Suman Kuppahally, Nazem Akoum, Troy Badger, Nathan S. 
Burgon, Dennis Parker, Thomas S. Haslam, Rob MacLeod, Eugene 
Kholmovski, Chris McGann, Nassir F. Marrouche, University of Utah, 
Salt Lake City, UT
Learning Objective: Demonstrate reverse remodeling of left atrium 
after catheter ablation of atrial fibrillation
1079-136 Cryoballoon Ablation of Paroxysmal 
Atrial Fibrillation Guided by Intracardiac 
Echocardiography: Prediction of Acute Success by a 
Non-Fluoroscopic Imaging Technique
Georg Nölker, Johannes Heintze, Klaus J. Gutleben, Bogdan G. 
Muntean, Ameera Yalda, Vanessa Pütz, Dieter Horstkotte, Jürgen Vogt, 
Department of Cardiology, Heart and Diabetes Center North Rhine-
Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany
Learning Objective: describe how to identify cryo balloon pulmonary 
vein occlusion
1078-125 Zasp1-D117N On Z-line Decreases HNav1.5 
Function In A Dcm Subject With Conduction 
Disturbances
Yutao Xi, Tomohiko AI, Zhaohui Li, Geru Wu, Enkhsaikhan Purevjav, 
Shahrzad Abbasi, Jie Cheng, Matteo Vatta, Electrophysiology 
Research Laboratory, Texas Heart Institute/St. Luke’s Episcopal 
Hospital, Hoston, TX, Pediatric Cardiology, Texas Children’s 
Hospital/Baylor College of Medicine, Houston, TX
Learning Objective: elucidate the role of ZASP1-D117N in 
regulating the cardiac sodium channel, which is critically involved in 
conduction system diseases.
1078-126 Calcium Overload is Potentially the Main Cause of 
Cardiomyocyte Death after Heavily Infecting with 
Adv-hHCN4
Yong-Fu Xiao, Alena Nikolskaya, Lepeng Zeng, Xiaohong Qiu, 
Deborah A. Jaye, Vinod Sharma, Daniel C. Sigg, Medtronic, Inc., 
Mounds View, MN
Learning Objective: Demonstrate that hHCN4 overexpression in 
cultured cardiomyocytes creates biopacemaker activities, but may 
cause cell death. Adding specific channel inhibitors can prevent the 
toxicity.
1078-127 Cardiac Phenotyping the TASK-1 Deficient Mouse
Birgit C. Donner, Martina Schullenberg, Ulrich Decking, William 
Wisden, Klaus G. Schmidt, Department of Pediatric Cardiology, 
Duesseldorf, Germany, Imperial College London, London, United 
Kingdom
Learning Objective: distinguish the effect of TASK-1 deficiency on 
repolarisation of the cardiac action potential detected by measuring 
monophasic action potential duration and analyzing surface ECGs.
1079 CLINICAL ELECTROPHYSIOLOGY--
SUPRAVENTRICULAR ARRHYTHMIAS
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1079-129 Risk of Esophageal Injury in a standardized Ablation 
Cohort undergoing Atrial Fibrillation Ablation
Martin Martinek, Christian Meyer, Said Hassanein, Rainer Schoeﬂ, 
Hans-Joachim Nesser, Helmut Purerfellner, Elisabethinen University 
Teaching Hospital, Linz, Austria
Learning Objective: Identify patients at higher risk for esophageal 
injury during radiofrequency ablation of atrial fibrillation.
1079-130 Women Have a Higher Complication Rate When 
Undergoing Ablation for Atrial Fibrillation
Aysha Arshad, Naga Vamsi Garikipati, VijayaPraveena Paruchuri, 
Akshay Avula, Suneet Mittal, Jonathan S. Steinberg, St. Luke’s and 
Roosevelt Hospitals, New York, NY
Learning Objective: Gender differences in AF ablation outcomes
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1080-143 Should Anti-arrhythmics Be Held Prior to Atrial 
Fibrillation Ablation?
Jonathan W. Dukes, Karuna Chilukuri, Daniel Scherr, Joseph E. 
Marine, Ronald D. Berger, Saman Nazarian, Alan Cheng, David 
Spragg, Hugh Calkins, Charles A. Henrikson, The Johns Hopkins 
Hospital, Baltimore, MD
Learning Objective: Evaluate the impact of periprocedural 
antiarrhythmic agents on the outcomes of atrial fibrillation ablation.
1080-144 Long Term Efficacy and Impact of Balloon Size in 
Antral Cryo Isolation of Pulmonary Veins
Juergen Vogt, Johannes Heintze, Georg Nölker, Klaus J. Gutleben, 
Ameera Yalda, Vanessa Pütz, Dieter Horstkotte, Department of 
Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr 
University Bochum, Bad Oeynhausen, Germany
Learning Objective: evaluate the efficacy of cryoballoon ablation and 
the impact of different balloon sizes
1081 CLINICAL ELECTROPHYSIOLOGY--
SUPRAVENTRICULAR ARRHYTHMIAS
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1081-146 The Conversion of Paroxysmal or Initial Onset Atrial 
Fibrillation with Oral Ranolazine: Implications for 
“Pill in the Pocket” Approach in Structural Heart 
Disease
David K. Murdock, James A. Reiffel, Jeffrey W. Kaliebe, German 
Larrain, Cardiovascular Associates of Northern Wisconsin, S.C., 
Wausau, WI, CaRE Foundation, Inc., Wausau, WI
Learning Objective: Describe our experience using oral ranolazine 
as a “pill in the pocket” agent for the treatment of episodes of 
atrial fibrillation
1081-147 Impact of Treatment Strategies on Clinical 
Outcomes of Atrial Fibrillation Patients with Thyroid 
Disease
Sanjeev Saksena, April Slee, Tina Liu, Ankush Verma, Snehal 
Rathod, Electrophysiology Research Foundation, Warren, NJ, UMDNJ-
RWJ Medical School, New Brunswick, NJ
Learning Objective: Evaluate the impact of treatment strategies on 
outcomes in patients with atrial fibrillation and thyroid disease
1081-148 Impact of Individual Treatment Strategies on 
Composite and Individual Cardiovascular Outcomes 
in the AFFIRM trial
April Slee, Snehal Rathod, Ankush Verma, Tina Liu, Sanjeev 
Saksena, Electrophysiology Research Foundation, Warren, NJ, 
UMDNJ-RWJ Medical School, New Brunswick, NJ
Learning Objective: Assess clinical outcomes after atrial fibrillation 
treatment strategies from an evidence based viewpoint
1080 CLINICAL ELECTROPHYSIOLOGY--
SUPRAVENTRICULAR ARRHYTHMIAS
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1080-137 Fluoroscopy-Free Ablation of Paroxysmal and 
Persistent Atrial Fibrillation
Georg Nölker, Klaus J. Gutleben, Johannes Heintze, Jürgen Homberger, 
Ameera Yalda, Vanessa Pütz, Dieter Horstkotte, Jürgen Vogt, 
Department of Cardiology, Heart and Diabetes Center North Rhine-
Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany
Learning Objective: minimize radiation exposure during pulmonary 
vein isolation
1080-138 A Novel Catheter Ablation System for Atrial 
Fibrillation Using Unipolar and Bipolar 
Radiofrequency Energy - Single-Center Report on 
100 Consecutive Patients
Thomas Deneke, Marc Horlitz, Ron Haberkorn, Annely Bastian, 
Kathrin Bünz, Markus Pässler, Beatrix Reinartz, Rainer Lehmann, 
Wolfgang Meuser, Dong-In Shin, Academic Heart Center Cologne, 
Cologne, Germany
Learning Objective: Using a novel ablation system for atrial fibrillation
1080-140 Acute Effects and Long-Term Outcome of 
Ganglionated Plexi Ablation for Chronic Atrial 
Fibrillation
Evgeny Pokushalov, Alexander Romanov, Sergey Artemenko, Pavel 
Shugaev, Vitaliy Shabanov, Alex Turov, Nataliya Shirokova, State Research 
Institute of Circulation Pathology, Novosibirsk, Russian Federation
Learning Objective: We demonstrated that ganglionated plexi 
ablation in chronic AF leads to acute AF termination in 23.6% and 
long-term maintenance of sinus rhythm in 71.9% of cases.
1080-141 Cardiovascular MRI is Equally Effective as 
Transesophageal Echocardiogram in Evaluation 
of Left Atrial Appendage Thrombus in Atrial 
Fibrillation: A Strategy for Pulmonary Vein Isolation
Sukhraj Balhan, Robert WW Biederman, June A. Yamrozik, Ronald 
B. Williams, Mark Doyle, Saundra Grant, Sandeep Anreddy, Vikas K. 
Rathi, The Center for CVMRI, The Gerald McGinnis Cardiovascular 
Institute at Allegheny General Hospital, Pittsburgh, PA
Learning Objective: Demostrate the use of non-contrast and 
contrast cardiac MRI for evaluation of atrial thrombus in patients 
with atrial fibrillation
1080-142 Left Atrial Appendage Far Field Potentials 
Mimicking Left Superior Pulmonary Vein Potentials: 
Does Proximity Matter?
Subba Reddy Vanga, Mazda Biria, Jayasree Pillarisetti, Rajeshwar 
Guda, Mike Feldkamp, Thomas Rosamond, James L. Vacek, 
Buddhadeb Dawn, Dhanunjaya Lakkireddy, University of Kansas 
Hospital, Kansas City, KS, University of Kansas Medical Center, 
Kansas City, KS
Learning Objective: describe how far field potentials in left superior 
pulmonary vein during pulmonary vein isolation can be predicted 
from preablation cardiac CT scan measurements
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1133-121 Risk Factors for Recurrent Syncope in Long QT 
Syndrome
Judy F. Liu, Christian Jons, Scott McNitt, Ilan Goldenberg, Ming Qi, 
Wojciech Zareba, Jennifer L. Robinson, Arthur J. Moss, University of 
Rochester Medical Center, Rochester, NY
Learning Objective: Identify the predictors for recurrent syncope in 
Long QT Syndrome
1133-123 Can Sleep-Disordered Breathing be an Independent 
Predictor of Malignant Ventricular Arrhythmias in 
Patients with Heart Failure?
Naoki Serizawa, Dai Yumino, Daigo Yagishita, Yoshimi Yagishita, 
Koichiro Ejima, Tetsuyuki Manaka, Atsushi Takagi, Morio Shoda, 
Nobuhisa Hagiwara, Tokyo Women’s Medical University, Tokyo, Japan
Learning Objective: identify sleep-disordered breathing as a risk of 
life-threatening ventricular arrhythmia in patients with heart failure
1133-124 High Frequency of Electrocardiographic 
Abnormalities at Early Repolarization Phase in 
Idiopathic Ventricular Fibrillation
Yuka Hayashi, Hiroshi Watanabe, Kazuki Okamura, Masahito Sato, 
Yukio Hosaka, Hiroshi Furushima, Masaomi Chinushi, Hirotaka Oda, 
Masaaki Okabe, Yoshifusa Aizawa, Division of Cardiology, Niigata 
University School of Medicine, Niigata, Japan, Niigata Idiopathic 
Ventricular Fibrillation Study Group, Niigata, Japan
Learning Objective: evaluate ECG characteristics assocaited with 
idiopathic ventricular fibrillation.
1133-125 Focal Atrial and Ventricular Tachycardias from the 
Mitral Annulus: Common Mechanism?
Sei Iwai, Jeffrey H. Chung, Ryan J. Broderick, Steven M. Markowitz, 
Christopher F. Liu, Bruce B. Lerman, Stony Brook University Medical 
Center, Stony Brook, NY, Cornell University Medical Center, New 
York, NY
Learning Objective: describe the clinical characteristics of focal 
mitral annular atrial and ventricular tachycardias
1133-126 Cavo-tricuspid Isthmus Ablation by Novel 
Photodynamic Laser Catheter in Swine Heart in vivo
Shunichiro Miyoshi, Arisa Itoh, Takuro Kajihara, Mizuki Ide, Hajime 
Suenari, Mei Takahashi, Takehiro Kimura, Kojiro Tanimoto, Kotaro 
Fukumoto, Seiji Takatsuki, Toshiaki Satoh, Yasuhiko Futami, Satoshi 
Ogawa, Tsunenori Arai, Keio University School of Medicine, Tokyo, 
Japan, Keio University School of Science and Technology, Tokyo, 
Japan
Learning Objective: To learn feasibility of novel photodynamic laser 
catheter ablation in vivo.
1133-127 Does Parasympathetic-mediated Change in 
Restitution and Alternans Characteristics Contribute 
to Vagal Atrial Fibrillation?
David Gordon, Rishi Arora, Roger Villuendas, Brandon Beneﬁeld, 
Kathy Harris, Rodney Greene, Greg Shade, Jeffrey J. Goldberger, 
Alan H. Kadish, Jason Ng, Northwestern University, Chicago, IL
Learning Objective: describe the important contributors to vagally 
mediated atrial fibrillation.
1081-149 Elevated BNP Predicts New Onset Atrial Fibrillation 
Complicating Acute Myocardial Infarction: Analysis 
of the Triumph Registry
Susmita Parashar, Jonathan J. Langberg, Viola Vaccarino, Kimberly 
J. Reid, John Spertus, Michael S. Lloyd, Emory University, Atlanta, 
GA, Mid America Heart Institute, Kansas City, MO
Learning Objective: interpret the role of biomarkers in predicting 
new atrial fibrillation after acute myocardial infarction.
1081-150 Serum Uric Acid as a Predictor of Incident 
Atrial Fibrillation: The Atherosclerosis Risk in 
Communities Study
Leonardo Tamariz, Sunil Agarwal, Elsayed Soliman, Alanna 
Chamberlain, Ronald Prineas, Aaron Folsom, Marietta Ambrose, 
Alvaro Alonso, University of Miami, Miami, FL
Learning Objective: Describe the relationship between uric acid and 
atrial fibrillation
1081-152 N-3 Poly-Unsaturated Fatty Acids for the 
Prevention of Atrial Fibrillation Recurrence After 
Electrical Cardioversion of Chronic Persistent 
Atrial Fibrillation. A Randomized, Double-Blind, 
Multicentre Study.
Leopoldo Bianconi, Leonardo Calò, Silvia Mennuni, Luca Santini, 
Paolo Morosetti, Paolo Azzolini, Giuseppe Barbato, Francesco 
Biscione, Paolo Romano, Massimo Santini, Rome, Italy
Learning Objective: know that n-3 poly-unsaturated fatty acids 
are not useful for prevention of atrial fibrillation recurrece after 
electrical cardioversion of chronic persistent atrial fibrillation
1081-153 Prevention of Recurrent Atrial Fibrillation with 
Angiotensin-Converting Enzyme Inhibitors or 
Angiotensin Receptor Blockers: A Meta-analysis of 
Randomized Trials
Rohit Bhuriya, Updesh Bedi, Amol Bahekar, Janos Molnar, Mukesh 
Singh, Pawan Patel, Param Puneet Singh, Sandeep Khosla, Rohit 
Arora, The Chicago Medical School, North Chicago, IL
Learning Objective: Identify the role of angiotensin blockade in the 
prevention of recurrent atrial fibrillation
1133 CLINICAL ELECTROPHYSIOLOGY--VENTRICULAR 
ARRHYTHMIAS: RISK STRATIFICATION
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1133-120 Risk Factors of Self-Terminating and Perpetuating 
Ventricular Tachyarrhythmias in Post-Infarction 
Patients with Moderately Depressed Left Ventricular 
Function, a CARISMA Sub-Analysis
Juha Perkiomaki, Poul-Erik Bloch Thomsen, Marc Messier, Heikki 
Huikuri, the CARISMA Study Investigators, Dept. of Internal 
Medicine, University of Oulu, Oulu, Finland
Learning Objective: identify differences in electrophysiological 
substrate and modifiers of arrhythmias between self-terminating 
and perpetuating ventricular tachyarrhythmias
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1134-135 Atrial Fibrillation After Lung Transplantation: 
Incidence, Predictors and Long-Term Implications
Santiago Garcia, Mariana Canoniero, Srinivasan Sattiraju, Wayne 
Adkisson, Lyn Chen, Marshall Hertz, David G. Benditt, Univerity of 
Minnesota, Minneapolis, MN
Learning Objective: To describe the natural history of atrial 
fibrillation after lung transplantation
1134-136 Significance of Cardiac Troponin T levels in 
Supraventricular Tachycardia
Junji Kawagoe, Takuroh Imamura, Keishi Kubo, Sumiharu Sakamoto, 
Erika Nagatomo, Yunosuke Matsuura, Takeshi Ideguchi, Toshihiro 
Tsuruda, Hisamitsu Onitsuka, Riichiro Kawamoto, Tetsunori 
Ishikawa, Toshiro Nagoshi, Haruhiko Date, Kazuo Kitamura, ﬁrst 
department of internal medicine,faculty of medicine,university of 
miyazaki, miyazaki, Japan
Learning Objective: To demonstrate the relationship between 
supraventricular arrhythmia and atrial remodeling
1135 CLINICAL ELECTROPHYSIOLOGY--
SUPRAVENTRICULAR ARRHYTHMIAS
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1135-137 CHADS
2
 score Predicts the Occurrence of Death, 
Stroke and Heart Failure in Patients with Atrial 
Fibrillation: a single-center cohort study
Sylvie LANG, Stephane EDERHY, Louise BOYER-CHATENET, Ghislaine 
DUFAITRE, Emanuele Di ANGELANTONIO, Catherine MEULEMAN, 
Nabila HADDOUR, Emmanuelle BERTHELOT, Fanny DOUNA, Nadia 
AISSAOUI, Franck BOCCARA, Ariel COHEN, hopital saint Antoine 
service de cardiologie, Paris, France
Learning Objective: describe the markers of thrombo embolism
1135-138 Underlying Coronary Artery Disease Potentiates 
the Antiarrhythmic Efficacy of Dofetilide on Atrial 
Fibrillation
Venkata V. Bavikati, J. Ryan Jordan, Pankaj Manocha, Jonathan J. 
Langberg, Richard N. Vest, III, Heather L. Bloom, Michael S. Lloyd, 
Emory University School of Medicine, Atlanta, GA
Learning Objective: To identify the predictors of effectiveness 
of dofetilide in maintaining sinus rhythm in patients with atrial 
fibrillation
1135-140 Do All Patients With Non Valvular Atrial Fibrillation 
And A Chads
2
 Scoring System = 1 Patients Have 
The Same Risk Of Cardiovascular Events : The 
Eastern-paris Cohort-study Of Atrial Fibrillation ?
stephane ederhy, Louise Boyer-Chatenet, Sylvie LAng, Ghislaine 
Dufaitre, Catherine Meuleman, Nabila Haddour, Emmanuelle 
Berthelot, Fanny Douna, Nadia Aissaoui, Franck Boccara, Emmanuel 
Di Angelantonio, Ariel Cohen, Hopital Saint Antoine, Paris, France
Learning Objective: evaluate stroke risk stratification
1134 CLINICAL ELECTROPHYSIOLOGY--
SUPRAVENTRICULAR ARRHYTHMIAS
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1134-129 High Success and Low Recurrence Rates after 
Cryoablation for AVNRT in Children - a Multi-Center 
Experience
Srikant Das, Ian Law, Nicholas Von Bergen, MacDonald Dick, David 
J Bradley, Susan Etheridge, Elizabeth Saarel, Patrick Frias, Margaret 
Strieper, Peter Fischbach, Children’s Healthcare of Atlanta, Sibley 
Heart Center, Atlanta, GA
Learning Objective: Recognize the safety and efficacy of 
cryoablation for treatment of AVNRT in children.
1134-130 Difference in Ventriculoatrial Intervals During 
Entrainment and Tachycardia: A Simpler Method in 
Distinguishing Supraventricular Tachycardias With 
Long Ventriculoatrial Intervals
Esteban Gonzalez-Torrecilla, Angel Arenal, Francisco Javier García-
Fernández, Miguel Angel Arias, Felipe Atienza, Tomás Datino, 
Leonardo Atea, Marta Pachón, David Calvo, Angel Miracle, Francisco 
Fernández-Avilés, Hospital General Universitario Gregorio Marañón, 
Madrid, Spain
Learning Objective: Distinguish the main mechanism of PSVT in the 
EP lab
1134-131 Predictors of Sudden Death in Patients with Wolff-
Parkinson-White Syndrome. A Prospective Follow-
Up Study of 201 Symptomatic WPW Patients 
Presenting with Malignant Arrhythmias
Vincenzo Santinelli, Andrea Radinovic, Giuseppe Ciconte, Gabriele 
Vicedomini, Pasquale Vergara, Gabriele Paglino, Cristiano Ciaccio, 
Stefania Sacchi, Massimo Saviano, Amarild Cuko, Valerio Giordano, 
Carlo Pappone, San Raffaele University-Hospital, Milan, Italy
Learning Objective: Identify symptomatic patients with WPW 
syndrome at risk of sudden death
1134-132 Minimally Invasive Surgical MAZE is Inadequate 
Without Intra-operative Electrophysiology Testing
Yosef Kahn, Kathleen Benson, Francisco Gonzalez, Kenneth B. 
Desser, Kenneth Fang, Wilber Su, Banner Good Samaritan Medical 
Center, Phoenix, AZ, Veterans Affair Medical Center, Phoenix, AZ
Learning Objective: Evaluate the importance of EP testing intra-
operatively in minimally invasive surgical MAZE.
1134-133 Short and Long Term Mortality in New Onset Atrial 
Fibrillation after Coronary Artery Bypass Graft: A 
Sytematic Review and Meta-Analysis
Roop K. Kaw, Adrian V. Hernandez, Iqbal Masood, Walid Saliba, A. 
Marc Gillinov, Eugene H. Blackstone, Cleveland Clinic, Cleveland, OH
Learning Objective: Identify modifiable risk factors of New Onset 
Atrial Fibrillation after Coronary Artery Bypass Grafting
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1136-148 General Anesthesia Reduces the Prevalence of 
Pulmonary Vein Reconnection during Repeat 
Ablation when Compared to Conscious Sedation: 
Results from a Randomized Study
Luigi Di Biase, J. David Burkhardt, Prasant Mohanty, Javier Sanchez, 
Rodney Horton, Shane Bailey, Pasquale Santangeli, Vladimir 
Astudillo, Claude S. Elayi, Conor Barrett, Karla Wolker, Jacquie Kim, 
Kai Zedlitz, Dimpi Patel, Mitra Mohanty, Steven Hao, Richard Hongo, 
Salwa Beheiry, Andrea Natale, St. David’s Medical Center, Austin, TX
Learning Objective: evalute if the use of general aneshtesia during 
catneter ablation of atrial fibrillation is associated with a lower 
pulmonary vein reconnection when compared to conscious sedation
1136-149 Remote Magnetic Navigation for Ablation of 
Atrial Fibrillation with the Open Irrigation Ablation 
Catheter: Acute Endpoint with Circumferential 
Ablation versus Circular Mapping Guided Ablation
Luigi Di Biase, J. David Burkhardt, Dhanunjay Lakkireddy, 
Javier Sanchez, Jayasree Pillarisetti, Rodney Horton, G. Joseph 
Gallinghouse, Shane Bailey, Prasant Mohanty, Mitra Mohanty, 
Richard Hongo, Steven Hao, Salwa Beheiry, Pasquale Santangeli, 
Vladimir Astudillo, Dimpi Patel, Claude S. Elayi, Conor Barrett, 
Andrea Natale, St. David’s Medical Center, Austin, TX
Learning Objective: determine if magnetic robotic navigation 
with open irrigated catheter is effective or not without achieving 
electrical isolation of the pulmonary vein
1136-150 Intravenous Corticosteroid Use Is Associated with 
Reduced Early Recurrence of Atrial Fibrillation 
Following Radiofrequency Catheter Ablation
Guru M. Krishnan, Nitesh A. Sood, Craig I. Coleman, Jeffrey Kluger, 
Moise Anglade, Christopher A. Clyne, University of Connecticut, 
Hartford, CT, Hartford Hospital, Hartford, CT
Learning Objective: Describe the effect of intravenous corticosteroid 
use on early recurrence of atrial fibrillation (ERAF) following 
successful radiofrequency catheter ablation for AF.
1136-152 Catheter Ablation of Atrial Fibrillation Is Associated 
with Significant Reduction in Left Atrial And 
Pulmonary Vein Dimensions
Shahriar Iravanian, Robert L. Eisner, Mikhael F. El-Chami, Robert E. 
O’Donnell, Jr., Emory University, Atlanta, GA
Learning Objective: In this study, we describe the anatomical 
changes in the heart after catheter ablation of atrial fibrillation as 
measured by cardiac MRI.
1136-153 The Prevalence and Clinical Significance of Carina-
LA Conduction after Successful Pulmonary Vein 
Isolation for Atrial Fibrillation
Takigawa Masateru, Yukihiko Yoshida, Takashi Yamamoto, Kiyotake 
Ishikawa, Natsuo Inoue, Yasushi Tatematsu, Mamoru Nanasato, 
Naoya Tsuboi, Haruo Hirayama, Japanese Red Cross Society Nagoya 
Daini Hospital, Nagoya, Japan
Learning Objective: know the clinical significance of carina-left atrial 
conduction after successful pulmonary vein isolation
1135-141 Left Atrial Expansion Index in Patients with 
Atrial Fibrillation Is a Predictor of Sinus Rhythm 
Maintenance after Cardioversion
Malini Govindan, Anatoli Kiotsekoglou, Velislav Batchvarov, Samir 
K. Saha, Kate Dougal, Evaun Teoh, Lars-Ake Brodin, John Camm, St 
Georges University of London, London, United Kingdom
Learning Objective: Predictive value of LA expansion index in AF
1135-142 Melphalan Induced Atrial Arrhythmias: Incidence 
and Risk Factors
Victor Feliz, Saleem Saiyad, Sumana M. Ramarao, Hammad Khan, 
Maya Guglin, University of South Florida, Tampa, FL, H. Lee Mofﬁtt 
Cancer Center and Research Institute, Tampa, FL
Learning Objective: To determine which chemotherapeutic agent is 
more arrhythmogenic and therefore needs closer monitoring.
1135-143 The Ventricular Rate at Onset of Atrial Fibrillation 
Predicts Heart Failure Hospitalization and Mortality 
in Cardiac Resynchronization Patients
Bruce A. Koplan, Stan Weiner, Milan Seth, Paul W. Jones, Shelly A. 
Christman, Brigham and Women’s Hospital, Boston, MA
Learning Objective: identify CRT patients with AF who have an 
increased morbidity and mortality
1135-144 Genetic, but Not Conventional Risk Factors Predict 
Risk of Stroke or Transient Ischemic Attack in Lone 
Atrial Fibrillation
Edwin T. Zishiri, Peter Hanna, Michael Tchou, Diana Bauer, Robert C. 
Wirka, John Barnard, Jonathan Smith, David Van Wagoner, Mina K. 
Chung, Cleveland Clinic, Cleveland, OH
Learning Objective: Indentify the need for genetic epidemiology research 
to understand the risk predictors of stroke or TIA in lone atrial fibrillation
1136 CLINICAL ELECTROPHYSIOLOGY--
SUPRAVENTRICULAR ARRHYTHMIAS
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1136-146 A Novel Technique to Achieve Better Lesions in the 
Coronary Sinus: Safety And Feasibility
Luigi Di Biase, Daniel T. Wallace, Aaron P. Grogan, Dale J. Bergman, 
Narayan R. Raju, Prasant Mohanty, Andrea Natale, Texas Cardiac 
Arrhythmia Institute, Austin, TX
Learning Objective: identify a possible alterative way to isolate the 
coronary sinus during radiofrequency ablation
1136-147 The Strategy of Catheter Ablation for Persistent/
permanent Atrial Fibrillation in the Patients with 
Immediate Recurrence after Cardioversion
Koichi Inoue, Toshiya Kurotobi, Ryusuke Kimura, Yuko Toyoshima, 
Norihisa Ito, Katsuomi Iwakura, Cardiovascular Center, Sakurabashi-
Watanabe Hospital, Osaka, Japan
Learning Objective: identify the patients who do not need intensive 
left atrial modification at the ablation procedure for persistent atrial 
fibrillation
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1188-125 The Effect of ICD Replacement on the Requirement 
for Surgical Re-intervention due to Infectious and 
Non-Infectious Causes.
Joep Thijssen, C. Jan Willem Borleffs, Mihály K. de Bie, Johannes 
B. van Rees, Guido H. van Welsenes, Ernst E. van der Wall, Lieselot 
van Erven, Jeroen J. Bax, Suzanne C. Cannegieter, Martin J. Schalij, 
Leiden University Medical Center, Leiden, The Netherlands
Learning Objective: describe the requirement of pocket related 
surgical re-interventions and the effect of device replacement 
following ICD treatment
1188-126 Aggregate National Experience with the Wearable 
Cardioverter-Defibrillator Vest: Event Rates, 
Compliance and Survival
Mina K. Chung, Steven J. Szymkiewicz, Mingyuan Shao, Mark J. 
Niebauer, Bruce D. Lindsay, Patrick J. Tchou, Cleveland Clinic, 
Cleveland, OH
Learning Objective: To evaluate the compliance and effectiveness of 
the wearable cardioverter defibrillator
1188-127 Blood Pressure, BUN, Creatinine, Congestive Heart 
Failure and Cardiac Arrest (B2C3 Score) Predicts 
Procedure Mortality for Elective ICD Implantation: 
Data from the National ICD Registry (ICDR®)
David E. Haines, Jeptha P. Curtis, Yongfei Wang, Beaumont 
Hospitals, Royal Oak, MI
Learning Objective: Understand the predictors of complications 
after elective ICD implantation
1189 DEFIBRILLATION/IMPLANTABLE 
ANTIARRHYTHMIA DEVICES
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1189-129 Defibrillation Threshold Testing Does not Improve 
Overall Survival or Predict Clinical Outcomes: A 
Meta Analysis
Aditya S. Bharadwaj, Rajeev Aravindhakshan, Luis C. Afonso, Sony 
Jacob, Wayne State University, Detroit, MI
Learning Objective: describe the futility of Defibrillation Threshold 
Testing.
1189-130 Incidence and Predictors of Implantable 
Cardioverter-Defibrillator Therapies in Ambulatory 
Patients with Ventricular Assist Devices
Mehmet Aktas, Sushma Koneru, Abrar Shah, Samit Shah, Todd 
Massey, Leway Chen, David T. Huang, University of Rochester 
Medical Center, Rochester, NY
Learning Objective: determine the incidence of ICD therapies in 
patients with ventricular assist devices.
1188 DEFIBRILLATION/IMPLANTABLE 
ANTIARRHYTHMIA DEVICES
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1188-120 Exercise Training and Implantable Cardioverter 
Defibrillator Shocks in Patients with Heart Failure: 
Results from HF-ACTION
Jonathan P. Piccini, Anne S. Hellkamp, David J. Whellan, Stephan J. 
Ellis, Steven J. Keteyian, Lawton Cooper, William E. Kraus, Ileana 
L. Piña, Christopher M. O’Connor, Duke Clinical Research Institute, 
Durham, NC, Jefferson Medical College, Philadelphia, PA
Learning Objective: Describe arrhythmic outcomes in patients with 
heart failure who have an ICD and undergo exercise training.
1188-121 Relation between Renal Function and Response to 
Preventive Cardiac Resynchronization Therapy in 
MADIT-CRT
Ilan Goldenberg, Arthur J. Moss, Scott McNitt, Alon Barsheshet, 
Mary W. Brown, Wojciech Zareba, Marc A. Pfeffer, the MADIT-CRT 
Investigators, University of Rochester Medical Center, Rochester, NY, 
Brigham and Women’s Hospital, Boston, MA
Learning Objective: To evaluate the relationship between renal 
function and the benefit of preventive cardiac resynchronization 
therapy
1188-123 The Role of Different Types of Atrial Fibrillation on 
Appropriate and Inappropriate Device Therapy and 
Survival in Implantable Cardioverter Defibrillator 
Patients
Johannes B. Van Rees, C. Jan Willem Borleffs, Guido H. Welsenes, 
Enno T. van der Velde, Lieselot van Erven, Jeroen J. Bax, Martin J. 
Schalij, Leiden University Medical Center, Leiden, The Netherlands
Learning Objective: demonstrate the prognostic importance of atrial 
fibrillation in implantable cardioverter defibrillator recipients
1188-124 Risk Factors for Response to Cardiac 
Resynchronization Therapy in Patients with 
Ischemic and Nonischemic Cardiomyopathy from 
the MADIT-CRT Study
Alon Barsheshet, Ilan Goldenberg, Arthur J. Moss, Michael Eldar, 
David T. Huang, Scott McNitt, Mary W. Brown, Jeffrey J. Goldberger, 
Robert E. Goldstein, Claudio Schuger, Wojciech Zareba, James 
P. Daubert, Cardiology Division, University of Rochester Medical 
Center, Rochester, NY, Cardiology Division, Duke University Medical 
Center, Durham, NC
Learning Objective: Identify differences in clinical course and 
response to preventive CRT-D therapy between ischemic and 
nonischemic patients enrolled in MADIT-CRT
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1190 MAPPING AND ABLATION OF VENTRICULAR 
TACHYCARDIA: NEW INSIGHTS
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1190-137 Mapping and Ablation of Ventricular Arrhythmias 
Originating from Right Ventricular Papillary Muscles
Miki Yokokawa, Thomas Crawford, Timir S. Baman, Karl J. IIg, 
Sanjaya K. Gupta, Eric Good, Aman Chugh, Krit Jongnarangsin, 
Frank Pelosi, Jr, Hakan Oral, Fred Morady, Frank Bogun, Division 
of Cardiovascular Medicine, Cardiovascular Center, University of 
Michigan, Ann Arbor, MI
Learning Objective: identify the ventricular arrhythmias arising from 
the right ventricular papillary muscle
1190-138 Combined Endocardial And Epicardial 
Electroanatomic Mapping Of A Novel Porcine Infarct 
Model: A Comparison Of Navx And Carto
Roderick Tung, Shiro Nakahara, Rafael Ramirez, Chi Lai, Daniel 
Ennis, Michael Fishbein, Paul Finn, Kalyanam Shivkumar, UCLA 
Medical Center, Los Angeles, CA
Learning Objective: Evaluate the accuracy of electroanatomic 
mapping systems for ventricular scar mapping.
1190-140 Local Voltage Potentials Are Prerequisites for 
Outflow Tract Ectopy
Poul Erik Bloch Thomsen, Arne Johannessen, Christian Jons, Jorgen 
K. Kanters, Knud Saermark, Charles Antzelevitch, Peter Sogaard, 
Cardiology Department P, Gentofte University Hospital, Copenhagen, 
Denmark, Masonic Medical Research Laboratory, Utica, NY
Learning Objective: Identify and understand the mechanisms of 
local potentials at successful ablation sites for right ventricular 
outflow tract ectopy
1190-141 Externally-Irrigated Radiofrequency Ablation is Safer 
and more Effective than Non-Irrigated Ablation 
in the Aortic Cusp Region-Insights Provided by a 
Retrograde ICE-Guided Approach
Raveen R. Bazaz, Samir Saba, Brion Winston, University of 
Pittsburgh Medical Center, Pittsburgh, PA
Learning Objective: Understand ablation technology to use for aortic 
cusp ablation
1190-142 Limited Linear Ablation for Regional Scar Encircling 
to Treat Post-infarction Ventricular Tachycardia 
Using a Standardized Mapping and Ablation 
Approach
Thomas Deneke, Thomas Lawo, Dong-In Shin, Marc Horlitz, Andreas 
Mügge, Leif Bösche, Bernd Lemke, Academic Heart Center Cologne, 
Cologne, Germany
Learning Objective: Easy and effective ablation of post-ischemic 
ventricular tachycardia
1189-131 Inappropriate Implantable Cardioverter Defibrillator 
Shocks Increase Mortality
Johannes B. Van Rees, C. Jan Willem Borleffs, Mihály K. de Bie, 
Theo Stijnen, Lieselot van Erven, Jeroen J. Bax, Martin J. Schalij, 
Leiden University Medical Center, Leiden, The Netherlands
Learning Objective: demonstrate that inappropriate ICD shocks are 
associated with increased mortality in the ‘real’ world
1189-132 Implantable Cardiac Rhythm Devices are 
Associated with an Increased Risk of Sternal 
Wound Infection after Cardiac Surgery
Alireza Nazeri, James M. Wilson, Abdi Rasekh, Mohammad Saeed, 
Christopher Frank, Vei-Vei Lee, MacArthur Elayda, Ali Massumi, 
Mehdi Razavi, Texas Heart Institute at St. Luke’s Episcopal Hospital, 
Houston, TX, Houston, TX
Learning Objective: Describe the relationship between implanted 
cardiac rhythm devices (ICRDs) and sternal wound infection (SWI) 
after coronary artery bypass grafting (CABG).
1189-133 Experience With Fidelis Lead Extractions at a Single 
Academic Center
Jayasree Pillarisetti, Jillian Falbe, Raghuveer Dendi, Rhea Pimentel, 
Martin Emert, Dhanunjaya Lakkireddy, Loren Berenbom, University 
of Kansas Hospital, Kansas City, KS
Learning Objective: describe the experience of a single academic 
center with extraction of Fidelis leads
1189-135 Chronic Kidney Disease is a Significant Risk Factor 
of Pocket Hematoma Formation after Pacemaker 
and Implantable Cardioverter- Defibrillator 
Placement Independent of Anticoagulation and 
Antiplatelet Agents
Imdad Ahmed, William B. Nelson, Chad M. House, Ranjan Dahiya, 
Dennis W.X. Zhu, Regions Hospital,University of Minnesota, St.Paul, 
MN
Learning Objective: Identify the risk factors of pocket hematoma 
formation in patients with pacemaker and ICD placement
1189-136 Respiratory and Hepatic Impairment, in Addition 
to Renal Dysfunction, Up to One Week Prior to ICD 
Implantation Predicts Increased Mortality
Daniel Chong, Kah Leng Ho, Reginald Liew, Wee Siong Teo, Chi 
Keong Ching, National Heart Centre, Singapore, Singapore
Learning Objective: Identify predictors of mortality pre-ICD 
implantation
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1191-149 Does Previous Coronary Revascularization 
in Patients with an Implantable Cardioverter 
Defibrillator and Ischemic Cardiomyopathy Improve 
Outcomes?
Karlyn B. Huddy, Sanjeev P. Bhavnani, Craig I. Coleman, Danette 
Guertin, Ravi Yarlagadda, Christopher A. Clyne, Jeffery Kluger, 
Hartford Hospital, Hartford, CT
Learning Objective: Identify ischemic cardiomyopathy patient 
populations with implantable cardioverter defibrillators who 
demonstrate benefit in mortality and appropriate shock therapy 
after coronary revascularization.
1191-150 Living Wills for Defibrillators: Patient Perspectives 
on End of Life Handling of ICDs
James N. Kirkpatrick, Priya Sehgal, Rutuke Patel, Ralph J. Verdino, 
University of Pennsylvania, Philadelphia, PA
Learning Objective: describe the opinions of patients regarding end 
of life care of ICDs
1191-153 Should Defibrillation Threshold Be Tested in 
Patients With Cardiac Resynchronization Therapy-
Defibrillator Implantation?
Tahmeed A. Contractor, Yoav Michowitz, Tara Bourke, Kalyanam 
Shivkumar, University of California at Los Angeles/David Geffen 
School of Medicine, Los Angeles, CA, Michigan State University, 
East Lansing, MI
Learning Objective: Recognize that defibrillation testing in cardiac 
resynchronization therapy-defibrillator recipients is probably not 
needed and larger studies are required to justify its routine practice.
1243 ECG - ANATOMIC AND PHYSIOLOGIC 
CORRELATES
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1243-123 Usefulness of Electrocardiographic Parameters as 
Compared to Computed Tomography Measures of 
Left Atrial Volume Enlargement: From the ROMICAT 
Trial
Quynh A. Truong, Elizabeth M. Charipar, Leon Ptaszek, Carolyn Taylor, 
Joao D. Fontes, Matthias Kriegel, Thomas Irlbeck, Amir A. Mahabadi, 
Fabian Bamberg, Ron Blankstein, Thomas J. Brady, John T. Nagurney, 
Udo Hoffmann, Massachusetts General Hospital, Boston, MA
Learning Objective: determine which ECG parameter will have the 
greatest utility for detecting left atrial enlargement by CT.
1243-124 The Role of Three-Dimensional Electrocardiography 
in Identifying Left Ventricular Hypertrophy
Curtis J. Carothers, Terry D. Bauch, University of Texas Health 
Sciences Center at San Antonio, San Antonio, TX 
Learning Objective: recognize the value of 3-D ECG in the diagnosis 
of LVH
1190-143 Real Time Intracardiac Echocardiography and 
Electroanatomic Mapping in Patients with Post 
Infarction Ventricular Tachycardia
Chin Pang Chan, Hakan Oral, Frank Pelosi, Eric Good, Aman Chugh, 
Fred Morady, Frank Bogun, University of Michigan, Ann Arbor, MI
Learning Objective: Evaluate the value of real time intracardiac 
echocardiography to guide ablation of ventriuclar tachycardia in 
patients with ischaemic cardiomyopathy
1190-144 Complex Fractionated Atrial Electrograms in a Focal 
Model of Atrial Fibrillation: Are All CFAEs Significant 
in Perpetuating Atrial Fibrillation?
Aleksey Borodyanskiy, Jason Ng, Jeffrey J. Goldberger, Alan H. 
Kadish, Northwestern University, Feinberg School of Medicine, 
Chicago, IL
Learning Objective: Understand the potential limitation of using 
complex fractionated atrial electrograms (CFAE)s in electrogram-
guided radiofrequency ablation of atrial fibrillation.
1191 DEFIBRILLATION/IMPLANTABLE 
ANTIARRHYTHMIA DEVICES
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1191-146 Are Physicians Less Likely to Offer an Implantable 
Cardioverter Defibrillator to Women, Racial 
Minorities, and Older Patients?
Sana M. Al-Khatib, Gillian D. Sanders, Daniel D. Matlock, Sean 
O’Brien, Louise Zimmer, Fred A. Masoudi, Eric D. Peterson, Duke 
Clinical Research Institute, Durham, NC, University of Colorado, 
Denver, CO
Learning Objective: Learn about what physicians say they do in their 
practice in relation to ICD therapy
1191-147 Safety Outcomes in Patients with Implantable 
Cardioverter-Defibrillators and Permanent 
Pacemakers Undergoing Magnetic Resonance 
Imaging at 1.5-Tesla
Roshan Vatthyam, Matthew Cantrell, Michael D. Elliott, Richard I. 
Fogel, Eric N. Prystowsky, Saint Vincent Hospital; The Care Group, 
LLC, Indianapolis, IN
Learning Objective: identify a subset of pacemaker-non-dependent 
patients with ICDs or PPMs undergoing MRI with safe clinical 
outcomes at follow-up of > 6 months
1191-148 Nursing-Administered, Proceduralist-Directed 
Propofol Use: A Safe and Effective Sedation Option 
in Defibrillator Implantation
Sameh Sayfo, Kairav P. Vakil, Ahmad M. Alqaqa’a, Helen L. Flippin, 
Miriam R. Groh, Deepak Bhakta, Anil Yadav, Mithilesh K. Das, John 
C. Lopshire, John M. Miller, William J. Groh, Krannert Institute of 
Cardiology, Indiana University School of Medicine, Indianapolis, IN
Cardiac Arrhythm
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1244-131 Clinical Predictors of Early Mortality among Patients 
with Implantable Cardioverter Defibrillators: The 
Enduring Value of the Charlson Co-morbidity Index
Sanjeev P. Bhavnani, Craig I. Coleman, Danette Guertin, Alfred 
Danielian, Ravi K. Yarlagadda, Christopher A. Clyne, Jeffery Kluger, 
Hartford Hospital, Hartford, CT
Learning Objective: To identify the prognostic impact of the Charlson 
co-morbidity index in the prediction of early mortality after ICD 
implantation
1244-132 Spatial QRS-T Angle Predicts Mortality in Chronic 
Dialysis Patients
Mihaly K. de Bie, Elsbeth Belt, Andre Gaasbeek, Roderick W.C. 
Scherptong, Cees A. Swenne, Martin J. Schalij, Ton J. Rabelink, 
J. Wouter Jukema, Leiden University Medical Center, Leiden, The 
Netherlands
Learning Objective: To assess the mortality risk of a dialysis patient 
based on the spatial QRS-T angle derived from the 12 lead ECG
1244-133 Heart Rate, Systematic Inflammation and Prognosis 
in Patients with Persistent Atrial Fibrillation
Koichiro Imai, Hiroyuki Okura, Tomoko Maehama, Ken Saito, Akihiro 
Hayashida, Yoji Neishi, Kiyoshi Yoshida, Kawasaki Medical School, 
Kurashiki, Japan
Learning Objective: Interpret the relationship between atrial 
fibrillation , heart rate and C-reactive protein
1244-135 J-Point Elevation Prior to Acute Myocardial 
Infarction Does Not Increase Risk for Ventricular 
Arrhythmias
Ravi Patel, Leonard Ilkhanoff, Jason Ng, Moulin Chokshi, Anas 
Mouchli, Satish Jacob Chacko, Haris Subacius, Sanjay Bhojraj, 
Jeffrey J. Goldberger, Alan H. Kadish, Northwestern University 
Feinberg School of Medicine, Chicago, IL
Learning Objective: distinguish the various morphological types of 
J-point elevation, and interpret their clinical significance with resepct 
to patients who have experienced acute myocardial infarctions.
1244-136 Atrial Protective Effects of n-3 Polyunsaturated 
Fatty Acids: A Long Term Study in Ovine Chronic 
Heart Failure
Dennis H. Lau, Angelo Carbone, Peter J. Psaltis, Lorraine 
Mackenzie, Robert Metcalf, Pawel Kuklik, Christopher X. Wong, 
Adam J. Nelson, Anthony G. Brooks, David A. Saint, Michael J. 
James, Glenn D. Young, Stephen G. Worthley, Prashanthan Sanders, 
The University of Adelaide & Royal Adelaide Hospital, Adelaide, 
Australia
Learning Objective: appreciate the beneficial atrial effects of PUFAs 
in chronic heart failure
1243-125 Magnetocardiography Can Idenfity ‘Local’ 
Ventricular Conduction Delay in Patients with LV 
Dysfunction and CLBBB/IVCD on ECG: Comparison 
with ‘Isolated’ CLBBB
Shogo Oishi, Sr., Hiroshi Takaki, Shuji Hashimoto, Wataru Shimizu, 
Masaru Sugimachi, Shiro Kamakura, Department of Cardiology, 
National Cardiovascular center, Suita, Japan, Department of 
Cardiovascular Dynamics, National Cardiovascular Center Research 
Institute, Suita, Japan
Learning Objective: identify minute peripheral ventricular conduction 
disturbance accompanied by myocardial damage in patients with LV 
dysfunction and with CLBBB/IVCD on ECG by Magnetocardiography 
non-invasively.
1243-126 Initial Experience of the Novel Mobile Telemedicine 
System in Real-Time Transmission of Prehospital 
12-lead ECG for Cardiac Emergency
Nobuhito Yagi, Yoritaka Otsuka, Yukiko Oe, Takafumi Yamane, 
Futoshi Yamanaka, Eiji Tada, Yoichiro Kasahara, Yu Kataoka, Hiroyuki 
Yokoyama, Hiroshi Nonogi, National Cardiovascular Cneter, Suita, Japan
Learning Objective: Mobile Telemedicine System
1243-127 Early Repolarization is Attenuated During Exercise 
and Recovery in Healthy Volunteers
David McNamara, Shiraaz Rahman, Jason Ng, Leonard Ilkhanoff, 
Vinod Sehgal, Jeffrey J. Goldberger, Alan H. Kadish, Northwestern 
University, Chicago, IL
Learning Objective: Describe the effects of exercise and recovery on 
early repolarization
1244 ECG - RISK STRATIFICATION FOR CLINICAL 
EVENTS
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1244-129 Epidemiology of P Wave Indices in Healthy Post-
Menopausal Women: The Women’s Health Initiative
Eiran Z. Gorodeski, Jared W. Magnani, Ronald J. Prineas, Mara Z. 
Vitolins, Mary J. O’Sullivan, Elsayed Z. Soliman, Lisa W. Martin, 
Marian C. Limacher, J. David Curb, Barbara B. Cochrane, Eugene 
H. Blackstone, Michael S. Lauer, Cleveland Clinic, Cleveland, OH, 
Boston University School of Medicine, Boston, MA
Learning Objective: Describe the prognostic importance of P wave 
indices in healthy women with normal resting ECGs.
1244-130 Presence of Fragmented Wide- QRS Complex 
and the Risk of Death and Sudden Cardiac Death 
among MADIT- II Patients with Left Bundle Branch 
Block.
Grzegorz M. Pietrasik, Slava Polonsky, Arthur J. Moss, Wojciech 
Zareba, Heart Research Follow-Up Program, University of Rochester, 
Rochester, NY
Learning Objective: At the conclusion of ths presentation, 
participants will be able to identify higher risk patient with LBBB 
and ischemic cardiomyopathy based on baseline ECG,
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1245-143 Relation of Body Mass Index to Sudden Cardiac 
Mortality and Defibrillator Efficacy in Patients With 
Left Ventricular Dysfunction
Eric D. Hansen, Bonnie Choy, Arthur J. Moss, Scott McNitt, Wojciech 
Zareba, Ilan Goldenberg, Multicenter Automatic Deﬁbrillator 
Implantation Trial-II Investigators, Cardiology Unit of the Department 
of Medicine, University of Rochester Medical Center, Rochester, NY
Learning Objective: Describe the relationship between sudden 
cardiac death and body-mass index in patients with left ventricular 
dysfunction.
1245-144 Racial Differences in Primary Prevention 
Implantable Cardioverter Defibrillator Therapy: 
Findings From the PROSE-ICD Study
Robert Kennedy, Yiyi Zhang, Sameer Gafoor, Mansour Mehdi, Bharat 
Singh, Darshan Dalal, Barbara Butcher, Manish H. Shah, Eric Bukata, 
Joseph E. Marine, David D. Spragg, Sunil K. Sinha, Ronald D. Berger, 
Hugh Calkins, Robert G. Weiss, Eliseo Guallar, Gordon F. Tomaselli, 
Alan Cheng, Johns Hopkins University School of Medicine, Baltimore, 
MD, Washington Hospital Center, Washington, DC
Learning Objective: Identify racial differences in primary prevention 
ICD therapy
1246 ECG/AMBULATORY MONITORING - ATRIAL 
FIBRILLATION
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1246-146 Reverse Remodeling of Left Atrium after Catheter 
Ablation to Atrial Fibrillation: Its Impact on Left 
Ventricular Function and Recurrence
Yuko Toyoshima, Koichi Inoue, Toshiya Kurotobi, Ryusuke Kimura, 
Norihisa Ito, Katsuomi Iwakura, Atsunori Okamura, Yasushi 
Koyama, Motoo Date, Yoshiharu Higuchi, Hiroyuki nagai, Makito 
Ozawa, Yukinori Okazaki, Masahiko Shibuya, Shigemiki Omiya, 
Takashi Takagi, Daisuke Morisawa, Kenshi Fujii, Cardiovascular 
Center,Sakurabashi-Watanabe Hospital, Osaka, Japan
Learning Objective: interpret the impact of catheter ablation on left 
atrial size in relation to the recurrence of atrial fibrillation.
1246-147 Progression from New Onset to Established 
Persistent Atrial Fibrillation: Correlating Clinical 
Classifications with Implantable Device Datalog 
Insights
Rangadham Nagarakanti, Sanjeev Saksena, Douglas Hettrick, Jodi 
Koehler, Andrea Grammatico, Luigi Padeletti, Electrophysiology 
Research Foundation, Warren, NJ, UMDNJ-RWJ Medical School, New 
Brunswick, NJ
Learning Objective: Analyse pacemaker diagnostic data in patients 
with atrial fibrillation or bradycardia tachycardia syndrome and relate 
it to clinical status
1245 DEFIBRILLATION/IMPLANTABLE 
ANTIARRHYTHMIA DEVICES
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1245-137 Impact of the Medtronic Fidelis Lead Recall on 
Utilization of Implantable Cardioverter Defibrillators: 
Data from the NCDR ICD Registry
Paras S. Bhatt, Jeptha Curtis, Yongfei Wang, Rachel Lampert, Yale 
University School of Medicine, New Haven, CT
Learning Objective: Describe the impact of the Medtronic Fidelis 
lead recall on ICD implant volume
1245-138 Prediction of Mortality Risk in Primary Prevention 
ICD Recipients with Ischemic Heart Disease: An 
Easy Applicable Risk Score
Joep Thijssen, C. Jan Willem Borleffs, Johannes B. van Rees, Guido 
H. Welsenes, Rutger J. van Bommel, Lieselot van Erven, Ernst E. 
van der Wall, Johanna G. van der Bom, Frits R. Rosendaal, Jeroen J. 
Bax, Martin J. Schalij, Leiden University Medical Center, Leiden, The 
Netherlands
Learning Objective: apply an easy-to-use mor demonstrate that the 
Implementation of an easy-to-use mortality risk score in ischemic 
primary prevention ICD patients
1245-140 Risk Factors for Appropriate Cardioverter-
Defibrillator Shocks, Inappropriate Cardioverter-
Defibrillator Shocks, and Mortality in 549 Patients 
with Heart Failure and Implantable Cardioverter-
Defibrillators
Wilbert S. Aronow, Harit Desai, Kaushang Gandhi, Chul Ahn, Sadaf 
Hussain, Hoang M. Lai, Mala Sharma, William H. Frishman, Martin 
Cohen, Carmine Sorbera, New York Medical College, Valhalla, NY, 
University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Learning Objective: know risk factors for appropriate and 
inappropriate ICD shocks and mortality in patients with heart failure 
and ICDs.
1245-141 Complications of Implanting Implantable 
Cardioverter-Defibrillator on the Same Day of 
Electrophysiology Study
Madhu Reddy, Senthil Thambidorai, Manu Kaushik, Suman 
Pasupuleti, Mahesh Alla, Kelly Airey, Nazih Kadri, Creighton 
University, Omaha, NE
Learning Objective: Identify the risk of performing electrophysiology 
study on the same day of implantable cardioverter-defibrillator 
implantation.
1245-142 Prognostic Role Of Post-infarction C-Reactive 
Protein In Implantable Cardioverter Defibrillator 
Patients: Results Of The Cami Guide Study.
Luigi M. Biasucci, Fulvio Bellocci, Maurizio Landolina, Filippo Crea, 
Seraﬁno Orazi, Massimo Sassara, Antonio Castro, Riccardo Massa, 
Antoine Kheir, Gabriele Zaccone, Filippo Achilli, Marcello Piacenti, 
Piergiorgio Golzio, Francesco Accardi, Catholic University, rome, Italy
Learning Objective: use of biomarkers for prevention of sudden 
death
Cardiac Arrhythm
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1246-152 Detecting Atrial Fibrillation at Home with a Novel 
Blood Pressure Monitor with Atrial Fibrillation 
Detection Functionality
Joseph Wiesel, Saji Abraham, Frank C. Messineo, Microlife USA, Inc, 
Dunedin, FL, Lenox Hill Hospital, New York, NY
Learning Objective: Determine if asymptomatic atrial fibrillation can 
be accurately detected at home by patients using a novel blood 
presure monitor with atrial fibrillation detection functionality.
1246-153 Carvedilol Attenuates Atrial Fibrillation Promotion 
via Antioxidant Properties in Dogs with Atrial 
Tachycardia Remodeling
Hiroyuki Motoda, Akiko Shiroshita-Takeshita, Tomoko Morikawa, 
Kazuhiko Sekine, Shinya Abe, Masaru Suzuki, Shingo Hori, 
Satoshi Ogawa, Keio University School of Medicine, Tokyo, Japan, 
International University of Health and Welfare Mita Hospital, Tokyo, 
Japan
Learning Objective: identify the pathophysiology of atrial fibrillation 
and the novel possible therapeutic approaches to atrial fibrillation
1246-148 Patent Foramen Ovale Closure with a Conventional 
Radiofrequency Ablation Catheter: Early Feasibility
Luigi Di Biase, J. David Burkhardt, Rodney Horton, Javier Sanchez, 
Prasant Mohanty, Mitra Mohanty, Dimpi Patel, Shane Bailey, G. 
Joseph Gallinghouse, Andrea Natale, St. David’s Medical Center, 
Austin, TX
Learning Objective: evaluate if energy delivery via the 3.5 mm 
ablation catheter in patients with PFO is a good strategy to obtain 
PFO closure
1246-149 Does Atrial Fibrillation-induced Left Atrial 
Remodeling Cause Mitral Valve Dysfunction?
Laszlo Saghy, Martin G. Keane, David J. Callans, Frank E. Silvestry, 
University of Pennsylvania, Philadelphia PA, Philadelphia, PA
Learning Objective: identify a potential relationship between atrial 
fibrillation induced left atrial remodelling and mitral regurgitation.
1246-150 Characteristics of Atrial Substrate and Inducibility 
for Atrial Fibrillation in Hypercholesterolemia 
Rabbits
Kun-Tai Lee, Wen-Ter Lai, Kaohsiung Medical University Hospital, 
Kaohsiung, Taiwan,ROC
Learning Objective: deonstratre the characteristics of atrial 
substrate for atrial fibrillation in hypercolesterolemia rabbits
A16 ABSTRACTS: Cardiac Function and Heart Failure JACC    March 9, 2010
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910 EFFECTS OF NOVEL AGENTS ON VENTRICULAR 
FUNCTION
Monday, March 15, 2010, 2:00 p.m. - 3:30 p.m.
Georgia World Congress Center, Room B408
CME/CE Hours: 1.5
2:00 Acute Intravenous Bolus Injection of Poloxamer-188 
Improves Left Ventricular Function in Dogs with 
Heart Failure
Itamar Ilsar, Mengjun Wang, Alice Jiang, Kaitlin Dye, Bruce 
Markham, Hani N. Sabbah, Henry Ford Hospital, Detroit, MI, Phrixus 
Pharmaceuticals, Ann Arbor, MI
Learning Objective: Describe the effects of injection of poloxamer 
-188 on LV function in dogs with experimental heart failure.
2:15 Cinaciguat, a Soluble Guanylate Cyclase Activator, 
Unloads the Heart in Acute Decompensated Heart 
Failure
Erland Erdmann, Marc J. Semigran, Markku S. Nieminen, Rahul 
Agrawal, Veselin Mitrovic, Alexandre Mebazaa, Universität zu Köln, 
Medizinische Klinik III, Cologne, Germany
Learning Objective: evaluate the therapeutic potential of 
cinaciguat, which is being developed as a new treatment for acute 
decompensated heart failure with a novel mode of action.
2:30 Effect Of N-3 Polyunsaturated Fatty Acids and 
Rosuvastatin on Left Ventricular Function in Patients 
with Chronic Heart Failure. A Substudy of the Gissi-
hf Trial
Stefano Ghio, Laura Scelsi, Ermanno Eleuteri, Michela Palvarini, 
Olga Vriz, Serge Masson, Renato Urso, Roberto Latini, Michele 
Pasotti, Gianni Tognoni, Luigi Tavazzi, Stefano Ghio, Pavia, Italy
Learning Objective: better interpret the effects of N-3 pufa in 
patients with chronic heart failure
2:45 Long-Term Therapy with Rosuvastatin Increases 
Protein Expression of Growth Factors and Stem Cell 
Markers in Left Ventricular Myocardium of Dogs 
with Moderate Heart Failure
Sharad Rastogi, Michael S. Sabbah, Sudhish Mishra, Kaitlin Dye, 
Andrew Cavanagh, Hani N. Sabbah, Henry Ford Hospital, Detroit, MI
Learning Objective: Evaluate the potential role of statins in 
improving LV function in heart failure.
3:00 Pioglitazone Affects Left Ventricular Filling Pressure 
in Patients with Ischemic Heart Disease and Type 
2 Diabetes Who Underwent Coronary Intervention: 
An Echo Doppler Sub-Analysis from the Prevention 
of In-Stent Neointimal Proliferation by Pioglitazone 
Study (POPPS)
Hiroyuki Okura, Tsutomu Takagi, Iku Toda, Bell Land General 
Hospital, Sakai, Japan, Takagi Cardiology Cinic, Kyoto, Japan
Learning Objective: investigate impact of pioglitazone on left 
ventricular diastolic function and filling pressure in patients with 
ischemic heart disease
ORAL CONTRIBUTIONS
913 NOVEL ELECTRICAL STIMULATION THERAPIES IN 
HEART FAILURE
Monday, March 15, 2010, 4:30 p.m. - 6:00 p.m.
Georgia World Congress Center, Room B408
CME/CE Hours: 1.5
4:30 Right Vagus Nerve Stimulation Improves Left 
Ventricular Function in Dogs with Heart Failure
Hani N. Sabbah, Mengjun Wang, Alice Jiang, Stephen B. Ruble, 
Jason J. Hamann, Henry Ford Hospital, Detroit, MI, Boston Scientiﬁc 
Corp., St. Paul, MN
Learning Objective: Evaluate the effects of Vagus Nerve Stimulation 
on LV function in dogs with heart failure
4:45 Transvenous Vagus Nerve Stimulation: A Potential 
Heart Failure Therapy Is Feasible in Humans
Katherine Fan, Raymond Yee, Lorna Gula, Cathy Bentley, Avram 
Scheiner, Sum Lam, Macrina Wong, Maria Parke, Ruth Nicholson 
Klepfer, Allan Skanes, Grantham Hospital, Aberdeen, Hong Kong, 
London Health Sciences Center, London, ON, Canada
Learning Objective: describe the current thresholds required for 
laryngeal vibration when stimulating the vagus nerve from the IJV. 
describe the relationship between cervical location and laryngeal 
vibration threshold.
5:00 Chronic Vagal Nerve Stimulation Impacts 
Biomarkers of Heart Failure in Canines
Stephen B. Ruble, Jason J. Hamann, Ramesh C. Gupta, Sudhish 
Mishra, Hani N. Sabbah, Henry Ford Hospital, Detroit, MI, Boston 
Scientiﬁc Corp., St. Paul, MN
Learning Objective: Describe the effects of Vagus nerve stimulation 
on biomarkers of heart failure
5:15 Low Amplitude Vagus Nerve Stimulation Affects 
Heart Rate and Neurohormones in Humans
Katherine Fan, Raymond Yee, Lorna Gula, Cathy Bentley, Avram 
Scheiner, Sum Lam, Macrina Wong, Maria Parke, Ruth Nicholson 
Klepfer, Allan Skanes, Grantham Hospital, Aberdeen, Hong Kong, 
London Health Sciences Center University Hospital, London, ON, 
Canada
Learning Objective: describe the effects of low amplitude 
transvenous stimulation of the vagus nerve in humans.
5:30 Sustained Benefit at One Year Follow-Up from 
Transapical Left Ventricular Endocardial Pacing for 
End Stage Heart Failure
Attila Mihalcz, Imre Kassai, Csaba Foldesi, Attila Kardos, 
Tamas Szili-Torok, Hungarian National Institute of Cardiology, 
Budapest, Hungary, Thoraxcentre, Department of Clinical Cardiac 
Electrophysiology, Erasmus MC, Rotterdam, The Netherlands
Learning Objective: Our data demonstrate that transapical 
endocardial CRT is a feasible alternative for patients in whom 
percutaneous delivery of the LV pacing lead fails.
JACC    March 9, 2010 ABSTRACTS: Cardiac Function and Heart Failure A17
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916 MYOCARDIAL RECOVERY/REVERSE 
REMODELING
Tuesday, March 16, 2010, 8:00 a.m. - 9:30 a.m.
Georgia World Congress Center, Room B408
CME/CE Hours: 1.5
8:00 Impact of Reduction in Functional Mitral 
Regurgitation on Left Ventricular Reverse 
Remodeling after Cardiac Resynchronization 
Therapy
Yu-Jia Liang, Qing Zhang, Gabriel WK Yip, Alex PW Lee, Yat-Yin Lam, 
Fang Fang, Cheuk-Man Yu, The Chinese University of Hong Kong, 
Hong Kong, Hong Kong, West China Hospital, Sichuan University, 
Chengdu, Sichuan, People’s Republic of China
Learning Objective: understand the positive impact of reduction in 
functional MR on LV reverse remodeling after CRT.
8:15 Relationship of QRS Morphology on Reverse 
Remodeling and Clinical Outcomes with Cardiac 
Resynchronization Therapy (CRT) in Mild Heart 
Failure: Results from the REsynchronization 
reVErses Remodeling in Systolic left vEntricular 
Dysfunction (REVERSE) trial
Michael Robert Gold, Cecilia Linde, Angel Arenal Maiz, Jean-Claude 
Daubert, William T. Abraham, Medical University of South Carolina, 
Charleston, SC
Learning Objective: Evaluate the importance of QRS morphology as 
a predictor of reverse remodeling with CRT
8:30 Persistent Intraventricular Dyssynchrony Impairs 
Left Ventricle Systolic Function During Acute 
Withdrawal of Cardiac Resynchronization Therapy 
in Patients with Extensive Left Ventricle Reverse 
Remodeling
Radu-Gabriel Vatasescu, Alexandra Vasile, Corneliu Iorgulescu, Dana 
Constantinescu, Diana Zamﬁr, Maria Dorobantu, FACC, FESC, Clinic 
Emergency Hospital, Bucharest, Romania
Learning Objective: to identify a specific mechanism of disease in 
super-responders to CRT
8:45 Reversing Left Ventricular Remodeling: Acute 
Results from Epicardial Catheter-based Ventricular 
Reconstruction in an Ovine Heart Failure Model
Yanping Cheng, Michael Aboodi, Andrew Wechsler, Gerard Conditt, Diane 
Ordanes, Alyssa Flynn, Greg L Kaluza, Juan F Granada, Lon S Annest, 
Geng-hua Yi, Cardiovascular Research Foundation, Orangeburg, NY
Learning Objective: To evaluate the acute reduction in left 
ventricular volume achieved with a minimally invasive device for 
epicardial catheter-based ventricular reconstruction in an ovine 
heart failure model
9:00 Echocardiographic Predictors of Recovery of Left 
Ventricular Ejection Fraction after Renal Transplant
Poh Shuan Daniel Yeo, Carmel M. Halley, Richard Fatica, WH Wilson 
Tang, Tan Tock Seng Hospital, Singapore, Singapore, Cleveland 
Clinic, Cleveland, OH
Learning Objective: In patients with impaired LVEF and end-stage 
renal failure, baseline LVEF is a simple predictor of recovery of LVEF 
after renal transplant
922 CIRCULATING BIOMARKERS IN HEART FAILURE
Tuesday, March 16, 2010, 2:00 p.m. - 3:30 p.m.
Georgia World Congress Center, Room B211
CME/CE Hours: 1.5
2:00 Plasma Galectin-3 Levels Predict Left Ventricular 
Remodelling Determined by Sequential 
Echocardiography: Results from the Deventer-
Alkmaar Heart Failure Study
Dirk Lok, Peter van der Meer, Pieta Bruggink Andre de la Porte, Eric 
Lipsic, Jan van Wijngaarden, Yigal Pinto, Dirk Jan van Veldhuisen, 
Deventer Hospital, Deventer, The Netherlands, University Medical 
Centre Groningen, Groningen, The Netherlands
Learning Objective: understand the value of measuring Galectin-3 
as a novel marker for remodeling in heart failure
2:15 Troponin I Is Chronically and Persistently Elevated 
in Hospitalized Heart Failure Patients and Is 
Associated with Increased Mortality Over Five Years
Ravi S. Hira, Maithili Shenoy, Omid Fatemi, Mariana Bolos, Wenyaw 
Chan, Biykem Bozkurt, Baylor College of Medicine, Houston, TX, 
Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX
Learning Objective: Describe the prevalence of chronic persistence 
of Troponin I elevation and it’s association with higher mortality over 
5 years.
2:30 Small Troponin Elevations in Heart Failure 
Exacerbation Patients Are Associated with 
Increased 90-Day Mortality
Yang Xue, Alan S. Maisel, VA San Diego Healthcare System, San 
Diego, CA, University of California San Diego, San Diego, CA
Learning Objective: Demonstrate that small troponin elevations 
can lead to increased mortality in patients with heart failure 
exacerbation.
2:45 St2 for Stratifying Preserved Ejection Fraction 
Patients with Shortness of Breath
Christopher R. DeFilippi, Keyur Shah, Robert Christenson, Sue 
Hender, Willem Kop, University of Maryland, Baltimore, MD
Learning Objective: Identify the prognostic role for ST2 in dyspnea 
patients with preserved LVEF
3:00 Increased 90-Day Mortality in Patients with 
Elevated Copeptin: Secondary Results from the 
Biomarkers in Acute Heart Failure (BACH) Study
Yang Xue, Kevin Shah, Alan S. Maisel, VA San Diego Healthcare 
System, San Diego, CA, Charite, Campus Virchow-Klinikum, Berlin, 
Germany
Learning Objective: Demonstrate that elevated copeptin levels are 
associated with increased mortality in heart failure patients.
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1011 LEFT VENTRICULAR ASSIST DEVICES-- CLINICAL 
INSIGHTS
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1011-41 Patients with End-Stage Heart Failure Can be Safely 
Discharged Home on Biventricular Assist Devices to 
Await Transplant
Jessica L. Ackerman, Colleen M. Smith, Leslie M. Grifﬁn, Gregory 
S. Couper, Michael M. Givertz, Brigham and Women’s Hospital, 
Boston, MA
Learning Objective: Describe common complications and reasons 
for re-hospitalizations in BiVAD and LVAD patients
1011-42 Increased Incidence of Aortic Insufficiency in 
HeartMate II Compared to HeartMate I Left 
Ventricular Assist Device Recipients
Sang-Woo Pak, Nir Uriel, Hiroo Takayama, Sarah Cappleman, 
Paolo C. Colombo, Donna Mancini, Yoshifumi Naka, Ulrich P. Jorde, 
Columbia University, New York, NY
Learning Objective: Discribe AI development during continuous flow 
device support.
1011-43 Have LVADs Rendered Fixed Pulmonary 
Hypertension In Heart Failure A Vestige Of The 
Past?
Barry A. Boilson, John A. Schirger, Yan Topilsky, Lucian A. Durham, 
III, Sudhir S. Kushwaha, Lyle D. Joyce, Richard C. Daly, Soon J. Park, 
Mayo Clinic, Rochester, MN
Learning Objective: To understand the potential of LVAD therapy to 
treat “fixed” pulmonary hypertension in severe heart failure.
1011-44 High Prevalence of Bleeding with Continuous Flow 
Devices
nir uriel, Sang-Woo Pak, Hiroo Takayama, Robert Song, Yoshifumi 
Naka, Ulrich P. Jorde, Donna Mancini, Columbia University, New 
York, NY
Learning Objective: Describe major bleeding events during 
HeartMate II LVAD support and identify acquired von Willebrand 
disease in those patients.
1011-45 Changing Trends In Mechanical Circulatory 
Assistance: A Single Center Experience
Veli K. Topkara, Sreekanth Kondareddy, I-Wen Wang, Douglas L. 
Mann, Gregory A. Ewald, Nader Moazami, Washington University in 
St. Louis, St. Louis, MO
Learning Objective: Distinguish pulsatile and continuous flow assist 
devices and their mid-term clinical outcomes
1010 LEFT VENTRICULAR ASSIST DEVICES--
METABOLIC AND CLINICAL ASPECTS
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1010-35 Improved Glucose Utilization and Mitochondrial 
Function Following Left Ventricular Assist Device 
Support
Dale J. Hamilton, Norma E. Vazquez, Keith A. Youker, Ahmad Khalil, 
Anisha A. Gupte, Willa A. Hsueh, Guillermo Torre-Amione, The 
Methodist Hospital Research Institute, Houston, TX
Learning Objective: Distinguish Pre and Post-LVAD metabolic gene 
expression.
1010-36 Factors Influencing Hospital LOS Following 
Successful LAVD Therapy
Yan Topilsky, barry boilson, kiick sung, lucian durham, richard daly, sudir 
kushwaha, naveen pereira, soon park, mayo clinic, rochester, MN
Learning Objective: Identify patients for LVAD referral
1010-37 Increased Insulin Sensitivity in Advanced Heart 
Failure Patients Treated with Left Ventricular Assist 
Device
nir uriel, Sang-Woo Pak, Paolo Colombo, Vlad Cotarlan, Maryjane 
Farr, Donna Mancini, Yoshifumi Naka, Yoshifumi Naka, Ulrich P. 
Jorde, Columbia University, New York, NY
Learning Objective: Demonstrate improved insulin sensitivity in 
advanced heart failure patients who underwent LVAD implantation.
1010-38 Changing Cost-Effectiveness of Left Ventricular 
Assist Devices as Destination Therapy
Mark J. Russo, Annetine Gelijns, Keith Aaronson, Leslie Miller, 
Kimberly Hong, Mehmet Oz, Deborah Ascheim, Frank Pagani, 
Yoshifumi Naka, Eric Rose, Alan Moskowitz, Mount Sinai Medical 
Center, New York, NY, Columbia University, New York, NY
Learning Objective: To highlight how substantial changes in 
technology and its application can significantly impact clinical and 
economic endpoints
1010-39 Implantation of Ventricular Assist Devices to 
Mediate Weight Loss in Obese Heart Failure 
Patients
Pavittarpaul Dhesi, Faramarz Tehrani, Sriran Simsir, Lawrence Czer, 
Ernst Schwarz, Cedars Sinai Medical Center, Los Angeles, CA
Learning Objective: Evaluate the role of using left ventricular assist 
devices in obese patients with advance heart failure
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1012-51 Is Stress Myocardial Perfusion Imaging with 
Regadenoson, A New Pharmacologic Stress Agent, 
Safe in Orthotopic Heart Transplant Patients? First 
Report of Regadenoson, A Selective A2a Receptor 
Agonist in the Heart Transplant Population
Joao L. Cavalcante, Mouaz Al-Mallah, Cristina Tita, David 
Lanfear, Celeste Williams, Barbara Czerska, Karthikeyan 
Ananthasubramanian, Henry Ford Hospital - Heart and Vascular 
Institute, Detroit, MI
Learning Objective: Describes safety and feasibility of new 
pharmacological stress agent - Regadenoson - in heart transplant 
patients
1013 MYOCARDIAL FUNCTION/HEART FAILURE---
BASIC/MOLECULAR--TISSUE ENGINEERING
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1013-52 Cardiospheres and Tissue Engineering for 
Myocardial Regeneration: Potential for Clinical 
Application
Mariangela Peruzzi, Giacomo Frati, Ilaria Chirichilli, Ursula Tuderti, 
Giuseppe Pugliese, Juan Carlos Chachques, Massimo Ricci, 
Federica Papetti, Andrea Marcantonio, Chiara Santo, University 
of Rome Sapienza Cardiac Surgery Unit Polo Pontino, Rome, 
Italy, 3Department of Experimental Medicine University of Rome 
Sapienza, Rome, Italy
Learning Objective: identify the best complex to achieve myocardial 
regeneration
1013-53 Protective Effect of BBTMH-007 on Development of 
Cardiomyopathy
Guillermo Torre-Amione, Keith A. Youker, Ahmad Khalil, Jose Flores-
Arredondo, Sergio Serna, Jorge Moreno, Jerry D. Estep, Guillermo 
Torre-Amione, The Methodist Hospital, Houston, TX, The Methodist 
DeBakey Heart & Vascular Center, Houston, TX
Learning Objective: Demonstrate the effect of BBTMH007 on 
nonischemic cardiomyopathy
1013-56 Angiotensin Receptor Blockers Improved 
Cardiomyogenic Transdifferentiation Efficiency of 
Human Marrow-derived Mesenchymal Stem Cells in 
vitro
Yohei Numasawa, Shunichiro Miyoshi, Takehiro Kimura, Nobuhiro 
Nishiyama, Hiroko Tsuji, Naoko Hida, Daisuke Shinmura, Hikaru 
Nakamizo, Ikuko Togashi, Kaoru Segawa, Akihiro Umezawa, Satoshi 
Ogawa, Keio Univsersity School of Medicine, Tokyo, Japan
Learning Objective: To learn favorable effect of ARBs on the 
caridomyogenic transdifferentiation efficiency of human marrow-
derived mesenchymal stem cells (MSCs)
1012 CARDIAC TRANSPLANTATION--BASIC AND 
CLINICAL
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1012-47 Inhibition of Angiotensin Signaling Reduces 
Incidence of Antibody Mediated Allograft Rejection.
Sanjay K. Shah, Divya Ratan Verma, Greg Snow, Abadallah G. 
Kfoury, Feras Bader, Kim Brunisholz, Stavros G. Drakos, Elizabeth 
ME Hammond, Monica P. Revelo, Edward Gilbert, Rami Alharethi, 
Deborah Budge, Melanie D. Everitt, Craig Selzman, Josef Stehlik, 
UTAH Cardiac Transplant Program, Salt Lake City, UT
1012-48 Effect of Everolimus Introduction and Calcineurin 
Inhibitor Reduction on Graft Vasculopathy in Heart 
Transplant Recipients
Satish Arora, Bertil Wennerblom, Bengt Rundqvist, Hans Eiskjær, 
Hans Bøtker, Svend Aage Mortensen, Kari Saunameki, Bjørn 
Ekmehag, Kjell Janssson, Svein Simonsen, Einar Gude, Knut 
Endresen, Dag Solbu, Lars Gullestad, Oslo University Hospital 
Rikshospitalet, Oslo, Norway 
Learning Objective: evaluate the effect of everolimus introduction 
and calcineurin inhibitor reduction on graft vasculopathy in heart 
transplant recipients
1012-49 Risk of Stroke and Death in Patients with 
Symptomatic Cerebrovascular Disease Undergoing 
Heart Transplantation: An Analysis of the United 
Network for Organ Sharing Registry
Vishnu Patlolla, Vanajakshi Mogulla, Benjamin Kalsmith, David 
DeNofrio, Rajan Krishnamani, Tufts Medical Center, Boston, MA, 
UMass Medical Center, Worcester, MA
Learning Objective: To describe the effect of symptomatic 
cerebrovascular disease on outcomes in patients undergoing heart 
transplantion
1012-50 Desensitization of Highly HLA-Sensitized Heart 
Transplant Candidates Using High-Dose Intravenous 
Immunoglobulin and Rituximab with Successful 
Transplantation
Lawrence S. C. Czer, Bernice Coleman, Sinan Simsir, Ernst R. 
Schwarz, Chih-Hung Lai, Kai Cao, Stanley Jordan, Ashraf Osman, 
Gina Jamero, Anita Phan, Matthew Raﬁei, Nancy Reinsmoen, 
Cedars-Sinai Medical Center, Los Angeles, CA
Learning Objective: determine that desensitization with intravenous 
immunoglobulin and rituximab may allow cardiac transplantation in 
highly sensitized patients.
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1014-65 A Polymorphism in the PDE3A Gene Promoter that 
Prevents cAMP-Induced Increases in Transcriptional 
Activity, and May Protect Against PDE3A inhibitor 
Drug Tolerance.
Michael R. Bristow, Matthew RG Taylor, Dobromir Slavov, Penny 
L. Blain-Nelson, Karin R. Nunley, Allen M. Medway, Carmen C. 
Sucharov, University of Colorado Denver; CU Cardiovascular 
Institute, Aurora, CO
Learning Objective: Identify and interpret Mechanisms of drug 
action and mechanisms of drug tolerance
1014-67 Myocardial Tissue Levels of Protein Arginine 
N-Methyltransferase 1 (PRMT-1) and 
Dimethylarginine Dimethylaminohydrolase-1 (DDAH-
1) in the Human Failing Heart are Influenced by 
Raised Intracardiac Filling Pressures
Zhili Shao, Wendy E. Sweet, Matthew Baumann, Christine S. 
Moravec, Wai Hong Wilson Tang, Cleveland Clinic, Cleveland, OH
Learning Objective: To describe the myocardial deterimants of 
methylarginine accumulation in advanced heart failure
1014-68 Erythropoietin Receptor Deficient Mice Have 
Impaired Cardiac Adaptation During Voluntary 
Exercise
Willem-Peter T. Ruifrok, Laura M. Meems, B. Daan Westenbrink, 
Alexander H. Maass, Herman H. Sillje, Dirk J. van Veldhuisen, Wiek 
H. van Gilst, Rudolf A. de Boer, University Medical Center Groningen, 
Groningen, The Netherlands
Learning Objective: appreciate the physiology behind cardiac 
adaptation during exercise
1015 MYOCARDIAL FUNCTION/HEART FAILURE--
-BASIC/MOLECULAR--DIVERSE SIGNALING 
PATHWAYS
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1015-69 Galectin-1 Deficient Mice Have Abnormal Baseline 
Cardiac Function And Worse Remodeling After 
Acute Myocardial Infarction
Ignacio M. Seropian, Stefano Toldo, Benjamin W. Van Tassell, 
Gabriel A. Rabinovich, Antonio Abbate, VCU Pauley Heart Center 
and VCU School of Pharmacy, Richmond, VA, Laboratorio de 
Inmunopatología, Instituto de Biología y Medicina Experimental, 
Buenos Aires, Argentina
Learning Objective: Identify Galectin-1 as an important 
immunomodulator for cartdiac function and remodeling after AMI
1015-70 Interleukin-1β Neutralization Ameliorates Post-
infarction Cardiac Remodeling In The Mouse
Antonio Abbate, Benjamin W. Van Tassell, Ignacio M. Seropian, 
Stefano Toldo, Fadi N. Salloum, Amit Varma, Charles A. Dinarello, 
Virginia Commonwealth University, Pauley Heart Center, Richmond, 
VA, University of Colorado, Arora, CO
Learning Objective: To identify IL-1 blockade as a potential 
therapeutic strategy in acute myocardial infarction
1013-57 Tumor Necrosis Factor Alpha Induces the 
Differentiation of Bone Marrow Stem Cells into 
Cardiomyocytes
Mayra E. Guerrero, Sharad Rastogi, Sudhish Mishra, Ramesh C. 
Gupta, Hani N. Sabbah, Henry Ford Hospital, Detroit, MI
Learning Objective: Describe the cardiomyogenic effect of tumor 
necrosis factor alpha on adult bone marrow mesenchymal stem 
cells in chronic heart failure
1013-58 Diastolic Dysfunction Induced By Mild Hypothermia 
Alters Left Ventricular Filling In A Porcine Model
Andreas W. Espinoza, Helge Skulstad, Viesturs Kerans, Per Steinar 
Halvorsen, Jacob Bergsland, Jan Fredrik Bugge, Thor Edvardsen, 
Rikshospitalet Oslo University Hospital, Oslo, Norway
Learning Objective: describe the effects on diastolic properties 
and LV filling from mild hypothermia as used in post-resuscitation 
treatment
1014 MYOCARDIAL FUNCTION/HEART FAILURE---
BASIC/MOLECULAR--MYOCARDIAL FUNCTION
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1014-61 Hydrogen Sulfide Therapy Attenuates Ischemia-
Induced Heart Failure via Nrf2 and NRF1 Signaling
John W. Calvert, Marah Elston, Saurabh Jha, Susheel Gundewar, 
Juan Pablo Aragon, David Bennett Grinsfelder, Arun Ramachandran, 
John W. Elrod, David J. Lefer, Emory University School of Medicine, 
Atlanta, GA
Learning Objective: identify a role for Nrf2 signaling in hydrogen 
sulfide-mediated protection against experimental heart failure
1014-62 Constitutive GSK-3 Activity Permits Adaptive 
Myocardial Remodelling And Maintains Adrenergic 
Sensitivity With Chronic Isoproterenol Stimulation
Ian G. Webb, James Clark, Colin Murdoch, Ajay Shah, Michael 
Marber, King’s College London BHF Centre, London, United Kingdom
Learning Objective: To understand better the role of role of GSK-3 
signalling in cardsiac hypertrophy
1014-63 Interleukin-1β Induces Left Ventricular Systolic 
Dysfunction Through p38α MAP Kinase
Ignacio M. Seropian, Stefano Toldo, Ayobami Omosola, Neeru Goyal, 
Benjamin W. Van Tassell, Abbate Antonio, VCU Pauley Heart Center, 
Richmond, VA, VCU School of Pharmacy, Richmond, VA
Learning Objective: to identify p38a MAPK as a target for septic 
cardiomyopathy
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1016 MYOCARDIAL FUNCTION/HEART FAILURE---
BASIC/MOLECULAR--CARDIAC SIGNALING - 
FIBROSIS
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1016-78 Inhibition of Cardiac Fibrosis Mediated by 
Non-Myocyte Proliferation in Hypertrophic 
Cardiomyopathy
Polakit Teekakirikul, Seda Eminaga, Okan Toka, Libin Wang, Hiroko 
Wakimoto, Matthew Nayor, Tetsuo Konno, Cordula M. Wolf, Ronny 
Alcalai, Joshua Gorham, Joachim P. Schmitt, Brendan Caine, Roger 
R. Markwald, Standley R. Hoffman, Jeffery D. Molkentin, Christine 
E. Seidman, Jonathan G. Seidman, Department of Genetics Harvard 
Medical School, Boston, MA, Division of Cardiovascular Medicine 
Brigham and Women’s Hospital, Boston, MA
Learning Objective: Describe the cardiac fibrotic responses to 
sarcomere gene mutation and the mechanisms by which cardiac 
fibrosis is inhibited in hypertrophic cardiomyopathy.
1016-79 Progressive Strain Imaging Change and Role of the 
Natriuretic Peptides as Predictors of Left Ventricular 
Dysfunction and Fibrosis in Aging Myocardium
Diego Bellavia, Jeson S. Sangaralingham, Elise Oehler, Alessandro 
Cataliotti, Paul McKie, Gerald E. Harders, Margaret M. Redﬁeld, 
Fletcher A. Miller, Jr., John C. Burnett, Jr, Mayo Clinic, Rochester, MN
Learning Objective: Identify parameter to assess LV dysfunction in 
myocardial aging
1016-80 Thrombomodulin Inhibits Cardiomyocyte Apoptosis 
and Improves Cardiac Contractile Dysfunction in 
Response to Chronic Pressure Overload in Mice
Yi-Heng Li, Hsing-Chun Chung, Chawn-Yau Luo, Ting-Hsing Chao, 
Ping-Yen Liu, Guey-Yueh Shi, Hua-Lin Wu, National Cheng Kung 
University Hospital, Tainan, Taiwan,ROC
Learning Objective: understand that thrombomodulin has anti-
apoptotic effect on cardiomyocyte and improves left ventricular 
contractile function
1016-81 Long-Term Therapy with Rosuvastatin Decreases 
Expression of Hypertrophic and Pro-inflammatory 
Proteins in Left Ventricular Myocardium of Dogs 
with Moderate Heart Failure
Sudhish Mishra, Sharad Rastogi, Michael S. Sabbah, Ramesh C. 
Gupta, Kaitlin Dye, Andrew Cavanagh, Hani N. Sabbah, Henry Ford 
Hospital, Detroit, MI
Learning Objective: Demonstrate the effectiveness of statins in 
reducing markers of LV hypertrophy and inflammation.
1015-72 Suppression Of PDK4 Is Associated With Enhanced 
Glucose Oxidation And Atrophy In Skeletal 
Muscle Of Animals With Chronic Left Ventricular 
Dysfunction
Aalap D. Chokshi, Raffay Khan, John Morrow, Chad Trent, Steven 
Marx, Ira Goldberg, P. Christian Schulze, Columbia University Medical 
Center, New York, NY
Learning Objective: Interpret metabolism in heart failure
1015-73 Interleukin Family Member ST2 and Mortality in 
Acute Dyspnea
Thenral Socrates, Christopher DeFilippi, Tobias Reichlin, Raphael 
Twerenbold, Tobias Breidhardt, Markus Noveanu, Mihael Potocki, 
Robert Christenson, Christian Mueller, University Hospital Basel, 
Basel, Switzerland, University of Maryland, School of Medicine, 
Baltimore, MD
Learning Objective: distinguish the value of various biomarkers for 
the prognosis of mortality in acute heart failure.
1015-74 Insulin-Like Growth Factor Prevents Diabetes 
Induced Cardiomyopathy Mediated by microRNA-1
Yangxin Li, Hanjing Wu, Mang Zhu, Harnath Shelat, Jiangbo Qu, 
Minjuan Zheng, Jiuhong Yuan, Guoqiang Yuan, Jiaming Xu, Hongwu 
Wang, Yong-jian Geng, Texas Heart Institute, Houston, TX, Univ of 
Texas Health Science Center, Houston, TX
Learning Objective: Identify the role of microRNA in cardiomyopathy
1015-75 Abnormal Myocardial Energetics in Peroxisome 
Proliferator Activated Receptor Gamma 
Coactivator-1 Beta deficient mice
Mohammad N. Jameel, Qiang Xiong, Qinglu Li, Xiaohong Wang, 
Jianyi Zhang, University of Minnesota, Minneapolis, MN
Learning Objective: describe myocardial energetic in PGC1α and 
PGC1β deficient mice.
1015-76 Inflammation Induces Transdifferentiation Of 
Fibroblasts To Myofibroblasts With Pathological 
Remodelling In Endomyocardial Biopsies Of 
Patients With Hfnef: One Trigger For Diastolic 
Dysfunction.
Dirk Westermann, Diana Lindner, Mario Kasner, Heinz-Peter 
Schultheiss, Carsten Tschope, Charite, Campus Benjamin Franklin, 
Berlin, Germany
Learning Objective: Understand that inflammation is one key trigger 
for matrix regulation in patients with heart failure and normal EF
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1065-37 Biventricular Pacing In Patients with Left Ventricular 
Assist Devices - Is Left Ventricular Pacing 
Proarrhythmic??
Andrew D. Choi, Avi Fischer, Anelechi Anyanwu, Sean Pinney, Eric 
Adler, The Mount Sinai Medical Center, New York, NY, Oregon Health 
Sciences University, Portland, OR
Learning Objective: Identify CRT as a possible provocateur of 
ventricular arrhythmias in patients having undergone Left Ventricular 
Assist Device implant
1065-38 Improved Right Ventricular Myocardial Performance 
Despite Reduced Longitudinal Deformation after 
Left Ventricular Assist Device Implantation in 
Patients with Severe Heart Failure
Ravi Rasalingam, Kyle R. Bilhorn, Stephanie N. Johnson, Carl B. 
Kapadia, Majesh Makan, Nader Moazami, Julio E. Perez, Washington 
University in St Louis, St Louis, MO
Learning Objective: Evaluate right ventricular function after LVAD 
implantation
1065-39 Quality of Life Improvements Are Greater in 
Destination Therapy than Bridge to Transplant 
Patients with a Continuous Flow Left Ventricular 
Assist Device
Juan M. Aranda, Jr., Joseph G. Rogers, Keith D. Aronson, Andrew J. 
Boyle, Stuart D. Russell, Brooks Edwards, Mark J. Zucker, Charles 
T. Klodell, Jr., Kartik S. Sundareswaran, David J. Farrar, Mark S. 
Slaughter, HeartMate II Clinical Investigators, University of Florida 
College of Medicine, Gainesville, FL
Learning Objective: understand the relative quality-of-life benefits 
conferred by continuous flow left ventricular assist devices in 
patients receiving destination therapy vs. bridge to transplant.
1066 DIAGOSIS AND TREATMENT OF HEART FAILURE
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1066-41 Differential Diagnosis of Constrictive Pericarditis 
from Restrictive Myocardial Disease by Speckle 
Tracking Echocardiography
Gabriella Veress, Kye H. Kim, Mitsuru Masaki, Raul E. Espinosa, Jae 
K. Oh, Mayo Clinic, Rochester, MN
Learning Objective: identify a new differential diagnostic tool, 
namely the Speckle Tracking Echocardiography distinguishing 
between Constrictive Pericarditis and Restrictive Myocardial 
Disease.
1016-82 Local Autologous Endothelial Progenitor Cell 
Transplantation (EPC-Tx) in the Chronic Ischemic 
Myocardium Enhances Contractility in the Non-
Ischemic Area: Prevention of Negative Remodeling
David J. Pedrosa, Dirk Cleppien, Angelica Karpi, Mate Borgulya, 
Edin Hadzijusufoviç, Holger Jansen, Nico Abegunewardene, Marcus 
Vosseler, Karl-Friedrich Kreitner, Oliver Kempski, Laura M. Schreiber, 
Georg Horstick, Johannes Gutenberg-University Mainz, Second 
Medical Clinic, Mainz, Germany
Learning Objective: Recognize the global repercussions of a local 
cell-based therapy in chronic-ischemic myocardium
1016-84 Potent Cardiorenal Antifibrotic Effects of the Rho-
Kinase Inhibitor Fasudil in Experimental Diabetes 
Mellitus.
Syed Ameenuddin, Elise A. Oehler, Josef Korinek, Jeson 
Sangaralingham, Alessandro Cataliotti, Fernando Martin, John A. 
Schirger, Horng H. Chen, Mayo Clinic, Rochester, MN
Learning Objective: Evaluate role of Rho-Kinase inhibitor in Diabetes 
mellitus
1016-85 Association of Parvovirus B19 Infection With 
Cardiac Amyloidosis and Myocardial Diseases 
Positive for Amyloid Fibrils at Electron Microscopy
Maria L. Higuchi, Dirk Lassner, Edimar Bocchi, Charles Mady, Heinz-
Peter Schultheiss, José AF Ramires, Uwe Kühl, Heart Institute 
(InCor) of Clinical Hospital of School of Medicine, Sao Paulo, Brazil, 
Charité - University Medicine, Berlin, Germany
Learning Objective: Demonstrate Parvovirus B19 in cardiac 
amyloidosis. 2: identify amyloid fibrils in DCM at EM. 3: 
demonstrate B19V with different techniques.
1065 CARDIAC TRANSPLANTATION/ASSIST DEVICES--
GENERAL
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1065-35 Impella 2.5 Is Safe and Drastically Reduces 
Procedure Times in High-Risk Percutaneous 
Coronary Interventions when Compared to the 
TandemHeart PTVA: Single-center Experience
Huy Trong Nguyen, Rucha Karajgikar, Dheeraj Kaplish, Samin K. 
Sharma, Annapoorna S. Kini, Mount Sinai Hosptial, New York, NY
Learning Objective: identify the major clinical differences between 
the TandemHeart and Imeplla 2.5 percutaneous LVADs for high-risk 
PCI
1065-36 NT-proBNP Assay may Preclude the Need for 
Routine Endomyocardial Biopsy to Detect 
Cardiac Allograft Rejection, but not Early After 
Transplantation
Carlos T. Aguiar, Maria José Rebocho, Marta Marques, Miguel 
Abecasis, José Neves, João Figueira, Rosa Gouveia, João Melo, 
Hospital Santa Cruz, Carnaxide, Portugal
Learning Objective: Recognize potential role of BNP for detecting 
cardiac allograft rejection
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1067-49 Pericardial Effusion Associated With Human 
Immunodeficiency Virus Infection in the Era of 
Highly Active Antiretroviral Therapy
William Strimel, David A. Stewart, II, D. Scott Gantt, Texas A&M 
University Health Science Center College of Medicine, Scott and 
White Hospital and Clinic, Temple, TX
Learning Objective: recognize the effect of antiretrioviral therapy on 
HIV-associated pericardial effusion
1067-50 Predictors of Therapy-Related Congestive Heart 
Failure (CHF) Following Hematopoietic Cell 
Transplantation (HCT)
Saro Armenian, Can-Lan Sun, George Mills, Tabitha Shannon, Liton 
Francisco, F. Lennie Wong, Jean-Bernard Durand, Stephen Forman, 
Smita Bhatia, City of Hope National Medical Center, Duarte, CA, 
M.D. Anderson Cancer Center, Houston, TX
Learning Objective: Idenitfy risk factors for therapy-related CHF 
following hematopoietic cell transplantation
1067-51 Determining the Electrocardiographic Features 
Specific to Transthyretin Cardiac Amyloid
Jason Dungu, Prayman T. Sattianayagam, Philip N. Hawkins, Lisa J. 
Anderson, St George’s Hospital, London, United Kingdom, National 
Amyloidosis Centre, London, United Kingdom
Learning Objective: identify more heart failure patients with possible 
cardiac amyloidosis, prompting further investigation. We propose 
cardiac amyloid is under diagnosed, particularly in the afrocaribbean 
population.
1068 CRT OPTIMIZATION AND OUTCOMES
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1068-52 Impact of Cardiac Resynchronization Therapy on 
Diastolic Function: a Meta-analysis
Sanjay Kumar, Amit Nautiyal, Saurabh Kaushik, Jason M. Lazar, 
Richard A. Grimm, Cleveland Clinic Foundation, Cleveland, OH
Learning Objective: Understand impact of CRT on diastolic function
1068-53 Comprehensive Device Interrogation and 
Pacemaker Optimization at Rest and Stress 
Improves Functional Class in Non Responders to 
Cardiac Resynchronization Treatment
Tasneem Z. Naqvi, Nima Taha, Rupesh Ranjan, Jing Zhang, Samuel 
Daneshvar, Elizabeth Guillen, University of Southern California, Los 
Angeles, CA
Learning Objective: Learn pacemaker programming and echo 
Doppler during pacemaker optimization
1066-42 Myocardial Strain Reveals Biventricular Impairment 
in Asymptomatic Arrhythmogenic Right Ventricular 
Cardiomyopathy Mutation Carriers
Kristina H. Haugaa, Sebastian I. Sarvari, Ole-Gunnar Anﬁnsen, 
Trond P. Leren, Otto A. Smiseth, Jan P. Amlie, Thor Edvardsen, Oslo 
University Hospital, Rikshospitalet, Oslo, Norway, Oslo, Norway
Learning Objective: evaluate asymptomatic ARVC mutation carriers 
with strain echocardiography
1066-43 Natural History of the Danon Disease Phenotype in 
a Large Affected Population
Luisa Mestroni, Dana Boucek, Jean Jirikowic, Cara Wells, Matthew 
R.G. Taylor, University of Colorado Denver, Aurora, CO
Learning Objective: Describe a rare inherited cardiomyopathy
1066-44 Hemoconcentration may be a Useful Predictor for 
Worsening Renal Function During the Treatment of 
Acute Decompensated Heart Failure
Jeffrey M. Testani, Michael Shumski, Brian D. McCauley, Richard P. 
Shannon, Hospital of the University of Pennsylvania, Philadelphia, PA
Learning Objective: identify increases in hematocrit during the 
treatment of acute decompensated heart failure as a possible 
warning sign for impending worsening renal function.
1066-45 Restoring Circulating Soluble ACE2 Activity 
Following Intensive Medical Therapy Predicts 
Improvement in Advanced Decompensated Heart 
Failure
Zhili Shao, Kevin L. Shrestha, Allen G. Borowski, Slava Epelman, Wai 
Hong Wilson Tang, Cleveland Clinic, Cleveland, OH
Learning Objective: Determine clinical, echocardiographic and 
hemodynamic determinants and prognostic utility of serial sACE2 
activity levels in setting of ADHF and intensive medical therapy
1067 CARDIOMYOPATHIES
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1067-47 Obesity Cardiomyopathy: A New Concept 
of Secondary Cardiomyopathy with Unique 
Ultrastructural Features
Tsunenori Saito, Kuniya Asai, Hiroshi Takahashi, Hidenori 
Komiyama, Koji Kato, Eisei Yamamoto, Hitoshi Takano, Toshihiko 
Ohara, Yuh Fukuda, Kyoichi Mizuno, Nippon Medical School 
Hospital, Tokyo, Japan
Learning Objective: clarify the functional and structural changes of 
myocardium with dilated cardiomyopathy and obesity
1067-48 Myocardial Fibrosis Attenuates the Effect Of 
Cibenzoline on Left Ventricular Diastolic Function in 
Patients with Hypertrophic Cardiomyopathy
Makoto Saito, Yasuhiro Sasaki, Toyofumi Yoshii, Go Hiasa, Takumi 
Sumimoto, Kazuhisa Nishimura, Katsuji Inoue, Hideki Okayama, 
Mareomi Hamada, Jitsuo Higaki, Kitaishikai hospital, Ozu, Japan
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1069 MYOCARDIAL REPAIR-STEM CELLS AND OTHER 
MECHANISMS
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1069-61 Efficacy of Intramyocardial Injections of Autologous 
Bone Marrow Mononuclear Stem Cells in Patients 
with Ischemic Heart Failure: Long-Term Results
Evgeny Pokushalov, Alexander Romanov, Sregey Artemenko, 
Alexander Cherniavskiy, Petr Larionov, Igor Terehov, Olga 
Poveschenko, Elena Kliver, Alexander Karaskov, State Research 
Institute of Circulation Pathology, Novosibirsk, Russian Federation
Learning Objective: Intramyocardial injection of autologous bone 
marrow mononuclear cells in ischemic heart failure patients is a 
safe procedure that improves clinical symptoms and has beneficial 
effect on LV function.
1069-62 Stromal Cell-Derived Factor-1, Granulocyte Colony 
Stimulating Factor, Fibroblast, Vascular Endothelial 
and Hepatocyte Growth Factors Are Increased in 
Hypoxia/Anoxia Conditioned Bone Marrow-Derived 
Stem Cell Medium
Sharad Rastogi, Michael S. Sabbah, Hani N. Sabbah, Henry Ford 
Hospital, Detroit, MI
Learning Objective: Demonstrate that stem cells can elaborate factors 
that are likely to be responsible for the beneficial effects on LV function.
1069-63 Exercise Training Reverses Dysfunction of Early 
Endothelial Progenitor Cells in Patients with Chronic 
Heart Failure.
Emeline M. Van Craenenbroeck, Paul Beckers, Nadine Possemiers, 
Kurt Wuyts, Vicky Hoymans, Geert Frederix, Christiaan Vrints, 
Viviane Conraads, Antwerp University Hospital, Edegem, Belgium
Learning Objective: identify one of the mechanisms for the 
beneficial effects of exercise training on endothelial function
1069-64 Bone Marrow EPC Function Relative to Time of 
Collection after Acute Myocardial Infarction
Mark S. Segal, Maria Grant, Doris Taylor, Chris Cogel, Lemuel Moyé, 
Carl Pepine, University of Florida, Gainesville, FL, University of 
Minnesota, Minneapolis, MN
Learning Objective: Describe the level of nitric oxide and its source 
in bone marrow cells after different times after an MI.
1069-65 Utility of Doppler Myocardial Imaging, Cardiac 
Biomarkers and Clonal Immunoglobulin Genes 
to Assess Left Ventricular Performance and 
Stratify Risk Following Peripheral Blood Stem Cell 
Transplantation in Patients with Systemic Light 
Chain Amyloidosis (AL).
Diego Bellavia, Roshini S. Abraham, Patricia A. Pellikka, Angela 
Dispenzieri, John C. Burnett, Jr., Ghormallah B. Al-Zahrani, Morie 
A. Gertz, Fletcher A. Miller, Jr., Theodore P. Abraham, Mayo Clinic, 
Rochester, MN
Learning Objective: Understand high sensitivity of strain and 
genetics in risk stratification
1068-55 Role of End-Systolic Pressure-Volume Relationship 
in the Identification of Responders to Cardiac 
Resynchronization Therapy
Quirino Ciampi, Lorenza Pratali, Rodolfo Citro, Michele Della Porta, 
Bruno Villari, Eugenio Picano, Rosa Sicari, Fatebenefratelli Hospital, 
Benevento, Italy, CNR, Institute of Clinical Physiology, Pisa, Italy
Learning Objective: to evaluate a new method to identy responders 
to cardiac resynchronization therapy
1068-56 Successful Restoration of Heart Rate 
Responsiveness to Exercise Using Cardiac 
Resynchronization Therapy Delays Anaerobic 
Threshold in Patients with Advanced Heart Failure
Daniel Sims, Andrea Mignatti, Paolo C. Colombo, Pierantonio 
Laveneziana, Nir Uriel, Frederick A. Ehlert, Ulrich P. Jorde, Columbia 
University Medical Center, New York, NY, New York University School 
of Medicine, New York, NY
Learning Objective: To describe the efffects of rate adaptive pacing 
on exercise capacity in patients with advanced heart failure and 
severe chronotropic incompetence.
1068-57 Detection of Regional Low Myocardial 
Perfusion Helps Predict a Response to Cardiac 
Resynchronization Therapy in Patients With Non-
ischemic Cardiomyopathy:Find Index by Nuclear 
Imaging for Dyssynchrony (FIND) Study
Takehiko Keida, Itsuro Morishima, Taketsugu Tsuchiya, Kouichi 
Sagara, Kaoru Okishige, Kenta Kumagai, Yoshiaki Mibiki, Tamon 
Yamanaka, Yukihiko Yoshida, Kentaro Nakamura, Akira Yamamoto, 
Mitsuaki Takami, Edogawa Hospital, Tokyo, Japan
Learning Objective: Predict Response to Cardiac Resynchronization 
Therapy
1068-58 CRT In Mild Heart Failure: Response In Relation 
To Heart Failure Etiology? 24 Month Results From 
The Resynchronisation Reverses Remodelling In 
Systolic Left Ventricular Dysfunction (reverse) Study
Cecilia Linde, William T. Abraham, Michael R. Gold, Martin St. John 
Sutton, Stefano Ghio, Jean Claude Daubert, University Hospital, 
Karolinska, Stockholm, Sweden
Learning Objective: To demonstrate that the effects of CRT in less 
severe heart failure (HF) patients is related to HF etiology
1068-59 Predicting Survival Among Patients Undergoing 
Cardiac Resynchronization Using a Simple Scoring 
System
Evan C. Adelstein, Sanjoy Bhattacharya, Samir Saba, University of 
Pittsburgh, Pittsburgh, PA
Learning Objective: Identify baseline clinical variables that predict 
survival after cardiac resynchronization therapy.
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1070-73 Increased Circulating Matrix Gla Protein In Heart 
Failure-association With Functional, Hemodynamic 
And Neurohormonal Disease Severity
Thor Ueland, Christen P. Dahl, Lars Gullestad, Pal Aukrust, Sven 
Aakhus, Kaspar Broch, Cees Vermeer, Leon J. Schurgers, Oslo 
University Hospital, Oslo, Norway, Maastricht University, Maastricht, 
The Netherlands
Learning Objective: Describe matrix gla protein in the context of 
heart failure development
1070-74 Novel Biomarkers Associated with Left Ventricular 
Hypertrophy
Palaniappan Manickam, Vikas Veeranna, Ankit Rathod, Pawan Hari, 
Sandip Zalawadiya, Apurva Badheka, Sony Jacob, Luis Afonso, 
Wayne State University, Detroit, MI
Learning Objective: to identify the strong positive association of 
intercellular adhesion molecule and soluble tumor necrosis factor 
with left ventricular hypertrophy.
1070-75 Plasma Nor-Epinephrine Levels and Mortality in 
Patients with Advanced Chronic Systolic Heart 
Failure: Insights from the BEST Study
Mustafa I. Ahmed, Marjan Mujib, Wilbert S. Aronow, Gerasimos 
Filippatos, Prakash Deedwania, Ali Ahmed, University of Alabama at 
Birmingham, Birmingham, AL, VA Medical Center, Birmingham, AL
Learning Objective: Understand associations between plasma 
norepineprhrine and outcomes in patients with advanced chronic 
systolic heart failure
1070-76 Left Ventricular Torsion Early after Myocardial 
Infarction: Its Determinants and Ability to Predict 
Left Ventricular Remodeling
Gaetano Nucifora, Matteo Bertini, Nina Ajmone Marsan, Victoria 
Delgado, Arnold CT Ng, Eduard R. Holman, Hans-Mark J. Siebelink, 
Jacob M. Van Werkhoven, Ernst E. Van Der Wall, Martin J. Schalij, 
Jeroen J. Bax, Leiden University Medical Center, Leiden, The 
Netherlands
Learning Objective: evaluate LV torsion post-AMI
1071 HEART FAILURE WITH PRESERVED EJECTION 
FRACTION
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1071-78 Preclinical Diastolic Dysfunction: The Kidney-Heart 
Connection
Horng H. Chen, Sherry Benike, Lynn Harstad, Lisa Costello-
Boerrigter, John A. Schirger, Robert D. Simari, Margaret M. Redﬁeld, 
John C. Burnett, Mayo Clinic, Rochester, MN
Learning Objective: To dtermine the renal function in LV dysfunction
1069-67 Polyunsaturated Fatty Acids and Omega-3 as 
Predictors of Mortality in Depressed Heart Failure 
(HF) Patients
Mona Fiuzat, Wei Jiang, Harry Oken, Linda Shaw, Maragatha 
Kuchibhatla, Michael Cuffe, Shelby Ladd, Ranga Krishnan, 
Christopher O’Connor, Duke University Medical Center, Durham, NC, 
Duke Clinical Research Institute, Durham, NC
Learning Objective: Describe the potential influence of Omega-3 
fatty acids on survival
1069-68 Patients With Underlying Right Bundle Branch Block 
Exhibit Worsened Longitudinal Myocardial Strain 
With Biventricular Pacing As Compared To Those 
With Left Bundle Branch Block
Sabe De, Zoran Popovic, David Verhaert, Thomas Dresing, Randall 
Starling, Wai Hong Tang, Bruce Wilkoff, James D. Thomas, Richard 
A. Grimm, Cleveland Clinic Foundation, Cleveland, OH
Learning Objective: To demonstrate differences in longitudinal strain 
for LBBB versus RBBB
1070 MYOCARDIAL FUNCTION/HEART FAILURE---
BASIC/MOLECULAR
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1070-69 Hydralazine-Nitroglycerin Combination Reduces 
Diastolic Calcium Leak In Adult Cardiomyocytes 
From Nitric Oxide Synthase-1-Deficient Mice
Raul A. Dulce, Daniel R. Gonzalez, Adriana V. Treuer, Joshua M. 
Hare, Interdisciplinary Stem Cell Institute, Miami, FL
Learning Objective: Interpret and distinguish the effects of 
hydralazine-nitroglycerin combination in a model of elevated 
sarcoplasmic reticulum calcium leakage
1070-70 Novel Heart Failure Markers in Systolic, Diastolic 
and Other Heart Failure
Raoul Stahrenberg, Frank Edelmann, Meinhard Mende, Jan Kunde, 
Jana A. Papassotiriou, Gerd Hasenfuss, Burkert Pieske, Rolf 
Wachter, University Hospital Goettingen, Goettingen, Germany, 
Germany
Learning Objective: describe the diagnostic value of novel 
biomarkers in diastolic heart failure.
1070-72 Diastolic Function Along the Diabetic Spectrum
Raoul Stahrenberg, Meinhard Mende, Frank Edelmann, Lisa 
Schoenbrunn, Gerd Hasenfuss, Burkert Pieske, Rolf Wachter, 
University Hospital Goettingen, Goettingen, Germany, Germany
Learning Objective: describe the association between glucose 
metabolism and diastolic function across a wide spectrum of 
glucose metabolism states.
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1120 HEMODYNAMICS AND QUALITY OF LIFE IN 
HEART FAILURE
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1120-35 The Correlation of B-Type Natriuretic Peptide to 
Pulmonary Capillary Wedge Pressure is Markedly 
Blunted in Overweight and Obese Patients
Jamil B. Dihu, William G. Cotts, Gudaye Tasissa, Micah J. Eimer, 
University of Chicago Pritzker School of Medicine, Chicago, IL, 
Northwestern University Feinberg School of Medicine, Chicago, IL
Learning Objective: Demonstrate an understanding of the 
relationship between BNP levels and PCWP in lean, overweight, and 
obese patients.
1120-36 The Kansas City Cardiomyopathy Questionnaire 
Predicts Long-Term Mortality and Heart Failure 
Rehospitalization in African American Patients with 
Acute Decompensated Heart Failure
sirikarn napan, M. Tarek Alahdab, Ibrahim N. Mansour, Howard 
University, Washington D.C., DC, John H. Stroger, Jr. Hospital of 
Cook County, Chicago, IL
Learning Objective: Evaluate the prognostic value of the Kansas City 
Cardiomyopathy Questionnaire in African-American population
1120-37 Laboratory Evidence of Congestive Hepatopathy 
Predicts Improvement in Renal Function During the 
Treatment of Acute Decompensated Heart Failure
Jeffrey M. Testani, Michael Shumski, Brian D. McCauley, Richard P. 
Shannon, Hospital of the University of Pennsylvania, Philadelphia, 
PA
Learning Objective: identify patients with laboratory evidence of 
hepatic congestion as a population that may also have venous 
congestion induced renal dysfunction and improve their renal 
function with diuresis.
1120-38 Can Echocardiographic Evaluation of 
Cardiopulmonary Hemodynamics Replace Right 
Heart Catheterization in End-Stage Heart Failure 
Patients Awaiting Transplantation?
Suman Kuppahally, Edward M. Gilbert, Sheldon E. Litwin, Stephen 
M. Ishihara, Renee Neuharth, Andrew D. Michaels, Anwar Tandar, 
Feras Bader, University of Utah, Salt Lake City, UT
Learning Objective: Identify the utility of echocardiography in 
assessing patients with end-stage cardiomyopathy awaiting 
transplantation
1120-39 Single Beat Estimation of the Left Ventricular End-
diastolic Pressure Volume Relationship in Humans 
With and Without Heart Failure
Rodrigo V. Wainstein, Zion Sasson, Joan Persaud, Susanna Mak, 
Division of Cardiology, Mount Sinai Hospital, Toronto, ON, Canada
Learning Objective: Identify that the single beat method can be 
used to assess EDPVR and that increases in heart rate exert 
greater effect on LV compliance of heart failure patients than in 
normal LV patients
1071-79 Clinical and Prognostic Value of Galectin-3, a 
Novel Fibrosis-Associated Biomarker. Relation with 
Clinical and Biochemical Correlates of Heart Failure.
Rudolf A. De Boer, Dirk Lok, Johannes L. Hillege, Adriaan A. Voors, 
Wiek H. van Gilst, Tiny Jaarsma, Dirk J. van Veldhuisen, University 
Medical Center Groningen, Groningen, The Netherlands
Learning Objective: Evaluate the role of a novel biomarker in heart 
failure
1071-81 Ultrafiltration in Heart Failure Patients with 
Preserved Systolic Function
Eugene S. Chung, Santosh Menon, Cheryl Bartone, Nanandakishore 
Akula, Jackie Wagner, The Christ Hospital, Cincinnati, OH, The Ohio 
Heart and Vascular Center, Cincinnati, OH
Learning Objective: evaluate effect of ultrafiltration on HF patients 
with preserved EF
1071-82 Clinical Characteristics, Hemodynamics, and 
Outcomes of Heart Failure with Preserved Ejection 
Fraction and Normal B-type Natriuretic Peptide 
Level
Venkatesh Y. Anjan, Sanjiv J. Shah, Northwestern University Feinberg 
School of Medicine, Chicago, IL
Learning Objective: describe the clinical characteristics of patients 
with HFpEF and normal BNP levels
1071-84 Heart Failure with Recovered Ejection Fraction: A 
Distinct Entity within Heart Failure and Preserved 
Ejection Fraction
Lynn Punnoose, Parakash Pratibhu, Michael M. Givertz, Eldrin F. 
Lewis, Lynne W. Stevenson, Akshay Desai, Brigham and Women’s 
Hospital, Boston, MA
Learning Objective: identify the distinct clinical and demographic 
features of heart failure patients with recovered EF, compared to 
those with stable preserved EF.
1071-85 Hyponatremia, Natriuretic Peptides and Outcomes 
in Acutely Destabilized Heart Failure
Asim A. Mohammed, Roland RJ van Kimmenade, Mark Richards, 
Antoni Bayes-Genis, Yigal Pinto, Stephanie A. Moore, James L. 
Januzzi, Jr, Massachusetts General Hospital, Boston, MA
Learning Objective: understand the long-term prognostic utility of 
hyponatremia and its association with amino-terminal pro-B type 
natriuretic peptide in acutely decompensated heart failure patients.
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1122 GENETICS AND CARDIOMYOPATHIES
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1122-47 Can CMR Characterize the Etiology of the Septal 
Bounce in Patients with Constrictive Pericarditis?
George O. Angheloiu, Geetha Rayarao, Mark Doyle, Saundra Grant, 
Robert WW Biederman, DuBois Regional Medical Center, DuBois, PA
To learn the etiology of the ‘septal bounce’ in proven constrictive 
pericarditis via CMR and dynamic Quiver Plot analysis
1122-48 Influence of Genetic Factors on Left Ventricular 
Structure and Function in Friedreich’s Ataxia
Sarah Lagedrost, Ted Plappert, Martin St John Sutton, David Lynch, 
CHOP, Philadelphia, PA, University of Pennsylvania, Philadelphia, PA
Learning Objective: Evaluate the cardiomyopathy of Friedreich ataxia
1122-49 Prognostic Stratification of Biopsy-Proven Active 
Myocarditis Presenting with Heart Failure: Are there 
Predictors of Long Term Prognosis?
Marco Merlo, Gastone Sabbadini, Bruno Pinamonti, Gherardo 
Finocchiaro, Alessandra Buiatti, Giulia Barbati, Andrea Di Lenarda, 
Gianfranco Sinagra, Ospedali Riuniti and University, Trieste, Italy
Learning Objective: Analyze the natural history of acute myocarditys 
presenting with heart failure and demonstrate the prognostic rolo 
of improvement of left ventricular ejection fraction on medical 
treatment
1122-50 The +49ag Polymorphism in Exon 1 of the Cytotoxic 
T-lymphocyte-associated Protein 4 Is Associated 
with Dilated Cardiomyopathy
Volker Ruppert, Thomas Meyer, Clarissa Struwe, Jana Petersen, 
Andreas Perrot, Maximilian G. Posch, Cemil Özcelik, Anette Richter, 
Bernhard Maisch, Sabine Pankuweit, German Competence Network 
of Heart Failure, Philipps-University, Marburg, Germany, Max-
Delbrück Center for Molecular Medicine, Berlin, Germany
Learning Objective: describe new polymorhisms associated with 
DCM
1122-51 Angiotensin-converting Enzyme Insertion/Deletion 
Polymorphisms Contributes to Favorable Clinical 
Courses of Hypertrophic Cardiomyopathy Caused by 
MYBPC3 Gene Mutations
Akira Funada, Noboru Fujino, Eiichi Masuta, Hidekazu Ino, Masakazu 
Yamagishi, Kanazawa University Hospital, Division of Intesive Care 
Unit, Kanazawa, Japan, Kanazawa University, Division of Cardiology, 
Kanazawa, Japan
Learning Objective: discribe that angiotensin-converting enzyme 
insertion/deletion polymorphisms contributes to favorable clinical 
courses of hypertrophic cardiomyopathy caused by MYBPC3 gene 
mutations
1121 COMORBIDITIES AND CARDIOMYOPATHIES
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1121-41 Deleterious Impact of Mild Anemia on 
Survival of Young Patients with Idiopathic 
Dilated Cardiomyopathy. Data from Trieste 
Cardiomyopathies Registry
Aneta Aleksova, Giulia Barbati, Marco Merlo, Davide Stolfo, Cosimo 
Carriere, Andrea Di Lenarda, Gianfranco Sinagra, Cardiovascular 
Department, Trieste, Italy, Cardiovascular Center, Azienda per i 
Servizi Sanitari (A.S.S.) N°1 of Trieste, Trieste, Italy
Learning Objective: understand the importance of mild anemia on 
survival of young patients with heart failure affected by Idioopathic 
Dilated Cardiomyopathy.
1121-42 Predictors of Constrictive Pericarditis Following 
Pericardiocentesis for Significant Pericardial 
Effusion
Kye Hun Kim, Lawrence Sinak, Gellian Nestbitt, Raul E Espinosa, 
A. Jamil Tajik, Jae K Oh, Mayo Clinic, Rochester, MN, Chonnam 
National University Hospital, Gwangju, South Korea
Learning Objective: know the predictive findings of constrictive 
pericarditis after pericardiocentesis
1121-43 Transient Left Ventricular Ballooning Syndrome: A 
Large Prospective Series
Peter M. Kayaert, Bert Ferdinande, Peter Sinnaeve, Christophe 
Dubois, Tom Adriaenssens, Mark Coosemans, Walter Desmet, 
Universitair Ziekenhuis Leuven, Leuven, Belgium
Learning Objective: identify patients with transient left ventricular 
ballooning syndrome and estimate outcome
1121-44 Prognostic Value of Left Ventricular Dimension 
Beyond Peak Oxygen Consumption in Systolic Heart 
Failure Patients
Eileen M. Hsich, Eiran Z. Gorodeski, David O. Taylor, Randall C. 
Starling, Penny Houghtaling, Michael S. Lauer, Cleveland Clinic, 
Cleveland, OH, NHLBI, NIH, Bethesda, MD
Learning Objective: To identify left ventricular end-systolic and end-
diastolic dimensionas a predictor for mortality in ambulatory heart 
failure patients with systolic dysfunction
1121-45 Predictive Factors For Survival in Patients with 
Diastolic Dysfunction of Varying Severity Who Do 
Not Have Systolic Dysfunction or Symptoms of 
Heart Failure
Mazda Biria, Subba Reddy Vanga, Dhanunjaya Lakkireddy, Patricia 
Howard, James L. Vacek, University of Kansas Hospital, Kansas 
City, KS, University of Kansas Medical Center, Kansas City, KS
Learning Objective: identify predictive factors for survival in patients 
with diastolic dysfunction without systolic dysfunction or symptoms 
of HF
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1123-58 Non-selective Beta-blockers Decrease Thrombotic 
Events in Patients with Heart Failure
Olav R. De Peuter, Patrick C. Souverein, Olaf H. Klungel, Gregory 
Y. Lip, Harry R. Büller, Anthonius De Boer, Pieter W. Kamphuisen, 
Academic Medical Center, Amsterdam, The Netherlands
Learning Objective: identify the possible antithrombotic effects of 
non-selective beta-blockers
1123-59 Atrial Fibrillation in Heart Failure is associated with 
an Increased Risk of Death only in Patients with 
Ischemic Heart Disease
Jakob Raunso, Ole D. Pedersen, Helena Dominguez, Morten L. 
Hansen, Jacob E. Moller, Jesper Kjaergaard, Christian Hassager, 
Christian Torp-Pedersen, Lars Køber, Gentofte Hospital, Hellerup, 
Denmark
Learning Objective: demonstrate that the prognostic impact of 
atrial fibrillation in a large heart failure population depends on an 
underlying ischemic etiology.
1124 -RISK STRATIFICATION IN HEART FAILURE
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1124-61 Determinants of Morbidity and Mortality in Chronic 
Heart Failure (CHF) with Systolic Dysfunction: 
Results of the HF-ACTION Predictive Model
Christopher M. O’Connor, Daniel Wojdyla, Eric Leifer, Stephen Ellis, 
Kerry Lee, Robert Clare, Ileana Pina, Steven Keteyian, Dalane 
Kitzman, William Kraus, David Rendall, Lawton Cooper, David 
Whellan, Duke Clinical Research Institute, Durham, NC, NIH/NHLBI, 
Bethesda, MD
Learning Objective: To describe predictive variables from a large 
clinical trial evaluating exercise training in HF
1124-62 Novel Utilization of the Seattle Heart Failure Model 
to Optimize Goals of Therapy in Patients Admitted 
with Acutely Decompensated Heart Failure.
Samira Bahrainy, Eliabeth Maas, Abhijeet Singh, Hal A. Skopicki, 
Stony Brook University Medical Center, Stony Brook, NY
Learning Objective: Identify the important clinical variables needed 
to optimize management in patients with ADHF
1124-63 Combined Predictive Value of Depression and 
B-type Natriuretic Peptide for Mortality in Heart 
Failure Patients: The Cardiovascular Health Study
Willem J. Kop, Krista C. van den Broek, Christopher R. DeFilippi, 
Robert H. Christenson, Stephen L. Seliger, John S. Gottdiener, 
University of Maryland, Department of Medicine (Cardiology), 
Baltimore, MD, Tilburg University, Ctr of Research on Psychology in 
Somatic diseases, Tilburg, The Netherlands
Learning Objective: Identify depression in conjunction with 
biomarkers as additive risk factors for mortality in heart failure 
patients
1123 HOSPITALIZATION AND MORTALITY IN HEART 
FAILURE
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1123-52 Risk Factors for Recurrent Heart Failure Events in the 
Multicenter Automatic Defibrillator Trial II (MADIT-II)
Edward Sze, Arthur J. Moss, Scott McNitt, Wojciech Zareba, Ilan 
Goldenberg, University of Rochester, School of Medicine and 
Dentistry, Rochester, NY
Learning Objective: Identify risk factors for recurrent heart failure 
events in patients with left ventricular dysfunction.
1123-53 Serial Studies of Seattle Heart Failure Model 
Improve the Prediction of Pump Failure Death, 
not Sudden Death, in Stable Outpatients With 
Mild to Moderate Chronic Heart Failure: A 10-Year 
Prospective Study
Takahisa Yamada, Yuji Okuyama, Takashi Morita, Yoshio Furukawa, 
Koji Tanaka, Yusuke Iwasaki, Taku Yasui, Michihiro Ueda, Takeshi 
Okada, Masato Kawasaki, Yuki Kuramoto, Wayne C. Levy, Masatake 
Fukunami, Osaka General Medical Center, Osaka, Japan
Learning Objective: learn the prognostic significane of serial 
evaluation of Seattle Heart Failure Model
1123-55 Non invasive Lung Impedance Monitoring In The 
Outpatient Clinic Facilitates The Prediction Of 
Hospitalization Of Patients With Decompensated 
Heart Failure And Enables Early Therapy To Prevent 
Hospitalizations
Michael Shochat, Avraham Shotan, David Blondhaim, Mark 
Kazatsker, Vladimir Gurovich, Aya Asif, Lubov Vasilenko, Elena 
Neiman, Aaron Frimerman, Paul Rabinovich, Simcha Meisel, Hillel 
Yaffe Heart Institute, Hadera, Israel, Sorasky Medical Center, Tel 
Aviv, Israel
Learning Objective: To demonstrate that using surface thoracic 
impedance monitoring for chronic heart failure patients reliably 
predicts decompensation two weeks before and early impedance 
guided treatment prevent readmi
1123-56 Factors That Precipitate Hospitalizations for 
Heart Failure With Preserved Ejection Fraction - 
Characteristics and Impact on Post-Discharge Outcome
Dan Rusinaru, Otilia Buiciuc, Franck Lévy, Marcel Peltier, Christophe 
Tribouilloy, University Hospital Amiens, France, Amiens, France
Learning Objective: Understand the importance of factors that 
precipitate hospital admissions in heart failure with preserved 
ejection fraction
1123-57 Hydralazine and Isosorbide Dinitrate Improve 
Mortality in Blacks and Non-Blacks With Diastolic 
Heart Failure
Jeremy A. Mazurek, Ronald Zolty, Monteﬁore Medical Center, Albert 
Einstein College of Medicine, Bronx, NY
Learning Objective: identify a treatment that may decrease mortality 
in both Black and Non-Black patients with diastolic heart failure.
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1125-70 History Of Heart Failure Hospitalizations And 
Benefit From Home-based Nurse Care In Chronic 
Heart Failure
deddo moertl, Raisa Hutuleac, Andreas Gleiss, Alexandra Hammer, 
Asima Delalic, Rudolf Berger, Medical University of Vienna, Vienna, 
Austria
Learning Objective: identify markers that predict benefit from home-
based nurse care in chronic heart failure
1125-72 New Model Of Home-based Tele-ecg-monitored 
Cardiac Rehabilitation In Patients With Heart 
Failure: Effectiveness, Quality Of Life, Safety, And 
Adherence
Ewa Piotrowicz, Rafał Baranowski, Maria Bili ska, Monika 
Stepnowska, Małgorzata Piotrowska, Tomasz Zieli ski, Ryszard 
Piotrowicz, Institute of Cardiology, Warsaw, Poland
Learning Objective: demonstrated that in heart failure patients 
home-tele-cardiac rehabilitation is as effective and improves the 
HRQoL as standard cardiac rehabilitation on cycle ergometers
1125-73 Discharge Education Improves Knowledge And 
Outcomes In Heart Failure Patients
Naga V. Kommuri, Arun Damodaran, Todd M. Koelling, DMC-Sinai-
Grace Hospital, DETROIT, MI, University of Michigan Hospital, Ann 
Arbor, MI
Learning Objective: Nurse educator delivered discharge education 
improves knowledge and clinical outcomes in heartfailure patients
1125-74 Improved Algorithm to Detect Fluid Accumulation 
via Intrathoracic Impedance Monitoring in Heart 
Failure Patients with Implantable Devices
Douglas A. Hettrick, Shantanu Sarkar, Jodi Koehler, Tyson Rogers, 
Cheuk-Man Yu, William Abraham, Roy Small, W.H. Wilson Tang, 
Medtronic, Inc., Minneapolis, MN, Cleveland Clinic, Cleveland, OH
Learning Objective: Identify clinically usefull tools to monitor heart 
failure patients.
1125-75 Effects of the Oral Direct Renin Inhibitor Aliskiren 
on Plasma BNP concentration in Patients 
with Symptomatic Heart Failure According to 
Background Dose of ACE inhibitor
John JV McMurray, Claudio Gimpelewicz, Roberto Latini, Aldo P. 
Maggioni, Bertram Pitt, Scott D. Solomon, Anil Verma, Beverly A. 
Smith, Deborah L. Keefe, Margaret F. Prescott, James D. Lewsey, 
University of Glasgow, Glasgow, United Kingdom
Learning Objective: undestand possible actions of renin inhibitors in 
heart failure
1125-76 Short-term Waiting List Survival Without Support By 
A Ventricular Assist Device
Mark J. Russo, Jonathan Yang, Alexander Iribarne, Kimberly N. 
Hong, Hiroo Takayama, Ryan R. Davies, MD, Allan S. Stewart, 
Jonathan M. Chen, Mathew Williams, Michael Argenziano, Yoshifumi 
Naka, Columbia University Medical Center, New York, NY
Learning Objective: Demonstrate understanding of patient risk 
factors at the time of listing that predict 30-day survival without the 
need for a ventricular assist device .
1124-64 Relation Between Myocardial Viability, Clinical 
Presentation, and Risk Stratification in Patients 
with Ischemic Cardiomyopathy on Optimal Medical 
Therapy. A Report from the STICH Trial
Federico M. Asch, Thomas A. Holly, Lilin She, Gerald Maurer, 
Matthias Siepe, Eric J. Velazquez, Adam Ostrzycki, Beata Sredniawa, 
Tiziana Attisano, Jonathan Howlett, Robert O. Bonow, Julio A. 
Panza, Washington Hospital Center, Washington, DC, Northwestern 
University Feinberg School of Medicine, Chicago, IL
Learning Objective: describe the lack of impact of myocardial 
viability in the clinical presenation of patients with ischemic 
cardiomyopathy.
1124-65 Variations in the Cardiovascular Effect of Uric Acid 
by Serum Insulin Levels: Mechanistic Insights from 
Epidemiological Observations
Ali Ahmed, UAB and VAMC, Birmingham, AL
Learning Objective: To understand that uric acid may not have any 
intrinsic effect on cardiovascular events
1124-67 Change in ST2 Level: Refining Risk Stratification in 
the Dyspnea Patient
Christopher R. DeFilippi, Robert Christenson, Keyur Shah, Sue 
Henderson, Willem Kop, University of Maryland, Baltimore, MD
Learning Objective: Determine for patients with acute dyspnea 
presentations the frequency of change in ST2 levels at follow-up 
and the significance of absence of change.
1124-68 Serum Albumin Concentration and Heart Failure 
Risk
Deepa Mangalat, Emory University, Atlanta, GA
Learning Objective: evaluate serum albumin as a time-dependent 
risk for heart failure. Further studies are needed to delineate the 
screening potential of serum albumin for high-risk persons and for 
clinical practice.
1125 HEART FAILURE DISEASE MANAGEMENT
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1125-69 Impedance-guided Treatment Prevents Acute Heart 
Failure in the Course of Acute Myocardial Infarction 
and reduced long-term mortality
Michael Shochat, Avraham Shotan, David Blondhaim, Mark 
Kazatsker, Vladimir Gurovich, Aya Asif, Lubov Vasilenko, Elena 
Neiman, Morris Mosseri, Aaron Frimerman, Paul Rabinovich, Simcha 
Meisel, Hillel Yaffe Heart Institute, Hadera, Israel, Sorasky Medical 
Center, Tel Aviv, Israel
Learning Objective: To know that using surface thoracic impedance 
monitoring in course of acute myocardial infarction for beginning 
treatment for prevention acute heart failure development improve 
hospital stay, reduce
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1126-82 Adaptive Servoventilation Treatment of Complex 
Sleep Apnea in Heart Failure Patients Improves 
Subjective and Objective Cardiac Functional 
Parameters
Thomas Bitter, Roman Lehmann, Christian Prinz, Christoph Langer, 
Dieter Horstkotte, Olaf Oldenburg, Department of Cardiology, Heart 
and Diabetes Center North Rhine-Westphalia, Ruhr University 
Bochum, Bad Oeynhausen, Germany
Learning Objective: identify complex sleep apnea and learn about 
treatment effects of adaptive servoventilation in heart failure 
patients with complex sleep apnea
1126-84 Central Sleep Apnea Events are Terminated By 
Phrenic Nerve Stimulation
Piotr Ponikowski, Shi-Jiang Zhang, Thomasz Witkowski, Ayesha 
Hasan, Rami Khayat, Bradley Bart, Dariusz Jagielski, Xilong Zhang, 
Center for Heart Disease - Clinical Military Hospital, Wroclaw, 
Poland, Jiangsu Provincial People’s Hospital, Nanjing, People’s 
Republic of China
Learning Objective: Understand that stimulation of the phrenic 
nerve during central apnea event may halt or avert the apnea.
1126-85 Cardiac Resynchronization Differentially Impacts 
Survival in Heart Failure Patients Based Upon 
Baseline Renal Function
Evan C. Adelstein, Alaa Shalaby, Samir Saba, University of 
Pittsburgh, Pittsburgh, PA, Pittsburgh VA Health System, Pittsburgh, 
PA
Learning Objective: Describe the impact of renal insufficiency upon 
survival among patients undergoing cardiac resynchronization 
therapy .
1175 GENETICS AND CARDIOMYOPATHIES II
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1175-35 Cardiovascular Events in Patients with Fabry 
Disease: Natural History Data from the Fabry 
Registry
Manesh R. Patel, Franco Cecchi, Marta Cizmarik, Ilkka Kantola, Ales 
Linhart, Kathy Nicholls, Jorg Strotmann, Jose Tallaj, Thi Chien Tran, 
Michael L. West, Ademola Abiose, Duke University, Durham, NC
Learning Objective: Better understand the cardiovascular 
complications of Fabry disease
1175-36 Prognostic Significance of Carbohydrate Antigen 
125 in Patients with Heart Failure and Preserved 
Ejection Fraction
sirikarn napan, Taweewat Aussawapokee, Erol Nargileci, Ataul 
Qureshi, Suhail Khadra, Howard University, Washington D.C., DC, 
John H. Stroger, Jr. Hospital of Cook County, Chicago, IL
Learning Objective: Evaluate the prognostic value of carbohydrate 
antigen 125 in patients with heart failure and preserved ejection 
fraction
1126 NONPHARMACOLOGIC THERAPIES FOR HEART 
FAILURE
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1126-78 Improvement of Longitudinal Left Ventricular Strain 
is Associated with Left Atrial Strain Enhancement 
After Pulmonary-vein Isolation for Atrial Fibrillation
Jun Koyama, Hirohiko Motoki, Kazunori Aizawa, Megumi Koshikawa, 
Hiroki Kasai, Atsushi Izawa, Takeshi Tomita, Yusuke Miyashita, 
Setsuo Kumazaki, Uichi Ikeda, Shinshu University Graduate School 
of Medicine, Matsumoto, Japan
Learning Objective: learn relation between left atrial and left 
ventricular function after pulmonary-vein isolation for atrial 
fibrillation.
1126-79 Atrial Lead Implantation is Associated With 
Conversion to Sinus Rhythm and Maintenance 
of Sinus Rhythm in Patients With Long-Standing 
Atrial Fibrillation Undergoing Atrioventricular Node 
Ablation and Biventricular Pacemaker Implantation
Raul Alexis Torres Heisecke, Vassilis Dimas, Andrew W. Owens, Jose 
A. Joglar, Owen A. Obel, University of Texas Southwestern Medical 
Center Dallas, Dallas, TX
Learning Objective: Evaluate patients for atrial lead implantation 
while undergoing AVN ablation+BiV implantation for long-standing 
atrial fibrillation as they may be more likely to convert to and 
maintain sinus rhythm
1126-80 Pulmonary Vein Isolation For Persistent Atrial 
Fibrillation In Patients With Severe Heart Failure
Michael R. MacDonald, John McMurray, Tracey Steedman, Morag 
Shaw, Henry Dargie, Nathaniel Hawkins, Martin Denvir, Sai Bhagra, 
John Payne, Derek Connelly, Mark Petrie, Golden Jubilee National 
Hospital, Glasgow, United Kingdom
Learning Objective: describe the efficacy of pulmonary vein isolation 
in patients with severe heart failure.
1126-81 Adaptive Servo Ventilation Improves Cardiac 
Dysfunction in Heart Failure Patients with Cheyne-
Stokes Respiration
Akiomi Yoshihisa, Takamasa Sato, Hiroyuki Kunii, Kazuhiko 
Nakazato, Hitoshi Suzuki, Shu-ichi Saitoh, Toshiyuki Ishibashi, 
Yasuchika Takeishi, Department of Cardiology and Hematology, 
Fukushima Medical University, Fukushima, Japan
Learning Objective: Demonstrate that ASV improved cardiac function 
in HF patients with CSR.
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1176-43 Concentric LV Remodeling Is Related To Decreased 
Circumferential Strain And Strain Rate After 
Exercise In Obese Patients.
Boaz Rosen, Travis Ault, Theophilus Owan, Bhavananda Reddy, 
Ronny Jiji, Ted Adams, Ted Adams, Steven Hunt, Sheldon E. Litwin, 
University of Utah, Salt Lake City, UT
Learning Objective: To understrand the relationship between LV 
concentric remodeling and the change in strain and strain rate 
during exercise,
1176-44 Impact of Angiotensin-Converting Enzyme Deletion 
Allele as a Modifier Causing Left Ventricular 
Systolic Dysfunction in Genotyped Hypertrophic 
Cardiomyopathy: Results from Longitudinal Study
Akira Funada, Noboru Fujino, Eiichi Masuta, Akihiko Muramoto, 
Hidekazu Ino, Masakazu Yamagishi, Kanazawa University Hospital, 
Division of Intensive Care Unit, Kanazawa, Japan, Kanazawa 
University, Division of Cardiology, Kanazawa, Japan
Learning Objective: describe that angiotensin-converting enzyme 
deletion allele is a modifier causing left ventricular systolic 
dysfunction and transition to dilated phase in genotyped 
hypertrophic cardiomyopathy
1176-45 Prevalence of Fabry Disease in Korean Male 
Patients with Left Ventricular Hypertrophy
Woo-Shik Kim, Toshihiro Takenaka, Bang Hun Lee, Soon Pyo Hong, 
Jong Chun Park, Jin-Won Jeong, Jae Ki Ko, Kyung Hoon Choe, Jae 
Hyung Kim, Namsik Chung, Han-Wook Yoo, Chuwa Tei, Jong-Hoa 
Bae, Kyung Hee University Medical Center, Seoul, South Korea, 
Korea-Japan Joint Study Group for Fabry Disease
Learning Objective: By means of a screening based on low plasma 
enzymatic activity, we evaluated the prevalence of Fabry disease in 
male patients with left ventricular hypertrophy.
1177 CARDIOMYOPATHIES BASIC AND CLINICAL II
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1177-47 Cardiac Autonomic Neuropathy is Independently 
Associated with Diastolic Dysfunction in Type 2 
Diabetes
Julian W. Sacre, Bennett Franjic, Christine L. Jellis, Thomas H. 
Marwick, The University of Queensland, Brisbane, Australia
Learning Objective: identify the importance of cardiac autonomic 
neuropathy in the aetiology of diabetic myocardial dysfunction.
1177-48 Elevated Peripheral Augmentation Index and Pulse 
Wave Amplitude in Patients with Hypertrophic 
Cardiomyopathy
Kevin Heffernan, Martin S. Maron, Eshan Patvardhan, Richard H. 
Karas, Jeffrey T. Kuvin, Tufts Medical Center, Boston, MA
Learning Objective: interpret the systemic nature and clinical 
relevance of vascular dysfunction in patients with hypertrophic 
cardiomyopathy
1175-37 Mutation Screening Of Sarcomere Genes MYH7, 
MYBPC3, LDB3, And TNNT2 In A Large Cohort Of 
Dilated Cardiomyopathy Families
Luisa Mestroni, Marco Merlo, Elisa Carniel, Dobromir Slavov, Xiao 
Zhu, Debra Ferguson, Ernesto E. Salcedo, Jean Cavanaugh, Andrea 
Di Lenarda, Gianfranco Sinagra, Matthew R.G. Taylor, University 
of Colorado Denver, Aurora, CO, Hospital and University of Trieste, 
Trieste, Italy
Learning Objective: Evaluate molecular epidemiology of DCM
1175-38 Role of AMP-activated Protein Kinase in 
Cardioprotection in Doxorubicin-Induced 
Cardiomyopathy of Mice
Mi-Jeong Kim, Doo Soo Jeon, Dong Il Shin, Man Young Lee, Incheon 
St Mary`s Hospital, Incheon, South Korea
Learning Objective: Activation of AMPK could be a protector from 
DXR-induced myocardial injury.
1175-39 Endothelial Dysfunction In Peripheral Conduit 
Arteries, But Not Peripheral Resistance Arteries, In 
Hypertrophic Cardiomyopathy
Eshan A. Patvardhan, Kevin S. Heffernan, Craig A. Napolitano, 
Martin M. Maron, Richard H. Karas, Jeffrey T. Kuvin, Tufts Medical 
Center, Boston, MA
Learning Objective: Recognize that vascular dysfunction occurs 
in peripheral conduit arteries along with coronary microvessels 
in hypertrophic cardiomyopathy. However, peripheral resistance 
vessels are unaffected.
1176 CARDIOMYOPATHIES BASIC AND CLINICAL
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1176-41 Enhanced Storage Reduction in Hearts of Fabry 
Mice Mediated by Expression of an Alpha-
galactosidase A-Tat Fusion Enzyme
Koji Higuchi, Makoto Yoshimitsu, Xin Fan, Xiaoxin Guo, Vanessa I. 
Rasaiah, Toshihiro Takenaka, Chuwa Tei, Jeffrey A. Medin, Ontario 
Cancer Institute, Toronto, ON, Canada, Kagoshima University, 
Kagoshima, Japan
Learning Objective: demondtrate alpha-galactosidase A-Tat fusion 
protein improve reduction of Gb3 levels in hearts of Fabry mice
1176-42 Therapy with Adult Bone Marrow-derived 
Mesenchymal Stem Cells Ameliorates Doxorubicin-
Induced Cardiomyopathy
Santosh K. Sanganalmath, Atul R. Chugh, Manjunatha R. 
Benakanakere, Robert J. Vincent, Greg Hunt, Roberto Bolli, 
Buddhadeb Dawn, University of Kansas Medical Center, Kansas City, 
KS, University of Louisville, Louisville, KY
Learning Objective: demonstrate the significance of stem cells in 
dilated cardiomyopathy
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1178-55 Medication Dosing Adherence in Outpatients 
with Heart Failure Following Implementation 
of a Practice-based Performance Improvement 
Intervention: Results from IMPROVE HF
Mihai Gheorghiade, Gregg C. Fonarow, Nancy M. Albert, Anne 
B. Curtis, Wendy Gattis Stough, J Thomas Heywood, Mark L. 
McBride, Patches Johnson Inge, Mandeep R. Mehra, Christopher 
M. O’Connor, Dwight Reynolds, Mary N. Walsh, Clyde W. Yancy, 
Medtronic, Inc., Minneapolis, MN
Learning Objective: To describe the impact of a practice-based 
performance improvement intervention on adherence to target 
doses of guideline-recommended medication therapies for heart 
failure.
1178-56 Elderly Patients are Less Likely to Receive Evidence-
Based Medications Indicated for Systolic Heart 
Failure: Results from the Study of Anemia in a 
Heart Failure Population (STAMINA-HFP) Registry
Ileana L. Pina, Rebecca S. Boxer, Douglas D. Schocken, G. Michael 
Felker, Carla A. Dupree, Alan B. Miller, Mandeep R. Mehra, Javed 
Butler, J. Herbert Patterson, Lynne E. Wagoner, Jalal K. Ghali, 
Stephanie H. Dunlap, Kirkwood F. Adams, Jr, Case Western 
Reserve University, Cleveland, OH, University of North Carolina, 
Chapel Hill, NC
Learning Objective: Describe the association of advancing age and 
prescribing practices for systolic heart failure from the STAMINIA-
HFP Registry
1178-57 Obesity Paradox in Heart Failure: Is it the 
Accumulation or the Medication?
Venkataramana K. Reddy, Jun R. Chiong, K. Kim, S. Westrom, D. 
Petersen, Loma Linda Medical Center, Loma Linda, CA
Learning Objective: To understand the favorable prognosis behind 
obesity in the heart failure population
1178-58 In the End, Its What Our Heart Failure Patients Want
Hal Skopicki, Elizabeth Maas, Stony Brook University Medical 
Center, Stony Brook
Learning Objective: To identify the factors important in the decision 
process concerning advanced directives in heart failure patients
1178-59 Diabetes is an Independent Risk Factor for Heart 
Failure among Community Dwelling Older Adults
Prakash C. Deedwania, V A Medical center, Birmingham, AL, 
University of Alabama, Birmingham, AL
Learning Objective: After this presentation the participant should be 
able to define the risk of CHF in the elderly subjects
1177-49 Recovery of Left Ventricular Function in Patients 
with Anthracycline-Induced Cardiomyopathy.
Malik Tariq Rahim, Joseph Dubin, Guilherme H. Oliveira, Jean-
Bernard Durand, Daniel Lenihan, MD Anderson Cancer Center, 
Houston, TX
Learning Objective: To demonstrate improvement of systolic 
function in with aggressive medical therapy in anthracycline-induced 
cardiomyopathy.
1177-50 The Incidence and Prognosis of Constrictive 
Pericarditis after Pericardiocentesis for Pericardial 
Effusion
Kye Hun Kim, Lawrence Sinak, Gillian Nesbitt, Raul E Espinosa, 
A. Jamil Tajik, Jae K Oh, Mayo Clinic, Rochester, MN, Chonnam 
National University Hospital, Gwangju, South Korea
Learning Objective: know that constrictive pericarditis is not a rare 
complication following pericardiocentesis, and most of them are 
transient
1177-51 Eosinophilic Heart Disease: Diagnosis and 
Indivualized Treatment
Bernhard Maisch, Ulrik Baandrup, Roland Moll, Sabine Pankuweit, 
Philipps-University, Marburg, Germany
Learning Objective: Identify the clinical histologica phenotype of 
eosinophilic heart disease.
1178 EPIDEMIOLOGY, MEDICATION AND ADVANCED 
DIRECTIVES
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1178-52 Increasing Heart Failure Hospital Admissions with 
Decreasing New Heart Failure Patients in New 
Jersey, 1996-2005
Yingzi Deng, William J. Kostis, Abel E. Moreyra, John Pantazopoulos, 
Nora M. Cosgrove, Alan C. Wilson, John B. Kostis, for the MIDAS 
group, University of Medicine and Dentistry, New Jersey, New 
Brunswick, NJ
Learning Objective: To examine trends of heart failure incidence, 
admissions and factors associated with 30-day and 1-year case 
fatality.
1178-53 Time Trends in Cardiovascular Drug Treatment and 
Cardiovascular Events in Patients with Acute Heart 
Failure
Olav R. De Peuter, Gregory Y. Lip, Olaf H. Klungel, Patrick C. 
Souverein, Deirdre Lane, Harry R. Büller, Anthonius De Boer, 
Pieter W. Kamphuisen, Academic Medical Center, Amsterdam, The 
Netherlands
Learning Objective: describe the adherence to advised heart failure 
treatment and the effect on cardiovascular disease
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1179-67 Should we Anticoagulate Patients With Advanced 
Systolic Heart Failure Without Atrial Fibrillation? 
Insights From the Beta-Blocker Evaluation of 
Survival Trial (BEST)
Marjan U. Mujib, Mustafa I. Ahmed, Wilbert S. Aronow, Prakash 
Deedwania, Ali Ahmed, University of Alabama at Birmingham, 
Birmingham, AL
Learning Objective: Understand the role of anticoagulants in 
advanced systolic heart failure patients without atrial fibrillation.
1179-68 Continuous Axial Flow Left Ventricular Assist 
Devices Improve Pulmonary Hemodynamics in 
Patients with Severe Congestive Heart Failure.
Ravi Rasalingam, Kyle R. Bilhorn, Stephanie N. Johnson, Carl B. 
Kapadia, Majesh Makan, Nader Moazami, Julio E. Perez, Washington 
University in St Louis, St Louis, MO
Learning Objective: Perform non-invasive pulmonary hemodynamic 
assessment of patients with LVAD.
1180 CARDIOPULMONARY EXERCISE TESTING NEW 
FINDINGS
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1180-69 Sympathoinhibitory Effect is Sustained Even After 
Removal of Adaptive Servo-ventilation in Patients 
with Heart Failure
Shuji Joho, Daisuke Harada, Yoshitaka Oda, Tadakazu Hirai, 
Hidetsugu Asanoi, Hiroshi Inoue, University of Toyama, Toyama, 
Japan
Learning Objective: identify that respiratory stabilization might 
induce sympathetic inhibition both during and after application of 
ASV.
1180-70 Serial Studies of 6-Minute Walk Test Improve the 
Prediction of Pump Failure Death, not Sudden 
Death, in Patients With Mild to Moderate Chronic 
Heart Failure: A 10-Year Prospective Study
Takahisa Yamada, Yuji Okuyama, Takashi Morita, Yoshio Furukawa, 
Koji Tanaka, Yusuke Iwasaki, Taku Yasui, Michihiro Ueda, Takeshi 
Okada, Masato Kawasaki, Yuki Kuramoto, Masatake Fukunami, 
Osaka General Medical Center, Osaka, Japan
Learning Objective: interpret the long-term prognostic significance of 
serial studies of 6-minute walk test, relating to the mode of death, 
in patients with chronic heart failure
1180-72 Improved Exercise Capacity In Hfnef Correlates 
With Improved Diastolic Function, But Unchanged 
Chronotropic Competence
Rolf Wachter, Hans-Dirk Düngen, Götz Gelbrich, Silja Schwarz, 
Markus Löfﬂer, Gerd Hasenfuß, Martin Halle, Burkert Pieske, Frank 
Edelmann, University of Goettingen, Goettingen, Germany, Medical 
University of Graz, Graz, Austria
Learning Objective: know the effects of exercise training in patients 
with heart failure and normal ejection fraction
1179 ANEMIA AND THE CARDIORENAL SYNDROME
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1179-61 Optimal Therapeutic Regimen for Rapid Correction 
of Anemia due to Iron Deficiency in Patients with 
Advanced Heart Failure
Elisavet Kaldara, John Terrovitis, Eleni Tseliou, George Alexopoulos, 
Vanessa Kontopidi, Zaﬁria Margari, Argirios Ntalianis, Lampros 
Katsaros, Charis Matsouka, Maria Anastasiou-Nana, John N. Nanas, 
University of Athens, 3rd Cardiology Dept, Athens, Greece
Learning Objective: Determine the etiology of anemia in patients 
with severe heart failure and select the most appropriate treatment
1179-62 Relative Deficiency of Endogenous Erythropoietin 
and Increased Muscle Sympathetic Nerve Activity in 
Patients with Cardio-renal Anemia Syndrome
Shuji Joho, Yoshitaka Oda, Daisuke Harada, Tadakazu Hirai, Hiroshi 
Inoue, University of Toyama, Toyama, Japan
Learning Objective: interpret that EPO depletion coexisting 
sympathetic overactivation is frequently complicated in patients 
with CRAS.
1179-63 Effectiveness of Aggressive Heart Failure 
Management Despite Cardiorenal Syndrome in the 
Outpatient Setting: Symptom Improvement and 
Prevention of Readmission
Mridula Rai, Faisal Zaeem, Dalia Giedrimiene, Lynn O’Bara, Daniel 
Madison, Joseph Radojevic, Detlef Wencker, Hartford Hospital and 
University of Connecticut, Hartford, CT
Learning Objective: To evaluate the safety and effectiveness of high 
dose intravenous diuretic therapy in the outpatient setting among 
patients with Cardiorenal Syndrome.
1179-64 Clinical Outcomes of Heart Failure Patients 
with Anemia of Chronic Kidney Disease Taking 
Erythropoietin
Cynthia Jackevicius, Alberta Warner, Western University of Health 
Sciences, Los Angeles, CA, VA Greater Los Angeles Healthcare 
System, Los Angeles, CA
Learning Objective: Describe the association between use of 
erythropoietin and outcomes in CRAS patients.
1179-65 Effects of the Adenosine A1-antagonist Rolofylline 
on Renal Function in Acute Heart Failure Patients: 
Results From the Protect Study
Adriaan A. Voors, Howard C. Dittrich, Barry M. Massie, Paul 
DeLucca, George Mansoor, Michael M. Givertz, PROTECT 
Investigators and Committees, Merck & Co., Inc., Rahway, NJ
Learning Objective: understand the effects of the adenosine 
A1-antagonist rolofylline on renal function in acute heart failure 
patients.
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1181-79 Markedly Increased Circulating Rho-kinase Activity 
In Patients With Chronic Heart Failure
Luigi Gabrielli, Jorge Jalil, Maria P. Ocaranza, Ivan Godoy, Paul 
McNab, Pablo Castro, Ulises Novoa, Italo Mora, Sergio Lavandero, 
Lorena Garcia, Ivonne Padilla, Pontiﬁcia Universidad Catolica, 
Santiago, Chile
Learning Objective: to determine the Rho kinase activity in stable 
chronic systolic heart failure patients with optimal medical 
treatment.
1181-80 Galectin-3, Cardiac Structure and Function, and Long-
term Mortality in Patients with Acute Heart Failure
Ravi V. Shah, Annabel A. Chen-Tournoux, Michael H. Picard, Roland 
RJ van Kimmenade, James L. Januzzi, Massachusetts General 
Hospital, Boston, MA
Learning Objective: Identify relationships between gal-3 and cardiac 
structure, and use gal-3 in addition to traditional echocardiographic 
markers of risk for enhanced risk stratification in patients with 
acute HF
1181-81 Prognostic Impact Of Matrix Metalloproteinases In 
Patients With Acute Heart Failure
Akihiro Shirakabe, Kuniya Asai, Noritake Hata, Shiya Yokoyama, 
Takuro Shinada, Nobuaki Kobayashi, Kyoichi Mizuno, Chiba Hokusoh 
Hospital, Nippon Medical School, Chiba, Japan, Nippon Medical 
School, Tokyo, Japan
Learning Objective: Evaluate the prognostic impact of matrix 
metalloproteinases in patients with acute heart failure
1181-82 Levels of Soluble Wnt-Inhibitors are Related to 
Systolic Function and Predict Outcome in Patients 
With Chronic Heart Failure
Erik T. Askevold, Christen P. Dahl, Kaspar Broch, Svend Aakhus, Arne 
Yndestad, Lars Gullestad, Pål Aukrust, Thor Ueland, Oslo University 
Hospital, Rikshospitalet, Oslo, Norway, University of Oslo, Oslo, Norway
Learning Objective: identify a role for the Wnt-pathway in heart 
failure in a clinical setting.
1181-84 Clinical and Prognostic Implications of Early 
Troponin I Increase in Trastuzumab Induced 
Cardiotoxicity.
Carlo M. Cipolla, Alessandro Colombo, Rosalba Torrisi, Maria Teresa 
Sandri, Maurizio Civelli, Giuseppina Lamantia, Nicola Colombo, 
Michela Salvatici, Sarah Cortinovis, Maria Antonietta Dessanai, 
Franco Nole’, Fabrizio Veglia, Daniela Cardinale, European Institute 
of Oncology, Milan, Italy, Centro Cardiologico Monzino, Milan, Italy
Learning Objective: identify patients at risk of TIC and of not recover 
from cardiac dysfunction.
1181-85 Subclinical Hypothyroidism as a Risk Factor for 
Cardiac Death in Patients with Chronic Heart 
Failure, Irrespective of Renal Dysfunction: A 
Prospective 10-year Follow up Study
Hiromichi Ueda, Takahisa Yamada, Yuji Okuyama, Takashi Morita, 
Yoshio Furukawa, Koji Tanaka, Yusuke Iwasakki, Taku Yasui, Takeshi 
Okada, Masato Kawasaki, Yuki Kuramoto, Masatake Fukunami, 
Osaka General Medical Center, Osaka, Japan
Learning Objective: evaluate a risk factor of cardiac death in chronic 
heart failure patients
1180-73 Role of Oscillatory Breathing during 
Cardiopulmonary Exercise Test for Prognostic 
Stratification of Elderly Patients with Chronic Heart 
Failure
Angela Beatrice Scardovi, Renata De Maria, Alessandro Ferraironi, 
Andrea Celestini, Silvia Forte, Marina Parolini, Laura Gatto, Loretta 
Bordi, Sebastiano Sciarretta, Roberto Ricci, Marco Guazzi, Dr. 
Roberto Ricci, Rome, Italy
Learning Objective: evaluate
1180-74 Clinical Importance and Interdependence of 
Periodic Breathing During Asleep and Exercise in 
Patients With Heart Failure
Yoshitaka Oda, Shuji Joho, Daisuke Harada, Tadakazu Hirai, Hiroshi 
Inoue, The Second Department of Internal Medicine, Toyama 
University Hospital, Toyama, Japan
Learning Objective: recognize that lower carbon dioxide level and cycle 
length of sleep apnea contribute to periodic breathing during asleep 
and exercise in heart failure patients with central sleep apnea.
1180-75 Increased Exhaled Nitric Oxide Levels in Ambulatory 
Patients with Chronic Systolic Heart Failure 
Following Exercise: Importance of Pulmonary 
Venous Hypertension
Wai Hong Wilson Tang, Akanksha Thakur, Praneet Kumar, Anne 
Kanderian, Alan G. Borowski, Gary S. Francis, Cleveland Clinic, 
Cleveland, OH
Learning Objective: To examinine the cardiac determinants of 
exhaled nitric oxide in chronic systolic heart failure
1180-76 Left Ventricular Systolic Dyssynchrony is more 
Common in Acute Decompensated than Chronic 
Stable Heart Failure with Reduced Ejection Fraction
Qing Zhang, Yong-Tai Liu, Alex PW Lee, Yu-Jia Liang, Gabriel WK Yip, 
Rui-Jie Li, Jun-Min Xie, Cheuk-Man Yu, The Chinese University of 
Hong Kong, Hong Kong, Hong Kong, West China Hospital, Sichuan 
University, Chengdu, Sichuan, People’s Republic of China
Learning Objective: identify the difference in mechanical 
dyssynchrony between acute and chronic systolic heart failure that 
may explain for the acute exacerbation of HF symptoms.
1181 PREDICTORS OF REMODELING AND OUTCOME
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1181-78 Urine 8-hydroxy-2’-deoxyguanosine is a Marker 
for Predicting Mortality and Morbidity as well 
as Evaluating the Effectiveness of Beta-blocker 
Therapy in Patients with Chronic Heart Failure
Tekehisa Susa, Shigeki Kobayashi, Takeo Tanaka, Shinichi Okuda, 
Masahiro Doi, Yasuaki Wada, Jutaro Yamada, Takeshi Ueyama, 
Shuji Kawamura, Masafumi Yano, Masunori Matsuzaki, Yamaguchi 
University Graduate School of Medicine, Ube, Japan
Learning Objective: Clarify that urine 8-OHdG is a useful biomarker 
for predicting mortality and morbidity as well as evaluating the 
effectiveness of beta-blocker therapy in patients with CHF.
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1231 MYOCARDITIS AND DILATED CARDIOMYOPATHY
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1231-41 WITHDRAWN
1231-42 Impact Of Dual Mutations Of Sarcomere Gene 
On Clinical Manifestation Of Hypertrophic 
Cardiomyopathy Associated With Myosin-binding 
Protein C Gene Mutation: Evidence From Serial 
Analysis Of 50 Genotyped Patients
Akihiko Muramoto, Noboru Fujino, Kenshi Hayashi, Katsuharu 
Uchiyama, Eiichi Masuta, Akira Funada, Yuichiro Sakamoto, 
Junichiro Yokawa, Hidekazu Ino, Masakazu Yamagishi, Division of 
Cardiology, Kanazawa University, Kanazawa, Japan
Learning Objective: evaluate the risk of HCM patients
1231-43 Biopsy-Proven Active Myocarditis in Systemic 
Sclerosis Patients With Recent-Onset Cardiac 
Involvement
Costantino Smaldone, Maurizio Pieroni, Maria De Santis, Gaetano 
Zizzo, Mara Campioni, Antonella Ventrone, Antonia Camporeale, 
Andrea Macchione, Anna Severino, Fulvio Bellocci, Gianfranco 
Ferraccioli, Filippo Crea, Catholic University of the Sacred Heart, 
Rome, Italy
Learning Objective: Identify scleroderma patients with cardiac 
involvement
1231-44 MURC encoding Muscle-Restricted Coiled-Coil is a 
Novel Gene for Human Dilated Cardiomyopathy
Ali J. Marian, Gabriela Rodriguez, Grazyna Czernuszewicz, Simon 
Sims, Yanli Tan, Gerald W. Dorn, Roberta Bogaev, James Willerson, 
institute of Molecular Medicine, Center for Cardiovascular Genetics, 
Houston, TX, Texas Heart Institute, Houston, TX
Learning Objective: To identify genetic basis of heart failure
1231-45 Prevalence of Different Etiologies in Dilated 
Cardiomyopathy
Sabine Pankuweit, Anette Richter, Volker Ruppert, Götz Gelbrich, 
Bernhard Maisch, Competence Net work heart failure, Dept. of 
Cardiology, Philipps-University Marburg, Marburg, Germany
Learning Objective: distinguish different etiologies in DCM and will 
be able to evaluate a given patient with regard to his etiology
1230 MYOCARDIAL FIBROSIS AND CARDIAC MRI
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1230-35 Immunohistochemical Expression of N-cadherin is 
Decreased in Autopsy Tissues with ARVC
Nathaniel B. Cresswell, Fabio Tavora, Wei-Sing Chu, Erik Mont, 
Marcello Franco, Allen Burke, Armed Forces Institute of Pathology, 
Washington, DC, Federal University of Sao Paulo, Sao Paulo, Brazil
Learning Objective: Immunohistochemical expression of 
desmosomal related proteins in ARVC
1230-36 Slowed Ventricular Untwisting is Related to 
Decreased Elastic Recoil but not to Increased 
Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Ayumi Nakaboh, Akiko Goda, Katsumi Oka, Misato Otsuka, Mika 
Matsumoto, Chikako Yoshida, Akiyo Eguchi, Shohei Fujiwara, 
Naoki Yoshimoto, Masaaki Lee-Kawabata, Takeshi Tsujino, Tohru 
Masuyama, Department of Internal Medicine, Cardiovascular 
Division, Hyogo College of Medicine, Nishinomiya, Japan
Learning Objective: apply echo speckle tracking method to assess 
the degree of myocardial fibrosis with impaired LV twisting and 
slowed active relaxation and/or decreased elastic recoil with slowed 
LV untwisting in HCM.
1230-37 SCN5A Mutations Associated With Dilated 
Cardiomyopathy Commonly Localize To The Voltage-
sensing Mechanism
Luisa Mestroni, William McNair, Gianfranco Sinagra, Andrea Di 
Lenarda, Debra Ferguson, Ernesto E. Salcedo, Dobromir Slavov, 
Dobromir Slavov, Xiao Zhu, John Caldwell, Matthew R.G. Taylor, 
Familial Cardiomyopathy Registry, University of Colorado Denver, 
Aurora, CO, Hospital and University of Trieste, Trieste, Italy
Learning Objective: identify molecular epidemiology of DCM
1230-38 Visualization of Myocardial Scarring/Fibrosis in 
Patients with Hypertrophic Cardiomyopathy: Cardiac 
Magnetic Resonance vs Dual Source Computed 
Tomographic Imaging
Aya Kino, Jennifer Berliner, James C. Carr, Robert O. Bonow, Lubna 
Choudhury, Northwestern University, Chicago, IL
Learning Objective: Demonstrate the feasibility of ce MDCT to 
detect focal myocardium scarring in HCM patients.
1230-39 Variability of Adiponectin Levels at Different Stages 
of Atherogenesis, from Obesity to Advanced 
Atherosclerosis and Heart Failure
Alexis S. Antonopoulos, Charalambos Antoniades, Dimitris 
Tousoulis, Antigoni Miliou, Constantinos Bakogiannis, Kyriakoula 
Marinou, Michael Dimosthenous, Costas Psarros, Keith M. 
Channon, Christodoulos Stefanadis, 1st Cardiology Department 
Hippokration Hospital, Athens, Greece, University of Oxford, Oxford, 
United Kingdom
Learning Objective: Intrerpret adiponectin expression in different 
stages of cardiovascular disease
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1233 DILATED CARDIOMYOPATHY AND AMYLOIDOSIS
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1233-55 Left Atrial Dysfunction in Patients with Systemic 
Amyloidosis
Masatoshi Minamisawa, Jun Koyama, Hirohiko Motoki, Ayako 
Takahashi, Kazunori Aizawa, Megumi Koshikawa, Hiroki Kasai, 
Atsushi Izawa, Takeshi Tomita, Yusuke Miyashita, Setsuo Kumazaki, 
Uichi Ikeda, Shinshu University School of Medicine, Matsumoto, 
Japan
Learning Objective: learn the existence of latent atrial dysfunction in 
patients with systemic amyloidosis.
1233-56 Relation of Plasma Neutrophil Gelatinase-
Associated Lipocalin (NGAL) Levels with Myocardial 
Function and Prognosis in Patients with Chronic 
Systolic Heart Failure
Kevin L. Shrestha, Richard W. Troughton, Allen G. Borowski, Allen L. 
Klein, Wai Hong Wilson Tang, Cleveland Clinic, Cleveland, OH
Learning Objective: Identify clinical and echocardiographic 
determinants of plasma NGAL levels independent of renal function 
in the setting of chronic systolic heart failure
1233-57 Left Atrial Volume as a Predictor of Reversible 
Myocardial Dysfunction in Patients with 
Dilated Cardiomyopathy Who Have No Delayed 
Enhancement on Magnetic Resonance Imaging
Jeonggeun Moon, In Jeong Cho, Chi Young Shim, Seok-Min Kang, 
Yangsoo Jang, Namsik Chung, Jong-Won Ha, Yonsei University 
College of Medicine, Seoul, South Korea
Learning Objective: identify which patient will recover even in the 
absence of delayed enhancement on cardiac MRI using left atrial 
volume index as an predictor with high specificity.
1233-58 Reduction in Ventricular Wall Thickness Following 
High-dose Chemotherapy and Stem-cell 
Transplantation for AL Cardiac Amyloidosis
Frederick L. Ruberg, Vaishali Sanchorawala, John Berk, Kathleen T. 
Finn, Martha Skinner, David C. Seldin, Hans Meier-Ewert, Boston 
University School of Medicine/Boston Medical Center, Boston, MA
Learning Objective: Describe the ventricular remodeling that 
occurs following successful stem-cell transplantation for cardiac 
amyloidosis.
1233-59 Detection of Autoimmune T-cell Responses 
to Cardiac Troponin I in Idiopathic Dilated 
Cardiomyopathy using Enzyme-Linked Immunospot 
Assay
Carmel M. Halley, Jason M. Lappe, Anne C. Cotleur, Wai Hong 
Wilson Tang, Heart and Vascular Institute, Cleveland Clinic 
Foundation, Cleveland, OH
Learning Objective: Understand the complexity of autoimmune T-cell 
response to pathogenesis of idiopathic dilated cardiomyopathy
1232 HYPERTROPHIC CARDIOMYOPATHY AND 
AMYLODOSIS
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1232-47 Induction of Apoptosis from Acute Exposure to 
AL Amyloidosis Light Chains in Bovine Aortic 
Endothelial Cells and Protection by Simvastatin
Mitchell A. Timmons, Seth Truran, Brittany Schlundt, David D. 
Gutterman, Sergey Gurevich, Parameswaran Hari, Raymond Q. 
Migrino, Medical College of Wisconsin, Milwaukee, WI
Learning Objective: Identify that acute exposure of human 
amyloidogenic light chains induces apoptosis in bovine aortic 
endothelial cells that is attenuated by simvastatin.
1232-48 Peripheral Collagen Markers Predict All-cause 
Mortality and Cardiovascular Hospitalisation in 
Patients with Heart Failure and Preserved Ejection 
Fraction: Results of the I-PRESERVE Collagen Sub-
study
Henry Krum, Maros Elsik, Hans G. Schneider, Agata Ptaszynska, 
Marion Black, Peter Carson, Barry Massie, Monash University, 
Melbourne, Australia
Learning Objective: suggesting a key pathophysiological role of 
fibrosis in this setting
1232-49 Targeting Frequent Ventricular Ectopic Beats as 
Therapeutic Strategy for a Form of Reversible 
Dilated Cardiomyopathy: A Single-Center Experience
Deven M. Patel, Mandeep Bhargava, Wai Hong Wilson Tang, 
Cleveland Clinic Foundation, Cleveland, OH
Learning Objective: identify a potentially reversible dilated 
cardiomyopathy if the culprit PVCs are ablated.
1232-50 The Complex Interplay Between Late-enhancement 
on Cardiac Magnetic Resonance, Outflow 
Obstruction and Left Ventricular Function During 
Exercise in Hypertophic Cardiomyopathy. An 
Exercise Echocardiography-Magnetic Resonance 
Study
Elena Biagini, Massimiliano Lorenzini, Guido Rocchi, Fabio Coccolo, 
Rossella Fattori, Francesco Lai, Claudia Borghi, Angelo Branzi, 
Claudio Rapezzi, Institute of Cardiology, S.Orsola-Malpighi Hospital, 
Bologna University, Bologna, Italy, Italy
Learning Objective: Understand the complex pathophysiology of 
hypertophic cardiomyopathy during exercise
1232-51 High Prevalence of Metabolic Gene Mutations in 
Patients Referred for Hypertrophic Cardiomyopathy 
Genetic Testing
Tom E. Callis, Lisa Susswein, William Ferguson, Michael J. 
Ackerman, Benjamin A. Salisbury, PGxHealth, New Haven, CT, Mayo 
Clinic, Rochester, MN
Learning Objective: Describe the spectrum and prevalence of 
sarcomeric and metabolic gene mutations in suspected HCM 
patients.
JACC    March 9, 2010 ABSTRACTS: Cardiac Function and Heart Failure A37
Cardiac Function and H
eart Failure
1235 BETABLOCKERS AND HEART FAILURE; NEW 
FINDINGS
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1235-69 Which Beta Blocker Restores Left Ventricular 
Synchronisation Better? A Randomised Trial 
Of Carvedilol And Metoprolol In Patients With 
Idiopathic Dilated Cardiomyopathy And Heart 
Failure
MEHMET KAYA, BAHADIR SARLI, YAT Y. LAM, ESMA G. KAYA, 
ALI DOGAN, TUGRUL INANC, OZGUR GUNEBAKMAZ, MIKAIL 
YARLIOGLUES, NIHAT KALAY, RAMAZAN TOPSAKAL, ERCIYES 
UNIVERSITY, KAYSERI, Turkey
Learning Objective: Both carvedilol and metoprolol similarly restore 
intraventricular and interventricular synchronization and LV reverse 
remodeling in patients with idiopathic DCMP and heart failure.
1235-70 Beta-blocker Intensification in Ambulatory Heart 
Failure Patients and Short-term Association with 
Subsequent Hospitalization
Larry Allen, Pamela N. Peterson, Chan Zeng, Christina L. Clark, 
Susan Shetterly, Joann Lindenfeld, David J. Magid, Frederick A. 
Masoudi, University of Colorado Denver, Division of Cardiology, 
Aurora, CO, Kaiser Permanente of Colorado, Instutite for Health 
Research, Denver, CO
Learning Objective: Consider potential adverse effects of beta-
blocker intensification in heart failure patients and potential 
methods for preventing these events.
1235-72 Impact of Baseline Volume Status and LVEF on All-
Cause Mortality in the BEST Trial
Inderjit S. Anand, Mona Fiuzat, Christopher O’Connor, JoAnn 
Lindenfeld, Peter Carson, Eric Eicchorn, James Udelson, Michael 
Domanski, Gordon Davis, Michael Bristow, VAMC Minneapolis, 
Minneapolis, MN, University of Colorado, Denver, CO
Learning Objective: Identify appropriate patient populations for use 
of BBs
1235-73 Higher Neurohormonal Activation Is Associated with 
a Positive Response to Carvedilol in Patients with 
Systolic Heart Failure
Roberto Spoladore, Gabriele Fragasso, Altin Palloshi, Angelo 
Corti, Guido Lattuada, Barbara Colombo, Massimo Locatelli, 
Anna Salerno, Alberto Margonato, Cardiothoracic and Vascular 
Department, Clinical Cardiology, San Raffaele Hospital, Milan, Italy
Learning Objective: To indentify heart failure patients responder and 
not-responder to carvedilol therapy
1235-74 Left Ventricular Ejection Fraction Decrease after 
Response to Beta Blocker Therapy in Patients with 
Non-Ischemic Cardiomyopathy
Patrick Hourani, Iosif Kelesidis, Christopher Varughese, Ronald 
Zolty, Albert Einstein College of Medicine / Monteﬁore, Bronx, NY
Learning Objective: Measure the frequency of left ventricular 
ejection fraction decline after initial response to beta blocker 
therapy in patients with non-ischemic cardiomyopathy.
1234 HYPERTROPHIC CARDIOMYOPATHY AND AORTIC 
FUNCTION
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1234-61 Elevated Pulse Pressure Is Associated with an 
Abnormal Blood Pressure Response to Exercise in 
Patients with Hypertrophic Cardiomyopathy
Kevin Heffernan, Martin S. Maron, Eshan Patvardhan, Richard H. 
Karas, Jeffrey T. Kuvin, Tufts Medical Center, Boston, MA
Learning Objective: understand the role of pulse pressure in 
predicting high risk patients with hypertrophic cardiomyopathy.
1234-62 Myocardial Systolic Deformation and Torsion 
Assessed by Speckle Tracking for Early Detection 
of Epirubicin-Induced Cardiac Dysfunction in 
Asymptomatic Patients with Breast Cancer
Maria Florescu, Stefania Magda, Oana Aurelia Enescu, Dan Jinga, 
Mircea Cinteza, Dragos Vinereanu, University Hospital of Bucharest, 
Bucharest, Romania, University of Medicine and Pharmacy Carol 
Davila, Bucharest, Romania
Learning Objective: Identify early cardiac dysfunction in 
asymptomatic patients with breast cancer treated with epirubicin
1234-63 Pre-Existing Left Ventricular Dysfunction in Patients 
Undergoing Kidney Transplantation: Implications 
for Patient Selection,Cardiac Risk Stratification and 
Impact on Post Transplant Outcomes
Joseph Chattahi, Vanji Karthikeyan, Haitham Kanneh, Jayanth 
Koneru, Sylvia Hayek, Anita Patel, Mariella Goggins, Karthikeyan 
Ananthasubramaniam, Henry Ford Health System, Detroit, MI
Learning Objective: Demonstrate that low EF in patients with chronic 
kidney disease should not preclude them from getting kidney 
transplant as it is not associated with worse graft function or overall 
mortality
1234-64 Long-term Outcome of Percutaneous Septal 
Ablation for Symptomatic Hypertrophic Obstructive 
Cardiomyopathy
Lothar Faber, Dirk Welge, Hubert Seggewiss, Detlef Hering, Olaf 
Oldenburg, Dieter Horstkotte, Department of Cardiology, Heart 
Center North Rhine-Westphalia, Ruhr-University Bochum, Bad 
Oeynhausen, Germany, Medical Clinic I, Leopoldina Hospital, 
Schweinfurt, Germany
Learning Objective: interpret long-term data after interventional 
treatment of symptomatic HOCM
1234-65 Aortic Stiffness, In Addition to Myocardial Scarring 
and Mitral Regurgitation, Incrementally Predicts 
Outcomes in Severe Ischemic Cardiomyopathy 
Patients
Ashley M. Lewis, Deborah H. Kwon, Zoran B. Popovic, Carmel M. 
Halley, Paul Schoenhagen, Scott D. Flamm, Brian P. Grifﬁn, Randall 
C. Starling, Milind Y. Desai, Cleveland Clinic, Cleveland, OH
Learning Objective: To understand various multi-modality 
imaging predictors of outcomes in patients with severe ischemic 
cardiomyopathy
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1236-81 Acute Coronary Syndromes in Patients with Heart 
Failure with Preserved Ejection Fraction:  
A Harbinger of Death?
John R. Teerlink, Michael R. Zile, Michel White, Alan B. Miller, 
Jose Lopez-Sendon, William C. Little, Markus Haass, Inderjit 
S. Anand, Agata Ptaszynska, Scott J. Hetzel, Michel Komajda, 
John JV McMurray, Barry M. Massie, Peter E. Carson, I-Preserve 
Investigators, San Francisco VAMC/UCSF, San Francisco, CA
Learning Objective: Evaluate the important role that ACS 
hospitalization has on mortality on patients with HFPEF.
1236-82 Early Estrogen Replacement Prevents Lusitropic 
Impairment Following Ovariectomy in Middle-Aged 
Cynomolgus Monkeys
Leanne Groban, Jewell Jessup, Thomas Register, Wake Forest Univ 
School of Medicine, Winston-Salem, NC
Learning Objective: Describe the effects of estrogen replacement 
on left ventricular diastolic function in postmenopausal female 
cynomologous monkeys
1236-84 Aldosterone Antagonism Increases Post-Exercise 
Recruitment of Systolic Myocardial Motion Over Left 
Ventricular Lateral Wall in Hypertensive Patients 
with Diastolic Heart Failure
Yi-Chih Wang, Chih-Chieh Yu, Fu-Chun Chiu, Chia-Ti Tsai, Ling-Ping 
Lai, Juey-Jen Hwang, Jiunn-Lee Lin, National Taiwan University 
Hospital, Taipei, Taiwan,ROC
Learning Objective: identify the effects of aldosterone antagonism 
on segmental myocardial motion in diastolic heart failure
1236-85 Severity and Acute Changes in Diastolic Function 
with Vasoactive Therapy in Decompensated Systolic 
Heart Failure
Carmel M. Halley, Allen G. Borowski, Kevin Shrestha, James D. 
Thomas, Wai Hong Wilson Tang, Heart and Vascular Institute, 
Cleveland Clinic Foundation, cleveland, OH
Learning Objective: Describe the changes with therapy in diastolic 
function in decompensated systolic heart failure
1235-75 The Nondifferential Effect of Chronic -blocker 
Treatment on Left Ventricular Function and 
Myocardial Glucose Uptake in Heart Failure Patients
Biykem Bozkurt, Mariana Bolos, Maithili Shenoy, Haby Henary, Lance 
K. Gould, Michael E. DeBakey Veterans Affairs Medical Center, 
Houston, TX, Baylor College of Medicine, Houston, TX
Learning Objective: Identify effects of beta blocker tratment on 
myocardial glucose uptake in heart failure patients
1235-76 Nebivolol in Primary Prevention of Chemotherapy-
Induced Cardiomyopathy
Mehmet Kaya, Ozgur Gunebakmaz, Metin Ozkan, Hasan Akkaya, 
Nihat Kalay, Esma G. Kaya, Ali Dogan, Tugrul Inanc, Mustafa 
Dikilitas, Ibrahim Ozdogru, Erciyes University, Kayseri, Turkey
Learning Objective: This study shows that use of prophylactic 
nebivolol have cardioprotective effects in patients with 
chemotherapy-induced cardiotoxicity
1236 HEART FAILURE WITH PRESERVED EJECTION 
FRACTION AND DIASTOLIC FUNCTION
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1236-78 Baseline Systolic Blood Pressure and Outcomes in 
Patients with Heart Failure and Preserved Ejection 
Fraction - Results from the I-Preserve Trial
Inderjit S. Anand, Scott J. Hetzel, Alan B. Miller, Peter E. Carson, 
William H. Gaasch, Markus Haass, William C. Little, Jose Lopez-
Sendon, Barry M. Massie, John J. McMurray, Agata Ptaszynska, 
John R. Teerlink, Michel White, Michael R. Zile, VA Medical Center, 
Minneapolis, MN
Learning Objective: To understand the relation between blood 
pressure and adverse outcomes in patients with heart failure and 
preserved ejection fraction
1236-79 Intravenous GP531, an Adenosine Regulating 
Agent, Improves Left Ventricular Diastolic Function 
in Dogs with Chronic Heart Failure
Hani N. Sabbah, Mengjun Wang, Itamar Ilsar, Ramesh C. Gupta, 
Alice Jiang, Michael S. Sabbah, Kaitlin Dye, Henry Ford Hospital, 
Detroit, MI
Learning Objective: Evaluste the effects of GP531, an adenosine 
regulating agent, on LV distolic function in dogs with heart failure.
1236-80 Do Patients with Diastolic Heart Failure Progress to 
Systolic Heart Failure?
Sultan A. Mirzoyev, Theophilus E. Owan, Omar F. AbouEzzeddine, 
Barry A. Borlaug, David J. Huschka, William D. Edwards, Margaret 
M. Redﬁeld, Mayo Clinic and Foundation, Rochester, MN, University 
of Utah, Salt Lake City, UT
Learning Objective: Assess interval EF measurements from 
hospitalization for DHF to death among DHF patients who had 
autopsy.
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907 CATHETER AND SURGICAL INTERVENTIONS IN 
CONGENITAL HEART DISEASE: FROM FETUS TO 
ADULT
Monday, March 15, 2010, 10:30 a.m. - 12:00 p.m.
Georgia World Congress Center, Room B401
CME/CE Hours: 1.5
10:30 Current Status of Patients with a Biventricular 
Circulation Following Fetal Aortic Valvuloplasty for 
Evolving Hypoplastic Left Heart Syndrome
Lindsay R. Freud, Doff B. McElhinney, Audrey C. Marshall, Gerald R. 
Marx, Pedro J. del Nido, Emile A. Bacha, Carol B. Benson, Louise E. 
Wilkins-Haug, James E. Lock, Wayne Tworetzky, Children’s Hospital 
Boston, Boston, MA, Brigham and Women’s Hospital, Boston, MA
Learning Objective: Describe the current clinical and 
echocardiographic status of patients with a biventricular circulation 
following fetal aortic valvuloplasty for evolving hypoplastic left heart 
syndrome (HLHS).
10:45 Home Monitoring Program Reduces Interstage 
Mortality Following the Modified Norwood Operation
Gail E. Wright, Jennifer Bond, Dannielle Toner, Jana Norris, Frank L. 
Hanley, V. Mohan Reddy, Lucile S. Packard Childrens’ Hospital at 
Stanford University, Palo Alto, CA
Learning Objective: evaluate the efficacy of an interstage home 
monitoring program for reducing interstage mortality following the 
modified Norwood operation
ORAL CONTRIBUTIONS
11:00 Risk Factors for Long Term-Outomes in Balloon 
Valvuloplasty for Aortic Stenosis
Shiraz Maskatia, Frank F. Ing, Henri Justino, Matthew A. Crystal, 
Charles E. Mullins, Raphael J. Mattamal, E. O’Brian Smith, 
Christopher J. Petit, Section Pediatric Cardiology, Department of 
Pediatrics, Baylor College of Medicine, Houston, TX
Learning Objective: identify factors that predict long term outcome 
in balloon valvuloplasty for aortic stenosis
11:15 Arrhythmia Recurrence in Adult Patients with Single 
Ventricle Physiology Following Surgical Fontan 
Conversion
Jamil A. Aboulhosn, Ryan J. Williams, Kalyanam Shivkumar, 
Mark Plunkett, Rakhi Barkowski, Pamela Miner, Hillel Laks, Brian 
Reemtsen, Kevin Shannon, John Child, University of California Los 
Angeles, Los Angeles, CA
Learning Objective: Evaluate the incidence of atrial tachy-arrhythmia 
recurrence following conversion from RA-PA Fontans to total 
cavopulmonary connection in adults.
11:30 Ventricular Function at the Time of Systemic 
Atrioventricular Valve Replacement in Congenitally 
Corrected Transposition of the Great Arteries 
Predicts Long-Term Ventricular Function
François-Pierre Mongeon, Heidi M. Connolly, Joseph A. Dearani, 
Zhuo Li, Carole A. Warnes, Mayo Clinic, Rochester, MN
Learning Objective: Identify surgical indications for systemic 
atrioventricular valve replacement in adult patients with congenitally 
corrected transposition of the great arteries.
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1063-397 Doppler Echocardiography after Bentall Procedure 
Compared to an Isolated Aortic Valve Prostheses
Paul Luijendijk, Michiel S. Evers, Berto J. Bouma, Renee BA van den 
Brink, Barbara JM Mulder, Academic Medical Centre, Amsterdam, 
The Netherlands, Interuniversity Cardiology Institute (ICIN), Utrecht, 
The Netherlands
Learning Objective: interpret the importance of baseline 
echocardiographic examination in patients after a Bentall 
procedure, because of significant higher transvalvular pressure 
gradients compared to isolated AVR
1063-398 Absence of Abdominal Aneurysm in Adults with 
Coarctation and/or Bicuspid Aortic Valve - Is This 
Really An “Aortopathy”?
Anurag Sahu, Vidu Garg, Bethany Boettner, Stephen Cook, The Ohio 
State University, Columbus, OH, Nationwide Children’s Hospital, 
Columbus, OH
Learning Objective: Identify the unique aortopathy associated 
with Coarctation of the Aorta and Bicuspid Aortic Valve and its 
limited involvment of the thoracic aorta without involvement of the 
abdominal aorta.
1064 RIGHT VENTRICLES AND SINGLE VENTRICLES IN 
ADULT CONGENITAL HEART DISEASE
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1064-401 Serial Changes in Systemic Ventricular Volume Long 
After Fontan Operation: Insight Into Better Patient 
Care
Iki Adachi, Hajime Ichikawa, Koji Kagisaki, Takayoshi Ueno, Haruki 
Ide, Takaya Hoashi, Kazuhiko Ishimaru, Masaki Taira, Toru Kuratani, 
Junjiro Kobayashi, Toshikatsu Yagihara, Yoshiki Sawa, Osaka 
University Graduate School of Medicine, Osaka, Japan, National 
Cardiovascular Center, Osaka, Japan
Learning Objective: evaluate the long-term effect of chronic volume 
unloading on a single ventricle sustaining the Fontan circulation
1064-402 Prognostic Implications of Stress Testing in Adults 
with Single Ventricle Congenital Heart Disease
Brenton Bauer, Jamil Aboulhosn, Ryan Williams, University of 
California Los Angeles, Los Angeles, CA
Learning Objective: Evaluate the usefulness of stress test 
parameters in predicting the risk of adverse events in adults with 
single ventricle congenital heart disease.
1064-403 Longitudinal Exercise Function of Patients with 
Repaired Tetralogy of Fallot
Alaina K. Kipps, David M. Harrild, Erik Lewis, Dionne A. Graham, 
Andrew J. Powell, Jonathan Rhodes, University of California, San 
Francisco, San Francisco, CA, Children’s Hospital Boston, Boston, 
MA
Learning Objective: Describe the longitudinal exercise capacity in 
patients with repaired tetralogy of Fallot.
1063 AORTIC ISSUES IN MARFAN SYNDROME AND 
ADULT CONGENITAL HEART DISEASE
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1063-392 The Role of Imaging the Distal Aorta in Adults with 
Marfan Syndrome
Angela T. Yetman, Melanie D. Everitt, Primary Children’s Medical 
Center, Salt Lake City, UT
Learning Objective: demonstrate the frequency of distal aortic 
disease in adults with Marfan Syndrome.
1063-393 Aortic Distensibility is a Predictor for Aortic Events 
in Patients with Marfan Syndrome: a 12 year-
survival analysis
Piet De Witte, Teodora Radonic, Kim Laan, Aeilko H. Zwinderman, 
Barbara JM Mulder, Maarten Groenink, Academic Medical Center, 
Amsterdam, The Netherlands, Interuniversity Cardiology Institute, 
Utrecht, The Netherlands
Learning Objective: identify high risk Marfan patients
1063-395 Are Guidelines Recommending Primary 
Echocardiography Adequate to Screen For Aortic 
Complications in Patients With Bicuspid Aortic 
Valve?
Shane Tsai, Mira Trivedi, Beth Boettner, Curt Daniels, The Ohio 
State University, Columbus, OH, Nationwide Children’s Hospital, 
Columbus, OH
Learning Objective: Evaluate accuracy of echocardiography 
compared to cardiac MRI in detecting aortic complications in 
patients with bicuspid aortic valve
1063-396 Assessment Of Endothelial Function, Numbers 
Of Circulating Endothelial Progenitor Cells, 
Soluble Adhesion Molecules And Serum Levels Of 
Inflammatory Markers Suggest The Absence Of 
Relevant Endothelial Dysfunction In Contemporary 
Patients With Repaired Coarctation
Robert M. Radke, Gerhard-Paul Diller, Michaela Duck, Stefan Orwat, 
Aleksander Kempny, Thomas Thum, Helmut Baumgartner, Adult 
congenital and valvular heart disease center, University Hospital of 
Muenster, Muenster, Germany, Hannover Medical School, Institute 
for Molecular and Translational Therapeutic Strategies, Hannover, 
Germany
Learning Objective: interpret the significance of endothelial 
dysfunction in contemporary patients after surgical repair of aortic 
coarctation.
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1118-393 Mortality in Congenital Heart Disease; are 
Governmental Registries Reliable for Cause of 
Death?
C. Zomer, Cuno S.P.M. Uiterwaal, Enno T. van der Velde, Jan G.P. 
Tijssen, Edwin C.M. Mariman, Carianne L. Verheugt, Petronella G. 
Pieper, Folkert J. Meiboom, Diederick E. Grobbee, Barbara J.M. 
Mulder, Academic Medical Center, Amsterdam, The Netherlands, 
University Medical Center, Utrecht, The Netherlands
Learning Objective: At the conclusion of this presentation, 
participants will be able to evaluate the use of governmental 
registries for cause of death.
1118-395 High Risk Cardiovascular Disease and Pregnancy: 
Can We Change the Risk of Maternal Mortality and 
Complications?
Stephen R. Crumb, David F. Colombo, Stephen C. Cook, Patricia L. 
Woods, Curt J. Daniels, Nationwide Children’s Hospital, Columbus, 
OH, The Ohio State University, Columbus, OH
Learning Objective: Describe the impact of multidisciplinary 
collaboration on high risk pregnancy in women with cardiovascular 
disease
1118-396 Circumstances of Death in Adult Congenital Heart 
Disease
A. C. Zomer, Cuno S.P.M. Uiterwaal, Enno T. v.d. Velde, Lambert 
F.M. van den Merkhof, L. H.B. Bauer, J. M. Ansink, L. Cozijnsen, 
Petronella G. Pieper, Folkert J. Meiboom, Diederick E. Grobbee, 
Barbara J.M. Mulder, Academic Medical Center, Amsterdam, The 
Netherlands, University Medical Center, Utrecht, The Netherlands
Learning Objective: At the conclusion of this presentation, 
participants will be able to describe circumstances of death in adult 
congenital heart disease
1118-397 Risk Factors for Death Following Adult Congenital 
Heart Surgery in Pediatric Hospitals
Yuli Y. Kim, Kimberlee Gauvreau, Emile Bacha, Michael J. Landzberg, 
Oscar J. Benavidez, Children’s Hospital Boston, Boston, MA
Learning Objective: Identify risk factors for inpatient death in adults 
who undergo congenital heart surgery in pediatric hospitals
1118-398 Intra-Atrial Reentry Tachycardia Ablation in Adults 
With Congenital Disease - Curative or Just a 
Successful Procedure?
Jeffrey P. Moak, Marco A. Mercader, Vicki Freedenberg, Mujeeb 
Basit, Jonathan R. Kaltman, Karen S. Kuehl, Children’s National 
Medical Center, Washington, DC, George Washington University, 
Washington, DC
Learning Objective: Identify the likely outcome of arrhythmias after 
ablation of IART in adult patiens with congenital heart disease.
1118-399 Clinical and Echocardiographic Follow-up after 
Surgical Ventricular Septal Defect Closure in Adults
François-Pierre Mongeon, Harold M. Burkhart, Naser M. Ammash, 
Joseph A. Dearani, Zhuo Li, Carole A. Warnes, Heidi M. Connolly, 
Mayo Clinic, Rochester, MN
Learning Objective: Describe the outcomes of surgical ventricular 
septal defect closure in adults.
1064-404 Atrial Baffle Complications Following the Mustard 
Operation in Young Adults with D-Transposition of 
the Great Arteries
Sheetal Patel, Disha Shah, Kavitha Chintala, Peter P. Karpawich, 
Children’s Hospital of Michigan, Detroit, MI
Learning Objective: learn incidence and catheter based treatment 
of atrial baffle complications following Mustard operation for 
d-transposition of great arteries
1064-405 Relationship of Right Ventricular Restrictive 
Physiology with Pulmonary Regurgitation and Age of 
Repair in Patients with Repaired Tetralogy of Fallot
Jimmy C. Lu, Timothy B. Cotts, Prachi P. Agarwal, Anil K. Attili, Adam 
L. Dorfman, University of Michigan, Ann Arbor, MI, University of 
Kentucky, Lexington, KY
Learning Objective: Describe the relationship of right ventricular 
restrictive physiology with right ventricular size and pulmonary 
insufficiency.
1064-407 Accuracy of Right Ventricular Volume and Function 
Analysis in Patients with Systemic Right Ventricles 
Using Knowledge Based Reconstruction
David J. Sahn, Mary-Pierre Waiss, Philip Kilner, Wim Helbing, Harold 
Litt, Karen Stout, Emanuela Valsangiacomo Buechel, Alan Shurman, 
Oregon Health & Science University, Portland, OR, VentriPoint, Inc., 
Seattle, WA
Learning Objective: appreciate complex RV geometry
1064-408 Two-dimensional Echocardiography For Assessment 
Of Right Ventricular Volumes Revisited: An MRI 
Comparison Study In Adults With Repaired 
Tetralogy Of Fallot
Matthias Greutmann, May Ling Mah, Daniel Tobler, Patric Biaggi, 
Andrew Crean, Candice Silversides, Erwin Oechslin, Toronto General 
Hospital, Toronto, ON, Canada
Learning Objective: Estimate the importance of standardized two-
dimensional echocardiographic measurements for assessment of 
right ventricular dimensions.
1118 MORBIDITY AND MORTALITY IN ADULTS WITH 
CONGENITAL HEART DISEASE
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1118-392 Long Term Outcome of Implantable Cardioverter 
Defibrillators in Adults with Congenital Heart 
Disease
Zeliha Koyak, Bart A. Mulder, Isabelle C. van Gelder, Joris R. de 
Groot, Marcelle D. Smit, Pascal F.H.M. van Dessel, Alexander H. 
Maass, Arthur A.M Wilde, Petronella G. Pieper, Reinoud E. Knops, 
Barbara J.M. Mulder, Academic Medical Center, Amsterdam, The 
Netherlands, University Medical Center Groningen, Groningen, The 
Netherlands
Learning Objective: demonstrate that implantable cardioverter 
defibrillators in adults with congenital heart disease is a safe and 
effective therapy
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1119-407 Safety and Efficacy of Intravenous Ultrasound 
Contrast in Evaluating Surgically Corrected 
Congenital Heart Disease Patients with Difficult 
Windows
Shelby Kutty, Christopher Danford, Scott E. Fletcher, Christopher C. 
Erickson, David A. Danford, John D. Kugler, Joan Olson, Thomas R. 
Porter, University of Nebraska Medical Center, Childrens Hospital 
and Medical Center, Omaha, NE
Learning Objective: Understand the role of ultrasound contrast in 
congenital heart disease
1119-408 Effect of Patent Foramen Ovale Closure Device on 
Aortic and Tricuspid Valve Function
Patrick T. Siegrist, Nazmi Krasniqi, Christiane Gruner, Matthias 
Greutmann, Thomas F. Luscher, Roberto Corti, University Hospital 
Zurich, Zurich, Switzerland
Learning Objective: Identify possible complications of percoutanous 
closure of patent foramen ovale
1173 CARDIAC FUNCTION AND CARDIOMYOPATHY IN 
PEDIATRIC PATIENTS
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1173-392 Long-Term Outcomes of Dilated Cardiomyopathy 
Presenting During Childhood: Results From a 
National Population-Based Study of Childhood 
Cardiomyopathy
Peta M. a. Alexander, Katherine Lee, Piers Daubeney, Christian 
Turner, Terry Robertson, Alan Nugent, Andrew Davis, James Ramsay, 
Robert Justo, Tara Bharucha, Ingrid King, Robert G. Weintraub, 
National Australian Childhood Cardiomyopathy Study, Melbourne, 
Australia
Learning Objective: Describe outcomes in a population-based study 
of childhood dilated cardiomyopathy.
1173-393 Altered Cardiac Function and Cardiac Steatosis 
in Overweight Adolescents: Does Obesity 
Cardiomyopathy Evolve in Pediatric Age?
Gautam K. Singh, Bernadette Vitola, Mark Holland, Samuel Klein, 
Washington University School of Medicine, St. Louis, MO
Learning Objective: Describe cardiac dysfunction in adolescents 
with obesity and its association with non alcoholic fatty liver 
disease and insulin resistance
1173-395 Biventricular Pacing Leads To A Sustained 
Increase In Cardiac Index In Infants With Electrical 
Dyssynchrony Following Surgery For Congenital 
Heart Disease
Mark Friedberg, Steven Schwartz, Hargen Zhang, Maria Ilina, 
Elizabeth A. Stephenson, The Hospital for Sick Children, Toronto, 
ON, Canada
Learning Objective: Describe the effect of Biventricular Pacing 
as a therapy for low cardiac output in the setting of electrical 
dyssynchrony in infants after surgery for congenital heart disease
1119 ADULT CONGENITAL HEART DISEASE
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1119-401 Atherosclerosis Progression in Adult Post-
Coarctectomy Patients
Paul Luijendijk, Eric E. de Groot, Joris JW Vriend, Johan J. Gort, 
Berto J. Bouma, Barbara JM Mulder, Academic Medical Centre 
- Department of Cardiology, Amsterdam, The Netherlands, 
Interuniversity Cardiology Institute, Utrecht, The Netherlands
Learning Objective: demonstrate that CIMT increase over time is 
similar in patients after coarctation repair compared to unaffected 
controls, despite an increased baseline CIMT compared to healthy 
controls.
1119-402 Benefits of Exercise Prescriptions in Adults with 
Congenital Heart Disease
Jennifer L. Smith, Anne M. Valente, Mark E. Alexander, Tracy J. Curran, 
Julieanne O’Neill, Kathleen M. Solly, Caitlyn O’Brien-Joyce, Michael J. 
Landzberg, Jonathan Rhodes, Children’s Hospital, Boston, MA
Learning Objective: appreciate the potential benefits and limitations 
of an exercise prescription program for adults with congenital heart 
disease.
1119-403 Transfer Destinations and Risk Factors for No 
Follow-up and ‘No Appropriate Follow-up’ in Young 
Adults with Congenital Heart Disease after Leaving 
Pediatric Cardiology
Eva Goossens, Ine Stephani, Deborah Hilderson, Marc Gewillig, 
Werner Budts, Kristien Van Deyk, Philip Moons, Center for Health 
Services and Nursing Research, Leuven, Belgium
Learning Objective: identify risk factors that are associated with 
‘no follow-up’ and ‘no appropriate follow-up’ in young adults with 
congenital heart disease after leaving pediatric cardiology.
1119-404 Clinical Study on Mortality and Morbidity of Patients 
with Eisenmenger Syndrome -Japanese Multicenter 
study
Hisanori Sakazaki, Koichiro Niwa, Makoto Nakazawa, Tsutomu Saji, 
Toshio Nakanishi, Motoki Takamuro, Michihiko Ueno, Hitoshi Katou, 
Shinichi Takatsuki, Seiki Matsushima, Namiko Kojima, Fukiko Ichida, 
Shigetoyo Kogaki, Sachiko Kido, Yoshio Aragaki, Kenji Waki, Teiji 
Akagi, Kunitaka Jo, Atsushi Souuchi, Kenji Suda, Study committee 
of Japanese Society of Pediatric Cardiology and Cardiology Surgery, 
Hyogo prefectural Amagasaki Hospital, Amagasaki, Japan
Learning Objective: demonstrate prognosis and risk factor
1119-405 Relationship of Orifice Geometry of Anomalous 
Coronary Arteries Arising from Opposing Coronary 
Sinuses (ACAOS) to Functional Myocardial Ischemia 
and Clinical Outcomes: Evaluation by 64-Detector 
Row Coronary Computed Tomographic Angiography
Kelly Axsom, Troy LaBounty, Jin-Ho Choi, James K. Min, Fay Y. Lin, 
Weill-Cornell Medical Center, New York City, NY
Learning Objective: describe the correlates and outcomes of 
anomalous coronary arteries as evaluated by cardiac computed 
tomographic angiography
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1174-402 Evaluation of Bacterial Cellulose as a New Patch 
Material for Closure of Muscular Ventricular Septal 
Defects
Nora F. Lang, Matthias Sigler, Elena Merkel, Franziska Fuchs, Dieter 
Schumann, Dieter Klemm, Friederike Kramer, Anja Meyer, Franz 
Freudenthal, Christian Schroeder, Susanne Mayer, Heinrich Netz, 
Rainer Kozlik-Feldmann, University Hospital Grosshadern, Munich, 
Germany
Learning Objective: Evaluation of biocompatibility
1174-403 Total Anomalous Pulmonary Venous Return--Impact 
of Preoperative Obstruction and Early Elective 
Repair on Outcome and Need for Prolonged 
Mechanical Ventilatory Support
Peter C. Frommelt, David Sheridan, Michele A. Frommelt, S. Bert 
Litwin, James S. Tweddell, Medical College of Wisconsin, Milwaukee, 
WI, Children’s Hospital of Wisconsin, Milwaukee, WI
Learning Objective: identify risk factors for morbidity and mortality 
after repair of total anomalous pulmonary venous return surgery.
1174-404 Parental Knowledge Regarding Life-Long Congenital 
Cardiac Care
Susan M. Fernandes, Amy Verstappen, Kathy Ackerman, Elizabeth 
E. Adams, Cheryl Barton, Petar Breitinger, Stephen Crumb, Kirsten 
Dummer, Paul Khairy, Michael J. Landzberg, Rachel Linstead 
Goldsmith, JoAnn Nieves, Arwa Saidi, Masato Takahashi, Sonja 
Ziniel, Roberta Williams, Children’s Hospital, Boston, MA
Learning Objective: Understand that parents of children with 
moderate and complex congenital heart disease need education 
regarding life long cardiac care.
1174-405 Mechanical Circulatory Support in the Treatment of 
Children with Acute Fulminant Myocarditis: A Single 
Center 14-Year Experience
Ivan Wilmot, Mary C. McGarry, David L. Morales, John L. Jefferies, 
Texas Children’s Hospital, Houston, TX
Learning Objective: Participants will be able to identify mechanical 
circulatory support as a successful therapy for acute myocarditis in 
children.
1174-407 Cardiac Magnetic Resonance Can Obviate The Need 
For Routine Cardiac Catheterization Prior to Fontan: 
A Study of 3 Groups
Mark A. Fogel, Thomas Pawlowski, Matthew Harris, Kevin 
Whitehead, Marc Keller, Jack Rome, Childrens Hospital of 
Philadelphia, Philadelphia, PA
Learning Objective: Identify the issues surrounding routine cardiac 
cath prior to Fontan and how CMR alleviates it
1174-408 Histopathologic Evaluation of Patent Ductus 
Arteriosus Stents after Hybrid Palliation of 
Hypoplastic Left Heart Syndrome
Matthew Egan, Aaron J. Trask, Peter B. Baker, Jonathan Lawrence, 
Elena Ladich, Renu Virmani, Sharon L. Hill, Pamela A. Lucchesi, 
Mark Galantowicz, John P. Cheatham, John P. Kovalchin, Nationwide 
Children’s Hospital, Columbus, OH
Learning Objective: Describe the histology of neointima formation in 
PDA stents
1173-396 Left Ventricular Noncompaction in a Pediatric 
Population: Predictors of Survival
Warren Zuckerman, Marc E. Richmond, Rakesh K. Singh, Carroll J. 
Sheila, Thomas J. Starc, Linda J. Addonizio, New York Presbyterian 
Hospital/Columbia University Medical Center, New York, NY, New 
York Presbyterian/Cornell University Medical Center, New York, NY
Learning Objective: determine the likely clinical outcome of a 
pediatric patient with left ventricular noncompaction.
1173-397 Long-Term Outcomes of Hypertrophic 
Cardiomyopathy Presenting During Childhood: 
Results from a National Population-Based Study of 
Childhood Cardiomyopathy
Peta M. a. Alexander, Katherine Lee, Alan Nugent, Christian Turner, 
Terry Robertson, Piers Daubeney, Andrew Davis, James Ramsay, 
Robert Justo, Tara Bharucha, Ingrid King, Robert G. Weintraub, 
National Australian Childhood Cardiomyopathy Study, Melbourne, 
Australia
Learning Objective: Describe outcomes from a population-based 
study of childhood hypertrophic cardiomyopathy.
1173-398 Genetic and Viral Genome Analysis of Childhood 
Cardiomyopathy: The PCMR/PCSR Experience
Jeffrey A. Towbin, Lynn Sleeper, John L. Jefferies, Steven Colan, 
Steven A. Webber, Charles E. Canter, Daphne T. Hsu, Stephanie 
M. Ware, James D. Wilkinson, E. John Orav, Steven E. Lipshultz, 
Cincinnati Children’s Medical Center, Cincinnati, OH, University of 
Miami, Miami, FL
Learning Objective: describe genetic variants and viral causes of 
cardiomyopathy and myocarditis in children
1173-399 NT- Pro BNP Versus BNP And Their Correlation With 
Cardiac Function In Pediatric Transplant Or Heart 
Failure Patients
Chesney Castleberry, Stanley Lo, Kathryn Tillman, Gail Stendahl, 
Kwang Woo Ahn, Stuart Berger, Steven Zangwill, Children’s Hospital 
of Wisconsin, Milwaukee, WI, Medical College of Wisconsin, 
Milwaukee, WI
Learning Objective: Determine correlation between BNP and pro 
BNP in pediatric heart failure or transplantation.
1174 PEDIATRIC CARDIOLOGY
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1174-401 Route of Delivery Does Not Impact Perinatal 
Hemodynamics in Infants with Hypoplastic Left 
Heart Syndrome
Amy Peterson, Michael D. Quartermain, Anne Ades, Jack Rychik, The 
Children’s Hospital of Philadelphia, Philadelphia, PA
Learning Objective: Describe the impact mode of delivery has on 
perinatal hemodynamics in infants with Hypoplastic Left Heart 
Syndrome.
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1228-399 Defining Normative Values and Dispersion in 
Outcome Measures after Cardiac Surgery in Infants
Mark Scheurer, Kimberlee Gauvreau, Andrew M. Atz, Peter Laussen, 
John E. Mayer, Jr., Jane Newburger, Children’s Hospital Boston, 
Boston, MA
Learning Objective: Understand the national variation of outcome 
measures after infant cardiac surgery
1229 PRACTICAL ISSUES IN PEDIATRIC CARDIOLOGY
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1229-401 Patent Foramen Ovale in Children with Migraine 
Headache
Rachel T. McCandless, Cammon B. Arrington, Douglas C. Nielsen, 
James F. Bale, Jr., L. LuAnn Minich, Primary Children’s Medical 
Center, University of Utah, Salt Lake City, UT
Learning Objective: Decribe the association of patent foramen ovale 
and pediatric migraine headache with aura.
1229-402 Oxygen Consumption Recovery Following a Maximal 
Bicycle Exercise Test in Children: A Potential Tool for 
Assessing Cardiac Performance in Children
Tajinder P. Singh, Mark Alexander, Tracy Curran, Yael H. Rhodes, 
Jonathan Rhodes, Children’s Hospital Boston, Boston, MA
Learning Objective: To understand the predictors of oxygen 
consumption recovery following an exercise test in children
1229-403 Outpatient Evaluation of Innocent Murmurs in 
Children: Utilization Benchmarking.
Patrick A. Frias, Dara A. Rastegar, William T. Cole, William T. Mahle, 
Children’s Healthcare of Atlanta Sibley Heart Center, Atlanta, GA, 
Emory University School of Medicine, Atlanta, GA
Learning Objective: Define benchmarking data for echo utilization 
in the outpatient evaluation of innocent murmurs by pediatric 
cardiologists.
1229-404 Adverse Events Associated with Oral 
Anticoagulation of Patients with Congenital Heart 
Disease
Michael Colon, Andrea Benin, Veronika Northrup, Nancy Rollinson, 
Yale University, New Haven, CT
Learning Objective: Identify risk factors for adverse events related 
to oral anticoagulation in congential heart disease patients
1229-405 The Prevalence of Atrial Level Shunts in Children 
with Migraine
Christa Miliaresis, John Fahey, Susan Levy, Francine Testa, Yale New 
Haven Hospital, New Haven, CT, Bridgeport Hospital, Bridgeport, CT
Learning Objective: identify the relationship between PFO and 
children with migraine
1228 FETAL AND NEONATAL CARDIOLOGY
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1228-392 Insights into Ventricular Mechanics in the Unlooped 
Heart: Ventricular Twisting and Untwisting in a Right 
Atrial Isomerism Single Ventricle Fetal Mouse Model
David J. Sahn, Lowell H. Frank, Linda Leatherbury, Uyen T. Truong, 
Cecelia W. Lo, Qing Yu, Petra S. Niemann, Oregon Health & Science 
University, Portland, OR, Children’s National Medical Center, 
Washington, DC
Learning Objective: understand fetal ventricular-ventricular 
interaction
1228-393 Right Atrial Dysfunction in Fetuses with Severe 
Tricuspid Valve Disease: Novel Experience with 
Velocity Vector Imaging
Lisa W. Howley, Nee Szce Khoo, Anita Moon-Grady, Fayeza Alrais, 
Jean Trines, Tiina Ojala, Lisa K. Hornberger, University of Alberta, 
Edmonton, AB, Canada, University of California, San Francisco, CA
Learning Objective: Describe the differences in fetal right atrial and 
left ventricular function in tricuspid valve disease when compared to 
right heart obstructive lesions and normals.
1228-395 Fetal Cardiovascular Response to Increased 
Afterload with Ductal Constriction in the Third 
Trimester: An Experimental Study in Sheep
David J. Sahn, Juha R. Rasanen, Leah S. Bernard, Roger Hohimer, 
Muhammad Ashraf, Minjuan Zheng, Petra S. Niemann, Xiaokui Li, 
Lowell E. Davis, Oregon Health & Science University, Portland, OR
Learning Objective: understand ultrasound evaluation of fetal 
cardiac mechanics
1228-396 Studies of Fetal Left Ventricular Mechanics by an 
Advanced New 4D Dense Speckle Tracking Program
David J. Sahn, Xubo Song, Andrij Myronenko, Muhammad Ashraf, 
Roger R. Hohimer, Juha R. Rasanen, Oregon Health & Science 
University, Portland, OR
Learning Objective: understand fetal 3D echo
1228-397 The Myocardium of Fetuses with Endocardial 
Fibroelastosis Contains a Paucity of B and T Cells 
Compared with Normal Controls
Nisha Fernandes, The Hospital for Sick Children, Toronto, ON, 
Canada
Learning Objective: describe the differences in myocardial cellular 
immune activity in fetuses with EFE and DCM or structural heart 
disease compared to normal controls
1228-398 Comparison of Norwood Shunt Types: Do the 
Outcomes Differ 5 Years Later?
Eric Graham, Jacob W. Phillips, Sinai C. Zyblewski, Girish S. Shirali, 
Scott M. Bradley, Geoffrey A. Forbus, Varsha M. Bandisode, Andrew 
M. Atz, Medical University of South Carolina, Charleston, SC
Learning Objective: Identify how the shunt type at Norwood 
procedure effects outcomes 5 years later
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1280-396 Bicuspid Aortic Valve in Children: Are We 
Overestimating the Risk?
William T. Mahle, Patricio A. Frias, Children’s Healthcare of Atlanta, 
Atlanta, GA
Learning Objective: To analyze the clinical significance of the dilated 
aorta in children with isolated bicuspid aortic valve
1280-397 Aortic Valve Reintervention after Balloon Aortic 
Valvuloplasty for Congenital Aortic Stenosis: 
Intermediate and Late Follow-up
David W. Brown, Amy E. Dipilato, Erin C. Chong, James E. Lock, Doff 
B. McElhinney, Children’s Hospital, Boston, MA
Learning Objective: Describe intermediate and long-term results of 
balloon aortic valvuloplasty for congenital aortic stenosis.
1280-398 Early Cardiac Catheterization Following Congenital 
Heart Surgery Is Not Associated with Increased Risk 
for Serious Adverse Events
Joshua W. Salvin, Lisa Bergersen, Peter C. Laussen, Sarah A. Teele, 
Audrey C. Marshall, John E. Mayer, Doff McElhinney, Children’s 
Hospital Boston, Boston, MA
Learning Objective: Evaluate the safety and efficacy of early post 
operative catheterization following congenital heart surgery
1281 TRANSPLANTATION AND OTHER ADVANCED 
CARDIAC THERAPIES IN CHILDREN
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1281-401 Comparative Evaluation of two Surgical Techniques 
for Pediatric Heart Transplantation: Is the bicaval 
approach better?
Liwen Tang, Thomas J. L’Ecuyer, Sanjeev Aggarwal, children’s 
hospital of michigan, detroit, MI
Learning Objective: evaluate the poutcome of type of transplant 
surgery
1281-402 Long Term Left Ventricular Systolic Alteration 
Persists After Repair Of Anomalous Left Coronary 
Artery Arising From The Pulmonary Artery
Andreea Dragulescu, Beatrice Bonello, Pascal Amedro, Alain Fraisse, 
Timone Children’s Hospital, Marseille, France
Learning Objective: describe long term sequellae after repair of 
anomalous origin of the left coronary artery from the pulmonary 
artery
1281-404 Platelet Reactivity And Endothelial Function 
In Children Of Patients With Premature Acute 
Myocardial Infarction
Gaetano A. Lanza, Giancarla Scalone, Ilaria Coviello, Roberto Nerla, 
Irma Battipaglia, Lucy Barone, Alessia De Nisco, Angelica Delogu, 
Fabio Infusino, Filippo Crea, Università Cattolica del Sacro Cuore, 
Rome, Italy
Learning Objective: To evaluate endothelial and platelet function in 
offsprings of premature acute myocardial infarction patients
1229-407 Cost And Efficiency Analysis Of Thiopental Versus 
Chloral Hydrate For Sedating Children During 
Echocardiography
Carol A. Stefaniak, John Kovalchin, Steve Cassidy, Bethany 
Hashiguchi, Karen Texter, Nationwide Children’s Hospital, Columbus, 
OH
Learning Objective: Identify the time saving benefits of sedating 
patients for pediatric echocardiography using thiopental vs. chloral 
hydrate.
1229-408 Implementing Pulse Oximetry Screening for Critical 
Congenital Heart Disease in a Community Nursery
Gerard R. Martin, Elizabeth A. Bradshaw, Jeffrey Becker, Sandra 
Cuzzi, Sharon Kiernan, Nancy Nagel, Children’s National Medical 
Center, Washington, DC, Holy Cross Hospital, Silver Spring, MD
Learning Objective: Identify best practice for implementation of 
pulse oximetry screening for detection of critical congenital heart 
disease in the newborn nursery.
1280 OUTCOMES IN PEDIATRIC CARDIOLOGY
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1280-392 Outcome of the Left Ventricle in Children and Young 
Adults with Severe Combined Aortic and Mitral 
Valve Regurgitation Compared to Isolated Lesions
Tom L. Gentles, Kirsten A. Finucane, Jonathan Mervis, Nigel J. 
Wilson, Starship Children’s Hospital, Auckland, New Zealand
Learning Objective: describe risk factors for left ventricualr 
dysfunction after surgery for severe aortic and mitral regurgitation
1280-393 Establishment of a Dedicated Single Ventricle 
Program Reduces Interstage Mortality and 
Improves Weight Gain in Infants with Single 
Ventricle
Christopher J. Petit, Connie Cephus, David Nelson, Raphael 
Mattamal, Elena O’Campo, Texas Children’s Hospital, Houston, TX
Learning Objective: appreciate the benefits of a dedicated single 
ventricle team as it pertains to interstage death and infant growth 
rates.
1280-395 Long-Term Pulmonary Regurgitation Following 
Balloon Valvuloplasty for Pulmonary Stenosis: Risk 
Factors and Relationship to Exercise Capacity and 
Ventricular Volume and Function
David M. Harrild, Andrew J. Powell, Trang X. Trang, Tal Geva, James 
E. Lock, Jonathan Rhodes, Doff B. McElhinney, Children’s Hospital 
Boston, Boston, MA
Learning Objective: Identify the impact of long-term pulmonary 
regurgitation on exercise capacity
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1281-405 The Successful Use of Oral Sildenafil in Right 
Ventricular Dysfunction and High Pulmonary 
Vascular Resistance After Pediatric Heart 
Transplantation
Rakesh Singh, Marc Richmond, Tara B. Giblin, Rose Rodriguez, 
Jonathan M. Chen, Linda J. Addonizio, Columbia University Medical 
Center, New York, NY
Learning Objective: describe the use of oral sildenafil in right 
ventricular dysfunction and high pulmonary vascular resistance after 
pediatric heart transplantation.
1281-407 10 Year Experience with Surgical Unroofing of 
Anomalous Origin of a Coronary Artery from the 
Opposite Sinus with an Interarterial Course
Peter C. Frommelt, Stuart Berger, Michele A. Frommelt, Kathy 
A. Mussatto, James S. Tweddell, Medical College of Wisconsin, 
Milwaukee, WI, Children’s Hospital of Wisconsin, Milwaukee, WI
Learning Objective: demonstrate an understanding of the anatomy 
and symptoms assocated with anomalous origin of a coronary 
artery with an interarterial course and surgical unroofing as a 
potential repair technique
1281-408 Validation of a Risk Prediction Model for In-hospital 
Mortality Following Pediatric Heart Transplantation
Christoher S. d. Almond, Kimberlee Gauvreau, Charles E. Canter, 
Gary E. Piercey, TP Singh, Children’s Hospital Boston, Boston, MA, 
St. Louis Children’s Hospital, St. Louis, MO
Learning Objective: Demonstrate the utility of a risk prediction 
model for post-heart transplant survival in children.
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904 WHAT’S NEW ABOUT HIGH-DENSITY 
LIPOPROTEIN?
Monday, March 15, 2010, 8:00 a.m. - 9:30 a.m.
Georgia World Congress Center, Room B408
CME/CE Hours: 1.5
8:00 Effect of Dalcetrapib Plus Pravastatin on 
Lipoprotein Metabolism in Dyslipidemic Patients: 
Results of a Phase 2b Dose-Ranging Study
Christie M. Ballantyne, Michael Miller, Eric J. Niesor, Tracy Burgess, 
David Kallend, Evan A. Stein, Baylor College of Medicine, Houston, 
TX, Hoffman-LaRoche Ltd, Basel, Switzerland
Learning Objective: At the conclusion of this presentation, 
participants will be able to describe the effects of dalcetrapib on 
the lipoprotein profile in dyslipidemic patients.
8:15 Measures of High-Density Lipoprotein Quantity and 
Quality Predict Cardiovascular Outcome at all Levels 
Of Myeloperoxidase
Stephen J. Nicholls, Wai Hong Wilson Tang, Danielle M. Brennan, 
Stanley L. Hazen, The Cleveland Clinic Foundation, Cleveland, OH
Learning Objective: demonstrate the cardiovascular risk prediction 
of myeloperoxidase with parameters reflecting quantity and quality 
of HDL
8:30 Triple Therapy with Statin, Fibrate (Trilipix) and 
Niacin Raises High-Density Lipoprotein Cholesterol 
without Changing Apolipoprotein A-I Levels
Richard L. Dunbar, Ramprasad Gadi, Amanda Baer, Ashwani Gupta, 
Arshad Javed, Christine Lord, Daniel J. Rader, John Millar, University 
of Pennsylvania, Philadelphia, PA
Learning Objective: evaluate the sequential effects of adding a 
novel fibrate and extended-release niacin to background statin 
therapy in terms of clinical lipids and apolipoprotein kinetics.
8:45 Fenofibric and Nicotinic Acid Progressively 
Suppress Postprandial Triglyceridemia in Statin-
Treated Patients with Low High-Density Lipoprotein 
Cholesterol
Richard L. Dunbar, Ramprasad Gadi, Amanda Baer, Harsh Goel, 
Aurangzeb Baber, Mohammad Rehan, Daniel J. Rader, John Millar, 
University of Pennsylvania, Philadelphia, PA
Learning Objective: evaluate progressive effects of fenofibric acid 
and nicotinic acid on postprandial triglyceridemia in statin-treated 
patients with low HDLc
908 ANTIPLATELET AGENTS AND CORONARY ARTERY 
DISEASE
Monday, March 15, 2010, 10:30 a.m. - 12:00 p.m.
Georgia World Congress Center, Room B408
CME/CE Hours: 1.5
10:30 Use of Nonsteroidal Anti-Inflammatory Drugs and 
Risk of Acute Myocardial Infarction and All-Cause 
Mortality in the Australian Veteran Community
Arduino A. Mangoni, Richard J. Woodman, Paraskevi Gaganis, 
Andrew L. Gilbert, Kathleen M. Knights, Flinders University, 
Adelaide, Australia, University of South Australia, Adelaide, Australia
Learning Objective: evaluate the impact of NSAID use on the risk of 
acute myocardial infarction and all-cause mortality in elderly patients
10:45 Gastrointestinal Symptoms in Low-Dose Aspirin 
Users in the Community: A Comparison Between 
Plain and Buffered Aspirin
Jeroen Jaspers Focks, Marc A. Brouwer, Etiënne G. Cramer, Merel 
M. Tielemans, Leo G. van Rossum, Ties Eikendal, Robert J. Laheij, 
Jan B. Jansen, Martijn G. van Oijen, Radboud University Nijmegen 
Medical Centre, Nijmegen, The Netherlands
Learning Objective: distinguish the effect of different forms of 
aspirin on dyspeptic symptoms.
11:00 The Antiplatelet Effect of Aspirin Is Reduced by 
Proton Pump Inhibitors in Patients with Coronary 
Artery Disease
Morten Würtz, Erik L. Grove, Steen D. Kristensen, Anne-Mette Hvas, 
Aarhus University Hospital, Skejby, Aarhus, Denmark
Learning Objective: The frequently used combination of aspirin and 
proton pump inhibitors might reduce the cardiovascular protection 
by aspirin.
11:15 Upfront Clopidogrel Use and the Efficacy and Safety 
of Early Eptifibatide Use in Patients with Acute 
Coronary Syndrome: An Analysis from the Early 
versus Delayed Provisional Eptifibatide in Acute 
Coronary Syndromes (EARLY ACS) Trial
Tracy Wang, Jennifer A. White, Robert P. Giugliano, Pierluigi Tricoci, 
Robert A. Harrington, Gilles Montalescot, Uwe Zeymer, Frans Van 
de Werf, Paul W. Armstrong, Eugene Braunwald, Robert M. Califf, L. 
Kristin Newby, Duke Clinical Research Institute, Durham, NC
Learning Objective: describe the efficacy and safety of early eptifibatide 
with upfront clopidogrel use in ACS patients undergoing angiography.
11:30 Impact of Low Dose Aspirin on Acetylcholine-
Induced Coronary Artery Spasm and 12 Month 
Clinical Outcome
Ji Young Park, Seung Woon Rha, Kanhaiya L. Poddar, Sureshkumar 
Ramasamy, Lin Wang, Byoung Geol Choi, Ji Bak Kim, Seung Yong 
Shin, Un Jung Choi, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, 
Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh, Korea 
University Guro Hospital, Seoul, South Korea
Learning Objective: We evaluated the impact of low dose asprin on 
acetylcholine induced coronary artery spasm and 12 month clinical 
outcome
ORAL CONTRIBUTIONS
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1017-90 Cross-Sectional Relationships of Urinary Albumin 
Excretion With Osteoprotegerin, C-reactive Protein 
and Asymmetric Dimethylarginine in Essential 
Hypertension
Kyriakos Dimitriadis, Konstantinos Tsiouﬁs, Dimitris Tsiachris, 
Alexandros Kasiakogias, Eirini Andrikou, Antigoni Miliou, Elli 
Stefanadi, Andreas Michaelides, Christodoulos Stefanadis, First 
Cardiology Clinic, University of Athens, Hippokration Hospital, 
Athens, Greece
Learning Objective: describe the relationships of urinary albumin 
excretion with osteoprotegerin, asymmetric dimethylarginine and 
C-reactive protein in hypertension.
1018 DIABETES, METABOLIC SYNDROME AND 
ATHEROSCLEROSIS
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1018-92 Atorvastatin Worsens Glucose Metabolism and 
Insulin Sensitivity in Hypercholesterolemic Patients
Kwang K. Koh, Michael Quon, Seung H. Han, Kyounghoon Lee, 
Gachon University, Incheon, South Korea, NIH, Bethesda, MD
Learning Objective: identify
1018-93 Impact of Pioglitazone on Coronary Atherosclerosis 
in Patients with Non- and Early-Diabetes: A 
Prospective Randomized Study with Intravascular 
Ultrasound
Nobuyuki Komiyama, Toshihiko Kikutani, Tomomi Koizumi, Tohru 
Tamaki, Tetsuro Yamazaki, Atsushi Sakamato, Eiji Takagi, Shigeyuki 
Nishimura, Saitama International Medical Center, Hidaka, Japan
Learning Objective: identify the effect of pioglitazone on coronary 
atherosclerosis
1018-94 Microalbuminuria in Non-Diabetic Patients with 
Metabolic Syndrome is strongly associated with 
Systemic Inflammation
Pawan K. Hari, Vikas Veeranna, Palaniappan Manickam, Rajeev 
Sudhakar, Mengistu Simegn, Sandeep Zalawadiya, Sony Jacob, Luis 
Afonso, Wayne State University, Detroit, MI
Learning Objective: Identify that microalbuminuria in non-diabetic 
patients with metabolic syndrome is strongly associated with 
systemic inflammation
1018-95 Dose Dependant Effects of N-3 polyunsaturated 
Fatty Acids on Insulin Resistance and Inflammatory 
Marker in Metabolic Syndrome
Jang-Young Kim, Sang-Woo Han, Jungkyung Sung, NamSeok Lee, 
Jun-Won Lee, Young-Jin Youn, Byung-Su Yoo, Junghan Yoon, Seung-
Hwan Lee, Kyung-Hoon Choe, Wonju College of Medicien, Yonsei 
Univeristy, Wonju, South Korea
Learning Objective: In this study, N-3 PUFA clearly demonstrate the 
improvement of insulin resistance and anti-inflammatory effects in 
metabolic syndrome.
1017 INFLAMMATION AND ATHEROSCLEROSIS
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1017-86 Association of Tendon Xanthomas with Carotid 
Atherosclerosis in Patients with Familial 
Hypercholesterolemia
Constantina Masoura, Christos Pitsavos, Konstantinos Aznaouridis, 
Skoumas Ioannis, Charalambos Vlachopoulos, Vassiliki Metaxa, 
Themistoclis Psarros, Christodoulos Stefanadis, Athens Medical 
School, Hippokration Hospital, Athens, Greece
Learning Objective: appreciate the presence of tendon xanthomas 
as a marker of subclinical atherosclerosis in patients with familial 
hypercholesterolemia
1017-87 Disparities in Association of Various Lipid Ratios 
on the Location and Severity of Atherosclerosis in 
Different Vascular Beds
Palaniappan Manickam, Ankit Rathod, Apurva Badheka, Pawan 
Hari, Vikas Veeranna, Jyotiranjan Pradhan, Sony Jacob, Luis Afonso, 
Wayne State University, Detroit, MI
Learning Objective: identify the strong association of LDL/HDL 
particle ratio with subclinical carotid and peripheral atherosclerosis 
and to appreciate the lack of association of lipid ratios and 
coronary calcium score.
1017-88 Relationship of Fetuin-A to lipid abnormalities 
associated with Metabolic Syndrome in Type 2 
Diabetes Mellitus (T2DM)
Luis H. Eraso, Naeema Ginwala, Atif N. Qasim, Nehal N. Mehta, 
Muredach P. Reilly, Unniversity of Pennsylvania, Cardiovascular 
Institute, Philadelphia, PA
Learning Objective: Understand the role of fetuin-A, a novel 
biomarker of cardiovascular mortality and heterogeneous forms of 
vascular disease, has with the atherogenic dyslipidemia associated 
with metabolic syndrome
1017-89 Lipid and Lipoprotein Biomarkers and the Risk of 
Ischemic Stroke in Postmenopausal Women
Jeffrey S. Berger, Aileen McGinn, Barbara Howard, Lewis Kuller, 
JoAnn Mason, Jim Otvos, David Curb, Charles Eaton, Robert Kaplan, 
John Lynch, Daniel Rosenbaum, Sylvia Wassertheil-Smoller, New 
York University School of Medicine, New York, NY, Albert Einstein 
College of Medicine, Bronx, NY
Learning Objective: identify which lipid or lipoprotein markers are 
independently associated with an increased risk of ischemic stroke
POSTER CONTRIBUTIONS
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1019-101 Long-Term Efficacy of Fenofibric Acid 135 mg in 
Combination with Rosuvastatin 20 mg in Patients 
with Mixed Dyslipidemia
Peter H. Jones, Terry A. Jacobson, Carolyn M. Setze, Darryl J. Sleep, 
Maureen T. Kelly, Laura A. Williams, James C. Stolzenbach, Baylor 
College of Medicine, Houston, TX, Abbott, Abbott Park, IL
Learning Objective: Comprehend that the lipid efficacy of fenofibric 
acid + rosuvastatin was sustained for 2 years in patients with 
mixed dyslipidemia, without evidence of cumulative toxicity or late-
onset adverse events
1020 HYPERTENSION EFFECTS ON THE LEFT 
VENTRICLE
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1020-103 Adult Left Ventricular Mass Is Associated with 
Long-term Blood Pressure Variability Beginning 
in Childhood in Blacks, but not in Whites: The 
Bogalusa Heart Study
Wei Chen, Litao Ruan, Sathanur R. Srinivasan, Gerald S. Berenson, 
Tulane University, New Orleans, LA
Learning Objective: Evaluate the predictive value of blood pressure 
variations from childhood for left ventricular hypertrophy in 
adulthood, independent of blood pressure levels, among black 
individuals.
1020-104 Distinct Mechanisms for Diastolic Dysfunction in 
Diabetes Mellitus and Pressure-overload
Ines Pires, Giuseppina Palladini, Nádia Gonçalves, Jolanda van der 
Velden, Daniel Moreira-Gonçalves, Francesco Salinaro, Walter J. 
Paulus, Hans WM Niessen, Stefano Perlini, Adelino F. Leite-Moreira, 
Faculdade de medicina da Universidade do Porto, Porto, Portugal
Learning Objective: Distinguish between cardiac structural and 
functional abnormalities induced by pressure overload and diabetes 
mellitus
1020-105 Differential Effects of Ambulatory Isolated Systolic 
and Isolated Diastolic Hypertension in Cardiac 
Adaptations in the Early Stages of Hypertension
Efstathios Taxiarchou, Konstantinos Tsiouﬁs, Dimitris Roussos, 
Dimitris Syrseloudis, Dimitris Chatzis, Anastasia Mazaraki, Eirini 
Andrikou, Ioannis Andrikou, Christodoulos Stefanadis, First 
Cardiology Clinic, University of Athens, Hippokration Hospital, 
Athens, Greece
Learning Objective: evaluate the prognostic role of the components 
of ambulatory blood pressure load in hypertension
1018-96 Insulin Sensitizing Therapy Compared to Insulin 
Providing Therapy for Type 2 Diabetes Mellitus: 
Effects on Low Density Lipoprotein Particle 
Characteristics by Nuclear Magnetic Resonance 
LipoProfile-III
Trevor J. Orchard, David Robertson, Marnie Bertolet, James Otvos, 
Tom Donner, Teik Ooi, Georgia Pambianco, Jamal Rana, Donald 
Smith, Lynn Zoiopoulos, BARI 2D Study Group, University of 
Pittsburgh, Pittsburgh, PA
Learning Objective: Understand the differential effects of insulin 
sensitizing and insulin providing therapies on NMR lipoproteins in 
type 2 diabetes
1019 COMBINATION DRUG THERAPY IN THE 
TREATMENT OF HYPERLIPIDEMIA
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1019-98 Randomized Comparison of Rosuvastatin Plus 
Ezetimibe Versus Simvastatin Plus Ezetimibe: 
Results of the GRAVITY Study
Christie M. Ballantyne, Rick Schiebinger, Valerie Cain, Baylor College 
of Medicine and Methodist DeBakey Heart and Vascular Center, 
Houston, TX, AstraZeneca, Wilmington, DE
Learning Objective: evaluate the efficacy of combination therapies 
using either rosuvastatin with ezetimibe or simvastatin with 
ezetimibe for lipid lowering and LDL-C goal attainment.
1019-99 Effect of Ezetimibe Plus Low-Dose Atorvastatin 
versus Double-Dose Atorvastatin on Insulin 
Resistance and Lipid Metabolism in Coronary 
Artery Disease Patients with or without Metabolic 
Syndrome
Keiko Goshima, Kazuki Fukui, Tomoaki Shimizu, Yukiko Morita, 
Atsushi Wada, Tomohiko Shigemasa, Yasuyuki Mochida, Reimin 
Sawada, Takei Takahiro, Noriaki Iwahashi, Satoshi Umemura, 
Kazuo Kimura, Kanagawa Cardiovascular and Respiratory Center, 
Yokohama, Japan
Learning Objective: evaluate the effect of high-dose atrovastatin and 
low-dose atrovastatin plus ezetimibe combination therapy on lipid 
metabolism and insulin resistance in the patients with and without 
METS.
1019-100 Beyond LDL-Cholesterol Reduction: Effect of 
Ezetimibe in Combination with Atorvastatin on 
Oxidized LDL-Cholesterol in Patients with Coronary 
Artery Disease or Coronary Artery Disease 
Equivalent
Rabih R. Azar, Georges Badaoui, Antoine Sarkis, Mireille Azar, 
Hermine Aydanian, Serge Harb, Guy Achkouty, Roland Kassab, Hotel 
Dieu de France Hospital, Beirut, Lebanon
Learning Objective: understand the effects of ezetimibe on oxidized 
LDL and on LDL subfractions
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1021-112 Do Angiotensin Receptor Blockers Increase the Risk 
of Angioedema?
Harikrishna J. Makani, Franz H. Messerli, Aleksander Korniyenko, 
Jorge Romero, Maria Elena De Benedetti Zunino, Jorge Silva Enciso, 
St. Luke’s Roosevelt Hospital and Columbia University College of 
Physicians and Surgeons, New York, NY
Learning Objective: describe the incidence of angioedema with 
angiotensin receptor blockers and compare it with the incidence of 
angioedema with ACE inhibitors and other drug classes.
1021-113 Adverse Drug Events Resulting in Admissions to a 
Cardiac Care Unit
Heather A. Wroblewski, James E. Tisdale, Brian R. Overhaolser, 
Joanna R. Kingery, Richard J. Kovacs, Purdue University, West 
Lafayette, IN
Learning Objective: Decribe common adverse drug events leading to 
hospital admission to cardiac care units
1022 PHARMACOLOGY/HORMONES/LIPIDS—BASIC
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1022-115 Hyperglycemia And Oxidation Impairs The Impact 
Of High-density Lipoproteins On Endothelial Cell 
Growth And Migration.
Xing Chen, Ruliang Li, Woineshet Zenebe, MyNgan Duong, Stephen 
J. Nicholls, The Cleveland Clinic, Cleveland, OH
Learning Objective: demonstrate the influence of HDL and its major 
apolipoproteins on endothelial cell growth and migration
1022-116 Safflower Seed-derived Des-1,2-apoA1
milano
 
Reduces Atherosclerosis in Hypercholesterolemic 
Apolipoprotein E (-/-) Mice
Kuang-Yuh Chyu, Juliana Yano, Xiaojun Li, Jianchang Zhou, Wai Man 
Lio, Cheryl Chan, Paul C. Dimayuga, Bojan Cercek, Cory L. Nykiforuk, 
Yin Shen, Maurice M. Moloney, Prediman K. Shah, Cedars-Sinai 
Heart Institute, Los Angeles, CA, SemBioSys Genetics Inc., Calgary, 
AB, Canada
Learning Objective: Evaluate the therapeutic potential of Safflower 
seed-derived Des-1,2-apoA1milano in atherosclerotic disease.
1022-117 High Maintenance-dose Of Clopidogrel (150 mg/d) 
Can Not Overcome the Loss-of-function Effect of the 
Cytochrome 2C19 Polymorphism
Young-Hoon Jeong, In-Suk Kim, Yongwhi Park, Seok-Jae Hwang, 
Choong Hwan Kwak, Jin-Yong Hwang, Gyeongsang National 
University Hospital, Jinju, South Korea
Learning Objective: doubling dose of clopidogrel can not overcome 
the loss-of-function effect of CYP2C19 polymorphism
1020-106 Chronic Kidney Disease and Left Ventricular 
Hypertrophy as Prognosticators of Cardiovascular 
Events in Hypertension
Dimitris Tsiachris, Konstantinos Tsiouﬁs, Costas Thomopoulos, 
Dimitris Syrseloudis, Elena Vezali, Antonis Moulakakis, Dimitris 
Tousoulis, Ioannis Kallikazaros, Christodoulos Stefanadis, First 
Cardiology Clinic, University of Athens, Hippokration Hospital, 
Athens, Greece
Learning Objective: distinguish the comparative prognostic role of 
left ventricular hypertrophy and chronic kidney disease for major CV 
events
1020-107 Myocardial Injury in Hypertensive Heart
Erika Yamamoto, Yukihito Sato, Tadashi Miyamoto, Ryoji Taniguchi, 
Masanao Toma, Rei Fukuhara, Kiyoto Nishi, Sayaka Saijo, Yohei 
Tanada, Naoki Takahashi, Taisuke Goto, Takuma Sawa, Takashi 
Kiyonaka, Takako Fujiwara, Hisayoshi Fujiwara, Yoshiki Takatsu, 
Hyogo Prefectural Amagasaki Hospital, Hyogo, Japan
Learning Objective: identify the relationship between NT-proBNP 
and heart-type fatty acid-binding protein (H-FABP) in hypertensive 
patients.
1021 NOVEL EFFECTS OF COMMON CARDIAC 
MEDICATION
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1021-109 Acute Administration of Vardenafil Improves Arterial 
Stiffness and Wave Reflections
Dimitrios Terentes-Printzios, Charalambos Vlachopoulos, 
Nikolaos Ioakeimidis, Konstantinos Aznaouridis, Konstantinos 
Rokkas, Athanasios Aggelis, Katerina Baou, Athanasios Askitis, 
Christodoulos Stefanadis, 1st Department of Cardiology, 
Hippokration Hospital, Athens Medical School, Athens, Greece
Learning Objective: Describe the beneficial effects of vardenafil on 
arterial function.
1021-110 Pharmacodynamic Effects and Clinical Outcomes 
of Clopidogrel and Ticlopidine with or without a 
Proton-pump Inhibitor
Shuichi Oshima, Katuso Noda, Hironobu Fukushima, Shinichi 
Nakamura, Izsumi Taniguchi, Fumihito Kugimiya, Kenichiro Higa, 
Tsunenori Nishijima, Shinsuke Hanatani, Division of Cardiology, 
Kumamoto Central Hospital, Kumamoto, Japan
Learning Objective: assess the association between the use of a 
PPI, measurements of platelet function, and clinical outcomes for 
patients treated with clopidogrel or ticlopidine.
1021-111 Pedal Edema Associated with Calcium Antagonists - 
Incidence and Withdrawal Rate
Harikrishna J. Makani, Maria Elena De Benedetti Zunino, Christopher 
Di Giorgio, Jorge Romero, Gangadhara Kabbli, Jorge Silva Enciso, 
Franz H. Messerli, St. Luke’s Roosevelt Hospital and Columbia 
University College of Physicians and Surgeons, New York, NY
Learning Objective: describe the incidence of pedal edema with 
calcium channel blockers and evaluate the withdrawal rate.
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1072-88 Achieving Optimal Lipid Levels in Patients with 
Coronary Artery Disease in Clinical Practice
Raghunandan Dudda Subramanya, Scott E. Hessen, Longjan 
Liu, Mark F. Victor, Dean G. Karalis, Drexel University College of 
Medicine, Philadelphia, PA, Cardiology Consultants of Philadelphia, 
Philadelphia, PA
Learning Objective: evaluate whether pts with CAD achieve their 
recommended lipid goals in clinical practice.
1072-89 Impact of Adjunctive Cilostazol on Midterm Clinical 
and Angiographic Outcomes in Patients Undergoing 
Percutaneous Coronary Intervention with Drug 
Eluting Stent
Kanhaiya L. Poddar, Seung Woon Rha, Sureshkumar Ramasamy, Ji 
Young Park, Lin Wang, Byoung Geol Choi, Cheol Ung Choi, Hong Euy 
Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seo Seo, 
Dong Joo Oh, Korea University Guro Hospital, Seoul, South Korea
Learning Objective: Demonstrates equal efficacy of triple 
antiplatelet therapy even in high risk PCI (with DES) group
1072-90 Sustained Acting Atrial Natriuretic Peptide: A 
Novel Therapeutic in a Canine Model of Acute 
Hypertension and Left Ventricular Dysfunction 
Induced by Angiotension II
Paul M. McKie, Alessandro Cataliotti, Guido Boerrigter, Fernando L. 
Martin, S. Jeson Sangaralingham, John C. Burnett, Jr, Mayo Clinic, 
Rochester, MN
Learning Objective: describe the blood pressure lowering and renal 
enhancing properties of sustained acting atrial natriuretic peptide
1073 ANTI-PLATELET AGENTS AND CORONARY ARTERY 
DISEASE
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1073-92 Decreased Response To Clopidogrel Is A Risk Factor 
For Cardiovascular Events After Stent Implantation : 
CROSS Verify Study
Chi-hoon Kim, Kyung-Woo Park, Kihyun Jeon, Si-Hyck Kang, Kyung-
Hee Kim, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Dae-Won 
Sohn, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim, Cardiovascular 
center, Seoul National University Hospital, Seoul, South Korea
Learning Objective: Understand characteristic PRU value related to 
P2Y12 inhibition and non-responsiveness to clopidogrel in Asian 
(Korean) ethnicity.
1073-93 Impact of Clopidogrel on Serum Anti-Xa Levels in 
Patients Receiving Enoxaparin Treatment
Solomon C. Yang, Shing Chiu Wong, Juey-Jen Hwang, National 
Taiwan University Hospital, Taipei, Taiwan,ROC, New York Downtown 
Hospital, New York, NY
Learning Objective: notice potential interaction between clopidogrel 
and enoxaparin
1022-118 Atorvastatin Directly Reduces Vascular Superoxide 
Generation in Human Vein Grafts Ex Vivo, by 
Improving eNOS Coupling and Reducing NADPH-
Oxidase Activity
Constantinos Bakogiannis, Charalambos Antoniades, Dimitris 
Tousoulis, Michael Demosthenous, Alexios S. Antonopoulos, 
Themistokles Psarros, George Ekonomopoulos, Nikolaos Sfyras, 
Keith M. Channon, Christodoulos Stefanadis, 1st Cardiology 
Department, Athens University Medical School, Athens, Greece, 
Department of Cardiovascular Medicine, University of Oxford, 
Oxford, United Kingdom
Learning Objective: This study demonstrates that atorvastatin 
exerts a direct effect on vascular redox both by improving eNOS 
coupling and by reducing NADPH oxidase activity
1022-119 Associations between High-sensitivity C-reactive 
Protein and the Risk of Developing Hypertension
Jang Hoon Lee, Dong Heon Yang, Hun Sik Park, Yongkeun Cho, 
Shung Chull Chae, Jae-Eun Jun, Wee-Hyun Park, Byung Yeol Chun, 
Sin Kam, Jung Gook Kim, In Kyu Lee, Bo Wan Kim, Daegu City 
Hypertension-Diabetes Survey, Kyungpook National University 
Hospital, Daegu, South Korea
Learning Objective: know baseline levels of hs-CRP are modestly 
associated with an increased risk of developing hypertension.
1072 THE EFFECTS OF STATIN THERAPY ON 
CORONARY DISEASE
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1072-86 What Are the Short and Long Term Benefits of 
Statin Therapy Initiated around the Time of Invasive 
Procedures?: A Meta-analysis of Randomized 
Controlled Trials
David E. Winchester, Lola Xie, Anthony A. Bavry, University of Florida, 
Gainesville, FL
Learning Objective: Describe the short and long-term benefits of 
statins started around the time of invasive procedures
1072-87 Post-Hospital Discharge Treatment of Statin in 
Patients with Acute Myocardial Infarction: Is Statin 
Beneficial in Patient with LDL-cholesterol Lower 
Than 70 mg/dL?
Hyun Kuk Kim, Myung Ho Jeong, Youngkeun Ahn, Jong Hyun Kim, 
Shung Chull Chae, Young Jo Kim, Seung Ho Hur, In Whan Seong, 
Taek Jong Hong, Dong Hoon Choi, Myeong Chan Cho, Chong Jin 
Kim, Ki Bae Seung, Wook Sung Chung, Yang Soo Jang, Seung Woon 
Rha, Jang Ho Bae, Jeong Gwan Cho, Seung Jung Park, The Heart 
Center of Chonnam National University Hospital, Gwangju, South 
Korea
Learning Objective: identify the strategy of statin therapy
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1074-100 Relationship Between Lipoprotein(a), Homocysteine, 
and C-Reactive Protein and Metabolic Syndrome in 
South Asian Patients
Monica S. Divakaruni, Elena Flowers, Cesar Molina, Ashish Mathur, 
Megha Prasad, Leslie Abrams, Anita Sathe, Donna Malhotra, Ruby 
Basra, Gayatri Ratnam, Bradley E. Aouizerat, Mintu P. Turakhia, 
Stanford University, Department of Cardiovascular Medicine, 
Stanford, CA, South Asian Heart Center, Mountian View, CA
Learning Objective: Describe the relationship between 
Lipoprotein(a), homocysteine, and C-Reactive Protein and Metabolic 
Syndrome in South Asians
1074-101 Renin-Angiotensin Blockade in the African-American 
Population
Eric M. Bader, Ronald Zolty, Jacobi Medical Center, Albert Einstein 
College of Medicine, Bronx, NY, Monteﬁore Medical Center, Albert 
Einstein College of Medicine, Bronx, NY
Learning Objective: understand the role of renin-angiotensin 
blockade in specific racial groups.
1074-102 Prognostic Implications of Atherogenic/Anti-
atherogenic Lipid Ratios in an Ethnically Diverse 
Population.
Palaniappan Manickam, Ankit Rathod, Apurva Badheka, Vikas 
Veeranna, Pawan Hari, Ashutosh Niraj, Sony Jacob, Luis Afonso, 
Wayne State University, Detroit, MI
Learning Objective: identify increased LDL-particle/HDL-particle 
concentration as a strong predictor of cardiovascular outcomes in 
asymptomatic healthy individuals.
1075 SUB-CLASSES OF LIPOPROTEINS
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1075-103 LDL Subfractions as Predictors of Angiographic 
Coronary Artery Disease among those with Normal 
and Abnormal LDL Levels
Heidi Thomas May, Krishnaji R. Kulkarni, Benjamin D. Horne, Jeffrey 
L. Anderson, Tami L. Bair, Chrissa P. Mower, Joseph B. Muhlestein, 
Intermountain Medical Center, Murray, UT, University of Utah, Salt 
Lake City, UT
Learning Objective: Demonstrate that LDL subfractions may predict 
CAD risk, particularly among those with normal LDL levels.
1075-104 Lipoprotein (a) Levels Predict The Extent of 
Obstructive Disease and Longterm Cardiovascular 
Outcome in Patients Undergoing Coronary 
Angiography with Suboptimal Lipid Contorol
Stephen J. Nicholls, W.H.Wilson Tang, Danielle M. Brennan, Stanley 
L. Hazen, Cleveland Clinic, Cleveland, OH
Learning Objective: describe the ability of Lp(a) as a predictor of 
cardiovascular event
1073-94 Effect of Ticagrelor versus Clopidogrel on High 
Platelet Reactivity During Maintenance Therapy
Paul A. Gurbel, Kevin Bliden, Kathleen Butler, Cheryl Wei, Udaya 
S. Tantry, Sinai Center for Thrombosis Research, Baltimore, MD, 
AstraZenacza LP, Wilmington, DE
Learning Objective: To determine the The effect of Ticagrelor 
compared to clopidogrel on high platelet reactivity during 
maintenance therapy
1073-95 The Impact of Non-cytochrome 3a4 Metabolized 
Statin in Patients with High Post-clopidogrel Platelet 
Reactivity
Young-Hoon Jeong, In-Suk Kim, Yongwhi Park, Seok-Jae Hwang, 
Choong Hwan Kwak, Jin-Yong Hwang, Gyeongsang National 
University Hospital, Jinju, South Korea
Learning Objective: enhance platelet inhibition and reduce the rate 
of HPPR through switch administration of non-CYP3A4 metabolized 
statin in HPPR patients receiving atorvastatin
1073-96 Oxidative Stress is Associated with Reduced 
Glomerular Filtration Rate in a Population with 
Preserved Renal Function: the META-Health Study
Alanna Morris, Riyaz S. Patel, Liping Zhao, Yusuf Ahmed, Neli 
Stoyanova, Aurelian Bidulescu, Dorothy Coverson, Janice Lea, Viola 
Vaccarino, Gary Gibbons, Dean P. Jones, Rebecca Din-Dzietham, 
Arshed Quyyumi, Emory University School of Medicine, Atlanta, GA, 
Morehouse School of Medicine, Atlanta, GA
Learning Objective: Oxidative Stress is Associated with Decreased 
eGFR in people with preserved renal function.
1074 ETHNICITY AND ITS EFFECT ON LIPIDS
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1074-98 Effect of Lipid Subclasses on the Risk of 
Cardiovascular Outcomes in an Ethnically Diverse 
Asymptomatic Population
Ankit D. Rathod, Vikas Veeranna, Palaniappan Manickam, Apurva 
Badheka, Ashutosh Niraj, Jyotiranjan Pradhan, Sony Jacob, Luis 
Afonso, Wayne State Univeristy, Detroit, MI
Learning Objective: Identify Lipid subclasses associated with 
adverse cardiovascular outcomes in asymptomatic patients.
1074-99 Clinical Outcomes Following Coronary Stenting in 
Japanese Patients with and without Proton Pump 
Inhibitor
Hideki Shimomura, Seiji Hokimoto, Hisao Ogawa, The KICS 
investigators, Fukuoka Tokusyukai Hospital, Kasuga, Japan, 
Kumamoto University, Kumamoto, Japan
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1076-111 Diazoxide Choline Controlled Release in 
Hypertriglyceridemic Subjects: Lipid and Other 
Metabolic Effects
Harold E. Bays, Eli M. Roth, Iain Dukes, Gloria Lin-Luo, Neil Cowen, 
Yu Liu, Essentialis, Inc., Carlsbad, CA, Louisville Metabolic and 
Atherosclerosis Research Center Inc, Louisville, KY
Learning Objective: descirbe DCCR effects on triglyceride lowering
1076-112 A Double Blind, Randomized, Multicenter, Parallel 
Group, Placebo Control Trial to Evaluate the Effect 
of Statin Therapy on Triglycerides Levels in Mexican 
Hypertriglyceridemic Patients
Juan O. Talavera, Jose-Luis Cervantes, Javier A. Marin, Ignacio 
Briones, Jose-Gerardo Gonzalez, Gustavo Martinez, Ana C. Polanco, 
Hypertriglyceridemia Investigators Group, Instituto Mexicano del 
Seguro Social, Mexico City, Mexico, Hospital Angeles del Pedregal, 
Mexico City, Mexico
Learning Objective: To evaluate the efficacy of intensive statin 
therapy in improving the lipid profile and associated cardiovascular 
risk factors
1076-113 Optimal Plasma Low-Density Lipoprotein 
Cholesterol but Abnormal Triglycerides: Is it Also a 
Risk Profile for Cardiovascular Mortality?
Elena V. Kuklina, Nora L. Keenan, William M. Callaghan, Yuling 
Hong, CDC, Atlanta, GA
Learning Objective: To describe the associations between “optimal 
low-density lipoprotein cholesterol / abnormal triglycerides” 
lipid profile and cardiovascular mortality in the large nationally 
representative study.
1077 MARKERS OF INFLAMMATION AND 
ATHEROSCLEROSIS
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1077-115 Inverse Relationship Between HDL-C Raising and 
hsCRP Reduction in Older Patients Treated with 
Lipid-Lowering Therapy
William V. Brown, JoAnne M. Foody, Franklin Zieve, Charlotte Jones-
Burton, Qian Dong, Joanne E. Tomassini, Arvind Shah, Andrew M. 
Tershakovec, Merck & Co., Inc., North Wales, PA
Learning Objective: Describe the relationships between hsCRP, 
LDL-C, non-HDL-C and ApoB in older patients with moderate/high 
cardiovascular disease risk following treatment with ezetimibe/
simvastatin and atorvastatin
1077-116 Efficacy of Rosuvastatin in Primary Prevention 
According to Baseline Levels of hsCRP in the 
JUPITER Trial
Paul M. Ridker, Robert J. Glynn, on behalf of the JUPITER 
Investigators, Brigham and Women’s Hospital, Boston, MA
Learning Objective: understand the effectiveness of rosuvastaitn in 
the JUPITER trial according to entry levels of both hsCRP and LDLC.
1075-105 Are Post-treatment Low Density Lipoprotein 
Subclass Pattern Analyses Potentially Misleading?
Harold E. Bays, Scott Conard, Lawrence A. Leiter, Steve Bird, Mary 
E. Hanson, Erin Jensen, Arvind Shah, Andrew M. Tershakovec, Merck 
& Co., Inc., North Wales, PA
Learning Objective: Understand that there may be differences in 
and discuss the potential clinical implications of pre-treatment 
diagnostic vs post-treatment efficacy lipoprotein pattern analyses
1075-106 Associations between Lipoprotein Cholesterol 
Fractions and Measures of Platelet Aggregation in 
Patients with Peripheral Arterial Disease
Salim S. Virani, Vijay Nambi, Husam Athamneh, Anirudh Kumar, 
Angela L. Bergeron, Justin Saunders, Eric Yang, Carlos Bechara, 
Joel D. Morrisett, Changyi Chen, Peter H. Lin, Alan B. Lumsden, 
Jing-fei Dong, Christie M. Ballantyne, Baylor College of Medicine, 
Houston, TX
Learning Objective: Describe the associations between various lipid 
parameters and measures of platelet reactivity to various agonists 
in patients with peripheral arterial disease.
1075-107 Discordance between Traditional Lipid parameters, 
Apolipoproteins and Lipoprotein particle number: 
Insights from the Atherosclerosis Risk In 
Communities (ARIC) Carotid MRI Study
Salim S. Virani, Diane J. Catellier, Vijay Nambi, Ron C. Hoogeveen, 
Bruce A. Wasserman, Josef Coresh, Thomas H. Mosley, James D. 
Otvos, A. Richey Sharrett, Eric Boerwinkle, Christie M. Ballantyne, 
Baylor College of Medicine, Houston, TX
Learning Objective: Describe the degree of discordance between 
traditional cholesterol measures and newer lipoprotein measures in 
an ethnically diverse epidemiologic cohort.
1076 TREATMENT OF HYPERTRIGLYCERIDEMIA
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1076-109 Optimal Pharmacological Approach to 
Hypertriglyceridemia Combined with Low HDL-
Cholesterol: Effects of Fenofibrate 160 mg vs Niacin 
1500 mg on Apolipoprotein B/A1 Ratio, Lipid 
Profile, Glucose Metabolism, and Inflammation
Jin Wi, Sang-Hak Lee, Young-Guk Ko, Seok-Min Kang, Donghoon 
Choi, Jong-Won Ha, Myeong-Ki Hong, Yangsoo Jang, Namsik Chung, 
Won-Heum Shim, Seung-Yun Cho, Division of Cardiology, Yonsei 
University Severance Hospital, Seoul, South Korea
Learning Objective: make optimal pharmacological approach to 
hypertriglyceridemia combined with low HDL-cholesterol
1076-110 Efficacy and Safety of Fenofibrate 160 mg in 
Combination with Pravastatin 40 mg in Type 2 
Diabetic Patients with Combined Hyperlipidemia 
and without Cardiovascular Disease
Michel Farnier, Armin Steinmetz, Kjetil Retterstol, Miroslaw 
Dluzniewski, Albert Csazar, Point Medical, Dijon, France
Learning Objective: treat dyslipidemia of type 2 diabetic patients
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1127-88 Extended-Release Niacin/Laropiprant Lowers 
Serum Phosphorus Concentrations in Dyslipidemic 
Patients
Andrew G. Bostom, Darbie Maccubbin, Diane Tipping, Olga 
Kuznetsova, William A. Hanlon, Rhode Island Hospital, Providence, 
RI, Merck & Co., Inc., Whitehouse Station, NJ
Learning Objective: Understand the phosphorus-lowering 
capability of extended release niacin and its potential relevance to 
cardiovascular disease prevention.
1127-89 Effects of Nebivolol on Levels of Markers of 
Inflammation and Obesity in Response to Exercise-
induced Stress: Studies in Obese African-american 
Patients with Stage I Hypertension
Nadya Merchant, Syed T. Rahman, Keith C. Ferdinand, Guillermo E. 
Umpierrez, Bobby V. Khan, Emory University, Division of Cardiology, 
Atlanta, GA, Atlanta Vascular Research Foundation, Atlanta, GA
Learning Objective: Understand that the effects of nebivolol are 
not limited to hypertension, but this beta-blocker is also beneficial 
with regards to inflammation and obesity, specifically in the obese 
African-American
1127-90 Valproate Attenuates the Risk of Myocardial 
Infarction in Patients with Epilepsy: A Nationwide 
Cohort Study
Jonas B. Olesen, Peter R. Hansen, Steen Z. Abildstrøm, Charlotte 
Andersson, Peter Weeke, Michelle Schmiegelow, Jesper Erdal, 
Christian Torp-Pedersen, Gunnar H. Gislason, Gentofte University 
Hospital, Copenhagen, Denmark
Learning Objective: consider the potential benefit of valproate on 
the risk of myocardial infarction in the treatment of epilepsy
1128 EPIDEMIOLOGY
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1128-92 The American Association of Cardiovascular 
and Pulmonary Rehabilitation (AACVPR) Risk 
Classification Identifies Coronary Heart Disease 
Patients Who Are at Increased Risk of Death
Todd M. Brown, Bonnie K. Sanderson, Vera Bittner, University 
of Alabama at Birmingham, Birmingham, AL, Auburn University, 
Auburn, AL
Learning Objective: Evaluate the ability of the AACVPR Cardiac 
Rehabilitation Risk Classification to predict mortality in CAD 
patients.
1128-93 Association of Renal-Related Biomarkers with All-
Cause and Cause-Specific Mortality in Subjects with 
Different Framingham Risks
Jou-Wei Lin, Cho-Kai Wu, Yu-Sheng Lin, Dept of Environmental and 
Occupational Health, Univ of North Texas Health, Fort Worth, TX
Learning Objective: Cystatin C is predictive of CV mortality on top of 
Framingham risks.
1077-117 Efficacy of Rosuvastatin Among Men and Women 
with Chronic Kidney Disease and Elevated hsCRP: 
The JUPITER Trial
Paul M. Ridker, Robert J. Glynn, on behalf of the JUPITER 
Investigators, Brigham and Women’s Hospital, Boston, MA
Learning Objective: to understand the effectiveness of rosuvastatin 
in primary prevention among men and women with low LDLC, 
elevatd hsCRP, and concomitant evidence of chronic kidney disease.
1077-118 Quinapril and Lipoic Acid Improve Endothelial 
Function and Reduce Markers of Inflammation: 
Results of Quinapril and Lipoic Acid in the 
Metabolic Syndrome (QUALITY) study
Bobby V. Khan, Syed T. Rahman, Tahir Haque, Nadya Merchant, 
Atlanta Vascular Research Foundation, Atlanta, GA, Emory University 
School of Medicine, Atlanta, GA
Learning Objective: identify treatment of the metabolic syndrome
1077-119 Omega-3 Index: Relationship with Classic and 
Emerging Coronary Heart Disease Risk Factors
Mohammad Abuannadi, James H. O’Keefe, John A. Spertus, Kevin 
F. Kennedy, Krishnaji Kulkarni, William S. Harris, Mid America Heart 
Institute/University of Missouri-Kansas City, Kansas City, MO, 
Cardiovascular Health Research Center, Sanford Research/USD and 
Sanford School of Medicine, Sioux Falls, SD
Learning Objective: identify the relationship of omega-3 index with 
lipid and inflammatory risk markers
1127 CLINICAL TRIALS AND INTERVENTIONAL 
THERAPIES
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1127-86 Impact of Cardiac Rehabilitation on Mortality and 
Cardiovascular Events after Percutaneous Coronary 
Intervention
Kashish Goel, Ryan J. Lennon, R. T. Tilbury, Ray W. Squires, Randal 
J. Thomas, Mayo Clinic, Rochester, MN
Learning Objective: Identify the impact of cardiac rehabilitation on 
outcomes after percutaneous coronary intervention
1127-87 Usefulness of Anticoagulant Therapy for Atrial 
Fibrillation in Chronic Kidney Disease Patients after 
Percutaneous Coronary Intervention with Stenting
Yusuke Iwasaki, Takahisa Yamada, Yuji Okuyama, Takashi Morita, 
Yoshio Furukawa, Koji Tanaka, Taku Yasui, Hiromichi Ueda, Takeshi 
Okada, Masato Kawasaki, Yuki Kuramoto, Masatake Fukunami, 
Osaka General Medical Center, Osaka, Japan
Learning Objective: Anticoagulant therapy in CKD patients with AF 
after PCI with stenting.
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1129-100 Impact of Telemedicine System on CVD Risk 
Reduction and Adoption of Healthy Life Style 
Behaviors
Mohamad Alkhouli, Carol J Homko, Abdul Kashem, William P 
Santimore, Nabeel Memon, Jorge Gonzalez, Linda Zamora, 
Timothy R McConnell, Alfed A Bove, Temple University Hospital, 
Philadelphia, PA
Learning Objective: Recognize Telemedicine as an important tool in 
risk reduction in patient with CVD risk factors
1129-101 The Comparable Effect of Lifestyle and 
Pharmacological Intervention to Prevent Coronary 
Atherosclerosis in Japanese Early-stage Diabetic 
Patients - The DIAbetes and diffuse coronary 
Narrowing (DIANA) study
Yu Kataoka, Satoshi Yasuda, Yoshihiro Miyamoto, Kazuhiro Sase, 
Masami Kosuge, Kazuo Kimura, Yasunao Yoshimasa, Shunichi 
Miyazaki, National Cardiovascular Center, Osaka, Japan
1129-102 Whole Body Periodic Acceleration Improves 
Coronary Microcirculation in Healthy Subjects and 
Patients with Coronary Artery Disease
Kono Yasushi, Shota Fukuda, Kenei Shimada, Toshihiro Kawasaki, 
Satoshi Jissho, Haruyuki Taguchi, Kumiko Maeda, Minoru 
Yoshiyama, Masatoshi Fujita, Junichi Yoshikawa, Department of 
Medicine, Osaka Ekisaikai Hospital, Osaka, Japan, Department of 
Internal Medicine and Cardiology, Osaka City University School of 
Medicine, Osaka, Japan
1130 GENDER DIFFERENCES IN CARDIOVASCULAR 
MEDICINE
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1130-103 Effect Of Oral Vs. Patch Contraception On 
Inflammatory Markers, Oxidative Stress, And 
Vascular Reactivity In Healthy Pre-Menopausal 
Women
Pathmaja Paramsothy, Eric V. Kreiger, Elizabeth Chan, Eve Preus, 
Irina Rusanu, Sarah Prager, Brian Fish, Robert H. Knopp, University 
of Washington, Seattle, WA, Harborview Medical Center, Seattle, WA
Learning Objective: Demonstrate the effects of oral vs. patch 
hormone contraception on markers of inflammation and oxidative 
stress and on endothelial function as measured by brachial artery 
reactivity.
1130-104 Women Receive Smaller Aortic Valve Prosthes Than 
Men - For Anatomical Reasons?
Christina Fuchs, Elisabeth Pernicka, Gerald Maurer, Helmut 
Baumgartner, Julia Mascherbauer, Medical university of Vienna, 
Vienna, Austria
Learning Objective: demonstrating gender specific differences in 
aortic valve replacement
1128-94 Psoriasis is a Risk Factor for Atrial Fibrillation and 
Stroke: A Danish Nationwide Cohort Study
Ole Ahlehoff, Gunnar H. Gislason, Jesper Lindhardsen, Casper 
H. Jorgensen, Mette G. Charlot, Steen Z. Abildstrom, Lone Skov, 
Christian Torp-Pedersen, Peter R. Hansen, Department of Cardiology, 
Copenhagen University Hospital Gentofte, Hellerup, Denmark
Learning Objective: Identify psoriasis as a risk factor for atrial 
fibrillation and stroke
1128-95 Hyperhomocysteinemia ; Another Risk Factor 
Associated With Contrast Media Induced 
Nephropathy
Hyuck Yoon, Hong-won Shin, Ji-hyun Son, Hyoung-Seob Park, Yun-
Kyeong Cho, Chunduk Han, Hyungseop Kim, Chang-Wook Nam, 
Seung-Ho Hur, Yoon-Nyun Kim, Kwon-Bae Kim, Division of Cardiology, 
Keimyung University Dongsan Hospital, Daegu, South Korea
Learning Objective: identify
1128-96 Apolipoprotein A1 Predicts Future Death and 
Myocardial Infarction in Patients Undergoing 
Coronary Angiography
Heidi Thomas May, Krishnaji R. Kulkarni, Benjamin D. Horne, Jeffrey 
L. Anderson, Tami L. Bair, Chrissa P. Mower, John F. Carlquist, 
Joseph B. Muhlestein, Intermountain Medical Center, Murray, UT, 
University of Utah, Salt Lake City, UT
Learning Objective: Demonstrate that apolipoprotein A1 predicts 
short and long-term risk, even among those with normal HDL levels.
1129 LIFE STYLE MODIFICATIONS AND PHYSICAL 
ACTIVITY
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1129-98 Consumption of Alcohol, Particularly Wine, is 
Negatively Associated With Carotid Intima Media 
Thickness, and is in Part due to Familial Factors
Amit J. Shah, Emir Veledar, Jack Goldberg, Douglas Bremner, Viola 
Vaccarino, Emory University, Atlanta, GA, University of Washington, 
Seattle, WA
Learning Objective: Evaluate the association between alcohol 
consumption and carotid intima media thickness while controlling 
for familial and cardiovascular risk factors
1129-99 Behavioral Comparison Between Rural And Urban 
Populations In Cardiovascular Disease Risk 
Reduction
Mohamad Alkhouli, Carol F Homko, Memon Nabeel, abdul Kashem, 
Alfred A Bove, Temple University Hospital, Philadelphia, PA
Learning Objective: Learn about differences between rural and 
urban indivisuals participation in CVD risk reduction
A56 ABSTRACTS: General Cardiology: Hypertension, Prevention and Lipids JACC    March 9, 2010
G
en
er
al
 C
ar
di
ol
og
y:
  
H
yp
er
te
ns
io
n,
 P
re
ve
nt
io
n 
an
d 
Li
pi
ds
1131-111 Older Is Wiser: Low-Density Lipoprotein Cholesterol 
Goal Attainment in a Multinational Survey 
of Dyslipidemic Patients: A Lipid Treatment 
Assessment Project (L-TAP) 2 Substudy
Raul D. Santos, David D. Waters, Jean Ferrieres, J-Wouter Jukema, 
Cheng-Wen Chiang, Michael Messig, Lisa Tarasenko, for the L-TAP 
2 Investigators, Lipid Clinic Heart Institute (InCor) University of 
Sao Paulo, Sao Paulo, Brazil, Division of Cardiology, San Francisco 
General Hospital and University of California, San Francisco, CA
Learning Objective: Compare differences in risk factors and lipid 
control between younger and older individuals enrolled in the 
multinational LTAP-2 study
1131-112 Statin Therapy after Coronary Artery Bypass Graft 
Surgery Is Associated with Reduced All-cause 
Mortality.
Femi Philip, Cleveland Clinic Foundation, Cleveland, OH
Learning Objective: Understand the value of statin therapy after 
coronary artery bypass graft surgery
1131-113 Low-Dose Acetylsalicylic Acid-Associated Peptic 
Ulcers and Dyspeptic Symptoms are Reduced by 
Esomeprazole 20 mg and 40 mg Once Daily
James Scheiman, Johan Herlitz, Philip Devereaux, Emma Naucler, 
Lars-Erik Svedberg, University of Michigan Hospitals, Ann Arbor, MI
Learning Objective: evaluate the clinical benefit of esomeprazole 
treatment in patients who require low-dose ASA (75–100 mg) 
for cardiovascular risk management and are at risk of upper 
gastrointestinal adverse events.
1132 METABOLIC SYNDROME, DIABETES AND 
LIFESTYLE
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1132-115 Achievement of Dietetic and Exercise Therapy 
Evaluated by Self assessment Score Significantly 
Improved Endothelial Dysfunction in Patients with 
Metabolic Syndrome
yasushi matsuzawa, Seigo Sugiyama, Kazuo Kimura, Hisao Ogawa, 
Department of Cardiovascular Medicine, Graduate School of 
Medical Sciences, Kumamoto University, Kumamoto, Japan, Division 
of Cardiology, Yokohama City University Medical Center, Yokohama, 
Japan
Learning Objective: This study demonstrated the usefulness of the 
self assessment scoring system to evaluate efficacy of the life style 
intervention on achieving cardiovascular benefits.
1130-105 Treatment Strategy and Long-term Mortality in 
Female Patients with Non-ST-Elevation Acute 
Coronary Syndrome; a Substudy from the ICTUS 
Trial
Peter Damman, Fons Windhausen, Alexander Hirsch, Jan GP Tijssen, 
Robbert J. de Winter, Academical Medical Center, Amsterdam, The 
Netherlands
Learning Objective: Describe 5-year mortality in women with nSTE-
ACS and elevated troponin T after early invasive versus selective 
invasive strategy
1130-106 Lack of Effect of Thiazide Diuretics on Bone Mineral 
Density in Hypertensive Elderly African American 
Women
Fahad Javed, Emad F. Aziz, Alexandre M. Benjo, Ramya Suryadevara, 
Carlos Alviar, Jorge Romero, Iffat Shaheen, Eyal Herzog, Franz 
Messerli, St..Lukes-Roosevelt Hospital Center,Columbia College of 
Physicians & Surgeons, New York, NY
Learning Objective: Evaluate the effects of thiazide diuretics on the 
bone density of African American post menopausal women
1130-107 Prognostic Role of N-terminal pro-Brain Natriuretic 
Peptide in a Population at High Risk for 
Cardiovascular Disease.
Irene Betti, Piercarlo Ballo, Alessandro Barchielli, Alfredo Zuppiroli, 
Unità Operativa di Cardiologia, Ospedale S. Maria Annunziata, 
Azienda Sanitaria di Firenze, Firenze, Italy
Learning Objective: Evaluate the predictive value of NT-pro BNP 
in a large cohort of subjects with hypertension and diabetes from 
primary care
1131 PHARMACOLOGIC THERAPY
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1131-109 Role of Statin Therapy in Primary Prevention of 
Heart Failure
Jorge E. Silva Enciso, Harikrishna Makani, Jorge Romero, Emad 
Aziz, Marrick Kukin, Franz Messerli, St. Luke’s Roosevelt Hospital 
and Columbia University College of Physicians and Surgeons, New 
York, NY
Learning Objective: evaluate the benefits of statins in preventing or 
treating heart failure.
1131-110 Cardiovascular Event Rates in Stable Coronary 
Patients With Chronic Kidney Disease, Increased By 
the Presence of Obesity, are Reduced by Intensive 
Lipid Lowering With Atorvastatin
Prakash C. Deedwania, James Shepherd, Daniel J. Wilson, on behalf 
of the TNT Investigators, VACCHCS/UCSF School of Medicine, 
Fresno, CA, University of Glasgow, Glasgow, United Kingdom
Learning Objective: Describe the association of obesity with CKD 
and impact of lipid lowering therapy with atorvastatin
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1182-87 Socioeconomic status and cardiovascular disease 
mortality in Thailand: the Electricity Generating 
Authority of Thailand Study
Prin Vathesatogkit, Sukit Yamwong, Mark Woodward, David Batty, 
Federica Barzi, Sayan Cheepudomwit, Sarana Boonbaichaiyapruck, 
Supachai Tanomsup, Nongnuj Unkurapinun, Piyamitr Sritara, Mahidol 
University, Bangkok, Thailand, The George Institute for International 
Health, Sydney, Australia
Learning Objective: see the important of socioeconomic disparity, 
this data is new in ASIAN population.
1182-88 Impact of Gender and Ethnicity on Adherence to 
Guideline Recommended Aspirin Therapy.
Joji J. Varghese, Catherine McNeal, Juhee Song, Dean Kjar, Mazi 
Mahjoobi, MaryAnn Morgan-Cox, John P. Erwin, Scott and White 
Hospital, Texas A&M University, Temple, TX
Learning Objective: To identify the factors associated with non-use 
of aspirin in the recommended population.
1182-89 The Impact of Replacing Hard Cardiac Risk with 
Global Cardiovascular Risk Scores in the Older 
United States Adults
Matthew Tattersall, Kunal N. Karmali, Jon G. Keevil, University of 
Wisconsin School of Medicine and Public Health, Madison, WI
Learning Objective: Interpret the National implications of utilizing 
global cardiovascular risk assessment
1182-90 Association of Neighborhood Socioeconomic Status 
with C-reactive Protein and All-Cause Mortality: the 
REGARDS Study
Mehdi H. Shishehbor, Suzanne Judd, David Litaker, Saima Karim, 
Dawn Kleindorfer, Michael Lauer, George Howard, Virginia Howard, 
Mary Cushman, Cleveland Clinic, Cleveland, OH, University of 
Alabama, Birmingham, AL
Learning Objective: Describe the association between neighborhood 
of residence, hs-CRP, and all-cause mortality.
1183 INSULIN RESISTANCE, DIABETES AND 
METABOLIC SYNDROME
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1183-92 Association of Insulin Resistance with Preclinical 
Cardiovascular Disease in Adolescents and Young 
Adults: The Strong Heart Study.
Marina De Marco, Giovanni de Simone, Mary J. Roman, Marcello 
Chinali, Marie Russell, Elisa T. Lee, Barbara V. Howard, Richard B. 
Devereux, Federico II University, Napoli
Learning Objective: Identify factors associated to insulin resistance 
in adolescents and young adults
1132-116 Changes in Plasma Glucagon-like Peptide-1 Levels 
during Oral Glucose Tolerance Test Reflect Impaired 
Glucose Tolerance in Non-diabetic Subjects
Fumiyuki Otsuka, Masami Kosuge, Kiyoshi Hibi, Naohiro Komura, 
Nobuhiko Maejima, Tatsuya Nakachi, Katsutaka Hashiba, Naoki 
Nakayama, Masayoshi Kiyokuni, Noriaki Iwahashi, Jun Okuda, 
Kengo Tsukahara, Toshiaki Ebina, Satoshi Umemura, Kazuo Kimura, 
Division of Cardiology, Yokohama City University Medical Center, 
Yokohama, Japan
Learning Objective: demonstrate that incretin action as assessed 
by plasma glucagon-like peptide-1 level is reduced even in subjects 
with impaired glucose tolerance, the pre-stage of diabetes.
1132-117 Adherence to the Mediterranean Diet Is Associated 
with Renal Function among Healthy Adults: The 
Attica Study
Christina A. Chrysohoou, Demosthenes B. Panagiotakos, Christos 
Pitsavos, John Skoumas, Akis Zeibekis, Christina Kastorini, 
Constantina Masoura, Eﬁ Tsetsekou, Manolis Kambaxis, Nina 
Papaioannou, Vasiliki Metaxa, Christodoulos Stefanadis, 1st 
Cardiology Clinic, Hippokratio, Athens, Greece, Harrokopio 
University, Athens, Greece
Learning Objective: Greater adherence to the Mediterranean diet 
is independently associated with reduced urea, creatinine and 
increased Ccr rates among healthy men and women.
1132-118 Divergent Effects of Smoking Intensity on 
Inflammatory Markers in a Large Cohort of Active 
Smokers
Asha Asthana, Heather M. Johnson, Megan E. Piper, Michael C. 
Fiore, Timothy B. Baker, James H. Stein, University of Wisconsin 
School of Medicine and Public Health, Madison, WI
Learning Objective: Describe the relationships between hsCRP, WBC 
count, and markers of smoking intensity.
1132-119 Combined Effect of Physical Inactivity and 
Depression as Predictors of Mortality: The 
Cardiovascular Health Study
Sithu Win, Kapil Parakh, Chete Eze-Nliam, Willem J. Kop, Roy C. 
Ziegelstein, Johns Hopkins Medical Institutions, Baltimore, MD, 
University of Maryland, Baltimore, MD
Learning Objective: identify the prognostic importance of depression 
and physical inactivity among individuals older than 65 years of age.
1182 GENDER, AGE AND SOCIOECONOMIC STATUS
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1182-86 Gender and Ethnic Differences in Cardiovascular 
Events and Mortality in Patients with Depressive 
Symptoms
Pawan K. Hari, Vikas Veeranna, Rajeev Sudhakar, Palaniappan 
Manickam, Ashutosh Niraj, Ramanjit Kaur, Sony Jacob, Luis Afonso, 
Wayne State University, Detroit, MI
Learning Objective: identify that depression is associated with 
incident cardiovascular events, stroke, and all cause mortality in 
healthy adult US females regardless of ethnic background
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1184-99 Prevalence, Diagnosis, and Treatment of Impaired 
Fasting Glucose and Impaired Glucose Tolerance
Amrita M. Karve, Rodney Hayward, University of Michigan, Ann 
Arbor, MI
Learning Objective: Understand the rates of prevalence, diagnosis, 
and treatment of prediabetes in the American adult population
1184-100 High Prevalence of Obesity and Metabolic 
Syndrome in Women and Association with 
Insurance Status
Leonidas V. Athanasopoulos, Caitlin E. Johnson, Jennifer L. Jarvie, 
Farhan Aslam, Joanne M. Foody, Brigham & Women’s Hospital, 
Boston, MA
Learning Objective: To evaluate the prevalence of obesity and 
metabolic syndrome in women and their relationship to insurance 
status
1184-101 
Increased Cardiovascular Event Rate Observed in Stable 
Coronary Patients with Metabolic Syndrome Complicated 
by Chronic Kidney Disease Is Reduced by Intensive Lipid 
Lowering with Atorvastatin
Prakash C. Deedwania, James Shepherd, Daniel J. Wilson, on behalf 
of the TNT Investigators, VACCHCS/UCSF School of Medicine, 
Fresno, CA, University of Glasgow, Glasgow, United Kingdom
Learning Objective: Evaluate the effect of intensive lipid lowering 
on the increased cardiovascular risk observed in stable coronary 
patients with metabolic syndrome complicated by chronic kidney 
disease
1184-102 Comparison Of Anthropometric Indices In Predicting 
Metabolic Syndrome Components In Children
Mehmet A. Agirbasli, Nihat Bugra Agaoglu, Marmara University, 
Istanbul, Turkey, Uskudar Municipality, Istanbul, Turkey
Learning Objective: To understand the association of anthropometric 
indices with metabolic syndrome components in children
1185 DIAGNOSTIC APPROACHES AND METHODS
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1185-103 Detection of Subclinical Atherosclerosis by Office-
Based Carotid Ultrasound Increases Prescription of 
Preventive Therapies
Heather Johnson, Terry L. Turke, Mark Grossklaus, Tara Dall, 
Sanford Carimi, Laura M. Koenig, Susan E. Aeschlimann, Claudia E. 
Korcarz, James H. Stein, University of Wisconsin School of Medicine 
and Public Health, Madison, WI
Learning Objective: Describe the use of carotid ultrasound 
screening by primary care providers to improve cardiovascular risk 
prediction and management
1183-93 Absolute Glucose Changes With Lifestyle 
Modification in Impaired Glucose Tolerance
Elisa Bradley, Leonelo Bautista, Patrick McBride, The University of 
Wisconsin, Madison, WI
Learning Objective: identify expected glucose changes after lifestyle 
modification in patients with impaired glucose tolerance.
1183-94 Metabolic Phenotypes And Cardiovascular 
Abnormalities In Prediabetes
Giovanni de Simone, Brunella Capaldo, Mary J. Roman, Olga 
Vaccaro, Michele Iaccarino, Elisa T. Lee, Hong Wang, Barbara V. 
Howard, Richard B. Devereux, Federico II University, Naples, Italy, 
Weill-Cornell Medical College, New York, NY
Learning Objective: Evaluate potential CV risk associated with 
prediabetes status in relation to the type of abnormality of 
glucose regulation
1183-95 Improvement Of Metabolic Syndrome With Low 
Refined Carbohydrates, Relatively High Protein Diet 
Enriched With Mono-and Poly-unsaturated Fatty 
Acids
Francisco Lopez-Jimenez, Ling Xu, Kim L. Edens, Mayo Clinic, 
Rochester, MN
Learning Objective: A low refined carbohydrates, relatively high 
protein diet enriched with mono- and poly-unsaturated fatty acids 
would improve metabolic syndrome.
1183-96 Insulin Resistance is Associated with Metabolic 
Syndrome But Not With Angiographically 
Determined Coronary Artery Disease
Alexander Vonbank, Philipp Rein, Christoph H. Saely, Stephan Beer, 
Johannes Breuss, Heinz Drexel, VIVIT Institut, Feldkirch, Austria
Learning Objective: Insulin resistance is not significantly associated 
with angiographically coronary artherosclerosis
1184 INSULIN RESISTANCE, DIABETES AND 
METABOLIC SYNDROME
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1184-98 Effects Of Low Fat Vs. Moderate Fat Diet On Insulin 
Resistance And Endothelial Function In Metabolic 
Syndrome
Pathmaja Paramsothy, Arthi Thirumalai, Alice Dowdy, Brian Fish, 
Robert H. Knopp, University of Washington, Seattle, WA, Harborview 
Medical Center, Seattle, WA
Learning Objective: To identify the differences of a low fat vs. 
moderate fat diet on insulin resistance and endothelial function in 
Metabolic Syndrome
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1186-111 Supplementing Deficient Vitamin D Levels is 
Associated with Reduced Cardiovascular Risk
Tami Bair, Joseph B. Muhlestein, Heidi T. May, Benjamin D. 
Horne, John F. Carlquist, Donald L. Lappé, Jeffrey L. Anderson, 
Intermountain Medical Center, Murray, UT
Learning Objective: Evaluate whether increasing Vitamin D levels 
will decrease cardiovascular risk.
1186-112 Vitamin D Deficiency Highly Prevalent among Post-
MI Patients
John H. Lee, John A. Spertus, Paul Chan, Fengming Tang, James H. 
O’Keefe, Mid America Heart Institute, University of Missouri-Kansas 
City, Kansas City, MO, Ochsner Clinic Foundation, New Orleans, LA
Learning Objective: Realize the high prevalence of vitamin D 
deficieny in acute myocardial infarction patients.
1187 PHYSICAL ACTIVITY AND EXERCISE THERAPY
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1187-115 Physical Activity, Metabolic Syndrome and Coronary 
Risk; The Epic-Norfolk Prospective Population Study
Lysette N. Broekhuizen, Matthijs S. Boekholdt, Benoit J. Arsenault, 
Jean-Pierre Despres, Erik S.G. Stroes, John J.P. Kastelein, Nicholas 
J. Wareham, Kay-Tee Khaw, Department of Vascular Medicine, 
Academic Medical Centre., Amsterdam, The Netherlands, Institute 
of Public Health and Primary Care, University of Cambridge, 
Cambridge, United Kingdom
Learning Objective: describe that active participants with MS have 
a less severe form of MS and a lower risk for CHD than participants 
who are inactive
1187-116 Cardiopulmonary Fitness is Associated with Lower 
Cardiovascular Mortality in A Community-based 
Cohort
Abhijeet Dhoble, Brian Lahr, Thomas G. Allison, Iftikhar Kullo, 
Francisco Lopez-Jimenez, Ray W. Squires, Gerald Gau, Randal J. 
Thomas, Stephen L. Kopecky, Mayo Clinic, Rochester, MN
Learning Objective: Cardiopulmonary fitness reduces cardiovascular 
mortality by more than 50%, even in patients with traditional risk 
factors.
1187-117 Relationship Between Changes in Heart Rate 
Recovery after Cardiac Rehabilitation on 
Cardiovascular Mortality in Patients with Myocardial 
Infarction
Siu Han Jo Jo Hai, Pak-Hei Chan, Kelvin Chan, Simon Lam, Chung-
Wah Siu, Hee-Hwa Ho, Sheung-Wai Li, Hon-Wah Chan, Stephen Lee, 
Hung-Fat Tse, Queen Mary Hospital, Pokfulam, Hong Kong
Learning Objective: Identify that heart rate recovery improves with 
exercise training and that modified heart rate recovery predicts 
cardiac death in patients with prior myocardial infarction
1185-104 Effects of Office-Based Carotid Ultrasound on 
Health-Related Behaviors and Perceptions of 
Cardiovascular Disease Risk in Patients
Heather Johnson, Terry L. Turke, Mark Grossklaus, Tara Dall, 
Sanford Carimi, Laura M. Koenig, Susan E. Aeschlimann, Claudia E. 
Korcarz, James H. Stein, University of Wisconsin School of Medicine 
and Public Health, Madison, WI
Learning Objective: Describe the effects of carotid ultrasound 
screening on patient health-related behaviors and perception of 
cardiovascular risk
1185-105 High Sensitivity Troponin T Levels in Obstructive 
Sleep Apnea
Anna Randby, Silje K Namtvedt, Gunnar Einvik, Tor-Arne Hagve, 
Virend K Somers, Torbjorn Omland, Akershus University Hospital, 
Lorenskog, Norway
Learning Objective: interpret high sensitivity cardiac troponin T test 
results in patients with OSA.
1185-106 A Screening Glance to Abdominal Aorta and to 
Carotids During Transthoracic Echocardiography : A 
Real World prospective monocentre observational 
Study
Stalder Nicolas, JAUSSI ANDRES, CHUV, Lausanne, Switzerland
Learning Objective: distinguish
1185-107 Oxidative Stress and Inflammatory Biomarkers 
in Pre-hypertensive and Normotensive African 
Americans
Keith M. Diaz, Deborah L. Feairheller, Kathleen M. Sturgeon, Sheara 
Williamson, Praveen Veerabhadrappa, Deborah Crabbe, Michael D. 
Brown, Temple University, Philadelphia, PA
Learning Objective: describe the difference in oxidative stress 
and inflammatory biomarkers between pre-hypertensive and 
normotensive African Americans
1186 PRIMARY PREVENTION, VITAMINS AND 
ANTIOXIDANTS
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1186-109 Do Antioxidant Vitamins Ameliorate the Beneficial 
Effects of Exercise Training on Insulin Sensitivity?
Carl J. Lavie, Jr., Jenna N. Milani, Ochsner Health System, New 
Orleans, LA
Learning Objective: Describe the effects of exercise following 
cardiac rehabilitation on measures of insulin sensitivity
1186-110 Stratifying Cardiovascular Risk by Vitamin D Levels: 
What Are the Optimal Cutoffs?
Heidi Thomas May, Jeffrey L. Anderson, Donald L. Lappé, Benjamin 
D. Horne, Tami L. Bair, Joseph B. Muhlestein, Intermountain Medical 
Center, Murray, UT
Learning Objective: Identify the risk associated with different 
Vitamin D levels.
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1237-89 Arterial and Venous Endothelial Dysfunction in 
Resistant Hypertensive Patients
Juan Carlos Yugar-Toledo, Leoni A. Souza, Samira U. Girioli, Luiz 
C. Martins, Leandro B. Martins, José F. Vilela-Martin, Cláudia 
M. Irigoyen, Heitor Moreno Jr., Pharmacology Department State 
University of Campinas, Campinas, Brazil
Learning Objective: to evaluate endothelial-dependent and 
-independent venous and arterial vasodilation in optimized RH 
patients compared to well-controlled hypertensive (CH) patients and 
normotensive individuals
1237-90 Coronary microcirculation Dysfunction is 
Accompanied by an Impairment of Left Ventricular 
Diastolic Properties in Male Hypertensives
Dimitris Tsiachris, Konstantinos Tsiouﬁs, Dimitris Roussos, 
Kyriakos Dimitriadis, Kostas Toutouzas, Eleftherios Tsiamis, 
Dimitris Tousoulis, Christodoulos Stefanadis, First Cardiology Clinic, 
University of Athens, Hippokration Hospital, Athens, Greece
Learning Objective: demonstrate the parallel abnormalities of coronary 
blood flow reserve and diastolic function in male hypertensives, as well 
as their relationship with increased pulsatile load
1238 HYPERTENSION AND EFFECTS ON CIRCULATING 
FACTORS
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1238-92 Serum soluble Fas and soluble Fas Ligand in 
Hypertension in Pregnancy
Vellore J. Karthikeyan, Shahirose Jessani, Balu Balakrishnan, 
Deirdre A. Lane, Sabah Baghdadi, D. Gareth Beevers, Gregory Y H 
Lip, University Department of Medicine, City Hospital, Birmingham, 
United Kingdom
Learning Objective: To demonstrate a variability in apoptotic factors 
in hypertension in pregnancy
1238-93 Rho-kinase Activity Is Increased In Hypertensive 
Patients With Left Ventricular Hypertrophy.
Luigi Gabrielli, Jorge Jalil, Ivan Godoy, Paul McNab, Ivonne Padilla, 
Samuel Cordova, Paola Rigotti, Ulises Novoa, Italo Mora, Sergio 
Lavandero, Lorena Garcia, Maria P. Ocaranza, Pontiﬁcia Universidad 
Catolica de Chile, Santiago, Chile, Universidad de Chile, Santiago, Chile
Learning Objective: To evaluate circulating levels of Rho kinase 
activity in hypertensive patients with or without left ventricular 
hypertrophy
1238-94 The Impact of Genetic Polymorphism T45G on 
Adiponectin Gene on the Expression of Adipokines 
in Arterial Hypertension
Alexis S. Antonopoulos, Dimitris Tousoulis, Charalambos 
Antoniades, Antigoni Miliou, Nikolaos Koumallos, George Hatzis, 
Michael Dimosthenous, Constantinos Bakogiannis, Costas Tsiouﬁs, 
Kostas Toutouzas, Christodoulos Stefanadis, 1st Cardiology 
Department Hippokration Hospital, Athens, Greece
Learning Objective: Understand how adiponectin affects the risk of 
hypertension development
1187-118 Subjective Rather Than Physical Improvements 
Mediate the Reduction in Depression Associated 
With Participation in a Cardiac Rehabilitation 
Program in Women
Donna Chelle V. Morales, Beth Parker, Marie LaGasse, Edward 
Dostaler, Donna Polk, Hartford Hospital, Hartford, CT, University of 
Connecticut, Internal Medicine Residency, Farmington, CT
Learning Objective: Identify which factors affect reduction in 
depression with cardiac rehabilitation in women.
1187-119 Exercise Training Relieves Palpitation And 
Premature Ventricular Depolarizations Through 
Decrease In Peri-infarct Zone
Bai-Chin Lee, Ming-Fong Chen, Wen-Yih I. Tseng, Ssu-Yuan Chen, 
National Taiwan University Hospital, Taipei, Taiwan,ROC
Learning Objective: iidentify the role of periinfarct zone in postinfarct 
patients
1237 HYPERTENSION AND THE ARTERY WALL
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1237-86 The Adverse Effects of Nocturnal Hypertension on 
Arterial Stiffness and Urinary Albumin Excretion in 
Hypertension
Dimitris Syrseloudis, Konstantinos Tsiouﬁs, Eirini Andrikou, Ioannis 
Andrikou, Anastasia Mazaraki, Elli Stefanadi, Ioannis Kallikazaros, 
Christodoulos Stefanadis, First Cardiology Clinic, University of 
Athens, Hippokration Hospital, Athens, Greece
Learning Objective: identify the role of nocturnal hypertension in the 
development of target organ damage even in dipper hypertensives
1237-87 The Detrimental Effect of Chronic Periodontal 
Disease and Systemic Inflammation on Endothelial 
Dysfunction in Untreated Hypertensive Patients
C. THOMOPOULOS, K. TSIOUFIS, N. SOLDATOS, G. GIAMARELOS, 
C. DENDRINOS, M. SELIMA, A. KASIAKOGIAS, E. STEFANADI, D. 
TOUSOULIS, C. STEFANADIS, First Cardiology Clinic, University of 
Athens, Hippokration Hospital, Athens, Greece
Learning Objective: identify that early stages of periodontal disease 
may constitute a sub-clinical accelerator of widespread vascular 
damage
1237-88 Pulsatile Versus Steady Components of Blood 
Pressure and Their Relations With Aortic Stiffness: 
A Bone to Pick?
Panagiotis Xaplanteris, Charalambos Vlachopoulos, Gregory 
Vyssoulis, Ioanna Dima, Katerina Baou, Konstantinos Aznaouridis, 
Dimitrios Terentes-Printzios, Aikaterini Siama, Christodoulos 
Stefanadis, 1st Cardiology Department, Athens Medical School, 
Hippokration Hospital, Athens, Greece
Learning Objective: to distinguish between steady and pulsatile 
components of blood pressure as predictors of aortic stiffness.
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1239-100 Hormonal and Electrolyte Responses to the 
Aldosterone Synthase Inhibitor LCI699 in Sodium 
Depleted Healthy Subjects
Joël Menard, Catherine Watson, Sam Rebello, Yiming M. Zhang, 
William P. Dole, Université Paris Descartes, Paris, France, Novartis 
Institutes of Biomedical Research, Cambridge, MA
Learning Objective: Evaluate the pharmacokinetics and 
pharmacodynamics of LCI699, an aldosterone synthase inhibitor
1239-101 Blood Pressure Reduction with the Novel Dual-
Acting Angiotensin Receptor Neprilysin Inhibitor 
LCZ696: A Randomized, Multicenter, Double-Blind, 
Placebo-Controlled, Active-Comparator Study
Michael Böhm, Luis M. Ruilope, Yves Lacourciere, Andrej Dukat, 
Jim Gong, Martin Lefkowitz, Saarland University, Homburg/Saar, 
Germany, Hospital 12 de Octubre, Madrid, Spain
Learning Objective: appreciate that angiotensin receptor blockade 
and neprilysin inhibition are complementary modes of action as 
shown by the greater BP lowering of LCZ696 compared with valsartan
1239-102 Effect of Renin Angiotensin System (RAS) Blockade 
on Calcium Antagonist Associated Pedal Edema
Harikrishna J. Makani, Franz H. Messerli, Christopher Di Giorgio, 
Jorge Romero, Maria Elena De Benedetti Zunino, Jorge Silva Enciso, 
St. Luke’s Roosevelt Hospital and Columbia University College of 
Physicians and Surgeons, New York, NY
Learning Objective: appreciate that angiotensin receptor blockade 
and neprilysin inhibition are complementary modes of action 
as shown by the greater BP lowering of LCZ696 compared with 
valsartan
1240 CENTRAL BLOOD PRESSURE DRUGS AND GENES
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1240-103 Responses to Aliskiren/HCTZ versus Amlodipine on 
Peripheral and Central Blood Pressure in African 
American Patients with Stage 2 Hypertension
Keith Ferdinand, James Pool, Richard Weitzman, Das Purkayastha, 
Raymond Townsend, Emory University, Decatur, GA
Learning Objective: understand the disparity of response of 
antihypertensive agents on central pressure vs peripheral pressure 
and how that relates to treatment choices in hypertensive patients
1240-104 The Effect of Calibration Error on the Transfer-
function-derived Central Aortic Blood Pressure
Hao-min Cheng, Yuan-Ta Shih, Kang-Ling Wang, Yi-Jung Sun, Ying-
Hwa Chen, Shing-Jong Lin, Lung-Ching Chen, Lung-Ching Chen, Lung-
Ching Chen, Shih-Hsien Sung, Wen-Shin Lee, Wen-Chung Yu, Wei-
Chih Hu, Chen-Huan Chen, Taipei Veterans General Hospital, Taipei, 
Taiwan,ROC, National Yang-ming University, Taipei, Taiwan,ROC
Learning Objective: to understand the errors of central BP 
estimation could be resulted and predicted from the inaccuracy of 
cuff BP measurements
1238-95 Higher Chymase Dependent Angiotensin II-Forming 
Activity in the Circulating Mononuclear Leukocyte 
is a Significant Contributing Factor for Atrial 
Fibrillation
Keisuke Okamura, Yukiko Inoue, Yoshinari Uehara, Kenzo 
Matsumoto, Seiyo Maruyama, Shunichiro Sumi, Yusuke Fukuda, 
Shodai Furuyama, Sunao Kodama, Chie Andoh, Hideya Niimura, 
Kazumitsu Kubota, Hideaki Tohjoh, Kei Miyoshi, Shinichiro Miura, 
Yoshio Yamanouchi, Keijiro Saku, Hidenori Urata, Department of 
Cardiovascular Diseases,Fukuoka University Chikushi Hospital, 
Chikushino, Japan, Department of Cardiology, Fukuoka University, 
Fukuoka, Japan
Learning Objective: learn that higher chymase dependent 
angiotensin II-forming activity in the circulating mononuclear 
leukocyte is a significant contributing factor for atrial fibrillation
1238-96 Early Increase in Circulating Autoantibodies 
against Human Oxidized Low-density Lipoprotein in 
Hypertensive Patients after Blood Pressure Control
Maria Cristina Izar, Sergio A. Brandao, Simone C. Fischer, Rui M. 
Povoa, Carlos M. Monteiro, Andrea M. Monteiro, Magnus Gidlund, 
Antonio M. Figueiredo Neto, Antonio C. Carvalho, Francisco A. 
Fonseca, Federal University of Sao Paulo, Sao Paulo, Brazil, 
University of Sao Paulo, Sao Paulo, Brazil
Learning Objective: Describe antibody behaviour after blood 
pressure control
1239 HYPERTENSION AND THE RENIN-ANGIOTENSIN-
ALDOSTERONE SYSTEMS
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1239-98 Angiotensin Converting Enzyme Inhibitors and 
Angiotensin Receptor Blockers in Pregnancy: an 
Increasing Problem
Vellore J. Karthikeyan, Robin E. Ferner, Sabah Baghdadi, Deirdre 
A. Lane, Gregory Y H Lip, D. G. Beevers, University Department of 
Medicine, Birmingham, United Kingdom
Learning Objective: Demonstrate high incidence of adverse 
pregnancy outcomes in women on ACE-I or ARBs.
1239-99 Blockade of Aldosterone Production as a 
Novel Approach to the Management of High 
Blood Pressure: Efficacy and Tolerability of the 
Aldosterone Synthase Inhibitor LCI699 in Patients 
with Stage 1-2 Hypertension
William B. White, David A. Calhoun, Henry Krum, Weinong Guo, 
Angelo J. Trapani, Martin Lefkowitz, Joel Menard, University of 
Connecticut School of Medicine, Farmington, CT, University of 
Alabama at Birmingham, Birmingham, AL
Learning Objective: understand the antihypertensive efficacy and 
safety of aldosterone synthase inhibition
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1241-111 Systolic Blood Pressure and Treatment Outcomes in 
Chronic Heart Failure
Keun-Suh Kim, Venkataramana Reddy, DK Petersen, S. Westrom, 
Jun R. Chiong, Loma Linda University, Loma Linda, CA
Learning Objective: Identify the importance of proper titration of 
blood pressure medication in chronic heart failure patients and its 
role in the outcome of such patients
1241-112 Is Mid Ascending Aortic Diameter Smaller in 
Patients with Hypertension or Heart Failure with 
Preserved Ejection Fraction?
Selma F. Mohammed, Barry A. Borlaug, Alessandro Cataliotti, 
Margaret M. Redﬁeld, Mayo Clinic, Rochester, MN
Learning Objective: Define the factors affecting mid ascending 
aortic diameter. Compare mid ascending aortic diameter in normal, 
hypertensive and subjects with HFpEF.
1241-113 Prognostic Role of CA125 in a Population at High 
Risk for Cardiovascular Disease: Results From the 
PROBE-HF Study
Irene Betti, Piercarlo Ballo, Alessandro Barchielli, Alfredo Zuppiroli, 
Unità Operativa di Cardiologia, Ospedale S. Maria Annunziata, 
Azienda Sanitaria di Firenze, Firenze, Italy
Learning Objective: Evaluate the prognostic value of CA 125 in a large 
cohort of subjects with hypertension and diabetes from primary care.
1242 HYPERTENSION AND OBESITY
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1242-115 Type 2 Diabetes Mellitus and the Intrarenal Renin 
System: Influence of Obesity
George V. Moukarbel, Naomi D.L. Fisher, Norman K. Hollenberg, 
Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Learning Objective: understand the influence of obesity and 
abnormal glycemic control on renal hemodynamics.
1242-116 Sensitivity of Modern Electrocardiographic Criteria 
for Left Ventricular Hypertrophy in Severely Obese 
Patients
Brigham Smith, Theophilus Owan, Nathan Smith, Genaro Fernandez, 
Sheldon E. Litwin, University of Utah, Salt Lake City, UT
Learning Objective: Compare the utility of ECG with echo in 
diagnosis of left ventricular hypertrophy in severely obese patients.
1242-117 Obesity as a Determinant of Left Atrial Size in the 
Early Stages of Hypertension. The Crucial Role of 
Waist Circumference
Efstathios Taxiarchou, Konstantinos Tsiouﬁs, Dimitris Roussos, 
Dimitris Tsiachris, Dimitris Syrseloudis, Costas Thomopoulos, 
Dimitris Tousoulis, Ioannis Kallikazaros, Christodoulos Stefanadis, 
First Cardiology Clinic, University of Athens, Hippokration Hospital, 
Athens, Greece
Learning Objective: identify the predictors of left atrial dilation in 
hypertensives
1240-105 The p22phox -930A/G Polymorphism of NADPH 
Oxidase Adversely Affects Peripheral and Central 
Pressures in Healthy Normotensive Individuals
Panagiotis Xaplanteris, Charalambos Vlachopoulos, Katerina Baou, Carmen 
Vassiliadou, Ioanna Dima, Nikolaos Ioakeimidis, Nikolaos Alexopoulos, 
Dimitrios Tousoulis, Christodoulos Stefanadis, 1st Cardiology Department, 
Athens Medical School, Hippokration Hospital, Athens, Greece
Learning Objective: identify the role of the p22phox -930A/G 
polymorphism of NADPH oxidase in the regulation of peripheral and 
central blood pressure
1240-106 Different Effects of Aliskiren/Hydrochlorotiazide 
and Atenolol/Hydrochlorotiazide Combinations on 
Central Pressure in Elderly Hypertensive Patients
Roberto Fogari, Amedeo Mugellini, Paola Preti, Maurizio Destro, 
Luca Corradi, Giuseppe Derosa, Department of Internal Medicine, 
University of Pavia, Pavia, Italy
Learning Objective: These results indicate that in elderly 
hypertensive patients AL/HCTZ combination reduces central aortic 
pressure, augmentation pressure and plasma BNP more than AT/
HCTZ combination, despite a similar
1240-107 Estimation of Central Blood Pressure by Carotid 
tonometry, Radial tonometry, and Brachial 
Plethysmography: A Comparative study
Hao-min Cheng, Shih-Hsien Sung, Pai-Feng Hsu, Kang-Ling Wang, 
Wen-Shin Lee, Wen-Chung Yu, Yao-Ping Lin, Chen-Huan Chen, Taipei 
Veterans General Hospital, Taipei, Taiwan,ROC
Learning Objective: to understand the methods of estimation of 
central blood pressure and know the differences among them and 
their relations with left ventricular mass
1241 HYPERTENSION AND HEART FAILURE
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1241-109 Is Isolated Diastolic Hypotension a New Risk Factor 
for Incident Heart Failure in Community-Dwelling 
Older Adults?
Jason L. Guichard, Mustafa I. Ahmed, Marjan Mujib, Michel White, 
Wilbert S. Aronow, Prakash Deedwania, Ali Ahmed, University of 
Alabama at Birmingham, Birmingham, AL
Learning Objective: Appreciate isolated diastolic hypotension (IDH) 
as a novel risk factor for new-onset heart failure in older adults.
1241-110 Cardiac Remodeling and Diastolic Dysfunction 
Precede non MI-Related Heart Failure in High-Risk 
Hypertensive Patients: The LIFE Echo Substudy.
Marcello Chinali, Gerard P. Aurigemma, Peter M. Okin, Eva 
Gerdts, Kristian Wachtell, Sverre E. Kjeldsen, Stevo Julius, Björn 
Dahlöf, Giovanni de Simone, Richard B. Devereux, University of 
Massachusetts Medical School, Worcester, MA
Learning Objective: Describe the serial changes in cardiac geometry 
and function preceding an acute heart failure event in treated 
hypertensives
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1242-118 Association Between Large and Small Artery 
Elasticity and NT-pro B-type Natriuretic Peptide: 
Results of the Multi-Ethnic Study for Atherosclerosis
Daniel A. Duprez, David Jacobs, Jr, David Bluemke, Joao Lima, 
Hossein Bahrami, Carmen Peralta, Michael Criqui, Lori Daniels, Alan 
Maisel, University of Minnesota, Minneapolis, MN
Learning Objective: understand the association of large and small 
artery elasticity and NT-proB-type Natriuretic pepetide in subjects 
free of overt cardiovascular disease.
1242-119 Central Obesity Seems to Have the Highest 
Predictive Value among all Others Anthropometric 
Indices for the Five-Year Incidence of Hypertension 
in Apparently Healthy Individuals: The Attica Study
christina A. chrysohoou, Demosthenes B. Panagiotakos, Christos 
Pitsavos, John Skoumas, Yannis Lentzas, Anastasia Katinioti, 
Constantina Masoura, Akis Zeibekis, Lambros Papadimitriou, 
Manolis Kambaxis, Vasiliki Metaxa, Christodoulos Stefanadis, 
1st Cardiology Clinic, Hippokratio, Athens, Greece, Harrokopio 
University, Athens, Greece
Learning Objective: Evaluation of waist circumference as better 
predictor of the 5-year incidence of hypertension than other 
anthropometric indices.
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905 CT CORONARY ANGIOGRAPHY: INSIGHTS INTO 
PLAQUE IMAGING
Sunday, March 14, 2010, 8:00 a.m. - 9:30 a.m.
Georgia World Congress Center, Room B403
CME/CE Hours: 1.5
8:00 Usefulness of Plaque Assessment by 64-Slice Multi-
Detector Computed Tomography for Predicting 
Stenting-Related Periprocedural Myocardial 
Infarction
Tomoe Murakami, Yuichi Kawase, Shinsaku Shimamoto, Hiroshi 
Ueda, Hiroki Sakamoto, Japanese Red Cross Society Wakayama 
Medical Center, Wakayama, Japan
Learning Objective: Utilize 64-slice MDCT to predict stenting-related 
periprocedural myocardial infarction
8:15 Noninvasive Assessment of Morphological 
Changes in Lipid-Rich Coronary Plaque after 
Statin Treatment Using Dual-Source Computed 
Tomography
Tsunenari Soeda, Shiro Uemura, Satoshi Okayama, Hitoshi 
Nakagawa, Ayako Senoo, Taku Nishida, Ji Hee Sung, Yoshinobu 
Morikawa, Satoshi Somekawa, Ken-ichi Ishigami, Hiroyuki Kawata, 
Manabu Horii, Yoshihiko Saito, Nara Medical University, Kashihara, 
Japan
Learning Objective: demonstrate
8:30 Automated 3-D Plaque Quantification from 
Coronary CT Angiography: Comparison with 
Intravascular Ultrasound
Damini Dey, Tiziano Schepis, Mohamed Marwan, Piotr J. Slomka, 
Daniel S. Berman, Stephan Achenbach, Cedars-Sinai Medical 
Center, Los Angeles, CA, University of Erlangen, Erlangen, Germany
Learning Objective: Identify that automated threshold-based 
quantification of plaque components from coronary CT angiography 
allows accurate measurement compared with invasive intravascular 
ultrasound.
8:45 Coronary Computed Tomography Angiography with 
a 3-D Highly Standardized Method Can Accurately 
Quantify Plaque Geometry and Compositional 
Parameters Using Intravascular Ultrasound with 
Radiofrequency Analysis as Reference Standard
Sarah Rinehart, Gustavo Vazquez, Zhen Qian, Idean Marvasty, 
Anna Kalynych, Dimitri Karmpaliotis, Charles Brown, Szilard Voros, 
Piedmont Heart Institute, Atlanta, GA
Learning Objective: Identify that with utilization of a highly 
standardized method, CTA can accurately quantify coronary plaque 
compared to the gold standard VH-IVUS.
ORAL CONTRIBUTIONS
9:00 Increased Vascular Stiffness Measured as Pulse 
Wave Velocity Is Associated with the Presence and 
Severity of Coronary Artery Disease
Naser Ahmadi, Vahid Nabavi, Braynce L. Oyang, Shahin Moshreﬁ, 
Sagar J. Pathak, Sourya Sourya-nejad, Hussain Isma’eel, Ramin 
Ebrahimi, Matthew Budoff, Los Angeles Biomedical Research 
Institute at Harbor UCLA Medical Center, Torrance, CA
Learning Objective: Increased pulse wave velocity measured by 
computed tomography angiography strongly correlates with the 
presence and severity of coronary artery disease independent of 
conventional risk factors
909 ECHOCARDIOGRAPHY: NOVEL APPLICATIONS OF 
THREE-DIMENSIONAL ECHOCARDIOGRAPHY IN 
VALVE DISEASE
Monday, March 15, 2010, 10:30 a.m. - 12:00 p.m.
Georgia World Congress Center, Room B403
CME/CE Hours: 1.5
10:30 Automated Quantitative Modeling of the Aortic 
Valve and Root in Aortic Regurgitation Using 
Volume 3-D Transesophageal Echocardiography
Anna Calleja, Ionasec Razvan, Helene Houle, Shizhen Liu, Jennifer 
Dickerson, Paaladinesh Thavendiranathan, Chittoor Sai-Sudhakar, 
Juan Crestanello, Thomas Ryan, Mani Vannan, Ohio State University, 
Columbus, OH, Siemens Healthcare, Ultrasound, Mountain View, CA
Learning Objective: To demonstrate the feasibilty of obtaining 
conventional and non conventional aortic valve and root parameters 
in patients with aortic regurgitation using 3D echocardiography
10:45 Catheter Based, Percutaneous Mitral Valve Clipping 
- The Added Value of Real Time Transesophageal 
Echocardiography
Robert J. Siegel, Gila Perk, Takahiro Shiota, Itzhak Kronzon, James 
Slater, Saibal Kar, Asma Hussani, Simon Biner, Cedars-Sinai Medical 
Center, Los Angeles, CA, NYU Langone Medical Center, New York, NY
Learning Objective: Role of 3D TEE in percutaneous mitral repair
11:00 Automated 3-D Characterization and Quantification 
of Proximal Isovelocity Surface Area and Vena 
Contracta of Mitral Regurgitation by Real-Time 
Volume Color Doppler Imaging: Initial Clinical 
Experience
Shizhen Liu, Saurabh Datta, Adrien Ntinunu, Thomas Van Houten, 
Nathalie De Michelis, Joel Mancina, Mary Ellen Orsinelli, Helene 
Houle, Dawn Lombardo, Paaladinesh Thavendiranathan, David 
Orsinelli, Peng Li, Thomas Ryan, Mani Vannan, The Ohio State 
University, Columbus, OH, Siemens Medical Solutions USA Inc., 
Mountain View, CA
Learning Objective: Measure 3-D PISA and VC in Mitral Regurgitation
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2:30 Microvascular Obstruction Assessed by 3-Tesla 
Magnetic Resonance Imaging in Acute Myocardial 
Infarction: Correlation with Plasma Troponin I Levels
Charles Daragon, Jerome Iehl, Nicolas Meneveau, Alexandre Comte, 
Francois Schiele, Bruno Kastler, University Hospital Jean Minjoz, 
Besancon, France
Learning Objective: describe the correlation between plasma 
Troponin levels and microvascular obstruction as assessed by MRI 
in acute MI
2:45 Influence of Reperfusion Hemorrhage on Myocardial 
Infarct Size and Left Ventricular Function as 
Determined by Cardiovascular Magnetic Resonance 
Imaging
Adam Mather, Aleksandra Radjenovic, John P. Greenwood, Sven 
Plein, University of Leeds, Leeds, United Kingdom
Learning Objective: identify patients with reperfusion hemorrhage 
following primary percutaneous coronary intervention which may be 
useful in further risk stratification post acute myocardial infarction.
3:00 Role of Myocardial Haemorrhage in Predicting 
Adverse Left Ventricular Remodeling after 
Reperfused Acute Myocardial Infarction. Can We 
Outperform Microvascular Obstruction?
Claudia Raineri, Annalisa Turco, Sergio Leonardi, Mara Bonardi, 
Michela Cottini, Guido Tavazzi, Margherita Calcagnino, Gabriele 
Crimi, Maurizio Ferrario, Mario Previtali, Fondazione IRCCS 
Policlinico S.Matteo, Pavia, Italy
Learning Objective: Describe the relative ability of myocardial 
hemorrhage and microvascular obstruction in identifying patients at 
risk for adverse left ventricular remodeling after an acute myocardial 
infarction.
917 POSITRON EMISSION TOMOGRAPHY: ISCHEMIA 
AND MICROVASCULAR FUNCTION
Tuesday, March 16, 2010, 8:00 a.m. - 9:30 a.m.
Georgia World Congress Center, Room B403
CME/CE Hours: 1.5
8:00 Comparison of F-18 Labeled BMS747158 PET 
and Tc-99m Labeled SPECT Myocardial Perfusion 
Imaging for Detection and Evaluation of Coronary 
Artery Disease
Jamshid Maddahi, Johannes Czernin, Alexander Ehlgen, Joel 
Lazewatsky, Qi Zhu, Michael Phelps, David Geffen School of 
Medicine at UCLA, Los Angeles, CA, Lantheus Medical Imaging, 
Billerica, MA
Learning Objective: describe potential advantages of PET myocardial 
perfusion imaging with the new tracer BMS747158 vs. SPECT
11:15 Determination of Aortic Valve Annular Dimension 
Prior to Percutaneous Aortic Valve Replacement 
with CoreValve: A Comparison of Multi-Modality 
Imaging Techniques
Siobhan M. Lockwood, Ian T. Meredith, Paul R. Antonis, Sujith 
K. Seneviratne, Philip M. Mottram, Stuart Moir, MonashHeart, 
Melbourne, Australia, Monash Cardiovascular Research Centre, 
Melboure, Australia
Learning Objective: Demonstrate techniques for evaluation of aortic 
vavle annular dimension
11:30 Does 3D Transesophageal Imaging Add Value to 
Transcatheter Aortic Valve Implantation? Experience 
in 150 Cases
Amit Bhan, Rafal Dworakowski, Lindsay A. Smith, Philip A. 
MacCarthy, Simon Redwood, Ahmed El-Gamel, Christopher Young, 
Vinayat Bapat, Jane Hancock, Olaf Wendler, Martyn R. Thomas, 
Mark J. Monaghan, Kings Health Partners, London, United Kingdom
Learning Objective: Evaluate the use of 3D transesophageal 
echocardiography in transcatheter aortic valve implantation
911 MAGNETIC RESONANCE IMAGING: 
CARDIOVASCULAR MAGNETIC RESONANCE IN 
ACUTE CORONARY SYNDROMES
Monday, March 15, 2010, 2:00 p.m. - 3:30 p.m.
Georgia World Congress Center, Room B403
CME/CE Hours: 1.5
2:00 Clinical Assessment of No-Reflow in Humans: 
Comparison between Cardiac Magnetic Resonance 
and Angiography
Martina Perazzolo Marra, Luisa Cacciavillani, Francesco Corbetti, 
Giuseppe Tarantini, Cristina Basso, Armando Marzari, Manuel De 
Lazzari, Veronica Spadotto, Filippo Zilio, Sabino Iliceto, Division 
of Cardiology, Departments of Cardiac, Thoracic, and Vascular 
Sciences, Padua, Italy
Learning Objective: identify microvascular injury from a 
comprehensive evaluation between magnetic resonance and 
angiography
2:15 Impact of Early versus Late Microvascular 
Obstruction Assessed by Magnetic Resonance 
Imaging on Long-Term Outcome after ST-Elevation 
Myocardial Infarction
Suzanne De Waha, Steffen Desch, Ingo Eitel, Matthias Gutberlet, 
Gerhard Schuler, Holger Thiele, University of Leipzig – Heart Center, 
Department of Internal Medicine – Cardiology, Leipzig, Germany
Learning Objective: interpret the presence and extent of late MO 
as strong independent predictors for the occurrence of death, 
reinfarction and congestive heart failure after STEMI in contrast to 
early MO.
A66 ABSTRACTS: Imaging and Diagnostic Testing JACC    March 9, 2010
Im
ag
in
g 
an
d 
Di
ag
no
st
ic
 Te
st
in
g
923 TISSUE IMAGING: CLINICAL IMPACT OF NOVEL 
IMAGING APPROACHES TO QUANTIFY CARDIAC 
FUNCTION
Tuesday, March 16, 2010, 2:00 p.m. - 3:30 p.m.
Georgia World Congress Center, Room B403
CME/CE Hours: 1.5
2:00 Multiplane Speckle Tracking Imaging to Quantify 
Dyssynchrony and Predict Long-Term Outcome after 
Cardiac Resynchronization Therapy
Hidekazu Tanaka, Olusegun Oyenuga, Phillip Habib, Evan C. 
Adelstein, John Gorcsan, III, University of Pittsburgh, Pittsburgh, PA
Learning Objective: demonstrate that a multiplane speckle-tracking 
imaging approach successfully quantified dyssynchrony and 
predicted long-term outcome to CRT.
2:15 Analysis of Left Ventricular Lead Position in Cardiac 
Resynchronization Therapy Using Different Imaging 
Modalities
Michael Becker, Ertunc Altiok, Renate Hoffmann, Patrick Schauerte, 
Christian Koch, Rainer Hoffmann, Department of Cardiology, 
Aachen, Germany
Learning Objective: identify optimal LV lead position
2:30 Characterization of Regional Heterogeneity in Left 
Atrial Reservoir and Conduit Function by Speckle 
Tracking Echocardiography
Samir K. Saha, Paula L. Anderson, Giuseppe Caracciolo, Susan 
Wilansky, Anatoli Kiotsekoglou, James C. Moggridge, Satish C. 
Govind, A. J. Camm, Lars-Ake Brodin, Partho P. Sengupta, Sundsvall 
Regional Hospital, Sundsvall, Sweden, Mayo Clinic Arizona, 
Scottsdale, AZ
Learning Objective: To evaluate left atrial strain in atrial fibrillation
2:45 Two-Dimensional Speckle Strain Imaging Identifies 
Depressed Left Atrial Function in Hypertensive 
Patients with Diastolic Dysfunction
Umar A. Khan, Marcello Chinali, Gerard P. Aurigemma, Jeffrey C. Hill, 
Giovanni de Simone, Dennis A. Tighe, University of Massachusetts 
Medical School, Worcester, MA
Learning Objective: Identify early predictors of Diastolic Dysfunction
3:00 Diastolic Strain Rate Imaging Using a Prototype 
Radiofrequency-Based Speckle Tracking 
Echocardiography System for Assessment of 
Diastolic Function
Theodore J. Kolias, Matthew O’Donnell, Nicole M. Kline, Lingling 
Zhang, James D. Hamilton, University of Michigan, Ann Arbor, MI
Learning Objective: Evaluate a new method for assessing diastolic 
function using a prototype speckle tracking echocardiography 
system
8:15 A Pilot Study of Left Ventricular Ejection Fraction 
Reserve during Regadenoson Rubidium-82 
Myocardial Perfusion Imaging and the Magnitude of 
Ischemia and CAD
Edward Hsiao, Bilal Ali, Ron Blankstein, Raymond Kwong, Marcelo Di 
Carli, Sharmila Dorbala, Brigham and Women’s Hospital, Boston, MA
Learning Objective: to understand the relation between left 
ventricular ejection reserve and the extent of ischemic burden and 
angiographic CAD
8:30 Coronary Circulatory Dysfunction Is Associated 
with Diastolic Dysfunction in Individuals at 
Cardiovascular Risk
Alessandra Quercioli, Maria Gabriella Vincenti, René Nkoulou, 
Stephan Dewarrat, Yann Seimbille, Osman Ratib, François Mach, 
Thomas H. Schindler, University Hospital of Geneva, Cardiovascular 
Center, Geneva, Switzerland
Learning Objective: Evaluate the effect of coronary circulatory 
dysfunction on diastolic function in cardiovascular risk individuals 
without CAD by means of N-13 ammonia PET
8:45 PET-Determined Longitudinal, Myocardial Flow 
Gradient during Hyperemia in Cardiovascular 
Risk Individuals with or without Coronary Artery 
Calcifications
Thomas H. Schindler, Ines Valenta, Gabriella Vincenti, Alessandra 
Quercioli, Rene Nkoulou, Stefan Dewarrat, Yann Seimbille, Osman 
Ratib, Francois Mach, Thomas H. Schindler, Cardiovascular Center, 
University Hospital of Geneva, Geneva, Switzerland, Nuclear 
Medecine, University Hospitals of Geneva, Geneva, Switzerland
Learning Objective: interpret myocardial flow heterogeneity as 
functional precursor of CAD
9:00 Flow-Mediated Vasodilation Can Predict Silent 
Ischemia: Twins Study
Ambar Kulshreshtha, Emir Veledar, Yan Zheng, Durreshahwar Khan, 
Arshed A. Quyyumi, Jun Dai, Irina Uphoff, Douglas J. Bremner, Jack 
Goldberg, Viola Vaccarino, Emory University School of Medicine, 
Atlanta, GA
Learning Objective: Predict Silent Ischemia through Flow mediated 
Vasodilation
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1033-193 Effect of a Standardized Body Mass Index- and 
Heart Rate-Based Protocol on Radiation Dose 
and Diagnostic Accuracy of Coronary Computed 
Tomographic Angiography: A Prospective 
Multicenter Study
Troy LaBounty, Jonathon Leipsic, G.B. John Mancini, Brett Heilbron, 
Smita Patel, Ella A. Kazerooni, Fay Y. Lin, Adam Saltzman, Giora 
Weisz, Jonathan W. Weinsaft, Jin-Ho Choi, Nina Koduru, James K. 
Min, Cornell Medical College, New York, NY, University of Britich 
Columbia, Vancouver, BC, Canada
Learning Objective: Identify the impact of a standardized protocol 
on the radiation dose and diagnostic accuracy of coronary CT 
angiography.
1033-194 Emergency Department Discharge After a Single 
Troponin and Normal 320-Slice Coronary Computed 
Tomographic Angiogram: A Unique Model for Chest 
Pain Evaluation
Arthur Nasis, Ian T. Meredith, Nitesh Nerlekar, James D. Cameron, 
Paul R. Antonis, Philip M. Mottram, Sujith K. Seneviratne, Monash 
Cardiovascular Research Centre, MonashHEART, Melbourne, 
Australia, Monash University Department of Medicine (MMC), 
Melbourne, Australia
Learning Objective: describe the utility of a computed tomographhic 
guided approach to the investigation of acute chest pain.
1033-195 Coronary Calcium Score And Clinical Risk 
Factors Fail To Predict The Burden Of Coronary 
Atherosclerosis In Asymptomatic Diabetic Patients: 
The Factor 64 Study
Khurram S. Zakaria, Christopher T. Sibley, Andrea L. Vavere, David A. 
Bluemke, Rukhsar Ahmed, Hiroyuki Niinuma, Joao AC Lima, Donald 
L. Lappe, Jeffrey L. Anderson, Joseph B. Muhlestein, Johns Hopkins 
University, Baltimore, MD, Intermountain Medical Center, Murray, UT
Learning Objective: Corelation of calcium scores with total 
atherosclerotic plaque burden
1034 RADIATION EXPOSURE WITH CT CORONARY 
ANGIOGRAPHY
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1034-197 Reduction in Estimated Lifetime Cancer Incidence 
and Mortality Using Cardiac Prospective ECG 
Triggered CT Compared to Retrospective Gated CT
Kelley R.H. Branch, Adam M. Alessio, Kalpana M. Kanal, William 
P. Shuman, James H. Caldwell, James P. Earls, University of 
Washington, Seattle, WA, Fairfax Radiological Consultants PC, 
Fairfax, VA
Learning Objective: To describe the lifetime attributable risks of 
cancer for cardiac CT overall and for prospective-triggered CT 
compared to retrspective-gated CT
1033 CT CORONARY ANGIOGRAPHY: RADIATION 
EXPOSURE AND SPECIAL USES
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1033-188 Predictors of Various Artifacts in Coronary Arterial 
Images in Subjects with Chronic Atrial Fibrillation 
by 320 Slice Computed Tomography Considering 
Reconstruction Method
Masae Uehara, Nobusada Funabashi, Issei Komuro, Department 
of Cardiovascular Science and Medicine, Chiba University, Chiba, 
Japan
Learning Objective: identify that in subjects with chronic atrial 
fibrillation, various artifacts still occur in 320 slice CT, and 
sufficient heart rate control by administration of beta block may be 
recommended.
1033-189 Reduction of Radiation Dose of 320-Row Coronary 
Computed Tomography Angiography Through Prior 
Coronary Calcium Scanning
Marc Dewey, Elke Zimmermann, Ulrike Wollenberg, Matthias Rief, 
Johannes Greupner, Bernd Hamm, Charité, Berlin, Germany
Learning Objective: At the conclusion of this presentation, 
participants will be able to determine the dose-saving 
characteristics of coronary artery calcium scanning prior to 320-row 
coronary CT angiography.
1033-191 Low-Dose CT Coronary Angiography with 
Prospective ECG-Triggering Accurately Predicts 
Events in Patients with Known or Suspected 
Coronary Artery Disease
Ronny R. Buechel, Aju P. Pazhenkottil, Bernhard A. Herzog, René N. 
Nkoulou, Irene A. Burger, Ines Valenta, Christophe A. Wyss, Lars 
Husmann, Philipp A. Kaufmann, University Hospital Zurich, Zurich, 
Switzerland
Learning Objective: Recognize low-dose CT coronary angiography 
as a tool that accurately predicts outcome while using very low 
radiation dose (less than 2mSv)
1033-192 80 kV Coronary CT Angiography for Low-body 
Weight Patients
Sei Komatsu, Teruaki Kamata, Atsuko Imai, Jyunichi Yoshida, 
Tomoki Ohara, Kazuaki Miyaji, Yoshinobu Shimizu, Kazuisa Kodama, 
Department of Cardiology, Amagasaki Central Hospital, Hyogo, 
Japan, Department of Radiological Technology, Amagasaki Central 
Hospital, Hyogo, Japan
Learning Objective: learn minimum invasive CTCA
POSTER CONTRIBUTIONS
A68 ABSTRACTS: Imaging and Diagnostic Testing JACC    March 9, 2010
Im
ag
in
g 
an
d 
Di
ag
no
st
ic
 Te
st
in
g
1035 CONTRAST ECHOCARDIOGRAPHY
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1035-205 Angiogenic Effects of the HIF-1α With Triple-point 
Mutations Evaluated by Ultrasound Molecular 
Imaging
Jian_Ping Bin, Jia-jia Xie, Jue-fei Wu, Li Yang, Ming-yan Li, Guang-
quan Hu, Jing-jing Cai, Yun-bin Xiao, Ping-sheng Wu, Nanfang 
Hospital,Southern Medical University, Guangzhou, People’s Republic 
of China
Learning Objective: Demonstrate an optimal angiogenic effect of the 
HIF-1α with triple-point mutations in vivo. Identify the usefulness 
of ultrasound molecular imaging in assessment of therapeutic 
angiogenesis.
1035-206 In Vivo Ultrasound Molecular Imaging of Arterial 
Thrombus with Cyclic RGD-modified Microbubbles
Jian_Ping Bin, Guang-quan Hu, Jue-fei Wu, Li Yang, Jian-guo Bin, 
Ying Liu, Dong-dong Chen, Yun-bin Xiao, Li-jing Ji, Nanfang Hospital, 
Southern Medical University, Guangzhou, People’s Republic of China
Learning Objective: Demonstrate the efficacy of cyclic RGD-modified 
microbubbles on ultrasound molecular imaging of arterial thrombus 
in vivo, and address its value in detection of thrombus.
1035-208 Efficacy Of Novel Magnetic Microbubbles Targeted 
To Vcam-1 In The Assessment Of Inflammation In 
Early Stage Of Atherosclerosis
Juefei Wu, Jianping Bin, Li Yang, Jingjing Cai, Jiajia Xie, Dongdong 
Chen, Yuegang Wang, Guangquan Hu, Yili Liu, Nanfang Hospital, 
South Medical University, Guangzhou, People’s Republic of China
Learning Objective: Demonstrate the excellent efficacy of novel 
magnetic microbubbles targeted to VCAM-1 in high-shear flow. 
Address the value of the microbubbles in detecting inflammation in 
early stage atherosclerosis.
1035-209 Jeopardized Myocardium Assessed by Myocardial 
Contrast Echocardiography predicts Mortality in 
Heart Failure Patients
Brijesh Anantharam, Rajesh Chelliah, Sajad Hayat, Michael 
Hickman, Roxy Senior, Northwick Park Hospital, Harrow, United 
Kingdom
Learning Objective: To demonstrate prognostic value of MCE in 
heart failure patients
1035-210 Reduction in Ultimate Infarct Size Despite 
Persistent Epicardial Occlusion Using Three 
Dimensional Transthoracic Ultrasound and 
Intravenous Non-targeted Microbubbles
Thomas Richard Porter, Jeroen Slikkerveer, Shunji Gao, Evan Unger, 
Terry Matsunaga, John Lof, Feng Xie, University of Nebraska Medical 
Center, Omaha, NE
Learning Objective: To Determine how Ultrasound and Microbubbles 
restore Microvascular Flow
1034-198 0.3mSv Coronaries - Initial Experience With an Ultra 
Low Dose Scan Protocol Using a 128-Slice Dual 
Source CT Scanner
Kheng Thye Ho, Christoph Panknin, Kia Chong Chua, Tan Tock Seng 
Hospital, Singapore, Singapore
Learning Objective: Identify ultra low dose radiation techniques for 
CT angiography
1034-199 First Experience With Single Heart Beat Coronary Ct 
Angiography In 2Nd Generation Dual-source Ct
Bernhard Bischoff, Tanja Meyer, Bettina Gramer, Franziska Hein, 
Martin Hadamitzky, Albert Schömig, MD, Stefan Martinoff, Jörg 
Hausleiter, Deutsches Herzzentrum Muenchen, Munich, Germany
Learning Objective: understand radiation dose reduction techniques
1034-200 Image Quality and Radiation Exposure of Low-dose 
Protocols for Coronary CT Angiography: Comparison 
of Prospective Axial Scanning and High-pitch Spiral 
Acquisition
Stephan Achenbach, Martin Seltmann, Tobias Pﬂederer, Mohamed 
Marwan, Dieter Ropers, Michael Lell, Katharina Anders, Axel 
Kuettner, Michael Uder, Werner G. Daniel, Department of Cardiology, 
University of Erlangen, Erlangen, Germany, Department of Radiology, 
University of Erlangen, Erlangen, Germany
Learning Objective: Identify advantages and disadvantages of 
prospectively ECG-triggered axial versus high pitch spiral acquisition 
for coronary CT angiography
1034-201 A Prospective Multicenter Study Evaluating the 
Diagnostic Accuracy of High-Definition Coronary 
Computed Tomographic Angiography: An Intent-to-
Diagnose Analysis
Troy LaBounty, Jonathon Leipsic, G.B. John Mancini, Brett Heilbron, 
Smita Patel, Ella Kazerooni, Fay Y. Lin, Giora Saltzman, Adam 
Saltzman, Jonathan W. Weinsaft, Jin-Ho Choi, Nina Koduru, James 
K. Min, Cornell Medical College, New York, NY, University of Britich 
Columbia, Vancouver, BC, Canada
Learning Objective: Describe the diagnostic accuracy of high-
definition coronary CT angiography to detect significant coronary 
artery disease.
1034-203 Coronary CTA Below One Millisievert: Evaluation of 
Image Quality and Patient Dose, and Selection of 
Appropriate Scan Protocols in the First 200 Cardiac 
Patients on a 128-Slice Dual Source CT Scanner
Kheng Thye Ho, Christoph Panknin, Kia Chong Chua, Tan Tock Seng 
Hospital, Singapore, Singapore
Learning Objective: describe low-dose imaging of coronary arteries
1034-204 320-Multidetector Computed Tomography 
Angiography is Associated with Significant 
Reduction in Radiation Exposure, Compared to 
64-Multislice Technology
Ayesha F. Shaukat, II, Idean B. Marvasty, Lori Meyers, Allison Drew, 
Sarah Rinehart, Gustavo Vazquez, Zhen Qian, Parag Joshi, Eric 
Krivitsky, Szilard Voros, Piedmont Heart Institute, Atlanta, GA
Learning Objective: determine the significance of radiation dose 
difference
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1036-217 Prognostic Implications of Non-obstructive Coronary 
Plaques in Patients with Non-ST-segment Elevation 
Myocardial Infarction - A Multidetector Computed 
Tomography Study
Klaus F. Kofoed, Thomas S. Kristensen, Tobias Kühl, Walther B. 
Nielsen, Michael B. Nielsen, Henning Kelbæk, Department of 
Cardiology, Rigshospitalet, Copenhagen, Denmark, Department of 
Radiology, Rigshospitalet, Copenhagen, Denmark
Learning Objective: understand the potential prognostic implications 
of MDCT coronary plaque imaging
1036-218 Prognostic Value of Coronary Computed 
Tomographic Angiography in Asymptomatic Patients
Martin Hadamitzky, Tanja Meyer, Franziska Hein, Bernhard Bischoff, 
Stefan Martinoff, Albert Schoemig, Joerg Hausleiter, Deutsches 
Herzzentrum, Munich, Germany
Learning Objective: Describe the predictive value of coronary 
computed tomography angiography in asymptomatic patients.
1036-220 Prognostic Value Of Cta In Smokers And Non-
smokers
Jaap M. Van Werkhoven, Joanne D. Schuijf, Aju Pazhenkottil, 
Bernard A. Herzog, J Wouter Jukema, Eric Boersma, Ernst E. Van 
der Wall, Philipp Kaufman, Jeroen J. Bax, Leiden University Medical 
Center, Leiden, The Netherlands, University Hospital Zurich, Zurich, 
Switzerland
Learning Objective: interpret the prognostic value of significant CAD 
in smokers
1036-221 Impact of Cardiac Multidetector Computed 
Tomographic Angiography on Perioperative 
Outcomes and Cost in Reoperative Cardiac Surgery
Gabriel Maluenda, Matthew A. Goldstein, Shrinivas Hebsur, Sion 
K. Roy, Gaby Weissman, Guy Weigold, Peter C. Hill, Paul J. Corso, 
Steven W. Boyce, Augusto D. Pichard, Ron Waksman, Allen J. Taylor, 
Washington Hospital Center, Washington, DC
Learning Objective: To evaluate the potential benefit of cardiac CT 
guidance for redo of cardiac surgery
1037 CT CORONARY CALCIUM AND NONCORONARY CT 
APPLICATIONS
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1037-222 Elucidating the Association of Framingham 
and Reynolds Risk Scores with Incidence and 
Progression of Coronary Artery Calcification in the 
Multi-Ethnic Study of Atherosclerosis
Andrew P. DeFilippis, Michael J. Blaha, Matthew J. Budoff, Donald 
M. Lloyd-Jones, Robyn L. McClelland, Chiadi Ndumele, Susan G. 
Lakoski, Mary Cushman, Nathan D. Wong, Roger S. Blumenthal, 
Khurram Nasir, Johns Hopkins University, Baltimore, MD
Learning Objective: Describe the ability to predict incident and 
progression of coronary artery calcification, a surrogate for CHD, 
with the Framingham and Reynolds CHD risk prediction models.
1035-211 Clinical Usefulness of Myocardial Contrast 
Echocardiography for detecting Stress induced 
Cardiomyopathy in the Emergency Department
Geu-Ru Hong, Jong-Ho Nam, Kyu-Hwan Park, Chang-Woo Sohn, Jung-
Hyeon Choi, Sang-Hee Lee, Jong-Sun Park, Dong-Gu Shin, Young-Jo 
Kim, Bong-Sup Shim, Yeungnam University, Daegu, South Korea, 
Dankook University, Cheonan, South Korea
Learning Objective: distinguish stress induced cardiomyopathy 
from acute anterior wall infarction by real time myocardial contrast 
echocardiography
1035-212 Six Year Predictive Value of Real Time 
Perfusion Imaging During Dobutamine Stress 
Echocardiography
Kamran Akram, Saritha Dodla, Lynette Smith, Joan Olson, Feng Xie, 
Thomas Porter, University of Nebraska Medical Center, Omaha, NE
Learning Objective: Prognostic value of real time perfusion
1036 PROGNOSTIC VALUE OF CCTA
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1036-214 Prognostic Value of Normal Cardiac CT Angiography: 
a Meta-Analysis
Edward A. Hulten, Salvatore Carbonaro, Sara Petrillo, Josh Mitchell, 
Todd C. Villines, Walter Reed Army Medical Center, Washington, DC, 
Mid-Atlantic Permanente Medical Group, Rockville, MD
Learning Objective: Recognize the low risk prognosis of normal 
cardiac CT angiography
1036-215 Incremental Prognostic Value of Left Ventricular 
Function Analysis over Coronary Angiography with 
Multi-Detector Computed Tomography
Fleur Rianne de Graaf, Jacob van Werkhoven, Joanne Schuijf, Joëlla 
van Velzen, Lucia Kroft, Albert de Roos, Martin Schalij, J. Wouter 
Jukema, Ernst van der Wall, Jeroen Bax, Leiden University Medical 
Center, Leiden, The Netherlands
Learning Objective: describe that LV function analysis provides 
incremental prognostic information beyond the assessment of 
coronary artery stenosis using CTA.
1036-216 Prognostic Values Of Multidetector Computed 
Tomography In Patients With Known Or Suspected 
Coronary Artery Disease
So Yeon Kim, Kee-Sik Kim, Myeung Joon Seung, Jung Hyeun Kim, 
Jin Wook Jung, Seung Hee Moon, Young Soo Lee, Jin Bae Lee, Jae 
Kean Ryu, Ji Young Choi, Sung-Gug Chang, Division of Cardiology, 
Daegu Catholic University, Daegu, South Korea
Learning Objective: evaluate
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1038 CT CORONARY CALCIUM AND NONCORONARY CT 
APPLICATIONS
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1038-228 Normal Values of Left Ventricular Filling Indices by 
Multi-detector Computed Tomography
Yalcin Hacioglu, Mohit Gupta, Yasmin Hamirani, Song S. Mao, Tae 
Young Choi, Matthew J. Budoff, Los Angeles Biomedical Research 
Institute at Harbor-UCLA, Medical Center, Torrance, CA
Learning Objective: The current study presents a referance for 
normal values of left ventricular filling indices by MDCT.
1038-229 Epicardial Adipose Tissue and Coronary Artery 
Plaque Characteristics
Nikolaos Alexopoulos, Dalton S. McLean, Matthew Janik, Chesnal 
Arepalli, Arthur E. Stillman, Paolo Raggi, Emory University, Atlanta, GA
Learning Objective: understand the association of epicardial 
adipose tissue volume with the type of coronary atherosclerotic 
plaque
1038-230 Epicardial Adipose Tissue Volume and Coronary 
Artery Calcium to Predict Myocardial Ischemia 
on Positron Emission Tomography-Computed 
Tomography Studies
Matthew James Janik, Gregory Hartlage, Nikolaos Alexopoulos, Zaur 
Mirzoyev, Dalton S. McLean, Chesnal Arepalli, Arthur E. Stillman, 
Paolo Raggi, Emory University, Atlanta, GA
Learning Objective: identify epicardial adipose tissue (EAT) volume 
on CT as an independent predictor of myocardial ischemia on PET.
1038-231 Impact of Total Coronary Calcium Score on 
Procedural and Long- Term Outcomes in 
Patients Who Underwent Percutaneous Coronary 
Intervention with Drug Eluting Stents: Three Years 
Follow-up
Hae Chang Jeong, Youngkeun Ahn, Doo Sun Sim, Hyun Ju Yoon, 
Nam Sik Yoon, Young Joon Hong, Hyung Wook Park, Ju Han Kim, 
Myung Ho Jeong, Jeong Gwan Cho, Jong Chun Park, Jung Chaee 
Kang, Chonnam National University Hospital, Gwangju, South Korea
Learning Objective: High coronary calcium score was associated 
with poor prognosis
1038-232 Correlation of Coronary Artery Calcium Progression 
with Progression of Coronary Artery Stenosis on 
Cardiac Computed Tomography
Irfan Zeb, Tigran Khachatryan, Yasmin S. Hamirani, Khurram Nasir, 
Kelcey N. Nishihara, Sameer Raina, Song S. Mao, Naser Ahmadi, 
Matthew J. Budoff, Los Angeles Biomedical Research Institute at 
Harbor-UCLA Medical Center, Torrance, CA
Learning Objective: Correlation of coronary artery calcium score 
progression with coronary artery stenosis progression
1037-223 Utility of Cardiac Computed Tomography 
Angiography to Exclude Clinically Significant 
Obstructive Disease in Patients After Myocardial 
Perfusion Imaging
Nimish Patel, Raveen S. Pal, Ferdinand Flores, Matthew J. Budoff, 
Department of Cardiology, Los Angeles County- Harbor-UCLA 
Medical Center, Torrance, CA, Los Angeles Biomedical Research 
Institute, Torrance, CA
Learning Objective: Demonstrate that cardiac computed tomography 
angiography after equivocal, mild or moderate abnormal MPI results 
in significant cost savings.
1037-224 Measuring Coronary Artery Calcification in 
Combination with High-Sensitive C-Reactive Protein 
Predicts Hard Coronary Events Beyond Framingham 
Risk Score Categories - Data from the Heinz Nixdorf 
Recall Study
Stefan Möhlenkamp, Nils Lehmann, Susanne Moebus, Axel 
Schmermund, Nico Dragano, Marcus Bauer, Hagen Kälsch, Hagen 
Kälsch, Barbara Hoffmann, Andreas Stang, Martina Broecker-
Preuss, Klaus Mann, Johannes Siegrist, Karl-Heinz Jöckel, Raimund 
Erbel, University Clinic Duisburg-Essen, Essen, Germany
Learning Objective: understand the predictive value of measuring 
both subclinical coronary atherosclerosis and systemic 
inflammation
1037-225 Microalbuminuria in Non-Diabetic Patients 
with Metabolic Syndrome is a Strong Predictor 
of Subclinical Atherosclerosis: A Multi-Ethnic 
Perspective
Pawan K. Hari, Vikas Veeranna, Palaniappan Manickam, Rajeev 
Sudhakar, Jyotiranjan Pradhan, Ashutosh Niraj, Sony Jacob, Luis 
Afonso, Wayne State University, Detroit, MI
Learning Objective: Identify that microalbuminuria in non-diabetic 
patients with metabolic syndrome is an incremental predictor of 
coronary artery calcification in a majority of ethnic subgroups
1037-226 Utility of a Multiple Biomarker Index in 
Asymptomatic Adults Depends on Atherosclerotic 
Burden
Nathan D. Wong, Heidi Gransar, Jamal S. Rana, Johanna Kim, 
Romalisa Miranda-Peats, Leslee Shaw, Alan Rozanski, Sean Hayes, 
Louise Thomson, John Friedman, Daniel S. Berman, University 
of California, Irvine, Irvine, CA, Cedars-Sinai Medical Center, Los 
Angeles, CA
Learning Objective: Understand the possible role of atherosclerosis 
assessment in the utility of cardiac biomarkers
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1039-238 The Comparable Utility of Computed Tomography 
and Echocardiography in the Detection of Early 
Stage Calcific Aortic Valve Disease: An AGES-
Reykjavik Investigation.
David S. Owens, Jonathan F. Plehn, Sigurdur Sigurdsson, Jeffrey 
L. Probstﬁeld, Lenore J. Launer, Gudny Eiriksdottir, Vilmundur 
Gudnason, Tamara B. Harris, Kevin D. O’Brien, University of 
Washington, Seattle, WA, Icelandic Heart Association, Reykjavik, 
Iceland
Learning Objective: Compare the relative merits of echocardiography 
and CT in the detection of early stage calcific aortic valve disease.
1040 CT CORONARY CALCIUM AND NONCORONARY CT 
APPLICATIONS
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1040-239 Pericardial, Thoracic and Subcutaneous Fat 
Measured by Non-enhanced Computed Tomography 
is Associated with Coronary Artery Calcium
Naser Ahmadi, Mustapha Lakis, Vahid Nabavi, Fereshteh 
Hajsadeghi, Ramin Ebrahimi, Matthew Budoff, Los Angeles 
Biomedical Research Institute at Harbor UCLA Medical Center, 
Torrance, CA
Learning Objective: Increased pericardial, thoracic and 
subcutaneous fat depot is associated with coronary atherosclerosis 
measured by coronary artery calcium independent conventional 
cardiovascular risk factors
1040-240 The Potential of EBCT for Coronary Artery Calcium 
Screening to Evaluate Fatty Liver: Dallas Heart 
Study
Susan Matulevicius, Laura C. Huff, Colby R. Ayers, Roderick McColl, 
Lydia Sczcepaniak, Amit Khera, Ronald M. Peshock, University of 
Texas Southwestern Medical Center, Dallas, TX
Learning Objective: evaluate the role of coronary artery calcium 
screening electron beam computed tomography in detecting heaptic 
steatosis.
1040-241 The Incremental Prognostic Value of Abdominal 
Aortic Calcifications in Patients with Coronary 
Artery Disease
Steve Simpson, Bryan Zweig, Darshan Patel, Mouaz H. Al-Mallah, 
Henry Ford Heart and Vascular Institute, Detroit, MI
Learning Objective: identify patients at higher risk of mortality 
based on abdmonial aortic calcium.
1040-242 Heart Disease in Firefighters Linked to Thrombosis 
Risk
H. Robert Superko, Laksmana Pendyala, Steve Frohwein, Kathryn 
Momary, Brenda Garrett, Cathy Skrifvars, Radika Gadesam, Steve 
Rolader, Celera, Ala, CA, Saint Joseph’s Hospital, Atlanta, GA
Learning Objective: thrombogenic coronary heart disease risk in 
firefighters.
1039 CT CORONARY CALCIUM AND NONCORONARY CT 
APPLICATIONS
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1039-234 Incidental Detection of Malignancy and Other 
Non-Cardiovascular Abnormalities on Multislice 
Computed Tomography in Patients With Severe 
Aortic Stenosis Evaluated for Transcatheter Aortic 
Valve Implantation
Itsik Ben-Dor, Ron Waksman, Nicholas N. Hanna, Arnold Raizon, 
Lowell F. Satler, Rebecca Torguson, Gaby Weissman, Petros 
Okubagzi, Zhenyi Xue, Yanlin Li, Manuel A. Gonzalez, Michael A. 
Gaglia, Gabriel Maluenda, Kohei Wakabayashi, Cedric Delhaye, 
Asmir I. Syed, Sara D. Collins, William O. Suddath, Kenneth M. Kent, 
Joseph Lindsay, Augusto D. Pichard, Washington Hospital Center, 
Washington DC, DC
Learning Objective: To investigated the prevalence and the nature of 
significant and insignificant non-cardiovascular findings incidentally 
found by CT in patients evaluated for trans catheter aortic valve 
implatation
1039-235 Age and Gender-specific Pulmonary Artery 
Measurements by Multi-detector Computed 
Tomography: Framingham Heart Study
Quynh A. Truong, Joseph M. Massaro, Ian S. Rogers, Amir 
A. Mahabadi, Caroline S. Fox, Christopher J. O’ Donnell, Udo 
Hoffmann, Massachusetts General Hospital, Boston, MA, NIH/
NHLBI, Framingham, MA
Learning Objective: Determine the normal reference value for mPA 
and ratio PA by CT.
1039-236 Association of Coronary Artery diameter on Non 
Contrast Cardiac Computed Tomography with 
Coronary Artery Calcium Scores and traditional risk 
factors.
Yasmin S. Hamirani, Emil Avanes, Jigar Kadakia, Khurram Nasir, 
Amish Patel, Matthew J. Budoff, Los Angeles Biomedical Research 
Institute at Harbor-UCLA, Torrance, CA
Learning Objective: define the clinical utility and predictive value of 
measurement of coronary artery diameter in addition to detection of 
CAC on non contrast CT scans.
1039-237 Geometric Deformity of the Mitral Valve Apparatus 
in Ischemic Mitral Regurgitation: Three-Dimensional 
Analysis with Multislice Computed Tomography
Yoshimori An, Shuichiro Kaji, Kitae Kim, Atsushi Yamamuro, Makoto 
Kinoshita, Natsuhiko Ehara, Atsushi Kobori, Takeshi Kitai, Tomoko 
Tani, Toru Kita, Yutaka Furukawa, Kobe City Medical Center General 
Hospital, Kobe, CA, Japan
Learning Objective: provide more insights into underlying 
mechanisms of ischemic mitral regurgitation
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1041-249 Impact of Total Coronary Calcium Score on 
Procedural and Long-Term Outcomes in Patients 
Who Underwent Percutaneous Coronary 
Intervention with Drug Eluting Stents: 3 Years 
Follow-up
Youngkeun Ahn, Hae Chang Jeong, Jum Suk Ko, Min Goo Lee, Keun 
Ho Park, Hyun Ju Yoon, Nam Sik Yoon, Hyung Wook Park, Kye Hun 
Kim, Young Joon Hong, Myung Ho Jeong, Jeong Gwan Cho, Jong 
Chun Park, Jung Chaee Kang, Department of Cardiology, Chonnam 
National University Hospital, Gwangju, South Korea, Heart Research 
Center of Chonnam National University Hospital, Gwangju, South 
Korea
Learning Objective: to evaluate the correlation between the total 
coronary calcium score and long- term clinical outcomes in patients 
who underwent PCI with drug eluting stents
1042 CT CORONARY CALCIUM AND NONCORONARY CT 
APPLICATIONS
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1042-251 Assessment of plaque burden using Coronary CT 
calcium scores in Police Officers and Firefighters in 
New York State
M. Zubair Jafar, Navdeep Bhatti, Danyaal Moin, Lisa Pedevillano, 
Lakshmi Munnangi, Asma Siddiqui, Daniel O’Dea, Larry Schek, Mike 
Yen, Julie Ling, Larry Solomon, The Heart Center, Poughkeepsie, NY
Learning Objective: Assess the value of Ct coronary calcium scores 
in high risk populations
1042-252 Do Gender Differences in Atherosclerotic plaque 
Composition Persist with Aging? A Quantitative Non 
Invasive Assessment by Coronary CT Angiography
Ali Masud, Gudrun Feuchtner, Daniel Jodocy, Guy Friedrich, Roger S. 
Blumenthal, Matthew J J. Budoff, Khurram Nasir, Albert Einstein College 
of Medicine, Bronx, NY, John Hopkins University, Baltimore, MD
Learning Objective: Evaluate for gender difference in plaque
1042-253 Influence of Viewing and Image Reconstruction 
Parameters on Diagnostic Accuracy, Image Quality, 
and Reader Confidence at Myocardial Stress 
Computed tomography Perfusion
Brian B. Ghoshhajra, Tust Techasith, Nicola Drzezga, Ian S. Rogers, 
Hector Medina-Zuluaga, Ron Blankstein, Pal Maurovich-Horvat, Leif 
C. Engel, Thomas J. Brady, Ricardo C. Cury, Massachusetts General 
Hospital, Boston, MA, Baptist Cardiac and Vascular Institute, Miami, FL
Learning Objective: describe the effects that different viewing and 
image reconstruction parameters have on the diagnostic accuracy 
and perceived image quality of stress CT perfusion.
1040-243 Coronary Artery Calcium Predicts Mortality in Low-
Risk Asymptomatic Men
Jamal S. Rana, Heidi Gransar, Nathan D. Wong, Prediman K. 
Shah, Alan Rozanski, John D. Friedman, Sean W. Hayes, Louise E. 
Thomson, Leslee J. Shaw, Daniel S. Berman, Cedars-Sinai Medical 
Center, Los Angeles, CA
Learning Objective: Identify low risk asymptomatic men with 
coronary calcium
1041 CT CORONARY CALCIUM AND NONCORONARY CT 
APPLICATIONS
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1041-245 Diabetes Mellitus, Coronary Artery Calcification and 
All-Cause Mortality among Asymptomatic Men and 
Women
Jamal S. Rana, Heidi Gransar, Leslee J. Shaw, Nathan D. Wong, 
Paolo Raggi, James Min, Tracy Q. Callister, Mathew Budoff, Daniel S. 
Berman, Cedars-Sinai Medical Center, Los Angeles, CA
Learning Objective: Identify that diabetics with CAC score of zero 
are statistically not at an increased risk of all cause death.
1041-246 Biomarkers versus Coronary Artery Calcium for 
Prediction of Incident Cardiovascular Events
Jamal S. Rana, Heidi Gransar, Nathan D. Wong, Alan Rozanski, Sean 
Hayes, Louise Thompson, John Friedman, Leslee J. Shaw, Daniel S. 
Berman, Cedars-Sinai Medical Center, Los Angeles, CA
Learning Objective: Identify that addition of CAC but not multiple 
biomarkers,m substantially improves the risk stratification for CVD 
beyond that of established risk factors.
1041-247 Accuracy of Non-enhanced Cardiac Computed 
Tomography to detect myocardial infarcts.
Mohit Gupta, Jigar Kadakia, Amish Patel, Naser Ahmadi, Taeyoung 
Choi, Gregg Yamada, Matthew Budoff, Los Angeles Biomedical 
Research Institute at Harbor-UCLA, Torrance, CA
Learning Objective: identify the role of calcium scans to detect 
myocardial infarcts as compared to myocardial perfusion imaging.
1041-248 Coronary Artery Calcification and Thoracic Aortic 
Wall Calcification are Associated With Increasing 
Categories of Blood Pressure
Heidi Gransar, Jamal S. Rana, Nathan D. Wong, Prediman K. Shah, 
Alan Rozanski, Sean Hayes, John Friedman, Louise Thomson, Daniel 
S. Berman, Cedars-Sinai Medical Center, Los Angeles, CA
Learning Objective: demonstrate that advanced stages of 
hypertension are associated with a higher likelihood of coronary 
artery calcification, suggesting need for blood pressure control.
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1088-191 Near-term Post-test Treatment, Functional Status 
and Resource Utilization In Intermediate Risk 
Individuals With Stable Chest Pain Syndrome 
Undergoing 64-Detector Row Coronary Computed 
Tomographic Angiography Versus Myocardial 
Perfusion SPECT: A Prospective Multicenter 
Randomized Trial
Fay Lin, Sunaina Koduru, Jason H. Cole, Jerome L. Hines, Troy M. 
Labounty, Jonathan W. Weinsaft, Tracy Q. Callister, Leslee J. Shaw, 
Daniel S. Berman, James K. Min, Weill-Cornell Medical Center, New 
York City, NY
Learning Objective: describe downstream outcomes of initial 
evaluation of chest pain by cardiac computed tomographic 
angiography versus myocardial perfusion SPECT
1088-192 Defining Incremental Prognostic Value Of Exercise 
Electrocardiography Combined With Multidetector 
Coronary Computed Tomography In Patients With 
Suspected Coronary Artery Disease
Jaemin Shim, Hyuck-Jae Chang, Sung Woo Kwon, Dong-Won Kang, 
Mee-Eun Han, Young-Jin Kim, Byung-Wook Choi, Yangsoo Jang, 
Namsik Chung, Severance Hopsital, Seoul, South Korea
Learning Objective: define incremental prognostic value of exercise 
electrocardiography combined with multidetector coronary computed 
tomography
1088-193 Resource Utilization and Cardiac Risk Factor 
Management One Year after Coronary Computed 
Tomography Angiography
Meagan K. Murphy, Khurram Nasir, Quynh Truong, Suhny Abbara, 
G. Scott Gazelle, Thomas J, Brady, Ron Blankstein, Massachusetts 
General Hospital, Boston, MA, Brigham and Women’s Hospital, 
Boston, MA
Learning Objective: Identify patients in whom coronary CTA will 
impact subsequent management
1088-194 Rates of Invasive Coronary Angiography, 
Revascularization and Patient Outcomes after 
Computed Tomographic Coronary Angiography
Benjamin J. W. Chow, Yeung Yam, George A. Wells, Terrence Ruddy, 
University of Ottawa Heart Institute, Ottawa, ON, Canada
Learning Objective: Understand the downstream implications of CTA
1088-195 Spatial Clustering of Non-obstructive Plaque and 
All-cause mortality: A Prospective Multicenter 
Observational Cohort Study of 3,330 Symptomatic 
Patients Undergoing 64-Detector Row Coronary 
Computed Tomographic Angiography
Fay Lin, Daniel S. Berman, Leslee J. Shaw, Sunaina Koduru, 
Israel Guerrero, Troy LaBounty, Jin-Ho Choi, Jonathan W. Weinsaft, 
Augustin J. Delago, Tracy Q. Callister, James K. Min, Weill-Cornell 
Medical Center, New York City, NY
Learning Objective: Understand the interaction of coronary plaque 
burden and plaque distribution on mortality outcomes
1042-254 Patient and Scan Variables Contributing to Diagnostic 
Accuracy of Coronary Computed Tomography 
Angiography As Interpreted on an iPhone: Results 
from the Multicenter ACCURACY Trial
Troy LaBounty, Robert J. Kim, Fay Y. Lin, Matthew J. Budoff, Jonathan 
W. Weinsaft, James K. Min, Cornell Medical College, New York, 
NY, Los Angeles Biomedical Research Institute and Harbor-UCLA, 
Torrance, CA
Learning Objective: Indentify factors that impact the diagnostic 
performance of coronary CT angiography on a handheld device.
1042-255 Combination of Coronary Artery Calcium and 
Coronary CT Angiography for the Diagnosis of 
Obstructive Coronary Artery Disease
Bradley S. Messenger, Yasmin Hamirani, Irfan Zeb, Matthew J. 
Budoff, Los Angeles Biomedical Research Institute at Harbor-UCLA 
Medical Center, Torrance, CA
Learning Objective: Evaluate the diagnostic accuracy of combining 
coronary calcium scores with coronary computed tomographic 
angiography findings for coronary artery stenosis.
1088 CT CORONARY ANGIOGRAPHY AND POST 
RESOURCE UTILIZATION
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1088-188 Impact of Coronary CT Angiography on the Behavior 
of Physicians and Patients in an Asymptomatic 
Population
John W. McEvoy, Johns Hopkins Hospital, Baltimore, MD, Yonsei 
University Health System, Seoul, South Korea
Learning Objective: Evaluate the impact on referral for secondary 
tests, adverse cardiovascular events, and medication use of 
incorporating coronary CT angiography (CCTA) into a cardiac 
screening program
1088-189 Temporal Change in Cardiovascular Risk in Patients 
with Non-Obstructive Plaque on CTA.
Joanne D. Schuijf, Jacob M. van Werkhoven, Bernard A. Herzog, 
Aju Pazhenkottil, J Wouter Jukema, Eric Boersma, Ernst E. van der 
Wall, Philipp A. Kaufmann, Jeroen J. Bax, Leiden University Medical 
Center, Leiden, The Netherlands, University Hospital Zurich, Zurich, 
Switzerland
Learning Objective: The current study demonstrates that 
cardiovascular risk of patients with non-obstructive plaque on CTA 
changes over time
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1089-201 Combined Coronary Artery Calcium Scoring is 
No more Beneficial than Current Standard of 64-
row Multi-slice CT Angiography in Patients with 
Suspected Coronary Artery Disease
Sung Woo Kwon, Hyuk-Jae Chang, Jaemin Shim, Dong Won Kang, Mi 
Eun Han, Young Jin Kim, Byoung Wook Choi, Yangsoo Jang, Namsik 
Chung, Division of Cardiology, Yonsei Cardiovascular Center, Yonsei 
University College of Medicine, Seoul, South Korea
Learning Objective: Our study demonstrated that combined coronary 
artery calcium is no more beneficial than current standard of 64-
row multislice CT angiography in patients with suspected coronary 
artery disease.
1089-203 Validation of an Anatomic Measure Of Coronary 
Stenosis With Computed Tomography Angiography 
to Predict Hemodynamic Significance of Disease 
Defined by Flow Quantification Using Rubidium-82 
Positron Emission Tomography
Maria C. Ziadi, Paul Galiwango, Robert A. deKemp, Yeung Yam, 
Terrence D. Ruddy, Rob SB Beanlands, Benjamin JW Chow, 
University of Ottawa Heart Institute, Ottawa, ON, Canada
Learning Objective: Distinguish coronary lesions with a functional 
significance
1089-204 Preoperative Coronary Angiography with 
Multidetector CT is a Safe Alternative to Invasive 
Catheterization in Patients Undergoing Mitral Valve 
Repair
Javier G. Castillo, Gonzalo Pizarro, Leticia Fernandez-Friera, Valentin 
Fuster, David H. Adams, Mario J. Garcia, Javier Sanz, The Mount 
Sinai Medical Center, New York City, NY
Learning Objective: Evaluate the effciacy, reliability of CT 
angiography in patients undergoing mitral valve repair
1090 CT CORONARY ANGIOGRAPHY: INSIGHTS INTO 
PLAQUE IMAGING
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1090-205 Association of Aortic Valve Calcification and Mitral 
Annular Calcification to Noncalcified Coronary 
Atherosclerotic Lesion Assessed by 64-multidetector 
Computed Tomography
Hiroto Utsunomiya, Hideya Yamamoto, Eiji Kunita, Norihiko Ohashi, 
Toshiharu Oka, Ryo Yamazato, Takenori Okada, Tomoki Shokawa, 
Yukiko Nakano, Hiroki Teragawa, Futoshi Tadehara, Takafumi Ishida, 
Jun Horiguchi, Yasuki Kihara, Hiroshima University Graduate School 
of Biomedical Sciences, Hiroshima, Japan
Learning Objective: identfy patients with advanced coronary 
atherosclerotic lesions by non-enhanced computed tomography
1089 CT CORONARY ANGIOGRAPHY: DIAGNOSTIC 
ACCURACY II
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1089-197 Diagnostic Power of Multi-Detector Computed 
Tomography for Detecting Patients with Obstructive 
Coronary Artery Disease Is Not Influenced by Severe 
Coronary Arterial Calcification - The CorE-64 Study
Armin Arbab-Zadeh, Julie M. Miller, Carlos E. Rochitte, Marc Dewey, 
Hiroyuki Niinuma, Ilan Gottlieb, Narinder Paul, Melvin E. Clouse, 
Edward Shapiro, John Hoe, Albert C. Lardo, David E. Bush, Albert 
deRoos, Christopher Cox, Jeffrey Brinker, Joao A C Lima, Johns 
Hopkins University, Baltimore, MD
Learning Objective: To understand the diagnostic accuracy of MDCT 
to detect coronary artery disease in presence of severe coronary 
calcification
1089-198 Does An Abnormal Carotid Ultrasound Test 
Predict Coronary Atherosclerosis in Asymptomatic 
Subjects?
Hooman Madyoon, Brittany E. Yee, Norman Lepor, Lili Sadri, Philip 
Bretsky, Prediman K. Shah, Westside Medical Associates of 
Los Angeles, Los Angeles, CA, Cedars-Sinai Medical Center, Los 
Angeles, CA
Learning Objective: To determine the accuracy with which carotid 
ultrasound findings predict the presence or absence of coronary 
atherosclerosis detected by non-invasive 64 slice CT angiography
1089-199 Value of Family History of Premature Coronary 
Artery Disease as a Predictor of Obstructive 
Coronary Artery Disease on Coronary CT 
Angiography, The ACIC Registry
Joao L. Cavalcante, Kavitha Chinnaiyan, Gilbert Raff, Mouaz H. 
Al-Mallah, The Advanced Cardiovascular Imaging Consortium 
Investigators, Henry Ford Hospital - Heart & Vascular Institute, 
Detroit, MI, William Beaumont Hospital, Royal Oak, MI
Learning Objective: Demonstrates the significance of family history 
of premature CAD as an independent predictor for obstructive CAD
1089-200 Diagnostic Accuracy of 64 slice Multidetector 
Coronary Computed Tomographic Angiography for 
Evaluation of Coronary Artery Stenosis in Persons 
with Diabetes as Compared with Non- Diabetics
Mohit Gupta, Yalcin Hacioglu, Naser Ahmadi, James Min, Faye Lin, 
Matthew Budoff, Los Angeles Biomedical Research Institute at 
Harbor-UCLA, Torrance, CA
Learning Objective: identify the role of coronary computed 
tomographic angiography for evaluation of coronary artery stenosis 
in patients with diabetes
JACC    March 9, 2010 ABSTRACTS: Imaging and Diagnostic Testing A75
Im
aging and Diagnostic Testing
1090-212 Evaluation of Plaque Morphology by 64-Slice 
Computed Tomographic Angiography Compared to 
Intravascular Ultrasound in Non-Occlusive Segments 
of Coronary Arteries
Manoj Kesarwani, Taeyoung Choi, Lily Honoris, David M. Shavelle, 
Matthew J. Budoff, Los Angeles Biomedical Research Center at 
Harbor-UCLA Medical Center, Torrance, CA
Learning Objective: Describe the statistical relationships associated 
with the use of coronary computed tomographic angiography for 
plaque characterization in non-occlusive coronary artery segments.
1091 CT CORONARY ANGIOGRAPHY
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1091-214 Cost-Effectiveness of Alternative Diagnostic 
Evaluation Pathways for Individuals with Stable 
Chest Pain Syndrome without Known Coronary 
Artery Disease
James Min, Amanda Gilmore, Fay Y. Lin, Daniel S. Berman, MD, 
Leslee J. Shaw, Erica M. Jones, Ken O’Day, Weill Cornell Medical 
College, New York, NY, Xcenda Corporation, Palm Harbor, FL
Learning Objective: To understand cost-effectiveness of diagnostic 
strategies for coronary artery disease.
1091-215 Coronary CT Angiography Based Predictors of 
Myocardial Ischemia Detected by SPECT-MPI
Balaji Tamarappoo, Ariel Gutstein, Victor Cheng, Ryo Nakazato, Heidi 
Gransar, Louise Thomson, Sean Hayes, John Friedman, Damini Dey, 
Piotr Slomka, Daniel Berman, Cedars Sinai Medical Center, Los 
Angeles, CA
Learning Objective: describe the predictors of ischemia based on 
coronary CT angiographic findings
1091-216 Family history of Premature CAD and Traditional 
Clinical Risk Factors In Predicting Obstructive 
Coronary Atherosclerosis In Young Patients referred 
for Coronary CT Angiography
Aiden Abidov, Kavitha M. Chinnaiyan, James H. Wegner, Gilbert 
L. Raff, William Beaumont Hospital, Royal Oak, MI, Sarver Heart 
Center, Universtiy of Arizona, Tucson, AZ
Learning Objective: Identify importance of the family history of 
premature CAD as a powerful predictor of significant CAD in young 
patients referred for coronary CTA
1091-217 Practicability of Low-Dose CT Coronary Angiography 
with Prospective ECG-Triggering
Ronny R. Buechel, Aju P. Pazhenkottil, Bernhard A. Herzog, Lars 
Husmann, René N. Nkoulou, Irene A. Burger, Ines Valenta, Philipp A. 
Kaufmann, University Hospital Zurich, Zurich, Switzerland
Learning Objective: Identify low-dose CT coronary angiography with 
prospective ECG-triggering as a practicable tool in daily clinical 
routine
1090-206 Impact of Type 2 Diabetes on Coronary 
Atherosclerosis Related to Vulnerable Plaque in 
Asymptomatic Patients Without Coronary Artery 
Calcification Using Multislice Computed Tomography
Kenji Harada, Akihiro Saito, Takanobu Okumura, Norihito Kageyama, 
Takashi Yamamoto, Hiroyuki Fujinaga, Tokushima Prefectural Central 
Hospital, Tokushima, Japan
Learning Objective: identify that complication of type 2 diabetic 
relates to coronary atherosclerosis without coronary calcification, 
and that not diabetes but hypertension influenced the presence of 
vulnerable plaque
1090-208 Association Between Cardiovascular Risk Factors 
and the Presence and Extent of Coronary 
Atherosclerotic Plaque Detected by Multislice 
Computed Tomography Coronary Angiography
hikmet yorgun, Ergün B. Kaya, Tuncay Hazırolan, Ahmet H. AteƔ, 
Sercan Okutucu, UŒur Canpolat, Hamza Sunman, Hakan Aksoy, 
Kadri M. Gürses, Kudret Aytemir, Giray Kabakçı, Lale TokgözoŒlu, 
Hilmi Özkutlu, Ali Oto, Hacettepe University, Ankara, Turkey
Learning Objective: Patients with a low risk due to FRS or SCORE, 
had a significant percent of coronary artery plaque, which may 
necessiate cardiovascular risk reduction strategies on an individual 
basis.
1090-209 Increased Epicardial Adipose Tissue as a 
Predictor of Coronary Low Density Plaque, Using 
64-multidetector Computed Tomography
Toshiharu Oka, Hideya Yamamoto, Eiji Kunita, Hiroto Utsunomiya, 
Ryo Yamazato, Norihiko Ohashi, Toshiro Kitagawa, Takenori Okada, 
Tomoki Shokawa, Yukiko Nakano, Hiroki Teragawa, Futoshi Tadehara, 
Takafumi Ishida, Jun Horiguchi, Yasuki Kihara, Department of 
cardiovascular Medicine, Hiroshima University Graduate School of 
Biomedical Sciences, Hiroshima, Japan
Learning Objective: demonstrate
1090-210 Frequency and Distribution of CT-based Vulnerable 
Plaques
Makoto Kondo, Takeshi Kondo, Akitsugu Ohida, Hiroshi Fukazawa, 
Takahide Kodama, Tadaaki Orihara, Shinichi Takase, Jagat Narula, 
Takase Clinic, Takasaki, Japan
Learning Objective: identify frequency and distribution of CT-based 
vulnerable plaques.
1090-211 Outcomes of Patients Stratified Prospectively 
by Atherosclerotic Disease Burden Quantified by 
Cardiac Computed Angiography
Sanjay Gill, Marian F. Manankil, Tony Pallan, Claudius Mahr, Jerome 
L. Hines, Sorin C. Danciu, Advocate Illinois Masonic Medical Center, 
Chicago, IL
Learning Objective: Demonstrate predictive value of CCTA
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1092-224 Real-time Three-dimensional Echocardiography 
For A Comprehensive Pre-operative Assessment 
Of Heart Failure Patients With Left Ventricular 
Aneurysm: Validation Study With Magnetic 
Resonance Imaging
Nina Ajmone Marsan, Jos J M Westenberg, Stijntje D. Roes, Claudia 
Ypenburg, Rutger J. van Bommel, Victoria Delgado, Rob J. van der 
Geest, Robert J. Klautz, Johan C. Reiber, Martin J. Schalij, Jeroen J. 
Bax, Leiden Univeristy Medical Center, Leiden, The Netherlands
Learning Objective: to evaluate patients with LV aneursym with 
RT3DE in case MRI is not available
1092-225 Mitral Annular Area: Accuracy of Single and Biplane 
Linear Measurements Compared to 3D Planimetry
Eiichi Hyodo, Rebecca T. Hahn, Shunichi Homma, Linda Gillam, 
Columbia University, New York, NY
Learning Objective: interpret
1092-226 Real-time 3D Ultrasound to MR Image Fusion Can 
Guide Catheter-Based Cardiac Procedures
Charles R. Hatt, III, Amish N. Raval, Ameet Jain, Vijay Parasarathy, 
University of Wisconsin, Madison, WI, Philips Research, Briarcliff 
Manor, NY
Learning Objective: evaluate a novel ultrasound-MRI based image 
fusion system and identify its potential applications.
1093 ECHOCARDIOGRAPHY: THREE-DIMENSIONAL 
IMAGING OF THE RIGHT HEART
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1093-228 Validation of 3-Dimensional Echocardiography in 
Quantification of Right Ventricular Volume: An In-
Vitro Study
David J. Sahn, Keith DesRochers, Zhiwen Zhou, Li Xiong, Muhammad 
Ashraf, Oregon Health & Science University, Portland, OR
Learning Objective: understand 3D quantification of the right 
ventricle
1093-229 Accuracy of Right Ventricular Volumes and Function 
Determined by 3-Dimensional Echocardiography in 
Comparison with Magnetic Resonance Imaging: A 
Meta-Analysis Study
Yuichi J. Shimada, Takahiro Shiota, Beth Israel Medical Center, 
New York, NY, Cedars-Sinai Medical Center, David Geffen School of 
Medicine, University of California, Los Angeles, Los Angeles, CA
Learning Objective: identify existence and extent of underestimation 
of right ventricular volumes and ejection fraction by 3-dimeisonal 
echocardiography, the 10-year trend and factors affecting the 
systematic bias.
1091-218 Epicardial Adipose Tissue as a Predictor of 
Coronary Atherosclerosis Without Calcification 
Using Multislice Computed Tomography in Elderly 
Patients
Kenji Harada, Akihiro Saito, Takanobu Okumura, Norihito Kageyama, 
Takashi Yamamoto, Hiroyuki Fujinaga, Tokushima Prefectural Central 
Hospital, Tokushima, Japan
Learning Objective: identify that measurements of epicardial 
fat volume is useful marker for the presence of CAD without 
calcification in elderly patients
1091-220 The Potential of 64-slice Multidetector Computed 
Tomography Coronary Angiography to Replace 
Invasive Coronary Angiography - the Ontario 
Multidetector Computed Tomography Coronary 
Angiography Study (OMCAS)
Michael Richard Freeman, Ben Chow, James Bowen, Ron Goeree, 
OMCAS, University of Toronto, Toronto, Canada, Programs for 
Assessment of Technology in Health, Hamilton, Canada
Learning Objective: Determine the patient population best suited for 
MDCT coronary angiography
1091-221 Myocardial Bridging Does Not Increase Cardiac 
Risk in Patients with Chest Pain But no Obstructive 
Coronary Disease: A 64 Slice Coronary CT 
Angiography Study
Ronen Rubinshtein, Tamar Gaspar, Basil S. Lewis, Abhiram Prasad, 
Nathan Peled, David A. Halon, Lady Davis Carmel Medical Center, 
Haifa, Israel, Mayo Clinic, Rochester, MN
Learning Objective: Evaluate the association between myocardial 
bridging (on coronary CTA) and outcomes
1092 CLINICAL APPLICATIONS OF THREE-
DIMENSIONAL ECHOCARDIOGRAHPY
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1092-222 How Do the Linear Dimensions Contribute to Left 
Atrial Enlargement: A Real-Time Three-Dimensional 
Echocardiographic Study
Gui Hua Yao, Leng Jiang, Baystate Medical Center, Tufts University 
School of Medicine, Springﬁeld, MA
Learning Objective: identify that LA linear dimensions correlate 
logarithmically with LA volume and increase equally as LA enlarges, but 
their increases are significantly blunted when LA is severely enlarged.
1092-223 The Added Value of Real-Time Three Dimensional 
Transesophageal Echocardiography in Catheter-
based, Percutaneous Left Atrial Appendage 
Obliteration by the Watchman device.
Adam H. Skolnick, Simon Biner, Gila Perk, Robert J. Siegel, Roberto 
Lang, Lissa Sugeng, Bradley Knight, Larry Chinitz, Itzhak Kronzon, 
New York University, New York, NY, University of Chicago, Chicago, IL
Learning Objective: Describe the utility of real-time 3D TEE in the 
evaluation of percutaneous left atrial appendage occlusion device 
placement
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1094-235 Automated Contour Correction with Instantaneous 
Real-Time 3D-Volume Transthoracic 
Echocardiography Improves Accuracy of Left 
Ventricular Volume Measurements in Patients with 
Systolic Dysfunction: Comparison to Cardiac MRI
Paaladinesh Thavendiranathan, Shizhen Liu, Bogdan Georgescu, 
Adrien Ntinunu, Anna Calleja, David Verhaert, Helene Houle, Thomas 
Van Houten, Joel Mancina, Nathalie De Michelis, David Orsinelli, 
Mary Ellen Orsinelli, Subha Raman, Thomas Ryan, Mani Vannan, 
The Ohio State University, Columbus, OH, Siemens Healthcare, 
Ultrasound, Mountain View, CA
Learning Objective: To understand that automated virtual contour 
adjustment improves accuracy of LV volume measurements using 
real-time 3D-voulume transthoracic echocardiography in patients 
with LV dysfunction
1094-236 Changes in Aortic-Mitral Coupling with Severe Aortic 
Stenosis
Wendy Tsang, Lissa Sugeng, Federico Veronesi, Valluvan 
Jeevanandam, Jai Raman, Lynn Weinert, Roberto M. Lang, University 
of Chicago Medical Centre, Chicago, IL
Learning Objective: Describe the changes to the aortic and mitral 
valves with severe aortic stenosis.
1094-237 Automated 3-D Quantification of Left Ventricular 
Volumes and Ejection Fraction in Atrial Fibrillation 
by Transthoracic Real-Time Volume Imaging
Shizhen Liu, Bogdan Georgescu, Adrien Nitnunu, Thomas Van 
Houten, Helene Houle, Nathalie De Michelis, Anna Calleja, Mary 
Ellen Orsinelli, Peng Li, Paaladinesh Thavendiranathan, Thomas 
Ryan, Mani Vannan, The Ohio State University, Columbus, OH, 
Siemens Medical Solutions, Mountain View, CA
Learning Objective: Measure 3D LV systolic function in Afib
1094-238 Real-Time Three-Dimensional Quantitative 
Echocardiography Assessment of Right and Left 
Ventricular Mass in Healthy Human Fetuses
David J. Sahn, Minjuan Zheng, Michael Schaal, Xiaokui Li, Weihui 
Shentu, Mary E. Joyce, Muhammad Ashraf, Oregon Health & 
Science University, Portland, OR
Learning Objective: understand development of the fetal heart
1095 CT CORONARY CALCIUM AND NONCORONARY CT 
APPLICATIONS
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1095-239 Coronary Calcium Progression Predicts All Cause 
Mortality
Matthew J. Budoff, John E. Hokanson, Khurram Nasir, Leslee J. 
Shaw, Gregory L. Kinney, David Chow, Daniel DeMoss, Vivek Nuguri, 
Vahid Nabavi, Raghu Ratakonda, Daniel S. Berman, Paolo Raggi, 
Los Angeles Biomedical Research Institute, Torrance, CA, Emory 
University, Atlanta, GA
Learning Objective: To understand implications of coronary calcium 
progression
1093-230 Prediction Of Clinical Deterioration In Idiopathic 
Pulmonary Arterial Hypertension: Longitudinal 
Change In Right Ventricular Remodelling With Real 
Time 3d Echocardiography And Cardiac Magnetic 
Resonance.
IOULIA A. GRAPSA, David Dawson, Declan O’Regan, Giuliana 
Durighel, Petros Nihoyannopoulos, Hammersmith Hospital, London, 
United Kingdom
Learning Objective: To describe the effect of right ventricular 
remodeling- as studied with 3D echocardiography and Cardiac 
MRI - on clinical deterioration of idiopathic pulmonary arterial 
hypertensive patients.
1093-231 Vortex Flow Formation in Patients after Tetralogy of 
Fallot Repair with Pulmonary Regurgitation Utilizing 
3-Dimensional Phase Encoded Velocity Mapping - A 
Clue To Power Loss, Poor Exercise Performance and 
Better Surgery
Mark A. Fogel, Kartik Sundareswaran, Matthew Harris, Elizabeth 
Goldmuntz, Ajit Yoganathan, Childrens Hospital of Philadelphia, 
Philadelphia, PA, Georgia Institute of Technology, Atlanta, GA
Learning Objective: Describe the flow disturbances in the RVOT in 
TOF pts and the clinical implications.
1093-232 Real-Time 3D Echocardiographic Imaging of the 
Tricuspid Valve: Visualization Rates in Consecutive 
Patients
Amit Pursnani, Patrick Coon, Lynn Weinert, Georgeanne Lammertin, 
Heidi Pollard, Victor Mor-Avi, Roberto M. Lang, Lissa Sugeng, New 
York University Medical Center, New York, NY, University of Chicago 
Hospitals, Chicago, IL
Learning Objective: Undertstand the role of Real-Time 3D Echo in 
visualization of the tricuspid valve
1094 ECHOCARDIOGRAPHY: THREE-DIMENSIONAL 
ECHOCARDIOGRAPHY IN LEFT VENTRICULAR 
FUNCTION
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1094-234 Accuracy of Left Ventricular Volumes and Function 
Determined by 3-Dimensional Echocardiography 
Validated by Magnetic Resonance Imaging: A Meta-
Analysis and Investigation for the Source of Bias
Yuichi J. Shimada, Takahiro Shiota, Beth Israel Medical Center, New 
York, NY, Cedars-Sinai Medical Center, Los Angeles, CA
Learning Objective: identify existence, extent and factors of 
underestimation in left ventricular volumes and ejection fraction 
measured by 3-dimensional echocardiography
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1096-246 A Catenoid Configuration is Associated Strongly 
with Regional Strain Properties in Patients with 
Hypertrophic Cardiomyopathy
kazuhisa nishimura, Hideki Okayama, Katsuji Inoue, Makoto Saito, 
Toyofumi Yoshii, Go Hiasa, Takumi Sumimoto, Takayuki Nagai, Jun 
Suzuki, Akiyoshi Ogimoto, Tomoaki Ohtsuka, Junichi Funada, Jitsuo 
Higaki, Ehime University Graduate School of Medicine, Toon, Ehime, 
Japan, Department of Cardiology, Kitaishikai Hospital, Ozu, Ehime, 
Japan
Learning Objective: interpret an impact of septal catenoid 
configuration in patients with HCM
1096-247 Advanced Feature Tracking on 4D Echo Images 
Defines Anterior, Septal and Apical Dysfunction 
in Open Chest Pigs Subjected to Intermittent LAD 
Occlusion
David J. Sahn, Muhammad Ashraf, Berkley Cameron, Bill Kenny, 
Oregon Health & Science University, Portland, OR, Toshiba America 
Medical Systems, Tustin, CA
Learning Objective: understand use of 3D echo
1096-248 Three-Dimensional Radial, Circumferential and 
Longitudinal Speckle-Tracking Strain to Quantify 
Dyssynchrony
Hidekazu Tanaka, Olusegun Oyenuga, Phillip Habib, Samir Saba, 
John Gorcsan, III, University of Pittsburgh, Pittsburgh, PA
Learning Objective: demonstrate that 3-D speckle-tracking radial, 
circumferential and longitudinal strain can successfully quantify 
dyssynchrony.
1096-249 Cardiac Twist by Two-Dimensional and Three-
Dimensional Echocardiography: An in Vitro 
Comparison Study
David J. Sahn, Karen Li, Shiza Ashraf, Sarah Yang, Max Carlson, 
Colleen Newey, Li Xiong, Zhiwen Zhou, Muhammad Ashraf, Oregon 
Health & Science University, Portland, OR
Learning Objective: understand 3D methods of assessing heart 
function
1097 ECHOCARDIOGRAPHY OF THE LEFT ATRIUM
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1097-251 Role of Left Atrial Reservoir Dysfunction in 
Pathophysiology of Diastolic Heart Failure
Hidemichi Kouzu, Satoshi Yuda, Junichi Nishida, Naohiro 
Funayama, Atsushi Mochizuki, Maki Ichimura, Takahiro Doi, Hitomi 
Yamamoto, Atsuko Muranaka, Nobuaki Kokubu, Noriyuki Fujii, 
Shinya Shimoshige, Mamoru Hase, Akiyoshi Hashimoto, Kazufumi 
Tsuchihashi, Naoki Watanabe, Kazuaki Shimamoto, Sapporo 
Medical University School of Medicine, Sapporo, Japan
Learning Objective: evaluate the risk of developing heart failure in 
patients with diastolic dysfunction.
1095-240 Absence of Abdominal Aortic Calcium Is Associated 
with Low Prevalence of Obstructive Coronary 
Disease
Bryan Zweig, Steve Simpson, Darshan C. Patel, Mouaz H. Al-Mallah, 
Henry Ford Heart and Vascular Institute, Detrioit, MI
Learning Objective: Improve methods of risk stratification for 
patients evaluted for coronary artery disease.
1095-241 Head-to-Head Comparison of Coronary Calcium 
Imaging, Computed Tomography Coronary 
Angiography and Exercise Testing in Real-World 
Patients with Stable Chest Pain
Koen Nieman, Tjebbe Galema, Lisan Neefjes, Annick Weustink, Paul 
Musters, Adriaan Moelker, Pim De Feyter, Erasmus MC, Rotterdam, 
The Netherlands
Learning Objective: identify the need and means for further testing 
of symptomatic patients depending on the CT coronary calcium 
scan results.
1095-242 Relationships of Mitral Annular Calcification to 
Cardiovascular Risk Factors: The Multi-ethnic Study 
of Atherosclerosis (MESA)
Somsupha Kanjanauthai, Khurram Nasir, Ronit Katz, Juan J. 
Rivera, Junichiro Takasu, Roger S. Blumenthal, John Eng, Matthew 
J. Budoff, Medical College of Georgia, Augusta, GA, Los Angeles 
Biomedical Research Institute at Harbor-UCLA Medical Center, 
Torrance, CA
Learning Objective: To evaluate relationships between MAC and 
measured CVD risk factors in an ethnically diverse population 
without clinically apparent CVD
1095-243 Prevalence and Severity of Atherosclerosis in Young 
Persons With Diabetes
Nikhil A. Daga, Khurram Nasir, Yasmin Hamirani, John Tayek, Philip 
Bach, Matthew Budoff, Harbor UCLA Medical Center, Torrance, CA, 
Los Angeles Biomedical Cardiovascular Computed Tomography Core 
Laboratory, Torrance, CA
Learning Objective: Identify that a major percentage of Diabetics < 
40 years 1. Have detectable coronary atherosclerosis. 2. Are at a 
4-6 fold higher risk for presence of significant CAC. 3. May benefit 
from a statin.
1096 THREE-DIMENSIONAL/TWO- DIMENSIONAL 
ECHOCARDIOGRPAHY IN MYOCARDIAL 
FUNCTION
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1096-245 Three-Dimensional Strain Assessment of Rotational 
Shear within an In Vitro Pulsatile Balloon Heart 
Model with Two Layers of Rotation
David J. Sahn, Thomas L. Tee, Uyen T. Truong, Keith DesRochers, 
Muhammad Ashraf, Oregon Health & Science University, Portland, OR
Learning Objective: understand deformation imaging
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1143-191 Poor Blood Pressure Response to Exercise Predicts 
Adverse Prognosis in Patients with Non-Ischemic 
but not Ischemic Cardiomyopathy
Yusuke Sata, Hiroshi Takaki, Rika Kawakami, Michio Nakanishi, 
Michio Nakanishi, Teruo Noguchi, Yoichi Goto, Masaru Sugimachi, 
National Cardiovascular Center, Suita, Japan, Department of 
Cardiovascular Dynamics, National Cardiovascular Center Research 
Institute, Suita, Japan
Learning Objective: prognostic impact of cardiopulmonary exercise
1143-192 Overweight Is Associated with Dynamic Arterial 
Stiffening During Exercise in Non-diabetic Women: 
Implication on Exercise Intolerance
Chi Young Shim, Sungha Park, Donghoon Choi, Woo-In Yang, In-
Jeong Cho, Namsik Chung, Jong-Won Ha, Yonsei Cardiovascular 
Center, Yonsei University College of Medicine, Seoul, South Korea
Learning Objective: identify the dynamic arterial stiffening during 
exercise and it is associated with exercise intolerance in overweight 
women.
1143-193 Anemia and Abnormal Ventilatory Response to 
Exercise Predict Adverse Clinical Outcomes in 
Chronic Heart Failure
Takamasa Sato, Tomofumi Misaka, Akiomi Yoshihisa, Yasuchika 
Takeishi, Department of Cardiology and Hematology, Fukushima 
Medical University, Fukushima, Japan
Learning Objective: Demonstrate that combination of VE/VCO2 
slope and hemoglobin concentration can identify high risk patients 
in chronic heart failure
1143-194 Inability of Different Modalities of Stress Testing 
in Predicting Coronary Artery Disease in Obese 
Subjects
Anitha Rajamanickam, Samir Kapadia, Rubin Bahuva, Thadeo 
Catacutan, Alraies Chadi, Ali Usmani, Sam Butler, Stephen Ellis, 
James B. Young, Manuel Cerqueira, Cleveland Clinic, Cleveland, OH
Learning Objective: To identify the best modality of Stress testing in 
the obese patients
1143-195 Exaggerated Hypertensive Response to Exercise 
in the Early Stages of Hypertension: Relationships 
with Indices of Arterial Stiffness
Dimitris Tsiachris, Konstantinos Tsiouﬁs, Dimitris Roussos, 
Anastasia Mazaraki, Eirini Andrikou, Ioannis Andrikou, Andreas 
Michaelides, Christodoulos Stefanadis, First Cardiology Clinic, 
University of Athens, Hippokration Hospital, Athens, Greece
Learning Objective: demonstrate the association of exaggerated 
blood pressure response during exercise with adverse 
cardiovascular adaptations in the setting of uncomplicated 
essential hypertension
1097-252 Is Mitral Annulus Early Diastolic Velocity a Clinically 
Relevant Index of left Ventricular Relaxation?
Zoran Popovic, IV, Milind Y. Desai, Adisai Buakhamsri, Chirapa 
Puntawagkoon, Allen Borowski, Benjamin D. Levine, Wai Hong 
Wilson Tang, James D. Thomas, Cleveland Clinic, Cleveland, OH, 
University of Texas Southwestern Medical Center Dallas, Dallas, TX
Learning Objective: understand the determinants of early diastolic 
velocity of mitral annulus
1097-253 Mitral Annular Motion Contributes Left Atrial Filling 
During Systole By Providing Interactive Relationship 
Between Left Ventricular And Left Atrial Function
Sung Hee Shin, Sang Don Park, Seong Il Woo, Dae Hyeok Kim, 
Keum Soo Park, Woo Hyung Lee, Jun Kwan, Inha University Hospital, 
Incheon, South Korea
Learning Objective: evaluate the impact of the geometric change of 
the MA during systole on the left atrial filling
1097-254 Transesophageal Echocardiography and DC 
Cardioversion: 10 Years Experience in Over 2700 
Patients
Tristan B. Klosterman, Hirad Yarmohammadi, Kevin Shrestha, 
Brandon Varr, Bruce Lindsey, Andrew Zurich, Wai Hong W. Tang, Allan 
L. Klein, Cleveland Clinic, Cleveland, OH
Learning Objective: Evaluate the continuing clinical application 
of transesophageal echocardiography prior to direct current 
cardioversion in patients with atrial fibrillation.
1097-255 Transesophageal Echocardiography Confirms 
Validity of CHADS2 Score in Atrial Flutter
Milind Parikh, Zaid Aziz, Richard G. Trohman, Kousik Krishnan, Rush 
University Medical Center, Chicago, IL
Learning Objective: Evaluate the validity of the CHADS2 risk score 
in atrial flutter
1143 EXERCISE PHYSIOLOGY AND RISK FACTORS FOR 
CARDIOVASCULAR DISEASE
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1143-188 Additive Effect of Cardiorespiratory Fitness Level 
and Adiposity on Mortality in Patients with Coronary 
Artery Disease
Kashish Goel, Randal J. Thomas, Ray W. Squires, Virend K. Somers, 
John M. Miles, Francisco Lopez-Jimenez, Mayo Clinic, Rochester, MN
Learning Objective: Recognize the joint impact of cardiorespiratory 
fitness and adiposity on mortality in coronary artery disease patients.
1143-189 Direct Association Between Serum Vitamin D Level 
and Cardiorespiratory Fitness in Healthy Adults.
Afrooz Ardestani, Beth Parker, Shishir Mathur, Priscilla Clarkson, 
Linda Pescatello, Donna Polk, Paul D. Thompson, Henry Low Heart 
Center, Hartford Hospital, Hartford, CT, University of Connecticut, 
School of Medicine, Farmington, CT
Learning Objective: Determine the relationship between serum 
Vitamin D level and cardiorespiratory fitness in healthy adults.
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1144-203 Exercise Training Improves LV Mass, LV End 
Diastolic Volume and Stroke Volume and Reduces 
Upright Heart Rate in the Postural Orthostatic 
Tachycardia Syndrome
Paul S. Bhella, Tiffany B. VanGundy, Qi Fu, Benjamin D. Levine, The 
Institute of Exercise and Environmental Medicine at Texas Health 
Resources, Dallas, TX, The University of Texas-Southwestern, Dallas, TX
Learning Objective: The impact of exercise training on the disorder 
POTS (Postural Orthostatic Tachycardiac Syndrome)
1144-204 Aortic Root Dimensions in Elite Athletes
Antonello D’Andrea, Rosangela Cocchia, Lucia Riegler, Rodolfo Citro, 
Olga Vriz, Pio Caso, Raffaele Calabrò, Eduardo Bossone, Second 
University of Naples - Ao Monaldi, Naples, Italy, Department of 
Cardiac Surgery, Istituto di Ricovero e Cura a Carattere Scientiﬁco, 
Policlinico San, Milan, Italy
Learning Objective: Our objective was to explore the full range of 
aortic root diameters in elite athletes.
1145 CT CORONARY ANGIOGRAPHY: DIAGNOSTIC 
ACCURACY I
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1145-205 Patient Factors Predictive of Uninterpretable 
Results in Cardiac Computed Tomographic 
Angiography
Thomas E. Vanhecke, Ryan D. Madder, Patricia A. Peyser, Kavitha 
Chinnaiyan, William Beaumont Hospital, Royal Oak, MI
Learning Objective: To predict factors predictive of uninterpretable 
results on coronary computed tomography angiography in 
symptomatic patients
1145-206 Quantitative and Diagnostic Accuracy of 64-MDCTA 
for Segmental Coronary Artery Stenosis Detection: 
Results from The CORE-64 Multicenter International 
Study
Julie M. Miller, Carlos E. Rochitte, Marc Dewey, Hiroyuki Niinuma, 
Armin Arbab-Zadeh, Ilan Gottlieb, Narinder Paul, Melvin E. Clouse, 
Edward Shapiro, John Hoe, David E. Bush, Albert Lardo, Albert de 
Roos, Christopher Cox, John Texter, Andrea Vavere, Joao A. Lima, 
Jeffery Brinker, Johns Hopkins University, Baltimore, MD, InCor Sao 
Paulo Heart Institute, Sao Paulo, Brazil
Learning Objective: Interpret the segment based diagnostic 
accuracy of MDCTA, in comparison with the patient-based accuracy.
1145-208 Quantitative Computed Tomography Coronary 
Angiography is Highly Accurate in the Detection 
of Flow-Limiting Coronary Arterial Stenoses as 
Assessed by Fractional Flow Reserve
Sarah Rinehart, Dimitri Karmpaliotis, Charlie Brown, Anna Kalynich, 
Zhen Qian, Gustavo Vazquez, Idean Marvasty, Szilard Voros, 
Piedmont Heart Institute, Atlanta, GA
Learning Objective: Understand CT parameters that accurately 
predict obstructive FFR
1144 RELATIONSHIP OR FUNCTIONAL CAPACITY TO 
MORPHOLOGY AND HEMODYAMICS
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1144-197 Does Physical Functioning as Assessed by Short 
Form Health Survey Predict Peak Oxygen Uptake in 
Patients With Atrial Septal Defect Type Secundum?
Alexander Van De Bruaene, Roselien Buys, Luc Vanhees, Philip 
Moons, Werner Budts, University Hospitals, Leuven, Belgium
Learning Objective: evaluate perceived health status and its relation 
to peak oxygen consumption in ASD patients
1144-198 Does Exercise Always Cause Physiological 
Hypertrophy?
Maria Schoepe, Andrea Schrepper, Michael Schwarzer, Paulo 
Amorim, Friedrich W. Mohr, Torsten Doenst, University of Leipzig 
Heart Center, Leipzig, Germany
Learning Objective: evaluate exercise induced hypertrophy with 
different intensity protocols associated with impairment in cardiac 
function, reduced respiratory capacity and pathological alterations 
in gene expression.
1144-199 Marathon Runners Have Increased Aortic Stiffness
Despina Kardara, Charalambos Vlachopoulos, Aris Anastasakis, 
Katerina Baou, Dimitrios Terentes-Printzios, Ioanna Dima, Georgios 
Antoniou, Athanasios Gravos, Christodoulos Stefanadis, 1st 
Cardiology Department, Athens Medical School, Hippokration 
Hospital, Athens, Greece
Learning Objective: evaluate cardiovascular risk in marathon 
runners focusing on the proper training volumes, frequency and 
duration
1144-200 Impact of Physical Fitness on Echocardiographic 
Left Ventricular Mass in Healthy Young Black and 
White Adult Men and Women: The Coronary Artery 
Risk Development in Young Adults (CARDIA) Study
Eveline Oestreicher, Elyse Foster, Celina M. Yong, Stephen Sidney, 
Kofo O. Ogunyankin, Kirsten Bibbins-Domingo, University of 
California, San Francisco, San Francisco, CA
Learning Objective: recognize how physical fitness in early 
adulthood may impact left ventricular mass
1144-201 Life-long Patterns of Physical Activity Determine 
Exercise Capacity and Cardiac Function
Naoki Fujimoto, Paul S. Bhella, Shigeki Shibata, Jeff Hastings, 
Nicole Minnieﬁeld, Dean Palmer, Benjamin D. Levine, Institute for 
Exercise and Environmental Medicine, Texas Health Presbyterian 
Hospital Dallas, Dallas, TX, The University of Texas Southwestern 
Medical Center at Dallas, Dallas, TX
Learning Objective: identify that subjects with the highest amount 
of lifelong endurance exercise training had the greatest exercise 
capacity due to a larger stroke volume and cardiac outut at peak 
exercise.
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1146-215 Impact of Exercise Capacity Beyond Anaerobic 
Threshold
Mahoto Kato, Lynne W. Stevenson, Greg Flaker, L. Howard Hartley, 
Brigham and Women’s Hospital, Boston, MA
Learning Objective: The ability to exercise beyond anaerobic 
threshold may be an important additional point of interpretation of 
metabolic exercise testing results.
1146-216 Exercise Hyperventilation and Central Sleep 
Apnea in Heart Failure Patients: Relationship to 
Neurohumoral activation
Andrew D. Calvin, Virend K. Somers, Christelle van der Walt, Jennifer 
M. Fitz-Gibbon, Lyle J. Olson, Mayo Clinic, Rochester, MN
Learning Objective: describe the association between 
norepinephrine, endothelin-1, central sleep apnea, and 
hyperventilation
1146-217 Reversal Of Respiratory Muscles Dysfunction And 
Exercise Capacity Improvement After Continuous-
flow Left Ventricular Assist Device Implantation
Stavros Dimopoulos, Georgios Tzanis, Athanasios Tasoulis, Anthi 
Mpouchla, Christos Manetos, Nikolaos Diakos, Eleni Tseliou, 
Iraklis Pozios, Lambros Katsaros, Seraﬁm Nanas, 1st Critical Care 
Medicine Dept, Cardiopulmonary Exercise Testing and Rehabilitation 
Laboratory,NKUA, Athens, Greece, 3rd Cardiology “Laiko” Hospital, 
NKUA, Athens, Greece, Athens, Greece
Learning Objective: Demonstrate the reversal of respiratory muscles 
dysfunction and exercise capacity improvement after continuous-
flow left ventricular assist device implantation
1146-218 A Novel Method for Measuring Exercise Oscillatory 
Ventilation Among Heart Failure Patients
Andrew D. Calvin, Christopher G. Scott, Jennifer M. Fitz-Gibbon, Lyle 
J. Olson, Mayo Clinic, Rochester, MN
Learning Objective: describe exercise oscillatory ventilation
1146-220 Relation of Exercise Oscillatory Ventilation to 
Cardiac Remodeling and Hemoglobin Level in 
Patients with Idiopathic Dilated Cardiomyopathy
Takahiro Okumura, Akihiro Hirashiki, Yuji Kono, Jun Kojima, Satoru 
Ohshima, Kyosuke Takeshita, Xian Wu Cheng, Akiko Noda, Sumio 
Yamada, Toyoaki Murohara, Department of Cardiology, Nagoya 
University Graduate School of Medicine, Nagoya, Japan
Learning Objective: clarify the contribution of cardiac remodeling 
to exercise oscillatory ventilation in patients with idiopathic dilated 
cardiomyopathy.
1146-221 Obesity Paradox: Influence Of Age And Weight 
Changes On All-cause Mortality
Kusum Lata, Paul McAuley, Jonathan Myers, J. Pittsley, Victor 
Froelicher, Cardiology Division, Veterans Affairs Palo Alto Health 
Care System/Stanford University, Palo Alto, CA
Learning Objective: Demonstarte effect of age and weight changes 
to mortality
1145-209 Accuracy of Non-Invasive Multislice Computed 
Tomography Coronary Angiography; Detection 
of Significant Stenosis versus Detection of 
Atherosclerosis
Joella E. Velzen, Joanne D. Schuijf, Fleur R. de Graaf, Gabija 
Pundziute, Fabrizio Spano, Jacob M. van Werkhoven, Martin J. 
Schalij, Lucia J. Kroft, Albert de Roos, Johannes H. Reiber, J. Wouter 
Jukema, Ernst E. van der Wall, Jeroen J. Bax, Leiden University 
Medical Centre, Leiden, The Netherlands
Learning Objective: to understand that MSCT coronary angiography 
is superior in detection of the presence of atherosclerosis rather 
than the detection of precise degree of stenosis
1145-210 Relationship of Coronary Artery Plaque Composition 
to Coronary Artery Stenosis Severity: Results from 
the Prospective Multicenter ACCURACY Trial
James Min, Michael Edwardes, Fay Y. Lin, Troy M. Labounty, Nina 
Koduru, Jonathan W. Weinsaft, Jin-Ho Choi, Augustin Delago, Leslee 
J. Shaw, Daniel S. Berman, Matthew J. Budoff, Weill Cornell Medical 
College, New York, NY, Harbor UCLA Medical Center, Los Angeles, CA
Learning Objective: To understand the relationship between plaque 
composition and stenosis severity
1145-211 Evaluation of Chronic Total Occlusion by Multi-
Detector Computed Tomography: Comparison 
with Intravascular Ultrasound Imaging after 
Recanalization
Akiko Maehara, Michael Poon, Gary S. Mintz, Kazuhiro Ashida, 
Hisaya Sato, Masahiko Ochiai, Cardiovascular Research 
Foundation/Columbia University Medical Center, New York, NY, 
Showa University Northern Yokohama Hospital, Yokohama, Japan
Learning Objective: evaluation of morphology of chronic total 
occlusion by multi-detector row computed tomography
1145-212 Mechanism of Improvement in Mitral Regurgitation 
in the Acute Phase after Cardiac Resynchronization 
Therapy
Michio Imai, Katsuomi Iwakura, Atsunori Okamura, Yasushi Koyama, 
Motoo Date, Yoshiharu Higuchi, Koichi Inoue, Ryusuke Kimura, 
Hiroyuki Nagai, Yuko Toyoshima, Makito Ozawa, Norihisa Ito, Yukinori 
Okazaki, Masahiko Shibuya, Shigemiki Omiya, Takashi Takagi, 
Daisuke Morisawa, Kenshi Fujii, Cardiovascular Center,Sakurabashi-
Watanabe Hospital, Osaka, Japan
Learning Objective: learn a mechanizm of improvement in severe MR.
1146 EXERCISE PHYSIOLOGY AND VENTILATORY 
FACTORS
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1146-214 Determinants of Exercise Oscillatory Ventilation in 
Heart Failure
Ravi V. Shah, Ryan Murphy, Paul Pappagianopoulos, David Systrom, 
Marc Semigran, Gregory Lewis, Massachusetts General Hospital, 
Boston, MA
Learning Objective: To describe critical relationships between 
central hemodynamics and exercise oscillatory ventilation in 
patients with chronic systolic heart failure
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1148 MRI: VASCULAR IMAGING
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1148-228 Impaired Coronary Vascular Reactivity in Cardiac 
Syndrome X Measured Non-Invasively by 3T MRI
Tonia Yee, Alice Chang, Melanie Kotys, Elizabeth Holper, Ron 
Peshock, UT Southwestern, Dallas, TX
Learning Objective: Understand the potential of 3T MRI for 
measuring impairment in coronary vascular reactivity in women at 
risk for cardiovascular disease.
1148-229 Impact of Disease Etiology on Aortic Stiffness 
Determined by Cardiovascular Magnetic Resonance: 
a Cohort Study of Patients with Aortic Pathology
Andrew To, Ruvin S. Gabriel, Zoran B. Popovic, Rahul Renapurkar, 
Michael Bolen, Scott D. Flamm, Brian P. Grifﬁn, Milind Y. Desai, 
Cleveland Clinic Foundation, Cleveland, OH
Learning Objective: identify the important determinants of pulse 
wave velocity measured by cardiovascular magnetic resonance in 
various aortic pathologies
1148-230 Relationship between Coronary and Brachial Artery 
Endothelial Function in Normal and Abnormal 
Subjects
Hariharan Subramanian, Yi Wang, William Schapiro, Kathy McGrath, 
Simcha Pollack, Nathaniel Reichek, St.Francis Hospital, Roslyn, NY, 
Division of Cardiology, SUNY Stony Brook, Stony Brook, NY
Learning Objective: Understand the relationship between 
endothelial function in coronary and peripheral vascular beds 
and also demonstrate a direct non invasive method of evaluating 
coronary vasomotion
1148-231 Turner Syndrome Aortopathy Demonstrated by 
Cardiac MRI-Determined Aortic Pulse Wave Velocity
Sean Hagenbuch, Kan N. Hor, Wojciech Mazur, Robert J. Fleck, 
Phillipe Backeljauw, D Woodrow Benson, William M. Gottliebson, 
Janaka Wansapura, Cincinnati Children’s Hospital Medical Center, 
Cincinnati, OH
Learning Objective: Distinguish Turner syndrome aortopathy as a 
unique entity, and describe a novel technique for measuring MRI 
derived aortic pulse wave velocity
1148-232 Hyperintense Coronary Plaque on Non-Contrast 
T1-Weighted Cardiac Magnetic Resonance Is 
Associated with Carotid Artery Inflammation 
Evaluated by [18F]-Fluorodeoxyglucose Positron 
Emission Tomography
Atsushi Tanaka, Tomohiro Kawasaki, Teruo Noguchi, Yoshihiro 
Hiramatsu, Takaya Fukuyama, Nobuhiko Koga, Teruo Inoue, Koichi 
Node, koga Hospitai 21, Kurume, Japan
Learning Objective: identify not only high-risk coronary plaque, 
but also a severity carotid artery inflammation, by using cardiac 
magnetic resonance
1147 MRI: CMR - CLINICAL
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1147-222 Incidence of New Valvular Dysfunction in Normal 
Subjects Over Five Years: A Prospective Study
Dipti Gupta, Jing Han, Nathaniel Reichek, St Francis Hospital, 
Roslyn, NY, University of Iowa, Iowa City, IA
Learning Objective: Identify the increased incidence of new 
moderate valvular dysfunction in a healthy middle aged cohort as 
recognised by cardiac imaging modalities.
1147-223 Diagnostic Usefulness of Edema-infarct ratio to 
Differentiate Acutely from Chronically Damaged 
Myocardium Using Magnetic Resonance Imaging
Kiyoyasu Yamada, Isobe Satoshi, Kousuke Kinoshita, Susumu 
Suzuki, Kazuhiko Yokouchi, Hirokazu Iwata, Ken Sawada, Makoto 
Hirai, Gifu Social Insurance Hospital, Kani, Japan, Nagoya University 
Graduate School of Medicine, Nagoya, Japan
Learning Objective: The edema-infarct ratio of LV area is a useful 
index in detecting the stage of patients with acute myocardial 
infarction.
1147-224 Prognostic Value of Right Ventricular Ejection 
Fraction Determined by Cardiac Magnetic 
Resonance
Ijaz Ahmad, Aziz Rehman, Joe Y. Lau, Betty Hua, Frida Ashurova, 
Geetha Bhumireddy, Faisal Ali, Charles Vu, Joshua Fogel, Sorin 
J. Brener, Terrence Sacchi, John F. Heitner, New York Methodist 
Hospital, Brooklyn, NY
Learning Objective: Demonstrate the prognostic value of right 
ventricular ejection fraction
1147-225 Location Of Myocardial Fibrosis In Patients With 
Hypertrophic Cardiomyopathy Detected By Cardiac 
Magnetic Resonance Imaging Is Related To Various 
Electrocardiographic Changes
Bong Gun Song, Ga Yeon Lee, Eun Kyung Kim, Hye Jin Han, Dong 
Ryeol Ryu, Sung-A Chang, Sung-Ji Park, Jin-Oh Choi, Sang-Chol Lee, 
Seung Woo Park, Yeon Hyeon Choe, Jae K. Oh, samsung medical 
center, seoul, South Korea
Learning Objective: We demonstrated the characteristics of LGE and 
assessed relationships between ECG findings and LGE in patients 
with hypertrophic cardiomyopathy
1147-226 Apical Hypokinesis is a Sensitive Marker of 
Early Right Ventricular Dysfunction in Pulmonary 
Hypertension.
Leticia A. Fernandez-Friera, Ana Garcia-Alvarez, Ajith Nair, Gabriela 
Guzman, Alaitz Romero, Juan Gaztanaga, Valentin Fuster, Mario 
Garcia, Javier Sanz, Mount Sinai Hospital, New York, NY
Learning Objective: Identify apical right ventricle dysfunction in 
pulmonary hipertension patients before global right ventricular 
systolic function is reduced, using cardiac magnetic resonance 
imaging.
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1149-238 Impact of Extent of Myocardial Fibrosis on 
Occurrence of Ventricular Tachyarrhythmia in 
Hypertrophic Cardiomyopathy: Results from MRI 
with Late Gadolinium Enhancement Study in 
Genotyped Patients
Junichiro Yokawa, Eiichi Masuta, Noboru Fujino, Kenshi Hayashi, 
Katsuharu Uchiyama, Akira Funada, Yuichiro Sakamoto, Toshinari 
Tsubokawa, Akihiko Muramoto, Hidekazu Ino, Masakazu Yamagishi, 
Kanazawa University, Kanazawa, Japan
Learning Objective: demonstrate that CMR-determined myocardial 
fibrosis could be indicative of VT.
1150 MRI: CARDIOMYOPATHIES - RISK 
STRATIFICATION & OUTCOMES
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1150-239 Iron Chelation Therapy with Deferasirox (Exjade®) 
in Reducing Cardiac Siderosis in β-Thalassemia 
Patients: 2-Year Results from the EPIC Cardiac 
Substudy
Dudley J. Pennell, John Porter, Domenica Cappellini, Lee Lee Chan, 
Amal El-Beshlawy, Yesim Aydinok, Hishamshah Ibrahim, Chi-Kong Li, 
Vip Viprakasit, Mohsen Elalfy, Antonis Kattamis, Gillian Smith, Dany 
Habr, Gabor Domokos, Bernard Roubert, Ali Taher, Royal Brompton 
Hospital, London, United Kingdom
Learning Objective: UNderstand possible role of deferasirox for 
treatment of cardiac siderosis
1150-240 Can CMR be the ‘Crystal Ball’ for Patients with 
Dilated Cardiomyopathy? Risk Stratification for 
Cardiac Transplantation/LVAD
Jose Vicente Venero, Srinivas Murali, Mark Doyle, Vikas K. Rathi, 
Saundra B. Grant, June A. Yamrozik, Ronald B. Williams, Diane 
A. Vido, Geetha Rayarao, Robert WW Biederman, The Center for 
CVMRI, The Gerald McGinnis Cardiovascular Institute at Allegheny 
General Hospital, Pittsburgh, PA
Learning Objective: To understand the potential for a single 
image via CMR to effectively and accurately risk-stratify dilated 
cardiomyopathy and to predict LVAD/transplant requirements
1150-241 Cardiac Sarcoidosis with Preserved Systolic 
Function: Impact of Late Gadolinium Enhancement 
on Diastolic Function and Left Atrial Morphology
Amit R. Patel, Michael R. Klein, Nadera J. Sweiss, Kirk T. Spencer, 
Jeanne M. DeCara, Roberto M. Lang, Lissa Sugeng, Stephen L. 
Archer, D. Kyle Hogarth, Martin C. Burke, Timothy B. Niewold, John F. 
Beshai, University of Chicago, Chicago, IL
Learning Objective: Understand the relationship between cardiac 
sarcoidosis and diastolic function.
1149 MRI: APPLICATIONS IN ELECTROPHYSIOLOGY
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1149-234 Assessment of the Left Atrial Substrate in Lone 
Atrial Fibrillation: Implications for Staging of Atrial 
Fibrillation
Nathan Burgon, Troy J. Badger, Nazem W. Akoum, Gaston Vergara, 
Lori McMullan, Yaw A. Adjei-Poku, Thomas S. Haslam, Jeremy 
Fotheringham, Eugene G. Kholmovski, Rob S. MacLeod, Nassir F. 
Marrouche, University of Utah Health Sciences Ctr, Salt Lake City, UT
Learning Objective: Distinguish the term ‘lone’ AF as not 
appropriately categorizing AF patients based on LA substrate 
analysis & staging AF based on extent of substrate disease may be 
a more accurate way to classify AF.
1149-235 Evaluation of the Left Atrial Substrate and Age 
in Atrial Fibrillation Patients using Delayed-
Enhancement MRI
Thomas S. Haslam, Troy J. Badger, Nazem W. Akoum, Gaston 
Vergara, Lori McMullan, Yaw A. Adjei-Poku, Nathan S. Burgon, Kevin 
Tek, Eugene G. Kholmovski, Nassir F. Marrouche, University of Utah, 
Comprehensive Arrhythmia and Research Management Center, Salt 
Lake City, UT
Learning Objective: Describe that substrate analysis using DE-MRI 
confirms that aging plays an integral component in LA remodeling in 
AF patients.
1149-236 Cardiac Outcome after Cardiac Resynchronization 
Therapy Is Better Predicted by Late Gadolinium 
Enhancement Cardiac Magnetic Resonance than 
Left Ventricular Reverse Remodeling
Francisco Ridocci, Alfonso Valle, Jordi Estornell, Alesandro Pirola, 
Miguel Corbi, Javier Jimenez, Elena Lucas, Candela Rodriguez, 
Juan J. Restrepo, Leandro Perez, Aurelio Quesada, Rafael Paya, 
Consorcio Hospital General Universitari, Valencia, Spain
Learning Objective: identify late gadolinium enhanced cardiac 
magnetic resonance as predictor of long term outcome after cardiac 
resynchronization therapy irrespective of left ventricular remodeling
1149-237 Scar Morphology In Patients Presenting with 
Ventricular Arrhythmias: Implications for Risk 
Stratification in Patients with Chronic Ischemic 
Cardiomyopathy
Jaimie Manlucu, Lorne J. Gula, Mohammed Al-Admawi, Raymond 
Yee, Andrew Krahn, Allan Skanes, George Klein, Nowell Fine, 
Terry Thompson, Maria Drangova, James A. White, London Health 
Sciences Corporation, London, ON, Canada, University of Western 
Ontario, London, ON, Canada
Learning Objective: describe the emerging role of scar morphology, 
as identified by LGE MRI, in the risk stratification of patients with 
chronic myocardial infarction
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1151-248 Echocardiographic Dyssynchrony Predicts Survival 
Following Cardiac Resynchronization Therapy
Phillip J. Habib, Olusegun Oyenuga, Hidekazu Tanaka, Stephanie 
Haberman, Evan C. Adelstein, John Gorcsan, III, University of 
Pittsburgh, Pittsburgh, PA
Learning Objective: Demonstrate that the absence of echo 
dyssynchrony was predictive of a significantly less favorable 
event-free survival outcome following CRT than the presence of 
dyssynchrony.
1151-249 The Impact of Apical Imaging Level on 
Echocardiographic Measurement of Left Ventricular 
Torsion: The Need for Standardization
Rory B. Weiner, Michael H. Picard, Jonathan Kim, Ari D. Brettman, 
Arthur E. Weyman, Aaron L. Baggish, Massachusetts General 
Hospital, Boston, MA
Learning Objective: Describe the impact of standardized apical 
imaging level on echocardiographic measurement of left ventricular 
torsion.
1152 MRI: NEW DEVELOPMENTS IN CMR
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1152-251 Reinfarction-Specific Magnetic Resonance Imaging 
Contrast Agent
Robert Kirschner, Akos Varga-Szemes, Levente Toth, Tamas Simor, 
Pal Suranyi, Balazs Ruzsics, Pal Kiss, Attila Toth, Robert Baker, 
Brigitta C. Brott, Silvio Litovsky, Ada Elgavish, Gabriel A. Elgavish, 
University of Alabama at Birmingham, Birmingham, AL, Elgavish 
Paramagnetics Inc., Hoover, AL
Learning Objective: recognize the potential usefulness of the 
presented method in future clinical practice for differentiate 
between acute and older myocardial infarcts, and list the most 
common clinical scenarios
1152-252 Gadonanotubes as Magnetic Nanolabels: A 
Powerful and Safe Approach for Stem Cell 
Detection
Lesa A. Tran, Ramkumar Krishnamurty, Maria G. Cabreira-Hansen, 
Raja Muthupillai, Lon J. Wilson, Guilherme Silva, James T. Willerson, 
Emerson P. Perin, Texas Heart Institute, Houston, TX, Rice University, 
Houston, TX
Learning Objective: Evaluate gadonanotubes as a powerful and safe 
T1-weighted MRI contrast agent
1152-253 A Non-Invasive MR Speckle Tracking Study of 
Myocardial Strain and Rotational Velocity in 
Patients with Congenital Heart Disease
David J. Sahn, Petra S. Niemann, Helene Houle, Craig S. Broberg, 
Michael Silberbach, Zhiwen Zhou, Muhammad Ashraf, Oregon 
Health & Science University, Portland, OR, Siemens Medical 
Solutions, Mountain View, CA
Learning Objective: understand strain and twist in biventricular 
malformations
1150-242 Late Gadolinium Enhancement by Cardiac Magnetic 
Resonance Can Predict the non-Responders to 
β-blocker in Patients with Dilated Cardiomyopathy
Shiro Nakamori, Tairo Kurita, Takashi Tanigawa, Kei Sato, Hiroshi 
Nakajima, Yasutaka Ichikawa, Koji Matsuoka, Katsuya Onishi, 
Hajime Sakuma, Masaaki Ito, Matsusaka Central Hospital, 
Matsusaka, Japan, Mie University Hospital, Tsu, Japan
Learning Objective: The CMR LGE predicts the non-responders 
to optimal therapy including beta-blockers and may provide new 
risk stratification strategies (i.e.,determining the need for device 
therapy) in DCM patients.
1150-243 Degree of Mitral Regurgitation and Left Ventricular 
Scarring Are Much Better Predictors of Long-term 
Outcomes Compared to Volumes and Sphericity: 
A Multi-modality Imaging Study in Patients with 
Severe Ischemic Cardiomyopathy
Deborah Kwon, Zoran B. Popovic, Venugopal Menon, Carmel M. 
Halley, Danielle M. Brennan, Randall C. Starling, Scott D. Flamm, 
Paul Schoenhagen, Bruce W. Lytle, Brian P. Grifﬁn, Milind Y. Desai, 
Milind Y. Desai, Cleveland Clinic, Cleveland, OH
Learning Objective: To demonstrate that left ventricular sphericity is 
not an independent predictor of mortality in ICM
1151 MRI: CORONARY ARTERY DISEASE - DIAGNOSIS 
& PROGNOSIS
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1151-245 The Prognostic Value Of Dobutamine Cardiovascular 
Magnetic Resonance In Patients With Known Or 
Suspected Cad.
Sebastian Kelle, Christoph Klein, Amedeo Chiribiri, Juliane Vierecke, 
Christina Egnell, Ingo Paetsch, Cosima Jahnke, Ernst Wellnhofer, 
Eckart Fleck, German Heart Institute Berlin, Berlin, Germany
Learning Objective: interpret dobutamine induced wall-motion-
abnormalities at DCMR.
1151-246 Feasibility and Early Prognostic Data on Treadmill 
Exercise Magnetic Resonance Imaging Stress 
Testing
Brandon C. Drafts, Pairoj Rerkpattanapipat, Timothy M. Morgan, 
Craig A. Hamilton, William Ntim, W. Gregory Hundley, Wake Forest 
University School of Medicine, Winston-Salem, NC
Learning Objective: Evaluate the feasibility and prognostic utility 
of treadmill exercise cardiac magnetic resonance imaging stress 
testing.
1151-247 Detection of Myocardial Infarctions Early and Late 
After Heart Transplantation with Contrast-Enhanced 
MRI
Henning Steen, Grigorios Korosoglou, Nina Riedle, Stephanie 
Lehrke, Evangelos Giannitsis, Hugo A. Katus, University of 
Heidelberg, Heidelberg, Germany
Learning Objective: distinguish between infarct-atypical and -typical 
late enhancement
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1198-192 Acute Effects of Passive Smoking on Systolic and 
Diastolic Function and Pulmonary Artery Stiffness 
in Healthy Volunteers
Mehmet Kaya, Ibrahim Ozdogru, Ibrahim Gul, Ali Dogan, Tugrul Inanc, 
Mikail Yarlioglues, Nihat Kalay, Mehtap Ozdogru, Ramazan Topsakal, 
Namik K. Eryol, Abdurrahman Oguzhan, Erciyes University, Kayseri, Turkey
Learning Objective: Passive smoking has no effect on systolic 
function but has a subtle effect on diastolic function. However, 
passive smoking has prominent effect on pulmonary stiffness.
1198-193 Detection of Myocardial Amyloid Involvement Using 
2-Dimentional Speckle Tracking Echocardiography: 
Utilization of Inner and Outer Myocardial Strain and 
Strain Rate
Kenya Kusunose, Hirotsugu Yamada, Susumu Nishio, Noriko Tomita, 
Keisuke Endo, Toshiyuki Niki, Koji Yamaguchi, Kunihiko Koshiba, Yoshio 
Taketani, Takashi Iwase, Takeshi Soeki, Tetsuzo Wakatsuki, Masashi 
Akaike, Masataka Sata, The University of Tokushima, Tokushima, Japan
Learning Objective: We evaluated whether an amyloid 
involvement could be identified by 2-dimentional speckle tracking 
echocardiography.
1198-194 Acute Effect of Atrial Fibrillation on Left Ventricular 
Longitudinal Function: Serial Observation by 
Speckle Tracking Echocardiography
Jun Koyama, Hirohiko Motoki, Kazunori Aizawa, Megumi Koshikawa, 
Hiroki Kasai, Atsushi Izawa, Takeshi Tomita, Yusuke Miyashita, 
Setsuo Kumazaki, Uichi Ikeda, Shinshu University Graduate School 
of Medicine, Matsumoto, Japan
Learning Objective: learn longitidinal left ventricular dysfunction 
during atrial fibrillation.
1198-195 Relation of Myocardial Strain with Left Ventricular 
Geometry after Acute Myocardial Infarction
Maria Louisa Antoni, Victoria Delgado, Jael Z. Atary, Eduard R. 
Holman, Ernst E. Van der Wall, Martin J. Schalij, Jeroen J. Bax, 
Leiden University Medical Center, Leiden, The Netherlands
Learning Objective: evaluate the relation between myocardial 
deformation and alterations in left ventricular geometry after acute 
myocardial infarction.
1199 GENERAL ECHOCARDIOGRAPHY: RIGHT HEART 
FUNCTION EVALUATION BY STRAIN
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1199-197 Impact of Acute Moderate Right Ventricular 
Overload on Peak Apical Left Ventricular Diastolic 
Rotation Rate
Panupong Jiamsripong, Anna M. Calleja, Eun Joo Cho, Mohsen 
S. Alharthi, Eileen M. McMahon, Marek Belohlavek, Mayo Clinic 
Arizona, Scottsdale, AZ
Learning Objective: Demonstrate increasing in peak apical diastolic 
LV rotation rate leads to the increase LV untwisting and represents 
a marker of the compensatory response of the LV to moderate RV 
pressure overload
1152-254 Left Ventricular Remodeling In Response To 
Pressure Load: Changes In Myocardial Fiber 
Architecture As Assessed By Diffusion MRI
Kaitlyn M. Lam, Van Weeden, Jose-Luis Guerrero, Xin Zeng, Claudia 
Chae, Judy Hung, Massachusetts General Hospital, Boston, MA
Learning Objective: identify architectural changes associated with LV 
remodeling in response to hypertension
1152-255 Detection of Increased Left Ventricular Filling 
Pressure by Cardiovascular Magnetic Resonance
Tariq M. Alhogbani, Oliver Strohm, Matthias Friedrich, Stephenson 
cardiac MRI center, University of Calgary, Calgary, AB, Canada
Learning Objective: evaluate atrial contraction contribution to 
left ventricular filling and detect elevated LV filling pressure by 
cardiovascular magnetic resonance
1198 GENERAL ECHOCARDIOGRAPHY: EVALUATION OF 
CARDIAC FUNCTION
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1198-188 Applicability, Limitations and Impact of 
Echocardiography Utilization Based on the 2007 
Appropriateness Use Criteria for Transthoracic and 
Transesophageal Echocardiography at a Tertiary 
Care Medical Center
Jayanth Koneru, Mohammad Al Qarqaz, Karthikeyan 
Ananthasubramaniam, Henry Ford Hospital, Detroit, MI
Learning Objective: Evaluate Applicability of 2006 Appropriate Use 
Criteria In Real World Utilization of Echocardiography, Impact on 
Patient Management and to Identify Limitations of AUC
1198-189 Rapid Quantification of Left Ventricular Ejection 
Fraction Using Echocardiographic Speckle Tracking 
of the Mitral Annular Plane
Wendy Tsang, Sonal Chandra, Amit Patel, Lissa Sugeng, Ivan S. 
Salgo, Lynn Weinert, Victor Mor-Avi, Roberto M. Lang, University of 
Chicago Medical Centre, Chicago, IL
Learning Objective: Evaulate left ventricular ejection fraction using 
echocardiographic speckle tracking of mitral annular displacement.
1198-191 Echocardiographic Assessment of Left Ventricular 
Diastolic Filling Pressure Predicts Primary 
Cardiovascular Events in Older Adults
Gustavo G. Blume, Marion E. Barnes, Patricia A. Pellikka, Stephen 
S. Cha, Teresa S.M. Tsang, Department of Echocardiography Mayo 
Clinic, Rochester, MN
Learning Objective: Evaluate if left ventricular filling pressure 
predicts cardiovascular outcomes
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1200 EXERCISETESTING FOR CORONARY ARTERY 
DISEASE AND BEYOND
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1200-205 Exercise Stress Test Results In Patients With 
Bare Metal Stents Or Drug Eluting Stents: 
Pathophysiological And Clinical Implications
Gaetano A. Lanza, Roberto Nerla, Antonio Di Monaco, Gaetano 
Pinnacchio, Roberto Mollo, Cristina Aurigemma, Gregory A. Sgueglia, 
Alfonso Sestito, Filippo Crea, Università Cattolica del Sacro Cuore, 
Roma, Italy
Learning Objective: To evaluate the prognostic role of exercise 
stress test in patients with PCI and coronary stent implantation
1200-206 Exaggerated Blood Pressure Response Is 
Accompanied by a State of Pronounced 
Albuminuria, Hypoadiponectinemia, Increased 
Asymmetric Dimethylarginine and Osteoprotegerin 
Levels in Hypertension
Konstantinos P. Tsiouﬁs, Kyriakos Dimitriadis, Anastasia Mazaraki, 
Eirini Andrikou, Ioannis Andrikou, Athanasios Aggelis, Antigoni 
Miliou, Andreas Michaelides, Christodoulos Stefanadis, First 
Cardiology Clinic, University of Athens, Hippokration Hospital, 
Athens, Greece
Learning Objective: describe the relationships of exercise 
hypertensive response with asymmetric dimethylarginine, 
adiponectin, osteoprotegerin and albuminuria in hypertension
1200-208 Paced Rhythm at Baseline is Associated With Lower 
Exercise Capacity in Heart Failure
Amaar Ujeyl, Lynne W. Stevenson, Patricia Campbell, Mahoto Kato, 
Daniel E. Forman, Brigham and Women’s Hospital, Boston, MA
Learning Objective: consider the importance of heart rate reserve 
in heart failure patients with baseline pacing to optimize functional 
capacity
1200-209 The Prognostic Utility of Exercise ECG Testing in 
Patients over 75 Years of Age with Angina
Jun R. Chiong, Tricia Aguilar, Mark Ghamsary, Loma Linda University 
School of Medicine, Loma Linda, CA, Loma Linda University School 
of Public Health, Loma Linda, CA
Learning Objective: Exercise capacity is a better predictor of 
outcomes compared to ECG changes among 75 years and above 
referred for angina workup.
1200-210 Longitudinal Two-Dimensional Speckle Tracking 
Indices on Rest Echocardiographic Images Predicts 
Significant Coronary Disease
Kofo O. Ogunyankin, David E. Montgomery, Jyothy J. Puthumana, 
Daniel J. Schuster, Northwestern University Feinberg School of 
Medicine, Division of Cardiology, Chicago, IL
Learning Objective: Understand diagnostic value of deformational 
characteristics of the LV
1199-198 Assessment of Right Ventricular Function with 
Longitudinal Two Dimensional Strain: Comparison 
between Low and Intermediate Risk Pulmonary 
Embolism
Vincent DESCOTES GENON, Romain Chopard, Mathilde Morel, 
Joanna Dutheil, Nicolas Meneveau, Marie-France Seronde, Francois 
Schiele, Yvette Bernard, Service de Cardiologie, BESANCON, France
Learning Objective: evaluate right ventricule maximal systolic 2D 
longitudinal strain
1199-199 Right Ventricular Strain Patterns in Patients with 
Pulmonary Hypertension.
Mangeet Chahal, Steven Bruhl, Samer Khouri, University of Toledo 
Medical Center, Toledo, OH
Learning Objective: Identify early changes in right ventricular 
remodeling secondary to pulmonary hypertension
1199-200 First Documentation of Cardiac Dysfunction 
Following Exposure to the World Trade Center 
Disaster
Lori B. Croft, Maryann McLaughlin, Jeffrey Bander, Andrew Goldberg, 
Andrew Krasner, William L. Duvall, Martin E. Goldman, Jacqueline 
Moline, Mount Sinai Medical Center, New York, NY
Learning Objective: To evaluate evidence of cardiac involvement in 
subjects exposed to the World Trade Center disaster
1199-201 Prognostic Value of Right Ventricular Function in 
Patients After Acute Myocardial Infarction Treated 
with Primary Percutaneous Coronary Intervention
Maria Louisa Antoni, Roderick W. Scherptong, Jael Z. Atary, Eric 
Boersma, Eduard R. Holman, Ernst E. Van der Wall, Martin J. 
Schalij, Jeroen J. Bax, Leiden University Medical Center, Leiden, The 
Netherlands
Learning Objective: evaluate the prognostic importance of right 
ventricular function in patients after acute myocardial infarction.
1199-203 The Combination of Inferior Vena Cava and E/e’ 
Is a Powerful Index of the Deterioration of Renal 
Function and the Prognosis after a First ST-
Elevation Acute Myocardial Infarction
Noriaki Iwahashi, Masami Kosuge, Jun Okuda, Kengo Tsukahara, 
Yoshio Tahara, Kiyoshi Hibi, Toshiaki Ebina, Shinichi Sumita, Kazuaki 
Uchino, Toshiyuki Ishikawa, Satoshi Umemura, kazuo Kimura, 
Division of Cardiology, Yokohama City University Medical Center, 
Yokohama, Japan
Learning Objective: describe how to use of IVC size in patients with 
a first STEMI
1199-204 Bedside Ultrasound Assessment Of Right Atrial 
Pressure: Relationship To Venous Compliance
John J. Pacella, Christopher Defrancesco, Dustin E. Kliner, James 
P. Lynch, John P. Girod, Madhurmeet Singh, Flordeliza S. Villanueva, 
Marc A. Simon, University of Pittsburgh, Pittsburgh, PA
Learning Objective: Understand how venous compliance dictates 
the venous pressure-area relation
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1201-217 Two-Dimensional Echocardiographic Aortic Root 
Dimensions in Adolescents and Adults: Normal 
Limits in Relation to Age, Body Size and Gender
Richard B. Devereux, Giovanni de Simone, Donna K. Arnett, Lyle G. 
Best, Eric Boerwinkle, Barbara V. Howard, Dalane Kitzman, Elisa T. 
Lee, Thomas H. Mosley, Jr, Alan Weder, Mary J. Roman, Weill Cornell 
Medical College, New York, NY
Learning Objective: identify and understand factors associated with 
aortic root size
1201-218 Differences of Effect by Valvular Surgery on 
Left Ventricular Systolic Function Assessed by 
2-Dimensional Speckle-Tracking Echocardiography 
between Aortic Regurgitation and Aortic Stenosis
Hisao Yoshikawa, Makoto Suzuki, Takako Tsuchida, Tsukasa Osaki, 
Takenori Otsuka, Takayoshi Matsuyama, Hiromasa Yamashita, 
Makoto Uchida, Norio Uchimura, Shigeyuki Ozaki, Kaoru Sugi, Toho 
university ohashi medical center, Tokyo, Japan
Learning Objective: demonstrate
1201-220 Development and Validation of Corrected 
Pulmonary Vascular Resistance for Assessment 
of Patients with Pulmonary Hypertension with 
Echocardiography.
Arun Dahiya, David J Holland, Christine Jellis, David Prior, Thomas 
Marwick, University of Queensland, Brisbane, Australia, St Vincent’s 
Hospital, Melbourne, Australia
Learning Objective: Nonivasively identify and monitor patients with 
elevated pulmonary vascular resistance.
1201-221 Plasma Copeptin (Carboxy-terminal Pro-
Vasopressin) is Associated with Left Atrial Size and 
Left Ventricular Mass Index in African American 
Adults with Hypertension.
Umer Saleem, Thomas Mosley, Jr., Nils G. Morgenthaler, Andreas 
Bergmann, Joachim Struck, Iftikhar J. Kullo, Mayo Clinic, Rochester, 
MN, University of Mississippi Medical Center, Jackson, MS
Learning Objective: Describe the association of plasma copeptin, a 
surrogate for circulating AVP, with left atrial size and left venticular 
mass indexed to height in African American adults with hypertension.
1202 SPECT: RISK STRATIFICATION AND NEW AGENTS
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1202-222 Beneficial Effects of Early Statin Treatment on 
Microvascular Dysfunction and Left Ventricular 
Remodeling in Patients with Acute Myocardial 
Infarction
Kentarou Ishida, Tohru Geshi, Akira Nakano, Hiyoyasu Uzui, 
Yasuhiko Mitsuke, Naoki Amaya, Jyunji Sakata, Katsuhiko Sarasawa, 
Takehiko Satoh, Tetsuji Morishita, Kiwamu Murakami, Jong-Dae Lee, 
University of Fukui Hospital, Fukui, Japan
Learning Objective: Early Statin treatment may provide beneficial 
effects in terms of attenuating LV remodeling after MI, which may be 
associated with improved global microvascular dysfunction.
1200-211 Selection of Stress Modality as a Strong Marker 
of Prognosis in 12,770 Patients with Suspected 
Coronary Artery Disease
Ramdas G. Pai, Padmini Varadarajan, Terence Lin, Loma Linda 
University Medical Center, Loma Linda, CA
Learning Objective: To know the effect of type of stress test on 
survival
1200-212 Improving the Specificity of Exercise Testing in 
Women by High-Frequency QRS Analysis
David Rosenman, Yaakov Mogilevski, Shimon Abboud, Dan Tzivoni, 
Shaare Zedek Medical Center, Jerusalem, Israel, Tel-Aviv University, 
Tel-Aviv, Israel
Learning Objective: Recognize the added value of high-frequency 
QRS analysis in diagnosing ischemic heart disease in women
1201 GENERAL ECHOCARDIOGRAPHY: CARDIAC 
FUNCTION, MASS, AND RESISTANCE BY 
ECHOCARDIOGRAPHY
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1201-214 Correlation of N-Terminal Pro B-Type Natriuretic 
Peptide and Speckle Tracking Derived Longitudinal 
Strain in Severe Asymptomatic Aortic Stenosis
Jutta Bergler-Klein, Raphael Rosenhek, Harald Gabriel, Georg 
Goliasch, Gerald Maurer, Thomas Binder, Med. Univ. of Vienna, 
Dept. of Cardiology, Vienna, Austria
Learning Objective: Interpret BNP and strain as early markers of LV 
dysfunction in asymptomatic severe aortic stenosis
1201-215 Relationship Between Aortic Stiffness and Left 
Ventricular Systolic Function in Patients With 
Normal Ejection Fraction: a Study by Tissue Doppler 
and Strain Imaging
Cesare Russo, Yasuyoshi Takei, Takuya Hasegawa, Shun Koshaka, 
Shunichi Homma, Mitchell S.V. Elkind, Ralph L. Sacco, Marco R. Di 
Tullio, Columbia University, New York, NY, University of Miami, Miami, FL
Learning Objective: Describe the relationship between aortic 
stiffness and subclinical left ventricular systolic function reduction
1201-216 Risk Factor Burden in Diabetic Adults With Known 
Cardiovascular Disease Is Associated With Left 
Ventricular Hypertrophy and Dysfunction: The Strong 
Heart Study
Richard B. Devereux, Giovanni de Simone, Mary J. Roman, Elisa T. 
Lee, Lyle G. Best, Barbara V. Howard, Weill Cornell Medical College, 
New York, NY, University of Oklahoma, Oklahoma City, OK
Learning Objective: demonstrate the impact of CV risk factors on 
prognosis and preclinical CVD in diabetics without recognized CVD
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1203-229 Comparison of Ability Stress Tests to Accurately 
Predict Specific Areas of Ischemia
Anitha Rajamanickam, Samir Kapadia, Thadeo Catacutan, Alraies 
Chadi, Ankita Satra, Amit Maranganti, Marwan Nasif, Anuradha 
Ramaswamy, Sam Butler, Stephen Ellis, Manuel Cerqueira, James B. 
Young, Cleveland Clinic, Cleveland, OH
Learning Objective: To identify the ability of stress tests to 
accurately predict the area of ischemia in obese patients with and 
without prior CABG
1203-230 Impact of Type of Stress on Reduction In Perfusion 
Defect Size by Ranolazine in Patients with Coronary 
Artery Disease
Rajesh Venkataraman, Luiz Belardinelli, Brent Blackburn, Jaekyeong 
Heo, Ami Iskandrian, University of Alabama at Birmingham, 
Birmingham, AL, Gilead, Palo Alto, CA
Learning Objective: Describe the impact of exercise stress as 
opposed to vasodilator stress in improving perfusion pattern by 
ranolazine in patients with CAD and myocardial ischemia
1203-231 Revascularization improves myocardial perfusion 
abnormalities to a greater extent than medical 
therapy in patients with coronary artery disease: 
Insights from the Nuclear Cardiology Databank and 
Duke Databank for Cardiovascular Disease
Harry R. Phillips, Linda Shaw, Mona Fiuzat, Christopher O’Connor, 
Eric Velazquez, Salvador Borges-Neto, Duke University Medical 
Center, Durham, NC, Duke Clinical Research Institute, Durham, NC
Learning Objective: To compare revascularization vs. medical 
therapy on perfusion imaging in patients with severe coronary 
disease
1203-232 Gender-related Differences in Short-term Referral 
Rates To Catheterization After Non-invasive Cardiac 
Imaging in Patients Without Known CAD: Results 
From the Study of Myocardial Perfusion and 
Coronary Anatomy Imaging Roles in CAD (SPARC)
Marcelo F. Di Carli, James R. Johnson, Leslee J. Shaw, Mark A. 
Hlatky, Rob Beanlands, Benjamin Chow, Elizabeth Branscomb, 
Michael L. Ridner, John Lesser, Panithaya Chareonthaitawee, Subha 
Raman, Szilard Voros, Daniel S. Berman, Barbara H. Johnson, 
Mariya Gaber, Julie Williams, Rory Hachamovitch, Brigham and 
Women’s Hospital, Boston, MA
Learning Objective: Describe gender-related changes in referral to 
catheterization after cardiac imaging
1202-223 Location Location Location: Does it Matter with Stress 
SPECT Myocardial Perfusion Imaging Outcomes?
Sabeena Arora, Shishir Mathur, Vivian Teixeira, Abhijit Ghatak, 
Mahjabeen Rashid, Sanjeev U. Nair, Fawad Kazi, Alan W. Ahlberg, 
Gary V. Heller, Hartford Hospital, Hartford, CT, University of 
Connecticut, Farmington, CT
Learning Objective: Determine whether location of a perfusion defect 
imparts prognostic information independent of summed stress score.
1202-224 The Significance of Transient Ischemic Dilation 
in the Setting of Otherwise Normal SPECT 
Radionuclide Myocardial Perfusion Images
Carolina Valdiviezo, Apurva Motivala, Rory Hachamovitch, Murthy 
Chamarthy, Pablo Navarro, Robert J. Ostfeld, Mimi Kim, Mark 
I. Travin, Monteﬁore Medical Center/Albert Einstein College of 
Medicine, Bronx, NY, The Johns Hopkins Hospital, Baltimore, MD
Learning Objective: interpret the significance of TID in patients with 
otherwise normal SPECT myocardial perfusion imaging
1202-225 Can Stress Single Photon Emission Computed 
Tomography Myocardial Perfusion Imaging 
Provide Effective Cardiac Risk Stratification in 
Octogenarians with No Known Coronary Artery 
Disease?
Sanjeev U. Nair, Shishir Mathur, Abhijit Ghatak, Vivian Texeira, 
Mahjabeen Rashid, Fawad Kazi, Alan Ahlberg, Anuj Shah, Roger 
Mennett, Deborah Katten, Gary Heller, ; Henry Low Heart Center, 
Hartford Hospital, Hartford, CT, University of Connecticut School of 
Medicine, Farmington, CT
Learning Objective: Define the role of stress SPECT myocardial 
perfusion imaging in cardiac risk stratification of patients aged 80 
years and above.
1202-226 LMI1195: A New 18F Benzylguanidine Analog for 
PET Cardiac Sympathetic Neuronal Imaging
Ming Yu, Mary Guaraldi, Jody Bozek, Melanie Lamoy, Paula Silva, 
Mikhail Kagan, David Onthank, Mahesh Mistry, Joel Lazewatsky, 
Matthias Broekema, Heike Radeke, Ajay Purohit, Michael Azure, 
Richard Cesati, David Casebier, Simon Robinson, Lantheus Medical 
Imaging, N Billerica, MA
Learning Objective: appreciate the better imaging profile of 
this novel PET agent with high selectivity to the norepinephrine 
transporter for evaluation of cardiac neuronal function and its use 
in HF stratification
1203 ASSESSMENT OF ISCHEMIA AND RESPONSE TO 
THERAPY WITH SPECT
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1203-228 Adenosine Stress Myocardial Perfusion Imaging in 
Low Risk Emergency Department Acute Chest Pain 
patients
Faisal Nabi, Su Min Chang, Elizabeth Gigliotti, John Mahmarian, 
Methodist DeBakey Heart and Vascular Center, Houston, TX
Learning Objective: evaluate
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1205 IMAGING INFLAMMATION, NEURONAL 
INNERVATION AND METABOLISM
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1205-239 Demonstration of Increased Aortic Valve Inflammation 
in Aortic Stenosis using 18F-Fluorodeoxyglucose 
Positron Emission Tomography
Gergana N. Marincheva-Savcheva, Sadia Qadir, Thomas J. Brady, 
Ahmed Tawakol, Massachusetts General hospital, Boston, MA
Learning Objective: evaluate inflammation in Aortic Stenosis using 
FDG-PET imaging, which may have an important implication in the 
design of studies assessing the effect of therapeutic agents on AS.
1205-240 Impact of Age on Myocardial Uptake of I123-mIBG 
in Subjects without Heart Disease: Observations 
from the ADMIRE-HF Trial
Ji Chen, Liudmila Verdes, Russell D. Folks, Daya N. Manatunga, 
Arnold F. Jacobson, Ernest V. Garcia, Emory University, Atlanta, GA, 
GE Healthcare, Princeton, NJ
Learning Objective: Relationship between age and cardiac 
sympathetic neuronal uptake of I123-mIBG
1205-241 Prognostic Implications of Cardiac Sympathetic 
Innervation Assessed by MIBG in Heart Failure 
Patients with Preserved Left Ventricular Ejection 
Fraction
Takahiro Doi, Naohiro Funayama, Junichi Nishida, Atsushi Mchizuki, 
Hidemichi Kouzu, Noriyuki Fujii, Takeru Wakabayashi, Satoshi Yuda, 
Mamoru Hase, Akiyoshi Hashimoto, Kazufumi Tsuchihashi, Kazuaki 
Shimamoto, Tomoaki Nakata, Second Department of Internal 
Medicine, Sapporo Medical University School of Medicine, Sapporo, 
Japan, Hokkaido Prefecture Esashi Hospital, Esashi, Japan
Learning Objective: evaluate
1205-242 Men Are More Susceptible than Women to the 
Effects of Obesity on Cardiac Glucose Metabolism
Chun H. Lin, Pilar Herrero, Pablo Soto, Jasdeep Sidhu, Suraj 
Kurup, Al Waggoner, Deborah L. Delano, Robert J. Gropler, Linda R. 
Peterson, Washington University School of Medicine, St Louis, MO
Learning Objective: Describe the effect of obesity on myocardial 
glucose metabolism, potential hemodynamic effects, and gender-
related differences.
1205-243 Vagal Heart Rate Modulation Relates Inversely to 
Myocardial Oxidative Metabolism in Heart Failure 
Patients Both with and without Obstructive Sleep 
Apnea
Petsy Pui-Sze So, Albert Swedani, Maria C. Ziadi, Peter E. Picton, 
Judith A. Leech, Robert A. deKemp, Jennifer M. Renaud, Ann Guo, 
Haissam Haddad, Lisa M. Mielniczuk, Olga Walter, Jean N. DaSilva, 
Keiichiro Yoshinaga, Ian G. Burwash, Linda Garrard, John S. Floras, 
Rob S. B. Beanlands, University of Ottawa Heart Institute, Ottawa, 
ON, Canada, University of Toronto, Toronto, ON, Canada
Learning Objective: understand the relationship between vagal heart 
rate modulation and cardiac oxidative metabolism in heart failure 
patients with and without obstructive sleep apnea.
1204 ASSESSING DYSSYNCHRONY WITH NUCLEAR 
TECHNIQUES
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1204-234 Left Ventricular Dyssynchrony by Phase Analysis is a 
Predictor of Mortality in End-Stage Renal Disease
Himanshu Aggarwal, Fadi G. Hage, Wael Aljaroudi, Rajesh 
Venkataraman, Jaekyeong Heo, Ami E. Iskandrian, Division of 
Cardiovascular Disease, University of Alabama at Birmingham, 
Birmingham, AL, Division of Cardiology, Birmingham Veterans Affairs 
Medical Center, Birmingham, AL
Learning Objective: Identify Left Ventricular Dyssynchrony as 
Predictor of Mortality in End-Stage Renal Disease
1204-235 Relation of Left Ventricular Dyssynchrony by 
Phase Analysis of Gated SPECT Images and 
Cardiovascular Events in Patients with Implantable 
Cardiac Defibrillators.
Wael AlJaroudi, Fadi Hage, Daniel Hermann, Harrish Doppalapudi, 
Jaekyeong Heo, Ami E. Iskandrian, University of Alabama at 
Birmingham, Birmimgham, AL, Birmingham Veteran’s Administration 
Medical Center, Birmingham, AL
Learning Objective: Left ventricular dyssynchrony by phase analysis 
of gated SPECT MPI is predictive of cardiovascular events in 
patients with implantable cardiac defibrillators.
1204-236 Impact of Scar Burden by SPECT Perfusion Imaging 
and Echocardiographic Dyssynchrony on Long-Term 
Outcome after Cardiac Resynchronization Therapy 
in Patients with Ischemic Cardiomyopathy
Hidekazu Tanaka, Evan C. Adelstein, Prem Soman, Glen Miske, 
Stephanie C. Haberman, Samir Saba, John Gorcsan, III, University of 
Pittsburgh, Pittsburgh, PA
Learning Objective: demonstrate that ICM patients with a high scar 
burden had a low response to CRT and poor long-term outcome 
regardless of the presence of dyssynchrony
1204-237 Utility Of Intraprocedural Equilibrium Radionuclide 
Angiogram To Evaluate Left Ventricular Function And 
Synchrony During Cardiac Resynchronization Therapy
Nitish Badhwar, Deanna L. Green, William Graham, Nancy Wyatt, 
Teresa DeMarco, J. W. O’Connell, Elias H. Botvinick, University of 
California, San Francisco, San Francisco, CA
Learning Objective: identify role of radionuclide imaging based 
synchrony assessment of left ventricle in patients undergoing 
cardiac resynchronization therapy
1204-238 Left Ventricular Systolic and Diastolic 
Interdependence Demonstrated by Left Ventricular 
Emptying and Filling Rates by Gated SPECT MPI
William Lane Duvall, Lori B. Croft, Samantha Buckley, Eric Ginsberg, 
Tapan Godiwala, Thomas M. Klein, Eric Stern, Milena J. Henzlova, 
Martin E. Goldman, Mount Sinai Medical Center, New York, NY
Learning Objective: Identify the additional benefit of emptying and 
filling rates in evaluating cardiac function
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1207 RISK ASSESSMENT WITH SPECT MPI
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1207-251 A Stress Induced Fall in Ejection Fraction Within The 
Normal Range Does Not Adversely Effect Long and 
Short Term Survival
Michael Greenberg, B. K. Shamloo, Isaac Opoku-Asare, Jeannie 
Yu, Jason Morrissette, Ali Nasur, Washington VA Medical Center, 
Washington, DC
Learning Objective: Describe the prognostic signfican e of a decline 
in EF with stress remaining within the normal range
1207-252 Isolated Transient Ischemic Dilatation And The Risk 
Of Adverse Cardiac Events In A Cohort Of High Risk 
Individuals Undergoing Myocardial Perfusion Spect 
Imaging
Abdul Hakeem, Sabha Bhatti, Jeffrey R. Cook, Su Min Chang, 
University of Cincinnati College of Medicine, Cincinnati, OH
Learning Objective: understand the prognostic value of isolated TID 
in patients with an otherwise normal myocardial perfusion SPECT 
imaging
1207-253 Utility of Routine Screening for Myocardial Ischemia 
Using Technecium-99m Single Photon Emission 
Computed Tomography (Tc-99m SPECT) Imaging in 
Non-selected Post-renal Transplant Patients
Wee Tiong Yeo, Eric Hong, Arvind Sinha, Raymond Wong, National 
University Heart Centre, Singapore, Singapore, Singapore
Learning Objective: Describe the utility of SPECT imaging in 
screening renal transplant patients for ischemia.
1207-254 Does the Obesity Paradox Exist in Diabetic Patients 
with no Known Coronary Artery Disease? Risk 
Stratification using Stress Single Photon Emission 
Computed Tomography Myocardial Perfusion 
Imaging
Mahjabeen Rashid, Abhijit Ghatak, Vivian Teixeira, Sanjeev U. Nair, 
Fawad Kazi, Farooq Iqtidar, Alan Ahlberg, Mathur Shishir, Roger 
Mennett, Deborah Katten, Gary Heller, Donna Polk, Henry Low 
Heart Center, Hartford Hospital Nuclear Laboratories, Hartford 
Connecticut, Hartford, CT, University of Connecticut, Farmington, CT
Learning Objective: Evaluate
1207-255 Prevalence and Predictors of Abnormal Myocardial 
Perfusion in Patients with Type 1 Diabetes
Roxana Djaberi, Joanne D. Schuijf, Cornelis J. Roos, Marcel P. 
Stokkel, Petra Dibbets-Schneider, Arthur J. Scholte, Jan W. Smit, 
Johannes A. Romijn, Alberto M. Pereira, Ernst E. van der Wall, J. 
Wouter Jukema, Jeroen J. Bax, Leiden University Medical Center, 
Leiden, The Netherlands
Learning Objective: Describe the Prevalence of Silent Myocardial 
Ischemia in Type 1 Diabetes and Identify the Risk Factors 
Associated with Severe Myocardial Ischemia
1206 SPECT: NEWER APPLICATIONS
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1206-245 Safety of Regadenoson as a Pharmacologic Stress 
Agent for Myocardial Perfusion Imaging in Stage 
3, 4 and 5 Chronic Kidney Disease Patients Not on 
Hemodialysis
Karthikeyan Ananthasubramaniam, Gurunanthan Palani, Zehra 
Husain, Aarthee Karthikeyan, Vanji Karthikeyan, Henry Ford Hospital, 
Detroit, MI
Learning Objective: To demonstrate safety of Regadenoson 
pharmacologic stress perfusion imaging in chronic kidney disease 
patients not on hemodialysis
1206-246 The Nuclear Cardiology Report: Problems, 
Predictors and Improvement
Peter L. Tilkemeier, Eva R. Serber, Mary Beth Farrell, The Miriam 
Hospital, Providence, RI, Intersocietal Commission for the 
Accreditation of Nuclear Medicine Laboratories, Ellicott City, MD
Learning Objective: Demonstrate the important elements in high 
quality nuclear cardiology reporting and the associated factors 
leading to poor quality reporting and understand methods for 
improvement.
1206-247 Utility of a Low Dose Technetium Stress Protocol to 
Minimize Radiation Exposure in Patients with Low 
to Intermediate Pre-test Likelihood of Obstructive 
CAD
Mehreen Qureshi, Amsale Robi, Ketan Bhatia, Sabahat Bokhari, 
Columbia University, New York, NY
Learning Objective: identify a way to reduce radiation exposure for 
nuclear stress testing
1206-248 Reduced Isotope Dose and Rapid Imaging SPECT 
MPI with Excellent Image Quality
William Lane Duvall, Lori B. Croft, Tapan Godiwala, Eric Ginsberg, 
Titus George, Milena J. Henzlova, Mount Sinai Medical Center, New 
York, NY
Learning Objective: Describe new SPECT camera technology’s ability 
to significantly reduce radiation exposure while also substantially 
decreasing image acquisition time.
1206-249 Application of Appropriateness Criteria to Stress 
Single-Photon Emission Computed Tomography 
Sestamibi Studies: A Comparison of the 2009 
Revised Appropriateness Criteria to the 2005 
Original Criteria
Damita J. Carryer, J. Wells Askew, David O. Hodge, Todd D. Miller, 
Raymond J. Gibbons, Mayo Clinic, Rochester, MN
Learning Objective: Describe the impact of the application of the 
2009 ACCF/ASNC appropriateness criteria revisions for stress 
SPECT MPI studies as compared to the application of the criteria 
published in 2005.
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1253-192 2-D Ultrasound Speckle Tracking Strain Imaging of 
the left atrium in the Estimation of Left Ventricular 
Filling Pressures.
Mitsuru Masaki, Yong-Mei Cha, Toshinori Yuasa, Gabriella Veress, 
Kan Dong, Ying-Xue Dong, Sunil V. Mankad, Jae K. Oh, Mayo clinic, 
Rochester, MN
Learning Objective: Septal and lateral left atrial strain before atrial 
contraction measured by STSI (S-LA Pre-A) appears to be a useful 
adjunct measure for estimating mean LA pressure at various heart 
rates.
1253-193 Left Atrial Reservoir Function Predicts Atrial 
Fibrillation Recurrence After Catheter Ablation: A 
Two-dimensional Speckle Strain Study
Mahek Mirza, Giuseppe Caracciolo, Uzma Khan, Komandoor 
Srivathsan, Gregory Altemose, Luis Scott, Partho Sengupta, Arshad 
Jahangir, Mayo Clinic, Scottsdale, AZ
Learning Objective: Identify left atrial reservoir function as a 
predictor for atrial fibrillation recurrence after catheter ablation
1253-194 Predictors of Increasing Left Atrial Volume Over Five 
Years in Coronary Artery Disease Patients: Results 
From the Heart and Soul Study
Kabir J. Singh, Beth Cohen, Bee Ya Na, Mary A. Whooley, Nelson 
B. Schiller, San Francisco VA Medical Center, San Francisco, CA, 
University of California San Francisco, San Francisco, CA
Learning Objective: Identify factors that predict left atrial 
enlargement over time.
1253-195 Determinants of Left Atrial Volume in Healthy 
Individuals and Athletes
Stefano Nistri, Maurizio Galderisi, Leopoldo Pagliani, Iacopo 
Olivotto, Antonio Santoro, Barbara Papesso, Pasquale Innelli, Franco 
Cecchi, CMSR Veneto Medica, Altavilla Vicentina, Italy
Learning Objective: identify the determinants of left atrial volume 
index in healthy subjects
1254 GENERAL ECHOCARDIOGRAPHY: PROGNOSIS 
AND FILLING PRESSURE BY TDI AND STRAIN 
IMAGING
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1254-197 Identification of Restrictive Transmitral Flow 
Velocity Pattern by the Change of its Pattern after 
Nitroglycerin Spray Oral Administration
Hirotsugu Yamada, Kusunose Kenya, Susumu Nishio, Noriko Tomita, 
Keisuke Endo, Toshiyuki Niki, Kunihiko Koshiba, Koji Yamaguchi, 
Yoshio Taketani, Takahi Iwase, Takeshi Soeki, Tetsuzo Wakatsuki, 
Masashi Akaike, Masataka Sata, The University of Tokushima, 
Tokushima, Japan, Tokushima University Hospital, Tokushima, Japan
Learning Objective: distinguish pseudonormal from normal mitral 
inflow pattern
1207-256 Histogram Analysis Improves Diagnostic Value of 
2D Longitudinal Strain In Patients with Coronary 
Artery Disease (CAD)
Sarah Shimoni, Xavier Filtz, Oded Ayzenberg, Gera Gendelman, Fabio 
Kuznietz, Orly Edri, Nachum Smirin, Peter Lysyansky, Avraham Caspi, 
Zvi Friedman, Kaplan Medical Canter, Rehovot, Israel, GE healthcare, 
Haifa, Israel
Learning Objective: Thi study describes a new method of 
longitudinal strain assessment that can improve detection of 
coronary artery disease at rest in patients hospitalized with angina
1253 GENERAL ECHOCARDIOGRAPHY: ATRIAL 
FUNCTION ASSESSMENT
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1253-188 Left Atrial Function Assessed by Velocity Vector 
Imaging Is a Novel and Useful Marker to Predict the 
Risk for the Development of Atrial Fibrillation
Takeshi Hirose, Ryuhei Tanaka, Michio Arakawa, Koji Ono, Ritsuko 
Tanaka, Tomomi Endo, Humitaka Tokoro, Reiko Matsuoka, Shintaro 
Abe, Yoshiyuki Goto, Tomoko Hirose, Takashi kato, Tai Kojima, 
Makoto Iwama, Shunichiro Warita, Toshiyuki Noda, Sachiro 
Watanabe, Takatomo Watanabe, Masanori Kawasaki, Sinya 
Minatoguchi, Gifu Prefectural General Medical Center, Gifu, Japan
Learning Objective: Demonstrate that reduced left atrial function 
assessed by velocity vector imaging is a novel and useful marker to 
predict the high risk patients for the development of atrial fibrillation
1253-189 Preoperative Left Atrial Dysfunction and Risk of 
Postoperative Atrial Fibrillation (POAF) Complicating 
Thoracic Surgery
Tina Raman, Nancy Roistacher, Jennifer Liu, Hao Zhang, Weiji Shi, 
Howard Thaler, David Amar, Memorial Sloan-Kettering Cancer Center, 
New York, NY
Learning Objective: To understand risk factors for atrial fibrillation 
after thoracic surgery
1253-191 Differentiation of Left Atrial Volume by Time (dV/
dt) Is a Novel and Useful Echo Index to Assess Left 
Atrial Global and Phasic Function
Takeshi Hirose, Ryuhei Tanaka, Koji Ono, Satoshi Yamajima, Yaeko 
Furuta, Humitaka Tokoro, Reiko Matsuoka, Shintaro Abe, Yoshiaki 
Goto, Tomoko Hirose, Takashi Kato, Tai Kojima, Shunichiro Warita, 
Makoto Iwama, Toshiyuki Noda, Sachiro Watanabe, Takatomo 
Watanabe, Masanori Kawasaki, Sinya Minatoguchi, Gifu Prefectural 
General Medical Center, Gifu, Japan
Learning Objective: Evaluate the usefulness of differentiation of 
left atrial volume by time as a new marker of left atrial function and 
demonstrate that it will be a novel promising method to assess left 
atrial function
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1255 TISSUE IMAGING: ECHOCARDIOGRAPHIC 
ASSESSMENT OF VENTRICULAR FUNCTION
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1255-205 Resting Global and Regional Left Ventricular 
Contractility in Patients with Heart Failure and 
Normal Ejection Fraction - Insights from Speckle-
Tracking Echocardiography
Gabriel W.K. Yip, Qing Zhang, Jun-Min Xie, Yu-Jia Liang, Ying-Mei Liu, 
Bryan P. Yan, Yat-Yin Lam, Cheuk-Man Yu, The Chinese University of 
Hong Kong, Hong Kong, Hong Kong, West China Hospital, Sichuan 
University, Chengdu, Sichuan, People’s Republic of China
Learning Objective: gain better mechanistic insights of 
pathophysiology of heart failure with a normal ejection fraction.
1255-206 Strain Imaging Using Dynamic 3D 
Echocardiography: An In Vitro Validation Study
David J. Sahn, Li Xiong, Karen Li, Shiza Ashraf, Sarah Yang, Max 
Carlson, Colleen Newey, Zhiwen Zhou, Muhammad Ashraf, Oregon 
Health & Science University, Portland, OR
Learning Objective: understand speckle tracking assessment of 
myocardial infarct
1255-208 Assessment of Left Ventricular Function Using 
Speckle Tracking Echocardiography During 
Vasopressor-Induced Increases in Afterload in a 
Rabbit Model
David J. Sahn, Anneka Hooft, Jonathan Ho, Wei Zhou, Jennifer 
Corniea, Elizabeth Sanchez, Aman Mahajan, Muhammad Ashraf, 
Oregon Health & Science University, Portland, OR, University of 
California, Los Angeles, CA
Learning Objective: understand alteration of cardiac mechanics with 
adrenergic agents
1255-209 Left Ventricular Transmural Mechanics in ST-
segment Elevation Myocardial Infarction Following 
Primary Percutaneous Coronary Intervention
Giuseppe Caracciolo, Mackram Eleid, Nisha Bhatia, David F. Fortuin, 
Susan Wilansky, Scipione Carerj, Jagat Narula, Bijoy Khandheria, 
Partho P. Sengupta, Mayo Clinic Arizona, Scottsdale, AZ, Aurora 
Health Care, Milwaukee, WI
Learning Objective: To understand the incremental value to speckle 
tracking imaging in ST-elevation myocardial infarction
1255-210 The Sum of Systolic and Diastolic Velocity of the 
Mitral Annulus Can Predict the Prognosis in Acute 
Myocardial Infarction
Yamato Fukuda, Nobuo Fukuda, Koichi Sakabe, Satofumi Morishita, 
Hisanori Shinohara, Yoshiyuki Tamura, Department of Cardiology 
and Clinical Research, National Hospital Organization Zentsuji 
Hospital, Kagawa, Japan
Learning Objective: Evaluate that the sum of mitral annulus 
velocities may be useful index to predict the prognosis in patients 
with acute myocardial infarction
1254-198 Noninvasive Prediction of Complications with 
ST-Elevation Myocardial Infarction by Global 
Longitudinal Strain
Woo-Shik Kim, Jong Shin Woo, Sang Jin Ha, Seok Yeon Kim, Soo 
Joong Kim, Weon Kim, Myeung Kon Kim, Jong-Hoa Bae, Kwon Sam 
Kim, Kyung Hee University Medical Center, Seoul, South Korea
Learning Objective: We demonstrate that left ventricular global 
longitudinal strain is a noninvasive and simple method that enables 
the prediction of patient prognosis.
1254-199 Prognostic Value of Left Ventricle Function by Tissue 
Doppler Strain Imaging in Patients with Severe 
Sepsis or Septic Shock
Mitsuru Masaki, Juan N. Pulido, Toshinori Yuasa, Sunil V. Mankad, 
Jae K. Oh, Mayo clinic, Rochester, MN
Learning Objective: Evaluation of the left ventricular (LV) longitudinal 
contraction by tissue Doppler strain imaging may serve as useful 
tool to predict survival in patient with severe sepsis or septic shock 
with preser
1254-201 Left Atrial Volume Predicts Congestive Heart Failure 
in Patients with Atrial Fibrillation
Satoshi Tsujimoto, Yoko Miyasaka, Kinuko Dote, Hiroshi Maeba, 
Fumio Yuasa, Toshiji Iwasaka, Kansai Medical University, Hirakata, 
Japan
Learning Objective: Determine the clinical importance of LA volume 
in the prediction of CHF in AF
1254-203 Should Normal Cutoff Values for E/e’ and BNP 
Differ in the Presence of Obesity?
Aaron Matthew From, Carolyn S.P. Lam, Sridevi R. Pitta, Prasanna V. 
Kumar, Kais A. Balbissi, Jeffrey D. Booker, Guy S. Reeder, Inder M. 
Singh, Paul Sorajja, Barry A. Borlaug, Mayo Clinic, Rochester, MN
Learning Objective: Describe how E/e’ and NT-BNP cufoff values 
for the prediction of elevated wedge pressure change in obese and 
non-obese patients.
1254-204 Do E/E’ or E/Vp Track Changes in Left-Sided Filling 
Pressure in Individual Patients with Heart Failure 
with Preserved Ejection Fraction?
Paul S. Bhella, Eric L. Pacini, Anand Prasad, Jeffery L. Hastings, 
Benjamin D. Levine, The University of Texas-Southwestern, Dallas, 
TX, Dallas, TX, The Institute of Exercise and Environmental Medicine 
at Texas Health Resources, Dallas, TX
Learning Objective: Identify the limitations of echocardiographic 
indices to track changes in left-sided filling pressures in patients 
with heart failure with preserved ejection fraction.
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1256-217 Strain-rate by Tissue Strain Imaging Is Powerful 
Tool to Evaluate Ischemic Diastolic Stunning Course 
after Reperfused ST-Elevation Acute Coronary 
Syndrome
Noriaki Iwahashi, Masami Kosuge, Jun Okuda, Kengo Tsukahara, 
Yoshio Tahara, Kiyoshi Hibi, Toshiaki Ebina, Shinichi Sumita, Kazuaki 
Uchino, Toshiyuki Ishikawa, Satoshi Umemura, Kazuo Kimura, 
Division of Cardiology, Yokohama City University Medical Center, 
Yokohama, Japan
Learning Objective: understnad that strain-rate by tissue strain 
imaging might be useful to evaluate the time course of diastolic 
stunning in patients with reperfused ST elavation acute coronary 
syndrome.
1256-218 Transmural Myocardial Strain Profile is a Useful 
Method to Estimate the Regional Myocardial 
Stunnning Course among Patients with a 
Reperfused ST Elevation Acute Myocardial 
Infarction : A Comparison with Tc-99m Sestamibi 
Single Photon Emission Computed Tomography
Noriaki Iwahashi, Masami Kosuge, Jun Okuda, Kengo Tsukahara, 
Yoshio Tahara, Kiyoshi Hibi, Toshiaki Ebina, Shinichi Sumita, Kazuaki 
Uchino, Toshiyuki Ishikawa, Satoshi Umemura, Kazuo Kimura, 
Division of Cardiology, Yokohama City University Medical Center, 
Yokohama, Japan
Learning Objective: understand that tissue strain imaging might 
be useful to estimate the regional myocardial stunning course in 
reperfused STEMI.
1256-220 Echo-Derived Assessment of Pulsatility Diverges 
From Pump-Derived Assessment, and Defines 
Serious Adverse Events Late After Continuous Flow 
Left Ventricular Assist Device Implantation
Jennifer Goerbig, Guha Ashrith, Wassef Karrowni, Frances L. 
Johnson, Robert M. Weiss, University of Iowa, Iowa City, IA
Learning Objective: understand methods of assessment of VAD flow 
kinetics, and their application.
1257 NEW IMAGING APPROACHES TO ASSESS 
MYOCARDIAL FUNCTION
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1257-222 Myocardial Late Gadolinium Enhancement Does 
Occur in the Tako-tsubo Cardiomyopathy Syndrome 
- a Cardiac Magnetic Resonance Study
Christian R. Hamilton-Craig, Tanya Wood, Wendy E. Strugnell, 
Richard E. Slaughter, Centre for Cardiovascular Imaging, Prince 
Charles Hospital, Brisbane, Australia, University of Queensland, 
Brisbane, Australia
Learning Objective: Appreciate that diffuse late gadolinium 
enhancement does occur in the TakoTsubo cardiomyopathy if CMR 
is performed early.
1255-211 Impact of Loading Condition on the Two-
dimensional Speckle Tracking-derived Left 
Ventricular Dyssynchrony Index in Non-ischemic 
Dilated Cardiomyopathy
Hyung-Kwan Kim, Hyo-Eun Park, Sung-A Chang, Ji-Hyun Kim, Myung-
Ki Seo, Yong-Jin Kim, Goo-Yeong Cho, Dae-Won Sohn, Byung-Hee Oh, 
Young-Bae Park, Seoul National University Hospital, Seoul, South 
Korea, Seoul
Learning Objective: Demonstrate relationship between LV 
dyssynchrony and loading status
1256 TISSUE IMAGING: ADVANCES IN STRAIN 
IMAGING
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1256-214 Final Transmural Extent of Myocardial Infarction 
at 4-Month Cardiac Magnetic Resonance Can Be 
Predicted by 2-Dimensional Speckle Tracking Strain 
Imaging in the Acute Phase
Mario Previtali, Michela Cottini, Sergio Leonardi, Claudia Raineri, 
Annalisa Turco, Margherita Calcagnino, Guido Tavazzi, Fiorenza Fava, 
Erica Ferrara, Luigi Oltrona Visconrti, IRCCS Pol. S.Matteo-Univ. of 
Pavia, Pavia, Italy
Learning Objective: Evaluate the ability of 2-dimensional strain 
imaging performed in the acute phase of myocardial infarction to 
predict final transmural extent of infarction assessed by cardiac 
magnetic resonance
1256-215 Association of Decreased Left Atrial Strain and 
Strain Rate with Stroke in Chronic Atrial Fibrillation
Jhih-Yuan Shih, Wei-Chuan Tsai, Yao-Yi Huang, Yen-Wen Liu, Chih-
Chan Lin, Liang-Miin Tsai, Li-Jen Lin, Tainan Hospital Sin-Hua 
Branch, Tainan, Taiwan,ROC, Department of Internal Medicine, 
National Cheng Kung University Medical Center, Tainan, Taiwan,ROC
Learning Objective: describe that in chronic AF patients, those with 
decreased left atrial strain and strain rate would have higher risk of 
stroke.
1256-216 Myocardial Steatosis and Left ventricular Strain 
and Strain Rate Imaging in Patients with Type 2 
Diabetes Mellitus
Arnold C. Ng, Victoria Delgado, Matteo Bertini, See Hooi Ewe, 
Rutger W. van der Meer, Luuk J. Rijzewijk, Hans-Marc Siebelink, 
Johannes WA Smit, Michaela Diamant, Johannes A. Romijn, Albert 
de Roos, Dominic Y. Leung, Hildo J. Lamb, Jeroen J. Bax, Leiden 
University Medical Center, Leiden, The Netherlands
Learning Objective: Describe subtle changes in left and right 
ventricular myocardial functions in type 2 diabetic patients with 
myocardial steatosis on magnetic resonance imaging
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1258-230 What Is The Underlying Plaque Morphology Of 
Coronary Thrombosis? An Angioscopic And Virtual 
Histology Intravascular Ultrasound Correlative Study
Elias Sanidas, Akiko Maehara, Gary S. Mintz, Toshikazu Kashiyama, 
So-Yeon Choi, Jin Bae Lee, George Dangas, Martin Leon, Jeffrey 
Moses, Gregg W. Stone, Yasunori Ueda, Columbia University Medical 
Center and the Cardiovascular Research Foundation, New York, NY, 
Cardiovascular Division, Osaka Police Hospital, Osaka, Japan
Learning Objective: Identify the plaque morphology of coranary 
thrombosis
1258-231 Inhibition Of Interleukin-1 Activity Is Related 
with Reduced Apoptosis and Improved Speckle 
Tracking Myocardial Deformation in Patients with 
Rheumatoid Arthritis
Ignatios Ikonomidis, Stavros Tzortzis, Ioannis Paraskevaidis, John 
Lekakis, Ioanna Andreadou, Maria Nikolaou, Pelagia Katsibri, 
Pinelopi Dasou, Dimitrios Th Kremastinos, 2nd Cardiology 
Department, University of Athens, Attikon Hospital, Athens, Greece
Learning Objective: Evaluate the relation of reduced apoptosis and 
improvement in myocardial deformation in rheumatoid arthritis after 
inhibition of Il-1 receptors
1258-232 Carotid Ultrasound Identifies High Risk Subclinical 
Atherosclerosis in Adults with Low Framingham 
Risk Scores
Mackram Eleid, Steven Lester, Troy Wiedenbeck, Sharad Patel, 
Christopher Appleton, Matthew Nelson, Julie Humphries, R. Todd 
Hurst, Mayo Clinic, Scottsdale, AZ
Learning Objective: Demonstrate the ability of carotid ultrasound 
to identify high risk subclinical atherosclerosis in young individuals 
with low Framingham Risk Score
1259 ADVANCES IN IMAGING AND MYOCARDIAL 
FUNCTION
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1259-234 Apical Rotation Plays a Significant Role in 
Determining Left Ventricular Diastolic Function: 
Observation During Apical Immobilization Using 
StarfishTM Positioner
Mariko Iwasaki, Yumi Fukuta, Kasumi Masuda, Toshihiko Asanuma, 
Satoshi Nakatani, Osaka University Graduate School of Medicine, 
Suita, Japan
Learning Objective: evaluate the effect of apical rotation and twist 
on cardiac function
1259-235 3-Dimensional Speckle Tracking Imaging for Left 
Ventricular Rotation Measurement: An In Vitro 
Validation Study
David J. Sahn, Zhiwen Zhou, Li Xiong, Muhammad Ashraf, Da-Yi 
Hu, Xaio-Nan Dai, Ya-Wei Xu, Berkley Cameron, Bill Kenny, Oregon 
Health & Science University, Portland, OR, Toshiba America Medical 
Systems, Tustin, CA
Learning Objective: understand quantification of LV rotation
1257-224 Evaluation of Right Ventricular Dysfunction in 
Patients with Intestinal Carcinoid Disease -Added 
Value by Myocardial Strain Echocardiography and 
Tricuspid Annular Plane Systolic Excursion
Kristina H. Haugaa, Laura G. Sahakyan, D. S. Bergestuen, Helge 
Skulstad, Espen Thiis-Evensen, Thor Edvardsen, Oslo University 
Hospital, Rikshospitalet, Oslo, Norway
Learning Objective: evaluate right ventricular function in patients 
with intestinal carcinoid tumors
1257-225 Serial Changes Of Left Ventricular Long And Short 
Axis Function In Doxorubicin-treated Murine Heart
Yong H. Kim, Mi-Na Kim, Sun-Won Kim, Seong-Mi Park, Woo-Hyuk 
Song, Wan-Joo Shim, Korea University Anam Hospital, Seoul, South 
Korea
Learning Objective: understand the usefulness of 2-D speckle 
tracking echocardiography in early detection of progressive left 
ventricular failure
1257-226 Identification of Myocardial Edema in Acutely 
Reperfused Infarction by Echocardiographic 
Deformation Parameters
Patricia Mahia, Río Aguilar, Víctor Pineda, Bruno Garcia, Martín 
Thomas, Jose Rodriguez, Arturo Evangelista, David García-Dorado, 
Hospital Vall d´Hebron, Barcelona, Spain
Learning Objective: Identify stunned myocardium by means of 
echocardiographic deformation analysis
1258 TISSUE IMAGING AND VASCULAR BIOLOGY
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1258-228 Reproducibility of Near-Infrared Spectroscopy 
for the Detection of Lipid Core Coronary Plaques 
and Observed Changes after Coronary Stent 
Implantation
Bobby A. Garcia, Frances Wood, Abdul-rahman Riyad Abdel-karim, 
Pratik A. Mehta, Daisha Cipher, Subhash Banerjee, Emmanouil 
Brilakis, Veteran Affairs North Texas Healthcare System, Dallas, TX, 
University of Texas Southwestern Medical Center, Dallas, TX
Learning Objective: to evaluate the reproducibility of intracoronary 
near-infrared spectroscopy and identify changes in lipid core plaque 
after stenting
1258-229 Abnormal Collagen Turnover and MMP-9 Are the 
Common Link between Increased Arterial Stiffness, 
Impaired Coronary Flow Reserve and LV Untwisting 
in Untreated Patients with Essential Hypertension
Ignatios Ikonomidis, John Lekakis, Stavros Tzortzis, Costas 
Papadopoulos, Ioannis Paraskevaidis, Helen Triantafyllidi, Paraskevi 
Trivilou, Dimitrios Th Kremastinos, 2nd Cardiology Department, 
Attikon Hospital, University of Athens, Athens, Greece
Learning Objective: evaluate the association of collagen turnover 
with vascular and LV deformation markers in hypertensives
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1260-240 Pharmacologic Single Photon Emission Computed 
Tomography (SPECT) Imaging or Pharmacologic 
Echocardiography? A Meta Analysis of 
Pharmacologic Testing for Diagnosis of High-Risk 
Coronary Artery Disease.
Nitin Mahajan, Amit Sagar, Vipin Khetarpal, Ashok Kondur, Sinan 
Sarsam, Latha Polavaram, Hema Venkalaya, Yun Wang, Joel Agar, 
Luis Afonso, Wayne State University, Detroit, MI
Learning Objective: In the absence of a head to head comparison 
of the 2 commonly used non invasive tests, pharmacologic ECHO 
has a higher sensitivity, and appears to be the screening method of 
choice for high riak CAD.
1260-241 Prognostic Value of the Accelerated Dobutamine 
Stress Echocardiography Protocol
Ricardo Sanz, Jose R. Ortega, Matias Pérez-Paredes, María J. 
Rollán, Marta Pinedo, Roman Arnold, Jose M. Novoa, Diego Jimenez, 
Ana C. Muñoz, Francisco Fernández-Avilés, Jose A. San Román, 
Institute of Heart Sciences (ICICOR), Valladolid, Spain, Hospital Dr. 
Negrin, Las Palmas de Gran Canaria, Spain
Learning Objective: identify patients at high risk for future MACE 
(cardiac death, myocardial infarction and revascularization) from all 
patients referred to an stress echocardiography lab for diagnostic 
and prognosticat
1260-242 Role of Stress Echocardiography in Risk 
Stratification and Prognosis of Patients with HIV
omar enrique wever pinzon, Jorge Silva Enciso, Emad Aziz, Jorge 
Romero, Deborah Cantales, Farooq A. Chaudhry, St. Luke’s 
Roosevelt Hospital Center, New York, NY
Learning Objective: Evaluate the prognostic value of stress 
echocardiography in patients with HIV.
1260-243 Framingham Risk Score Should Not Be Used 
to Predict Results of Stress Echocardiogram in 
Patients with Intermediate or Higher Risk of CAD
Michael Shea, Chandra Ojha, Gabriel Fischer, Nitendra Agarwal, 
Steven A. Fein, Mikhail Torosoff, Albany Medical College, Albany, NY
Learning Objective: describe the utility of risk factor assessment in 
predicting the likelihood of an abnormal stress echocardiogram.
1261 ARTERIAL BIOLOGY AND STRESS 
ECHOCARDIOGRAPHY
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1261-245 Does E/E’ Predict Left Ventricular Filling Pressures 
During Dobutamine Stress Echocardiography?
Albert K. Chan, Marc L. Del Rosario, Youngju Pak, Kul Aggarwal, 
Kevin C. Dellsperger, Anand Chockalingham, University of Missouri-
Columbia School of Medicine, Columbia, MO, Harry S Truman 
Memorial Veterans Hospital, Columbia, MO
Learning Objective: Demonstrate the hemodynamic effects of 
dobutamine on E/E’ and left ventricular filling pressures
1259-236 Planar Maps of Left Ventricular Vorticity Fields 
in Human Hearts: Novel Insights with the use of 
High Resolution Echo Contrast Particle Imaging 
Velocimetry
Haruhiko Abe, Giuseppe Caracciolo, Marek Belohlavek, Bijoy 
Khandheria, A. Jamil Tajik, Jagat Narula, Krishnaswamy 
Chandrasekaran, Partho P. Sengupta, Mayo Clinic Arizona, 
Scottsdale, AZ, University of California, Irvine, CA
Learning Objective: Learn the features of left ventricular blood flow 
vortex formation in human hearts
1259-237 Diastolic Circumferential Strain Rate during 
Isovolumic Relaxation: A Novel Measure of 
Diastolic Function Obtained Using a Prototype 
Radiofrequency-based Speckle Tracking 
Echocardiography System
Theodore J. Kolias, Matthew O’Donnell, Nicole M. Kline, Lingling 
Zhang, James D. Hamilton, University of Michigan, Ann Arbor, MI
Learning Objective: Describe a novel measure of diastolic function 
obtained using a prototype speckle tracking echocardiography 
system
1259-238 Clinical and Echocardiographic Characteristics of 
Heart Failure Patients with Wide QRS but without 
Mechanical Dyssynchrony and their Response to 
Resynchronization Therapy
Hidekazu Tanaka, Olusegun Oyenuga, Phillip Habib, Stephanie 
Haberman, Samir Saba, John Gorcsan, III, University of Pittsburgh, 
Pittsburgh, PA
Learning Objective: evaluate clinical and echocardiographic 
characteristics of HF patients with wide QRS but without mechanical 
dyssynchrony and their response to CRT
1260 RISK ASSESSMENT AND STRESS 
ECHOCARDIOGRAPHY
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1260-239 Application of the Appropriateness Criteria to Stress 
Echocardiographic Studies in an Academic Center
Constantina Aggeli, Konstantinos Lampropoulos, Dimitra Koveou, 
John Felekos, Christina Kazazaki, Georgios Roussakis, Maria 
Salourou, Stavroula Lagoudakou, Christos Pitsavos, Christodoulos 
Stefanadis, 1st Department of Cardiology, University of Athens 
Medical School, Hippokration Hospital, Athens, Greece
Learning Objective: This retrospective study demonstrates the 
need for the application of the appropriateness criteria in order to 
achieve quality improvement in the clinical use of this test
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1262 STRESS ECHOCARDIOGRAPHY: NOVEL 
MEASURES AND SPECIAL POPULATIONS
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1262-251 Euglycemic Hyperinsulinemia Improves LV 
Performance More in Insulin Resistant Subjects 
During Stress Echocardiography
Patrick M. Heck, Stephen P. Hoole, Sadia N. Khan, Phillip A. Read, 
David P. Dutka, Department of Cardiovascular Medicine, Universtiy of 
Cambridge, Cambridge, United Kingdom
Learning Objective: indentify that altering myocardial metabolism in 
subjects with insulin resistance can improve LV performance during 
stress echo
1262-252 Euglycemic Hyperinsulinemia but not Hyperglycemic 
Hyperinsulinemia Improves LV Function During 
Stress Echo
Patrick M. Heck, Stephen P. Hoole, Sadia N. Khan, Phillip A. Read, 
David P. Dutka, Department of Cardiovascular Medicine, University of 
Cambridge, Cambridge, United Kingdom
Learning Objective: evaluate the effects of byperinsulinemia and 
acute hyperglycemia on LV function during stress echo
1262-253 Feasibility of Real-Time 3D Stress Contrast 
Echocardiography and Agreement with 2D Stress 
Contrast Echocardiography
Constantina Aggeli, John Felekos, Konstantinos Lampropoulos, 
Georgios Roussakis, Christina Kazazaki, Stavroula Lagoudakou, 
Emmanouil Poulidakis, Christos Pitsavos, Christodoulos Stefanadis, 
1st Department of Cardiology, University of Athens Medical School, 
Hippokration Hospital, Athens, Greece
Learning Objective: Contrast enhanced 3D dobutamine stress 
echocardiography is a feasible technique for both wall motion and 
perfusion evaluation
1262-254 Isovolumic but not Protodiastolic Left Ventricular 
Untwisting Determines Diastolic Response to 
Dobutamine Stress Echocardiography
Willis Lam, Thomas Marwick, University of Queensland, Brisbane, 
Australia
Learning Objective: identify the association between LV torsion 
and filling pressure response during dobutamine stress 
echocardiography
1262-255 Global Longitudinal Strain Measured from Rest 
Echocardiography Images Has Comparable 
Diagnostic Accuracy as Stress Induced Wall Motion 
Score Index in Detecting Significant Coronary Artery 
Disease
Kofo O. Ogunyankin, Jyothy J. Puthumana, Shelley L. Sarson, 
Northwestern University, Feinberg School of Medicine. Division of 
Cardiology, Chicago, IL
Learning Objective: Appraise the utility of global longitudinal strain 
in identifying the presence of coronary artery disease
1261-246 Deceleration Time of the Left Ventricular Outflow 
Tract Flow Velocity : A Useful Doppler Parameter for 
Dynamic Arterial Stiffness During Exercise Stress 
Echocardiography
Chi Young Shim, Sungha Park, Donghoon Choi, Woo-In Yang, In-
Jeong Cho, Sung-Ai Kim, Sun-Ha Moon, Jin-Mi Kim, Eui-Young Choi, 
Namsik Chung, Jong-Won Ha, Yonsei Cardiovascular Center, Yonsei 
University College of Medicine, Seoul, South Korea
Learning Objective: demonstrate that a Doppler parameter of 
left ventricular outflow tract flow is well correlated with central 
hemodynamics and arterial stiffness not only at rest but also at 
peak exercise.
1261-247 Systolic Stress versus Diastolic Stress 
Echocardiography for Functional Imaging and 
Correlation with Fractional Flow Reserve in Patients 
with Stable Angina
Motoyoshi Maenaka, Kansai Electric Power Hospital, Osaka, Japan, 
Koto Memorial Hospital, Higashioumi, Japan
Learning Objective: Fractional flow reserve <0.83 could be optimal 
index for detection of the reversible myocardial ischemia by using 
diastolic stress echocardiography.
1261-248 The Value of Systemic Endothelial Dysfunction 
and Increased Arterial Stiffness for Identifying 
Wall Motion Abnormalities During Stress 
Echocardiography Testing in Hypertensive Men with 
Vascular Erectile Dysfunction
Nikolaos Ioakeimidis, Charalambos Vlachopoulos, Constadina 
Aggeli, Dimitrios Terentes-Printzios, Athanasios Aggelis, George 
Roussakis, Konstantinos Rokkas, Konstantinos Aznaouridis, Alexios 
Samentzas, Christodoulos Stefanadis, Cardiovascular Diseases and 
Sexual Health Unit, 1st Department of Cardiology, Athens Medical 
School, Athens, Greece
Learning Objective: identify
1261-249 Inotropic Contractile Reserve can Risk Stratify and 
Prognosticate Patients With HIV Cardiomyopathy: a 
Dobutamine Stress Echo Study
omar enrique wever pinzon, Jorge Silva Enciso, Jorge Romero, Emad 
Aziz, Daniel Pudpud, Farooq A. Chaudhry, St. Luke’s Roosevelt 
Hospital Center, New York, NY
Learning Objective: Evaluate the value of Inotropic Contractile 
Reserve during DSE, in the risk stratification and prognosis of 
patients with HIV cardiomyopathy
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912 NOVEL BIOMARKERS AND NEW APPLICATIONS 
OF EXISTING TOOLS WITH PRACTICAL 
IMPLICATIONS
Monday, March 15, 2010, 2:00 p.m. - 3:30 p.m.
Georgia World Congress Center, Room B404
CME/CE Hours: 1.5
2:00 Diminished Paroxonase-1 Activity, A Marker of 
Dysfunctional High-Density Lipoprotein Cholesterol, 
Reclassifies Stable Cardiac Patients at Higher Risk 
for Developing Major Adverse Cardiac Events
Wai Hong Wilson Tang, Yuping Wu, Stephen J. Nicholls, Stanley L. 
Hazen, Cleveland Clinic, Cleveland, OH
Learning Objective: To describe the independent prognostic value of 
serum arylesterase activity level in reclassifying patients at higher 
risk of major adverse cardiac events
2:15 Insulin-Like Growth Factor Binding Protein (IGFBP) 
2: A Novel Metabolic Biomarker Strongly Predictive 
of Future Cardiovascular Events
Svati Hasmukh Shah, Jie-Lena Sun, Karen Pieper, Carol Haynes, 
Michael Muehlbauer, James R. Bain, Elizabeth R. Hauser, William E. 
Kraus, Christopher B. Newgard, Christopher B. Granger, Robert M. 
Califf, L. Kristin Newby, Duke University, Durham, NC
Learning Objective: Describe a novel biomarker for incident 
cardiovascular events.
2:30 New Universal Definition of Myocardial Infarction for 
Risk Stratification and Revascularization Decision 
Making: Is it Enough?
Rita Calé, Jorge Ferreira, Carlos Aguiar, Nuno Santos, Pedro 
Carmo, João Figueira, Luis Raposo, Pedro Gonçalves, José A. Silva, 
Cardiology Department, Hospital Santa Cruz, C.H.L.O., Lisbon, 
Portugal, Clinical Laboratory Department, Hospital Santa Cruz, 
C.H.L.O., Lisbon, Portugal
Learning Objective: Measurement of cardiac troponins is an 
important tool for diagnosis, risk assessment and therapeutic 
choices in patients with NSTE-ACS. Nevertheless, it should be 
included in a global evaluation.
2:45 High Sensitivity Troponin Assays Predict Major 
Adverse Events at 2 Years and at Levels Below the 
99th Percentile
Sally Aldous, Christopher Florkowski, Peter George, Martin Than, Ian 
Crozier, Christchurch Hospital, Christchurch, New Zealand
Learning Objective: evaluate different troponin assays including high 
sensitivity troponins for use in diagnosing myocardial infarction and 
prediction of long term adverse events
3:00 Multimarker Risk Model Containing Troponin, 
Interleukin-10, Myeloperoxidase and Placental 
Growth Factor Predicts Long-Term Cardiovascular 
Risk after Non-ST-Segment Elevation Acute 
Coronary Syndrome
Rohit M. Oemrawsingh, Timo Lenderink, K. Martijn Akkerhuis, 
Christopher Heeschen, Stephan Baldus, Stephan Fichtlscherer, 
Christian W. Hamm, Maarten L. Simoons, Eric Boersma, 
Thoraxcenter ErasmusMC, Rotterdam, The Netherlands, 
Interuniversity Cardiology Institute Netherlands, Utrecht, The 
Netherlands
Learning Objective: evaluate the additional value of testing multiple 
biomarkers for long-term post-ACS risk prediction.
914 ACUTE MYOCARDIAL INFARCTION: COMPLETE 
REVASCULARIZATION: CAN WE? SHOULD WE? IN 
WHOM?
Monday, March 15, 2010, 4:30 p.m. - 6:00 p.m.
Georgia World Congress Center, Room B404
CME/CE Hours: 1.5
4:30 Complete versus Culprit Only Revascularization Is 
Not Beneficial in Acute ST Elevation Myocardial 
Infarction: A Meta-Analysis
Ankur Sethi, Amol Bahekar, Rohit Bhuriya, Sarabjeet Singh, Aziz 
Ahmed, Sandeep Khosla, Rosalind Franklin University,Chicago 
Medical School, North Chicago, IL
Learning Objective: Evaluate current evidence demonstrating 
no benefit of complete revascularization over culprit only 
revascularization in ST elevation Myocardial infarction.
4:45 Is Multi-Vessel Primary PCI Advisable? Differences 
in Clinical Outcomes Among Medicare Beneficiaries 
Undergoing Single versus Multi-Vessel PCI During a 
Primary ST-Segment Elevated Myocardial Infarction 
Hospitalization in Fiscal Year 2007
Aaron D. Kugelmass, Phillip P. Brown, Matthew R. Reynolds, Steven 
D. Culler, April W. Simon, David J. Cohen, Baystate Medical Center, 
Springﬁeld, MA, Cardiac Data Solutions, Inc, Atlanta, GA
Learning Objective: identify the increased risk of multivessel PCI for 
STEMI patients
5:00 Culprit and Non-Culprit PCI Compared to Culprit only 
PCI in Multi-Vessel Coronary Artery Disease Patients 
with Acute ST Elevation Myocardial Infarction 
Treated by Primary Percutaneous Coronary 
Intervention: A Systematic Review
Naji Alhulaimi, William Midodzi, Robert C. Welsh, UNIVERSITY OF 
ALBERTA, EDMONTON, AB, Canada
Learning Objective: Understand available evidence regarding primary 
PCI in patients with multivessel CAD
ORAL CONTRIBUTIONS
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5:15 Clinical and Angiographic Outcomes in Patients 
with ST-Segment Elevation Myocardial Infarction 
Undergoing Single Versus Multiple Vessel 
Percutaneous Coronary Intervention
Mohamed Rahman, Tonga Nfor, Suhail Allaqaband, Anjan Gupta, 
Tanvir Bajwa, Aurora Cardiovasc Svcs, Aurora Sinai/St. Luke’s Med 
Ctrs, Univ Wisconsin Sch Med & Public Health-MCC, Milwaukee, 
WI, Center for Urban Population Health, University of Wisconsin-
Milwaukee, Milwaukee, WI
Learning Objective: understand that multivessel intervention in 
acute STEMI in the setting of multivessel disease is as safe and 
effective as single-vessel PCI during STEMI.
5:30 Mortality And Morbidity Reduction By Primary 
Percutaneous Coronary Intervention Is Consistent 
Across Spectrum Of Age
Sanneke P. De Boer, Cindy W. Westerhout, John Simes, Cindy L. 
Grines, Chris B. Granger, Felix Zijlstra, Eric Boersma, ErasmusMC, 
Rotterdam, The Netherlands
Learning Objective: We aimed to obtain a valid estimate of the 
clinical effects of PPCI in relation to age
919 FACTORS ASSOCIATED WITH OUTCOME IN 
ACUTE AND CHRONIC ISCHEMIA
Tuesday, March 16, 2010, 10:30 a.m. - 12:00 p.m.
Georgia World Congress Center, Room B403
CME/CE Hours: 1.5
10:30 In Women with Symptoms of Cardiac Ischemia, 
Nonobstructive Coronary Arteries and Microvascular 
Dysfunction, ACE Inhibition Is Associated with 
Improved Microvascular Function: A Double-Blind 
Randomized Ancillary Study from the NHLBI 
Women’s Ischemia Syndrome Evaluation (WISE)
Daniel F. Pauly, B. Delia Johnson, R. David Anderson, Eileen M. 
Handberg, Karen M. Smith, Rhonda M. Cooper-DeHoff, Keith 
E. Muller, George Sopko, Barry M. Sharaf, Sheryl F. Kelsey, C. 
Noel Bairey Merz, Carl J. Pepine, University of Florida College of 
Medicine, Division of Cardiovascular Medicine, Gainesville, FL
Learning Objective: Evaluate the usefulness of angiotensin-
converting enzyme inhibitors in women with microvascular 
dyfunction with signs and symptoms of ischemia who lack 
obstructive coronary artery disease.
10:45 Relationship of Heart Rate and Cardiovascular 
Events in Patients after Acute Coronary Syndromes: 
An Analysis from the PROVE-IT TIMI 22 Trial
Sripal Bangalore, Jie Qin, Sabina Murphy, Christopher P. Cannon, 
Brigham and Women’s Hospital, Boston, MA, TIMI Study Group, 
Boston, MA
Learning Objective: Evaluate the role of heart rate in the prognosis 
of patients post acute coronary syndromes
11:00 Impact of Pretreatment Ischemia on Therapeutic 
Risk Reduction and Long-Term Prognosis in 
Patients with Stable Angina: Results from COURAGE 
Trial
Leslee J. Shaw, Daniel S. Berman, David J. Maron, Rory 
Hachamovitch, Pamela M. Hartigan, James K. Min, Steven P. Sedlis, 
Marcin Dada, G. B. John Mancini, Robert A. O’Rourke, John A. 
Spertus, Bernard R. Chaitman, Eric R. Bates, Koon K. Teo, William 
E. Boden, William S. Weintraub, Emory University, Atlanta, GA, 
Cedars-Sinai Medical Center, Los Angeles, CA
Learning Objective: To understand the role of pre-treatment 
ischemia on therapeutic outcomes.
11:15 Resistance to Clopidogrel Assessed by VASP 
Phosphorylation Is a Negative Prognostic Factor 
in Patients Undergoing Elective PCI for Stable 
Coronary Artery Disease: Analysis from Laboratory 
Substudy of Prague 8 Trial
Robert Petr, Zuzana Motovska, Iuri Marinov, Danuse Bilkova, Petr 
Widimsky, Cardiocenter, 3rd faculty of medicine Charles University 
Prague, University Hospital Kral. Vinohrady, Prague, Czech Republic, 
The Institute of Hematology and Blood Transfusion, Prague, Czech 
Republic
Learning Objective: identify
11:30 Long-Term Follow-Up to Evaluate the Safety of 
the Neovasc Reducer A Device-Based Therapy for 
Chronic Refractory Angina
Shmuel Banai, Marc Schwartz, Horst Sievert, Ashok Seth, Gad 
Keren, Keyur H. Parikh, The Tel Aviv Medical Center, Tel Aviv, Israel
Learning Objective: Identify new therapeutic option for patients with 
refractory angina who are not candidates for revascularization
924 CORONARY ARTERY BYPASS SURGERY: 
CONTEMPORARY ISSUES IN GRAFT SURVIVAL 
AND PATIENT OUTCOMES
Tuesday, March 16, 2010, 2:00 p.m. - 3:30 p.m.
Georgia World Congress Center, Room B404
CME/CE Hours: 1.5
2:00 Coronary Artery Bypass Grafting with and without 
Concomitant Epicardial Cardiac Resynchronization 
Therapy in Patients with Ischemic Heart Failure: 
Long-Term Results
Evgeny Pokushalov, Alexander Romanov, Darya Prohorova, Alexander 
Cherniavskiy, State Research Institute of Circulation Pathology, 
Novosibirsk, Russian Federation
Learning Objective: We revealed that epicardial implantation of the 
ˁRT system concomitantly with CABG improves clinical status, LV 
systolic function, decreases LV dyssynchrony signs
2:15 A Randomized Trial Radial Artery Versus Saphenous 
Vein Grafts in Coronary Artery Bypass Surgery: VA 
Cooperative Study
Steven Goldman, Gulshan Sethi, William Holman, Hoang Thai, 
Yvette Rodriguez, Kelvin Lee, CSP 474 Study Group, Southern 
Arizona VA Medical Center, Tucson, AZ
Learning Objective: Data on comparative conduit patency with CABG
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2:30 Vein Graft Failure Following Coronary Artery Bypass 
Surgery: Does it Matter?
Renato Lopes, John H. Alexander, Rajendra H. Mehta, Gail E. 
Haﬂey, Michael J. Mack, Keith B. Allen, Eric D. Peterson, Robert 
A. Harrington, C. Michael Gibson, Robert M. Califf, Nicholas T. 
Kouchoukos, T. Bruce Ferguson, Duke Clinical Research Institute, 
Duke University Medical Center, Durham, NC
Learning Objective: Evaluate the relationship between vein graft 
failure and long-term clinical outcomes in patients undergoing 
coronary artery bypass surgery
2:45 Combined Clopidogrel and Aspirin Treatment up 
to Surgery Increases the Risk of Postoperative 
Myocardial Infarction, Bleeding and Reoperation 
in Patients Undergoing Coronary Artery Bypass 
Grafting
Antonio Miceli, Paolo M. de Siena, Brenno Fiorani, Francesco 
Romeo, Gianni D. Angelini, Massimo Caputo, Bristol Heart Institute, 
Bristol, United Kingdom
Learning Objective: evaluate the risk associated with clopidogrel in 
combination with aspirin in patients undergoing CABG
3:00 Modern Era Coronary Artery Bypass Graft Patency: 
Angiographic and Functional Outcomes in the 
Cascade Multicenter Randomized Controlled Trial
Alexander Kulik, Pierre Voisine, Patrick Mathieu, Roy G. Masters, 
Thierry G. Mesana, Michel Le May, Marc Ruel, University of Ottawa 
Heart Institute, Ottawa, ON, Canada, Hopital Laval, Quebec City, QC, 
Canada
Learning Objective: Describe modern era CABG outcomes
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1043-261 Effects Of Low Versus Moderate-dose Atorvastatin 
In 8-month Follow-up Coronary Flow Reserve And 
Stem Cell Mobilizations In Patients With Acute 
Myocardial Infarction
Jae Hyoung Park, Soon Jun Hong, Seung Cheol Choi, Je Sang Kim, 
Chul-Min Ahn, Do-Sun Lim, Korea University Anam Hospital, Seoul, 
South Korea
Learning Objective: learn about stem cell mobilization according to 
the statin therapy in patients with acute myocardial infarction
1043-262 Intracoronary Stem Cell Therapy After Myocardial 
Infarction - Twelve Months Follow-up Of A 
Randomized, Rigorous Double-blind, Placebo 
Controlled Trial
Jochen Wöhrle, Nico Merkle, Volker Mailänder, Thorsten Nusser, 
Peter Schauwecker, Fabian von Scheidt, Klaus Schwarz, Martin 
Bommer, Markus Wiesneth, Hubert Schrezenmeier, Vinzenz 
Hombach, Clinic of Internal Medicine II, University of Ulm, Ulm, 
Germany, Institute of Transfusion Medicine and Institute of Clinical 
Transfusion Medicine and Immunogenetics, Ulm, Germany
Learning Objective: interpret results of bone marrow cell therapy in 
patients with acute myocardial infarction in the setting of a rigorous 
randomized placebo-controlled trial
1043-263 The Calcitonin Gene-Related Peptide Receptor 
Antagonist Telcagepant Does Not Reduce Exercise 
Tolerance in Patients with Exercise Induced 
Myocardial Ischemia
Bernard R. Chaitman, Andrew P. Ho, Martin O. Behm, Janice F. 
Rowe, John S. Palcza, Tine Laethem, Ingeborg Heirman, Deborah 
L. Panebianco, Valentin S. Moiseev, Sergey Y. Martsevich, Almena 
L. Free, Neville Bittar, Steven G. Chrysant, Tony W. Ho, Jeffrey A. 
Chodakewitz, M. Gail Murphy, Rebecca L. Blanchard, Saint Louis 
University School of Medicine, Division of Cardiology, St. Louis, MO, 
Merck & Co., Inc., North Wales, PA
Learning Objective: Evaluate Telcagepant (MK-0974), a novel 
investigational calcitonin gene-related peptide CGRP receptor 
antagonist, being developed to treat migraines on exercise induced 
myocardial ischemia threshold.
1044 ACUTE MYOCARDIAL INFARCTION--OUTCOMES
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1044-265 Predictors of In-hospital Mortality in a 
Contemporary Acute Myocardial Infarction 
Population: Results from the ACTION Registry-Get 
with the Guidelines Program
Matthew T. Roe, Anita Y. Chen, Elizabeth DeLong, Tracy Y. Wang, 
John S. Rumsfeld, Christopher P. Cannon, Gregg C. Fonarow, Eric D. 
Peterson, Duke Clinical Research Institute, Durham, NC
Learning Objective: use a risk model developed from the ACTION 
Registry-GWTG program to predict in-hospital mortality among 
patients with acute myocardial infarction (both NSTEMI and STEMI).
1043 ACUTE MYOCARDIAL INFARCTION--CELL BASED 
THERAPY AND CELLULAR MANIPULATIONS
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1043-256 Increase in Endothelial Progenitor Cells after Acute 
Myocardial Infarction May Reduce Late Luminal 
Loss in the Stent Deployed in Infarc Related 
Coronary Artery
Motoo Date, Hiroshi Ito, Katsuomi Iwakura, Atsunori Okamura, 
Yasushi Koyama, Yoshiharu Higuchi, Koichi Inoue, Ryusuke Kimura, 
Hiroyuki Nagai, Kenshi Fujii, Cardiovascular Center,Sakurabashi-
Watanabe Hospital, Osaka, Japan
Learning Objective: learn the effect of CD34 positive cells on 
restenosis in the bare-metal stent implanted in coronary artery.
1043-257 First-in-Man Experience of Adipose-Derived Stem 
Cell Transplantation in the Treatment of Patients 
with an Acute ST-Elevation Myocardial Infarction 
(APOLLO Trial)
H. J. Duckers, Sr., Jaco Houtgraaf, RobertJan van Geuns, Francisco 
J. Fernandez-Aviles, Patrick W. Serruys, Thoraxcenter Rotterdam, 
Erasmus University Medical Center Rotterdam, Rotterdam, The 
Netherlands, Hospital General Universitario Gregorio Marañón, 
Madrid, Spain
Learning Objective: Identify alternative treatment of patients 
admitted with an acute myocardial infarction
1043-259 N-terminal Pro-B-Type Natriuretic Peptide Levels 
Is Associated with Endothelial Progenitor Cell 
Mobilization after Percutaneous Coronary 
Intervention in Patients with Acute Myocardial 
Infarction
Youngkeun Ahn, Seo Na Hong, Keun Ho Park, Nam Sik Yoon, Do Sun 
Sim, Young Joon Hong, Ju Han Kim, Myung Ho Jeong, Jeong Gwan 
Cho, Jong Chun Park, Jung Chaee Kang, Department of Cardiology, 
Chonnam National University Hospital, Gwangju, South Korea, 
Seonam University Hospital, Namwon, South Korea
Learning Objective: to evaluate the relation between the EPC 
mobilization and improvement of left ventricular function and 
predictor for EPC mobilization
1043-260 Red Ginseng Extracts Improved Coronary Flow 
Reserve and Increased Absolute Numbers of 
Various Circulating Angiogenic Cells in Patients with 
ST-elevation myocardial infarction
Doosup Shin, Soon Jun Hong, Jae Hyoung Choi, Ju Hyeon Kim, 
Je Sang Kim, Jae Hyoung Park, Chul-Min Ahn, Do-Sun Lim, Korea 
University Anam Hospital, Seoul, South Korea
Learning Objective: to learn about effect of Red Ginseng to coronary 
flow reserve in patients with ST-elevation myocardial infarction
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1044-271 Major Bleeding Complications in Patients With 
STEMI Account for a Doubling in Hospital Mortality 
in Clinical Practice: Lessons From the Euro Heart 
Survey ACS Registry
Anselm K. Gitt, Frank Towae, Ralf Zahn, Huo Katus, Marek 
Gierlotka, Wojtek Wojakowski, Michal Tendera, Francois Schiele, 
Jean-Pierre Bassand, Euro Heart Survey ACS Registry, Institut 
f. Herzinfarktforschung Ludwigshafen, University of Heidelberg, 
Ludwigshafen, Germany, Herzzentrum Ludwigshafen, Ludwigshafen, 
Germany
Learning Objective: identify patients with high risk for bleeding
1044-272 Gender Outcomes in a Community Level 1 Program 
of Catheter-Based Rapid Reperfusion for Acute ST-
Segment Elevation Myocardial Infarction
Elizabeth Grey, Catherine A. Pastorius, Timothy D. Henry, Sue Duval, 
Denise C. Windenburg, Robert G. Hauser, Minneapolis Heart Institute 
Foundation at Abbott Northwestern Hospital, Minneapolis, MN
Learning Objective: Understand gender differences in STEMI
1045 ACUTE MYOCARDIAL INFARCTION--NOVEL 
PHARMACOLOGIC APPROACHES
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1045-273 Use of Ivabradine in the Management of Acute 
Anterior Wall Myocardial Infarction Complicated by 
Left ventricular Failure
Rajagopal J, Srinivas Arun, Keshavamurthy B. Chakrabhavi, 
Guruprasad HP, Jayakumar P, Arjun Adnaik, Vikram Hospital and 
Heart Care, Mysore, India
Learning Objective: Evaluate the newer agent ivabradine in the 
management of acute heart failure
1045-274 Bivalirudin Therapy is Associated with Improved 
Clinical and Economic Outcomes in STEMI Patients 
Undergoing PCI: Results from an Observational 
Database
Duane S. Pinto, M.P.H., Augustina Ogbonnaya, Sharon-Lise Normand, 
Beth Israel Deaconess Medical Center, Boston, MA, Harvard 
Medical School, Boston, MA
Learning Objective: Understand the advantages and disadvantages 
of using a large database for evaluation of costs and outcomes in 
STEMI.
1045-276 Time Course Of Urinary Isoprostane Excretion And 
Effect Of Atrial Natriuretic Peptide Administration 
On Oxidative Stress During Acute Phase Of 
Myocardial Infarction
Ryosai Nakamura, Hideki Nagoshi, Tetsunori Ishikawa, Haruhito 
Kumagae, Kouji Kobayashi, Takahiro Sumi, Hironao Iwakiri, Shohei 
Koyama, Takuroh Imamura, Kazuo Kitamura, Miyakonojo Resional 
Medical Center, Miyakonojo, Japan
Learning Objective: identify
1044-266 The Influence of Previous Myocardial Infarction 
on 12-month Clinical Outcomes in Patients with 
Recurrent ST-segment Elevation Acute Myocardial 
Infarction Undergoing Primary Percutaneous 
Coronary Intervention
Seung Woon Rha, Lin Wang, Ji Young Park, Kanhaiya L. Poddar, 
Sureshkumar Ramasamy, Byoung Geol Choi, Ji Bak Kim, Seung 
Yong Shin, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju 
Kim, Eung Ju Kim, Hong Seog Seo, Dong Joo Oh, Myung Ho Jeong, 
Cardiovascular Center, Korean University Guro Hospital, Seoul, 
South Korea, Cardiovascular Center, Chon Nam National University 
Hospital, Gwangju, South Korea
Learning Objective: The Influence of Previous Myocardial Infarction on 
12-month Clinical Outcomes in Patients with Recurrent ST-segment 
Elevation Acute Myocardial Infarction Undergoing Primary PCI
1044-267 Trends in the Management and Outcomes of 
Cardiogenic Shock Complicating Acute Myocardial 
Infarction
Sen Matsumoto, Yasuhiko Sakata, Masahiko Shimizu, Shinichirou 
Suna, Masaya Usami, Tatsuya Sasaki, Masami Nishino, Issei 
Komuro, Hiroshi Sato, Osaka University Graduate School of 
Medicine, Suita, Japan
Learning Objective: Clinical outcomes in patients with cardiogenic 
shock complicating AMI became getting better, along with progress 
of reperfusion therapy.
1044-268 Predicting Major Adverse Cardiac Events and Infarct 
Size using ST-Segment Resolution as a Continuous 
Rather than a Dichotomous Variable in Patients 
Achieving Thrombolysis in Myocardial Infarction 
Flow Grade III after Primary Percutaneous Coronary 
Intervention for ST-Segment Elevation Myocardial 
Infarction
Wichert J. Kuijt, Andrzej S. Kosinski, Niels J. Verouden, Joost D. 
Haeck, Matthew T. Roe, Cindy L. Green, Karel T. Koch, Ricardo 
Baeza, Dan Tzivoni, Robbert J. De Winter, Mitchell W. Krucoff, Duke 
Clinical Research Institute, Durham, NC
Learning Objective: Demonstrate that STR is more predictive of clinical 
outcome and infarct size when expressed as a continuous variable in 
all patients and those achieving TIMI-3 flow after primary PCI
1044-269 Female Gender in STEMI: Influence on Mortality 
and Reperfusion: Results from the Belgian STEMI 
Registry
Soﬁe Agnes Gevaert, Antoine De Meester, Patrick Evrard, Marc 
Renard, Christophe Beauloye, Patrick Coussement, Herbert De 
Raedt, Marc Claeys, Ghent University Hospital, Gent, Belgium, 
BIWAC, Belgium
Learning Objective: to evaluate sex differences in treatment and 
outcome of ST segment elevation myocardial infarction
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1046-283 Risk-Treatment-Paradox In STEMI With Impaired 
Renal Function in Clinical Practice in Europe: 
Lessons From the Euro Heart Survey ACS Registry
Anselm K. Gitt, Frank Towae, Ralf Zahn, Hugo Katus, Alexander 
Pakhomenko, Francois Schiele, Jean-Pierre Bassand, Euro Heart 
Survey ACS Registry, Institut f. Herzinfarktforschung Ludwigshafen, 
University of Heidelberg, Ludwigshafen, Germany, Herzzentrum 
Ludwigshafen, Ludwigshafen, Germany
Learning Objective: identify patients with STEMI at high risk
1046-284 Impact of Chronic Kidney Disease and Anemia on 
5-Year Mortality after Acute Myocardial Infarction
Kazuoki Dai, Masaharu Ishihara, Ichiro Inoue, Takuji Kawagoe, Yuji 
Shimatani, Satoshi Kurisu, Yasuharu Nakama, Eisuke Kagawa, 
Takayuki Otani, Hiroki Ikenaga, Yoshimasa Morimoto, Kentaro Ejiri, 
Nozomu Oda, Hiroshima City Hospital, Hiroshima, Japan, Hiroshima, 
Japan
Learning Objective: evaluate prognostic utility of combination 
of chronic kidney disease and anemia in patients with acute 
myocardial infarction.
1046-285 Safety and Efficacy of Adjusted-Dose Eptifibatide 
in Patients with Acute Coronary Syndromes and 
Reduced Renal Function
Chiara Melloni, Stefan K. James, Jennifer A. White, Robert P. 
Giugliano, Robert A. Harrington, Kurt Huber, Paul W. Armstrong, 
Robert M. Califf, Frans Van de Werf, Gilles Montalescot, L. Kristin 
Newby, Duke Clinical Research Institute, Durham, NC
Learning Objective: describe the safety and efficacy of eptifibatide 
dose adjustment in patients with reduced renal function.
1046-286 Prevention of Contrast-Induced Nephropathy 
with Bolus Injection of Sodium Bicarbonate in 
Patients with Chronic Kidney Disease Undergoing 
an Emergent Coronary Procedure: A Prospective 
Randomized Controlled Trial
Hiromichi Ueda, Takahisa Yamada, Yuji Okuyama, Takashi Morita, 
Yoshio Furukawa, Koji Tanaka, Yusuke Iwasaki, Taku yasui, Takeshi 
Okada, Masato Kawasaki, Yuki Kuramoto, Masatake Fukunami, 
Osaka General Medical Center, Osaka, Japan
Learning Objective: demonstrate the effect of sodium bicarbonate 
bolus injection.
1046-288 Relationship Between Renal Function, 
Anticoagulation Levels and Clinical Outcome in 
ST-elevation Myocardial Infarction Patients Treated 
with Primary Percutaneous Coronary Intervention 
and Unfractionated Heparin
Wouter Kikkert, Bimmer EPM Claessen, Annemarie E. Engstrom, 
Marije Vis, Jan Baan, Jr., Martijn Meeuwissen, Robbert J. de Winter, 
Jan GP Tijssen, Jan J. Piek, Jose PS Henriques, Academic Medical 
Center Amsterdam, Amsterdam, The Netherlands
Learning Objective: Acknowkledge the influence of renal 
insufficiency on anticoagulation levels and clinical outcome during 
treatment with unfractionated heparin in the setting of primary PCI.
1045-277 Effect of Apixaban on Coagulation Acitvity 
Biomarkers Following Acute Coronary Syndrome: 
Lessons from the APPRAISE Trial
Richard C. Becker, John H. Alexander, YuChen Barrett, Honqqui 
Yang, Jessie Wang, Lars Wallentin, Robert A. Harrington, Duke 
University Medical Center, Durham, NC
Learning Objective: Demonstrate the affect of Factor Xa inhibition 
on biomarkers of coagulation activity
1045-278 Interleukin-1 Blockade Ameliorates Left Ventricular 
Remodeling Following St-segment Elevation Acute 
Myocardial Infarction - The VCU-ART Pilot Study
Antonio Abbate, Michael C. Kontos, John Grizzard, Giuseppe GL 
Biondi-Zoccai, Benjamin W. Van Tassell, Roshanak Robati, Ross 
Arena, Charlotte Roberts, Amit Varma, Christopher Gelwix, Fadi N. 
Salloum, Andrea Hastillo, Charles A. Dinarello, George W. Vetrovec, 
Virginia Commonwealth University, Pauley Heart Center, Richmond, VA
Learning Objective: To describe the beneficial effects of IL-1 
blockade in STEMI
1045-279 Cardiovascular Effects of Tumour Necrosis 
Factor Alpha Antagonism in Patients with Acute 
Myocardial Infarction
Gareth J. Padﬁeld, Jehangir N. Din, Nicholas L. Mills, Elena 
Koushiappi, Simon D. Robinson, Andrew J. Lucking, Nicholas L. 
Cruden, Stan Chia, Scott A. Harding, David E. Newby, University Of 
Edinburgh, Edinburgh, United Kingdom
Learning Objective: TNF-alpha antagonism in acute coronary 
syndromes does not improve vasomotor or fibrinolytic function and 
may be harmful
1045-280 Feasibility of Continuous Intravenous Administration 
of Landiolol for Acute Myocardial Infarction :first 
clinical experience and its safe directions for use
haruhiko higuchi, Hitachi General Hospital,Department of 
Cardiology, Hitachi, Japan
Learning Objective: demonstrate that intravenous ultra short-
acting beta-blockade reduce cardiac damage in patients with acute 
myocardial infarction.
1046 ACUTE MYOCARDIAL INFARCTION--OPTIMIZING 
THERAPY IN HIGH RISK SUBSETS: RENAL 
FAILURE
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1046-282 Trends in the Prevalence of Acute Kidney Injury in 
Patients with Acute Myocardial Infarction
Amit P. Amin, Kensey Riley, John A. Spertus, Lakshmi Venkitachalam, 
Joshua M. Stolker, Peter A. McCullough, Frederick A. Masoudi, 
Phillip G. Jones, Mikhail Kosiborod, Saint Luke’s Mid-America Heart 
Institute, University of Missouri, Kansas City, MO
Learning Objective: To identify the trends in the incidence of acute 
kidney injury over time in patients hospitalized with an acute 
myocardial infarction
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1047-293 Randomized Comparison of Prehospital Initiated 
Facilitated PCI versus Primary PCI in Acute 
Myocardial Infarction with < 3 h after Symptom 
Onset
Holger Thiele, Ingo Eitel, Claudia Meinberg, Gerd Plock, Wolfgang 
Strauß, Dietrich Pfeiffer, Andreas Hartmann, Gerhard Schuler, LIPSIA 
STEMI Group, University of Leipzig - Heart Center, Leipzig, Germany
Learning Objective: Demonstrate infarct size after different 
reperfusion regimens
1047-294 Pre-Hospital Fibrinolysis Followed By Urgent 
Percutaneous Intervention within the First Two 
Hours of STEMI Are Associated With a Significant 
Reduction in Microvascular Obstruction and Infarct 
Size
Colin M. Barker, Lisa Torres, Daniel Maland, Eugene Stautberg, 
John Ledoux, Catalin Loghin, Troy Weirick, Ali Denktas, H. Vernon 
Anderson, Stefano Sdringola, Richard W. Smalling, University of 
Texas Health Sciences Center at Houston, Houston, TX
Learning Objective: To identify the timing of a beneficial effect 
of pre-hospital lytics and PCI as assessed by microvascular 
obstruction.
1048 ACUTE MYOCARDIAL INFARCTION--PRESERVING 
MICROVASCULAR FUNCTION AND PROMOTING 
FAVORABLE REMODELLING
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1048-296 Intracoronary Nicorandil Can Improve Microvascular 
Dysfunction Following Primary Percutaneous 
Coronary Intervention in Patients with ST-Segment 
Elevation Myocardial Infarction: Its Superiority to 
Intracoronary Nitroglycerin
Noritoshi Ito, Shinsuke Nanto, Yasuji Doi, Hirotaka Sawano, Daisaku 
Masuda, Shizuya Yamashita, Mai Hatano, Daisuke Tonomura, Yuma 
Kurozumi, Tomoaki Natsukawa, Yusuke Ito, Kazuyuki Oka, Jiro Ooba, 
Taizo Hasegawa, Makoto Kobayashi, Hiroshi Ichiyanagi, Koji Akashi, 
Koichi Otsuya, Shoji kaibe, Ken-ichiro Okada, Yasuyuki Hayashi, 
Tatsuro Kai, Toru Hayashi, Osaka Saiseikai Senri Hospital, Suita, 
Japan, Osaka University Graduate School of Medicine, Suita, Japan
Learning Objective: identify the beneficial effect of intracoronary 
nicorandil, a hybrid K-ATP channel opener and nitric oxide donor, 
on microvascular dysfunction comparing with the efficacy of 
Nitroglycerin.
1048-297 Prognostic Value of Left Ventricular Sphericity after 
Acute Myocardial Infarction
Shinichi Okino, Shigeru Fukuzawa, Masayuki Inagaki, Juji Sugioka, 
Atsushi Ikeda, Jumpei Maekawa, Jumpei Maekawa, Soiciro Ichikawa, 
Takashi Uchiyama, Norihiko Kamioka, Funabashi Municipal Medical 
Center, Funabashi, Japan
Learning Objective: find that left ventricular sphericity is a new and 
possibly important for the prognosis of acute myocardial infarction.
1046-289 Impact of Renal Failure on Mortality, Stroke and 
Bleeding Complications in the Setting Of PCI for 
ACS or Stable Angina in Europe: Lessons From the 
Euro Heart Survey PCI Registry
Anselm K. Gitt, Timm Bauer, Uwe Zeymer, Ralf Zahn, Franz 
Weidinger, Matthias Hochadel, Christian Hamm, Euro Heart 
Survey PCI Registry, Institut f. Herzinfarktforschung Ludwigshafen, 
University of Heidelberg, Ludwigshafen, Germany, Herzzentrum 
Ludwigshafen, Ludwigshafen, Germany
Learning Objective: identify patients undergoing PCI at high risk
1047 ACUTE MYOCARDIAL INFARCTION--CAN PRIMARY 
PCI BE FACILITATED?
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1047-290 Upstream versus Deferred Administration of Small-
Molecule Glycoprotein IIb/IIIa Inhibitors in Primary 
Percutaneous Coronary Intervention for ST-Segment 
Elevation Myocardial Infarction: Insights from 
Randomized Clinical Trials
Lili Dong, Feng Zhang, Xianhong Shu, Shanghai Institute of 
Cardiovascular Diseases, Zhongshan Hospital, Fudan University, 
Shanghai, People’s Republic of China
Learning Objective: demonstrate that in STEMI patients scheduled 
for primary PCI, upstream administration of smGPIs improves initial 
epicardial patency before angioplasty, without an increase in major 
bleeding risk.
1047-291 Interaction Between Time to Treatment and Type of 
Reperfusion Therapy in STEMI: A Pooled Analysis of 
One-Year Mortality in the Comparison of Angioplasty 
& Prehospital Thrombolysis in Acute Myocardial 
Infarction (CAPTIM) and Which Early ST-elevation 
Myocardial Infarction Therapy (WEST) Trials
Cynthia M. Westerhout, Eric Bonnefoy, Robert C. Welsh, Florent 
Boutitie, Philippe Gabriel Steg, Paul W. Armstrong, University of 
Alberta, Edmonton, AB, Canada
Learning Objective: To identify optimal therapy, as it pertains to 
the risk of long-term mortality, in ST-elevation myocardial infarction 
patients according to their presentation delay.
1047-292 Optimal Timing of Percutaneous Coronary 
Intervention after Fibrinolysis in St-segment 
Elevation Myocardial Infarction: A Meta-analysis
Steffen Desch, Ingo Eitel, Suzanne de Waha, Gerhard Schuler, 
Holger Thiele, University of Leipzig Heart Center, Department of 
Internal Medicine/Cardiology, Leipzig, Germany
Learning Objective: to determine the optimal timing of percutaneous 
coronary intervention (PCI) in patients with ST-elevation myocardial 
infarction (STEMI) who have initially been treated with fibrinolysis.
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1049-303 Impact of Admission Blood Glucose Level on 
Bleeding and Ischemic Complications in Patients 
With Acute Myocardial Infarction: Analysis From the 
Harmonizing Outcomes With Revascularization and 
Stents in Acute Myocardial Infarction Trial
OLAYINKA AFOLABI-BROWN, Eugenia Nikolsky, Roxana Mehran, 
LeRoy Rabbani, Martin Fahy, Selene Leon, Adriano Caixeta, Bruce 
R. Brodie, Dariusz Dudek, Martin Möckel, Andrzej Ochala, Gregg W. 
Stone, The Cardiovascular Research Foundation, New York, NY
Learning Objective: identify the relationship between plasma 
glucose on admission and outcomes of patients with ST-elevation 
myocardial infarction treated with primary percutaneous coronary 
intervention
1049-304 The Frequency, Etiology and Outcome of ST-
Elevation Myocardial Infarction Patients Requiring 
Urgent Coronary Artery Bypass Graft
Craig Tschautscher, David M. Larson, Timothy D. Henry, Jason T. 
Henry, Monique G. Ross, Robert S. Schwartz, Scott W. Sharkey, 
Timothy J. Kroshus, Minneapolis Heart Institute Foundation at 
Abbott Northwestern Hosptial, Minneapolis, MN
Learning Objective: Learn the incidence of emergency surgery in 
STEMI patients pretreated with Clopidogrel
1049-305 Effects of Oral Glucose-Lowering Drugs on Long 
Term Outcomes in Patients With Diabetes Mellitus 
and Non-ST Elevation Myocardial Infarction
Casper H. Jorgensen, Gunnar H. Gislason, Charlotte Andersson, 
Ole Ahlehoff, Mette G. Charlot, Steen Z. Abildstrom, Allan Vaag, 
Christian Torp-Pedersen, Peter R. Hansen, Department of Cardiology, 
Copenhagen University Hospital Gentofte, Hellerup, Denmark
Learning Objective: Investigate the cardiovascular risk of individual 
glucose-lowering drugs in patients with Diabetes Mellitus and Non-
ST myocardial infarction
1049-306 Which is Worst in Patients Undergoing Primary 
Angioplasty for Acute Myocardial Infarction? 
Hyperglycemia?, Diabetes Mellitus? or Both?
Mehmet Ergelen, Huseyin Uyarel, Gokhan Cicek, Turgay Isık, 
Damirbek Osmonov, Zeki Y. Gunaydın, Mehmet Bozbay, Ayca Turer, 
Mehmet Gul, Gul B. Abanonu, Department of Cardiology, Siyami 
Ersek Cardiovascular and Thoracic Surgery Center, Istanbul, Turkey, 
Department of Cardiology, Balıkesir University, School of Medicine, 
Balıkesir, Turkey
Learning Objective: We should focuse on NDH, and especially DH 
patients. Global cardiometabolic risk control by intensive care 
should be a part of management in these patients.
1048-298 Effect of Nitroprusside on Reducing Infarct Size 
After Primary Percutaneous Coronary Intervention 
for Acute Myocardial Infarction
Hiroki Sakamoto, Shinsaku Shimamoto, Yuichi Kawase, Hiroshi 
Ueda, Tomoe Murakami, Takashi Tamura, Japanese Red Cross 
Society Wakayama Medical Center, Wakayama, Japan
Learning Objective: Understand the effect of intracoronary 
nitroprusside injection during primary coronary intervention for 
acute myocardial infarction.
1048-299 Prognostic Value of Reverse Left Ventricular 
Remodeling After Primary Percutaneous Coronary 
Intervention.
Nazario Carrabba, Angela Migliorini, Renato Valenti, Guido Parodi, 
Emilio V. Dovellini, David Antoniucci, Division of Cardiology, Careggi 
Hospital, Florence, Italy
Learning Objective: interpret the clinical significance of reverse 
remodeling after primary PCI for STEMI
1048-300 Thromboaspiration Before Primary PCI in STEMI 
Patients Reduces Infarct Size, but Not Microvascular 
Obstruction: A Magnetic Resonance Imaging Study
Nicolas F. Meneveau, Vincent Descotes-Genon, Romain Chopard, 
Joanna Dutheil, Marie-France Seronde, Florent Briand, Francois 
Schiele, University Hospital Jean Minjoz, Besancon, France
Learning Objective: describe the contribution of thromboaspiration 
to outcome after PCI in STEMI and effect on microvascular 
obstruction
1049 ACUTE MYOCARDIAL INFARCTION--HIGH RISK 
SUBSETS
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1049-302 Predictor, Impact, and Prognostic Factor of 
Angiographic No-reflow Phenomenon in Patients 
Treated with Drug-eluting Stent for Acute ST-
segment Elevation Myocardial Infarction
Youngkeun Ahn, Seo Na Hong, Nam Sik Yoon, Hae Chang Jeong, 
Doo Sun Sim, Young Joon Hong, Hyung Wook Park, Ju Han Kim, 
Myung Ho Jeong, Jeong Gwan Cho, Jong Chun Park, Jung Chaee 
Kang, Chonnam National University Hospital, Gwangju, South Korea, 
Seonam University Hospital, Gwangju, South Korea
Learning Objective: investigate the predictor and prognostic factor 
for no-reflow phenomenon in patients with acute ST-segment 
elevation myocardial infarction treated with drug-eluting stent
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1051 ACUTE MYOCARDIAL INFARCTION--PCI 
STRATEGIES
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1051-313 Early PCI After Thrombolysis Versus Standard 
Therapy in STEMI Patients: a Cumulative Meta-
analysis
Federico Piscione, Warren J. Cantor, Francisco Fernandez-Aviles, 
Sigrun Halvorsen, Michel Le-May, Paul W. Armstrong, Scheller Bruno, 
Shaun G. Goodman, Konstantinos Dimopoulos, Francesco Borgia, 
Carlo Di Mario, Federico II University, Naples, Italy, Royal Brompton 
Hospital and The National Heart and Lung Institute, London, Italy
Learning Objective: demonstrate benefit of a routine invasive 
strategy after lysis in STEMI patients
1051-314 Short- and Long-term Outcomes of Systematic 
Primary Percutaneous Coronary Intervention in 
Patients who Develop Cardiogenic Shock after a ST-
elevation Myocardial Infarction (STEMI)
Bethany E. Durling, Michel R. Le May, Derek Y. So, Michael P. V. 
Fröeschl, Edward R. O’Brien, Marino Labinaz, Jean-François Marquis, 
Melissa Fong, George A. Wells, Chris A. Glover, University of Ottawa 
Heart Institute, Ottawa, ON, Canada
Learning Objective: Evaluate the mortality rates of patients who 
developed cardiogenic shock after a STEMI in the setting of Primary 
PCI
1051-315 High-risk MI patients derive greatest absolute 
benefit from primary percutaneous coronary 
intervention: Results from the Primary Coronary 
Angioplasty Trialist Collaboration
Sanneke P. De Boer, Liz Barnes, Cyntia W. Westerhout, John Simes, 
Christopher B. Granger, Felix Zijlstra, Eric Boersma, ErasmusMC, 
Rotterdam, The Netherlands
Learning Objective: We investigated which (categories of) MI 
patients would benefit most of the strategy of PPCI, and thus have 
lowest numbers needed to treat (NNTs).
1051-316 Time Distribution of Re-Infarction After 
Thrombolysis: Relevance for Optimal Treatment 
Strategy in Acute Myocardial Infarction
Giovanna Giannotti, Paola Capozza, Silva Severi, Giovanni Micheli, 
Marta Focardi, Mario Marzilli, Cardiac and Thoracic Department, 
University Hospital of Pisa, Pisa, Italy, Division of Cardiology, 
Misericordia Hospital, Grosseto, Italy
Learning Objective: Identify the importance of a timely strategy to 
combine benefit of PCI and thrombolysis in STEMI.
1050 ACUTE MYOCARDIAL INFARCTION--
PERCUTANEOUS INTERVENTIONAL TECHNIQUES
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1050-307 Radial Access during Primary Angioplasty in Acute 
Myocardial Infarction. Experience of a Unique 
Center in Southamerica
Luis A. Pérez, Eduardo Lecannelier, Reinaldo Venegas, Jorge 
Gajardo, Alvaro Saldaña, Jessica Parra, Virginia Segall, Isabel 
Robles, Guillemo Grant Benavente Hospital, Concepcion, Chile, 
School of Medicine, University of Concepcion, Concepcion, Chile
Learning Objective: Know that transradial percutaneous coronary 
intervention during primary angioplasty for acute myocardial 
infarction is as safe and effective as femoral approach.
1050-308 Assessment Of The Safety And Performance Of The 
Stentys Self-expanding Coronary Stent System In 
Acute Myocardial Infarction
Christian Spaulding, Giovanni Amoroso, Stefan Verheye, Robert-
Jan van Geuns, Karl Hauptmann, Martin Rothman, Shahrzad 
Sepehrkhouy, Hopital Cochin, Paris, France
Learning Objective: Demonstrate continued vessel lumen increase 
after implantation of a self-expanding stent for AMI treatment
1050-309 Long-term Efficacy And Safety Of Zotarolimus-
Eluting Stent Versus Sirolimus-Eluting Stent In 
Patients With ST-Elevation Myocardial Infarction 
Who Underwent Primary Percutaneous Coronary 
Intervention
Yoon Seok Koh, Ki-Bae Seung, Wook-sung Chung, Kiyuk Chang, Hun-
Jun Park, Eun-ho Choo, Jae-Sun Uhm, GeeHee Kim, Suk-Min Seo, 
Woo Baek Chung, Mahn Won Park, Min Seok Choi, Seung Jung Park, 
KAMIR invastigators, Seoul St. Mary’s Hospital, Seoul, South Korea
Learning Objective: distinguish
1050-310 Left versus Right Radial Access Provide Rapid and 
Equivalent Procedure Times for Primary PCI in 
STEMI
Christopher T. Pyne, Peter Larsen, Cathy Jeon, Sergio Waxman, 
Thomas Piemonte, Saumil Shah, Lahey Clinc Medical Center, 
Burlington, MA
Learning Objective: Demonstrate equivelence of radial access sites 
in primary PCI for STEMI.
1050-311 In-Hospital and Long-Term Outcome of Primary 
Percutaneous Coronary Intervention for Acute 
Myocardial Infarction due to Left Main Coronary 
Artery Occlusion
Takuya Izumikawa, Shingo Sakamoto, Satoshi Takeshita, Akihiko 
Takahashi, Shigeru Saito, Shonan Kamakura General Hospital, 
Kamakura, Japan, Sakurakai Takahashi Hospital, Kobe, Japan
Learning Objective: Demonstrate In patients with AMI due to LMT-
occlusion, successful reperfusion did not improve the survival when 
hemodynamic collapse existed upon arrival.
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1052-323 Rosiglitazone Alters Characteristics of Ischemic 
Ventricular Fibrillation in Pigs
Mohammad Sarraf, Li Lu, Ya Xu, Michael J. Reiter, Clifford Greyson, 
Gregory G. Schwartz, VA Medical Center and University of Colorado, 
Denver, CO
Learning Objective: describe the effects of anti-diabetic 
thiazolidinedione drugs on characteristics of ischemic ventricular 
fibrillation.
1098 NOVEL BIOMARKERS FOR DIAGNOSIS AND RISK 
STRATIFICATION IN ACS
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1098-256 Plasma Soluble Lectin-Like Oxidized Low-Density 
Lipoprotein Receptor-1 Levels Measurement for 
the Early Diagnosis of ST Elevation Myocardial 
Infarction: Comparative Study with Myocardial 
Necroses Markers
Nobuaki Kobayashi, Noritake Hata, Yoshihiko Seino, Noriaki Kume, 
Takuro Shinada, Yasuhiro Takahashi, Kyoichi Mizuno, Chiba Hokusoh 
Hospital, Nippon Medical School, Chiba, Japan
Learning Objective: evalutate the usefulness of soluble lectin-like 
oxidized low-density lipoprotein receptor-1
1098-257 Cytokine And Chemokine Expression Profile Within 
The Coronary Circulation Of Patients With Acute 
Coronary Syndromes.
Paolo Golino, Raffaele De Palma, Elena D’Aiuto, Plinio Cirillo, 
Gianluca Petrillo, Paola Mariettta, Paolo Calabrò, Federico Piscione, 
Massimo Chiariello, Second University of Naples, Naples, Italy, 
University of Naples “Federico II”, Naples, Italy
Learning Objective: Identify citokine production within the coronary 
circulation as an important pathophysiological mechanism in acute 
coronary syndromes
1098-259 A Prognostic Proteomic Biomarker Algorithm for 
Acute Myocardial Infarction: a Kaiser Permanente - 
Orentreich Foundation Nested Case-Control study.
Carlos Iribarren, Charles P. Quesenberry, Evangelos Hytopoulos, 
Bruce H. Phelps, Edward R. McCluskey, WuXiong Li, Huang Huang, 
Jeanne A. Darbinian, Norman Orentreich, Joseph Vogelman, Kaiser 
Permanente Division of Research, Oakland, CA
Learning Objective: Demonstrate the ability of a panel of 
inflammatory biomarkers to predict AMI
1098-260 Expansion of Th17 cells and IL-17 production are 
detectable in selected patients with Acute Coronary 
Syndromes.
Paolo Golino, Plinio Cirillo, Elena D’Aiuto, Danilo Rinaldi, Francesco 
Borriello, Gianfranco Abbate, Paolo Calabrò, Greta Luana D’Ascoli, 
Raffaele Calabrò, Raffaele De Palma, Second University of Naples, 
Naples, Italy, University of Naples “Federico II”, Naples, Italy
Learning Objective: Identify Th17 cells as important contributor to 
plaque complication
1051-317 The Salvaged Area at Risk In Rescue Percutaneous 
Coronary Intervention: Quantification by 
Cardiovascular Magnetic Resonance
Jessica Sánchez-Quinones, Juan Miguel Ruiz-Nodar, Feliu Rey 
Eloisa, Jose Valencia, Garcia-Carbonell Milagros, Patricio Perez-
Berbel, Vicente Mainar Tello, Patricia Martin, Francisco Sogorb Garri, 
Hospital General Universitario de Alicante, Alicante, Spain
Learning Objective: To identify by means of Cardiovascular Magnetic 
Resonance (CMR) the salvaged area at risk in patients that 
underwent rescue PCI as well as to identify the variables in relation 
with the salvaged area.
1052 NOVEL THERAPIES FOR CARDIOGENIC SHOCK
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1052-319 Hemodynamic Assessment Of Impedance 
Cardiography Compared With Clinical Evaluation 
And B Type Natriuretic Peptide (BNP) In Patients 
With Acute Heart Failure.
marcelo westerlund montera, Sabrina Pereira, Raphael Osugi, Yvana 
Pereira, Marcelo Diniz, Ana Luiza Silva, André Volschan, Evandro 
Mesquita, Procardiaco Hospital, Rio de Janeiro, Brazil
Learning Objective: Demonstrate that cardiography impedance 
has an aditional value to clinic assessment through definition of 
hemodynamic condition in acute heart failure patients.
1052-320 Acute Hemodynamic Changes Following Placement 
of TandemHeart Percutaneous Ventricular Assist 
Device for Refractory Cardiogenic Shock
Thomas M. Todoran, Sripal Bangalore, Alexandra Sims, Scott Kinlay, 
Andrew C. Eisenhauer, Piotr S. Sobieszczyk, Brigham and Women’s 
Hospital, Boston, MA
Learning Objective: Demonstrate the acute hemodynamic changes 
associated with insertion of TandemHeart percutaneous ventricular 
assist device in patients with refractory cardiogenic shock.
1052-321 Incidence of Left Ventricular Systolic Dynamic 
Obstruction in Non-Cardiogenic Shock Treated with 
Positive Ionotropic Agents.
Vikas Aggarwal, Elena Tessitore, Ujwal R. Neravetla, Jay S. Meisner, 
Jacobi Medical Center, Bronx, NY
Learning Objective: Investigate whether treatment of non-cardiogenic 
shock with vasopressors possessing positive ionotropic properties 
can induce systolic dynamic obstruction of the left ventricle.
1052-322 Impact of Initial Recorded Rhythm on Cardiac 
Arrest Patients Treated with Extracorporeal 
Cardiopulmonary Resuscitation
Eisuke Kagawa, Ichiro Inoue, Takuji Kawagoe, Masaharu Ishihara, 
Yuji Shimatani, Satoshi Kurisu, Yasuharu Nakama, Kazuoki Dai, 
Takayuki Otani, Hiroki Ikenaga, Yoshimasa Morimoto, Kentaro Ejiri, 
Nozomu Oda, Hiroshima City Hospital, Hiroshima, Japan
Learning Objective: We demonstrated the neurological outcomes in 
the PEA-group and asystole-group patients were poor, but 2 patients 
in the PEA-group achieved a favourable neurological outcome and 
returned to their forme
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1099-266 Implications of Bundle Branch Block in Patients 
Undergoing Primary Angioplasty in the Stent Era: 
Short and Long-Term Prognosis
David Vivas, Maria Jose Pérez-Vizcayno, Antonio Fernández-Ortiz, 
Camino Bañuelos, Javier Escaned, Pilar Jiménez-Quevedo, Ivan 
Núñez-Gil, Juan Jose González-Ferrer, Rosana Hernández-Antolin, 
Carlos Macaya, Fernando Alfonso, Cardiovascular Institute, San 
Carlos University Hospital, Madrid, Spain
Learning Objective: Identify higher risk patients with ST-segment 
elevation myocardial infarction
1099-267 New or Presumed New Left Bundle Branch Block in 
Patients with Acute Myocardial Infarction: Findings 
From ACTION Registry-GWTG
Khung Keong Yeo, Shuang Li, Tracy Y. Wang, Deepak L. Bhatt, Jorge 
Saucedo, Michael C. Kontos, Matthew T. Roe, William J. French, 
University of California, Davis Medical Center, Sacramento, CA, 
Harbor-UCLA Medical Center, Torrance, CA
Learning Objective: To describe the differences in clinical 
presentation and outcomes in patients with acute myocardial 
infarction presenting with left bundle branch block and ST-segment 
elevation
1099-268 ST-resolution Following Primary Percutaneous 
Coronary Intervention in Acute Myocardial Infarction 
is Associated With Early Recovery of Vagal Reflexes.
Gaetano Maria De Ferrari, Antonio Sanzo, Grazia M. Castelli, 
Annalisa Turco, Fabio Badilini, Peter J. Schwartz, Dept. of Cardiology 
- Fondazione IRCCS Policlinico San Matteo and University of Pavia, 
Pavia, Italy, AMPS-llc, New York, NY
Learning Objective: Acknowledge the possibility to measure vagal 
reflexes in acute myocardial infarction from spontaneous BP and 
HR recordings. Assess the correlation between reperfusion and 
recovery of vagal reflexes
1099-269 Patients with New or Presumably New Left Bundle 
Branch Block Have a Low Rate of Acute Myocardial 
Infarction
Michael C. Kontos, Vinh Q. Chau, Charlotte S. Roberts, Joseph 
P. Ornato, George W. Vetrovec, Virginia Commonwealth University, 
Richmond, VA
Learning Objective: Describe ECG criteria for diagnosing patients 
with LBBB and possible MI
1099-271 Lateral ST-Segment Elevation Is a Strong Predictor 
of Impaired Myocardial Reperfusion in Patients with 
Inferior Acute Myocardial Infarction
Masami Kosuge, Toshiaki Ebina, Kiyoshi Hibi, Satoshi Morita, 
Kengo Tsukahara, Noriaki Iwahashi, Jyun Okuda, Kazuaki Uchino, 
Toshiyuki Ishikawa, Satoshi Umemura, Kazuo Kimura, Yokohama 
City University Medical Center, Yokohama, Japan
Learning Objective: Evaluate the clinical significance of ST-segment 
elevation in leads V5-6 in patients with recanalized inferior acute 
myocardial infarction
1098-261 Elevated Soluble Lectin-like Oxidized LDL 
Receptor-1 (LOX-1) in Coronary Circulation of 
Patients with Acute Coronary Syndrome
Hiroyuki Kunii, Yasuto Hoshino, Tomofumi Misaka, Hiroyuki 
Mizukami, Nobuo Sakamoto, Koichi Sugimoto, Kazuhiko Nakazato, 
Yoshiko Fujita, Tetsuya Sawamura, Toshiyuki Ishibashi, Yasuchika 
Takeishi, Department of Cardiology and Hematology, Fukushima 
Medical University, Fukushima, Japan, Department of Vascular 
Physiology, National Cardiovascular Center Research Institute, 
Osaka, Japan
Learning Objective: Demonstrate that soluble LOX-1 in coronary 
circulation is elevated in ACS
1098-262 Identification of Salivary Biomarkers of Acute 
Myocardial Infarction Using Classification and 
Regression Tree Analysis
Joseph D. Foley, III, Charles L. Campbell, Craig S. Miller, J. Darrell 
Sneed, Alison L. Bailey, Dawn G. Dawson, Pierre N. Floriano, 
Nicolaos Christodoulides, Beate G. Rose, Jackie Singleton, Jeffrey 
L. Ebersole, Steven Steinhubl, Denis F. Kinane, Richard J. Kryscio, 
M. John Novak, John T. McDevitt, Department of Internal Medicine, 
Cardiology Division, College of Medicine, University of Kentucky, 
Lexington, KY
Learning Objective: To determine if salivary biomarkers could 
help facilitate an earlier screening diagnosis of acute myocardial 
infarction.
1098-263 The Impact Of Genetic Variability Of Fibrinogen 
A-Chain Gene Defines Fibrinogen Levels Between 
Healthy Individuals And Patients With Documented 
Atherosclerosis: Effects On Prothrombotic Profile
Nikos Papageorgiou, Dimitris Tousoulis, George Hatzis, Antigoni 
Miliou, Charalambos Antoniades, Anastasios Giolis, Maria 
Kozanitou, Alexandros Briasoulis, Alexios Antonopoulos, Eirini 
Bosinakou, Christodoulos Stefanadis, 1st Cardiology Unit 
Hippokration Hospital, Athens, Greece
Learning Objective: Evaluate the impact of the G58A polymorphism 
on fibrinogen levels and prothrombotic profile in patients with CAD
1099 THE ELECTROCARDIOGRAM, CHEST PAIN 
EVALUATION AND ACS OUTCOME
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1099-265 Association of Morphologic Variability with 
Ventricular Tachycardia and Ventricular Pause 
in Patients Treated with Ranolazine or Placebo 
Following Non-ST-Elevation Acute Coronary 
Syndrome
Zeeshan Syed, Benjamin M. Scirica, David A. Morrow, Collin M. 
Stultz, John V. Guttag, University of Michigan, Ann Arbor, MI, TIMI 
Study Group, Brigham and Women’s Hospital, Boston, MA
Learning Objective: identify patients at increased risk of arrhythmia 
post-NSTEACS
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1100-277 One-Year Outcomes after Tirofiban Versus 
Abciximab Infusion in 745 Patients with St-segment 
Elevation Myocardial Infarction Undergoing Primary 
Intervention: Insights from the Mltistrategy Trial
Marco Valgimigli, Gianluca Campo, Matteo Tebaldi, Leonardo 
Bolognese, Maurizio Anselmi, Salvatore Colangelo, Nicoletta De 
Cesare, Alfredo E. Rodriguez, Maurizio Ferrario, Raul Moreno, 
Cardiovascular Institute, University of Ferrara, Ferrara, Italy, 
Cardiovascular Research Centre, Salvatore Maugeri Foundation, 
IRCCS Gussago (BS), Gussago, Italy
Learning Objective: evaluate long-term benefit of tirofiban treatment 
compared to abciximab in STEMI patients undergoing primary PCI
1100-278 Patients with Previous Definite Stent Thrombosis 
Have a Larger Fraction of Immature Platelets and a 
Reduced Antiplatelet Effect of Aspirin
Morten Würtz, Erik L. Grove, Lise N. Wulff, Anne K. Kaltoft, Hans H. 
Tilsted, Lisette O. Jensen, Anne-Mette Hvas, Steen D. Kristensen, 
Aarhus University Hospital, Skejby, Aarhus, Denmark
Learning Objective: Patients with previous stent thrombosis have a 
reduced antiplatelet effect of aspirin compared to matched controls. 
This might be caused by an increased platelet turnover.
1100-279 Comparison of Net Clinical Efficacy of Novel 
Antiplatelet Agents for Acute Coronary Syndrome 
Using Bayesian Analysis
Christopher Lang, Rohit Arora, Chicago Medical School, Chicago, IL, 
University of Rochester Medical Center, Rochester, NY
Learning Objective: Interpret the net clinical efficancy using 
Bayesian analysis of novel antiplatelet agents
1100-280 Aspirin Failure Is Associated with Worse Clinical 
Outcome but Not with an Inadequate Platelet 
Response to Aspirin in Patients with Acute 
Myocardial Infarction
Roy S. Beigel, Hanoch Hod, Boris Shenkman, Paul Fefer, Naphtali 
Savion, David Varon, Shlomi Matetzky, The Heart Institute, Sheba 
Medical Center, Tel Hashomer, Israel, Sackler School of Medicine, 
Tel Aviv University, Tel Aviv, Israel
Learning Objective: To clarify the clinical significance and 
pathogenesis of aspirin failure in patients with acute myocardial 
infarction.
1101 ACUTE MYOCARDIAL INFARCTION--TIMING 
ISSUES IN REPERFUSION THERAPY
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1101-282 Does Weekend Effect of Myocardial Infarction Still 
Exist - A Nationwide Analysis?
Nilay Kumar, Abhishek Deshmukh, Emily McGinley, Daniel Eastwood, 
Sergey Tarima, Gagan Kumar, Medical College of Wisconsin, 
Milwaukee, WI
Learning Objective: Identify the discrepancies in the outcomes of 
myocardial infarction
1099-272 ASia Pacific Evaluation of Chest pain Trial (ASPECT) 
- New Zealand arm
Sally Aldous, Martin Than, Mark Richards, Christchurch Hospital, 
Christchurch, New Zealand
Learning Objective: identify low risk patients presenting to the 
emergency department with symptoms suggestive of acute coronary 
syndromes
1100 ACUTE MYOCARDIAL INFARCTION--NEW 
INSIGHTS INTO ANTIPLATELET THERAPY
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1100-273 Proton Pump Inhibitors are Associated with 
Cardiovascular Risk Independent of Clopidogrel Use 
in Patients with Myocardial Infarction: A Nationwide 
Propensity Score Matched Study
Mette G. Charlot, Ole Ahlehoff, Casper H. Jorgensen, Steen Z. 
Abildstrom, Lars Køber, Peter R. Hansen, Christian Torp-Pedersen, 
Gunnar Gislason, Department of Cardiology,Gentofte Hospital, 
Copenhagen University Hospital, Hellerup, Denmark, The Heart 
Centre, Department of Cardiology, Rigshospitalet, Copenhagen 
University Hospital, Copenhagen, Denmark
Learning Objective: Demonstrate that proton pump inhibitors are 
associated with cardiovascular risk independent of clopidogrel use 
in patients with myocardial infarction.
1100-274 The Incidence of Arrhythmias and Clinical 
Arrhythmic Events in Patients with Acute Coronary 
Syndromes Treated with Ticagrelor or Clopidogrel in 
the PLATO Trial
Benjamin M. Scirica, Christopher P. Cannon, Håkan Emanuelsson, 
Robert A. Harrington, Steen Husted, Stefan K. James, Hugo Katus, 
Eric L. Michelson, Pais Prem, Raev Dmitar, Jindrich Spinar, MD, Ph 
Gabriel Steg, Robert F. Storey, Lars Wallentin, TIMI Study Group, 
Brigham and Women’s Hospital, Boston, MA
Learning Objective: To understand relationship between ticagrelor 
and bradycardic events
1100-276 Ticagrelor Does Not Affect Pulmonary Function 
Tests Compared to Clopidogrel in Acute Coronary 
Syndromes: Results of the Plato Pulmonary 
Substudy
Robert F. Storey, Richard C. Becker, Christopher P. Cannon, Frank 
Cools, Håkan Emanuelsson, Robert A. Harrington, Steen Husted, 
Stefan James, Hugo Katus, Khurmi Nardev, Soo Teik Lim, Ph Gabriel 
Steg, Lars Wallentin, University of Shefﬁeld, Shefﬁeld, United 
Kingdom, Uppsala Clinical Research Center, Uppsala, Sweden
Learning Objective: Understand the nature of dyspnea associated 
with ticagrelor
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1102 VASCULAR BIOLOGY OF MYOCARDIAL ISCHEMIA/
INFARCTION
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1102-290 Extent of Cholesterol Crystals in Coronary Artery 
Aspirates During Acute Myocardial Infarction
George S. Abela, Fadi Shamoun, Ameeth Vedre, Dorothy R. Pathak, 
Ibrahim Shah, Guarav Dhar, Dale Lefﬂer, Michigan State University, 
East Lansing, MI, Sparrow Hospital, Lansing, MI
Learning Objective: This demonstrates the extent of cholesterol 
crystals in the aspirate obstructing the coronary artery.
1102-291 ROCK2 Polymorphisms Are Not Associated With 
Vasospastic Angina
Sang-Yong Yoo, Joung-Wook Kim, Sangsig Cheong, Dae-Hee Shin, 
Jinkun Jang, Changkun Lee, Kyoung-Hee Kim, University of Ulsan 
College of Medicine Gangneung Asan Hospital, Gangneung, South 
Korea
Learning Objective: demonstrate that ROCK2 polymorphisms may 
not associated with the pathogenesis of vasospastic angina.
1102-292 Erythropoietin Enhances Arginase Ii Activity Against 
Nitric Oxide Synthase Mediated Nitrosative Stress In 
Rat Post-ischemic Hearts
Yih-Sharng Chen, Ming-Chieh Ma, National Taiwan University 
Hospital, Taipei, Taiwan,ROC, Fu Jen Catholic University, Taipei, 
Taiwan,ROC
Learning Objective: At the conclusion of this presentation, 
participants will be able to understand a novel mechanism of 
erythropoietin-mediated cardioprotection
1102-293 Correlation Between Microvascular Obstruction 
And Index Of Microcirculatory Resistance For 
Assessment Of Microvascular dysfunction In 
Patients With Acute Myocardial Infarction
Jong Hoon Koh, Duk Kyu Cho, Hee Woo Lee, Miyoung Kim, 
Kwandong University Mongji Hospital, Goyang, South Korea, Goyang, 
South Korea
Learning Objective: microvascular dysfunction
1102-294 Association of Morphological Characteristics of 
Culprit Atheromatic Plaques With the Outcome of 
Thrombolytic Therapy: New Implications of Optical 
Coherence Tomography
Konstantinos Toutouzas, Elefterios Tsiamis, Antonis Karanasos, 
Maria Drakopoulou, Andreas Synetos, Maria Riga, Costas Tsiouﬁs, 
Dimitrios Tousoulis, Elli Stefanadi, Christodoulos Stefanadis, 1st 
Department of Cardiology, Hippokration Hospital, Athens, Greece
Learning Objective: gain new insight about the impact of plaque 
morphology on the outcome of thrombolytic therapy.
1101-283 Ripple Effects of a Novel D2B Pathway
Monica G. Sanchez-Ross, James M. Maher, Mike Kasper, Gerard 
Oghlakian, Brijesh Patel, Vivek N. Dhruva, Edo Kaluski, David 
Langley, William Dougan, Diane Alfano, Marc Klapholz, University of 
Medicine and Dentistry New Jersey, Newark, NJ
Learning Objective: Identify a novel method for shortening D2B 
times
1101-284 Delays in Time to Reperfusion Therapy in Patients 
who develop ST-Elevation Myocardial Infarction 
During Hospitalization
Jeff Booker, Anthony Hilliard, Chris Bjerke, Heather Wiste, Ryan 
Lennon, Malcolm Bell, Charanjit Rihal, Bernard Gersh, David 
Holmes, Henry Ting, Mayo Clinic, Rochester, MN
Learning Objective: identify the characteristics of patients 
developing STEMI while in-hospital and the challenges of providing 
timely reperfustion.
1101-285 Achieving First Door-to-Balloon Times of 90 Minutes 
for Transfer ST-Elevation Myocardial Infarction
B. Hadley Wilson, Angela D. Humphrey, Robert H. Haber, John 
C. Cedarholm, Glen K. Kowalchuk, Michael J. Rinaldi, William E. 
Downey, Kevin M. Collier, Patricia M. Pye, Denise A. Miller, Jennifer 
L. Saraﬁn, Tom Blackwell, J. Lee Garvey, Carolinas Medical Center, 
Charlotte, NC
Learning Objective: Identify components essential to improving 
transfer STEMIs first door-to-balloon times
1101-286 False Positive Catheterization Laboratory Activation 
Rates in the RACE Regional ST Elevation Myocardial 
Infarction Program
James G. Jollis, J. Lee Garvey, Lisa Monk, Jonathan R. Studnek, 
Mayme L. Roettig, Christopher B. Granger, Duke University, Durham, 
NC, Carolinas Medical Center, Charlotte, NC
Learning Objective: Understand benchmark rates for cath. lab 
activation accuracy
1101-288 The Importance Of Pre-hospital Infarct Diagnosis 
And Therapy On Initial Patency Of The Infarct 
Related Vessel Before PCI In Patients With Stemi
Sonja Postma, J.H.E. Dambrink, M.J. De Boer, A.T.M Gosselink, J.P. 
Ottervanger, J.C.A. Hoorntje, E. Kolkman, H. Suryapranata, A.W.J. 
Van ‘t Hof, Diagram B.V., Zwolle, The Netherlands
Learning Objective: Demonstrate that pre-hospital infarct diagnosis 
with concomitant early initiation of aspirin and heparin is associated 
with improved initial patency of the infarct related vessel before PCI.
1101-289 Late Open for Infarct-Related Artery Still Work 
Better Than Not for Patients with Acute Myocardial 
Infarction: A 15-year Survival Analysis
Ta-Chen Su, Ming-Fong Chen, Juey-Jen Hwang, Tsun-Den Tseng, 
Hsian-Li Kao, Yuan-Teh Lee, Chiau-Suong Liau, Division of 
Cardiology, Department of Internal Medicine, National Taiwan 
University Hospital, Taipei, Taiwan,ROC, Cardiovascular Center, Tzu-
Chi Hospital, Hsin-Dian, Taipei, Taiwan,ROC
Learning Objective: The better treatment strategies in patients with 
AMI
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1104 MYOCARDIAL ENERGETICS AND PROTECTION
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1104-302 Abnormal Myocardial Energetics in Chronic 
Hibernating Myocardium at High Cardiac Work Load
Mohammad N. Jameel, Qiang Xiong, Qinglu Li, Abdul Mansoor, Jianyi 
Zhang, University of Minnesota, Minneapolis, MN
Learning Objective: describe myocardial energetics in chronic 
hibernating myocardium.
1104-303 Exercise Training Improves Cardiac FunctionThrough 
Increase In Autophagosome Degradation And Fatty 
Acid Uptake
Bai-Chin Lee, Ching-Yi Chen, Hsiu-Ching Hsu, Ming-Fong Chen, 
National Taiwan University Hospital, Taipei, Taiwan,ROC
Learning Objective: identify the role of exercise on cardiac 
autophagosome degradation and fatty acid uptake
1104-304 Cardioprotective Effects of α1-Antitrypsin in 
Experimental Acute Myocardial Infarction due to 
Transient Ischemia in the Mouse
Antonio Abbate, Benjamin W. Van Tassell, Ignacio M. Seropian, 
Stefano Toldo, Lisa Smithson, Charles A. Dinarello, Virginica 
Commonwealth University, Pauley Heart Center, Richmond, VA, 
University of Colorado, Arora, CO
Learning Objective: To learn that AAT is an endogenous anti-
inflammatory protein able to protect the heart during ischemic injury
1104-305 The Aging Heart is Susceptible to Cardiomyocyte 
Apoptosis and Resistant to Anti-Apoptotic Therapies
Joy I. Hwang, Henry H. Shih, Brian Lee, Yan Zhang, Jianqin Ye, 
Richard E. Sievers, Eddie Rame, William Grossman, Randall J. Lee, 
Yerem Yeghiazarians, Andrew J. Boyle, University of California, San 
Francisco, San Francisco, CA
Learning Objective: identify the difference in apoptosis between 
young and old mice, as well as understand the importance of 
creating a well-characterized aging mouse model.
1104-306 Cardioprotective Effects of PPARγ in the Developing 
Heart
Xiaoping Jin, Brian Crawford, Ming Shen, Ronald W. Joyner, Mary B. 
Wagner, Guoliang Ding, Departemnt of Pediatrics, Emory University, 
Atlanta, GA, Children’s Healthcare of Atlanta, Atlanta, GA
Learning Objective: Demonstrate
1103 MYOCARDIAL ISCHEMIA/INFARCTION: CELL-
BASED THERAPY
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1103-296 Myocardial Perfusion After Intracoronary Infusion 
of Mononuclear Cells of Bone Marrow or Peripheral 
Blood After Acute Myocardial Infarction
Farshid Afsharzada, Robin Nijveldt, Alexander Hirsch, Pieter A 
van der Vleuten, Aernout M. Beek, Jan G.P. Tijssen, Jan J. Piek, 
Felix Zijlstra, Albert C. van Rossum, VU University Medical Center, 
Amsterdam, The Netherlands, Interuniversity Cardiology Institute of 
the Netherlands, Utrecht, The Netherlands
Learning Objective: evaluate the effects of intracoronary infusion 
of mononuclear cells on the recovery of myocardial perfusion after 
reperfused acute myocardial infarction (AMI)
1103-297 Transplantation Of Cardiogenic Cells Differentiated 
From Mesenchymal Stem Cells Improves Cardiac 
Repair In Ischemic Hearts
Ki-Chul Hwang, Byeong-Wook Song, Heesang Song, Min-Ji Cha, 
Eunju Choi, Onju Ham, Namsik Chung, Yangsoo Jang, Cardiovascular 
Research Institute, Division of Cardiology, Yonsei University College 
of Medicine, Seoul, South Korea
Learning Objective: demonstrate
1103-298 Endothelial Colony-Forming Cells are Associated 
With Infarct Size Reduction Through Reduction of 
Microvascular Obstruction
Nicolas F. Meneveau, Frederic Deschaseaux, Vincent Descotes-
Genon, Francois Schiele, Pierre Tiberghien, Jean-Pierre Bassand, 
Siamak Davani, University Hospital Jean Minjoz, Besancon, France, 
INSERM U645, Etablissement Français du Sang Bourgogne Franche-
Comté, Besancon, France
Learning Objective: describe the mechanism by which endothelial 
progenitor cells improve left ventricular remodeling after MI
1103-299 Human Umbilical Cord Blood Stem Cells Secrete 
Growth Factors and Anti-Inflammatory Cytokines 
that Protect Vascular Endothelial Cells and Cardiac 
Myocytes from Ischemia and Injury
Robert J. Henning, Darrell Sawmiller, David Fleming, Lorynn Hunter, 
Jeffrey Aufman, Michael B. Morgan, James A. Haley Hospital, Tampa, 
FL, University of South Florida College of Medicine, Tampa, FL
Learning Objective: identify that stem cells have paracrine effects 
that limit apoptosis and necrosis in myocardial infarction
1103-300 Hypoxia Accelerates and Enhances 
Cardiomyogenesis in Mesenchymal Stem Cells: An 
Environmental Cue for a Cardiac Challenge
Arti A. Ramkisoensing, Daniel A. Pijnappels, Antoine A. de Vries, 
Arnoud van der Laarse, Martin J. Schalij, Douwe E. Atsma, Leiden 
University Medical Center, Leiden, The Netherlands
Learning Objective: to identify the importance of local environmental 
cues on the regenerative potential of MSCs in cardiac cell therapy
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1106 PRE-HOSPITAL EMERGENCY THERAPIES FOR 
CARDIAC ARREST
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1106-313 Increasing Trend of Pre-Transport Death of Heart 
Attack in the United States From 2000 to 2006
Shifan Dai, Jing Fang, Nora L. Keenan, Robert K. Merritt, Centers for 
Disease Control and Prevention, Atlanta, GA
Learning Objective: demonstrate that, in the most recent years, 
the proportion of heart attack deaths that occurred before patients 
were being transported to a hospital increased substantially in US.
1106-314 Regional Brain Oxygen Saturation as a Novel Index 
of Neurological Outcomes in Patients With Out-of-
Hospital Cardiogenic Cardiac Arrest
Noritoshi Ito, Shinsuke Nanto, Yasuji Doi, Hirotaka Sawano, Daisaku 
Masuda, Shizuya Yamashita, Mai Hatano, Daisuke Tonomura, Yuma 
Kurozumi, Tomoaki Natsukawa, Yusuke Ito, Kazuyuki Oka, Jiro Ooba, 
Taizo Hasegawa, Makoto kobayashi, Hiroshi Ichiyanagi, Koji Akashi, 
Koichi Otsuya, Shoji Kaibe, Ken-ichiro Okada, Yasuyuki Hayashi, 
Tatsuro Kai, Toru Hayashi, Osaka Saiseikai Senri Hospital, Suita, 
Japan, Osaka University Graduate School of Medicine, Suita, Japan
Learning Objective: identify that regional brain oxygen saturation 
(rSO2) can be used as a new useful index for estimating the 
neurological prognosis in patients with out-of-hospital cardiogenic 
cardiac arrest.
1106-315 Obtaining a Pre-hospital Electrocardiogram by 
Emergency Medical Personnel Shortens Total 
Ischemic Time for ST Elevation Myocardial 
Infarction Patients
Mitul Patel, James Dunford, Steve Aguilar, Edward Castillo, Ehtisham 
Mahmud, University of California San Diego, San Diego, CA, City of 
San Diego EMS, San Diego, CA
Learning Objective: Appreciate the impact of pre-hospital 
electrocardiography in reducing total ischemic time for STEMI 
patients
1106-316 The Earlier, the Better
Tomoki Shokawa, Koichi Tanigawa, Ken Ishibashi, Takenori Okada, 
Kenji Nishioka, Yukiko Nakano, Hiroki Teragawa, Futoshi Tadehara, 
Hideya Yamamoto, Tkafumi Ishida, Yasuki Kihara, Hiroshima 
University, Hiroshika, Japan
1106-317 CPR Before Defibrillation for Out-of-Hospital Cardiac 
Arrest: A Systematic Review and Meta-Analysis of 
Randomized Controlled Clinical Trials
Pascal Meier, Hitinder S. Gurm, Bettina Henzi, Ozlem Ozdemir, 
Stanley Chetcuti, Paul M. Grossman, Guido Knapp, University of 
Michigan Medical Center, Ann Arbor, MI
Learning Objective: Our data demonstrate that current evidence 
clearly advocates immediate defibrillation.
1105 HYPOTHERMIC THERAPY FOR CARDIAC ARREST
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1105-307 Early Induction of Hypothermia Therapy Prior to 
Revascularization Therapy Improved Neurologic 
Outcomes in Cardiac Arrest Caused by Acute 
Coronary Syndrome: J-PULSE- Hypo Registry.
Shinichi Shirai, Kenji Ando, Yoshimitsu Soga, Kyohei Yamaji, 
Tatsuki Doijiri, Masahiko Goya, Masashi Iwabuchi, Hiroyoshi Yokoi, 
Hideyuki Nosaka, Masakiyo Nobuyoshi, Naohiro Yonemoto, Hiroyuki 
Yokoyama, Hiroshi Nonogi, Ken Nagao, Kokura Memorial Hospital, 
Kitakyushu, Japan
Learning Objective: interpret that early induction of hypothermia 
therapy prior to percutaneous intervention was effective to achieve 
favorable neurologic outcome
1105-308 Rapid Isolated Moderate Bilateral Cerebral 
Hypothermia Achieved With a Self Insulating 
Catheter System
David Meerkin, Sarai Mckemie, Glen Lieber, Ronald J. Solar, Shaare 
Zedek Medical Center, Jerusalem, Israel
Learning Objective: Demonstrate the ability to achieve bilateral 
moderate cerebral hypothermia using a single carotid artery 
catheter approach and evaluate the systemic temperature effects of 
this intervention
1105-309 Induced Hypothermia Improves Survival in Cardiac 
Arrest Patients
Michael C. Y. Chan, Carolyn Hoffman, William Hui, Demetrios J. 
Kutsogiannis, Punkiat Topipat, Randy Williams, Royal Alexandra 
Hospital, Edmonton, AB, Canada, University of Alberta, Edmonton, 
AB, Canada
Learning Objective: At the conclusion of this presentation, 
participants will be able to evaluate the usefulness of Induced 
Hypothermia for Cardiac Arrest patients, as well select appropriate 
patients for this treatment.
1105-310 The Prevalence and Prognostic Value of Myoclonus 
and Status Epilepticus Prior to or Following 
Therapuetic Hypothermia in Patients After Cardiac 
Arrest
Michael Bryant Kelley, James A. Wantuck, Kathleen Burns, John A. 
McPherson, Vanderbilt Heart and Vascular Institute, Nashville, TN
Learning Objective: describe the prevalence and prognostic impact 
of seizures in patients resuscitated from in-hospital and out of 
hospital cardiac arrest and treated with therapeutic hypothermia.
1105-311 Faster, Cooler, Better? A Comparison of Two 
Methods for Instituting Mild Therapeutic 
Hypothermia in Comatose Out of Hospital Cardiac 
Arrest Patients
Maximilian Mulder, Stephen W. Smith, Bradley A. Bart, Hennepin 
County Medical Center, Minneapolis, MN
Learning Objective: To determine which clinical approach to 
therapeutic hypothermia achieves target temperatures faster: 
surface or intravascular cooling?
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1152 MRI: NEW DEVELOPMENTS IN CMR
Monday, March 15, 2010, 9:30 am - 12:30 pm
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. – 10:30 a.m.
CME/CE Hours: 1
1152-256 Cardiac Causes of One-Year Readmission Following 
Percutaneous Coronary Intervention (PCI) for 
Ischemic Heart Disease: Retrospective Analysis of a 
Single-System Patient Cohort
Vipul Gupta, Anwar Tandar, Harpreet Bhutani, Dmitriy Kireyev, Clifford 
Graves, William E. Boden, University at Buffalo, Buffalo, NY
Learning Objective: Demonstrate high rate of cardiac cause of 
readmission after successful initial PCI within 1 year of follow up.
1152-257 Clinical Presentation and Plaque Morphology in 
Unstable Angina Pectoris: An Optical Coherence 
Tomography Study
Masato Mizukoshi, Takashi Kubo, Atsushi Tanaka, Shigeho 
Takarada, Hironori Kitabata, Takashi Tanimoto, Akio Kuroi, Hideyuki 
Ikejima, Kenichi Komukai, Yasushi Ino, Kumiko Hirata, Hiroto 
Tsujioka, Keishi Okochi, Manabu Kashiwagi, Yuichi Ozaki, Aiko 
Shimokado, Toshio Imanishi, Takashi Akasaka, Wakayama Medical 
University, Wakayama, Japan
Learning Objective: interpret the association of the etiology and 
clinical presentation in primary unstable angina
1153 OUTCOMES AFTER PERCUTANEOUS CORONARY 
INTERVENTION
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1153-259 Coronary Angiogram Findings in Patients Who 
Abuse Amphetamines: a Retrospective Analysis
Christopher B. Seaman, Zhongmin Li, Garrett B. Wong, UC Davis 
Medical Center, Sacramento, CA
Learning Objective: describe the effects of amphetamine use on 
coronary artery disease.
1153-260 Is Visual Interpretation of Coronary Epicardial 
Flow Reliable in ST Elevation Myocardial Infarction 
Patients Undergoing Primary Angioplasty? Insights 
from APEX-AMI
Osama Al-Hadramy, Cynthia M. Westerhout, Sorin J. Brener, 
Christopher B. Granger, Paul W. Armstrong, University of Alberta, 
Edmonton, AB, Canada
Learning Objective: To assess observer bias in estimation of TIMI 
flows in STEMI pts undergoing primary PCI
1107 PLATELETS AND INFLAMMATION IN MYOCARDIAL 
ISCHEMIA/INFARCTION
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1107-319 Clopidogrel and Aspirin versus Aspirin Alone in 
High-Risk Patients with Established Vascular 
Disease; A Meta-Analysis of Randomized Controlled 
Trials
Swapna Kamireddy, Marc S. Sabatine, Deepak L. Bhatt, Steven R. 
Steinhubl, William E. Boden, University at Buffalo, Buffalo, NY
Learning Objective: To show the benefits and risks of early 
clopidogrel and aspirin in high-risk patients with established 
vascular disease.
1107-320 Perioperative Clopidogrel Cessation and Risk of 
Adverse Cardiovascular Events
Beau Michael Hawkins, Michael Koehler, Pedro Lozano, University of 
Oklahoma Health Sciences Center, Oklahoma City, OK
Learning Objective: Understand the significant risk that 
perioperative clopidogrel discontinuation poses to patients receiving 
noncardiac surgery
1107-321 The Platelet Inhibition and Patient Outcomes Trial 
Is Representative of Patients With Acute Coronary 
Syndromes in a National Heart Registry
Ulf Stenestrand, Saga Johansson, Magnus Janzon, Lars Wallentin, 
Department of Cardiology, University Hospital, Linköping, Sweden
Learning Objective: compare the patient population enrolled in 
the PLATelet inhibition and patient Outcomes (PLATO) trial with an 
unselected ACS population seen in a national heart registry
1107-322 Proteomic Analysis of Circulating Human Platelets 
Reveals Potential Biomarkers in non-ST Segment 
Elevation Acute Coronary Syndrome
José Ramón González-Juanatey, Andrés F. Parguiña, Isaac Rosa, 
Lilián Grigorian-Shamagián, Elvis Teijeira-Fernández, Jana Alonso, 
Rosa Agra, Ángel García, Universidade de Santiago de Compostela, 
Santiago de Compostela, Spain, Complexo Hospitalario 
Universitario de Santiago, Santiago de Compostela, Spain
Learning Objective: understand how platelet proteomics can be 
used in cardiovascular research
1107-323 Increased Baseline Rho Kinase (ROCK) Activity is an 
Independent Predictor of 6 Month Cardiovascular 
Outcomes After Acute Coronary Syndrome (ACS)
Ming Dong, Mang Zhang, Rui-Jie Li, Qian-Huan Zhang, James K. 
Liao, Cheuk-Man Yu, The Chinese University of Hong Kong, Hong 
Kong, Hong Kong, Brigham and Women’s Hospital and Harvard 
Medical School, Boston, MA
Learning Objective: observe that baseline ROCK activity may be 
a potential independent predictor for the future cardiovascular 
outcomes
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1154-268 Effect Of Cilostazol Adding Or Clopidogrel Doubling 
On Platelet Function With Diabetes Mellitus And 
Coronary Artery Disease On Dual Antiplatelet 
Therapy
Sang Jin Ha, Weon Kim, Jong Shin Woo, Tae-Kyung Yu, Soo Joong 
Kim, Woo-Shik Kim, Myeong Kon Kim, Kwon Sam Kim, Kyunghee 
University Medical Center, seoul, South Korea
Learning Objective: demonstrate that adjunctive treatment with 
cilostazol in T2DM patients on standard dual antiplatelet therapy 
was strategy for overcoming clopidogrel resistance.
1154-269 Impact of Prior Chronic Antiplatelet Therapy on 
Short- and Long-term Adverse Events in Patients 
Presenting with an Acute Coronary Syndrome: 
Insights from the Acuity Trial
Giuseppe Ambrosio, Steven R. Steinhubl, Paolo Gresele, Isabella 
Tritto, Maurizio Bentivoglio, Cinzia Zuchi, David A. Cox, Brent T. 
McLaurin, Jeffrey W. Moses, Harvey D. White, Frederick Feit, Philip E. 
Aylward, Antonio Colombo, Harald Darius, Ramin Ebrahimi, Martial 
Hamon, Roxana Mehran, Gregg W. Stone, University of Perugia 
School of Medicine, Perugia, Italy
Learning Objective: appreciate the different, more severe risk profile 
typical of chronic antiplatelet users who get hospitalized for an 
episode of Non-ST elevation acute coronary syndrome.
1154-271 Effect of Proton Pump Inhibitors On Outcome Of 
Patients Discharged On Dual Antiplatelet Therapy 
After Percutaneous Coronary Intervention And Stent 
Implantation
Ioannis Tentzeris, Rudolf Jarai, Serdar Farhan, Ivan Brosovic, Peter 
Smetana, Alexander Geppert, Jolanta Siller-Matula, Kurt Huber, 
3rd Medical Department with Cardiology and Emergency Medicine, 
Wilhelminen Hospital, Vienna, Austria, Department of Clinical 
Pharmacology, University of Medicine, Vienna, Austria
Learning Objective: identify the effect of proton pump inhibitors on 
antiplatelet therapy
1154-272 Comparison of High-Dose (600mg) vs. Moderate-
Dose (300mg) Clopidogrel Loading in Patients 
Receiving Drug-Eluting Stents: A Subanalysis of a 
Randomized Trial
O Sung Kwon, Seung-Jung Park, Asan medical center, Seoul, South 
Korea
1153-261 Angiographic Characteristics of Coronary Stent 
Thrombosis
William Bennett, Khung Keong Yeo, Jason H. Rogers, Reginald I. 
Low, Etisham Mahmud, University of California San Diego, San 
Diego, CA, University of California Davis, Sacremento, CA
Learning Objective: Identify Agniographic characteristic of in stent 
thrombosis.
1153-262 Trends and Predictors of Length of Stay after 
Primary Percutaneous Coronary Intervention: A 
Report from the National Cardiovascular Data 
Registry
Chee Tang Chin, Tracy Y. Wang, David Dai, Matthew T. Roe, Rajendra 
H. Mehta, John S. Rumsfeld, H. Vernon Anderson, William S. 
Weintraub, John C. Messenger, Michael A. Kutcher, Ralph G. Brindis, 
Eric D. Peterson, Robert A. Harrington, Sunil V. Rao, Duke Clinical 
Research Institute, Durham, NC
Learning Objective: Identify temporal trends and predictors of length 
of stay after primary percutaneous coronary intervention
1154 PLATELET RESPONSIVENESS: ANTIPLATELET 
THERAPY
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1154-265 Association of Platelet Responsiveness with 
Clopidogrel Metabolism: Role of Compliance in the 
Assessment of “Resistance”
Victor Serebruany, Ganesh Cherala, Craig Williams, Wiktor 
Kuliczkowski, Dan Atar, Johns Hopkins University, Towson, MD
Learning Objective: Define the frequency of clopidogrel non 
compliance among patients with coronary artery disease and 
ischemic stroke
1154-266 ABCB1 Genetic Variants, Pharmacodynamic 
Response, and Cardiovascular Outcomes Following 
Treatment with Clopidogrel and Prasugrel
Jessica L. Mega, Sandra L. Close, Stephen D. Wiviott, Lei Shen, 
Joseph R. Walker, Elliott M. Antman, Eugene Braunwald, Marc 
S. Sabatine, TIMI Study Group, Brigham and Women’s Hospital, 
Boston, MA
Learning Objective: Identify the role of genetic variants in ABCB1 
on platelet inhibition and outcomes in the setting of treatment with 
clopidogrel.
1154-267 Cytochrome P450 2C19 Loss-of-function 
Polymorphism And Cardiovascular Events In 
Patients Treated With Drug-eluting Stent
Il-Young Oh, Chang-Hwan Yoon, Seung-Jung Park, Kyung-Woo Park, 
Hae-Young Lee, Hyun-Jai Cho, Hyun-Jai Kang, Hyo-Soo Kim, Seoul 
National University Hospital, Seoul, South Korea
Learning Objective: This study demonstrated the strong 
correlation between CYP2C19 loss-of-function polymorphism and 
cardiovascular events in patients treated with drug-eluting stent.
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1155-279 Single-center Evaluation of Epidemiology and 
Treatment of Patients With Acute Coronary 
Syndrome and Non Obstructive Coronary Artery 
Disease in the Real Life
Gaetano Maria De Ferrari, Sergio Leonardi, Lara Baduena, 
Alessandra Repetto, Enrico Chieffo, Angela Lesce, Maddalena 
Lettino, Mario Previtali, Dept. of Cardiology - Fondazione IRCCS 
Policlinico San Matteo and University of Pavia, Pavia, Italy, Dept. of 
Cardiology University of Piemonte Orientale, Novara, Italy
Learning Objective: Acknowledge the existence of patients with 
acute coronary syndrome and non obstructive coronary artery 
disease and estimate the prevalence of this condition.
1155-280 Threshold Level of Low-density Lipoprotein 
Cholesterol for the Effect of Statin Therapy in the 
Acute Phase of Myocardial Infarction: An Analysis 
from the Korea Acute Myocardial Infarction Registry
Jang Hoon Lee, Dong Heon Yang, Hun Sik Park, Yongkeun Cho, 
Shung Chull Chae, Jae-Eun Jun, Wee-Hyun Park, Young Jo Kim, Kee-
Sik Kim, Seung Ho Hur, Myung Ho Jeong, Korea Acute Myocardial 
Infarction Registry Investigators, Kyungpook National University 
Hospital, Daegu, South Korea
Learning Objective: evaluate the threshold level of LDL-C in which 
statin therapy is no longer effective for reducing major adverse 
cardiac events in patients with myocardial infarction
1156 PREDICTING RISK OF ISCHEMIC EVENTS AND 
BLEEDING IN ACS
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1156-282 Comparison Of The HEART, TIMI And GRACE Risk 
Scores For Chest Pain Patients At The Emergency 
Room
Barbra E. Backus, A. J. Six, J. C. Kelder, T. P. Mast, F. vanden Akker, 
H. W. de Beaufort, E. G. Mast, P. A. Doevendans, St Antonius 
Hospital, Nieuwegein, The Netherlands, University Medical Center, 
Utrecht, The Netherlands
Learning Objective: identify low risk and high risk chest pain 
patients with the use of the HEART score
1156-283 Differential Performance of the Global Registry of 
Acute Coronary Events (GRACE) Risk Score Among 
Asian Ethnic Groups: A GRACE Model Discrimination 
and Calibration Study of 13,041 Asian Subjects
Mark Y. Chan, Bimal R. Shah, Fei Gao, Ling Ling Sim, Terrance Chua, 
Huay Cheem Tan, Tiong Cheng Yeo, Hean Yee Ong, Keng Thye Ho, 
Ping Ping Goh, Soondal K. Surrun, Tian Hai Koh, Karen S. Pieper, E 
Shyong Tai, National University Heart Centre, Singapore, Singapore, 
National Heart Centre, Singapore, Singapore
Learning Objective: Describe the performance of the GRACE model 
in Asian populations
1155 NEW INSIGHTS IN TREATMENT OF ACUTE 
CORONARY SYNDROMES
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1155-273 Impact of Anticoagulation Regimen in Patients 
with Non-ST-Elevation Acute Coronary Syndromes 
Undergoing an Early Invasive Strategy Independent 
of Revascularization: The ACUITY Trial
Tobias Geisler, Meinrad Gawaz, Steven R. Steinhubl, Michel E. 
Bertrand, A. Michael Lincoff, Angel R. Cequier, Walter Desmet, 
Lars H. Rasmussen, James Hoekstra, Roxana Mehran, Gregg 
W. Stone, Royal Brompton Hospital / Imperial College, London, 
United Kingdom, Klinikum der Eberhard-Karls-Universität Tübingen, 
Tübingen, Germany
Learning Objective: distinguish the benefits of initiating bivalirudin 
monotherapy early in the NSTEMI ACS patient compared to heparin 
+ a GPI.
1155-274 Effects of Varespladib Methyl on Biomarkers and 
Major Cardiovascular Events in Acute Coronary 
Syndrome Patients
Robert S. Rosenson, Colin Hislop, SUNY Downstate, Brooklyn, NY, 
Anthera, Hayward, CA
Learning Objective: Describe role of secretory phospholipase A2 
in lipoprotein remodeling, activation of inflammatory pathways and 
potential use in acute cardiovascular syndromes.
1155-276 Increased Risk of Cardiac Ischemia and Arterial 
Thromboembolic Events in Cancer Patients Treated 
with Bevacizumab: A Meta-Analysis
Vishal Ranpura, Jeff Chuang, Shenhong Wu, Stony Brook University 
Hospital, Stony Brook, NY
Learning Objective: know the risk of Myocaridal infarction and other 
arterial thromboembolic events associated with use of Bevacizumab
1155-277 Impact Of Combined Therapy Of Clopidogrel And 
Atorvastatin With Perindopril And Valsartan On 
Inflammatory Markers And Prognosis In Patients 
With Unstable Angina.
Anahit Gabrielyan, Rudolf Semyon RS. Gabrielyan, Ashot Vardan 
Davtyan, Institute Of Cardiology, Yerevan, Armenia
1155-278 Upstream versus Downstream Administration of 
Glycoprotein IIb/IIIa Inhibitors in Patients with Non-
ST-Elevation Acute Coronary Syndromes: A Meta-
Analysis of Randomized Trials
Alessandro Sciahbasi, Giuseppe Biondi Zoccai, Enrico Romagnoli, 
Ernesto Lioy, Policlinico Casilino - ASL RMB, Rome, Italy, University 
of Turin, Turin, Italy
Learning Objective: compare the efficacy of the upstream 
or downstream use of glycoprotein IIb/IIIa in acute coronary 
syndromes
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1157 MECHANISMS OF ISCHEMIC INJURY AND 
PROTECTION
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1157-290 Non-invasive Imaging of the Localization and 
Time Course of Cell Death in a Canine Model of 
Acute Myocardial Infarction and Reperfusion: 
Demonstration of Early and Late Phases of 
Reperfusion Cell Death
Patrick M. Burns, Patrick Kearns, Pedro Vargas-Pinto, Yoshinori 
Nishijima, Yu Ding, Mihaela Jekic, Tam Tran, Jiarui Lian, Kun Huang, 
Orlando P. Simonetti, Jay L. Zweier, The Ohio State University, 
Columbus, OH
Learning Objective: appreciate the acute changes in myocardial 
morphology and function during a myocardial infarction.
1157-291 Mitochondrial Depolarization Is Not Responsible for 
Cardioprotection During Ischemic Preconditioning
Daniel S. Lee, Ricardo Quarrie, Gregory Steinbaugh, Douglas 
Pfeiffer, Jay Zweier, Juan Crestanello, The Ohio State University 
Medical Center, Columbus, OH
Learning Objective: understand that mito membrane depolarization 
is not responsible for the cardioprotective effect IPC
1157-292 Mast cell Could Regulate the Survival of 
Cardiomyocytes in a Myocardial Infarction Rat 
Model
Youngkeun Ahn, Jin Sook Kwon, Yong Sook Kim, Ae Sin Cho, Mun 
Hwa Hong, Myung Ho Jeong, Seung Uk Lee, Jeong Gwan Cho, Jong 
Chun Park, Jung Chaee Kang, Department of Cardiology, Chonnam 
National University Hospital, Gwangju, South Korea, Gwangju 
Christian Hospital, Gwangju, South Korea
Learning Objective: to elucidate the effects of mast cell in a 
myocardial infarction rat model.
1157-293 Downregulation of Cardiac Myoglobin May Limit the 
Cardioprotective Effects of Nitrite Therapy Following 
Exercise
Chad K. Nicholson, Juan Pablo Aragon, David Bennett Grinsfelder, 
Marah Elston, David J. Lefer, John W. Calvert, Emory University 
School of Medicine, Atlanta, GA
Learning Objective: identify myoglobin as an important nitrite 
reductase
1157-294 Hypoxia Limits the Cardiac Regenerative Potential 
of Hypoxia-Inducible- Factor-1alpha Transduced 
Cardiac-Derived Stem Cells
Michail Bonios, John Terrovitis, Connie Chang, Aurelio Pinheiro, 
James Engles, Andreas Barth, Pei Dong, Veronica Lea Dimaano, 
Miguel Aon, Inhwa Tina Lee, Christina Melexopoulou, Richard Wahl, 
Brian O’ Rourke, Theodore Abraham, Roselle Abraham, Johns 
Hopkins University, Baltimore, MD
Learning Objective: evaluate the role of hypoxia inducible factor in 
the regenerative capacity of cardiac derived stem cells
1156-284 Comparison of GRACE Risk Score Versus TIMI 
Risk Score on Angiographic Findings in Patients 
With Non-ST-Segment Elevation Acute Coronary 
Syndrome
Tatsuya Nakachi, Masami Kosuge, Kiyoshi Hibi, Toshiaki Ebina, 
Kengo Tsukahara, Jun Okuda, Satoshi Morita, Tetsuji Kaneko, 
Satoshi Umemura, Kazuo Kimura, Yokohama City University Medical 
Center, Yokohama, Japan
Learning Objective: evaluate the relation between GRACE and TIMI 
scores and angiographic findings in patients with non-ST-segment 
elevation acute coronary syndrome.
1156-285 Left Atrial Function Assessed by Tissue Doppler 
Imaging as a New Predictor of Cardiac Events After 
Non-ST-Elevation Acute Coronary Syndrome
Yong-Tai Liu, Rui-Jie Li, Qing Zhang, Gabriel WK Yip, Bryan P. Yan, 
Yat-Yin Lam, Alex PW Lee, Cheuk-Man Yu, The Chinese University of 
Hong Kong, Hong Kong, Hong Kong, West China Hospital, Sichuan 
University, Chengdu, Sichuan, People’s Republic of China
Learning Objective: observe the predictive value of atrial function 
assessed by tissue Doppler imaging.
1156-286 Determinants of Major Bleeding Complications 
and its Impact on Hospital Outcome in NSTE-ACS 
in Clinical Practice: Lessons From The Euro Heart 
Survey ACS Registry
Anselm K. Gitt, Frank Towae, Ralf Zahn, Marek Gierlotka, Hugo 
Katus, Wojtek Wojakowski, Michal Tendera, Jean-Pierre Bassand, 
Euro Heart Survey ACS Registry, Institut f. Herzinfarktforschung 
Ludwigshafen, University of Heidelberg, Ludwigshafen, Germany, 
Herzzentrum Ludwigshafen, Ludwigshafen, Germany
Learning Objective: identify patients with high risk for bleeding
1156-288 Validation Of The Crusade Bleeding Risk Score In 
Patients With Non-st Elevation Acute Myocardial 
Infarction In Spain
Rafael Vidal-Perez, Sr., Emad Abu-Assi, Sr., José María Garcia-
Acuña, Sr., Carlos Peña-Gil, Sr., Jose Ramón Gonzalez-Juanatey, 
Sr, Cardiologiy Department. Clinico Universitario de Santiago de 
Compostela, Santiago de Compostela, Spain
Learning Objective: Evaluate the performance of the CRUSADE 
Bleeding risk score in an independent cohort different from the 
original study
1156-289 Hemoglobin Levels at Admission Add Prognostic 
Value to the GRACE Score in Non-ST Elevation Acute 
Coronary Syndromes
Luis Correia, Jamile Leal, Maria C. Almeida, Alexandre C. Souza, 
Ana P. Bittencourt, Rafael Freitas, J Péricles Esteves, Medical School 
of Bahia, Salvador, Brazil, Portuguese Hospital, Salvador, Brazil
Learning Objective: identify whether hemoglobin should be 
evaluated as part of prognostic assessment in pacientes with non-
ST elevation ACS
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1159 LIMITATION OF INFARCT SIZE
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1159-302 Exogenous Reconstituted High-density lipoprotein 
(rHDL) Attenuates The Myocardial Ischemic-
reperfusion Injury
Eun-Ji Kim, Dong-Ju Choi, Min-Jung Park, In-Ho Chae, Goo Yeong 
Cho, Tae-Jin Youn, Yung-Seok Cho, Jung-Won Suh, Ki-Yong Kim, 
Seoul National University, Bundang Hospital, Seoungnam, South 
Korea, Protein research Lab, CRC, Green Cross Corp., Youngin, 
South Korea
Learning Objective: investigate the protective effect of rHDL on 
Ischemia/reperfusion Injury
1159-303 Intraaortic Balloon Pump Counterpulsation 
Augments the Benefits of Reperfusion on Left 
Ventricular Mechanoergetics - Experimental Study
Konstantinos Malliaras, Nikolaos Diakos, Iraklis Pozios, Eleni 
Tseliou, Dimitrios Koudoumas, Lampros Katsaros, Michalis Bonios, 
Stella Vakrou, Emmanouil Konstantakis, John Terrovitis, John N. 
Nanas, University of Athens, 3rd Cardiology Dept, Athens, Greece
Learning Objective: understand the role of IABP support on 
myocardial systolic and diastolic function, during both acute 
ischemia and reperfusion
1159-304 Infusion of Glucagon-Like Peptide-1 Protects 
Against Ischemic Left Ventricular Dysfunction 
During Dobutamine Stress Echocardiography in 
Patients with Coronary Artery Disease
Philip Read, Fakhar Z. Khan, David P. Dutka, University of Cambridge, 
Cambridge, United Kingdom
Learning Objective: understand that glucagon-like peptide-1 protects 
the heart against ischemia during dobutamine stress
1159-305 The Stable Hydrogen Sulfide Donor, Diallyl Trisulfide, 
Protects against Acute Myocardial Infarction in Mice
Benjamin L. Predmore, D. Bennett Grinsfelder, Juan Pablo Aragon, 
Marah Elston, John W. Calvert, David J. Lefer, Emory University, 
Atlanta, GA
Learning Objective: evaluate the use of the stable hydrogen sulfide 
donor, DATS, in the treatment of MI/R injury.
1159-306 The β1 Blocker/β3 Agonist Nebivolol Protects 
Against Acute Myocardial Infarction in Mice
Juan Pablo Aragon, Sandeep Patel, Marah Elston, John W. Calvert, 
David Bennett Grinsfelder, David J. Lefer, Emory University School of 
Medicine, Atlanta, GA
Learning Objective: identify the potential of nebivolol as a 
cardioprotective agent
1158 NOVEL STRATEGIES TO LIMIT ISCHEMIC LV 
DYSFUNCTION
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1158-296 The Generation and Storage of Nitric Oxide 
Metabolites During Exercise Training Contributes to 
Exercise-Mediated Cardioprotection
John W. Calvert, Marah Elston, Amy Sindler, Susheel Gundewar, 
David Bennett Grinsfelder, Juan Pablo Aragon, Douglas R. Seals, 
David J. Lefer, Emory University School of Medicine, Atlanta, GA
Learning Objective: identify a role of nitrite in exercise-mediated 
cardioprotection
1158-297 Hydrogen Sulfide Confers Cardioprotection in the 
Setting of Diabetes
John W. Calvert, Susheel Gundewar, John Elrod, David J. Lefer, 
Emory University School of Medicine, Atlanta, GA
Learning Objective: identifyf a role for hydrogen sulfide in the 
treatment of myocardial ischemia in the setting of diabetes
1158-298 Extracardiac Injection of Plasmid VEGF
165
 Improves 
Myocardial Function by Stimulating Myocytes to 
Re-enter the Cell Cycle in Swine with Hibernating 
Myocardium
Mohamad Bourji, Gen Suzuki, Techung Lee, John M. Canty, Jr., 
University at Buffalo, Buffalo, NY
Learning Objective: Skeletal muscle injection of plasmid VEGF165 
stimulates cardiac repair in large animal model with chronically 
ischemic myocardium
1158-299 Effect of AT2 Receptor Deficiency as well as 
Pharmacological AT2 Receptor Stimulation on 
Myocardial Infarction-Associated Morbidity and 
Mortality
Ralf A. Benndorf, Martha Kirstein, Daniel Biermann, Michael 
Didié, Wolfram H. Zimmermann, Rainer H. Böger, Institute of 
Pharmacology, Toxicology, and Clinical Pharmacy, Technical 
University of Braunschweig, Braunschweig, Germany
Learning Objective: At the conclusion of this presentation, 
participants will be able to describe the impact of the AT2 receptor 
on myocardial infarction-associated morbidity and mortality
1158-300 Sildenafil In Conjunction With Angiotensin-
Converting Enzyme Inhibitor Is Effective In Limiting 
Infarct Expansion In A Porcine Model Of Anterior 
Myocardial Infarction
Doo Sun Sim, Myung Ho Jeong, Yun Hyeon Kim, Song Choi, Hyun 
Kuk Kim, Sung Soo Kim, Jum Suk Ko, Min Goo Lee, Keun Ho Park, 
Hyun Ju Yoon, Nam Sik Yoon, Young Joon Hong, Hyung Wook Park, 
Ju Han Kim, Youngkeun Ahn, Jeong Gwan Cho, Jong Chun Park, Jung 
Chaee Kang, Chonnam National University Hospital, Gwangju, South 
Korea
Learning Objective: understand the benefits of sildenafil in patients 
with acute myocardial infarction, especially those with erectile 
dysfunction.
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1160-311 Enhanced Therapeutic Effects of Mesenchymal 
Stem Cells on Myocardial Infarction by Ischemic 
Postconditioning in Rats
Jun Fang, Lianglong Chen, Lin Fan, Liming Wu, Xiangqi Chen, Weiwei 
Li, Yunlin Lin, Weiwei wang, Department of Cardiology, Union 
Hospital, Fujian Medical University, Fuzhou, People’s Republic of 
China
Learning Objective: demonstrate that ischemic postconditioning 
can promote the survival of engrafted stem cells and enhance their 
benefits to myocardial infarction by endogenously modifying host 
micro-environment
1161 MYOCARDIAL ISCHEMIA/INFARCTION: 
ANIMAL MODELS
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1161-313 A Reliable Porcine Coronary Model Of Chronic Total 
Occlusion Using Copper Stents
Doo Sun Sim, Myung Ho Jeong, Young Joon Hong, Youngkeun Ahn, 
Robert S. Schwartz, Jung Chaee Kang, Chonnam National University 
Hospital, Gwangju, South Korea
Learning Objective: find this animal model of chronic total occlusion 
useful in developing new interventional devices
1161-314 Trans-Iliac Rat Aorta Stenting Model: A Novel High 
Throughput Preclinical Stent Model for Restenosis 
and Thrombosis
Shizu Oyamada, Xiaodong Ma, Tim Wu, Michael P. Robich, Cesario 
Bianchi, Frank W. Sellke, Roger J. Laham, Beth Israel Deaconess 
Medical Center, Boston, MA, VasoTech, Inc., Lowell, MA
Learning Objective: describe that human-sized stents can be 
successfully implanted into the rat aorta via iliac artery insertion 
with good survival
1161-315 Lack of Effect of the Stretch-Activated Channel 
Blocker GsMtx4 on Ventricular Arrhythmias 
Following Coronary Occlusion in Swine
Jose A. Barrabes, Luis Agulló, Javier Inserte, M Ángeles García, 
David Garcia-Dorado, Hospital Universitari Vall d’Hebron, Barcelona, 
Spain
Learning Objective: Interpret the effect of the SAC blocker GsMtx4 
on ischemic ventricular arrhythmias
1161-317 Percutaneous Induced Left Ventricle Myocardial 
Infarction with Re-open LAD in a Clinical Relevant 
Animal Model
Jin-Shen Li, Xinhua Yin, Nakamura Takamitsu, Pendyala K. 
Lakshmana, Irena Brants, Stephen Frohwein, Jack P. Chen, 
Nicolas Chronos, Robert Matheny, Dongming Hou, Saint Joseph’s 
Translational Research Institute/Saint Joseph’s Hospital of Atlanta, 
Atlanta, GA, CorMatrix Cardiovascular Inc., Atlanta, GA
Learning Objective: demonstrate MI function in pig free LV
1160 OPTIMIZING STEM CELL THERAPY
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1160-307 Improvement of Biodistribution in Cardiac Stem Cell 
Therapy Using Fibrinogen
Andreas Martens, Sebastian V. Rojas, Robert Zweigerdt, Christian 
Rathert, Ulrich Martin, Axel Haverich, Ingo Kutschka, Clinic for 
Cardiac, Thoracic, Transplantation and Vascular Surgery; Hannover 
Medical School, Hannover, Germany, Leibniz Research Laboratories 
for Biotechnology and Artiﬁcial Organs, Hannover Medical School, 
Hannover, Germany
Learning Objective: demonstrate the advantage of using fibrinogen 
as carrier for intracardiac stem cell delivery in terms of cell 
retention.
1160-308 Oxytocin; A Priming Reagent to Commit UCB-MSCs 
for Cardiac Repair -Function study and Phase 
Retardation Imaging Technique of Oxytocin-Treated 
UCB-MSC
Youngkeun Ahn, Yong Sook Kim, Ae Shin Jo, Mun Hwa Hong, Jin 
Sook Kwon, Sang Mo Shin, Myung Ho Jeong, Jeong Gwan Cho, Jong 
Chun Park, Jung Chaee Kang, Department of Cardiology, Chonnam 
National University Hospital, Gwangju, South Korea, Heart Research 
Center of Chonnam National University Hospital, Gwangju, South 
Korea
Learning Objective: to evaluate the effect of oxytocin on umbilical 
cord blood derived mesenchymal stem cells
1160-309 Endothelial Progenitor Cell Transplantation 
Decreases Lymphangiogenesis and Adverse 
Ventricular Remodeling In A Mouse Model Of Acute 
Myocardial Infarction
Jae-Hyeong Park, Jung Yeon Yoon, Sun Mi Koh, Jun Hyung Kim, Jae-
Hwan Lee, Si Wan Choi, In-Whan Seong, Jin-Ok Jeong, Department 
of internal medicine, Chungnam national university, Daejeon, South 
Korea
Learning Objective: EPC transplantation demonstrated decreased 
lymphangiogenesis and favorable ventricular remodeling after MI
1160-310 Presence of Endothelial Colony-Forming Cells at 
Admission is Associated With a Reduction in Infarct 
Size at 6 Months Follow-up: A Magnetic Resonance 
Imaging Study in Patients With Acute Myocardial 
Infarction
Nicolas F. Meneveau, Frederic Deschaseaux, Marie-France Seronde, 
Vincent Descotes-Genon, Francois Schiele, David Chalmers, Pierre 
Tiberghien, Jean-Pierre Bassand, Jean-Pierre Kantelip, Siamak 
Davani, University Hospital Jean Minjoz, Besancon, France, INSERM 
U645, Etablissement Français du Sang Bourgogne Franche-Comté, 
Besancon, France
Learning Objective: Describe the relationship between initial ECFC 
colony levels and changes in infarct size at 6 months
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1208 EVOLUTION OF TROPONIN TESTING IN ACUTE 
CORONARY SYNDROMES
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1208-256 Interpreting New High Sensitive Troponin I And T 
Assays In The Setting Of Chronic Kidney Disease
Christopher R. DeFilippi, Robert Christenson, Sue Henderson, Show-
Hong Duh, James Januzzi, University of Maryland, Baltimore, MD, 
Massachusetts General Hospital, Boston, MA
Learning Objective: Evaluate potential confounders to intepretation 
of new high senstive troponin assays in patients with chronic kidney 
disease
1208-257 High Sensitivity Troponin Assay for Early Diagnosis 
of Acute Coronary Syndrome in a Real-World 
Situation: Comparison Between hs-TnT, LOCI hs-TnI, 
hs-TnI Roche and Conventional TnT.
Gina Biasillo, Luigi M. Biasucci, Roberta Della Bona, Ilaria Dato, 
Milena Leo, Massimo Gustapane, Maria T. Cardillo, Antonella 
Stefanelli, Pio Cialdella, Andrea Silenzi, Giulia Pignataro, Niccolò 
Gentiloni Silveri, Martina Zaninotto, Mario Plebani, Filippo Crea, 
Catholic University of Sacred Heart, Rome, Italy, Hospital University, 
Padua, Italy
Learning Objective: evaluate patients with chest pain
1208-259 High Sensitive Troponin T Rules Out Myocardial 
Infarction 2 Hours From Admission In Chest Pain 
Patients.
Dina Melki, Suzanne Lind, Stefan Agewall, Tomas Jernberg, 
Karolinska University Hospital and Karolinska Institutet, Stockholm, 
Sweden, Aker University Hospital and Oslo University, Oslo, Norway
Learning Objective: Demonstrate that New high sensitive troponin 
assays will improve the early diagnostic assessment of chest pain 
patients
1208-260 Impact of Troponin Elevation on Outcomes of 
Patients with Acute Coronary Syndromes and 
Chronic Renal Insufficiency
Subasit Acharji, Eugenia Nikolsky, Giora Weisz, George Dangas, 
Fredrick Feit, Steven Manoukian, Alexandra J. Lansky, Roxana 
Mehran, Gregg W. Stone, Cardiovascular Research Foundation, New 
York, NY, Columbia University Medical Center, New York, NY
Learning Objective: Evaluate outcomes of troponin elevation in CRI 
patients presenting with ACS
1208-261 Characteristics of Chest Pain Patients Without 
Acute Coronary Syndromes Stratified by a “Hyper-
sensitive” Troponin I Assay
Christopher R. DeFilippi, Puneet Gandotra, Mary Lou Gantzer, Sue 
Henderson, Jill Heckendorf, Robert Christenson, University of 
Maryland, Baltimore, MD
Learning Objective: Identify the signficance of an elevated hsTnI 
level in the absence of an acute corornary syndrome
1162 RISK PREDICTION IN MYOCARDIAL ISCHEMIA/
INFARCTION
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1162-319 Psoriasis is a Risk Factor for Myocardial Infarction 
and Percutaneous Coronary Intervention: A Danish 
Nationwide Cohort Study
Ole Ahlehoff, Gunnar H. Gislason, Jesper Lindhardsen, Casper 
H. Jorgensen, Mette G. Charlot, Steen Z. Abildstrom, Lone Skov, 
Christian Torp-Pedersen, Peter R. Hansen, Department of Cardiology, 
Copenhagen University Hospital Gentofte, Hellerup, Denmark
Learning Objective: Identify psoriasis as a risk factor for 
cardiovascular disease
1162-320 Uric Acid Level is a Predictor of Coronary Collateral 
Development in Patients with Non ST Segment 
Elevation Acute Coronary Syndrome
MEHMET KAYA, AHMET KASAPKARA, BAHADIR SARLI, ALI DOGAN, 
TUGRUL INANC, MUSTAFA DURAN, ABDURRAHMAN OGUZHAN, 
RAMAZAN TOPSAKAL, ERCIYES UNIVERSITY, KAYSERI, Turkey
Learning Objective: Coronary collateral development is poor in 
patients with high levels of uric acid. Uric acid level is an indicator 
of coronary collateral development.
1162-321 Measurement of Circulating Pregnancy-Associated 
Plasma Protein A (cPAPP-A) Identifies Patients with 
Acute Coronary Syndromes
Maha A. Al-Mohaissen, John Hill, Claire Heslop, Andrew Ignaszewski, 
Jiri Frohlich, University of British Columbia, Vancouver, BC, Canada, 
St Paul’s Hospital, Vancouver, BC, Canada
Learning Objective: evaluate the diagnostic ability of cPAPP-A, 
which may be of help in the evaluation of unstable plaques and the 
identification of patients preseting with acute coronary syndromes.
1162-322 Plasma and Tissue Metabolomic Profiling in a 
Porcine Ischemia-Reperfusion Model Reveals Novel 
Early Markers of Myocardial Injury
Renato Lopes, E. Marc Jolicoeur, Svati H. Shah, Mark Y. Chan, 
Tracy Y. Wang, Robert D. Stevens, Brett R. Wenner, Olga R. Ilkayeva, 
James R. Bain, Jean-Francois Tanguay, Christopher B. Newgard, L. 
Kristin Newby, Duke Clinical Research Institute, Duke University 
Medical Center, Durham, NC
Learning Objective: Examine plasma and tissue metabolomic 
profiles in an ischemic-reperfusion animal model
1162-323 CK-MB Has Prognostic Value Independent of 
Troponins in Non ST-Elevation ACS Population.
Nicholas Kalayeh, Ramil Goel, Madhavagopal Cherukuri, Akil I. 
Loli, Kenneth B. Desser, Banner Good Samaritan Medical Center, 
Phoenix, AZ, Phoenix VA Health Care System, Phoenix, AZ
Learning Objective: Patients with elevated CK-MB had higher 
mortality regardless of troponin status.
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1209-268 Increased Admission Glucose Relates with 
Increased 5-Year Mortality in Myocardial Infarction 
Patients, Irrespective of the Initially Applied 
Reperfusion Strategy
Maarten de Mulder, Jan Hein Cornel, Tjeerd van der Ploeg, Victor 
A. Umans, Eric Boersma, Medical Center Alkmaar, Alkmaar, The 
Netherlands, Erasmus University Medical Center, Rotterdam, The 
Netherlands
Learning Objective: recognize that elevated admission glucose 
remains a predictor of mortality in spite of advances that have been 
made in reperfusion with e.g. primary PCI
1209-269 Differential Impact of Renal Dysfunction on 
Mortality Following First Acute Myocardial Infarction 
in Nonelderly and Elderly Patients
Masami Kosuge, Kazuo Kimura, Sunao Kojima, Hisao Ogawa, the 
Japanese Acute Coronary Syndrome Study (JACSS)Investigators, 
Yokohama City University Medical Center, Yokohama, Japan, 
Kumamoto University, Kumamoto, Japan
Learning Objective: Evaluate the association between renal 
dysfunction and in-hospital mortality following acute myocardial 
infarction in nonelderly and elderly patients
1209-271 Additional Prognostic Value of Suspected 
Obstructive Sleep Apnea in Individuals with Non-ST 
Elevation Acute Coronary Syndromes
Luis Correia, Alexandre C. Souza, Jamile Leal, Maria C. Almeida, 
Rafael Freitas, Ana P. Bittencourt, J Péricles Esteves, Medical School 
of Bahia, Salvador, Brazil, Portuguese Hospital, Salvador, Brazil
Learning Objective: Know whether OSA should be assessed as a 
potential prognostic factor during ACS
1209-272 Effect of Postprandial Hyperglycemia on Clinical 
Outcomes in Nondiabetic Patients with Stable 
Angina
Shoichi Kuramitsu, Hiroyoshi Yokoi, Takenori Domei, Kyohei Yamaji, 
Yoshimitsu Soga, Takeshi Arita, Shinichi Shirai, Kenji Ando, Koyu 
Sakai, Masashi Iwabuchi, Hideyuki Nosaka, Masakiyo Nobuyoshi, 
Kokura Memorial Hospital, Kitakyushu, Japan
Learning Objective: interpret the postprandial hyperglycemia as an 
independent predictor of clinical outcomes in nondiabetic patients 
with stable angina.
1208-262 Comparison of the Prognostic Value of Peak CK-MB 
and Troponin Levels among Patients with Acute 
Myocardial Infarction
Chee Tang Chin, Tracy Y. Wang, Shuang Li, Eric D. Peterson, Stephen 
D. Wiviott, James A. deLemos, Michael C. Kontos, Matthew T. Roe, 
Duke Clinical Research Institute, Durham, NC
Learning Objective: Compare prognostic implications of peak 
biomarkers in acute myocardial infarction
1209 DIABETES, RENAL INSUFFICIENCY AND OTHER 
HIGH-RISK CO-MORBIDITIES
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1209-265 Renal Insufficiency in Patients with a Total 
Occlusion of a Coronary Artery after Myocardial 
Infarction
Judith S. Hochman, Ramin Hastings, Harmony R. Reynolds, Vladimir 
Dzavik, Dimitris Mikas, Lampros K. Michalis, Francois Schiele, 
Sandra A. Forman, Gervasio A Lamas A. Lamas, New York University 
School of Medicine, New York, NY
Learning Objective: Describe outcomes and safety for subjects 
with renal insufficiency presenting with late total occlusion after MI 
randomized to PCI or medical therapy.
1209-266 Impact of Impaired Renal Function on Acute 
Treatment and Hospital Mortality of NSTE-ACS in 
Clinical Practice in Europe: Lessons From the Euro 
Heart Survey ACS Registry
Anselm K. Gitt, Ralf Zahn, Frank Towae, Hugo Katus, Alexander 
Pakhomenko, Francois Schiele, Jean-Pierre Bassand, Euro Heart 
Survey ACS Registry, Institut f. Herzinfarktforschung Ludwigshafen, 
University of Heidelberg, Ludwigshafen, Germany, Herzzentrum 
Ludwigshafen, Ludwigshafen, Germany
Learning Objective: identify patients with NSTE-ACS at high risk
1209-267 The Contribution of Renal Failure and Diabetes 
Mellitus to the Prognosis of Patients with Acute 
Myocardial Infarction Undergoing Percutaneous 
Coronary Intervention
Manuel A. Gonzalez, Sara D. Collins, Itsik Ben-Dor, Gabriel 
Maluenda, Asmir I. Syed, Michael A. Gaglia, Jr., Zhenyi Xue, Cedric 
Delhaye, Kohei Wakabayashi, Nicholas N. Hanna, Rebecca Torguson, 
William O. Suddath, Kenneth M. Kent, Joseph Lindsay, Augusto D. 
Pichard, Lowell F. Satler, Ron Waksman, Washington Hospital Center, 
Washington, DC
Learning Objective: recognize the worse prognosis of acute 
myocardial infarction patients having a combination of renal failure 
and diabetes
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1211-288 Sex Differences in Presentation without Chest Pain 
for Confirmed Myocardial Infarction Are Attenuated 
with Advancing Age in the National Registry of 
Myocardial Infarction (NRMI)
John G. Canto, William J. Rogers, Robert J. Goldberg, Eric D. 
Peterson, Nanette K. Wenger, Viola Vaccarino, Catarina I. Kiefe, Paul 
Frederick, George Sopko, Z. J. Zheng, For the NRMI Investigators, 
Watson Clinic, Lakeland, FL, National Heart, Lung, and Blood 
Institute, Bethesda, MD
Learning Objective: Understand relationship of age and sex on 
symptom presentation after MI
1211-289 Frequency of Coronary Angiography and 
Revascularization among Men and Women with 
Myocardial Infarction and their Relationship to 
Mortality at One Year: An Analysis of the Geisinger 
Myocardial Infarction Cohort
Kimberly A. Skelding, Peter B. Berger, James C. Blankenship, Vernon 
H. Mascarenhas, Christopher W. Good, Thomas D. Scott, John M. 
Hodgson, Geisinger Medical Center, Danville, PA
Learning Objective: Identify sex bias in the selection of strategies to 
evaluate patients with myocardial infarction (MI), and if the choice 
of strategy influenced survival.
1212 NOVEL EMERGING THERAPIES FOR CHRONIC 
ISCHEMIC SYNDROME
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1212-290 Echo-Guided Extracorporeal Shock Wave Therapy 
for Refractory Angina Improves Regional Myocardial 
Blood Flow as Assessed by PET Imaging
Lothar Faber, Oliver Lindner, Christian Prinz, Eva Fricke, Detlef 
Hering, Wolfgang Burchert, Dieter Horstkotte, Department of 
Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr 
University Bochum, Bad Oeynhausen, Germany, Inst Radiol, Nucl 
Med, Mol Imag, Heart and Diabetes Center NRW, Ruhr University 
Bochum, Bad Oeynhausen, Germany
Learning Objective: identify patients who might benefit from 
noninvasive therapies for refractory angina
1212-291 Treatment with Whole Body Periodic Acceleration 
with a Horizontal Motion Platform Reverses Left 
Ventricular Remodeling in Angina Patients with Old 
Myocardial Infarction
Shoichi Miyamoto, Moriaki Inoko, Tetsuya Haruna, Muneo Oba, 
Yoshiaki Saji, Eisaku Nakane, Tomomi Abe, Ken-ichi Sasaki, Hidehiro 
Itoh, Terunobu Fukuda, Junji Nakashima, Nozomi Tanaka, Koji 
Ueyama, Ryuji Nohara, Masatoshi Fujita, Cardiovascular Center, 
Kitano Hospital, Tadukekofukai Medical Research Institute, Osaka, 
Japan, Human Health Sciences, Kyoto University Graduate School of 
Medicine, Kyoto, Japan
Learning Objective: evaluate the improvement of exercise capacity, 
LV function and myocardial ischemia through central and peripheral 
effects by using whole body periodic acceleration
1211 SEX DIFFERENCES IN EVALUATION, TREATMENT 
AND OUTCOMES IN PATIENTS WITH ACUTE 
CORONARY SYNDROMES
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1211-282 Gender Differences in Adjunctive Treatment and 
Hospital Outcome of NSTE-ACS Patients Undergoing 
PCI In Clinical Practice In Europe: Lessons From The 
Euro Heart Survey PCI Registry
Anselm K. Gitt, Timm Bauer, Uwe Zeymer, Ralf Zahn, Franz 
Weidinger, Ricardo Seabra-Gomes, Jean Marco, Euro Heart Survey 
PCI Registry, Institut f. Herzinfarktforschung Ludwigshafen, 
University of Heidelberg, Ludwigshafen, Germany, Herzzentrum 
Ludwigshafen, Ludwigshafen, Germany
Learning Objective: evaluate the impact of female gender on 
treatment of NSTE-ACS
1211-283 Underutilization Influencing Factors of Evidence 
Based Therapies in Women
Raffaele Bugiardini, Andrew T. Yan, Raymond T. Yan, David Fitchett, 
Anatoly Langer, Shaun G. Goodman, Olivia Manfrini, on the behalf 
of the Canadian Acute Coronary Syndrome Registry I and II 
Investigators, University of Bologna, Bologna, Italy, University of 
Toronto, Toronto, ON, Canada
Learning Objective: interpret the reasons of gender related 
treatment disparities
1211-284 Gender-Associated Difference in Pre-Hospital 
Evaluation in Acute Coronary Syndromes
Johanna P. Contreras, TUFTS MEDICAL CENTER, BOSTON, MA
Learning Objective: Demonstrated the presence of gender 
disparities in acute coronary syndrome
1211-285 Contemporary Outcomes of Primary Percutaneous 
Coronary Intervention in Men and Women for Acute 
ST-Segment Elevation Myocardial Infarction: Does 
Gender Still Matter?
M. Fuad Jan, Abdul-Moiz Haﬁz, Naoyo Mori, Angela Schlemm, 
Anthony C. DeFranco, Anjan Gupta, Tanvir Bajwa, Suhail Allaqaband, 
Aurora Cardiovasc Srvs, Aurora Sinai/St. Luke’s Med Ctrs, Univ 
Wisconsin Sch Med & Public Health-MCC, Milwaukee, WI, Center 
for Urban Population Health, University of Wisconsin-Milwaukee, 
Milwaukee, WI
Learning Objective: identify the immediate outcomes of 
percutaneous intervention in men and women after acute STEMI
1211-286 Sex Differences in High-Risk Acute Coronary 
Syndromes: Insights from EARLY-ACS
Jean-François Tanguay, L Kristin Newby, Judith Hochman, Cynthia M. 
Westerhout, Robert M. Califf, C Michael Gibson, Robert P. Giugliano, 
Robert A. Harrington, Frans Van de Werf, Paul W. Armstrong, 
Montreal Heart Institute, Montreal, QC, Canada
Learning Objective: To understand the role of gender in ACS 
presentation and outcome.
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1213-299 Medical Management Of Stable Coronary Artery 
Disease Before And After Elective PCI
Amer Ardati, Mauro Moscucci, Dean Smith, Stanley Chetcuti, 
P. Michael Grossman, Hitinder Gurm, University of Michigan 
Cardiovascular Center, Ann Arbor, MI
Learning Objective: Describe the use of medical therapy in patients 
receiving PCI for stable CAD
1213-300 Impact of Ranolazine on Revascularization and 
Healthcare Costs Among Angina Patients
Charles E. Phelps, Erin Buysman, Gabriel Gomez Rey, Matt 
Cheung, Noreen Henig, Francois Everhard, University of Rochester, 
Rochester, NY
Learning Objective: Understand the impact of ranolazine, a novel 
antianginal treatment, on risk of revascularization and healthcare 
costs
1214 STABLE ISCHEMIC SYNDROME--INTERVENTIONAL 
STRATEGIES
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1214-302 SPIRIT II Study: Evaluation of the XIENCE V 
Everolimus Eluting Coronary Stent in the Treatment 
of Patients with de novo Native Coronary Artery 
Lesions
Yoshinobu Onuma, Patrick W. Serruys, the SPIRIT II Investigators, 
Thorax Center, Erasmus MC, Rotterdam, The Netherlands
Learning Objective: demonstrate long-term outcome after 
everolimus-eluting stent implantation
1214-303 Percutaneous Coronary Intervention versus Medical 
Therapy in Stable Coronary Artery Disease: A Meta-
analysis
Pawan Patel, Mukesh Singh, Dipal Patel, Janos Molnar, Rohit R. 
Arora, Rosalind Franklin University of Medicine and Science/Chicago 
Medical School, North Chicago, IL
Learning Objective: Evaluate role medical therapy and PCI in stable 
coronary artery disease
1214-304 Mechanism of Side Branch Jailing in Bifurcation 
Lesion: Plaque or Carina Shift?
Ji-Hyun Kim, Bon-Kwon Koo, Myung-Ki Seo, Seung-Jung Park, Kyung 
Woo Park, Hye-Young Lee, Hyun-Jae Kang, Hyo-Soo Kim, Byung-Hee 
Oh, Young-Bae Park, Chang-Wook Nam, Seung-Ho Hur, Donghoon 
Choi, Yangsoo Jang, Joo-Yong Hahn, Hyeon-Cheol Gwon, Myeong-Ho 
Yoon, Seung-Jea Tahk, Woo-Young Chung, Young-Seok Cho, Dong-
Ju Choi, Sung Jin Oh, Yasuhiro Honda, Peter J. Fitzgerald, William 
F. Fearon, Seoul National University hospital, Seoul, South Korea, 
Stanford University Medical center, Stanford, CA
Learning Objective: understand and interpret the mechanism of side 
branch luminal narrowing after main branch stent implantation.
1212-292 Physiologic Evaluation Of Myocardial Bridging-A 
New Analysis For An Old Disease
Kyungil Park, Kyung Woo Park, Hae-Young Lee, Hyun-Jae Kang, Bon-
Kwon Koo, Hyo-Soo Kim, Byung-Hee Oh, Young-Bae Park, Division 
of Cardiology, Department of Internal Medicine, Seoul National 
University Hospital, Seoul, South Korea
Learning Objective: evaluate severity of myocardial bridging
1212-293 Long-term Clinical Course of Patients with Isolated 
Myocardial Bridge
SungSoo Kim, Myung Ho Jeong, Hyun Kuk Kim, Min Chul Kim, Kyung 
Hun Cho, Min Goo Lee, Jeom Seok Ko, Keun Ho Park, Doo Sun Sim, 
Nam Sik Yoon, Hyun Ju Yoon, Hyun Yuk Park, Ju Han Kim, Young 
Joon Hong, Young Keun Ahn, Jung Kwan Cho, Jong chun Park, Jung 
Chaee Kang, Chonnam National University, Gwang Ju, South Korea
Learning Objective: identify that myocardial bridge is not benign and 
and recurrent hospitalization is common.
1212-294 Trends of Enhanced External Counterpulsation 
Therapy in the US: Reimbursement Shapes the Use 
but Not the Outcome
William E. Lawson, John CK Hui, Elizabeth D. Kennard, Gregory W. 
Barsness, IEPR Investigators, Stony Brook University Hospital, Stony 
Brook, NY, University of Pittsburgh, Pittsburgh, PA
Learning Objective: Identify appropriate patients for treatment with 
EECP
1213 STABLE ISCHEMIC SYNDROME--MEDICAL 
COTHERAPIES FOR SECONDARY PREVENTION
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1213-296 Statins Moderate Coronary Atheroma but not 
Coronary Calcification: Results from Meta-Analyses
Michael Henein, Andrew Owen, Public Health, Umea, Sweden
Learning Objective: distinguish between the response of atheroma 
and calcification to statins therapy
1213-297 Long-Term Beta-Blocker Use Is Associated With 
Increased Risk of Myocardial Infarction Among 
Cocaine Users
Avinash Singavarapu, Ronald Zolty, Monteﬁore Medical Center, 
Bronx, NY
Learning Objective: Evaluate the interaction between beta-blockers 
and cocaine among users with heart disease
1213-298 Ivabradine Reduces Angina Pectoris in Patients 
After PCI: Results From the REDUCTION-Study
Ralf Koester, Jan Kaehler, Thomas Meinertz, for the REDUCTION 
Study Investigators, University of Hamburg Heart Center, Hamburg, 
Germany
Learning Objective: Demonstrates that ivabradine offers additional 
benefit in patients with ongoing angina pectoris despite PCI
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1215-310 The Outcome of Primary Percutaneous Coronary 
Intervention for Stent Thrombosis Causing ST 
Elevation Myocardial Infarction
Mehmet Ergelen, Sevket Gorgulu, Huseyin Uyarel, Tugrul Norgaz, 
Huseyin Aksu, Erkan Ayhan, Zeki Y. Gunaydın, Turgay Isık, Gokhan 
Cicek, Tuna Tezel, Department of Cardiology, Siyami Ersek 
Cardiovascular and Thoracic Surgery Center, Istanbul, Turkey, 
Department of Cardiology, Balıkesir University, School of Medicine, 
Balıkesir, Turkey
Learning Objective: primary PCI for treatment of ST is less effective, 
and these patients are
1215-311 Prognosis of Totally Occluded Infarct Related Artery 
Can be Worse than Non-totally Occluded Infarct 
Related Artery in Asian Patients with Acute Non-ST 
Elevation Myocardial Infarction?
Sureshkumar Ramasamy, Seung-Woon Rha, Kanhaiya L Poddar, Ji 
Young Park, Lin Wang, Byoung Geol Choi, Myung Ho Jeong, Ji Bak 
Kim, Seung Yong Shin, Un-Jung Choi, Cheol Ung Choi, Hong Euy Lim, 
Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong 
Joo Oh, KAMIR Investigators, Korea University Guro Hospital, Seoul, 
South Korea, Chonnam National University Research Institute of 
Medical Science, Gwangju, South Korea
Learning Objective: identify high risk cases in NSTEMI
1216 MYOCARDIAL ISCHEMIA/INFARCTION: 
BIOMARKER IMPLICATIONS
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1216-313 The Relationship Between Glomerular Filtration 
Rate, Plasma Asymmetric Dimethylarginine (ADMA) 
Level and Development of Coronary Collateral 
Circulation
Murat Çelik, Atila Iyisoy, Turgay Celik, Mahmut Ilker Yilmaz, Halil 
Yaman, Ersoy Isik, Gulhane Military Medical Academy, School of 
Medicine, Department of Cardiology, Ankara, Turkey
Learning Objective: To elucidate the pathophysiological patways 
which could cause poor coronary collateral development in patients 
with renal failure.
1216-314 Extracorporeal CRP-Apheresis after Myocardial 
Infarction decreases Infarction Size and Preserves 
Left Ventricular Ejection Fraction in Pigs
Timo Jerichow, Birgit Vogt, Dörte Mans, Frank Gebauer, Hassan 
Abdel-Aty, Anna Christine Slagman, Malte Schröder, Christopher 
Bock, Gunnar Janelt, Sascha Ott, Franziska Wohlgemuth, Gülcan 
Yapici, Astrid Puppe, Jeanette Schulz-Menger, Diethelm Modersohn, 
Ralf Schindler, Ahmed Sheriff, Martin Möckel, Department 
of Cardiology, Charité-Universitätsmedizin, Berlin, Germany, 
Department of Nephrology and Intensive Care Medicine, Charité-
Universitätsmedizin, Berlin, Germany
Learning Objective: Interpret the role of C-reactive protein (CRP) 
in the pathophysiology of reperfusion damage after myocardial 
infarction and identify a new way to reduce infarction size by 
extracorporeal CRP-apheresis
1214-305 Clinical Outcomes Associated with Off-Label Use of 
Sirolimus- versus Paclitaxel-Eluting Stents
Myong Hwa Yamamoto, Masahiko Ochiai, Kazuhiro Ashida, Tadayuki 
Yakushiji, Kennosuke Yamashita, Shigeo Saito, Koichi Hoshimoto, 
Yuki Mikoshiba, Naoei Isomura, Hiroshi Araki, Chiaki Obara, Showa 
University Northern Yokohama Hospital, Yokohama, Japan
Learning Objective: interpret clinical outcomes associated with off-
label use of sirolimus- versus paclitaxel-eluting stents.
1214-306 The Risk Factors and Characters for Progressing 
New Lesions in the Patients Undergoing PCI
Atsuko Nakayama, Hiroyuki Morita, Hiroshi Iwata, Yasushi Imai, 
Takahide Kohro, Jiro Andoh, Tsutomu Yamazaki, Ryozo Nagai, 
Department of cardiology, University of Tokyo, Tokyo, Japan
Learning Objective: evaluate the risk factors of new lesion formation 
after CAG
1215 MYOCARDIAL ISCHEMIA/INFARCTION: 
IMPLICATIONS OF STENTS
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1215-307 In Vivo Biocompatibility Comparison Between 
Novel Biodegradable Polymer and Existing Non-
Biodegradable Polymer Coated Stents
Shizu Oyamada, Xiaodong Ma, Tim Wu, Michael P. Robich, Cesario 
Bianchi, Frank W. Sellke, Roger J. Laham, Beth Israel Deaconess 
Medical Center, Boston, MA, VasoTech, Inc., Lowell, MA
Learning Objective: demonstrate a novel PLGA/ACP copolymer has 
better biocompatibility than an existing non-biodegradable polymer
1215-308 Is Stent Fracture Still a Problem in the Era of the 
Second-generation Drug-eluting Stent?
SukMin Seo, Kiyuk Chang, Mahnwon Park, Eunho Choo, Jihee kim, 
Yoonseok Koh, Woobaek Chung, Minseok Choi, Sunggyu Yoon, 
Hunjun Park, Hunjun Park, Hunjun Park, Hunjun Park, Hunjun Park, 
Hunjun Park, Wooksung Chung, Wooksung Chung, Kibae Seung, 
Seoul St. Mary’s hospital, Seoul, South Korea
1215-309 Drug-eluting versus Bare-metal Stents in Treatment 
of Diabetic Patients with Acute Coronary 
Syndromes: Analysis from the Randomized ACUITY 
Trial
Karthik K. Challa, Eugenia Nikolsky, Roxana Mehran, Alexandra J. 
Lansky, George D. Dangas, Adriano Caixeta, Brent T. McLaurin, David 
A. Cox, Jeffrey W. Moses, Frederick Feit, Monica Embacher, Gregg W. 
Stone, Cardiovascular Research Foundation, Manhattan, NY
Learning Objective: identify the early and long-term outcomes of 
using bare-metal stents vs drug-eluting stents in treating diabetes 
mellitus patients presenting with acute coronary syndrome
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1217-321 Atorvastatin Rapidly Modifies Vascular Redox and 
Increases Nitric Oxide Bioavailability In Human 
Arteries
Charalambos A. Antoniades, Andreas Paschalis, Dimitris 
Tousoulis, Constantinos Bakogiannis, Michael Dimosthenous, 
Alexis S. Antonopoulos, Costas Psarros, Nikolaos Sfyras, Dimitris 
Lymperiadis, Kyriakoula Marinou, Keith M. Channon, Christodoulos 
Stefanadis, 1st Cardiology Department Hippokration Hospital, 
Athens, Greece, University of Oxford, Oxford, United Kingdom
Learning Objective: Understand statins direct effects on vacular 
redox state in patients with coronary atherosclerosis
1217-322 Anti-ischemic Efficacy Of Ivabradine In Combination 
With Bisoprolol Versus Uptitration Of Bisoprolol
Ekaterina N. Amosova, E. Andrejev, I. Zadereij, National Medical 
University, Kiev, Ukraine
Learning Objective: Identify new strategy of the antianginal therapy
1217-323 Ivabradine for the Treatment of Stable Angina 
Pectoris in Octogenarian Patients
Ralf Koester, Jan Kaehler, Thomas Meinertz, for the REDUCTION 
Study Investigators, University of Hamburg Heart Center, Hamburg, 
Germany
Learning Objective: Demonstrates efficacy and safety of ivabradine 
in the treatment of octogenarians without relevant symptomatic 
bradycardia
1263 STABLE ISCHEMIC SYNDROMES--BIOMARKERS 
AND OUTCOMES
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1263-256 Neopterin Predicts Left Ventricular Remodeling 
in Patients with ST-segment Elevation Myocardial 
Infarction Undergoing Primary Percutaneous 
Coronary Intervention
Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez, Sima Samimi-
Fard, Eduardo Arroyo-Ucar, Ruben Juarez-Prera, Antonio Lara-Padrón, 
Francisco Bosa-Ojeda, Pablo Avanzas, Juan C. Kaski, Hospital 
Universitario de Canarias, Tenerife, Spain, St George’s Hospital., 
London, United Kingdom
Learning Objective: see a correlation between markers of 
inflammation and LV function. Neopterin may represent a useful 
biomarker of LV dysfunction.
1263-257 Plasma Myeloperoxidase Level Aids in Predicting 
Long-term Outcome of Acute Myocardial Infarction
Mehmet Kaya, Ridvan Yalcin, Kaan Okyay, Fatih Poyraz, Nilufer 
Bayraktar, Hatice Pasaoglu, Bulent Boyaci, Atiye Cengel, ERCIYES 
UNIVERSITY, KAYSERI, Turkey
Learning Objective: High plasma MPO levels identify patients 
with a worse prognosis after acute STEMI at two-year follow up 
period. Evaluation of plasma MPO levels may be useful at high risk 
patients, who might benefit 
1216-315 Galectin-1, A Galactoside Binding Lectin With 
Immunomodulatory Effects, Is Upregulated In The 
Mouse Heart During Acute Myocardial Infarction
Ignacio M. Seropian, Stefano Toldo, Diego O. Croci, Antonio Abbate, 
Gabriel A. Rabinovich, Benjamin W. Van Tassell, VCU School of 
Pharmacy and VCU Pauley Heart Center, Richmond, VA, Laboratorio 
de Inmunopatología, Instituto de Biología y Medicina Experimental, 
Buenos Aires, Argentina
Learning Objective: Describe cardiac Galectin-1 expression after AMI
1216-316 Candesartan Suppresses Increase in Secreted 
Frizzled Related Protein 2 and Fibrosis During 
Healing after Reperfused Myocardial Infarction in 
the Rat Model
Bodh I. Jugdutt, Ariv Palaniyappan, Halliday Idikio, University of 
Alberta, Edmonton, AB, Canada
Learning Objective: Demonstrate the effect of an AT1 receptor on 
sFRP2 during healing after reperfused myocardial infarction in rats
1216-317 High HDL Cholesterol Levels and Markers of 
Inflammation and Metabolic Health in Patients 
Hospitalized With Acute Myocardial Infarction
Mikhail Kosiborod, John A. Spertus, Phillip G. Jones, Paul A. 
Heidenreich, Krishnaji R. Kulkarni, Sergio Fazio, Mid America Heart 
Institute of Saint-Luke’s Hospital, Kansas City, MO
Learning Objective: Describe the relationship between HDL levels 
and the markers of inflammation and glucose metabolism
1217 STABLE ISCHEMIC SYNDROME--MYOCARDIAL 
PROTECTION
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1217-319 Myocardial Protection by Intracoronary 
Administration of Short-acting Beta-Blocker, 
Landiolol, during Elective Percutaneous Coronary 
Intervention
Park Haengnam, Secondary department of internal medicine,Kansai 
medical University, Moriguchi, Japan
Learning Objective: evaluate
1217-320 Low-Dose Aspirin May Ameriorate Long-Term 
Clinical Outcome in Patients with Coronary Spastic 
Angina
Hitoshi Takano, Eisei Yamamoto, Shuhei Tara, Koji Kato, Shigenobu 
Inami, Gen Takagi, Satoshi Aoki, Kuniya Asai, Masahiro Yasutake, 
Kyoichi Mizuon, Nippon Medical School, Tokyo, Japan
Learning Objective: demonstrate the beneficial effect of aspirin in 
patients with coronary spastic angina
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1264 UNSTABLE ISCHEMIC SYNDROME/BLEEDING 
ISSUES & OUTCOME
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1264-265 Major Bleeding Is an Independent Predictor of One-
Year Post-discharge Mortality in Patients with Non-
ST-Segment Elevation Acute Coronary Syndromes
Renato Lopes, Karen P. Alexander, Anita Y. Chen, Tracy Y. Wang, Sunil 
V. Rao, E. Magnus Ohman, Matthew T. Roe, Eric D. Peterson, Duke 
Clinical Research Institute, Durham, NC
Learning Objective: Describe the long-term impact of in-hospital 
major bleeding in patients with non-ST-segment elevation myocardial 
infarction.
1264-266 Ticagrelor Versus Clopidogrel in Patients with Acute 
Coronary Syndromes Undergoing Coronary Artery 
By-pass Surgery: Results from the PLATO Trial
Claes Held, Jean Pierre Bassand, Richard C. Becker, Christopher 
P. Cannon, Marc J. Claeys, Robert A. Harrington, Jay Horrow, Steen 
Husted, Stefan K. James, Kenneth W. Mahaffey, José C. Nicolau, 
Sylvia Olofsson, Benjamin M. Scirica, Robert F. Storey, Marius 
Vintila, Joseph Ycas, Lars Wallentin, Uppsala Clinical Research 
Center and Dept of Cardiology, Uppsala University Hospital, 
Uppsala, Sweden
Learning Objective: Evaluate efficay and safety of patients with 
acute coronary syndromes undergoing CABG surgery treated with 
ticagrelor or clopidogrel
1264-267 Transfusing Old Stored Blood after an Early Invasive 
Strategy for ACS is Associated with Increased Long-
Term Mortality
Thomas P. Carrigan, Farzad Azimpour, Ming Shao, Priscilla Figueroa, 
Michael Lincoff, Cleveland Clinic, Cleveland, OH
Learning Objective: Describe the association between old 
transfused blood and mortality in an ACS population.
1264-268 Correlation of Thrombus Area with Angiographic 
and Clinical Outcomes in Patients with ST-segment 
Elevation Myocardial Infarction Undergoing Primary 
PCI: Analysis from the HORISONS-AMI Trial
Yong He, Eugenia Nikolsky, Alexandra J. Lansky, Roxana Mehran, 
Adriano Caixeta, George Dangas, LeRoy Rabbani, Gregg W. Stone, 
Cardiovascular Research Foundation and Columbia University 
Medical Center, New York, NY
Learning Objective: learn the impact of thrombus burden assessed 
by thrombus area on clinical outcomes
1263-259 Clinical Outcome and Sensitive Troponin I Assay in 
Patients With Suspected Acute Coronary Syndrome
Nicholas L. Mills, Antonia MD Churchhouse, Atul Anand, David 
Gamble, Margaret MacLeod, Catriona Graham, Simon Walker, Martin 
Denvir, Keith AA Fox, David E. Newby, The University of Edinburgh, 
Edinburgh, United Kingdom, The Royal Inﬁrmary of Edinburgh, 
Edinburgh, United Kingdom
Learning Objective: Understand that use of a sensitive troponin 
assay markedly increases the incidence of myocardial infarction and 
identifies patients at high-risk of reinfarction and death
1263-260 Elevated Plasma Myeloperoxidase as Indicator 
for Vulnerable Plaque in Stable Patients with 
Significant Atherosclerotic Burden
Wai Hong Wilson Tang, Yuping Wu, Stephen J. Nicholls, Stanley L. 
Hazen, Cleveland Clinic, Cleveland, OH
Learning Objective: To describe the role of myeloperoxidase as 
marker of vulnerable plaque in predicting risk of major adverse 
cardiac events in stable cardiac patients with significant 
atherosclerotic plaque burden
1263-261 Relationship of Inflammatory Biomarkers to the 
Presence of Ischemia in Pateints with Coronary 
Artery Disease Undergoing Cardiac Stress Testing
Salman Ashfaq, Peter El Haddad, Dory Abou Jaoude, Saad Iqbal, 
Syed Rafﬁ, Samer Antonios, W Craig Hopper, University of Kansas 
School of Medicine-Wichita, Wichita, KS
Learning Objective: Demonstrate relationship of inflammatory 
biomarker levels in the blood to the presence of myocardial 
ischemia in patients with known coronary artery disease
1263-262 Serum Osteoprotegerin Levels and Long-Term 
Prognosis in Subjects with Stable Coronary Artery 
Disease
Shuji Otsuki, Shuichi Jono, Yasutomi Higashikuni, Atsushi Shioi, 
Katsuhito Mori, Kengo Tanabe, Hiroyoshi Nakajima, Kazuhiro Hara, 
Yoshiki Nishizawa, Yuji Ikari, Mitsui Memorial Hospital, Tokyo, Japan
Learning Objective: interpret the association between serum 
osteoprotegerin (OPG) level and long-term prognosis in patients with 
stable coronary artery disease
1263-263 Association of Genome Wide Loci for CAD with 
Distribution of Coronary Disease
Atif Qasim, Lena Matthews, Liming Qu, Rajesh Movva, Kambiz 
Parcham-Azad, Stephanie DerOhannessian, Jane Ferguson, Mingyao 
Li, Daniel J. Rader, Muredach P. Reilly, Hospital of the University of 
Pennsylvania, Philadelphia, PA
Learning Objective: Understand the nature of the genomewide 
asocation loci and their possible future use in CAD risk assessment
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1265-276 Effect of Preinfarction Angina on Microvascular 
Function and Long-Term Outcome after Primary 
Angioplasty for First Anterior Wall Myocardial 
Infarction
Takefumi Takahashi, Yoshikazu Hiasa, Shin-ichiro Miyazaki, Shinobu 
Hosokawa, Koichi Kishi, Ryuji Ohtani, Tokushima Red Cross 
Hospital, Komatsushima, Japan
Learning Objective: evaluate the effect of preinfarction angina 
on microvascular function and long-term outcome after acute 
myocardial infarction
1265-277 QRS Score at Hospital Discharge is a Strong 
Prognostic Marker in Patients with ST-Segment 
Elevation Myocardial Infarction Undergoing Primary 
Percutaneous Coronary Intervention
Michael C. Tjandrawidjaja, Yuling Fu, Cynthia M. Westerhout, Galen 
S. Wagner, Christopher B. Granger, Paul W. Armstrong, University of 
Alberta, Edmonton, AB, Canada
Learning Objective: Understand the prognostic utility of QRS scoring 
in patients with STEMI undergoing primary PCI
1265-278 Application of the TIMI Risk Score, a Simple 
Bedside Tool, for Timing of Discharge after 
Fibrinolysis or Primary Angioplasty for ST-elevation 
MI in the ExTRACT-TIMI 25 and TRITON-TIMI 38 
Trials
Sean R. Wilson, Stephen D. Wiviott, Elliott M. Antman, Robert P. 
Giugliano, Sabina A. Murphy, Sarah Sloan, Eugene Braunwald, David 
A. Morrow, Brigham and Women’s Hospital, Boston, MA
Learning Objective: Evaluate the application of the TIMI risk score, 
a simple bedside tool, for timing of discharge after fibrinolysis or 
primary angioplasty in patients with ST-elevation MI.
1265-279 Mitral Regurgitation after Myocardial Infarction 
Predicts Increased Medical Costs and Decreased 
Quality of Life: Analysis of the VALIANT (VALsartan 
In Acute myocardial iNfarcTion) Trial
Daniel William Mudrick, Shelby D. Reed, Yanhong Li, John JV 
McMurray, Lars Kober, Robert M. Califf, Eldrin F. Lewis, Scott D. 
Solomon, Eric J. Velazquez, Duke Clinical Research Institute, 
Durham, NC
Learning Objective: describe the association between mitral 
regurgitation and subsequent costs and quality of life after 
myocardial infarction.
1265-280 Myocardial Infarction Symptom Presentation and 
Hospital Mortality: Relationship to Age and Sex 
in the National Registry of Myocardial Infarction 
(NRMI)
John G. Canto, William J. Rogers, Robert J. Goldberg, Eric D. 
Peterson, Nanette K. Wenger, Viola Vaccarino, Catarina I. Kiefe, Paul 
Frederick, George Sopko, Z. J. Zheng, Watson Clinic, Lakeland, FL, 
National Heart, Lung, and Blood Institute, Bethesda, MD
Learning Objective: Understand the relationship between symptom 
presentation, mortality by sex and age following MI.
1264-269 Stent Thrombosis, Bleeding, and Antiplatelet 
Therapy in the e-Select Registry: OneYear Follow-
up of 15000 Patients Treated with the Sirolimus-
eluting Cypher-Select Stent Plus
Philip M. Urban, Alexander Abizaid, Adrian Banning, Antonio 
Bartorelli, Vladimir Dzavik, Stephen G. Ellis, Runlin Gao, David 
Holmes, Muyng Ho Jeong, Victor Legrand, Franz-Jozef Neumann, 
Maria Nyakern, Christian Spaulding, Hans-Peter Stoll, Stephen 
Worthley, La Tour Hospital, Geneva, Switzerland
Learning Objective: demonstrate the necessary balance between 
thrombosis and bleeding after DES implantation, and the need for a 
RCT of the duration of dual antiplatelet treatment
1264-271 Temporal Trends in Cardiovascular Risk Factors and 
Outcomes in Patients with Premature Coronary 
Artery Disease
Farhan Javed Khawaja, Ryan Lennon, MS, Abhiram Prasad, MD, 
Mayo Clinic, Rochester, MN
Learning Objective: Identify the increasing prevalence of 
Cardiovascular Risk Factors in Young Patients Treated with PCI
1264-272 Impaired Outcome with Acute Coronary Occlusions 
in Non-ST-Elevation Myocardial Infarction
Bjørnar Grenne, Christian Eek, Benthe Sjøli, Thomas Dahlslett, 
Michael Uchto, Per K. Hol, Helge Skulstad, Otto A. Smiseth, Thor 
Edvardsen, Harald Brunvand, Sørlandet Hospital, Arendal, Norway, 
Rikshospitalet University Hospital, Oslo, Norway
Learning Objective: describe outcome in patients with non-ST-
elevation myocardial infarction with and without acute coronary 
occlusions
1265 UNSTABLE ISCHEMIC SYNDROME/OUTCOMES & 
NOVEL RISK MODIFIERS
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1265-273 Living Alone and Outcomes after Hospitalization for 
Acute Myocardial Infarction
Emily M. Bucholz, Saif S. Rathore, Kensey Riley, Amy Schoenfeld, 
John A. Spertus, Harlan M. Krumholz, Yale University School of 
Medicine, New Haven, CT, Mid America Heart Institute, University of 
Missouri-Kansas City, Kansas City, MO
Learning Objective: Characterize the association between living 
alone and long-term mortality, rehospitalization, and quality of life 
after myocardial infarction
1265-274 Association of Body Mass Index and Mortality after 
Acute Myocardial Infarction
Emily M. Bucholz, Saif S. Rathore, Kimberly J. Reid, John A. Spertus, 
Harlan M. Krumholz, Yale University School of Medicine, New Haven, 
CT, Mid America Heart Institute, University of Missouri-Kansas City, 
Kansas City, MO
Learning Objective: Describe the relationship between body mass 
index (BMI) and long-term mortality after myocardial infarction
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1266-288 Impact of Hyperglycemia On Long-Term Clinical 
Outcomes In Patients With Non-ST Elevation Acute 
Coronary Syndromes Treated With Percutaneous 
Coronary Intervention
Ryan J. Magnuson, Justin B. Lundbye, Francis J. Kiernan, Abdul 
Alkeylani, Thomas Schultz, Daniel S. Stewart, Kevin Dougherty, 
Dadong Li, Jeffrey Mather, Deborah Murphy, Raymond G. McKay, 
Hartford Hospital, Hartford, CT
Learning Objective: Demonstrate the negative impact of 
hyperglycemia at the time of percutaneous coronary intervention 
in patients presenting with non-ST elevation acute coronary 
syndromes.
1266-289 High-dose Plasmid-mediated Vascular Endothelial 
Growth Factor Gene Transfer in Patients With 
Severe Coronary Artery Disease (GENESIS-I). Six 
Months Results of the First Phase I Latin American 
Trial of Gene Therapy in Myocardial Ischemia
Liliana Ethel Favaloro, Mirta Diez, Oscar Mendiz, Leon Valdivieso, 
Andres Bercovich, Marcelo E. Criscuolo, Gustavo Vera Janavel, 
Alberto J. Crottogini, Favaloro University Hospital, Buenos Aires, 
Argentina, Bio Sidus, Buenos Aires, Argentina
Learning Objective: demonstrate safety of high-dose plasmid-
mediated gene therapy
1267 STABLE ISCHEMIC SYNDROME--NOVEL RISK 
MARKERS FOR VASCULAR DISEASE AND 
SUCCESSFUL INTERVENTION
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1267-302 Prognostic Significance of Serum Resistin Levels 
in Patients Undergoing Percutaneous Coronary 
Intervention
Yukihiko Momiyama, Reiko Ohmori, Ryuichi Kato, Hiroaki Taniguchi, 
Haruo Nakamura, Fumitaka Ohsuzu, NHO Tokyo Medical Center, 
Tokyo, Japan, National Defense Medical College, Saitama, Japan
Learning Objective: interpret prognostic significance of serum 
resistin levels in patients undergoing PCI
1267-303 Granulocyte-Colony Stimulating Factor in Angina 
Patients with Ischaemic Heart Diesase to Stimulate 
Neovascularisation (GAIN II Trial)
Sharon S. Chih, Peter Macdonald, Jane A. McCrohon, David Ma, 
Moore John, Matthew Law, Michael P. Feneley, Andrea Herbert, Jason 
C. Kovacic, Robert M. Graham, Victor Chang Cardiac Research 
Institute, Sydney, Australia, St Vincent’s Hospital, Sydney, Australia
Learning Objective: Evaluate the use of granulocyte colony 
stimulating factor to treat angina in patients with severe ischaemic 
heart disease
1266 UNSTABLE ISCHEMIC SYNDROME/PCI & 
OUTCOMES
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1266-282 Prospective Randomized Comparison Between 
XienceV and Cypher Stents
Ad J. Van Boven, Sjoerd H. Hofma, Michel Quere, Jan Brouwer, 
Cees-Jan de Vries, Evalien Kolkman, Heart Centre Friesland, MCL, 
Leeuwarden, The Netherlands, Diagram BV, Zwolle, The Netherlands
Learning Objective: Learn that new generation stents should be 
compared by the best of the old generation, i.e. Cypher
1266-283 Percutaneous Coronary Intervention In Native 
Vessels With Angiographically Visible Thrombus. 
Temporal Trends and the impact of drug eluting 
stents
manivannan srinivasan, Charanjit S. Rihal, Mandeep Singh, Ryan J. 
Lennon, David R. Holmes, Abhiram Prasad, Mayo Clinic, Rochester, 
MN
Learning Objective: get an idea about temporal trends in PCI for 
patients with angiographically visible thrombus and the safety and 
efficacy of DES in such lesions.
1266-284 Long-Term Outcome of Bare Metal Stent vs. Drug-
Eluting Stent Implantation in Octogenarians
Junya Matsumi, Shigeru Saito, Junko Honne, Satoshi Takeshita, 
Shinji Tanaka, Saeko Takahashi, Yutaka Tanaka, Hidetaka Suenaga, 
Shingo Mizuno, Nobuhiro Okamura, Kazuya Sugitatsu, Takuya 
Izumikawa, Kouki Shishido, Shonan Kamakura General Hospital, 
Kamakura, Japan
Learning Objective: We demonstrated that decision-making for DES-
implantation in octogenarians will require careful assessment of the 
risk of bleeding complication.
1266-285 Does “The Obesity Paradox” exist for survival after a 
Percutaneous Intervention?
Anitha Rajamanickam, Samir Kapadia, Sam Butler, Stephen Ellis, 
James B. Young, Cleveland Clinic, Cleveland, OH
Learning Objective: Does obesity paradox exists in patients after a 
percutaneous catheterization?
1266-286 Long-Term Safety Profile of XIENCE V Everolimus-
Eluting Compared to TAXUS Express Paclitaxel-
Eluting Stents
Robert J. Applegate, Krishnankutty Sudhir, James B. Hermiller, Julie 
Doostzadeh, Shui Yu, Kyoko Hattori, Alexandra J. Lansky, Donald E. 
Cutlip, Charles A. Simonton, Gregg W. Stone, Wake Forest University 
School of Medicine, Winston-Salem, NC
Learning Objective: To distinguish rates of late adverse events after 
first and second generation drug-eluting stents.
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1268-309 The Utility of Adenosine Stress-Rest Cardiac 
Magnetic Resonance Imaging in Evaluating Cardiac 
Function and Perfusion in Women with Systemic 
Lupus Erythematosus
Pavel Goykhman, Louise E.J. Thomson, Yuching Yang, Leslee J. 
Shaw, Daniel S. Berman, Edward Gill, Mariko L. Ishimori, Rebecca 
Martin, Daniel J. Wallace, Jay N. Schapira, Chrisandra L. Shufelt, 
Michael H. Weisman, C. Noel Bairey Merz, Women’s Heart Center, 
Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA
Learning Objective: Describe the utility of CT and MRI for 
identification of atherosclerotic plaque and ischemia in Systemic 
Lupus Erythematosus patients.
1268-310 Impact of Myocardial Viability on Echocardiographic 
Parameters of Cardiac Structure and Function in 
Patients with Ischemic Cardiomyopathy. A Report 
from the STICH Trial
Federico M. Asch, Thomas A. Holly, Lilin She, Gerald Maurer, Jacek 
Myc, William A. Zoghbi, Anna Teresinska, Bozena Birkenfeld, Eric 
J. Velazquez, Patricia A. Pellikka, Christopher Adlbrecht, Robert O. 
Bonow, Julio A. Panza, Washington Hospital Center, Washington, DC, 
Northwestern University Feinberg School of Medicine, Chicago, IL
Learning Objective: describe the association of myocardial viability 
with the severity of cardiac structure and hemodynamic compromise 
in patients with ischemic cardiomyopathy
1268-311 Utility of Stress Echocardiography for Predicting 
Long Term Cardiac Outcomes Among Patients 
Undergoing Liver Transplant Surgery
Anas Safadi, Kathleen A. Lane, Stephen G. Sawada, Jo 
Mahenthiran, Krannert Institute of Cardiology, Indiana University, 
Indianapolis, IN
Learning Objective: Identify the utility of stress echocardiography for 
predicting long term cardiac outcomes in patients undergoing liver 
transplant surgery.
1269 STABLE ISCHEMIC SYNDROME--CLINICAL 
DRIVERS OF RISK AND OUTCOMES
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1269-313 Impact of Residual Myocardial Jeopardy 
on Long-Term Outcome Following Coronary 
Revascularization in Patients With Type 2 Diabetes 
Mellitus
Leonard Schwartz, Marnie Barolet, Frederick Feit, Charles J. 
Davidson, Mehrdad S. Toosi, Edward Y. Sako, Spencer B. King, III, 
BARI 2D Study Group, Toronto General Hospital, Toronto, Canada
Learning Objective: to detrmine the impact of incomplete 
revascularization in patients with diabetes mellitus
1267-304 Incremental Risk Stratification in Stable Patients 
Undergoing Elective Cardiac Catheterization with 
Cardiac Biomarker Score (CBS)
Wai Hong Wilson Tang, Yuping Wu, Alan Pratt, Michael Pepoy, Shirley 
Mann, Stanley L. Hazen, Cleveland Clinic, Cleveland, OH
Learning Objective: To describe the incremental value of combining 
muliple cardiac biomakers to predict future risk of major adverse 
cardiac events in stable cardiac patients
1267-305 Usefulness of Soluble Fms-like Tyrosine Kinase 
1 as a Biomarker of Acute and Chronic Phase of 
Coronary Artery Disease
Shiro Uemura, Kenji Onoue, Ken-ichi Ishigami, Satoshi Somekawa, 
Tsuneari Soeda, Satoshi Okayama, Hiroyuki Kawata, Manabu Horii, 
Yoshihiko Saito, Nara Medical University, Kashihara, Nara, Japan
Learning Objective: demonstrate that plasma soluble Flt-1 is not 
only a biomarker for CAD, but also plays an important role in the 
development of CAD
1267-306 High Circulating Levels of Tenascin-c Were 
Associated with Coronary Arterial Calcification in 
Patients with Stable Effort Angina Pectoris
Sakamoto Nobuo, Kazuhiko Nakazato, Hiroyuki Kunii, Tomofumi 
Misaka, Hiroyuki Mizukami, Koichi Sugimoto, Shu-ichi Saitoh, 
Toshiyuki Ishibashi, Yasuchika Takeishi, Department of Cardiology 
and Hematology, Fukushima Medical University, Fukushima, Japan
Learning Objective: Circulating tenascin-C is related to the degree of 
coronary calcification in the patients of stable angina. Tenascin-C is 
a novel biomaker of coronary calcification.
1268 STABLE ISCHEMIC SYNDROME--NONINVASIVE 
ASSESSMENT OF CAD AND PVD
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1268-307 A Randomized Controlled Trial of Fractional Flow 
Reserve to Optimize Percutaneous Coronary 
Intervention
Eric Durand, Martine Gilard, Alain Furber, Pierre Coste, Michel Slama, 
Jean Luc Dubois-Randé, Paul Barragan, Patrick Dupouy, Saliha Rahal, 
Antoine Lafont, University Paris Descartes, Paris, France
Learning Objective: To evaluate the value of FFR for stent 
deployment optimization.
1268-308 The Utility of CARDx Early Cardiac Diagnostic 
System for the Detection of Coronary and 
Peripheral Artery Disease
Asha P. Mansukhani, Ehtisham Mahmud, University of California San 
Diego, San Diego, CA
Learning Objective: Evaluate a new diagnostic modality for detecting 
coronary artery disease and peripheral artery disease
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1270-320 Prognosis of Asymptomatic Coronary Artery 
Disease after Percutaneous Coronary Intervention
Kohei Wakabayashi, Cedric Delhaye, Gabriel Maluenda, Itsik Ben-
Dor, Manuel A. Gonzalez, Sara D. Collins, Asmir I. Syed, Michael A. 
Gaglia, Rebecca Torguson, Zhenyi Xue, William O. Suddath, Lowell F. 
Satler, Kenneth M. Kent, Augusto D. Pichard, Joseph Lindsay, Ron 
Waksman, Washington Hospital Center, Washington DC, DC
Learning Objective: In patients undergoing elective PCI, the absence 
of symptom is associated with an increase in one-year mortality.
1270-321 A Comparison of Clinical Outcomes in the Bypass 
Angioplasty Revascularization Investigation in Type-
2 Diabetes Mellitus (BARI 2D) by Type of Stent 
Implantation
Vankeepuram S. Srinivas, Jiang Lu, John J. Lopez, Jorge Escobedo, 
GS Das, Zoran S. Nedeljkovic, Vijay Misra, Eric Bates, on behalf of 
the BARI2D Investigators, Monteﬁore Medical Center, New York, NY, 
University of Pittsburgh, Pittsburgh, PA
Learning Objective: Compare clinical outcomes in patients 
with Diabetes and Coronary Disease receiving percutaneous 
revascularization with drug eluting stents or bare metal stents to 
Medical therapy in the BARI2D clinica
1270-322 Prevalence of Angina after Successful PCI
Alda Huqi, Doralisa Morrone, Eugenia Capati, Rossella Urselli, Mario 
Marzilli, Cardiac and Thoracic Department, University of Pisa, Pisa, 
Italy, Department of Cardiology, University of Siena, Siena, Italy
Learning Objective: Removal of coronary stenosis does not 
consistently cure angina.
1270-323 Clinical Characteristics and Outcomes of 
Japanese Female Patients Undergoing Coronary 
Revascularization Therapy
Shunsuke Funakoshi, Natsuhiko Ehara, Takeshi Kitai, Makoto 
Kinoshita, Atsushi Kobori, Shuichirou Kaji, Atsushi Yamamuro, 
Tomoko Tani, Michihiro Nasu, Yukikatsu Okada, Toru Kita, Yutaka 
Furukawa, Takeshi Morimoto, Takeshi Kimura, Kobe City Medical 
Center General Hospital, Kobe, HI, Japan, Kyoto University Hospital, 
Kyoto, Japan
Learning Objective: interpret gender differences in risk factor 
profiles and cardiovascular outcomes for patients with coronary 
artery disease.
1269-314 Association of Coronary Risk Factors with Proximal 
and Distal Atherosclerosis
Atif Qasim, Lena Matthews, Rajesh Movva, Kambiz Parcham-Azad, 
Daniel J. Rader, Muredach P. Reilly, Hospital of the University of 
Pennsylvani, Philadelphia, PA
Learning Objective: Describe the differences between risk factors 
and location of coronary atherosclerotic lesions
1269-315 Long term Impact of Race/Ethnicity on Death, 
Myocardial Infarction and Stroke among 
patients enrolled in the Bypass Angioplasty 
Revascularization Investigation of Type 2 Diabetes 
Trial (BARI 2D)
Nirat Beohar, Veronica Sansing, V.S. Srinivas, Andrew Davis, 
Stephen Thomas, Tarek Helmy, Luis Lepe, Maria Brooks, BARI 2D 
Study Group, Northwestern University, Chicago, IL, University of 
Pittsburgh, Pittsburgh, PA
Learning Objective: Race/ethnic differences in patients with DM 
and CAD
1269-316 Relationship between Erectile Dysfuntion and 
Coronary Artery Calcification in a population of 
Middle Aged Men in the World Trade Center Medical 
Monitoring and Treatment Program.
Sima J. Patel, Mary Ann A. McLaughlin, Boback M. Berookhim, Rupa 
L. Iyengar, Danielle R. Platt, Simonette T. Sawit, Jaqueline M. Moline, 
Natan Bar-Chama, Mount Sinai School of Medicine, New York, NY
Learning Objective: evaluate the association of erectile dysfunction 
with cardiovascular disease based on coronary artery calcium scores.
1269-317 Does the SYNTAX Score Have a Relation with 
Myocardial Ischemia?
Hirokazu Tanaka, Taishiro Chikamori, Satoshi Hida, Yuko Igarashi, 
Yuka Ohtaki, Chie Shiba, Yasuhiro Usui, Tsuguhisa Hatano, Akira 
Yamashina, Department of Cardiology, Tokyo Medical University, 
Toko, Japan
Learning Objective: evaluate the relation between SYNTAX score and 
myocardial ischemia assessed by stress myocardial perfusion SPECT
1270 STABLE ISCHEMIC SYNDROME--
REVASCULARIZATION IN SPECIAL POPULATIONS
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1270-319 Lack of Sex-Based Differences in Outcomes in 
Patients with Type 2 Diabetes and Coronary Artery 
Disease Treated with Contemporary Medical 
Therapy with or without Prompt Revascularization: 
A Report from BARI 2D
Jacqueline E. Tamis-Holland, Jiang Lu, Mary Korytkowski, William 
J. Rogers, Neuza Lopes, Michelle Magee, Lisa Mighton, Alice K. 
Jacobs, BARI 2D Investigators, St Luke’s Hospital, New York, NY, 
University of Pittsburgh, Pittsburgh, PA
Learning Objective: Understand that there are little differences 
in outcome among women and men, when they are equally 
aggressively treated for coronary artery disease.
JACC    March 9, 2010 ABSTRACTS: Quality of Care and Outcomes Assessment A129
Quality of Care and  
Outcom
es Assessm
ent
918 COMPARATIVE EFFECTIVENESS AND OUTCOMES
Tuesday, March 16, 2010, 8:00 a.m. - 9:30 a.m.
Georgia World Congress Center, Room B404
CME/CE Hours: 1.5
8:00 Outpatient Compliance with Performance Measures 
for Atrial Fibrillation: A Report of the first 14,000+ 
Patients from the American College of Cardiology’s 
IC3 (Improving Continuous Cardiac Care) Program
Paul Chan, Stuart Winston, Donna Buchanan, Fran F. Fiocchi, 
Fengming Tang, Kristi Mitchell, Tracie Breeding, William J. Oetgen, 
John S. Rumsfeld, Carole Decker, John A. Spertus, Mid America 
Heart Institute, Kansas City, MO, The American College of 
Cardiology, Washington DC, DC
Learning Objective: Describe the quality of outpatient non-valvular 
atrial fibrillation care in a large registry.
8:15 Early Physician Follow-Up and 30-Day Readmission 
among Medicare Beneficiaries Hospitalized with 
Heart Failure: Data from OPTIMIZE-HF and GWTG-HF
Adrian F. Hernandez, Melissa A. Greiner, Gregg C. Fonarow, Bradley 
G. Hammill, Paul A. Heidenreich, Clyde Yancy, Eric D. Peterson, 
Lesley H. Curtis, Duke Clinical Research Institute, Durham, NC, 
University of California-Los Angeles, Los Angeles, CA
Learning Objective: Evaluate the relationship of early follow-up and 
readmission after a hospitalization for heart failure
8:30 The Relation Between Hospital Procedure Volume 
and Complications of Cardioverter-Defibrillator 
Implantation from the National Cardiovascular Data 
Registry
James V. Freeman, Yongfei Wang, Jeptha Curtis, Paul A. Heidenreich, 
Mark Hlatky, Stanford University School of Medicine and Palo Alto 
Veterans Affairs Health Care System, Stanford, CA, Yale University 
School of Medicine, New Haven, CT
Learning Objective: At the conclusion of this presentation, 
participants will be able to identify the effect of hospital ICD implant 
volume on procedural complications.
8:45 Methods of Evaluating Comparative Effectiveness in 
Observational Studies: The Example of Drug-Eluting 
and Bare Metal Stents
Robert W. Yeh, Malini Chandra, Alan S. Go, Massachusetts General 
Hospital, Boston, MA, Kaiser Division of Research, Oakland, CA
Learning Objective: describe alternative methods of evaluating 
comparative effectiveness from observational data.
9:00 Introducing ASCERT: The American College of 
Cardiology-The Society of Thoracic Surgeons 
Collaboration on the Comparative Effectiveness of 
Revascularization Strategies
William S. Weintraub, Fred Edwards, Study Co-Investigators, 
American College of Cardiology Foundation, Washington, DC, The 
Society of Thoracic Surgeons, Chicago, IL
Learning Objective: Describe the comparative effectiveness 
research being performed by ACCF and STS to compare PCI with 
CABG, funded by an NHLBI Grant.
920 OUTCOMES IN CHRONIC HEART FAILURE
Tuesday, March 16, 2010, 10:30 a.m. - 12:00 p.m.
Georgia World Congress Center, Room B404
CME/CE Hours: 1.5
10:30 Post Discharge Management Programs for Elderly 
Heart Failure Patients: A Systematic Review and 
Meta-Analysis of Randomized Clinical Trials
Sanjeev Suri, Adrian Hernandez, Ali Usmani, Anitha Rajamanickam, 
Cleveland Clinic, Cleveland, OH
Learning Objective: describe the effectiveness of disease 
management programs in reducing readmissions and mortality for 
hospitalized elderly heart failure patients
10:45 Health Related Quality of Life and Functional 
Class Are Independently Related to Outcomes in 
Unselected Outpatients with Heart Failure: Insights 
from the Study of Anemia in a Heart Failure 
Population (STAMINA-HFP) Registry
Jalal K. Ghali, Jun R. Chiong, Javed Butler, William G. Cotts, 
Stephanie . H. Dunlap, J. Herbert Patterson, Ron M. Oren, Ileana L. 
Piña, Douglas D. Schocken, Todd A. Schwartz, Kirkwood F. F. Adams, 
Jr, University of North Carolina, Chapel Hill, NC, Detroit Medical 
center, Detroit, MI
Learning Objective: Demonstrate an understanding of the 
relationship of health related quality of life to prognosis in patients 
with heart failure.
11:00 Influence of Predictive Modeling in Implementing 
Optimal Heart Failure Therapy
Dwight D. Stapleton, Hari Prasad, Jaspinder Sra, Wayne C. Levy, MD, 
GUTHRIE CLINIC, LTD, SAYRE, PA
Learning Objective: Describe the influence of using the Seattle 
Heart Failure Model in the intensification of both device and 
medical therapy in an ambulatory heart failure population.
11:15 Which Adiposity Measure Is a Better Predictor of 
Cardiovascular Morbidity Risk Factors and Mortality 
in Obese Patients with Heart Failure?
Nancy M. Albert, James F. Bena, Anne S. Tang, Jennifer Forney, Ellen 
Slifcak, Cleveland Clinic, Cleveland, OH
Learning Objective: Distinguish predictors of morbidity and mortality 
in obese patients with heart failure based on adiposity measure 
studied.
11:30 Relationship between Cardiology Practice Teaching 
Status and Improvement in the Use of Evidence-
Based Therapy for Heart Failure: Findings from 
IMPROVE HF
Christopher M. O’Connor, Gregg C. Fonarow, Nancy M. Albert, Anne 
B. Curtis, Wendy Gattis Stough, Mihai Gheorghiade, J Thomas 
Heywood, Mark L. McBride, Patches Johnson Inge, Mandeep R. 
Mehra, Dwight Reynolds, Mary N. Walsh, Clyde W. Yancy, Medtronic, 
Inc., Minneapolis, MN
Learning Objective: To evaluate the relationship between cardiology 
practice teaching status and improvement in the use of evidence-
based therapy for heart failure
ORAL CONTRIBUTIONS
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1027 GENETICS AND CARDIAC EVENTS
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1027-154 Regulation of Plasma ET-1 Levels by Chromosome 
4q25 SNP Associated With Atrial Fibrillation
Fadia Mayyas, Jonathan D. Smith, John Barnard, Mina K. Chung, 
David R. Van Wagoner, Cleveland Clinic, Cleveland, OH
Learning Objective: To describe the association between 
rs2200733 genotype, a SNP associated with atrial fibrillation, and 
plasma endothelin-1 levels
1027-155 Meta-analysis of the Association Between a 
Common Variant in the Beta-2 Adrenergic Receptor 
and Sudden Cardiac Death
Michael C. Gavin, Christopher Newton-Cheh, Martin Van Denbergh, 
J Michael Gaziano, Nancy R. Cook, Christine M. Albert, Brigham and 
Women’s Hospital, Boston, MA, Massachusetts General Hospital, 
Boston, MA
Learning Objective: Demonstrate an understanding of the 
association between polymorphisms in the beta adrenergic 
receptors and sudden cardiac death
1027-156 Trigger-Specific Risk Factors for Cardiac Events in 
Patients with the Congenital Long-QT Syndrome 
Type 2
James A. Kim, Arthur J. Moss, Coeli M. Lopes, Scott McNitt, 
Jennifer L. Robinson, Wojciech Zareba, Ilan Goldenberg, University 
of Rochester Medical Center, Rochester, NY
Learning Objective: Identify trigger-specific clinical and genetic risk 
factors in patients with the Type 2 Long-QT syndrome.
1027-157 Genetic Factors Associated with Non-fatal 
Myocardial Infarction and Hospitalized Unstable 
Angina - A Marshfield Clinic Case-Cohort Study
Deanna S. Cross, Daniel Hoefner, Evangelos Hytopoulos, WuXiong 
Li, Bruce H. Phelps, Michael Beggs, Douglas S. Harrington, Edward 
R. McCluskey, Catherine A. McCarty, Marshﬁeld Clinic Research 
Foundation, Marshﬁeld, WI, Aviir Inc., Palo Alto, CA
Learning Objective: describe an approach to study the impact of 
adding genetics to the detection of those at risk of a coronary 
event.
1027-158 Correlation of Mutation Location and Ion Channel 
Characteristics with Cardiac Event Triggers in Long 
QT Syndrome Type 1
Princy Thottathil, Arthur J. Moss, Coeli M. Lopes, Scott McNitt, 
Wojciech Zareba, Jennifer L. Robinson, Ilan Goldenberg, The 
International Long QT Syndrome Investigative Group, University of 
Rochester Medical Center, Rochester, NY
Learning Objective: Evaluate trigger-specific clinical and genetic risk 
factors for cardiac events in the LQT1 population.
1028 PHARMACOGENOMICS
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1028-160 Warfarin Dosing Algorithm Refinements after 
7-9 Days of Therapy based on Pharmacogenetic, 
Pharmacokinetic, Clinical, and Laboratory Data
Benjamin D. Horne, Petra A. Lenzini, Mia Wadelius, Andrea L. 
Jorgensen, Stephen E. Kimmel, Niclas Eriksson, Jeffrey L. Anderson, 
Munir Pirmohamed, Nita A. Limdi, James K. Burmester, Daniel 
Kurnik, Charles M. Stein, Michael D. Caldwell, Charles S. Eby, 
Anders Rane, John D. Lindh, Jae-Gook Shin, Ho-Sook Kim, Pantep 
Angchaisuksiri, Jinbo Chen, John F. Carlquist, Gloria R. Grice, 
Kathryn E. Kronquist, Brian F. Gage, Intermountain Medical Center, 
Murray, UT, University of Utah, Salt Lake City, UT
Learning Objective: Demonstrate that a warfarin dose-refinement 
algorithm, which incorporates pharmacogenetic data, provides 
better prediction of therapeutic warfarin dose.
1028-161 Pravastatin Therapy Among All Ethnic Groups of 
CARE Reduced Primary End Point Events in Carriers 
of the KIF6 719Arg Allele, but not in Noncarriers
Dov Shiffman, Marc S. Sabatine, Judy Z. Louie, Charles M. Rowland, 
Olga A. Iakoubova, Hannia Campos, Frank M. Sacks, James J. 
Devlin, Celera, Alameda, CA
Learning Objective: Evaluate the benefit of pravastatin therapy 
among carriers and noncarriers of the 719Arg allele of KIF6
1028-162 The Influence of Cytochrome P450 2C19*2 and*17 
Genotype, Diplotype and Metabolizer Status on 
Platelet Reactivity in Patients on Maintenance 
Clopidogrel Therapy
Paul A. Gurbel, Udaya S. Tantry, Mark J. Antonino, Kevin P. Bliden, 
Ruth E. Pakyz, Alan R. Shuldiner, Sinai Center for Thro,bosis 
Research, Baltimore, MD, University of Maryland School of 
Medicine, Baltimore, MD
Learning Objective: To determine whether CYP2C19*2 and*17 
allele status influences platelet reactivity in response to clopidogrel 
therapy
1028-163 Cytochrome 2C19 Polymorphism and Response to 
Adjunctive Cilostazol versus High Maintenance-dose 
Clopidogrel in Patients Undergoing Percutaneous 
Coronary Intervention
Young-Hoon Jeong, Seok-Jae Hwang, Yongwhi Park, In-Suk Kim, 
Choong Hwan Kwak, Jin-Yong Hwang, Gyeongsang National 
University Hospital, Jinju, South Korea
Learning Objective: Among patients with CYP2C19 mutant allele 
undergoing elective PCI, adjunctive cilostazol achieves intensified 
platelet inhibition and reduces the rate of HPPR than high-MD 
clopidogrel.
POSTER CONTRIBUTIONS
JACC    March 9, 2010 ABSTRACTS: Quality of Care and Outcomes Assessment A131
Quality of Care and  
Outcom
es Assessm
ent
1030 COST OF CARE IN CARDIOVASCULAR DISEASE
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1030-171 Medical Cost Burden and Outcomes after Acute 
Myocardial Infarction
Sachin J. Shah, Saif S. Rathore, Aditya Mandawat, Kimberly J. Reid, 
Oliver J. Wang, John A. Spertus, Harlan M. Krumholz, Yale University 
School of Medicine, New Haven, CT, Mid America Heart Institute, 
Kansas City, MO
Learning Objective: describe the association between the burden of 
medical costs and outcomes after acute myocardial infarction.
1030-172 Statin Therapy is Cost-Effective for Vascular Event 
Prevention in Adults with Elevated C-Reactive 
Protein: Implications of JUPITER
Julia F. Slejko, Robert L. Page, II, Patrick W. Sullivan, University of 
Colorado Denver School of Pharmacy, Aurora, CO, Regis University 
School of Pharmacy, Denver, CO
Learning Objective: evaluate the cost-effectiveness of statin therapy 
for a population with low LDL cholesterol, but elevated hs-CRP.
1030-173 The Impact of Pharmacy Benefit Managers on 
Physician Practice Time, Cost, and Efficiency
James A. Heinsimer, Danny A. Mammo, Phil Mendys, Kevin A. 
Schulman, Duke University, Durham, NC
Learning Objective: understand how PBMs impact physician 
practices
1030-174 Total Healthcare Costs Among Atrial Fibrillation 
Patients in the United States in 2010
Michael H. Kim, Bong-Chul Chu, Jay Lin, Kathy L. Schulman, 
Northwestern University, Chicago, IL, Thomson Reuters, Cambridge, 
MA
Learning Objective: appreciate the magnitude of the economic 
burden imposed by atrial fibrillation (AF) in the United States, 
and the substantial non-cardiovascular and cardiovascular cost 
components of AF management
1030-175 Reappraisal of the Evaluation of Chest Pain in the 
Emergency Room - A Modern Cost Analysis Just in 
Time for Health Care Reform
Fahd A. Chaudhry, Fatima Ilyas, Saira Rashid, Vincent Sorrell, 
University of Arizona, Tucson, AZ
Learning Objective: Accurately estimate the cost of various stress 
tests, and identify factors adding to patient (and hospital) expense.
1028-164 Estimation of Incremental Cardiovascular 
Healthcare Costs in Patients with Atrial Fibrillation 
in the United States
Michael H. Kim, Stephen S. Johnston, Jay Lin, Kathy L. Schulman, 
Northwestern University, Chicago, IL, Thomson Reuters, Cambridge, MA
Learning Objective: appreciate that most of the cardiovascular 
healthcare costs incurred by patients with atrial fibrillation (AF) in the 
US stem from management of CV comorbidities rather than AF per se.
1029 GENOMICS AND MYOCARDIAL PHENOTYPES
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1029-166 Prognostic Value of a Systematic Familial Screening 
in Idiopathic Dilated Cardiomyopathy. The 
Experience of Trieste Heart Muscle Disease
Marco Merlo, Michele Moretti, Giulia Barbati, Dario Gregori, Andrea 
Di Lenarda, Luisa Mestroni, Gianfranco Sinagra, Ospedali Riuniti 
and University, Trieste, Italy
Learning Objective: Compare long-term prognosis of familial dilated 
cardiomyopathy with respect to sporadic forms in order to assess 
the role of familial screening
1029-167 Nuclear Receptor Co-Activator-1 Modifies the 
Hypertrophic Cardiomyopathy Phenotype
Nicole Orr, Amil M. Shah, Alyson Kelley-Hedgepeth, Daniel Kramer, 
Martin S. Maron, Gordon Huggins, Molecular Cardiology Research 
Institute, Boston, MA, Tufts Medical Center, Boston, MA
Learning Objective: To identify and understand the role of potential 
genetic modifiers of the hypertrophic cardiomyopathy phenotype
1029-168 Mutations in 6 Genes Identified in Patients With 
Peripartum Cardiomyopathy
Ana Morales, Thomas Painter, Ran Li, Jill D Siegfried, Duanxiang Li, 
Nadine Norton, Miller School of Medicine, University of Miami, Miami, FL
Learning Objective: Describe evidence supporting the hypothesis 
that rare DCM variant mutations may contribute to PPCM/PACM.
1029-169 Network Analysis of Epistatic Interactions among 
Four Myocardial Fatty Acid Metabolism Candidate 
Genes Modulating Hypertensive Heart Disease
Lisa de las Fuentes, Jyh M. Juang, Sharlee Climer, Victor G. Davila-
Roman, Washington University, St. Louis, MO
Learning Objective: better understand the important role played by 
epistasis with PPARGC1A in modulating HHD traits.
1029-170 Beta-1 Adrenergic Receptor Gene Polimorphism 
in Heart Failure: a Gender Specific Clinical and 
Prognostic Role?
Savina Nodari, Marco Triggiani, Anna Foresti, Giuseppe Milesi, 
Nicola Berlinghieri, Loredana Covolo, Livio Dei Cas, Department of 
Experimental and Applied Medicine-University of Brescia, Brescia, Italy
Learning Objective: Beta-1 adrenergic receptor gene polimorphism 
may contribute to explain gender differences in clinical and 
functional profiles and outcomes in heart failure patients
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1032 BIOMEDICAL COMPUTING/INFORMATION 
TECHNOLOGY
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1032-183 The Effect of Electronic Prescription Upon 
Attainment of Guideline-Based Cholesterol Goals
Katherine C. Michelis, Bassel Hassouna, Mina Owlia, Yousef Bader, 
Douglas V. Clarke, Jr., Lena Furmark, Shireen Khoury, Nina Kukar, 
Rayan Alhazmi, Raman S. Dusaj, Vandana Toteja, Heather A. Young, 
Brian G. Choi, George Washington University, Washington, DC
Learning Objective: identify the benefit of electronic prescription 
upon National Cholesterol Education Program Adult Treatment Panel 
III (NCEP ATP III) guideline-based LDL goal attainment.
1032-184 Trialresults-center: A Web-based Clinical Trial 
Results Database Providing Dynamic Systematic 
Reviews And Meta-analysis Of Clinical Trials In 
Cardiology
Michel Cucherat, TrialResults-center.org, Lyon, France
Learning Objective: describe TrialResults-center approach
1032-185 Clinical Validation of a Decision Support System for 
Acute Coronary Syndromes
Robert F. DeBusk, Nancy Houston-Miller, Lynda Raby, Stanford 
University School of Medicine, Stanford, CA
Learning Objective: Demonstrate familiarity with a computerized 
decision support system for patients with suspected acute coronary 
syndrome
1032-186 A New Schema for Problem Lists: Towards Real-
Time Decision Support
Matthew McCormick, Thomas A. Windle, John R. Windle, University 
of Nebraska Medical Center, Omaha, NE
Learning Objective: describe a more robust schema for problem list 
management
1032-187 A Computer Simulation Study of the Effectiveness 
of Left Ventricular Assist Device under Mitral 
Regurgitation and Mitral Stenosis
Salvatore Chiaramida, Michael L. Bernard, Adrian B. Van Bakel, 
Joseph J. Thompson, John M. Toole, Ying Sun, Medical University 
of South Carolina, Charleston, SC, University of Rhode Island, 
Kingston, RI
Learning Objective: : Demonstrate the use of a computer model to 
characterize the interaction between left ventricular assist devices 
and the circulatory system under mitral valvular diseases.
1031 OUTCOMES RESEARCH: APPROPRIATENESS AND 
CLINICAL TRIALS REPORTING
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1031-177 Adherence to the American College of Cardiology 
Foundation / American Society of Nuclear 
Cardiology - 2009 Appropriate Use Criteria for 
Cardiac Nuclear Imaging by Cardiologist and Non-
Cardiologist in a Community Hospital Setting
Shanmugam Uthamalingam, Imad Ahmado, James Flynn, New 
England Heart Institute at Catholic Medical Center, Manchester, NH, 
Division of Cardiology, Massachusetts General Hospital, Boston, MA
Learning Objective: to identify the importance of the application 
of ACCF and ASNC recently published appropriateness criteria for 
cardiac nuclear imaging and incorporate them in their practice 
patterns.
1031-178 Predictors of Normal Single Photon Emission 
Computed Tomography Myocardial Perfusion 
Imaging
Angela Koh, Jennifer Flores, Felix Keng, Terrance SJ Chua, National 
Heart Centre, Singapore, Singapore
Learning Objective: Assessment of appropriateness for SPECT MPI
1031-179 Trends in Appropriateness of Outpatient 
Transthoracic Echocardiography
Ali Rahimi, Meghan York, Neil Gheewala, Thomas H. Hauser, Warren 
J. Manning, Beth Israel Deaconess Medical Center, Department of 
Medicine (Cardiovascular Division), Boston, MA
Learning Objective: Identify Trends in Appropriateness of Outpatient 
Echocardiography
1031-180 The Selection of Hard Clinical Endpoints versus 
Surrogate Endpoints as the Primary Outcome 
Measure in Major Cardiovascular Clinical Trials is 
not Influenced by the Source of Funding
Ashish Aneja, Ricardo Esquitin, Kshitij Shah, Louai Razzouk, 
Rupa Iyengar, Irfan Wali, Verghese Mathew, Michael E. Farkouh, 
MetroHealth Medical Center Campus of Case Western Reserve 
University, Cleveland, OH, Mount Sinai School of Medicine, New 
York, NY
Learning Objective: Recognize that the source of funding of major 
cardiovascular clinical trials does not influence the choice of the 
primary outcome measure
1031-181 The Impact of Conflicts of Interest on Adjudication 
and Outcomes in Cardiovascular Clinical Trials
Ricardo Esquitin, Ashish Aneja, Kshitij A. Shah, Louai Razzouk, 
Devin M. Mann, Joseph S. Ross, Rupa Iyengar, Irfan U. Wali, 
Verghese Mathew, Michael E. Farkouh, Mount Sinai School of 
Medicine, New York, NY, MetroHealth Medical Center Campus of 
Case Western Reserve University, Cleveland, OH
Learning Objective: Indentify the impact of financial conflicts of 
interest on outcomes in cardiovascular trials.
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1083 OUTCOMES ASSESSMENT METHODS
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1083-160 Red Cell Distribution Width Predicts Adverse 
Long Term Outcomes in Subjects with Suspected 
Coronary Disease
Riyaz S. Patel, Emir Veledar, Ronak Patel, Salman Sher, A Umair 
Janjua, Douglas C. Morris, John S. Douglas, Stephen D. Clements, S 
Tanveer Rab, Habib Samady, A Maziar Zafari, Viola Vaccarino, Arshed 
A. Quyyumi, Emory University School of Medicine, Atlanta, GA
Learning Objective: Evaluate an existing and easily available test for 
prognostic utility in a cath lab population
1083-161 Would Observational Data have Predicted Results 
Found in Randomized Controlled Trials of Coronary 
Revascularization?
John B. Wong, Linda K. Shaw, Daniel B. Mark, Eric D. Peterson, 
Peter K. Smith, Elizabeth R. DeLong, Tufts Medical Center, Boston, 
MA, Duke Clinical Research Institute, Durham, NC
Learning Objective: Understand the generalizability of patient 
populations enrolled in and the results observed in randomized 
controlled trials when compared with an observational dataset
1083-162 Inclusion of Roll-in Patients in Pre-FDA Approval 
Cardiovascular Device Trials
Connie E. Chen, Sanket S. Dhruva, Lisa A. Bero, Rita F. Redberg, 
University of California, San Francisco, San Francisco, CA
Learning Objective: Define roll-in patient and characterize the use 
and reporting of data from roll-in patients in recent cardiovascular 
device studies
1083-163 Event Adjudication Changes Key Results in Open-
Label Trials: The AFFIRM Experience
Elaine M. Nasco, April Slee, Kent Koprowicz, Robert G. Hart, Axio 
Research, LLC, Seattle, WA
Learning Objective: Interpret event rates using both adjudicated and 
unadjudicated events.
1083-164 Small Artery Elasticity, but neither Carotid 
Artery Elasticity nor Aorta Distensibility, Predicts 
Cardiovascular Events in an Asymptomatic - Results 
of the Multi-Ethnic Study of Atherosclerosis
Daniel A. Duprez, David R. Jacobs, Jr, Pamela L. Lutsey, David A. 
Bluemke, David A. Bluemke, Lyndia C. Brumback, Jospeh Polak, 
Richard A. Kronmal, University of Minnesota, Minneapolis, MN
Learning Objective: interprete the predictive value of artial elasticity 
on CV events beyond blood pressure and CV risk factors.
1082 ECONOMIC OUTCOMES
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1082-154 Government-Sponsored Health Insurance and Lack 
of Insurance Are Associated with Adverse Cardiac 
Events
Michael Angelo Gaglia, Jr., Rebecca Torguson, Manuel A. Gonzalez, 
Zhenyi Xue, Itsik Ben-Dor, Sara D. Collins, Asimir I. Syed, Gabriel 
Maluenda, Cedric Delhaye, Kohei Wakabayashi, Nicholas N. Hanna, 
William O. Suddath, Kenneth M. Kent, Lowell F. Satler, Augusto D. 
Pichard, Ron Waksman, Washington Hospital Center, Washington, DC
Learning Objective: Describe the effect of different types of health 
insurance upon 1-year outcomes after PCI.
1082-155 Money Left Over at the End of the Month and 
Outcomes after Myocardial Infarction
Aditya Mandawat, Saif S. Rathore, Sachin J. Shah, Emily M. Bucholz, 
Kimberly J. Reid, Oliver J. Wang, Joseph S. Ross, John A. Spertus, 
Harlan M. Krumholz, Yale University School of Medicine, New Haven, 
CT, Case Western Reserve University, Cleveland, OH
Learning Objective: Characterize the relationship between self-
reported patient financial stress and outcomes after acute 
myocardial infarction
1082-156 Cost-Effective Primary Prevention of Coronary Heart 
Disease in Intermediate Risk Patients: Universal 
Aspirin and Statins Is Superior to Prevention Guided 
by Stress Testing
Benjamin Z. Galper, Andrew Moran, Mark J. Pletcher, Pamela 
Coxson, Lawrwence Lazar, Y. Claire Wang, Paul Heidenreich, Lee 
Goldman, Columbia University Medical Center, New York City, 
NY, University of California San Francisco Medical Center, San 
Francisco, CA
Learning Objective: Demonstrate the use of the CHD Policy Model 
to determine the Cost-Effectiveness of utilizing stress testing to 
improve the risk stratification of intermediate risk patients.
1082-157 Cost and Clinical Consequences of Stress/Single-
Photon Emission Computed Tomography Testing 
with Specific Medications
Onur Baser, James Spalding, Smita Kothari, Maria Laura Monsalvo, 
STATinMED Research, Ann Arbor, MI, Astellas Pharma, Deerﬁeld, IL
Learning Objective: Identify the cost of care and clinical events 
associated with dipyridamole vs. adenosine use in ST/SPECT 
myocaridal perfusion testing using real-wordl data.
1082-158 Comparison of United States Hospitals’ Heart 
Failure Quality Care measures: A National Sample 
from 2005 - 2009
Jun R. Chiong, Celso Perez, Mark Ghamsary, Loma Linda University, 
Loma Linda, CA
Learning Objective: to understand differences in performance 
measures For Profit Hospital (FP) and Not For Profit (NFP) hospital’s 
adherence to HF quality care measures.
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1085-171 Can the Syntax Score Be Used in Clinical Practice? 
Results of a Inter- and Intra-Observer Variability 
Study
Stéphane Zuily, Christophe Goetz, Julien Rosencher, Obay Oulmane, 
Zoheir Mami, Stéphane Manzo-Silberman, Nicolas Marque, Philippe 
Allouch, Olivier Bical, Alain Pavie, Christian Spaulding, Olivier 
Varenne, Cardiology Department, Cochin Hospital, Paris, France
Learning Objective: Use the SYNTAX score in clinical practice
1085 SCORING AND OUTCOMES
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1085-172 Preparticipation Screening of Athletes for Risk of 
Sudden Death, a Solution to the Cost Factor
Thomas DeBauche, Peter Razeghi, Connie Keasling, Phillip 
DeBauche, Andrew Collins, William Green, David Anthony, Cypress 
Cardiology PA, Cypress, TX
Learning Objective: Identify a low cost method of screening athletes 
for risk of SCD
1085-173 Improvement beyond the Framingham Risk Score 
for Prediction of Mortality by the Addition of the 
Intermountain Risk Score
Benjamin D. Horne, Heidi T. May, Joseph B. Muhlestein, Donald L. 
Lappé, Deborah Budge, Rami Alharethi, John F. Carlquist, Abdallah 
G. Kfoury, Jeffrey L. Anderson, Intermountain Medical Center, 
Murray, UT, University of Utah, Salt Lake City, UT
Learning Objective: Examine the result of combining the 
Intermountain Risk Score with the Framingham Risk Score on risk 
stratification.
1085-174 Independent US validation of the British Columbia 
PCI Risk Score
Rohit Khurana, Sharon-Lise T. Normand, Treacy Silbaugh, Karin 
H. Humphries, Min Gao, Lillian Ding, Ann Lovett, David J. Cohen, 
Jaap N. Hamburger, University of British Columbia, Vancouver, BC, 
Canada
Learning Objective: Identify with the international applicability of the 
British Columbia post PCI risk score to their practice
1085-175 Obstructive Ventilatory Disorder in Heart Failure: 
Not Always COPD!
Susanne Brenner, Gülmisal Güder, Kilian Fröhlich, Götz Gelbrich, 
Roland Jahns, Berthold Jany, Georg Ertl, Christiane E. Angermann, 
Stefan Störk, University of Würzburg, Dept. of Internal Medicine, 
Würzburg, Germany
Learning Objective: In patients with HF, COPD is common but often 
misdiagnosed (>70%). The correct diagnosis of COPD in patients 
with heart failure may only be made in course of the disease.
1084 OUTCOMES OF REVASCULARIZATION
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1084-166 What is the Right Definition of Contrast Induced 
Nephropathy Post Percutaneous Coronary Intervention?
Refat Jabara, Radhika Gadesam, Lakshmana Pendyala, Nicolas 
Chronos, Jack Chen, Spencer King, Steven Manoukian, Hadassah-
Hebrew University Medical Center, Jerusalem, Israel, Saint Joseph’s 
Hospital, Atlanta, GA
Learning Objective: Learn about the practical impact of the 
definition utilized on the rate of CIN post PCI
1084-167 Impact of Chronic Obstructive Pulmonary Disease 
on Cardiovascular Outcomes in Patients after PCI
Tomas Konecny, Marek Orban, Krishen Somers, Yuki Koshino, Paul 
D. Scanlon, Charanjit S. Rihal, Mayo Clinic, Rochester, MN
Learning Objective: identify worse prognosis for patients with COPD 
undergoing PCI
1084-168 Quantification of Amplitude, Speed and 
Completeness of ST-segment Recovery after 
Primary Percutaneous Coronary Intervention for 
ST-segment Elevation Myocardial Infarction: What Is 
the “Best ST” Recovery to Predict Clinical Outcome?
Wichert J. Kuijt, Matthew T. Roe, Cindy L. Green, Niels J. Verouden, 
Joost D. Haeck, Dan Tzivoni, Karel T. Koch, Gregg W. Stone, 
Alexandra J. Lansky, Robbert J. De Winter, Mitchell W. Krucoff, Duke 
Clinical Research Institute, Durham, NC
Learning Objective: This study demonstrates that various measures 
of STR, representing duration and intensity of ischemia, are highly 
predictive of clinical outcome and are best captured by continuous 
12-lead Holter
1084-169 The Impact of Vascular Access Site Complications on 
One-Year Outcome in the Setting of PCI: A Reappraisal
Erwin Schroeder, Dirck Faes, Jacques Jamart, Patrick Chenu, Vincent 
Dangoisse, Patrick Evrard, Laurence Gabriel, Antoine Guedes, 
Baudouin Marchandise, Emmanuel Morandini, Axel Muller, Jean-
Louis Paquay, Godefroy Perot, Mont-Godinne University Hospital, 
YVOIR, Belgium
Learning Objective: Identify a subgroup of bleeding events without 
impact on survival
1084-170 Prognostic value of the Mayo Clinic Risk Score 
for coronary artery revascularization using the 
Australasian Society of Cardiac and Thoracic Surgeons 
and the Melbourne Interventional Group Registries
Bryan P. Yan, Cheng-Hon Yap, Nick Andrianopoulos, Thomas J. 
Kiernan, Andrew E. Ajani, Julian A. Smith, David J. Clark, Stephen 
J. Duffy, Gilbert C. Shardey, Angela L. Brennan, Diem T. Dinh, 
Christopher M. Reid, Bernard J. Gersh, Australasian Society of 
Cardiac and Thoracic Surgeons and Melbourne Interventional Group, 
Chinese University of Hong Kong, Hong Kong, Hong Kong, Monash 
University, Melbourne, Australia
Learning Objective: Evaluate in-hospital mortality risk after coronary 
revascularization
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1087 IMAGINING AND OUTCOMES
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1087-183 2D Echo Training for Cardiac Nurses: The Effects of 
Intensive Repetition
Michael J. Barrett, Garima Sharma, Kristy Schering, Alfred Bove, 
Temple University, Philadelphia, PA
Learning Objective: Understand how to teach nurses to recognize 
normal echo images
1087-184 Real Time Cellular Video-Phone Electrocardiogram 
Transmission of Patients with ST-Segment Elevation 
Myocardial Infarction: A Novel Tele-Medicine 
Technology to Shorten Door-to-Balloon Time
Manuel A. Gonzalez, Sara D. Collins, Marie E. Rodrigo, Itsik 
Ben-Dor, Gabriel Maluenda, Asmir I. Syed, Michael A. Gaglia, Jr., 
Cedric Delhaye, Kohei Wakabayashi, Rebecca Torguson, William O. 
Suddath, Kenneth M. Kent, Joseph Lindsay, Augusto D. Pichard, 
Lowell F. Satler, Ron Waksman, Washington Hospital Center, 
Washington, DC
Learning Objective: familiarize themselves with new technology 
using pre-hospital real time video cell phone ECG interpretation of 
patients with STEMI
1087-185 Virtual Electrophysiologic Testing In A Three-
dimensional Cardiac MRI Model Of Myocardial 
Infarction In Pigs
Jason Ng, Jason Jacobson, Justin Ng, David Gordon, Daniel Lee, 
Alan H. Kadish, James Carr, Jeffrey J. Goldberger, Northwestern 
University, Chicago, IL
Learning Objective: describe how electrophysiolic testing can be 
performed using computer simulation
1087-186 Free Software Improves Accuracy of Pediatric EKG 
Decreasing Error by 45%
MARCOS SLEIMAN ,MOLINA, Alexandre Benjo, Alessandra Molina, 
Carlos A. Pastore, InCor - Heart Inst of Univ of Sao Paulo, Sao 
Paulo, Brazil, Clinica Sao Paulo, Moji das Cruzes, Brazil
Learning Objective: Validate the superiority of computer-aided 
evaluation of pediatric EKG
1087-187 The utility Of a Novel Software in Lipid Clinic
Demir Baykal, Medical Software,LLC, Duluth, GA
Learning Objective: The utility of a novel software in lipid clinic
1086 REVASCULARIZATION STRATEGIES
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1086-177 Non-Invasive Assessment of Stent Fracture with the 
Stent Boost Technique
Maria Papathanasiou, Evaggelia Zacharioglou, Periklis Davlouros, 
Lampros Papakosmas, Anastasia Damelou, Konstantinos 
Theodoropoulos, Vasileios Karantalis, Gerasimos Dimitropoulos, 
Georgia Mitropoulou, Ioanna Xanthopoulou, Grigorios Tsigkas, 
Dimitrios Alexopoulos, Patras University Hospital, Patras, Greece
Learning Objective: evaluate the incidence and clinical impact of 
stent fracture and the diagnostic utility of fluoroscopy in stent 
fracture diagnosis
1086-178 Fracture Potentials of Five Drug-Eluting-Stent 
Platforms in Proximal Right Coronary Artery 
Replica Under In-Vivo Simulated Cyclically-Bended 
Environment
Kiyotaka Iwasaki, Yutaro Hama, Tadashi Yamamoto, Yuichi Yagishita, 
Yusuke Noguchi, Syunsuke Tsubouchi, Ken Nakashita, Hiroshi 
Kasanuki, Mitsuo Umezu, Waseda University, Tokyo, Japan, Sapporo 
Orthopedic Cardiovascular Hospital, Sapporo, Japan
Learning Objective: examine fracture potentials of five DES 
platforms in proximal right coronary artery using a novel accelerated 
durability tester which can apply an in-vivo simulated cyclically-
bended load
1086-179 Vascular Physiologic Responses Associated With 
Drug-Eluting Stents: Evaluation Of A Stent Eluting 
Sirolimus From An Absorbable Salicylate Polymer 
Coating
Refat Jabara, Lisa Goodwin, Nicolas Chronos, Traci Goodchild, 
Hadassah-Hebrew University Medical Center, Jerusalem, Israel, 
Saint Joseph’s Translational Research Institute, Atlanta, GA
Learning Objective: Flow Cytometry and Western Blot of New 
Bioabsorbale Polymer Coating
1086-180 Do Appropriateness Criteria Adequately Assess the 
Usefulness of Repeat Echocardiograms
Abhijit Ghatak, Raja C. Pullatt, David I. Silverman, Hartford hospital, 
Hartford, CT, University of Connecticut Health center, Farmington, CT
Learning Objective: To evaluate Appropriateness criteria for repeat 
Transthoracic Echocardiogram.
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1138 OUTCOMES IN ACUTE CORONARY SYNDROMES
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1138-160 Decline in Hospitalizations for Acute Myocardial 
Infarction in a Metropolitan Population over Past 
Decade
Alan K. Berger, Lindsay G. Smith, David R. Jacobs, Jr, Russell V. 
Luepker, University of Minnesota, Minneapolis, MN
Learning Objective: Identify the trends in acute myocardial infarction 
in men and women in the Twin Cities over the past decade.
1138-161 Usual Source of Care and Outcomes after Acute 
Myocardial Infarction: Data from the Prospective 
Registry Evaluating Myocardial Infarction: Event and 
Recovery (PREMIER)
Erica S. Spatz, Mayur M. Desai, Kensey Riley, Joseph S. Ross, 
Sameer D. Sheth, John A. Spertus, Harlan M. Krumholz, Yale 
University School of Medicine, New Haven, CT, Mid America Heart 
Institute of Saint Luke’s Hospital, Kansas City, MO
Learning Objective: Identify the strength of a relationship with 
a usual care provider, and describe the association between 
relationship strength with risk of mortality and readmission 
following hospitalization for AMI
1138-162 Temporal Trends Over 15 Years in Clinical Trials 
of Non-ST Elevation Acute Coronary Syndromes: 
More Aggressive Treatment Yields Similar Mortality 
Despite Higher-Risk Profiles
Mark Y. Chan, Jie-Lena Sun, L. Kristin Newby, Harvey D. White, David 
J. Moliterno, Pierre Theroux, E. Magnus Ohman, Karen S. Pieper, 
Robert P. Giugliano, Paul W. Armstrong, Robert M. Califf, Frans Van 
de Werf, Robert A. Harrington, Duke Clinical Research Institute, 
Durham, NC
Learning Objective: describe temporal patterns in baseline risk, 
treatment, and outcomes of non-ST elevation acute coronary 
syndrome patients enrolled in randomized clinical trials over a 15-
year period.
1138-163 Validation of the Global Registry of Acute 
Coronary Events (GRACE) risk score for 6-month 
postdischarge death in 1183 Spanish patients
emad abu assi, Jose Maria Garcia-Acuna, Carlos Pena-Gil, Rafael 
Carlos Vidal Perez, Jose Ramon Gonzalez-Juanatey, Hospital Clínico 
Universitario, Santiago de Compostela, Spain
Learning Objective: To evaluate the performance of the GRACE risk 
score for 6-month post-discharge death
1138-164 Matching National EMS System Data to the NCDR 
ACTION Registry to Identify First Medical Contact 
Time.
James G. Jollis, Seth W. Glickman, Christopher B. Granger, 
Greg D. Mears, Duke University, Durham, NC, EMS Performance 
Improvement Center, University of North Carolina, Chapel Hill, NC
Learning Objective: Learn how to incorporate emergency medical 
system data into hospital information systems.
1137 DIABETES, LIPIDS, OBESITY
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1137-154 Influence Of Preoperative Diabetic Treatment Status 
On Long-term Cardiovascular Outcomes In Patients 
With Type 2 Diabetes Mellitus Undergoing Coronary 
Revascularization.
Natsuhiko Ehara, Yutaka Furukawa, Takeshi Morimoto, Satoshi 
Shizuta, Makoto Kinoshita, Shuichiro Kaji, Atsushi Kobori, Atsushi 
Yamamuro, Tomoko Tani, Takeshi Kitai, Satoshi Teramukai, Masanori 
Fukushima, Toru Kita, Takeshi Kimura, CREDO-Kyoto Investigators, 
Kobe City Medical Center General Hospital, Kobe, Japan, Kyoto 
University Hospital, Kyoto, Japan
Learning Objective: evaluate the association between preoperative 
diabetic treatment status and cardiovascular outcomes in patients 
with type 2 diabetes mellitus after coronary revascularization.
1137-155 Adiposity Associated Mortality and Cardiovascular 
Events in Patients with Coronary Artery Disease
YOEL KORENFELD, Felipe Albuquerque, Virend K. Somers, Rui Qin, 
Simona Boarin, Vijaykumar Jarsania, Abel Romero-Corral, Randall J. 
Thomas, Francisco Lopez-Jimenez, Mayo Clinic, Rochester, MN
Learning Objective: Undesrtand the relationship of adiposity and 
cardiovascular outcomes in patients with coronary artery disease
1137-156 Loss of Early Gains in Low-Density Lipoprotein 
Cholesterol Goal Attainment Among High Risk 
Patients
Joanne M. Foody, Shiva Sajjan, Henry Hu, Dena R. Ramey, David 
Neff, Andrew M. Tershakovec, Joanne E. Tomassini, Kaan Tunceli, 
Merck & Co., Inc., North Wales, PA
Learning Objective: Describe the proportion of high risk patients 
treated and untreated with lipid lowering therapy with LDL-C levels 
≥70mg/dL and the need for guideline based LDL-C lowering in 
these patients
1137-157 Effect of Intensive Blood-Glucose Control Compared 
to Conventional Treatment on Cardiovascular 
Endpoints In Patients with Type 2 Diabetes
Ganesh Athappan, Faisal M. Khan, Caritas St Elizabeth Medical 
Center, Brighton, MA
Learning Objective: identify the cardiovascular benefits of intensive 
glucose control inpatients with type II diabetes.
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1140 OUTCOMES IN THE ELDERLY
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1140-171 Acute Delirium Predicts Short-term Re-
hospitalization among Elderly patients Admitted 
with Acutely Decompensated Heart Failure.
SHANMUGAM UTHAMALINGAM, Jagdesh Kandala, Marilyn Daley, 
Robert Capodilupo, James L. Januzzi, New England Heart Institute 
at Catholic Medical Center, Manchester, NH, Division of Cardiology, 
Massachusetts General Hospital, Boston, MA
Learning Objective: identify patients admitted with ADHF and acute 
delirium are at increased risk of new nursing home placement and 
to involve multidisciplinary team for effective discharge planning.
1140-172 Post-MI Angina Status and Quality of Life in Older 
vs. Younger Adults
Ryan B. Longmore, John A. Spertus, Karen P. Alexander, Kimberly J. 
Reid, Phillip G. Jones, Harlan M. Krumholz, Frederick A. Masoudi, 
Michael W. Rich, Mid-America Heart Institute, Kansas City, MO
Learning Objective: Demonstrates the importance of angina 
treatment after MI for both older and younger patients.
1140-173 Prevalence and Outcomes of Cognitive Impairment 
in Older Adult Survivors of Acute Myocardial 
Infarction
S. Michael Gharacholou, Kimberly J. Reid, Harlan M. Krumholz, Eric 
D. Peterson, Karen P. Alexander, Mayo Clinic, Rochester, MN, Duke 
University, Durham, NC
Learning Objective: Demonstrate the prevalence of cognitive 
impairment and its association with outcomes in older adult 
survivors of acute myocardial infarction.
1140-174 Is Pre-diabetes Associated With Increased Mortality 
And Cardiovascular Morbidity In Community-
dwelling Older Adults?
Prakash C. Deedwania, Mustafa I. Ahmed, Marjan Mujib, Ali 
Ahmed, V A Medical center, Birmingham, AL, University of Alabama, 
Birmingham, AL
Learning Objective: evaluate the prognostic impact of Pre diabetes 
on CV outcome in Older adults
1139 EVALUATION OF RISK
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1139-166 Characteristics of patients rehospitalized with Acute 
Decompensated Heart Failure (ADHF) within 30 
days following discharge
Sandip K. Zalawadiya, Hammam D. Zmily, Jareer O. Farah, Suleiman 
Daifallah, Omaima A. Ali, Jalal K. Ghali, Wayne State University/
Detroit Medical Center, Detroit, MI, John D.Dingell VA Medical 
Center, Detroit, MI
Learning Objective: identify high risk ADHF patients at the time of 
admission the hospital for 30-day rehospitalization.
1139-167 Weighing the Evidence of Harm with PPI+ 
Clopidogrel verus Clopidogrel Alone for Secondary 
Prevention of CAD- Meta Analysis of Randomized 
Trials and Observational Studies Comprising Over 
50,000 Patients
Abdul Hakeem, Sabha Bhatti, Kunal Karmali, Florence Rothenberg, 
Robin H. Vandivier, University of Cincinnati College of Medicine, 
Cincinnati, OH
Learning Objective: understand the clinical outcomes associated 
with Proton pump inhibitor use with clopidogrel
1139-168 Can Strain by Speckle Tracking Imaging Predict 
Mortality in Primary Amyloid Patients with Normal 
left Ventricle Ejection Fraction?
Haydar K. Saleh, Hector R. Villarraga, Diego Bellavia, Yang Yu, 
Yuki Koshino, Su-Feng Hsiao, Garvan C. Kane, Patricia A. Pellikka, 
Fletcher A. Miller, Mayo Clinic, Rochester, MN
Learning Objective: Identify that in primary amyloid patients with 
normal LVEF, strain by speckle imaging is reduced and is a predictor 
of survival.
1139-169 Common Carotid Artery Intima Media Thickness 
Alone is Comparable to Carotid Intima Media 
Thickness of all Carotid Artery Segments in 
Improving Coronary Heart Disease Risk Prediction 
in the Atherosclerosis Risk In Communities (ARIC) 
Study
Vijay Nambi, Lloyd Chambless, Max He, Aaron R. Folsom, Tom 
Mosley, Eric Boerwinkle, Christie Ballantyne, Baylor College of 
Medicine, Houston, TX
Learning Objective: understand how to use carotid intima media 
thickness in coronary heart disease risk prediction
1139-170 Relative Risk of Death from Cardiovascular Disease
Robert J. Bryg, Tae Yang, David Bryg, Olive View-UCLA Medical 
Center, Sylmar, CA, UCLA, Los Angeles, CA
Learning Objective: describe the difference in mortality in differerent 
cardiovascular disease states.
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1142 GENDER AND OUTCOME
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1142-183 Temporal Effect on Gender Differences in Patients 
Undergoing Evaluation for Coronary Artery Disease
Monika Arora, Dina Sparano, Nils P. Johnson, Claire O’Connell, 
Thomas A. Holly, Martha Gulati, Northwestern Memorial Hospital, 
Chicago, IL
Learning Objective: Assess temporal effect of gender on referral 
to angiography after abnormal myocardial perfusion imaging and 
survival.
1142-184 Gender Differences in the Incidence of All Cause 
Mortality
Naser Ahmadi, Fereshteh Hajsadeghi, Hormoz B. Mirshkarlo, 
Matthew Budoff, Ramin Ebrahimi, Los Angeles Biomedical Research 
Institute at Harbor UCLA Medical Center, Torrance, CA
Learning Objective: This study point to an increasing incidence 
of mortality in both men and women with increasing CAC scores. 
In addition, for age and CAC adjusted groups, men had higher 
mortality rates than women
1142-185 Gender Difference in Novel Biomarkers for 
Predicting Future Cardiovascular and Coronary 
Events.
Vikas Veeranna, Ashutosh Niraj, Sandip Zalawadiya, Jyotiranjan 
Pradhan, Luis Afonso, Wayne State University, Detroit, MI
Learning Objective: Gender specific use of novel cardiovascular risk 
factors in cardiovascular risk assessment.
1142-186 Sex Differences in Outpatient Performance 
Measures: A Report of the first 14,000+ Patients in 
the American College of Cardiology’s IC3 (Improving 
Continuous Cardiac Care) Program
Paul Chan, Donna Buchanan, Fran F. Fiocchi, Philip G. Jones, Kristi 
Mitchell, Tracie Breeding, William J. Oetgen, John S. Rumsfeld, 
John A. Spertus, Mid America Heart Institute, Kansas City, MO, The 
American College of Cardiology, Washington DC
Learning Objective: Describe sex differences in rates of compliance 
with outpatient cardiovascular performance measures.
1142-187 Impact of Anemia in Men and Women with ST-
Segment Elevation Myocardial Infarction: The 
HORIZONS-AMI Trial
Kenichi Tsujita, Eugenia Nikolsky, Alexandra J. Lansky, Louise 
Gambone, Lynn Vandertie, Adriano Caixeta, George Dangas, Bruce 
R. Brodie, Dariusz Dudek, Martin Möckel, Andrzej Ochala, Roxana 
Mehran, Gregg W. Stone, Columbia University Medical Center and 
the Cardiovascular Research Foundation, New York, NY
Learning Objective: identify the difference of impact of anemia 
between men and women with STEMI
1141 QUALITY OF LIFE AND SOCIAL ISSUES
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1141-177 Leadership Qualities and Health Related Behaviors: 
Is There a Relationship?
Elizabeth A. Jackson, Preeti Iyer, Jean E. DuRussel-Weston, Caren S. 
Goldberg, Bruce Rogers, LaVaughn Palma-Davis, Susan Aaronson, 
Catherine M. Fitzgerald, Marc Zimmerman, Lindsey R. Mitchell, 
Roopa Gurm, Kim A. Eagle, University of Michigan Health Systems, 
Ann Arbor, MI
Learning Objective: Describe the potential relationship between 
leadership qualities and health related behaviors.
1141-178 Coronary Atherosclerosis, Posttraumatic Stress 
Disorder and Mortality incidence
Naser Ahmadi, Hormoz B. Mirshkarlo, Fereshteh Hajsadeghi, 
Matthew Budoff, Ramin Ebrahimi, Los Angeles Biomedical Research 
Institute at Harbor UCLA Medical Center, Torrance, CA
Learning Objective: Post-traumatic Stress Disorder (PTSD) is 
associated with increased subclinical atherosclerosis and 
predicts poor cardiovascular outcome independent of conventional 
cardiovascular risk factors
1141-179 Feasibility of Routine Quality of Life Assessment in 
an Ambulatory Heart Failure Clinic and Impact of 
Patient Perceptions on Health Status
Sabrina Badloe, Parakash Pratibhu, Lynne W. Stevenson, Akshay 
Desai, Michelle A. Young, Joanne R. Weintraub, Michael M. Givertz, 
Eldrin F. Lewis, Brigham and Women’s Hospital, Boston, MA
Learning Objective: To evaluate the role of quality of life 
assessment in heart failure management
1141-180 Has the U.S. Stock Market Collapse Impacted 
Cardiovascular Event Rates?
Mona Fiuzat, G. Michael Felker, Linda Shaw, Renato Lopes, 
Christopher O’Connor, Duke University Medical Center, Durham, NC, 
Duke Clinical Research Institute, Durham, NC
Learning Objective: To examine potential patterns between stressful 
events and CV event rates
1141-181 Inappropriate Clopidogrel Adherence In Insured 
Minority Populations And Its Impact In Stent 
Related Outcomes.
Ana Palacio, Mark Gilbert, Leonardo Tamariz, Hua Li, Mauro 
Moscucci, Olveen Carrasquillo, University of Miami, Miami, FL
Learning Objective: Describe the effects of clopidogrel adherence by 
ethnicity
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1193 OUTCOMES ASSESSMENT IN HEART FAILURE I
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1193-160 Changes in Incidence and Mortality Rates of 
Ischemic and Non-Ischemic Heart Failure. A 10-Year 
Study
Yingzi Deng, Abel E. Moreyra, William J. Kostis, John Pantazopoulos, 
Nora M. Cosgrove, Alan C. Wilson, John B. Kostis, for the MIDAS 
group, UMDNJ-Robert Wood Johnson Medical School, New 
Brunswick, NJ
Learning Objective: To study recent trends in incidence and 
outcomes of heart failure due to ischemic and non-ischemic 
etiologies.
1193-161 Gain in Life Expectancy in Patients with Left 
Ventricular Systolic Dysfunction Treated Early with 
Enalapril: A 23-Year Follow-Up of SOLVD Cohort in 
Belgium
Michel F. Rousseau, Philip Jong, Sylvie A. Ahn, University of Louvain, 
Brussels, Belgium, University of Toronto, Toronto, ON, Canada
Learning Objective: to demonstrate gain in life expectancy in 
patients with left ventricular systolic dysfunction treated early with 
enalapril
1193-162 Predictive Model For Six-month Risk Of Death Or 
Hospitalization In Ambulatory Heart Failure Patients
Scott Hummel, Todd M. Koelling, University of Michigan, Ann Arbor, MI
Learning Objective: Risk-stratify ambulatory heart failure patients for 
death and/or hospitalization
1193-163 Trends in Incident Hospitalizations, Management, 
and Outcomes of Heart Failure in Ontario, Canada: 
1995 to 2007
Darwin F. Yeung, Nicole K. Boom, Douglas S. Lee, Jack V. Tu, 
Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 
University of Toronto, Toronto, ON, Canada
Learning Objective: To identify trends in incident hospitalization, 
management, and outcomes of heart failure in Ontario, Canada.
1193-164 Can Serial Measurement of B-type Natriuretic 
Peptide Levels Provide Incremental Prognostic 
Information in Ambulatory Patients with Chronic 
Heart Failure?
Leonardo P. j. Oliveira, Esteban Walker, W.H. Wilson Tang, Cleveland 
Clinic Foundation, Cleveland, OH, OH
Learning Objective: Identify that serial BNP measurements has 
prognostic value in chronic heart failure patients.
1192 SAFETY
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1192-154 Risk of Upper Gastrointestinal Bleeding among Users 
of Clopidogrel and Low-dose Acetylsalicylic Acid
Luis Alberto Garcia Rodriguez, Saga Johansson, Spanish Centre 
for Pharmacoepidemiological Research (CEIFE), Madrid, Spain, 
AstraZeneca R&D, Mölndal, Sweden
Learning Objective: quantify the risk of upper gastrointestinal 
bleeding associated with low-dose acetylsalicylic acid and 
concomitant clopidogrel, and understand how use of proton pump 
inhibitors can reduce this risk
1192-155 In-Hospital Hemodialysis and Mortality Rates 
in Individuals Undergoing Invasive Cardiac 
Catheterization Procedures with Low Osmolar 
Contrast Agents: A Multicenter Study of 207,826 
Patients
James Min, Amy Ryan, Fay Y. Lin, Teresa David, Weill Cornell Medical 
College, New York, NY, Premier, Inc., Charlotte, NC
Learning Objective: To understand adverse events following low 
osmolar contrast media exposure in inpatients undergoing cardiac 
catheterization procedures
1192-156 Cumulative Exposure to Ionizing Radiation from 
Cardiac Imaging Procedures
Jersey Chen, Harlan M. Krumholz, Yongfei Wang, Joseph Ross, Reza 
Fazel, Henry Ting, Nilay Shah, James Brink, Khurram Nasir, Andrew 
J. Einstein, Brahmajee K. Nallamouthu, Yale University School of 
Medicine, New Haven, CT, University of Michigan, Ann Arbor, MI
Learning Objective: Understand cumulative radiation dose from 
cardiac imaging procedures
1192-157 The American College of Cardiology’s IC3 
(Improving Continuous Cardiac Care) Program and 
Heart Failure Performance Measures: A Report of 
the first 14,000+ Patients
Paul Chan, Donna Buchanan, Fran F. Fiocchi, Fengming Tang, Kristi 
Mitchell, Duane Thrutchley, William J. Oetgen, John S. Rumsfeld, 
John A. Spertus, Mid America Heart Institute, Kansas City, MO, The 
American College of Cardiology, Washington DC, DC
Learning Objective: Describe insights into outpatient heart failure 
quality of care.
1192-158 Congestive Heart Failure Performance Measures: 
Does Adherence Impact Early Unplanned Hospital 
Readmissions?
Sula Mazimba, Nakash Grant, Diklar Makola, Jessica Tan, Lata 
Parvathaneni, Trupti Patel, Vikas Kalra, Radha Kothapalli, Christina 
Redko, Harvey Hahn, Kettering Medical Center, Kettering, OH, Wright 
State University Boonshoft School of Medicine, Dayton, OH
Learning Objective: Identify factors responsible for unplanned early 
readmssions for Congestive Heart failure
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1195 COMPARATIVE EFFECTIVENESS STUDIES
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1195-172 Net Clinical Benefit of Combination Anticoagulant 
and Antiplatelet Therapy versus Anticoagulation 
alone in Atrial Fibrillation patients: Results from the 
AMADEUS trial
Deirdre Lane, Pieter Kamphuisen, Pascal Minini, Olaf R. De Peuter, 
Harry R. Buller, Gregory Y H Lip, University of Birmingham Centre 
for Cardiovascular Sciences, City Hospital, Birmingham, United 
Kingdom, Department of Vascular Medicine, Academic Medical 
Centre, Amsterdam, The Netherlands
Learning Objective: Combination antithrombotic therapy increases 
the risk of clinically relevant bleeding in AF patients and does not 
reduce the risk of stroke.
1195-173 Aspirin Therapy for Primary versus Secondary 
Prevention of Cardiovascular Disease: An Updated 
Meta-Analysis.
Jayanta Robert Das, Shervin Eshaghian, George A. Diamond, P.K. 
Shah, Sanjay Kaul, Cedars Sinai Medical Center, Los Angeles, CA
Learning Objective: Evaluate the benefit-risk balance for aspirin in 
primary versus secondary prevention of cardiovascular disease.
1195-174 Comparison of Everolimus-Eluting and Paclitaxel-
Eluting Coronary Stents in Patients Undergoing 
Multi-Vessel Stenting: Pooled Analysis from the 
SPIRIT III and SPIRIT IV Randomized Trials
Dean J. Kereiakes, Krishnankutty Sudhir, James B. Hermiller, 
Alexandra J. Lansky, Julie Doostzadeh, Wesley Pierson, Xiaolu 
Su, Paul C. Gordon, Gregg W. Stone, The Christ Hospital Heart & 
Vascular Ctr/The Lindner Research Ctr, Cincinnati, OH
Learning Objective: Evaluate the performance of XIENCE V 
everolimus-eluting stents in patients undergoing multi-vessel 
stenting in a large pooled analysis of the SPIRIT III and IV trials
1195-175 Performance Measures for In-Hospital Management 
of Acute Coronary Syndromes in Europe
francois schiele, Matthias Hochadel, Marco Tubaro, Keith 
A.A. Fox, Jean-Pierre Bassand, Anselm Gitt, Nicolas Danchin, 
University Hospital Jean Minjoz, Besancon, France, Institut für 
Herzinfarktforschung, Ludwigshafen, Germany
Learning Objective: describe the use of performance measures in 
the management of ACS in Europe
1194 OUTCOMES, HYPERTENSION AND KIDNEY 
DISEASE
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1194-166 Serum Cystatin C Levels and Long-Term Mortality 
among Subjects with Normal Creatinine-Based 
Estimated Glomerular Filtration Rates
Jou-Wei Lin, Cho-Kai Wu, Yu-Sheng Lin, Dept of Environmental and 
Occupational Health, Univ of North Texas Health, Fort Worth, TX, 
National Taiwan University Hospital Yun-Lin Branch, Dou-Liou City, 
Yun-Lin County, Taiwan,ROC
Learning Objective: Cystatin C is prognostic of long-term outcome.
1194-167 Sudden Cardiac Death in Relation to Changing 
Heart Rate During Treatment of Hypertension: The 
LIFE Study
Peter M. Okin, Darcy A. Hille, Sverre E. Kjeldsen, Stevo Julius, Björn 
Dahlöf, Richard B. Devereux, Weill Cornell Medical College, New York, NY
Learning Objective: Describe the relationship of sudden cardiac 
death to heart rate
1194-168 Left Ventricular Mass Index Predicts Renal 
Outcomes in High Vascular Risk men: a 3-year 
Follow-up Study
Konstantinos P. Tsiouﬁs, C. Thomopoulos, P. Kokkinos, C. Faselis, M. 
Doumas, D. Papadopoulos, N. Kukar, R. Amdur, V. Papademetriou, 
Veterans Administration and Georgetown University Medical 
Centers, Washington DC, WA, Greece
Learning Objective: identify the predictive value of LVMI on 
kidney dysfunction plus incident dialysis despite optimal ongoing 
vasoactive treatment accompanied by significant BP lowering within 
non-hypertensive levels
1194-169 Impact of Dialysis-Dependent End Stage Renal 
Disease and Advanced Chronic Kidney Disease 
on In-Hospital Outcomes in Patients Undergoing 
Percutaneous Coronary Intervention
Puja Parikh, Luis Gruberg, Allen Jeremias, Srihari S. Naidu, Richard 
A. Shlofmitz, Sorin J. Brenner, Thomas Pappas, Kevin P. Marzo, David 
L. Brown, Stony Brook University Medical Center, Stony Brook, NY, 
Winthrop University Hospital, Mineola, NY
Learning Objective: determine if dialysis-dependent end stage 
renal disease and advanced chronic kidney disease are predictive 
of adverse cardiac events in patients undergoing percutaneous 
coronary intervention
1194-170 Does the Presence of Microalbuminuria Portend 
a Worse Outcome in Non-Diabetic Patients with 
Metabolic Syndrome?
Pawan K. Hari, Vikas Veeranna, Rajeev Sudhakar, Palaniappan 
Manickam, Ramanjit Kaur, Jyotiranjan Pradhan, Sony Jacob, Luis 
Afonso, Wayne State University, Detroit, MI
Learning Objective: Identify that Microalbuminuria in non-diabetic 
patients with metabolic syndrome predicts higher cardiovascular 
morbidity and all cause mortality compared to metabolic syndrome 
alone
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1197 OBESITY AND DIET
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1197-183 Waist Hip Ratio, not Body Mass Index Predicted 
Cardiovascular Risk in a Multi Ethnic Cohort of 
Healthy Adults.
Sandip K. Zalawadiya, Jyotiranjan Pradhan, Ashutosh Niraj, Vikas 
Veerana, Palaniappan Manickam, Pavan Hari, Jacob Sony, Luis 
Afonso, Wayne State University/Detroit Medical Center, Detroit, MI
Learning Objective: utilize waist-hip ratio for prediction of future 
cardivascular events accross different ethinic strata.
1197-184 Cardiac Outcomes after Screening for 
Asymptomatic Coronary Artery Disease in Patients 
with Metabolic Syndrome: Post-Hoc Analysis of the 
DIAD Trial
Shanti Bansal, Frans J. Th. Wackers, Silvio Inzucchi, Lawrence H. Young, 
M.D., Deborah A. Chyun, Yale-New Haven Hospital, New Haven, CT
Learning Objective: Utility of screening myocardial perfusion imaging 
in metabolic syndrome patients
1197-185 Effects on Mortality and Morbidity in Overweight/
Obese Subjects: The Sibutramine Cardiovascular 
Outcomes (SCOUT) Trial
Philip James, Ian Caterson, Walmir Coutinho, Nick Finer, Luc Van 
Gaal, Aldo Maggioni, Arya M. Sharma, Christian Torp-Pedersen, The 
SCOUT Team, Abbott Laboratories, Abbott Park, IL
Learning Objective: To assess whether weight management with 
sibutramine together with standard care for weight management will 
reduce cardiovascular morbidity and mortality in high-risk subjects 
to a greater extent than
1197-186 Association between Vitamin D Deficiency and 
Prevalence of Cardiovascular Disease
Tami Bair, Nathaniel L. Hall, Heidi T. May, Jeffrey L. Anderson, 
Benjamin D. Horne, John F. Carlquist, Donald L. Lappé, Joseph B. 
Muhlestein, Intermountain Medical Center, Murray, UT
Learning Objective: Examine the relationship between Vitamin D 
and the risk of cardiovascular disease.
1247 QUALITY OF CARE - DISPARITIES
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1247-154 Prevalence of Vaccination in Systolic Heart Failure: 
A Prospective Study of 549 Patients by Race/
Ethnicity and Gender.
George R. Marzouka, Elyse Julian, Frank B. Cortazar, Andre Dias, 
Leonardo Tamariz, Kathy Hebert, University of Miami, Miami, FL, 
Jackson Memorial Hospital, Miami, FL
Learning Objective: Identify factors that influence vaccination in 
heart failure patients
1196 OUTCOMES ASSESSMENT IN HEART FAILURE II
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1196-177 Association of Heart Failure Beliefs and Self-Care 
Adherence in Patients Treated in an Emergency 
Department for Acute Decompensated Heart 
Failure
Nancy M. Albert, Phillip Levy, Elizabeth Langlois, Benjamin Nutter, 
Dongsheng Yang, Vijaya Arun Kumar, Patrick Medado, Elizabeth 
Nykun, Cleveland Clinic, Cleveland, OH, Wayne State University, 
Detroit, MI
Learning Objective: Evaluate the association between heart failure 
illness beliefs and self-care in acutely decompensated patients 
treated in an emergency care setting
1196-178 Coexistence of Multiple Cardiovascular Disease 
is a Independent Predictor of 30-day Mortality in 
Hospitalized Patients with Congestive Heart Failure: 
A Study in Beijing
Yusheng Zhao, Qiao Xue, Xingli Wu, Lei Gao, Jiayue Li, Ping He, Mei 
Zhu, Shiwen Wang, Chinese PLA General Hospital, Beijing, People’s 
Republic of China
Learning Objective: to identify the risk stratification in the patient 
with congestive heart failure
1196-179 Heart Failure with Preserved Ejection Fraction: 
Mortality Risk Post First Hospitalization - Data from 
I-PRESERVE
Peter E. Carson, Michael Zile, John McMurray, Robert McKelvie, 
Michel Komajda, Scott Hetzel, David DeMets, Christoph Staiger, 
Agata Ptaszynska, Barry Massie, Department of Veterans Affairs 
Medical Center, Washington, DC, DC, Georgetown University, 
Washington, DC
Learning Objective: assess mortality risk in HF-PEF
1196-180 The Impact of a Mental Health Related Diagnosis 
on Readmission Rates for Congestive Heart Failure
Ronald S. Freudenberger, Carol A. Foltz, Lou Lukas, Donna F. 
Petruccelli, Hannah Paxton, Victoria Sabella, Lehigh Valley Health 
Network, Allentown, PA
Learning Objective: Identify the impact of mental illness on 
readmission rates for patietns with heart failure
1196-181 Predictive Value of Ejection Fraction and Renal 
Function in High Risk Acute Coronary Syndrome 
Patients: Results from the SYNERGY Trial
Melvin R. Echols, Micheal C. Kontos, Kristi Prather, Douglas D. 
Schocken, Stuart D. Russell, Judith S. Hochman, Luigi Biasucci, 
John French, Kenneth Mahaffey, Duke Clinical Research Institute, 
Durham, NC, Duke University Health System, Durham, NC
Learning Objective: Understand the effect of renal function and 
heart failure in older patients with ACS
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1248-161 The Changing Definition Of Contrast Induced 
Nephropathy And Its Clinical Implications: Insights 
From The Blue Cross Blue Shield of Michigan 
Cardiovascular Consortium (BMC2)
Nicklaus Slocum, Mauro Moscucci, Dean Smith, Herb Aronow, 
Simon Dixon, David Share, Hitinder S. Gurm, University of Michigan 
Medical Center, Ann Arbor, MI
Learning Objective: Describe differences in CIN definitions and its 
clinical implications
1248-162 Patient and Cardiologists’ Perceptions of the 
Benefits of PCI for Stable Coronary Disease
Senthil Sivalingam, Michael Rothberg, Javed Asharf, Paul Visintainer, 
John Joelson, Reva Kleppel, Neelima Vallurupalli, Marc Schweiger, 
Baystate Medical Center, Springﬁeld, MA
Learning Objective: Recognize the difference in expectation between 
patient and cardiologist before elective PCI for stable angina
1248-163 Diminishing Racial Disparities in the Utilization of 
Drug-Eluting Stents Among Medicare Beneficaries: 
2003-2004
Jerome Federspiel, Sally C. Stearns, Laura P. D’Arcy, Kristin L. Reiter, 
Brett C. Sheridan, Joseph S. Rossi, UNC School of Public Health, 
Chapel Hill, NC, UNC School of Medicine, Chapel Hill, NC
Learning Objective: Describe how the the impact of patient race on 
the decision to use DES changed as DES became more common.
1248-164 Trends In Cardiac Rehabilitation Referral Rates 
For Patients Undergoing Percutaneous Coronary 
Intervention: Insights From The BMC2 Registry
Krishna G. Aragam, Mauro Moscucci, David Share, Dean E. Smith, 
Hitinder S. Gurm, University of Michigan Medical Center, Ann Arbor, MI
Learning Objective: Evaluate the prevalence and predictors of 
Cardiac Rehab referrals for patients undergoing PCI
1249 QUALITY OF CARE - PERFORMANCE MEASURES
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1249-166 Comparison of Hospital Performance of Acute 
Myocardial Infarction and Heart Failure Quality 
Measures: Findings from the Get With The 
Guidelines Registry
Tracy Wang, David Dai, Adrian Hernandez, Deepak Bhatt, Paul 
Heidenreich, Gregg Fonarow, Eric Peterson, Duke Clinical Research 
Institute, Durham, NC
Learning Objective: Describe the correlation between hospital 
performance of AMI and HF quality measures
1247-155 Does Obesity Account for Gender and Race 
Disparity for Subsequent Cardiac Catheterization in 
Patients Having Undergone Stress Testing?
Wael ElMallah, Douglas Einstadter, Robert S. Finkelhor, Case 
Western Reserve University / MetroHealth Medical Center, 
Cleveland, OH
Learning Objective: Describe the characteristics of patient referral 
to cardiac catheterization
1247-156 Equitable Improvement for Women and Men in the 
Use of Guideline-Recommended Therapies for Heart 
Failure: Findings from IMPROVE HF
Mary Norine Walsh, Gregg C. Fonarow, Nancy M. Albert, Anne 
B. Curtis, Wendy Gattis Stough, Mihai Gheorghiade, J Thomas 
Heywood, Mark L. McBride, Christopher M. O’Connor, Patches 
Johnson Inge, Mandeep R. Mehra, Dwight Reynolds, Clyde W. Yancy, 
Medtronic, Inc., Minneapolis, MN
Learning Objective: To identify differences and similarities between 
the sexes in use of guideline-recommended therapies for HF in 
the outpatient setting following a practiced-based performance 
improvement intervention.
1247-157 Potential Impact of Poor Patient Education 
Materials on Cardiovascular Outcomes
Clare Murphy, Madeline Keyes, Kimberli Taylor-Clarke, Andre L. 
Churchwell, Alfred S. Callahan, Henry Okafor, Russell Rothman, 
Douglas Sawyer, Uchechukwu K. Sampson, Vanderbilt University 
Medical Center, Nashville, TN
Learning Objective: Importance of attention to patient literacy levels 
in health care delivery
1247-158 Racial Differences in the Attainment of 
Cardiovascular Risk Factor Goals Among Insured 
Adults with Diabetes Mellitus
Abhinav Goyal, Tracy N. Thomas, Joshua Barzilay, Robert L. Davis, 
Viola Vaccarino, Peter W. F. Wilson, Emory University Schools of 
Public Health and Medicine, Atlanta, GA, The Center for Health 
Research, Kaiser Permanente Georgia, Atlanta, GA
Learning Objective: To describe how rates of achieving 
recommended cardiovascular risk factor goals differ between 
medically insured African-American and Caucasian adults with 
diabetes mellitus.
1248 QUALITY OF CARE - PCI
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1248-160 Comparison of Radiation Dose in Femoral and 
Radial Arterial Access Coronary Procedures; the 
Effect of Operator Experience.
Johanne Neill, Hannah Douglas, Niall Herity, Belfast City Hospital, 
Belfast, United Kingdom
Learning Objective: appreciate that whilst radial access coronary 
procedures are associated with fewer acces site complications, 
there is greater radiation dose than with femoral access.
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1250-173 Missed Opportunities in the Management of ST 
Segment Elevation Myocardial Infarction in the Arab 
Middle East: Patients and Physicians Impediments
Mouaz H. Al-Mallah, Alawi A. Alsheikh-Ali, Wael Almahmeed, Kadhim 
Sulaiman, Jassim Al Suwaidi, Mustafa Ridha, Ahmed Al-Motarreb, 
Fahad Alenezi, Mohammad Zubaid, Henry Ford Hospital, Detroit, MI
Learning Objective: to undertsand the indpendent predictor of lack 
of reperfusion therpay in the arab middle east.
1250-174 Time Trends in PCI and CABG Rates in Acute 
Myocardial Infarction Patients with Cardiogenic 
Shock
Khung Keong Yeo, Beate Danielsen, Patrick Romano, Richard White, 
Ezra A. Amsterdam, Zhongmin Li, University of California, Davis 
Medical Center, Sacramento, CA
Learning Objective: To describe the time trends in CABG and PCI 
procedures performed in California from 1997 to 2008 in patients 
wth AMI and cardiogenic shock
1250-175 Patterns and Predictors of Fast Food Consumption 
after Acute Myocardial Infarction
Adam C. Salisbury, Paul S. Chan, Kensey L. Riley, Donna M. 
Buchanan, Alpesh Amin, John A. Spertus, Mid-America Heart 
Institute/University of Missouri-Kansas City, Kansas City, MO
Learning Objective: Describe the prevalence and correlates of 
frequent fast food intake after acute myocardial infarction.
1251 QUALITY OF CARE - READMISSIONS
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1251-177 Prevalence, Correlates and Inter-hospital Variation 
of Early Outpatient Follow-up after Acute Myocardial 
Infarction
Adam C. Salisbury, Kevin F. Kennedy, John A. Spertus, Stacie 
L. Daugherty, Frederick A. Masoudi, Joseph S. Ross, Karen P. 
Alexander, Harlan M. Krumholz, Mid-America Heart Institute/
University of Missouri-Kansas City, Kansas City, MO, Yale University, 
New Haven, CT
Learning Objective: Describe the prevalence, correlates, and 
inter-hospital variation of early outpatient follow-up after acute 
myocardial infarction.
1251-178 Which Hospitals Have Higher Readmission Rates 
for Patients with Heart Failure?
Karen Joynt, Ashish K. Jha, Brigham and Women’s Hospital, Boston, 
MA, Harvard School of Public Health, Boston, MA
Learning Objective: describe characteristics of hospitals that have 
higher than average 30day readmission rates for HF, and describe 
the policy implications of these findings.
1249-167 Temporal Trends In The Management Of Severe 
Hyperglycemia Among Patients Hospitalized With 
Acute Myocardial Infarction
Lakshmi VENKITACHALAM, Kensey Riley, Kasia Lipska, Silvio E. 
Inzucchi, Abhinav Goyal, John A. Spertus, Frederick A. Masoudi, 
Philip G. Jones, Mikhail Kosiborod, Saint Luke’s Mid America Heart 
Institute, Kansas City, MO
Learning Objective: Understand the temporal trends in managment 
of severe sustained hyperglyemia in acute myocardial infarction 
patients
1249-168 In-Hospital Hemoglobin A
1c
 Testing and Its Relation 
to Initiation of Glucose Lowering Therapy in 
Hyperglycemic Patients with Acute Myocardial 
Infarction
Joshua Stolker, John A. Spertus, Darren K. McGuire, Silvio E. 
Inzucchi, Saif S. Rathore, Thomas M. Maddox, Frederick A. Masoudi, 
Fengming Tang, Philip G. Jones, Mikhail Kosiborod, St Luke’s Mid 
America Heart Institute, Kansas City, MO
Learning Objective: Evaluate the relationship between in-hospital 
A1C measurement and new antihyperglycemic therapy.
1249-169 Improving Perioperative Cardiac Risk Assessment 
and Beta-Blocker Use for Non-Cardiac Surgery 
(INCREASE): The INCREASE Quality Improvement 
Project
Anitha Rajamanickam, Ali Usmani, Eric Hixson, Prabhakaran 
Anbazhagan, Anuradha Ramaswamy, Mike Pecic, Amir Jaffer, Brian 
Harte, Cleveland Clinic, Cleveland, OH
Learning Objective: To determine whether referral to a standardized 
preoperative evaluation clinic increased the likelihood of 
administration of PBB
1250 QUALITY OF CARE - ACUTE MYOCARDIAL 
INFARCTION
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1250-171 System Delay as a Predictor of Mortality in Acute 
Myocardial Infarction - A DANAMI-2 Substudy
Michael Maeng, Peter H. Nielsen, Christian J. Terkelsen, Henning R. 
Andersen, Aarhus University Hospital, Skejby, Aarhus, Denmark
Learning Objective: describe the impact of system delay on 
mortality after acute myocardial infarction
1250-172 Early Invasive vs. Conservative Treatment in Non-ST-
Segment Myocardial Infarction: Evidence for a Risk 
Treatment Paradox?
Kim Smolderen, Paul S. Chan, Kensey Riley, Phil G. Jones, Donna M. 
Buchanan, Johan Denollet, Saket Girotra, Harlan M. Krumholz, John 
A. Spertus, Tilburg University, Tilburg, The Netherlands, Mid America 
Heart Institute, Kansas City, MO
Learning Objective: To understand that AMI patients with the 
highest disease burden, are less likely to be referred for early 
invasive treatment than patients with an excellent quality of life.
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1252-185 Racial Differences in Outpatient Performance 
Measures: A Report of the first 10,000+ Patients in 
the American College of Cardiology’s IC3 (Improving 
Continuous Cardiac Care) Program
Paul Chan, Donna Buchanan, Fran F. Fiocchi, Philip G. Jones, Kristi 
Mitchell, Duane Thrutchley, William J. Oetgen, John S. Rumsfeld, 
John A. Spertus, Mid America Heart Institute, Kansas City, MO, The 
American College of Cardiology, Washington DC, DC
Learning Objective: Describe racial differences in rates of 
compliance to outpatient cardiovascular performance measures.
1252-186 Racial and Ethnic Minorities in California Are More 
Likely to be Treated by Cardiac Surgeons with 
Higher Operative Mortality Rates
Luis Castellanos, Zhongmin Li, Khung K. Yeo, J. Nilas Young, 
Ezra Amsterdam, University of California, Davis Medical Center, 
Sacramento, CA
Learning Objective: Identify racial and ethnic disparties in access to 
high performing cardiac surgeons
1252-187 The New Jersey Study of the “Hispanic Paradox”
Jacob M. Mathew, Abel E. Moreyra, Yingzi Deng, Nora M. Cosgrove, 
Alan C. Wilson, John Pantazopoulos, John B. Kostis, The MIDAS 
Study Group, UMDNJ- Robert Wood Johnson Medical School, New 
Brunswick, NJ
Learning Objective: realize racial disparities in health care which 
can be minimized by better decisions by policy makers
1251-179 Factors Leading to 30 Day Readmission Following 
Hospitalization for Heart Failure
Jalal K. Ghali, Hammam D. Zmily, Ibrahim Shaik, Jareer O. Farah, 
Suleiman Daifallah, Ramanjit Kaur, Omaima A. Ali, Husam Al 
Samarah, Phillip Levy, S. William Tam, Michelle Schreiber, Detroit 
Medical Center/Wayne State University, Detroit, MI, John D. Dingell 
VA Medical Center, Detroit, MI
Learning Objective: Understand the factors that lead to early 
readmission for patients with HF in order to avoid or decrease early 
readmission and allow for a smooth transition from in-patient to 
outpatient follow up.
1251-180 Bridging the Gap Between Discharge and Follow-up: 
Initial Report on a Cardiology Bridge Clinic
Eva Kline-Rogers, Adam Leidal, Susan Housholder-Hughes, Lynette 
Mollo, Cheryl Bord, Julie Merz, Janice Norville, Danielle Stahlbaum, 
Elise Woznicki, Jeannette Figurel, Kim A. Eagle, Elizabeth A. 
Jackson, Melvyn Rubenﬁre, University of Michigan, Ann Arbor, MI
Learning Objective: Identify one way to improve timely follow-up care 
for patients recently discharged from the hospital
1251-181 Quality of Care for Comorbid Conditions in Heart 
Failure with Normal Ejection Fraction
Scott Hummel, Amar Kommuri, Todd M. Koelling, University of 
Michigan, Ann Arbor, MI, Sinai Grace Hospital/Detroit Medical 
Center, Detroit, MI
Learning Objective: describe quality of care for comorbid conditions 
in HF-NEF
1252 QUALITY OF CARE - DISPARITIES
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1252-183 Low Acculturation Predicts Rehospitalization among 
Underserved Patients with Heart Failure
Pamela N. Peterson, Elizabeth Campagna, L. Miriam Dickinson, 
Moises Maravi, Larry A. Allen, Frederick A. Masoudi, Denver Health 
Medical Center, Denver, CO, University of Colorado, Denver, Aurora, 
CO
Learning Objective: Evaluate the association between acculturation 
and rehospitalization among underserved patients with heart failure
1252-184 Financial Barriers to Care and Outcomes after 
Acute Myocardial Infarction: Does age matter?
Joseph S. Ross, Erica Spatz, Kimberly Reid, Paul Chan, Susannah 
Bernheim, Judith Lichtman, John Spertus, Harlan Krumholz, Mount 
Sinai School of Medicine, New York, NY
Learning Objective: Describe Age Variation in Outcomes After AMI 
Among Adults With Financial Barriers to Care
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901 HOT TOPICS: AORTIC VALVE
Sunday, March 14, 2010, 2:00 p.m. - 3:30 p.m.
Georgia World Congress Center, Room B408
CME/CE Hours: 1.5
2:00 Survival and Predictors of Mortality in Elderly 
Unoperated Patients with Severe Aortic Stenosis
M. Fuad Jan, Satish Velagapudi, Naoyo Mori, Brian Janosik, Kiran 
Sagar, Aurora Cardiovasc Svcs, Aurora Sinai/St. Luke’s Med 
Ctrs, Univ Wisconsin Sch Med & Public Health-MCC, Milwaukee, 
WI, Center for Urban Population Health, University of Wisconsin-
Milwaukee, Milwaukee, WI
Learning Objective: better identify predictors of mortality in the 
elderly population with symptomatic severe aortic stenosis.
2:15 Factors Affecting Management Decisions in Severe 
Aortic Stenosis Patients with Class I Indications for 
Aortic Valve Replacement
Aman Dua, Patricia Dang, Rimon Shaker, Padmini Varadarajan, Ramdas 
G. Pai, Loma Linda University Medical Center, Loma Linda, CA
Learning Objective: Learn that patients with severe AS are not 
referred for AVR despite class 1 indications
2:30 Early Hemodynamic and Neurohormonal Response 
after Percutaneous Versus Surgical Aortic Valve 
Replacement
Mohammad A. Sherif, Mohamed Abdel-Wahab, Volker Geist, Joerg 
Kynast, Reinhard Semmler, Ralph Tölg, Gert Richardt, Segeberger 
Kliniken GmbH, Bad Segeberg, Germany
Learning Objective: describe the hemodynamic and neurohormonal 
response after percutaneous and surgical aortic valve reolacement
2:45 Transcatheter Aortic Valve Implantation: Single 
Centre Outcomes from the First 250 High-Risk 
Patients
Ronen Gurvitch, Fabian Nietlispach, Anson Cheung, Jian Ye, David A. 
Wood, Namal Wijesinghe, Edgar L. Tay, Chris R. Thompson, Samuel 
Lichtenstein, John G. Webb, St. Paul’s hospital, Vancouver, BC, 
Canada
Learning Objective: appreciate the learning curve associated with 
transcatheter aortic valve implantation
3:00 Midterm Benefits of Perioperative Statin Therapy 
in Patients Undergoing Isolated Valvular Heart 
Surgery: Five-Year Surgical Experience
Muthiah Vaduganathan, Neil J. Stone, Satvik Ramakrishna, Eli I. 
Lev, Richard Lee, Edwin C. McGee, Jr., S. C. Malaisrie, Robert A. 
Silverberg, Patrick M. McCarthy, Bluhm Cardiovascular Institute, 
Northwestern University Feinberg School of Medicine, Chicago, IL
Learning Objective: Describe the short- and mid-term effects of 
perioperative statin therapy in patients undergoing isolated valvular 
heart surgery.
902 HOT TOPICS: MITRAL VALVE
Sunday, March 14, 2010, 4:30 p.m. - 6:00 p.m.
Georgia World Congress Center, Room B408
CME/CE Hours: 1.5
4:30 Analysis of 1000 Consecutive Cases of Mitral Valve 
Repair Cases with Dynamic Annular Sizing and No 
Leaflet Resection
Gerald M. Lawrie, Elizabeth Earle, Nan Earle, The Methodist 
DeBakey Heart Institute, Houston, TX
Learning Objective: evaluate the early and late results of a non-
resectional dynamic mitral valve repair technique.
5:00 Late Survival, Clinical and Echocardiographic 
Outcomes after Mitral Valve Repair in Patients with 
Impaired Ventricular Function
Eugene A. Grossi, Leora B. Balsam, Gregory H. Crooke, Charles 
Schwartz, David G. Greenhouse, Patricia A. Ursommano, Margaret 
Mirabella, Alfred T. Culliford, M.D., Greg H. Ribakove, Aubrey C. 
Galloway, New York University Medical Center, New York, NY
Learning Objective: Describe the predictors of late survival following 
mitral valve repair in patients with decreased ventricular function.
5:15 Is There Benefit in Performing Mitral Valve Repair in 
Patients with Severe Left Ventricular Dysfunction?
Vaughn A. Starnes, Mark J. Cunningham, Joshua Chan, Becky M. 
Lopez, University of Southern California Keck School of Medicine, 
Los Angeles, CA
Learning Objective: Distinguish which patients are appropriate as 
surgical candidates who suffer from left ventricular dysfunction and 
MR.
5:30 Early and Midterm Outcomes of Mitral Repair Are 
Superior to Mitral Replacement in Octogenarians
Joanna Chikwe, Jurgen Passage, Anelechi Anyanwu, Andrew B. 
Goldstone, Javier G. Castillo, Federico Milla, Jurgen Seeburger, 
Friedrich Mohr, David H. Adams, Mount Sinai Medical Center, New 
York, NY, Leipzig Heart Center, Leipzig, Germany
Learning Objective: Describe the outcomes of mitral valve repair 
compard to replacement in octogenarian patients
5:45 Outcomes of the Randomized Evaluation of a 
Surgical Treatment for Off-Pump Repair of the 
Mitral Valve (RESTOR-MV) Trial
Eugene A. Grossi, Nirav Patel, Y Joseph Woo, Judith Goldberg, 
Charles Schwartz, Valavanur A. Subramanian, Ted Feldman, 
Robert C. Bourge, Norman Baumgartner, Christopher Genco, Scott 
Goldman, Marco A. Zenati, J Alan Wolfe, Yugal K. Mishra, Naresh 
Trehan, Sanjay Mittal, Shulian Shang, New York University Medical 
Center, New York, NY
Learning Objective: Evaluate the outcomes of the RESTOR-MV trial.
ORAL CONTRIBUTIONS
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1060 MITRAL VALVE RINGS AND THINGS
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1060-375 Mitral Annular Cinching Eliminates Remnant Mitral 
Regurgitation after Edge-to-Edge Repair to Correct 
Posterior Leaflet Prolapse
Muralidhar Padala, Vinod H. Thourani, David H. Adams, Ajit P. 
Yoganathan, Georgia Institute of Technology, Atlanta, GA
Learning Objective: Demonstrate the need for concomitant 
annuloplasty with edge to edge repair
1060-376 The Influence of Annuloplasty Ring Shape on 
Leaflet Curvature in Human Ischemic Mitral 
Regurgitation
mathieu vergnat, Feroze Mahmood, Albert T. Cheung, Kamal 
Khabbaz, Stuart J. Weiss, Mickael A. Acker, Robert C. Gorman, 
Joseph H. Gorman III, University of Pennsylvania, Philadelphia, PA
Learning Objective: demonstrates effect of annular shape on human 
mitral leafet curvature
1060-377 Does Mitral Flail in Myxomatous Disease Result of 
Individual Geometric Predisposition?
mathieu vergnat, Xu Chun, Liam P. Ryan, Benjamin M. Jackson, 
Stuart J. Weiss, Albert T. Cheung, Joseph H. Gorman III, Robert C. 
Gorman, University of Pennsylvania, Philadelphia, PA
Learning Objective: describe normal mitral stress pattern
1060-378 Geometric Differences of Mitral Apparatus between 
Inferior and Anterior Myocardial Infarction with 
Significant Ischemic Mitral Regurgitation: Three-
Dimensional Analysis with Multislice Computed 
Tomography
Yoshimori An, Shuichiro Kaji, Kitae Kim, Atsushi Yamamuro, Makoto 
Kinoshita, Natsuhiko Ehara, Atsushi Kobori, Atsushi Kobori, Takeshi 
Kitai, Tomoko Tani, Toru Kita, Yutaka Furukawa, Kobe City Medical 
Center General Hospital, Kobe, CA, Japan
Learning Objective: understand he precise three-dimensional (3D) 
geometry of the mitral apparatus in patients with ischemic mitral 
regurgitation (IMR) accompanied by myocardial infarction
1060-379 Outcomes of Early Mitral Valve Repair for Severe 
Degenerative Mitral Regurgitation in Patients 
with no or Mild Symptoms: Impact of Comorbid 
Conditions
Takeshi Kitai, Tomoko Tani, Shunsuke Funakoshi, Yoshimori An, 
Kitae Kim, Shuichiro Kaji, Natsuhiko Ehara, Atsushi Yamamuro, 
Yukikatsu Okada, Yutaka Furukawa, Kobe City Medical Center 
General Hospital, Kobe, FL, Japan
Learning Objective: Reconsider optimal timing of mitral valve repair 
for asymptomatic severe MR with preserved LV function
1061 AORTIC STENOSIS
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1061-381 Veterans Administration Risk Score Accurately 
Predicts Peri-Operative Mortality and Outperforms 
the Euroscore in Aortic Valve Replacement for 
Aortic Stenosis
Jagroop Basraon, Adheesh Agnihotri, Selcuk Adabag, Marc Pritzker, 
Elizabeth Ziemba, Rosemary Kelly, Herb Ward, YS Chandrashekhar, 
VA Medical Center, Minneapolis, MN, University of Minnesota, 
Minneapolis, MN
Learning Objective: Understand the relevance of VA Risk Score and 
EUROSCORE for AVR risk stratification
1061-383 Improvement of Severe Anemia in Patients with 
Aortic Stenosis Complicated with Gastrointestinal 
Bleeding from Angiodysplasia ( Heyde’s syndrome ) 
After Aortic Valve Repair
Tomohisa Tada, Toshihiro Tamura, Junichi Tazaki, Toshikazu Jinnai, 
Neiko Ozasa, Satoshi Shizu, Ko Ono, Hisanori Horiuchi, Takeshi 
Kimura Kimu, Kyoto University Hospital, Kyoto, Japan
Learning Objective: describe about acquired von Willebrand 
syndrome(VWS-2A) caused by aortic stenosis.
1061-384 Transcatheter Aortic Valve Implantation for 
Severe Aortic Stenosis - a new paradigm for 
multidisciplinary intervention.
Rafal Dworakowski, Philip MacCarthy, Mark Monaghan, Simon 
Redwood, Ahmed El-Gamel, Christopher Young, Vinayat Bapat, Jane 
Hancock, Karen Wilson, Beth Brickham, Kailasam Rajagopal, Emma 
Alcock, Olaf Wendler, Martyn R. Thomas, Kings Health Partners, 
London, United Kingdom
Learning Objective: Identify
1062 CLINICAL PARAMETERS IN DIAGNOSING AND 
TREATING VALVULAR DISEASE- THE NEW 
FRONTIER
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1062-387 Determinants of Rapid Progression of Aortic Valve 
Stenosis in Hemodialysis Patients
Mizuho Hoshina, Hiroshi Wada, Kennichi Sakakura, Nahoko 
Ikeda, Yoshitaka Sugawara, Norifumi Kubo, Junya Ako, Shin-ichi 
Momomura, Cardiovascular Division, Saitama Medical Center, Jichi 
Medical University, Saitama, Japan
Learning Objective: evaluate determinants of rapid progression of 
AS in patients on hemodialysis.
POSTER CONTRIBUTIONS 
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1062-388 Impact of Early Surgery on Long-term Prognosis in 
Active Left-Sided Infective Endocarditis
Shunsuke Funakoshi, Shuichiro Kaji, Noriyuki Kimura, Yoshimori An, 
Kite Kim, Takeshi Kitai, Natsuhiko Ehara, Makoto Kinoshita, Atsushi 
Kobori, Atsushi Yamamuro, Tomoko Tani, Michihiro Nasu, Yukikatsu 
Okada, Yutaka Furukawa, Kobe City Medical Center General 
Hospital, Kobe, HI, Japan
Learning Objective: determine whether early valve surgery is 
associated with long-term survival in patients with left-sided 
infective endocarditis.
1062-389 The Prevalence and Significance of Coronary 
Disease among High-Risk Patients with Severe 
Symptomatic Aortic Stenosis
Itsik Ben-Dor, Augusto D. Pichard, Lowell F. Satler, Kohei 
Wakabayashi, Yanlin Li, Asmir I. Syed, Gabriel Maluenda, Manuel 
A. Gonzalez, Sara D. Collins, Cedric Delhaye, Michael A. Gaglia, 
Rebecca Torguson, Petros Okubagzi, Zhenyi Xue, William O. Suddath, 
Kenneth M. Kent, Joseph Lindsay, Ron Waksman, Washington 
Hospital Center, Washington DC
Learning Objective: To identify the prevalence, and clinical 
significance of coronary disese and its relation to the severity of the 
calcification or the degree of the stenosis of the aortic valve
1062-390 Relationships Between Left Ventricular Mass and 
Aortic Valve Calcification: The Multi-Ethnic Study of 
Atherosclerosis
Sammy Elmariah, Kevin D. O’Brien, Matthew J. Budoff, David A. 
Bluemke, Joseph A. Delaney, Valentin Fuster, Richard A. Kronmal, 
Jonathan L. Halperin, Zena and Michael A. Wiener Cardiovascular 
Institute, The Mount Sinai School of Medicine, New York, NY, 
University of Washington, Seattle, WA
Learning Objective: identify increased left ventricular mass as a 
risk factor for aortic valve calcification prevalence, severity, and 
incidence.
1062-391 Preoperative Anemia Increases Mortality and 
Postoperative Morbidity After Cardiac Surgery
Antonio Miceli, Paolo M. de Siena, Brenno Fiorani, Francesco 
Romeo, Gianni D. Angelini, Massimo Caputo, Bristol Heart Institute, 
Bristol, United Kingdom
Learning Objective: Demonstrate preoperative anemia is a risk 
factor in cardiac surgery
1115 SURGICAL OUTCOMES IN VALVULAR DISEASE
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1115-375 Predictors of Outcome in Asymptomatic Patients 
with Severe Rheumatic Mitral Regurgitation
Duk-Hyun Kang, Dae-Hee Kim, Byung Joo Sun, Jin Oh Na, Jong 
Seon Park, Jong-Min Song, Hyun Song, Joo Hee Zo, Jae-Kwan Song, 
Jae-Won Lee, Asan Medical Center, Seoul, South Korea, Catholic 
University Hospital, Seoul, South Korea
Learning Objective: demonstrate that the conventional treatment 
strategy showed satisfactory long-term outcomes in severe, 
asymptomatic rheumatic mitral regurgitation.
1115-376 Prognostic Significance of Diastolic Dysfunction in 
Unoperated Severe Aortic Stenosis
Jesse Naghi, Ryan Morrissey, Pavel Goykhman, Asim Raﬁque, Simon 
Biner, Robert J. Siegel, Heart Institute, Cedars Sinai Medical Center, 
Los Angeles, CA
Learning Objective: risk stratify patients with severe aortic stenosis 
who are not surgical candidates based on echocardiographic 
diastolic parameter E/E’>15.
1115-377 Edge-to-Edge Tricuspid Valve Repair Is Effective 
Strategy for the Management of Functional and 
Organic Tricuspid Regurgitation
Manatomo Toyono, Jose L. Navia, Yoshiki Matsumura, Tetsuhiro 
Yamano, Takahiro Shiota, Cleveland Clinic, Cleveland, OH, Cedars-
Sinai Medical Center and David Geffen School of Medicine at UCLA, 
Los Angeles, CA
Learning Objective: identify the effectiveness of edge-to-edge 
tricuspid valve repair for patients with severe tricuspid regurgitation.
1115-379 Procalcitonin is a Marker of Infection After Surgery 
for Valvular Heart Disease in a Predominantly 
Rheumatic Population
Antonio C. Bacelar, Flavio Tarasoutchi, Guilherme Spina, Antonio 
A. Lopes, Roney Sampaio, Tarso Accorsi, Ricardo S. Casalino, 
Fernando V. Reiche, Max Grinberg, Heart Institute (InCor), University 
of São Paulo Medical Scho, Sao Paulo, Brazil
Learning Objective: Demontrate that Procalcitonin is a good marker 
of infection after surgery for heart valve disease
1116 PERCUTANEOS AORTIC VALVE THERAPIES IN 
2010
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1116-381 Paieon’s C-THV System - A Novel Real-Time Image 
Processor to Facilitate Transcatheter Aortic Valve 
Implantation (TAVI).
Namal Wijesinghe, Jean-Bernard Masson, Fabian Nietlispach, Edgar 
Tay, Ronen Gurvitch, Amir Blumenfeld, Raﬁ Brada, David A. Wood, 
John G. Webb, St Paul’s Hospital, Vancouver, BC, Canada, Paieon 
Medical Ltd, Rosh Haaiyn, Israel
Learning Objective: identify new application to facilitate 
transcatheter aortic valve implantation
1116-382 Transcatheter Valve in Valve Implantation for Failed 
Bioprosthetic Heart Valves
David Alexander Wood, Ronen Gurvitch, Anson Cheung, Jian Ye, 
Jonathon Leipsic, Eric Horlick, Josep Rodés-Cabau, Eric Dumont, 
Mark Osten, Olaf Wender, Jean Bernard Masson, Namal Wijesinghe, 
Edgar Tay, Fabian Nietlispach, Mark Johnson, Brad Munt, Rob Moss, 
Christopher R. Thompson, Samuel V. Lichtenstein, John G. Webb, 
St. Paul’s Hospital, Vancouver, BC, Canada, University of British 
Columbia, Vancouver, BC, Canada
Learning Objective: Understand that transcatheter valve in valve 
implantation is a reproducible approach for the management of 
failed bioprosthetic valves regardless of valve position.
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1116-383 Transcatheter Aortic Valve Implantation (TAVI) in 
Bicuspid Aortic Stenosis
Namal Wijesinghe, Fabian Nietlispach, Ronen Gurvitch, Edgar Tay, 
David A. Wood, Josep Rodés-Cabau, James L. Velianou, Madhu K. 
Natarajan, Jian Ye, Eric Dumont, Anson Cheung, John G. Webb, St 
Paul’s Hospital, Vancouver, BC, Canada, Quebec Heart and Lung 
Institute, Quebec City, QC, Canada
Learning Objective: evaluate the success of transcatheter aortic 
valve implntation for bicuspid aortic stenosis.
1116-384 Factors Associated With Cardiac Conduction 
Disorders and Permanent Pacemaker Implantation 
After Percutaneous Aortic Valve Implantation
Ze Yie Yong, Jan Baan, Jr., Karel T. Koch, José P.S. Henriques, Berto 
J. Bouma, Marije M. Vis, Riccardo Cocchieri, Jan J. Piek, Bas A.J.M. 
de Mol, Academic Medical Center, Amsterdam, The Netherlands
Learning Objective: to be informed about the high incidence of 
cardiac conduction disorders after percutaneous aortic valve 
implantation with the CoreValve device and the factors predicting its 
occurrence
1116-385 Short Term Results of Transcatheter Aortic Valve 
Implantation: Global and Regional Systolic Left 
and Right Ventricular Function Evaluated by 
Echocardiography Extended With Tissue Doppler 
Imaging
Lena M. Helin, Éva Tamás, Farkas Vánky, Niels Erik Nielsen, 
Jan Engvall, Eva Nylander, Department of Clinical Physiology, 
Department of Medical and Health Sciences University Hospital, 
Linköping, Sweden, Department of Cardiothoracic Surgery, Heart 
Centre in Östergötland, University Hospital, Linköping, Sweden
Learning Objective: evaluate left and right systolic ventricular 
function after transcatheter aortic valve implantation by 
echocardiography and tissue Doppler imaging
1117 NOVEL APPROACHES TO MEASURING 
OUTCOMES IN VALVULAR DISEASE
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1117-387 Preoperative Exercise Capacity Best Predicts 
Survival after Surgery for Chronic Nonischemic 
Mitral Regurgitation
Phyllis Supino, Jeffrey S. Borer, Jacek J. Preibisz, Edmund M. 
Herrold, Monica M. Diaz, State University of New York (SUNY) 
Downstate Medical Center, Brooklyn, NY
Learning Objective: identify the prognostic significance of poor 
exercise capacity on survival and persistence of symptoms after 
mitral valve surgery.
1117-388 Myocardial Fibrosis in Aortic Stenosis: Molecular 
Mechanisms and an Approach to its Non-Invasive 
Assesment.
Felix M. Valencia-Serrano, Begoña Lopez Salazar, Juan Jose Gomez 
Doblas, Javier Diez Martinez, Eduardo de Teresa Galvan, Hospital 
Universitario Virgen de la Victoria, Malaga, Spain, Centre for Applied 
Medical Research, Pamplona, Spain
Learning Objective: Understand the pathophysiological relevance 
of myocardial fibrosis in aortic stenosis patients, its molecular 
mechanisms and an approach to its non invasive assesment.
1117-389 Gender Based Differences In Left And Right 
Ventricular Size And Function In Patients 
Undergoing Mitral Valve Surgery.
Karolina M. Zareba, Robert O. Bonow, Asim Ansari, Jyothy 
Puthumana, Venkatesh Y. Anjan, Brittany R. Lapin, Nausheen Akhter, 
Patrick M. McCarthy, Vera H. Rigolin, Northwestern University 
Feinberg School of Medicine, Chicago, IL
Learning Objective: Identify the gender differences in left and right 
ventricular volumes and function of patients undergoing mitral valve 
surgery.
1117-390 Gender Differences in Operative Rates for Patients 
with Severe Aortic Stenosis
Maryanne Hartzell, Rajeev Malhotra, Kibar Yared, Malissa J. Wood, 
Division of Cardiology, Massachusetts General Hospital, Boston, MA
Learning Objective: describe the influence of gender on operative 
rates for severe aortic stenosis.
1117-391 Thrombocytopenia After Aortic Valve Replacement 
With the Freedom Solo Stentless Bioprosthesis: a 
Propensity-Matched Study
Dan Rusinaru, Alessandro Piccardo, Benoit Petitprez, Paul Marticho, 
Ioana Vaida, Christophe Tribouilloy, Thierry Caus, University Hospital 
Amiens, Amiens, France
Learning Objective: Identify adverse effects associated with 
implantation of stentless bioprostheses
1170 BENCH TO BEDSIDE- CELLULAR MECHANISMS 
OF VALVULAR HEART DISEASE
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1170-375 Myocardial mRNA Concentrations for Secreted 
Biomarkers in Aortic Regurgitation vs Aortic 
Stenosis: Correlations with Plasma Protein 
Concentrations and Left Ventricular Dimensions
Daniel Catanzaro, Christopher Stuart, Ji-Sun Hong, Ada Ene, 
John Carter, Edmund Herrold, Phyllis G. Supino, Jason Lazar, Lou 
Salciccioli, Wilson Ko, Arash Salemi, Leonard Girardi, Karl H. 
Krieger, O. Wayne Isom, Jeffrey S. Borer, SUNY Downstate, Brooklyn, 
NY, Weill Cornell Medical College, New York, NY
Learning Objective: understand the basis for the identification of 
a secreted biomarker that may be relevant to the pathobiology of 
valvular heart disease
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1170-376 Interaction Between Rosuvastatin And High 
Sensitivity C-reactive Protein On Progression Of 
Aortic Stenosis
Kwan-Leung Chan, Andy Ni, James Tam, Randall Sochowski, Jean G. 
Dumesnil, John P. Giannoccaro, John Jue, A. Shekhar Pandey, Cam 
Joyner, Koon Teo, University of Ottawa Heart Institute, Ottawa, ON, 
Canada
Learning Objective: evaluate the effect of rosuvastatin on CRP 
levels and AS progression.
1170-377 The Potential Role of Cholesterol Crystals in the 
Mechanical Injury of Heart Valves
Umesh Tamhane, Ameeth Vedre, Ruiping Huang, Keerthy Narisetty, 
Joyce DeJong, George S. Abela, Michigan State University, Lansing, MI
Learning Objective: Demonstrate the role of cholesterol crystals as 
a mechanical cause of valvular injury
1170-378 Concurrence Of Neoangiogenesis And Inflammatory 
Activation In Leaflets Of Patients With Aortic Valve 
Stenosis: An In Vivo Study.
Maria I. Drakopoulou, Konstantinos Toutouzas, Eleftherios Tsiamis, 
Dimitrios Iliopoulos, Andreas Synetos, Dimitrios Tousoulis, George 
Agrogiannis, Efstratios Patsouris, Christodoulos Stefanadis, 
Hippokration Hospital, Athens, Greece, Medical Center, Athens, 
Greece
Learning Objective: Interpret the possible pathophysiologic 
mechanisms of aortic valve stenosis
1170-379 Bisphosphonates Prevent Oxidized Low-Density 
Lipoprotein-Induced Expression of Osteogenic 
Markers in Aortic Valve Myofibroblasts
Sammy Elmariah, Giovanni Cimmino, Valentin Fuster, Juan J. 
Badimon, Zena and Michael A. Wiener Cardiovascular Institute, The 
Mount Sinai School of Medicine, New York, NY, NY
Learning Objective: identify bisphosphonates as a potential 
pharmacologic intervention for aortic stenosis
1171 LONG TERM OUTCOMES IN VALVULAR DISEASE- 
NOVEL CLINICAL MARKERS
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1171-381 Risk of Silent and Apparent Cerebral Ischemia after 
Transfemoral Aortic Valve Implantation
Philipp Kahlert, Stephan C. Knipp, Marc Schlamann, Matthias 
Thielmann, Fadi Al-Rashid, Marcel Weber, Uwe Johansson, Daniel 
Wendt, Heinz Jakob, Michael Forsting, Stefan Sack, Raimund Erbel, 
Holger Eggebrecht, West German Heart Center Essen, Department 
of Cardiology, Essen, Germany, West German Heart Center Essen, 
Department of Thoracic and Cardiovascular Surgery, Essen, 
Germany
Learning Objective: understand that transfemoral aortic valve 
implantation is associated with a high number of lesions on 
cerebral diffusion-weighted magnetic resonance imaging which are 
clinically silent.
1171-383 Prevalence of Silent Cerebral Microembolism after 
Cardiac Catheterization of Patients with High-grade 
Aortic Stenosis
Dieter Ropers, Martin Arnold, Daniel Mundkowski, Josef Ludwig, 
Stephan Achenbach, Werner G. Daniel, Arndt Dörﬂer, Susanne 
Schulz-Heise, University of Erlangen, Department of Cardiology, 
Erlangen, Germany
Learning Objective: to estimate the risk for brain injury of cardiac 
catherization with retrograde passage of the aortic valve in patients 
with severe aortic valve stenosis
1171-384 An Analysis of Echocardiographic Variables 
Associated with Surgical Outcome in Patients with 
Severe Aortic Reguritation Due to Behcet Disease
Mi-Jeong Kim, Jong-Min Song, Duk-Hyun Kang, Jae-Won Lee, Jae-
Kwan Song, Catholic Univ Incheon St Mary`s Hospital, Incheon, 
South Korea, Asan Medical Center, Seoul, South Korea
Learning Objective: To identify the characteristic morphology in 
patients with AR due to Behcet disease
1171-385 Clinical and Echocardiographic Predictors of Long-
term Outcome in Asymptomatic Patients with 
Significant Aortic Stenosis
Duk-Hyun Kang, Jeong-Sook Seo, Byung Joo Sun, Jung Min Ahn, 
Dae-Hee Kim, Jong-Min Song, Jae-Kwan Song, Hyun Song, Joo Hee 
Zo, Asan Medical Center, Seoul, South Korea, Boramae Hospital, 
Seoul, South Korea
Learning Objective: identify predictors of outcome in asymptomatic 
significant aortic stenosis.
1172 PROGNOSTIC CLINICAL PARAMETERS IN 
VALVULAR HEART DISEASE
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1172-387 Preliminary Mechanistic Observations of Decrease 
Mitral Regurgitation Severity After Aortic Valve 
Replacement in Patients with Severe Isolated Aortic 
Stenosis and Functional Mitral Regurgitation
Visali Kodali, Florentina Petillo, Simcha Pollack, Nathaniel Reichek, 
Eddy Barasch, St. Francis Hospital/SUNY at Stony Brook, Roslyn, NY
Learning Objective: To determine the role of mitral valve geometrical 
changes in the genesis of functional mitral regurgitation in severe 
aortic stenosis.
1172-388 The Echocardiographic, Hemodynamic and Left 
Ventricular Afterload Characteristics of Patients 
with Severe Isolated Aortic Stenosis, Normal Left 
Ventricular Ejection Fraction and Absence of Left 
Ventricular Hypertrophy
Visali Kodali, Florentina Petillo, Simcha Pollack, Nathaniel Reichek, 
Eddy Barasch, St. Francis Hospital/SUNY at Stony Brook, Roslyn, NY
Learning Objective: To identify by echocardiography the possible 
mechanisms related to the absence of LVH in severe isolated AS 
and normal LVEF.
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1172-389 Relationship between Progression of Aortic 
Stenosis and Inflammatory Change in Aortic Valve 
in Hemodialysis Patients
Yoshiki Matsumura, Kenichi Sugioka, Takahiko Naruko, Takashi 
Omura, Tomoyuki Yamakawa, Yoshihiro Ikura, Yasuyuki Kato, 
Toshihiko Shibata, Shigefumi Suehiro, Akira Itoh, Takeshi Hozumi, 
Minoru Yoshiyama, Makiko Ueda, Department of Internal Medicine 
and Cardiology, Osaka City University Graduate School of Medicine, 
Osaka, Japan, Department of Pathology, Osaka City University 
Graduate School of Medicine, Osaka, Japan
Learning Objective: demonstrate that an active inflammatory 
process in the lesion of aortic valve may be one of the mechanisms 
of rapid progression of AS in hemodialysis patients.
1172-390 Causes of Death in Asymptomatic Aortic Stenosis in 
Japan
Satoko Wada, Takashi Murou, Hiroki Oe, Yoshiki Matsumura, Kenichi 
Sugioka, Ryo Ohtsuka, Yasuhiko Takemoto, Takeshi Hozumi, Minoru 
Yoshiyama, Department of Internal Medicine and Cardiology,Osaka 
City University Medical School, Osaka-shi, Japan
Learning Objective: clarify
1172-391 Risk and Outcome of Acute Renal Failure after 
Transcatheter Aortic Valve Implantation
Philipp Kahlert, Fadi Al-Rashid, Matthias Thielmann, Daniel Wendt, 
Heinz Jakob, Raimund Erbel, Holger Eggebrecht, West German 
Heart Center Essen, Department of Cardiology, Essen, Germany, 
West German Heart Center Essen, Department of Thoracic and 
Cardiovascular Surgery, Essen, Germany
Learning Objective: interpret the importance of acute renal failure 
as an important predictor of patient outcome after TAVI and may 
recognize the need for preventive strategies.
1225 PERCUTANEOUS VALVE THERAPIES- THE 
CUTTING EDGE
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1225-375 Aortic Regurgitation after Transcatheter Aortic Valve 
Implantation: Insights from Multi-detector Row 
Computed Tomography
Victoria Delgado, CT Arnold Ng, Nico RL van de Veire, Frank van 
der Kley, Joanne D. Schuijf, Rutger J. van Bommel, Arend de Weger, 
Giuseppe Tavilla, Miriam Shanks, Louisa M. Antoni, Matteo Bertini, 
Ernst E. van der Wall, Martin J. Schalij, Jeroen J. Bax, Leiden 
University Medical Center, Leiden, The Netherlands
Learning Objective: Demonstrate
1225-376 Percutaneous Paravalvular Leak Closure II - Clinical 
Data and Short Term Results
Claudia Martinez, Itzhak Kronzon, Vladimir Jelnin, Gila Perk, Howard 
Cohen, Carlos E. Ruiz, lenox Hill Heart and Vascular Institute, New 
York, NY, NYU School Of Medicine, New York, NY
Learning Objective: evaluate the short term results of percutaneous 
paravalvular leak repair
1225-377 Role of Percutaneous Balloon Aortic Valvuloplasty 
for Calcific Aortic Stenosis: Updated Technique, 
Indications and Immediate Haemodynamic Results 
in a Highly Experienced Center
Akira Furuta, Karim Bejar, Helene Eltchaninoff, Christophe Tron, 
Brahim Baala, Matthieu Godin, Carlos Sanchez Giron, Bogdan Borz, 
Alain Cribier, Hôpital Charles-Nicolle, CHU de Rouen, Rouen, France
Learning Objective: evaluate the in-hospital outcome of Balloon 
Aortic Valvuloplasty.
1225-378 Percutaneous Pulmonary Valve Replacement: 
Autologous Tissue Engineered Valved Stent 
Implantation
Anja Metzner, Ulrich A. Stock, Gunther Fischer, Wiebke de Buhr, 
Jessica Boldt, Jochen Cremer, Georg Lutter, Department of 
Cardiovascular Surgery University Hospital Schleswig-Holstein, 
Campus Kiel, Kiel, Germany, Department of Thoracic, Cardiac 
and Vascular Surgery, University Hospital Tuebingen, Tuebingen, 
Germany
Learning Objective: This study demonstrate the combination of 
percutaneous valved stent implantation and tissue engineering of 
autologous heart valves
1225-379 Longitudinal 2D Strain is Superior to EF in Detecting 
Myocardial Impairment and Postinterventional 
Improvement in Cardiac Function in Patients with 
Severe Aortic Stenosis Undergoing Transcatheter 
Aortic Valve Implantation
Aleksander Kempny, Gerhard-Paul Diller, Gerrit Kaleschke, 
Gregor Kerckhoff, Stefan Orwat, Monika Anna Stenzel, Julia 
Mascherbauer, Holger Reinecke, Helmut Baumgartner, Adult 
congenital and valvular heart disease center, University Hospital of 
Muenster, Muenster, Germany
Learning Objective: To understand the role of longitudinal strain 
in assessing early myocardial damage in patients undergoing 
transcatheter aortic valve implantation
1226 CLINICAL DECISION MAKING IN VALVULAR 
DISEASE
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1226-381 Pre-Operative Geometry of the Mitral Valve Impacts 
the Outcomes of Mitral Annuloplasty in Ischemic 
Mitral Regurgitation
Muralidhar Padala, Vinod H. Thourani, David H. Adams, Ajit P. 
Yoganathan, Georgia Institute of Technology, Atlanta, GA
Learning Objective: Investigate the mechanisms for failure of mitral 
annuloplasty
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1226-382 Anatomical Classification of Mitral Valve Prolapse 
Using Volumetric Analysis of Real-Time Three-
Dimensional Echocardiographic Images
Sonal Chandra, Ivan S. Salgo, Lissa Sugeng, Wendy Tsang, Lynn 
Weinert, Victor Mor-Avi, Roberto M. Lang, University of Chicago 
Medical Center, Chicago, IL, Philips Healthcare, Andover, MA
Learning Objective: Classify and distinguish volumetrically the 
disease process responsible for the prolpase and the cmplexit y of 
MV prolapse specific to each disease process.
1226-383 Prevalence Of Rheumatic Fever/ Rheumatic Heart 
Disease In India: Lessons From Active Surveillance 
And A Passive Registry
Anil Bharani, M.G.M. Medical College and M.Y. Hospital, Indore, India
Learning Objective: Learn about changing epidemiology and current 
prevalance and clinical characteristics of RF/RHD in India
1226-384 Decision Changes And Its Consequences In Patients 
With Severe Aortic Stenosis Who Initially Refused 
Aortic Valve Replacement
Yoshiki Matsuo, Takashi Kubo, Aiko Shimokado, Kenji Nakamura, 
Yasushi Okumoto, Hideharu Akagi, Tadao Yamamoto, Takashi 
Akasaka, Social Insurance Kinan Hospital, Tanabe, Japan, 
Wakayama Medical University, Wakayama, Japan
Learning Objective: evaluate the prognotic value of therapeutic 
decisions for patients with sever aortic stenosis
1226-385 Comparison Of The Hemoynamic Performance 
And Left Ventricular Remodeling Of Percutaneous 
Vs Surgical Bioprostheses In Treatment Of Severe 
Aortic Stenosis
Cristina Giannini, Marco De Carlo, Fabio Guarracino, Enrica Talini, 
Maria Grazia Delle Donne, Carmela Nardi, Frank Llojd Dini, Uberto 
Bortolotti, Gaetano Minzioni, Anna Sonia Petronio, Vitantonio Di 
Bello, Cardiac Thoracic and Vascular Dept, Pisa, Italy
Learning Objective: to demonstrate that the percutaneous 
thecnique is better than the surgical approach on the hemodynamic 
performance for the treatment of severe aortic stenosis
1227 OUTCOME ANALYSIS IN VALVULAR DISEASE
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1227-387 Neurohormonal Prolife And Prognosis In Chronic 
Severe Aortic Regurgitation Of Rheumatic Etiology - 
A 8 Year Prospective Study
Ricardo S. Casalino, Sr., Guilherme Spina, Antonio C. Bacelar, Roney 
O. Sampaio, Flavio Tarasoutchi, Tarso Accorsi, Max Grinberg, 1Heart 
Institute (InCor), University of São Paulo Medical School, Sao Paulo, 
Brazil
Learning Objective: Identify patients with severe aortic regurgitation 
at higher risk to become symptomatic
1227-388 Respiratory Variation of Tricuspid Regurgitation: 
Novel Physiologic Insights on the Plasticity of Right-
Sided Cardiac Cavities.
Yan Topilsky, Maurice Enriquez-Sarano, Mayo clinic, Rochester, MN
Learning Objective: Describe respiratory variation of tricuspid 
regurgitation
1227-389 Predictors of Significant Paravalvular Regurgitation 
after Transcatheter Aortic Valve Implantation: 
Results from the Prospective Multicenter German 
Aortic Valve Registry
Mohammad A. Sherif, Mohamed Abdel-Wahab, Volker Geist, 
Ralph Toelg, Jochen Senges, Steffen Schneider, Gert Richardt, 
The German aortic valve registry, Segeberger Kliniken GmbH, Bad 
Segeberg, Germany
Learning Objective: identify the predictors of significant AR after 
PAVR trying to minimize paravalvular AR, and implement the 
appropriate measures with careful screening of patients before 
intervention
1227-390 Long Term Durability Of Edwards Balloon 
Expandable Transcatheter Aortic Valve Implantation
Ronen Gurvitch, Edgar Tay, Anson Cheung, Fabian Nietlispach, Jian 
Ye, David A. Wood, Chris Thompson, Namal Wijesinghe, Jonathon 
Leipsic, Samuel V. Lichtenstein, John G. Webb, St. Paul’s Hospital, 
Vancouver, BC, Canada
Learning Objective: demonstrate long-term durability of 
transcatheter aortic valve replacement
1227-391 Outcomes and Cost of Cardiac Surgery in 
Octogenarians is Related to Type of Operation: A 
Multi-Institutional Analysis
Castigliano M. Bhamidipati, Damien J. LaPar, Edwin Fonner, Jr., John 
A. Kern, Irving L. Kron, Gorav Ailawadi, University of Virginia School 
of Medicine, Charlottesville, VA
Learning Objective: Identify complication risk and related costs to 
octogenarian patients evaluated for a proposed cardiac operation
1278 CELLULAR MECHANISMS IN VALVULAR DISEASE
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1278-375 Lower Total Arterial Elastance Augments 
Regurgitant Volume in Aortic Regurgitation
Kiyomi Niki, Motoaki Sugawara, Itaru Takamisawa, Hiroyuki 
Watanabe, Tetsuya Sumiyoshi, Saichi Hosoda, Shuichiro Takanashi, 
Tokyo City University, Tokyo, Japan
Learning Objective: identify the effect of Windkessel function of the 
arterial system on aortic regurgitation.
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1278-376 Anticardiac Antibodies in Acute Rheumatic Fever 
and Chronic Rheumatic Heart Disease - Analysis 
from Indian and Russian Patients
Bernhard Maisch, Daniela Tontsch, Thorsten G. Loof, Gursharan S. 
Chhatwal, Anil Grover, Volker Ruppert, Sabine Pankuweit, Philipps 
University, Department of Cardiology, Marburg, Germany
Learning Objective: Identify relevant anticardiac autoreactivity in 
rheumatic heart disease
1278-377 Elevated Serotonin Levels results in Accelerated 
Valve Fibrosis in Stretch-Overloaded Aortic Valve
Kartik Balachandran, Adrian Chester, Ajit Yoganathan, Georgia 
Institute of Technology, Atlanta, GA
Learning Objective: Understand the effects of serotonin and stretch-
overload on valve mechanics
1278-378 Recombinant Apolipoprotein A-I Milano Decreases 
Leaflet Inflammation and Calcification in 
Experimental Models of Aortic Stenosis
Giovanni Cimmino, Walter S. Speidl, Sammy Elmariah, Borja 
Ibanez, Randolph Hutter, Valentin Fuster, Juan Jose Badimon, 
Atherothrombosis Reserach Unit, Cardiovascular Institute, Mount 
Sinai Hospital, New York, NY
Learning Objective: identify
1278-379 The Association between Arterial Hypertension and 
Severe Isolated Aortic Stenosis with Preserved Left 
Ventricular Ejection Fraction; Echocardiographic and 
Prognostic Insights
Visali Kodali, Florentina Petillo, Simcha Pollack, Nathaniel Reichek, 
Eddy Barasch, St. Francis Hospital/SUNY at Stony Brook, Roslyn, NY
Learning Objective: To identify possible mechanisms and the 
prognosis of pts with severe AS, normal EF and history of 
hypertension.
1279 EARLY DETECTION OF VALVULAR DISEASE
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1279-381 Measurement Of Cardiac Function Using Pressure-
volume Conductance Catheter Technique In A New 
Rat Model Of Chronic Mitral Regurgitation
Kyong-Hee Kim, Yong-Jin Kim, Hyung-Kwan Kim, Dae-Won Sohn, 
Byung-Hee Oh, Young-Bae Park, Seoul national university hospital, 
Seoul, South Korea
Learning Objective: We demonstrate a new rat model of mitral 
regurgitation and evaluate cardiac function using pressure–volume 
conductance catheter.
1279-382 Plasma Biomarkers of Collagen and Fibronectin 
Biosynthesis are Unrelated to Tissue 
Imunohistochemical Protein Quantification or 
mRNA Determined by Myocardial Biospy Microarray 
in Aortic Valve Disease
Daniel Catanzaro, Christopher Stuart, Ji-Sun Hong, Ada Ene, John 
Carter, Edmund Herrold, Phyllis Supino, Jason Lazar, Lou Salciccioli, 
Wilson Ko, Arash Salemi, Leonard Girardi, Karl Krieger, O. Wayne 
Isom, Jeffrey Borer, SUNY Downstate, Brooklyn, NY, Weill Cornell 
Medical College, New York, NY
Learning Objective: understand the relationship between secreted 
biomarkers or extracellular matrix protein syntheis and degradation 
and the myocardial expression of their corresponding genes
1279-383 Cardiopulmonary Responses to Exercise in Patients 
with Aortic Stenosis: A Descriptive Study of 367 
Patients
Abhijeet Dhoble, Courtney Hayes, Ray W. Squires, Gerald Gau, 
Stephen L. Kopecky, Thomas G. Allison, Mayo Clinic, Rochester, MN
Learning Objective: recognize abnormalities in cardiopulmonary 
responses to exercise in patients with aortic stenosis
1279-384 Tricuspid Regurgitation In Patients With Severe 
Aortic Stenosis: Frequency, Risk Factors and 
Prognostic Implications In A Cohort of 740 Patients
Padmini Varadarajan, Ramdas G. Pai, Loma Linda University Medical 
Center, Loma Linda, CA
Learning Objective: To know the imporatnce of TR in patients with 
severe aortic stenosis
1279-385 Early Detection of Improvement of Left Ventricular 
Function After Undersized Mitral Annuloplasty for 
Functional Mitral Regurgitation: Two-Dimensional 
Speckle Tracking Echocardiography
Yasuhiro Shudo, Satoshi Nakatani, Taichi Sakaguchi, Shigeru 
Miyagawa, Yasushi Yoshikawa, Takashi Yamauchi, Koji Takeda, 
Shunsuke Saito, Yoshiki Sawa, Osaka University Graduate School of 
Medicine, Suita, Osaka, Japan
Learning Objective: Strain in functional MR
JACC    March 9, 2010 ABSTRACTS: Vascular Disease A153
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915 MODULATORS OF ENDOTHELIAL DYSFUNCTION
Monday, March 15, 2010, 4:30 p.m. - 6:00 p.m.
Georgia World Congress Center, Room B403
CME/CE Hours: 1.5
4:30 Constriction of the Brachial Artery During Brachial 
Artery Reactivity Testing Predicts Major Adverse 
Clinical Outcomes in Women with Suspected 
Myocardial Ischemia: The NHLBI-Sponsored 
Women’s Ischemia Syndrome Evaluation (WISE) 
Study
B. Delia Johnson, Steven E. Reis, Sheryl F. Kelsey, Carl J. Pepine, 
Vera Bittner, William J. Rogers, Eileen Handberg, Waﬁa Eteiba, 
George Sopko, Barry L. Sharaf, C. Noel Bairey Merz, University of 
Pittsburgh, Graduate School of Public Health, Pittsburgh, PA
Learning Objective: identify a novel and important non-invasive 
tool for estimating risk for major clinical events in women with 
suspected myocardial ischemia
4:45 Effect of Serum Concentration of Bilirubin in the 
Obese Patients: The Action for Coronary Endothelial 
Function and Inflammatory Stress
Satoshi Yoshino, Shuichi Hamasaki, Sanemasa Ishida, Tetsuro 
Kataoka, Akiko Yoshikawa, Naoya Oketani, Keishi Saihara, Takuro 
Takumi, Chuwa Tei, Department of Cardiovascular, Respiratory and 
Metabolic Medicine, Kagoshima University, Kagoshima, Japan
Learning Objective: descrive the effect of serum concentration of 
bilirubin in the obese patients
5:00 Effects of Smoking and Smoking Cessation on 
Endothelial Function: One-Year Outcomes from a 
Randomized Clinical Trial
Linda K. Gossett, Megan E. Piper, Heather M. Johnson, Susan E. 
Aeschlimann, Claudia E. Korcarz, Timothy B. Baker, Michael C. Fiore, 
James H. Stein, University of Wisconsin School of Medicine and 
Public Health, Madison, WI
Learning Objective: Describe the effects of smoking cessation on 
endothelial function
5:15 Coronary Microvascular Dysfunction in Primary 
Hyperparathyroidism Patients: A Hint for Their 
Increased Cardiovascular Risk
Elena Osto, Maria R Pellizzo, Francesco Fallo, Anna Maddalozzo, 
Nadia Sorgato, Roberta Montisci, Sabino Iliceto, Francesco Tona, 
Cardiology,University of Padua, Padua, Italy
Learning Objective: identify new determinants of the 
pathophysiology of coronary microvascular dysfunction in the setting 
of primary hyperparathyroidism
5:30 Systemic Inflammation and Arterial Endothelial 
Dysfunction as Possible Mechanisms of Renal 
Injury in Young Patients with Type 1 Diabetes
Petru Liuba, Peter Holmquist, Pediatric Cardiology, Lund University 
Hospital, Lund, Sweden
Learning Objective: to better understand the mechanisms of 
diabetes-related vascular complications in young patients with type 
1 diabetes
921 ANGIOGENESIS: PATHOPHYSIOLOGY -- CLINICAL
Tuesday, March 16, 2010, 10:30 a.m. - 12:00 p.m.
Georgia World Congress Center, Room B408
CME/CE Hours: 1.5
10:30 Angiogenesis and the Progression of Subclinical 
Atherosclerosis: A 24-Month Follow-Up Study
Sanghoon Shin, Sang-Hak Lee, Young-Guk Ko, Seok-Min Kang, 
Donghoon Choi, Jong-Won Ha, Namsik Chung, Won-Heum Shim, 
Seung-Yun Cho, Yangsoo Jang, Yonsei University College of 
Medicine, Seoul, South Korea\
Learning Objective: interpret that the elevation of sFlt-1 is 
potentially related to the progression of atherosclerosis.
10:45 The Relationship of Serum Erythropoietin Level with 
Coronary Collateral Development
Asife Sahinarslan, Ridvan Yalcin, Sinan Kocaman, Salih Topal, Ugur 
Ercin, Ali C. Tanalp, Neslihan Bukan, Bulent Boyaci, Atiye Cengel, 
Gazi University Department of Cardiology, Ankara, Turkey, Ankara, 
Turkey
Learning Objective: Demonstrate the relation between serum 
erythropoietin level and coronary collateral vessel development
11:00 The Relation between Serum Monocyte 
Chemoattractant Protein-1 and Coronary Collateral 
Development
Asife Sahinarslan, Sinan Kocaman, Salih Topal, Ugur Ercin, Neslihan 
Bukan, Ridvan Yalcin, Atiye Cengel, Gazi University Department of 
Cardiology, Ankara, Turkey
Learning Objective: These findings demonstrate that higher serum 
MCP-1 level is related with better coronary collateral development.
11:15 The Relationship between Plasma Asymmetrical 
Dimethylarginine Level and Coronary Collateral 
Development
Asife Sahinarslan, Ridvan Yalcin, Sinan Kocaman, Salih Topal, Ugur 
Ercin, Neslihan Bukan, Bulent Boyaci, Atiye Cengel, Gazi University 
Department of Cardiology, Ankara, Turkey
Learning Objective: These findings demonstrate that asymmetrical 
dimethylarginine may contribute to the difference in the coronary 
collateral development among the patients with similar degree of 
coronary artery stenosis
11:30 Targeted Delivery of Vascular Endothelial Growth 
Factor Favorably Alters Cardiac Remodeling and 
Function after a Large Myocardial Infarction
Jenna M. Rosano, Zhanna Ivanov, Robert C. Scott, Bin Wang, 
Parkson Lee-Gau Chong, Mohammad Kiani, Deborah Crabbe, 
Temple University, Philadelphia, PA
Learning Objective: Describe the effects of targeted VEGF therapy 
on left ventricular remodeling and function after a myocardial 
infarction.
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925 PULMONARY HYPERTENSION: PREDICTORS OF 
PROGNOSIS
Tuesday, March 16, 2010, 2:00 p.m. - 3:30 p.m.
Georgia World Congress Center, Room A408
CME/CE Hours: 1.5
2:00 Prognostic Value of Heart Rate and Systemic Blood 
Pressure in Pulmonary Arterial Hypertension
Malcolm M. Bersohn, Shelley Shapiro, Michelle P. Turner, Glenna 
Traiger, Adaani E. Frost, VA Greater Los Angeles Healthcare System, 
Los Angeles, CA, David Geffen School of Medicine at UCLA, Los 
Angeles, CA
Learning Objective: identify vital sign characteristics that predict a 
poor outcome in patients with pulmonary arterial hypertension.
2:15 Association of Hyponatremia and Outcomes in 
Pulmonary Hypertension and Right Ventricular 
Failure
Asaf Rabinovitz, Ronald Zolty, Monteﬁore Medical Center, Bronx, NY
Learning Objective: appreciate the prognostic significance of 
hyponatremia in patients with pulmonary hypertension and right 
ventricular failure
2:30 Clinical and Echocardiographic Predictors of 
Pulmonary Hypertension in Young Adults: Results 
from CARDIA
Swathy Kolli, Ren Chen, Maya Guglin, University of South Florida, 
Tampa, FL
Learning Objective: Identify the clinical and echocardiographic 
predictors of pulmonary hypertension in young adults, from a 
population based study.
2:45 Pulmonary Artery Stiffness Is Independently 
Associated with the Degree of Right Ventricular 
Dysfunction in Pulmonary Hypertension
Gerin Rachel Stevens, Ana Garcia-Alvarez, Sean Pinney, Mario J. 
Garcia, Valentin Fuster, Javier Sanz, Mount Sinai School of Medicine, 
New York, NY, Monteﬁore Medical Center, Bronx, NY
Learning Objective: To describe the independent assocations 
of pulmonary artery stiffness to right ventricular dysfunction in 
pulmonary hypertension
3:00 Vasodilator Response Predicts Long-Term Survival 
in Pulmonary Hypertension Regardless of Etiology
Ganesh Devendra, Stephen A. Hart, Shikhar Agarwal, Thomas M. 
Bashore, Richard A. Krasuski, The Cleveland Clinic, Cleveland, OH, 
Duke University Medical Center, Durham, NC
Learning Objective: Identify the prognostic utility of vasodilator 
testing in patients with pulmonary hypertension of various 
etiologies.
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1053 PERIPHERAL ARTERIAL/CAROTID DISEASE/
AORTIC DISEASE
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1053-324 The Effect of Insulin Resistance on the Risk of 
Stroke among National Health and Nutrition 
Examination Survey III Participants Aged 20 Years 
and Older
Jongoh Kim, Bhaskar Purushottam, Aman Amanullah, Albert Einstein 
Medical Center, Philadelphia, PA
Learning Objective: Recognize increased risk of stroke among those 
with insulin resistance
1053-325 The Role of Renal Function on the Five-Year 
Incidence of Cardiovascular Disease in Apparent 
Healthy Individuals; The Attica Study
Christina A. Chrysohoou, Christos Pitsavos, Demosthenes B. 
Panagiotakos, John Skoumas, Yannis Lentzas, Constantina 
Masoura, Marina Toutouza, Manolis Kambaxis, Lambros 
Papadimitriou, Vasiliki Metaxa, Christodoulos Stefanadis, 1st 
Cardiology Clinic, Hippokratio, Athens, Greece, Harrokopio 
University, Athens, Greece
Learning Objective: Creatinine clearance levels are inversely related 
with unhealthy lifestyle behaviors and increased inflammatory 
markers; while limited creatinine clearance rate increases 
cardiovascular risk
1053-327 Chromosome 9p21 Locus Is Associated with 
Vascular Stiffness and CDKN2A Expression in 
Human Arteries from Patients Undergoing Coronary 
Artery Surgery
Charalambos A. Antoniades, Tim Van-Assche, Colin Cunnington, 
Dimitris Tousoulis, Cheerag Shirodaria, Christodoulos Stefanadis, 
Aroon Hingorani, John Deanﬁeld, Keith M. Channon, Stefan 
Neubauer, Hugh Watkins, Paul Leeson, University of Oxford, 
Department of Cardiovascular Medicine, Oxford, United Kingdom, 
University of Athens, Athens, Greece
Learning Objective: Identify the mechanisms by which chromosome 
9 locus affects cardiovascular risk
1053-328 Monocyte Chemoattractant Protein 1 Predicts First 
Coronary Events But Not Recurrent Strokes: Results 
from the SPARCL Study
Peter Ganz, Pierre Amarenco, Larry Goldstein, Henrik Sillesen, 
Weihang Bao, Gregory M. Preston, K. Michael Welch, San Francisco 
General Hospital, San Francisco, CA
Learning Objective: Evaluate the ability of MCP-1 to predict future 
coronary events and strokes
1053-329 Association between Non-Invasive Arterial Pulse 
Volume Recordings and Extent of Coronary Artery 
Disease
Ashish Parikh, Shailja V. Parikh, Sandeep Das, Tayo Addo, Shoaib 
Saya, Sondra Rolator, Tamra Cooper, Elizabeth Holper, University of 
Texas - Southwestern, Dallas, TX, University of Missouri - Kansas 
City School of Medicine, Kansas City, MO
Learning Objective: identify whether there is an association between 
PVR and CAD
1053-330 Predictors Of Subclinical Peri-procedural Blood 
Loss Associated With Percutaneous Coronary And 
Peripheral Intervention.
Zehra Jaffery, Arthur G. Grant, Christopher J. White, Ochsner 
Medical Institution, New Orleans, LA
Learning Objective: Identify predictors of sub-clinical blood loss for 
coronary and peripheral interventions
1053-331 The 9p21 Genetic Variant Is Additive to Carotid 
Intima Media Thickness and Plaque in Improving 
Coronary Heart Disease Risk Prediction in 
White Participants of the Atherosclerosis Risk in 
Communities (ARIC) Study
Vijay Nambi, Eic Boerwinkle, Kim Lawson, Ariel Brautbar, Lloyd 
Chambless, Nora Franchescini, Kari North, Salim Virani, Aaron R. 
Folsom, Christie Ballantyne, Baylor College of Medicine, Houston, TX
Learning Objective: understand how to use information about 9p21 
mutation and carotid initima media thicnkess in coronary heart 
disease risk prediction
1054 PERIPHERAL ARTERIAL/CAROTID DISEASE/
AORTIC DISEASE
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1054-333 The Effect of Gravity on Foot Circulation in Patients 
with Critical Limb Ischemia
Osami Kawarada, Yoshiaki Yokoi, Nobuyuki Morioka, Akihiro 
Higashimori, Kishiwada Tokushukai Hospital, Kishiwada, Osaka, 
Japan
Learning Objective: identiy the effect of gravity on foot circulation
1054-334 Twelve Month Persistence of Poor Response to 
Aspirin in Patients with Peripheral Arterial Disease 
Enrolled in the Effect of Lipid Modification on 
Peripheral Arterial Disease after Endovascular 
Intervention Trial (ELIMIT)
Justin T. Saunders, Vijay Nambi, Salim Virani, Eric Yang, Angela 
Bergeron, Husam Athamneh, Anirudh Kumar, Joel D. Morrisett, Alan 
Lumsden, Changyi Chen, Peter Lin, Carlos Bechara, Christie M. 
Ballantyne, Jing-Fei Dong, Baylor College Of Medicine, Houston, TX
Learning Objective: describe the prevalence of clinically poor 
antiplatelet response to ASA therapy in a group of patients with PAD
POSTER CONTRIBUTIONS
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1054-335 Changes in Thigh Muscle Volume Over a One 
Year Period in Patients With Peripheral Arterial 
Disease (PAD): A Magnetic Resonance Imaging 
(MRI) Analysis from the Effect of Lipid Modification 
on Peripheral Arterial Disease after Endovascular 
Intervention Trial (ELIMIT)
Gerd Brunner, Joel D. Morrisett, Eric Yang, Anirudh Kumar, Salim S. 
Virani, Panagiotis Kougias, Alan Lumsden, Christie M. Ballantyne, 
Vijay Nambi, Baylor College of Medicine, Houston, TX
Learning Objective: describe the changes in thigh muscle volume 
in patients with peripheral arterial disease and the use of MRI in 
tracking these changes.
1054-336 The Long-term Quality of Life in Patients with 
Peripheral Arterial Disease After Peripheral Bypass 
Surgery
Eline S. Van Hattum, Marco J. Tangelder, James A. Lawson, Frans 
L. Moll, Ale Algra, University Medical Center Utrecht, Utrecht, The 
Netherlands
Learning Objective: describe the health related quality of life about 
10 years after peripheral bypass surgery in patients with peripheral 
arterial disease.
1054-337 Impairment of Vasomotor Function of Conduit but 
not Resistance Arteries after Long-term Femoral 
Artery Occlusion
Jin-Shen Li, Lakshmana K. Pendyala, Xinhua Yin, Jianing Yue, Jack P. 
Chen, Nicolas Chronos, Dongming Hou, Saint Joseph’s Translational 
Research Institute/Saint Joseph’s Hospital of Atlanta, Atlanta, GA
Learning Objective: evaluate SFA endotehlial function
1054-339 Increasing Carotid Calcifications Are Significantly 
Associated with Obstructive Carotid Artery Disease
John S. Ho, Ben Willis, Dale A. Reinhardt, Mike A. Cornett, Wendy A. 
Wade, Carolyn Barlow, John J. Cannaday, Cooper Clinic, Dallas, TX, 
The Cooper Institute, Dallas, TX
Learning Objective: Identify the relation between increasing carotid 
artery calcium and obstructive carotid vascular disease.
1054-340 Carotid Artery Intima-Media Thickness (CIMT) 
Accretion Rate and Risk of Atherogenesis in a 
Primary Prevention Population
Uchechukwu K.A. Sampson, Fazio Sergio, John W. Patton, Anne-
Sophie Sillesen, Amanda K. Wake, Andre L. Churchwell, Alfred 
S. Callahan, Vanderbilt University Medical Center, Nashville, TN, 
Meharry Medical College, Nashville, TN
Learning Objective: The need to incorporate routine CIMT 
determination in risk stratifcation algorithms
1055 PERIPHERAL ARTERIAL/CAROTID DISEASE/
AORTIC DISEASE
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1055-341 Peripheral Arterial Disease Progression in the 
Bypass Angioplasty Revascularization Investigation 
2 Diabetes Trial
J. Dawn Abbott, Manuel Lombardero, Jean-Claude Tardif, Ivan Pena-
Sing, Luisa Buitron, Prem Singh, Gail Woodhead, Greg Barsness, 
Sherry Kelsey, BARI 2D Investigators, Brown University, Providence, 
RI, University of Pittsburgh, Pittsburgh, PA
Learning Objective: Describe the annual incidence of a new low 
ankle brachial index in medically treated patients with diabetes 
mellitus.
1055-342 Increased Angiotensin Converting Enzyme is 
Associated with Increased Inflammation and 
Neovascularization in Peripheral Vascular Disease: 
Mechanistic Role of Angiotensin II type I Receptor, 
Interleukin-6, and Tumor Necrosis Factor Alpha in 
Diabetic Atherosclerosis
Purushothaman K-Raman, Prakash Krishnan, Fernando Ruiz, 
Meerarani Purushothaman, Jose Wiley, Yelena Zubatov, Annapoorna 
S. Kini, Samin K. Sharma, John T. Fallon, Valentin Fuster, Pedro R. 
Moreno, Mount Sinai Medical Center, New York, NY
Learning Objective: Interpret the role of Angiotensin Converting 
Enzyme-2 in the mediation of inflammation and neovascularization 
in Peripheral vascular Disease
1055-344 Peripheral Arterial Disease Status and 
Cardiovascular Outcomes in the Bypass Angioplasty 
Revascularization Investigation 2 Diabetes Trial
J. Dawn Abbott, Manuel Lombardero, Greg Barsness, Ivan Pena-
Sing, Luisa Buitron, Prem Singh, Gail Woodhead, Jean-Claude Tardif, 
Sherry Kelsey, BARI 2D Investigators, Brown University, Providence, 
RI, University of Pittsburgh, Pittsburgh, PA
Learning Objective: Identify that patients with diabetes and an 
abnormally low or non-compressible ankle brachial index are at an 
increased risk of mortality.
1055-345 Vascular Stiffness as a Predictor of Abnormal 
Myocardial Perfusion in Asymptomatic Patients with 
Diabetes Mellitus
Cornelis J. Roos, Roxana Djaberi, Joanne Schuijf, Eelco J. de 
Koning, Ton J. Rabelink, Jan W. Smit, Alberto M. Pereira, Marcel P. 
Stokkel, Arthur J. Scholte, Ernst E. van der Wall, J. Wouter Jukema, 
Jeroen J. Bax, Leiden University Medical Center, Leiden, The 
Netherlands
Learning Objective: identify asymptomatic diabetic patients with an 
increased risk for coronary artery disease non-invasively, based on 
arterial stiffnes.
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1055-346 High Ferritin Levels Confer Lower Cardiovascular 
Risk in Type 2 Diabetes
Michel F. Rousseau, Sylvie A. Ahn, Michel P. Hermans, University of 
Louvain, Brussels, Belgium
Learning Objective: To introduce an emerging cardiovascular risk 
factor in T2DM
1055-347 Effect of the Dual Peroxisome Proliferator-Activated 
Receptor Alpha/Gamma Agonist, Muraglitazar, on 
Cardiac Structure and Function in Type 2 Diabetic 
Patients
Vijay U. Rao, Dean Alokozai, Polina Voloshko, Nelson B. Schiller, 
University of California, San Francisco, San Francisco, CA, 
Cardiocore, South San Francisco, CA
Learning Objective: describe the effect of the dual peroxisome 
proliferator-activated receptor agonist, muraglitazar, on cardiac 
structure and function in type 2 diabetic patients
1055-348 Use of Mobile Phone Technology to Improve 
Outcomes in Patients with Critical Limb Ischemia 
and Diabetes
Jenny E. Freeman, Thomas L. Rosser, Matthew Brown, Thomas MJ 
Rosser, James F. Toy, IV, JEF Core, Inc., WESTON, MA
Learning Objective: Describe the advantages of cell-phone based 
monitoring of patients with wounds and diabetes and the potential 
vallue of applying this technology to the care of patients with critical 
limb ischemia
1056 PERIPHERAL ARTERIAL/CAROTID DISEASE/
AORTIC DISEASE
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1056-350 Comparison Of Various Diagnostic Modalities 
To Evaluate The Efficacy Of Cell-based Vascular 
Regeneration Therapy In Patients With Critical Limb 
Ischemia.
Makoto Kinoshita, Atsuhiko Kawamoto, Rie Baba, Yutaka Furukawa, 
Takayuki Asahara, Institute of Biomedical Research and Innovation, 
Kobe, Japan, Kobe City Medical Center General Hospital, Kobe, 
Japan
Learning Objective: evaluate the efficacy of vascular regeneration 
therapy in patients with critical limb ischemia
1056-351 Serum N-terminal pro-B-type Natriuretic Peptide 
Levels are Associated with Walking Capacity in 
Patients with Peripheral Arterial Disease
Jin Fan, Hayan Jouni, Kent R. Bailey, Guanghui Liu, Iftikhar J. Kullo, 
Mayo Clinic, Rochester, MN
Learning Objective: Identify a good marker for evaluation dynamic 
stress in PAD patients.
1056-352 Waon Therapy Up-regulates the HSP90 and Leads 
to Angiogenesis Through Akt-eNOS Pathway in a 
Mouse Model of Hindlimb Ischemia
Takahiro Miyauchi, Masaaki Miyata, Yoshiyuki Ikeda, Yuichi Akasaki, 
Narisato Hamada, Takahiro Shirasawa, Hideyuki Eto, Furusho 
Yuko, Shuichi Hamasaki, Chuwa Tei, Department of Cardiovascular, 
Respiratory and Metabolic Medicine, kagoshima, Japan
Learning Objective: demonstrate that Waon therapy induces 
angiogenesis
1056-353 Body Mass Index, Calf Muscle Characteristics and 
Functional Decline in Peripheral Arterial Disease
Zankhana Raval, Mary M. McDermott, Northwestern University’s 
Feinberg School of Medicine, Chicago, IL
Learning Objective: describe associations of higher BMI with 
adverse calf muscle characteristics in men and women with lower 
extremity peripheral arterial disease.
1056-354 Favorable Effects of L-arginine on Arterial Function, 
Inflammatory and Fibrinolytic Process in Smokers
Gerasimos Siasos, Dimitris Tousoulis, Charalampos Vlachopoulos, 
Elias Gialafos, Evaggelos Oikonomou, Aris Plastiras, Marina 
Zaromitidou, Konstantinos Zisimos, Charalampos Antoniades, 
Georgia Siasou, Dimitra Papaspiridi, Georgios Marinos, Athanasios 
G. Papavassiliou, Christodoulos Stefanadis, Hippocration General 
Hospital of Athens, Athens Univercity Medical School, Athens, 
Greece
Learning Objective: evaluate the role of oral l-arginine administration 
in endothelial function, arterial stiffness, inflammatory and 
fibrinolytic process in healthy smokers
1056-356 Ethnicity-Specific Associations of Novel Markers of 
L-arginine Metabolism with the Ankle-Brachial Index
Faisal F. Syed, Rainer H. Boger, Thomas Mosley Jr, Edzard 
Schwedhelm, Nicole Lüneburg, Iftikhar J. Kullo, Mayo Clinic, 
Rochester, MN
Learning Objective: Evaluate the associations of markers in the 
L-arginine metabolic pathway with the ankle-brachial index
1056-357 Higher Prevalence of Carotid Atherosclerosis in 
Men with Low HDL-Cholesterol Is Not Related to 
Cardiorespiratory Fitness or Inflammation
Kevin Heffernan, Richard H. Karas, Jeffrey T. Kuvin, Moon-Kyu Lee, 
Yoon-Ho Choi, Sae Young Jae, Tufts Medical Center, Boston, MA, 
Samsung Medical Center, Seoul, South Korea
Learning Objective: understand the athero-protective role of 
HDL-cholesterol as it relates to cardiorespiratory fitness and 
inflammation.
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1057 PERIPHERAL ARTERIAL/CAROTID DISEASE/
AORTIC DISEASE
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1057-358 Clinical Efficacy of Cilostazol after endovascular 
treatment in Patients with Critical Limb Ischemia.
Yoshimitsu Soga, Osamu Iida, Keisuke Hirano, Hiroyoshi Yokoi, 
Masaaki Uematsu, Toshiya Muramatsu, Seiki Nagata, Shinsuke 
Nanto, Masakiyo Nobuyoshi, Kokura Memorial Hospital, Kitakyushu, 
Japan
Learning Objective: to evaluate the influence of cilostazol on clinical 
outcomes after endovascular treatment in patients with critical limb 
ischemia
1057-359 Relating Carotid Plaque Volume Reduction 
Assessed by 3T MRI with Inflammatory Cytokine 
Change Following 6 Month Statin Treatment
Raymond Q. Migrino, Leanne Harmann, Robert Prost, Mark Bowers, 
Medical College of Wisconsin, Milwaukee, WI
Learning Objective: To assess the relationship between plaque 
component change and cytokines in carotid atherosclerosis.
1057-360 Recombinant Human Interleukin-11 Treatment 
Improves Reperfusion And Augments Collateral 
Vessel Growth In Mouse Model Of Severe Hindlimb 
Ischemia
Julius Aitsebaomo, Siddharth Srivastava, Hua Zhang, James E. 
Faber, Cam Patterson, University of North Carolina, Chapel Hill, NC
Learning Objective: Identify novel use of recombinant human 
interleukin-11 on the treatment of peripheral vascular disease
1057-361 Treadmill and Ergometer Exercise Once a Week 
Equally Improve Not only Exercise-tolerance but 
also Cardio-Renal Function In Peripheral Arterial 
Disease (PAD) Patients with Claudication
Masanari Kuwabara, the Department of Genetic Medicine and 
Regenerative, Tottori University, Tottori, Japan, Hitoshi Anzai, Yutaro 
Nishi, Noriaki Hayashida, Ichiro Hisatome, St Luke’s International 
Hospital, Tokyo, Japan, the Department of Genetic Medicine and 
Regenerative Therapeutics, Tottori University, Tottori, Japan
Learning Objective: interpret the importance of exercise 
rehabilitation in PAD patients with claudication even if the exercise 
is low frequent.
1057-362 Long Term Endothelin Receptor Antagonist 
Improves Coronary Endothelial Function in Patients 
with Early Atherosclerosis
Reriani Kaiga Martin, Eugenia Raichlin, Abhiram Prasad, Verghese 
Mathew, Ryan Lennon, Charanjit Rihal, Lilach Lerman, Amir Lerman, 
Mayo Clinic, Rochester, MN
Learning Objective: To demonstrate that endothelin plays a role in 
early coronary atherosclerosis
1058 ENDOVASCULAR THERAPY
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1058-364 Thoracic Endovascular Aortic Repair Versus Medical 
Treatment For Type B Aortic Dissections.  
A Comparative Retrospective Volumetric Analysis
MINH HOANG TRAN, Kim-Diep DANG-TRAN, MD, Omar El Aassar, 
Ramiro Moreno, Adil Baali, Benjamin HONTON, Julien Auriol, 
Bertrand Marcheix, Hervé Rousseau, Radiology dep. , CHU-Rangueil, 
toulouse, France
Learning Objective: understand the rational and superiority of TEVAR 
over medical treatment for aortic dissections type B
1058-365 Effect Of Renal Impairment In Patients Undergoing 
Percutaneous Coronary Intervention With Sirolimus-
eluting Stents Versus Paclitaxel-eluting Stents.
KENNOSUKE YAMASHITA, Masahiko Ochiai, Kazuhiro Ashida, 
Tadayuki Yakushiji, Myong Hwa Yamamoto, Shigeo Saito, Koichi 
Hoshimoto, Yuki Mikoshiba, Naoei Isomura, Hiroshi Araki, Chiaki 
Obara, Showa University Northern Yokohama Hospital, yokohama, 
Japan
Learning Objective: evaluate the effect of drug-eluting stents for 
chronic kidney disease patients
1058-366 Long-term Safety And Efficacy Of A Biodegradable 
Polymer Based Sirolimus Eluting Stents In Treating 
Diabetic Patients: Subgroup Analysis Of The Create 
Study
Yaling Han, Quanmin Jing, Yi Li, Gaoliang Yan, Shouli Wang, Yingyan 
Ma, Bo Luan, Geng Wang, Shenyang Northern Hospital, Shenyang, 
People’s Republic of China
Learning Objective: evaluate
1058-367 A Registry of Biodegradable Versus Durable 
Polymer Paclitaxel - Eluting Stents.
Peter P. Buszman, Bartlomiej Orlik, Michal Kozlowski, Marek Krol, 
Marek Kondys, Janusz Drzewiecki, Michal Tendera, R. Stefan Kiesz, 
Pawel E. Buszman, Upper Silesian Heart Center, Katowice, Poland, 
Ameican Heart Of Poland, Katowice, Poland
Learning Objective: Determine whether biodegradable polymer 
coated stents paclitaxel eluting stents are superior to durable 
polymer paclitaxel eluting stents
1058-368 Increased Mortality Associated With Impaired 
Left Ventricular Function Occurs Early After 
Percutaneous Coronary Intervention
Ian G. Webb, Kalpa DeSilva, Pierre Sicard, Tim Lockie, Simon 
Redwood, Divaka Perera, St Thomas’ Hospital, King’s Health 
Partners, London, United Kingdom
Learning Objective: To understand the early mortality post PCI in 
patients with impaired LV function inspite of contemporary practice
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1059 ENDOVASCULAR THERAPY
Sunday, March 14, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1059-370 Frequency of Repeat Revascularization after 
Femoropopliteal Stenting.
Atushi Tosaka, Kokura Memorial Hospital, Kitakyushu, Japan
Learning Objective: learn Frequency of Repeat Revascularization 
after Femoropopliteal Stenting.
1059-371 Six-Month Clinical Outcomes after Below-the-Knee 
Angioplasty for Critical Limb Ischemia in Patients 
on Hemodialysis
Nakano Masatsugu, Toshiya Muramatsu, Reiko Tsukahara, Keisuke 
Hirano, Yoshiaki Itou, Hiroshi Ishimori, Masahiro Yamawaki, 
Motoharu Araki, Yasunari Sakamoto, Shinya Sasaki, Ittuki Komatsu, 
Saiseikai Yokohama City Eastern Hospital, Yokohama, Japan
Learning Objective: identify
1059-372 A Crossover Balloon Occlusion Technique for 
Percutaneous Closure After Trans-Femoral Aortic 
Valve Implantation
Philippe Genereux, Mathew Williams, Susheel Kodali, Yanai Ben-Gal, 
Craig Smith, Jeffrey W. Moses, Martin B. Leon, Columbia University 
Medical Center, New York, NY
Learning Objective: Describe a new, safe and successful adjunctive 
technique to percutaneous closure device used post transcatheter 
aortic valve implantation.
1059-373 Feasibility and Durability of Percutaneous Aortic 
Valve Replacement: 30-Day and One-Year Outcomes
Robert M. Maier, Ronald M. Hoedl, Gergana Stoschitzky, Martin 
Grabenwoeger, Johann Pollak, Stephan Blazek, Dieter Paetzold, 
Norbert Watzinger, Burkert M. Pieske, Olev Luha, Medical University 
Graz, Graz, Austria, Hospital Hietzing, Vienna, Austria
Learning Objective: evaluate acute procedural success and mid-
term outcome of percutaneous aortic valve replacement
1059-374 Comparing the Efficacy and Outcomes of Various 
Stents Used in Iliac Artery Revascularization-A 
Meta-analysis
Ankur Sethi, Amol Bahekar, Janos Molnar, Rohit Arora, Rosalind 
Franklin University,Chicago Medical School, North Chicago, IL
Learning Objective: To interpret difference between various stent 
used in iliac artery revascularization on various end points
1108 PERIPHERAL ARTERIAL/CAROTID DISEASE/
AORTIC DISEASE
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1108-324 Assesment Of Elastic Properties Of Aorta To 
Determine Cardiovascular Risk In Non-obese 
Polycystic Ovarian Syndrome Patients
Mehmet Kaya, Ozgur Gunebakmaz, Cemil Zencir, Ayse Yilmazsoy, 
Mukaddes Karadag, Ramazan Topsakal, Ali Ergin, Fahrettin 
Kelestemur, Erciyes University, Kayseri, Turkey
Learning Objective: Hyperandrogenemia may play a role in the 
prevention of atherosclerosis in non-obese PCOS patients.
1108-325 Aortic Stiffness in Systemic Lupus Erythematosus 
by Transesophageal Echocardiography
Joseph Joson, Carlos Roldan, Janeen Sharrar, Qualls Clifford, 
Wilmer Sibbitt, University of New Mexico School of Medicine, 
Albuquerque, NM
Learning Objective: understand the association between systemic 
lupus erythematosus and aortic stiffness
1108-327 Gender Differences in Clinical and Angiographic 
Findings among Korean Patients with Takayasu 
Arteritis
Ga Yeon Lee, Eunkyung Kim, Mi-rae Lee, Kyoung-Min Byun, Min Ho 
Kang, Hyejin Han, Seung-Hyuk Choi, Yeon Hyeon Choe, Duk-Kyung 
Kim, Samsung Medical Center, Seoul, South Korea
Learning Objective: identify gender differences in clinical and 
angiographic findings among Korean patients with Takayasu arteritis
1108-328 Relationships between Glaucoma, Arterial Stiffness 
and Inflammatory Process
Georgia Siasou, Dimitris Tousoulis, Marilita Moschos, Gerasimos 
Siasos, Elias Gialafos, Evaggelos Oikonomou, Aris Plastiras, 
Marina Zaromitidou, Konstantinos Zisimos, Aleksios Verveniotis, 
Charalampos Antoniades, Georgios Marinos, Athanasios G. 
Papavassiliou, Christodoulos Stefanadis, Hippocration General 
Hospital of Athens, Athens Univercity Medical School, Athens, 
Greece
Learning Objective: evaluate the association between arterial 
stiffness, inflammatory process andsoluble intercellular cells 
adhesion molecule in primary open-angle glaucoma patients.
1108-329 Microcirculatory Dysfunction in HIV Infected 
Patients
Ignatios Ikonomidis, John Lekakis, Sotirios Tsiodras, John Palios, 
Garyfalia Poulakou, Periklis Panagopoulos, Periklis Panagopoulos, 
Antonios Papadopoulos, Anastasia Antoniadou, Helen Giamarellou, 
Dimitrios Kremastinos, Attikon University Hospital, Athens, Greece
Learning Objective: Identify vascular microcirculation dysfunction in 
HIV infected patients
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1108-330 Aortic Elastic Properties Are Altered in Patients 
after Kawasaki Disease even without Coronary 
Artery Aneurysm
Jun Oyamada, Manatomo Toyono, Shunsuke Shimada, Mieko Aoki-
Okazaki, Masamichi Tamura, Tsutomu Takahashi, Akita University, 
Akita, Japan
Learning Objective: be considered to prevent progression of the 
impaired arterial elastic properties with some medical intervention, 
if necessary.
1108-331 Increased NT-pro-BNP Levels in Patients with 
Peripheral Arterial Disease and “Stiff” Vessels
Hayan Jouni, Jin Fan, Allison A. Ellington, Kent R. Bailey, Iftikhar 
J. Kullo, Division of Cardiovascular Diseases, Mayo Clinic, 
Rochester, MN
Learning Objective: Describe the association of NT-pro-BNP levels 
with peripheral arterial disease, particularly in the subset with 
“stiff” vessels.
1109 PERIPHERAL ARTERIAL/CAROTID DISEASE/
AORTIC DISEASE
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1109-333 Renal Angioplasty and Stenting under Protection.
Limitations. First Human Study with a 3D filter: The 
Fibernet TM
Michel Henry, Dr HENRY Michel, NANCY, France
Learning Objective: Current embolic protection devices used in renal 
angioplasty and stenting have limitations which may be addressed 
by the new Fibernet filter.
1109-334 Elevated Intraluminal Velocities After Successful 
Renal Artery Stent Insertion: Is it Time for New 
Duplex Velocity Criteria Post-stenting?
Johannes K. Steiner, James T. DeVries, Dartmouth-Hitchcock 
Medical Center, Lebanon, NH
Learning Objective: interpret increased intraluminal renal artery 
velocities after stent insertion.
1109-335 The Utilization of PTFE Covered Stents for the 
Treatment of Renal Artery In-Stent Restenosis
Nicholas J. Ruggiero, II, Joseph Garasic, Michael R. Jaff, Andrew B. 
McCann, Thomas J. Kiernan, Brian G. Hynes, Douglas E. Drachman, 
Robert Schainfeld, Kenneth Rosenﬁeld, Gary M. Ansel, Massachusetts 
General Hospital, Boston, MA, Cardiology Research Foundation, A 
Division of OhioHealth Research Institute, Columbus, OH
Learning Objective: Evaluate the use of PTFE covered stents for the 
management of renal artery in-stent restenosis
1109-336 Percutaneous Transluminal Angiopmasty and 
Stenting of Extracranial Vertebral Artery Stenosis
Michel Henry, Isabelle Henry, Antonios Polydorou, Michele Hugel, Dr 
Henry Michel, Nancy, France
Learning Objective: PTA Stenting is the first treatment of the 
symptomatic vertebral artery stenosis. The role of DES and embolic 
protection devices will be discussed.
1109-337 Percutaneous Transluminal Angioplasty of the 
Subclavian Arteries. Long-Term Follow up
Michel Henry, Isabelle Henry, Antonios Polydorou, Michele Hugel, Dr 
Henry Michel, Nancy, France
Learning Objective: PTA Stenting is the treatment of choice for subclavian 
artery lesions with few complications and excellent long-term results.
1109-339 Factors of Success and Patency after Subintimal 
Angioplasty in Patients with TASC C and D Lower 
Extremity Disease
Weon Kim, Seung-Ju Kim, Won-Yu Kang, Sun-Ho Hwang, Wan Kim, 
Sang-Jin Ha, Kyung Hee University Medical Center, Seoul, South 
Korea, Gwangju Veterans Hospital, Gwangju, South Korea
Learning Objective: demonstrate that lengths of occlusion, distal 
SFA involving lesion, and post-procedural run-off vessels were strong 
independent predictors for reocclusion in TASC C and D disease 
that underwent SI-PTA
1109-340 Efficacy of Stent-supported Subintimal Angioplasty 
in Iliac Artery Occlusive Disease.
Sanghoon Shin, Young-Guk Ko, Jung-Sun Kim, Donghoon Choi, 
Myeong-Ki Hong, Yangsoo Jang, Won-Heum Shim, Seung-Yun Cho, 
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei 
University, Seoul, South Korea
Learning Objective: interpret that stent-supported subintimal 
angioplasty in occlusive iliac lesion is high efficant method.
1110 PERIPHERAL ARTERIAL/CAROTID DISEASE/
AORTIC DISEASE
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1110-341 A Percutaneous Device for Cerebral Embolic 
Protection During High Risk Cardiovascular 
Intervention
Jeffrey P. Carpenter, Judith T. Carpenter, Armando Tellez, Juan F. 
Granada, Robert Wood Johnson Medical School, Camden, NJ, Jack 
H. Skirball Center for Cardiovascular Research of the Cardiovascular 
Research Foundation, Orangeburg, NY
Learning Objective: describe aortic embolic protection
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1110-342 A Novel Method of Identifying Unstable Plaque by 
Simultaneous Carotid Ultrasound and Trans-Cranial 
Doppler
George S. Abela, Fadi Shamoun, Muhammad U. Farooq, Kevin 
Berger, Dorothy Pathak, Mounzer Kassab, Michigan State University, 
East Lansing, MI, Sparrow Hospital, Lansing, MI
Learning Objective: To identify plaques at increased risk for stroke
1110-344 Carotid Revascularization Immediately Prior 
To Urgent Cardiac Surgery: Clinical Outcomes 
Associated With The Choice Of Carotid Artery 
Stenting (CAS) Or Endarterectomy (CEA) From The 
NCDR-CARE Registry
Creighton W. Don, John House, Kevin Kennedy, Christopher White, 
Al Woodward, Mary Weideman, Kenneth Rosenﬁeld, University 
of Washington, Seattle, WA, Massachusetts General Hospital, 
Boston, MA
Learning Objective: Evaluate the 30 day outcomes of patients 
undergoing carotid stenting and carotid endarterectomy prior to 
urgent cardiac surgery
1110-345 Carotid Angioplasty and Stenting in Octogenarians 
Is as Safe as Surgery
Michel Henry, Isabelle Henry, Antonios Polydorou, Michele Hugel, Dr 
HENRY Michel, NANCY, France, NANCY, France
Learning Objective: Carotid angioplasty ans stenting is as safe as 
surgery in octogenarians and should be the treatment of choice 
with experienced operators.
1110-346 Carotid Revascularization Immediately Prior 
to Urgent Cardiac Surgery: Practice Patterns 
Associated with the Choice Of Carotid Artery 
Stenting (CAS) Or Endarterectomy (CEA) from The 
NCDR-CARE Registry
Creighton W. Don, John House, Christopher White, Al Woodward, 
Kevin Kennedy, Thomas Kiernan, Mary Weideman, Nicholas 
Ruggiero, Andrew McCann, Kenneth Rosenﬁeld, University of 
Washington, Seattle, WA, Massachusetts General Hospital, 
Boston, MA
Learning Objective: Identify patient characteristics associated with 
the use of carotid artery stenting and carotid endarterectomy in 
patients undergoing urgent cardiac surgery
1110-347 Time Window of Xenon Administration for 
Neuroprotective Effects During Transient Middle 
Cerebral Artery Occlusion
George L. Britton, Jr., Hyunggun Kim, David D. McPherson, Shaoling 
Huang, University of Texas Health Science Center, Houston, TX
Learning Objective: At the conlusion of this presentation, attendants 
will be able to understand xenon’s role in neuroprotectant following 
an ischemic injury.
1110-348 Influence of Participation in Clinical Trials on 
Outcomes after Carotid Artery Stenting - Results 
from the Carotid Artery Revascularization and 
Endarterectomy (CARE) Registry
Robert W. Yeh, Sahil A. Parikh, Kevin F. Kennedy, Rahul Sakhuja, 
John A. House, Kenneth Rosenﬁeld, Massachusetts General 
Hospital, Boston, MA, Mid America Heart Institute, Kansas City, MO
Learning Objective: Describe differences in patient characteristics 
and outcomes in clinial trial and non-clinical trial patients 
undergoing carotid artery stenting.
1111 PERIPHERAL ARTERIAL/CAROTID DISEASE/
AORTIC DISEASE
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1111-350 The spectrum of Aortic Disease in Loeys-Dietz 
Syndrome
Chetana Reddy, Angela Sharkey, Alan C. Braverman, Washington 
University School of Medicine, Saint Louis, MO
Learning Objective: Identify the cardiovascular features of Loeys-
Dietz syndrome
1111-351 Incidence of Neurologic Deficits in Acute Aortic 
Dissection and its Impact on Clinical Outcomes. 
Insights from the International Registry of Acute 
Aortic Dissection (IRAD)
David C. Corteville, Vijay S. Ramanath, Christoph A. Nienaber, Kim 
A. Eagle, James B. Froehlich, Jeanna V. Cooper, Reed E. Pyeritz, 
Anna M. Booher, Marek Ehrlich, Truls Myrmel, Patrick O’Gara, Linda 
Pape, Joshua A. Beckman, Santi Trimarchi, Eric M. Isselbacher, 
Eduardo Bossone, on behalf of the International Registry of Acute 
Aortic Dissection (IRAD) investigators, University of Michigan, Ann 
Arbor, MI
Learning Objective: To determine the incidence of neurological 
deficits in type A acute aortic dissection and its impact on clinical 
outcomes
1111-352 Characteristics Of Aortic Dissection In Patients 
With Bicuspid Aortic Valve: Insights From the 
International Registry of Acute Aortic Dissection 
(IRAD)
Rossella Fattori, Eric M. Isselbacher, Christoph A. Nienaber, James 
B. Froehlich, Arturo Evangelista, James L. Januzzi, Craig Strauss, 
Guillaume Jondeau, Jeanna V. Cooper, Daniel G. Montgomery, Elise 
M. Woznicki, Kristian Bartnes, Toru Suzuki, Alan C. Braverman, Kim 
A. Eagle, on behalf of the International Registry of Acute Aortic 
Dissection (IRAD) investigators, University Hospital S. Orsola, 
Bologna, Italy, University of Michigan, Ann Arbor, MI
Learning Objective: Describe Characteristics Of Aortic Dissection In 
Patients With Bicuspid Aortic Valve
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1111-353 Increased Incidence of Renal Simple Cysts in 
Patients with Aortic Dissection and intramural 
hematoma
Eunkyung Kim, E Ryoung Choi, Mi-rae Lee, Min Ho Kang, Hyjin 
Han, Ji Hyun Yang, Jeong Rang Park, Bong Gun Song, Yeon Hyun 
Choe, Young-Soo Do, Wook Sung Kim, Kiick Sung, Pyo-Won Park, 
Duk-Kyung Kim, Seung-Hyuk Choi, Samsung Medical Center, Seoul, 
South Korea
Learning Objective: demonstrate possible common correlation of 
renal simple cysts with aortic dissection and intramural hematoma
1111-354 Prevalence and Correlates of Aortic Dilatation in 
Adolescents and Young Adults: The Strong Heart 
Study.
Marina De Marco, Mary J. Roman, Giovanni de Simone, Marcello 
Chinali, Lyle G. Best, Elisa T. Lee, Damon Dixon, Barbara V. Howard, 
Richard B. Devereux, Federico II University, Napoli, Italy, Cornell 
Medical College, New York, NY
Learning Objective: Evaluate prevalence and correlates of aortic 
dilatation in a population based simple of adolescents and young 
adults.
1111-356 Impact of Imaging Methodology on Measurements 
of Aortic Size in Patients with Thoracic Aortic 
Aneurysms - Results from the GenTAC Imaging 
Database
Jonathan W. Weinsaft, Joseph Daoko, Jamie C. Fong, Sonia Sethi, 
Dorinna D. Mendoza, Richard B. Devereux, Craig T. Basson, Kathryn 
Holmes, Poyee P. Tung, Dianna M. Milewicz, Reed Pyeritz, Cheryl 
Maslen, Barbara Kroner, Donald Brambilla, H. E. Tolunay, Patrice 
Desvigne-Nickens, Kim Eagle, on behalf of the GenTAC study 
investigators, Weill Cornell Medical College, New York, NY
Learning Objective: Evaluate the impact of imaging methodology on 
aortic quantification among patients with with genetically triggered 
aortic aneurysms.
1111-357 Increased Number of Circulating Endothelial 
Progenitors Cells Are Associated with a Higher 
Degree of Collateral Circulation in Patients with 
CAD
Marcos Ibarra, Victor Ocana, Luis Villela, Erasmo De La Pena-
Almaguer, Jesus Siller, Enrique Ponce de Leon, Oscar Fajardo, 
Yolanda Ramos, Jose Borbolla, Guillermo Torre-Amione, Instituto de 
Cardiologia y Medicina Vascular Tec de Mty, Monterrey, Mexico, The 
Methodist Hospital, Houston, TX
Learning Objective: To demonstrate that increased progenitor cells 
related are related to a higher degree of collateral circulation
1112 ATHEROSCLEROTIC PLAQUE-- 
PATHOPHYSIOLOGY—CLINICAL
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1112-358 In Asymptomatic Firefighters the Burden of 
Subclinical Atherosclerosis as Measured by both 
Coronary Artery Calcification and Carotid Intimal 
Medial Thickening is associated with Metabolic 
Abnormalities and but Not with Standard Traditional 
Serological Risk Factors
Lakshmana K. Pendyala, Stephen Frohwein, Catherine Skrifvars, 
Brenda Garrett, Radhika R. Gadesam, Kathryn Momary, H Robert 
Superko, Saint Joseph’s Translational Research Institute, Atlanta, GA
Learning Objective: To identify predictive risk factors fo subclinical 
atherosclerosis in asymptomatic firefighters
1112-359 Factors Influencing The Natural History Of Coronary 
Atheroma Calcification: Insights From Serial 
Intravascular Ultrasound
Andrea Lavoie, Julie Thornton, Kathy Wolski, Kiyoko Uno, Ozgur 
Bayturan, Paul Schoenhagen, Samir Kapadia, E. Murat Tuzcu, 
Steven E. Nissen, Stephen J. Nicholls, The Cleveland Clinic 
Foundation, Cleveland, OH
Learning Objective: describe the natural progression of coronary 
calcification and its relationship to atheroma burden
1112-360 Aggressive Use of Anti-Atherosclerotic Therapies 
Slows Progression of Coronary Atheroma in Patients 
with a History of Coronary Revascularization
Kiyoko Uno, Stephen J. Nicholls, Julie Thornton, Craig Balog, Ozgur 
Bayturan, Andrea J. Lavoie, Ajai Shreevatsa, Paul Schoenhagen, 
Samir Kapadia, E. Murat Tuzcu, Steven E. Nissen, Cleveland Clinic, 
Cleveland, OH
Learning Objective: evaluate coronary atheroma burden according to 
with or without prior revascularization
1112-361 The First in Human Clinical Use of a Combined Near 
Infrared Spectroscopy and Intravascular Ultrasound 
Catheter to Identify and Characterise Intracoronary 
Plaque (SAVOIR study)
Evelyn Regar, Scot Garg, Martin van der Ent, Carl Schultz, Frits 
Mastik, Gijs van Soest, Jolanda J. Wentzel, Patrick W. Serruys, Mark 
A. Wilder, James E. Muller, Antonius FW van der Steen, Erasmus 
Medical Center, Rotterdam, The Netherlands
Learning Objective: undertsand the potential of invasive imaging for 
in vivo plaque characterization
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1112-362 High-density Lipoprotein Cholesterol And C-reactive 
Protein Are Associated with Tissue Composition 
of Coronary Atherosclerotic Plaque. - In Vivo 
Tissue Characterization by Integrated Backscatter-
Intravascular Ultrasound
Naoki Nakayama, Kiyoshi Hibi, Masayoshi Kiyokuni, Naohiro 
Komura, Kazutoshi Minami, Katsutaka Hashiba, Fumiyuki Otsuka, 
Tatsuya Nakachi, Nobuhiko Maejima, Noriaki Iwahashi, Jun Okuda, 
Kengo Tsukahara, Masami Kosuge, Toshiaki Ebina, Satoshi 
Umemura, Kazuo Kimura, Yokohama-City University Medical Center, 
Yokohama, Japan
Learning Objective: find the relationship between the tissue 
components of coronary plaques of culprit lesions and serum 
biomarkers such as high density lipoprotein cholesterol and 
C-reactive protein.
1113 VASCULAR WALL CHARACTERISTICS 2 -- 
PATHOPHYSIOLOGY—CLINICAL
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1113-364 The Different Central Hemodynamics in Patients 
with Bicuspid Aortic Valve and its Association with 
Ascending Aorta Dilatation
In Jeong Cho, Chi Young Shim, Jeonggeun Moon, Sungha Park, Jong-
Won Ha, Yangsoo Jang, Namsik Chung, Yonsei University College of 
Medicine, Seoul, South Korea
Learning Objective: evaluate the risk for subsequent aortic dilation 
in patients with bicuspid aortic valves.
1113-365 High Pulse Pressure Variation Predicts Mortality 
After Acute Myocardial Infarction
Petra Barthel, Alexander Müller, Kurt Ulm, Axel Bauer, Marek Malik, 
Georg Schmidt, 1. Medizinische Klinik, Klinikum rechts der Isar, 
Technische Universität München, Munich, Germany
Learning Objective: identifiy post-infarction patients at increased 
mortality risk by means of a novel hemodynamic parameter
1113-366 Increased Aortic Augmentation Index in Tako-Tsubo 
Cardiomyopathy
Stefan Buchholz, Ravinay Bhindi, Michael R. Ward, Gemma A. 
Figtree, Royal North Shore Hospital, Sydney, Australia, North Shore 
Heart Research Group, Sydney, Australia
Learning Objective: evaluate the aortic augmentation index
1113-367 Asymptomatic Firefighters with Metabolic 
Syndrome have a High Incidence of both Coronary 
and Carotid Premature Atherosclerosis-associated 
with Increased Thrombotic and Inflammatory 
Markers
Lakshmana K. Pendyala, CATHERINE SKRIFVARS, BRENDA GARRETT, 
RADHIKA R. GADESAM, KATHRYN MOMARY, H ROBERT SUPERKO, 
University of Louisville, Louisville, KY
Learning Objective: Evaluate the specific risk factors for increased 
risk for incidence and mortality from CAD in fire fighters
1113-368 Relationship of Epicardial Adipose Tissue to Plaque 
Vulnerability; the Study Combined Echocardiography 
and Virtual Histology Intravascular Ultrasound
Jin-Sun Park, So-Yeon Choi, Mingri Zheng, Yun-Suk Park, Eun-Ah 
Choi, Hyoung-Hwa Han, Hong-Seok Lim, Byoung-Joo Choi, Myeong-
Ho Yoon, Gyo-Seung Hwang, Seung-Jea Tahk, Joon-Han Shin, Ajou 
University School of Medicine, Suwon, South Korea
Learning Objective: To demonstrate the plaque vulnerability and the 
unstable clinical presentation of the patients having thick epicardial 
adipose tissue by echocardiography
1114 ARTERIAL WALL CHARACTERISTICS -- 
PATHOPHYSIOLOGY—CLINICAL
Sunday, March 14, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1114-370 Arterial Wall Characteristics Are Associated with 
Incident Cardiovascular Disease: An Analysis from 
the Atherosclerosis Risk In Communities (ARIC) 
Study
Eric Y. Yang, Lloyd Chambless, A. Richey Sharrett, Salim S. Virani, 
Zhengzheng Teng, Eric Boerwinkle, Christie M. Ballantyne, Vijay 
Nambi, Baylor College of Medicine, Houston, TX
Learning Objective: Changes in arterial wall stiffness/properties 
on carotid ultrasound provide an additional method to evaluate CV 
health of an individual
1114-371 Increased thickness of Aortic and Coronary Wall, 
and Carotid Intima Media is Associated with 
Impaired Aortic Distensibility in Subjects without 
Coronary Artery Calcium (from the Multi-Ethnic 
Study of Atherosclerosis [MESA])
Naser Ahmadi, Cuilian Miao, Songshou Mao, Junichiro Takasu, 
Khurram Nasir, W. Craig Johnson, Joseph F. Polak, David Bluemke, 
Gregory Hundley, Joao A. Lima, Matthew Budoff, Los Angeles 
Biomedical Research Institute at Harbor UCLA Medical Center, 
Torrance, CA
Learning Objective: Increased aortic wall thickness, carotid intima 
media thickness and coronary wall thickness are association with 
impaired aortic distensibility across all multi-ethnic groups without 
coronary calcium
1114-372 Is There A Correlation Between Stiffness Vascular 
Parameters And Auto-antibodies Against Nuclear 
Protein Scl-70 In Patients With Systemic Sclerosis?
Concetta Zito, Scipione Carerj, Gianluca Di Bella, Maurizio 
Cusmà Piccione, Caterina Longordo, Girolamo Gioffrè, Raffaella 
Iudicello, Maria Rosaria Giuffrè, Roberta Nava, Gianﬁlippo Bagnato 
J, Gianﬁlippo Bagnato, University of Messina, Department of 
Cardiology, Messina, Italy
Learning Objective: Identify early involvement of vascular system in 
patients with systemic sclerosis and increased serum levels of Scl-
70 autoantibodies
A164 ABSTRACTS: Vascular Disease JACC    March 9, 2010
Va
sc
ul
ar
 D
is
ea
se
1114-373 Effect of Acute Intense Exercise on Arterial Stiffness
Despina Kardara, Charalambos Vlachopoulos, Aris Anastasakis, 
Katerina Baou, Ioanna Dima, Dimitrios Terentes-Printzios, Georgios 
Antoniou, Athanasios Gravos, Grigorios Aggelidis, Christodoulos 
Stefanadis, 1st Cardiology Department, Athens Medical School, 
Hippokration Hospital, Athens, Greece
Learning Objective: demonstrate that marathon race results in an 
acute decrease of wave reflections,indicating reduced afterload and 
improved left ventricular performance
1114-374 Increased Pulse Wave Velocity is Associated 
with Coronary Artery Calcium in Asymptomatic 
Individuals
Souraya Sourayanezhad, Naser Ahmadi, Vahid Nabavi, Braynce 
L. Oyang, Shahin Moshreﬁ, Sagar J. Pathak, Hussain sma’eel, 
Ramin Ebrahimi, Tae Young Choi, Anila Saeed, Matthew Budoff, Los 
Angeles Biomedical Research Institute at Harbor UCLA Medical 
Center, Torrance, CA
Learning Objective: Aortic stiffness is associated with the presence 
and severity of coronary artery calcium in asymptomatic individual 
independent of cardiovascular risk factors
1163 VASCULAR BIOLOGY/ATHEROSCLEROSIS/
THROMBOSIS/ENDOTHELIUM
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1163-324 Interleukin-33 is Expressed in Human 
Atherosclerotic Tissue and Increases Pro-
inflammatory Mediators in Human Endothelial Cells 
but not in Smooth Muscle and Cardiac Cells.
Svitlana Demyanets, Christoph Kaun, Stefan Pfaffenberger, Kathrin 
Rychli, Igor Huk, Gerald Maurer, Kurt Huber, Johann Wojta, Medical 
University of Vienna, Vienna, Austria, Wilhelminenhospital, Vienna, 
Austria
Learning Objective: know that Interleukin-33, a novel member of 
the IL-1 family of cytokines, induces IL-6, IL-8 and MCP-1 production 
selectively in human endothelial cells, but not in human cardiac or 
smooth muscle cell
1163-325 Plaque Location in the Left Anterior Descending 
Coronary Artery and Tissue Characteristics in 
Angina Pectoris: An Integrated Backscatter 
Intravascular Ultrasound Study
Komura Naohiro, Hibi Kiyoshi, Nakayama Naoki, Kiyokuni 
Masayoshi, Minami Kazutoshi, Hashiba Katsutaka, Saka Kenichiro, 
Otsuka Fumiyuki, Nakachi Tatsuya, Maejima Nobuhiko, Iwahashi 
Noriaki, Okuda Jun, Tsukahara Kenngo, Kosuge Masami, Ebina 
Toshiaki, Umemura Satoshi, Kimura Kazuo, Division of Cardiology, 
Yokohama City University Medical Center, Yokohama, Japan
Learning Objective: distinguish the tissue characteristics of plaques 
between proximal and distal left descending coronary artery.
1163-327 Significant Differences in Changes of Plaque 
Composition and Vessel Remodeling between 
Progression and Regression of Coronary 
Atherosclerosis during Statins Therapy: Sub-
Analysis of TRUTH Study
Tsuyoshi Nozue, Shingo Yamamoto, Shinichi Tohyama, Shigeo 
Umezawa, Tomoyuki Kunishima, Akira Sato, Shogo Miyake, Youichi 
Takeyama, Yoshihiro Morino, Takao Yamauchi, Toshiya Muramatsu, 
Kiyoshi Hibi, Takashi Sozu, Mitsuyasu Terashima, Ichiro Michishita, 
Kanagawa PTCA Conference Study Group, Yokohama Sakae Kyosai 
Hospital, Yokohama, Japan
Learning Objective: learn how coronary artery plaque composition 
and vessel remodeling change during progression or regression with 
statins therapy
1163-328 Pentraxin 3 Is Involved in Pathogenesis of Unstable 
Plaque Associated with Intraplaque Hemorrhage
Yunosuke Matsuura, Takuroh Imamura, Kinta Hatakeyama, Yoshisato 
Shibata, Tatsuhiko Kodama, Kazuo Kitamura, Yujiro Asada, Miyazaki 
University, Miyazaki, Japan, Tokyo University, Tokyo, Japan
Learning Objective: To demonstrate what type and characteristic of 
plaque is associated with PTX3 accumulation in plaque
1163-329 Impact of Lipid-Lowering Therapy on Coronary 
Plaque Composition in Patients with Stable 
and Unstable Angina Evaluated by Intravascular 
Ultrasound with Virtual Histology; Findings from the 
Subanalyses of the TRUTH Study
Hiroyuki Ozaki, Kazuki Fukui, Yasuo Okusu, Tomoyori Nakatogawa, 
Takeshi Nakagawa, Kiyoshi Hibi, Takashi Sozu, Terashima 
Mitsuyasu, Tsuyoshi Nozue, Ichiro Michishita, Kanagawa PTCA 
Conference Study Group, Department of Cardiology, Kanagawa 
Cardiovascular and Respiratory Center, Yokohama, Japan
Learning Objective: evaluate the effects of statins on coronary 
plaques in patients with unstable angina
1163-330 Effect of LXR-623, Alone or in Combination with 
Simvastatin, on Regression and Stabilization of 
Atherosclerotic Plaques: an MRI Study in a Model of 
Advanced Atherosclerosis
Chiara Giannarelli, Giovanni Cimmino, Thomas M. Connolly, Borja 
Ibanez, Josè M. Garcia Ruiz, Giora Feuerstein, Matilde Alique, 
Valentin Fuster, Juan Badimon, AtheroThrombosis Research Lab, 
Cardiovascular Institute, Mount Sinai School of Medicine, New York, 
NY, Weyth Research, Collegeville, PA
Learning Objective: describe the anti-atherosclerotic effect of 
LXR-623, a novel oral LXR agonist, which alone reduces plaque 
progression and combined with statins significantly regress 
atherosclerotic lesions.
1163-331 Wall Shear Stress as a Determinate for Coronary 
Atherosclerotic Plaque Distribution, Composition 
and Remodeling as Assessed by Intravascular 
Ultrasound and Radiofrequency Tissue 
Characterization in humans in vivo
Holger Hetterich, Ahmad Ibrahim, Moritz Gehring, Tobias Potzger, 
Thomas Redel, Volker Klauss, Johannes Rieber, University of Munich, 
Medizinische Poliklinik, Department of Cardiology, Munich, Germany
Learning Objective: Understand the correlation of endothelial wall 
shear stress and coronary atherosclerosis
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1164 VASCULAR BIOLOGY/ATHEROSCLEROSIS/
THROMBOSIS/ENDOTHELIUM
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1164-333 RVX-208 Given Orally to Humans Raises Plasma 
ApoA-I and HDL in a Phase 1b/2a Clinical Trial.
Norman C. Wong, Allan Gordon, Jan Johansson, Gregory Wagner, 
Fabrizio S. Chiacchia, Kevin McLure, Ravi Jahagirdar, Resverlogix 
Corporation, Calgary, AB, Canada
Learning Objective: A new compound given orally raises apoA-I and 
HDL.
1164-334 Simvastatin Improves Endothelium-Dependent 
Dilation, but Reduces Adiponectin Levels and 
Insulin Sensitivity in Hypercholesterolemic Patients
Kwang K. Koh, Michael Quon, Seung H. Han, Kyounghoon Lee, 
Gachon University, Incheon, South Korea, NIH, Bethesda, MD
Learning Objective: identify
1164-335 Lipoprotein-Associated Phospholipase A
2
 Prediction 
of Coronary Artery Disease Diagnosis Among 
Patients with Differing Numbers of Risk Factors
Farangis Lavasani, Heidi T. May, Benjamin D. Horne, Jeffrey 
L. Anderson, John F. Carlquist, Robert L. Wolfert, Joseph B. 
Muhlestein, Intermountain Medical Center, Murray, UT
Learning Objective: Evaluate the predictive ability of Lp-PLA2 
among those with varying number of risk factors for coronary artery 
disease.
1164-336 Extended Release Niacin Improves Lipid Profile but 
Not Endothelial Function in Patients with Coronary 
Artery Disease on High Dose Statins
Jaroslav Hubacek, Andrew C. Philpott, Yichun C. Sun, Vincent Lee, 
Darlene Hilland, Todd J. Anderson, University of Calgary, Calgary, AB, 
Canada
Learning Objective: Evaluate effect of Niacin ER on endothelial 
function in CAD patients on optimal statin therapy
1164-337 Resveratrol Counters Atherogenic Effects of 
Interferon-gamma on Cholesterol Efflux in THP-1 
Human Monocytes/Macrophages
Ofek Y. Hai, Kamran Anwar, Peter A. Wirkowski, Iryna Voloshyna, 
Steven E. Carsons, Allison B. Reiss, Winthrop University Hospital 
Center, Mineola, NY
Learning Objective: To demonstrate anti-atherogenic potency of the 
polyphenol reseveratrol which, through a novel mechanism involving 
enhancement of cholesterol efflux, can counter the atheroma-
promoting effect of IFN-g
1164-339 The Effect of High Dose Statin Therapy 
on Lipoprotein-Associated and Secretory 
Phospholipase A
2
 Mass and Activity and Ischemic 
Events in Patients with Acute Coronary Syndromes
Sung Kee Ryu, Ziad Mallat, Gregory G. Schwartz, Joelle Benessiano, 
Alain Tedgui, Anders G. Olsson, Sotirios Tsimikas, Division Of 
Cardiovascular Diseases, University Of California San Diego, La Jolla, Ca
Learning Objective: Demonstrate that high dose atorvastatin 
therapy reduce Lp-PLA2 and sPLA2 effectively and it is related to 
beneficial clinical outcome
1164-340 The Time to Peak Vasodilatation is Significant 
Determinant of Brachial Artery Flow-mediated 
Vasodilatation in Hypertension: Analysis Using a 
Novel Semi-automatic Vessel Chasing System of 
UNEXEF18G
Bonpei Takase, Akimi Uehata, Yoshihiro Tanaka, Masayuki Ishihara, 
National Defense Medical College, Tokorozawa, Japan
Learning Objective: understand the new parameter and equipment 
of FMD in Hypertensive patients
1165 VASCULAR BIOLOGY/ATHEROSCLEROSIS I
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1165-341 Eosinophil Cationic Protein: a new biomarker of 
Coronary Atherosclerosis.
Giampaolo Niccoli, Giuseppe Ferrante, Nicola Cosentino, Micaela 
Conte, Andrea Silenzi, Flavia Belloni, Marcello Marino, Vito Sabato, 
Domenico Schiavino, Giampiero Patriarca, Luigi Marzio Biasucci, 
Filippo Crea, Institute of Cardiology, Catholic University of Sacred 
Heart, Rome, Italy
Learning Objective: Demonstrates a new marker for coronary 
atherosclerosis
1165-342 Microalbuminuria in Non-Diabetic Patients with 
Metabolic Syndrome is a Strong Predictor of Carotid 
Artery Distensibility and Thickness
Pawan K. Hari, Vikas Veeranna, Palaniappan Manickam, Sandeep 
Zalawadiya, Simegn Mengistu, Jyotiranjan Pradhan, Sony Jacob, Luis 
Afonso, Wayne State University, Detroit, MI
Learning Objective: Identify that microalbuminuria in non-diabetic 
patients with metabolic syndrome is an incremental predictor of 
subclinical atherosclerosis
1165-344 Circulating Adiponectin as a Predictor of 
Vascular Superoxide Generation and Nitric Oxide 
Bioavailability in Human Arteries and Veins
Charalambos A. Antoniades, Cheerag Shirodaria, Paul Leeson, 
Constantinos Bakogiannis, Michael Dimosthenous, Alexis S. 
Antonopoulos, Dimitris Tousoulis, Nikolaos Sfyras, Christodoulos 
Stefanadis, Keith M. Channon, University of Oxford, Department 
of Cardiovascular Medicine, Oxford, United Kingdom, University of 
Athens, 1st Department of Cardiology, Athens, Greece
Learning Objective: Interpret the role of adiponectin in the 
regulation of vascular function
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1165-345 Plasma Osteopontin Levels Were More Elevated 
In Coronary Artery Than In Systemic Circulation In 
Patients With Acute Coronary Syndrome
Yoshinori Yasuoka, Motohiro Kosugi, Ryo Araki, Takahiro Imanaka, 
Ryo Matsutera, Susumu Hattori, Yoshiki Noda, Hidenori Adachi, 
Hiroaki Irino, Tatsuya Sasaki, Osaka Minami Medical Center, Osaka, 
Japan
Learning Objective: interpret OPN in coronary artery as direct 
inflammatory biomarker in ACS
1165-346 The Association of Cox-2 Inhibitors and Non-
selective Nonsteroidal Antiinflammatory 
Medications with D-dimer in the Multi-Ethnic Study 
of Atherosclerosis (MESA)
Stewart G. Allen, Mary Cushman, David Sane, Craig Johnson, David 
Herrington, Wake Forest University School of Medicine, Winston-
Salem, NC
Learning Objective: Describe the association between the use of 
COX-2 inhibitors and Non-selective Nonsteroidal Antiinlfammatory 
Medications and D-dimer levels.
1165-347 Effect Of Bariatric Surgery On Flow Mediated 
Dilation And Coronary Microvascular Function
Gaetano A. Lanza, Pierpaolo Tarzia, Roberto Nerla, Antonio Di 
Monaco, Daniele Matera, Francesco Greco, Roberto M. Tacchino, 
Alfonso Sestito, Filippo Crea, Università Cattolica del Sacro Cuore, 
Rome, Italy
Learning Objective: To evaluate the effect of bariatric surgery on 
peripheral and coronary endothelial function
1165-348 Plasma Heme oxygenase-1 Level Is Associated 
with the Presence of Coronary Artery Disease and 
Unstable Clinical Presentation
William Chan, Swati Mukherjee, Bronwyn A. Kingwell, Anthony J. 
White, James A. Shaw, Alaina Natoli, Beth Johnson, Anthony S. 
Walton, Anthony M. Dart, Stephen J. Duffy, The Alfred Hospital, 
Melbourne, Australia
Learning Objective: appreciate that plasma heme oxygenase-1 level 
is associated with the presence of coronary artery disease and 
unstable clinical presentation
1166 VASCULAR BIOLOGY/ATHEROSCLEROSIS/BASIC 
SCIENCE
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1166-350 Effect of Ramiprilat-Coated Stent in a Porcine 
Coronary Restenosis Model
Young Joon Hong, Myung Ho Jeong, Jung Ha Kim, Kyung Seob Lim, 
Jum Suk Ko, Min Goo Lee, Doo Sun Sim, Keun Ho Park, Nam Sik 
Yoon, Hyun Ju Youn, Kye Hun Kim, Hyung Wook Park, Ju Han Kim, 
Youngkeun Ahn, Jeong Gwan Cho, Jong Chun Park, Jung Chaee 
Kang, Heart Center of Chonnam National University Hospital, 
Gwangju, South Korea
Learning Objective: to examine the anti-proliferative and anti-
inflammatory effects and arterial healing of ramiprilat-coated stent 
in a porcine coronary overstretch restenosis model.
1166-351 Subendothelial Matrix Composition Influences IFN-
Gamma induced MHCII-Expression by Endothelial 
Cells
Heiko Methe, Jong-Oh Kim, Department of Cardiology, University 
Hospital Grosshadern, Munich, Germany
Learning Objective: appreciate that contact of endothelial cells with 
their underlying basement membrane influences endothelial cell 
behavior in health and disease.
1166-352 The Therapeutic Angiogenesis and Systemic 
Endothelial Tone
Gen Takagi, Masaaki Miyamoto, Ikuyo Takagi, Shuhei Tara, Yasuhiko 
Tabata, Kyoichi Mizuno, Nippon Medical School, Tokyo, Japan
Learning Objective: Identify the relation between endothelial 
function and therapeutic angiogenesis
1166-353 Torcetrapib Induces Endothelial Dysfunction in 
Spontaneously Hypertensive Rats
Branko Simic, Matthias Hermann, Sidney Shaw, Thomas F. Luescher, 
Frank Ruschitzka, Cardiovascular Research, Department for 
Physiology, University of Zurich-Irchel, Zurich, Switzerland, University 
Hospital Zurich, Division of Cardiology, Zurich, Switzerland
Learning Objective: understand potential mechanisms about 
cardiovascular risk observed for torceptrapib.
1166-354 mir-155 and mir-221/222 Attenuate Angiotension 
II Induced Endothelial Inflammation by Targeting 
ETS-1
Ni Zhu, Yongwen Qin, Department of Cardiology, Changhai Hospital, 
Second Military Medical University, Shanghai, People’s Republic of 
China
Learning Objective: demosnstrate endothelial highly expressed 
miRNA may regulate endothelial inflammatory response
1166-356 Simvastatin and Aspirin Decrease Angiogenesis by 
Enhancing VE-cadherin Expression
Magomed Khaidakov, Jacob Szwedo, Sona Mitra, Jawahar L. Mehta, 
UAMS, Little Rock, AR
Learning Objective: To identify mechanisms responsible for 
angiostatic effects of statins and aspirin
1166-357 Upregulation of Ca
V
1.2 Expression in Atherosclerosis
Wenze Wang, Sung W. Rhee, Chien Chen, Philip Palade, Jawahar L. 
Mehta, University of Arkansas for Medical Sciences, Little Rock, AR
Learning Objective: Evaluate involvement of CaV1.2 channels in 
atherosclerosis
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1167 VASCULAR PHYSIOLOGY-- PATHOPHYSIOLOGY—
CLINICAL
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1167-358 Heart Vessel Coupling in Subject with Risk Factors: 
A Longitudinal Left Ventricular Function and Arterial 
Stiffness Study
Concetta Zito, Maurizio Cusmà Piccione, Gianluca Di Bella, Raffaella 
Iudicello, Caterina Longordo, Carmelo Nipote, Maria Rosaria Giuffrè, 
Roberta Nava, Girolamo Gioffrè, Scipione Carerj, University of 
Messina, Department of Cardiology, Messina, Italy
Learning Objective: Evaluate the relationship between LV 
longitudinal systolic function and arterial stiffness parameters in 
subjects with traditional risk factors
1167-359 Association of N-Terminal-Pro-B-type Natriuretic 
Peptide and Acetylcholine-induced Coronary Artery 
Spasm and 12 Month Clinical Outcome
Ji Young Park, Seung Woon Rha, Kanhaiya L. Poddar, Sureshkumar 
Ramasamy, Lin Wang, Byoung Geol Choi, Ji Bak Kim, Seung Yong 
Shin, Un Jung Choi, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, 
Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh, Korea 
University Guro Hospital, Seoul, South Korea
Learning Objective: we evaluated the impact of NT-pro BNP on the 
acterylcholin induced coronary artery spasm and 12 month clinical 
outcome
1167-360 Psoriasis Early Impairs Coronary Flow Reserve: 
new Insights Into Inflammation and Coronary 
Microvascular Dysfunction
Elena Osto, Stefano Piaserico, Anna Maddalozzo, Giulia Forchetti, 
Roberta Montisci, Andrea Peserico, Sabino Iliceto, Francesco Tona, 
Cardiology,University of Padua, Padua, Italy
Learning Objective: consider new determinants of the 
pathophysiology of coronary microvascular dysfunction in the setting 
of psoriasis
1167-361 Brachial-Ankle Pulse Wave Velocity Correlated 
with an Endothelium-Independent Vasodilation in 
Conduit Coronary Artery
Takuro Kubozono, Masaaki Miyata, Sanemasa Ishida, Tetsuro 
Kataoka, Akiko Yoshikawa, Naoya Oketani, Hideki Okui, Takuro 
Shinsato, So Kuwahata, Hitoshi Ichiki, Shoji Fujita, Satoshi Yoshino, 
Daisuke Kanda, Osamu Fukumoto, Shuichi Hamasaki, Chuwa Tei, 
Department of Cardiovascular, Respiratory and Metabolic Medicine, 
Kagoshima University, Kagoshima, Japan
Learning Objective: We elucidated the association between baPWV 
and coronary artery function.
1167-362 Arterial Wall Remodeling in Association with 
Abdominal Obesity, Adipocytokines and Progression 
of Coronary Atherosclerosis: Insights from The 
STRADIVARIUS Study
Kiyoko Uno, Stephen J. Nicholls, Jean-Pierre Després, Mingyuan 
Shao, Tingfei Hu, Paul Schoenhagen, Ozgur Bayturan, Andrea J. 
Lavoie, Ajai Shreevatsa, Samir Kapadia, Venu Menon, Christophe 
Gaudin, Bernard Job, E. Murat Tuzcu, Steven E. Nissen, Laval Hospital 
Research Center, Sanoﬁ-Aventis, Cleveland Clinic, Cleveland, OH
Learning Objective: characterize arterial wall remodeling associated 
with weight loss and atherosclerosis
1168 ATHEROSCLEROTIC RISK FACTORS 2 -- 
PATHOPHYSIOLOGY—CLINICAL
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1168-364 Drivers of Progression of Coronary Atherosclerosis 
in Patients with Chronic Kidney Disease
Amar Krishnaswamy, Amy Hsu, Samir R. Kapadia, Paul 
Schoenhagen, E. Murat Tuzcu, Steven E. Nissen, Stephen J. 
Nicholls, Cleveland Clinic, Cleveland, OH
Learning Objective: evaluate the impact of traditional risk factors for 
CAD in patients with CKD
1168-365 Hypertension in Offspring of Pregnancies 
Complicated by Pre-eclampsia: Underlying Vascular 
Mechanisms?
MERZAKA LAZDAM, Alex Pitcher, Arancha de la Horra, Ilias 
Kylintireas, Zola Mannie, Jonathan Diesch, Corinne Trevitt, Atul 
Singhal, Alan Lucas, Stefan Neubauer, Nicholas Alp, Brenda Kelly, 
Paul Leeson, University of Oxford, Oxford, United Kingdom
Learning Objective: Demonstrate that the pathology underlying the 
development of hypertension differs between premature offspring 
born following preeclampsia or normotensive pregnancy
1168-366 Vascular Superoxide As A Signaling Molecule 
Triggering Adiponectin Biosynthesis In Perivascular 
Adipose Tissue, In Human Atherosclerosis
Constantinos Bakogiannis, Charalambos A. Antoniades, Alexis 
S. Antonopoulos, Dimitris Tousoulis, Antigoni Miliou, Costas 
Triantafyllou, Nikolaos Sfyras, Costas Psarros, Keith M. Channon, 
Christodoulos Stefanadis, 1st Cardiology Department Hippokration 
Hospital, Athens, Greece, University of Oxford, Oxford, Greece
Learning Objective: Identify the mechanisms regulating adiponectin 
synthesis in perivascular adipose tissue in human atherosclerosis
1168-367 Vitamin D Levels Do Not Predict Cardiovascular 
Events in Statin-Treated Patients with Stable 
Coronary Disease
Vera Bittner, Nanette K. Wenger, David D. Waters, David A. DeMicco, 
Michael Messig, John C. LaRosa, University of Alabama at 
Birmingham, Birmingham, AL, Emory University, Atlanta, GA
Learning Objective: Determine the effect of serum vitamin D levels 
on CV morbidity and death in a population of statin-treated patients 
with stable CHD
A168 ABSTRACTS: Vascular Disease JACC    March 9, 2010
Va
sc
ul
ar
 D
is
ea
se
1168-368 Young Patients Infected with Human 
Immunodeficiency Virus Have Elevated 
Concentrations of Asymmetric Dimethylarginine 
and Coronary Artery Calcification
James J. Jang, Ashok Krishnaswami, Sarah Berkheimer, Kaiser 
Permanente, San Jose Medical Center, San Jose, CA
Learning Objective: Identify that young HIV-infected patients have an 
increased risk for cardiovascular disease.
1169 VASCULAR THERAPY-- PATHOPHYSIOLOGY—
CLINICAL
Monday, March 15, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1169-370 Atorvastatin Worsens Glucose Metabolism and 
Insulin Sensitivity in Patients with Metabolic 
Syndrome/type 2 Diabetes
Kwang K. Koh, Michael Quon, Seung H. Han, Kyounghoon Lee, 
Gachon University, Incheon, South Korea, NIH, Bethesda, MD
1169-371 Use of Non-Steroidal Anti-Inflammatory Drugs and 
Type-Specific Risk of Acute Coronary Syndrome
Hector Bueno, Alfredo Bardají, Paola Patrignani, Elisa Martín-Merino, 
A. García-Rodríguez, on behalf of the Spanish Case-Control Study to 
assess NSAID-associated ACS risk, Hospital General Universitario 
Gregorio Maranon, Madrid, Spain, CEIFE, Madrid, Spain
Learning Objective: know what kind of coronary risk is associated 
with the use of NSAIDs
1169-372 Brief Low-workload Myocardial Ischemia Induces 
Protection Against Increased Exercise-related 
Platelet Reactivity In Patients With Coronary Artery 
Disease
Gaetano A. Lanza, Giancarla Scalone, Ilaria Coviello, Gaetano 
Pinnacchio, Lucy Barone, Chiara Pisanello, Roberto Mollo, Priscilla 
Lamendola, Fabio Infusino, Filippo Crea, Università Cattolica del 
Sacro Cuore, Rome, Italy
Learning Objective: To describe the effect of a preconditioning-like 
model of ischaemia on platelet function
1169-373 The Effects of Pioglitazone in Reducing 
Atherosclerosis Progression and Neointima in 
Dabetic Patients: Prospective Randomized Study 
with IVUS volumetry
Jae Hyoung Choi, Sung Hye You, Bum-Suk Kim, Soon Jun Hong, 
Chul-Min Ahn, Je Sang Kim, Jae Hyoung Park, Do-Sun Lim, Korea 
University Anam Hospital, Seoul, South Korea
Learning Objective: learn about PPAR agent on coronary 
atherosclerosis and neointimal hyperplasia
1169-374 Enhanced External Counterpulsation 
Reduces Vascular Inflammation Promoted by 
Hypercholesterolemia
William E. Lawson, Yan Zhang, Xiaohong He, Donghong Liu, Guifu 
Wu, Yan Zhang, Xiaolin Chen, Hong Ma, Zhimin Du, Yugang Dong, 
Yafei Jin, Wen He, Kuijian Wang, John CK Hui, Zhensheng Zheng, 
The Key Laboratory on Assisted Circulation, Guangzhou, People’s 
Republic of China, First Afﬁliated Hospital, Sun Yat-Sen University, 
Guangzhou, People’s Republic of China
Learning Objective: Evaluate potential role of increased shear 
stress in attenuating vascular inflammation and injury
1218 INFLAMMATION AND ENDOTHELIAL FUNCTION
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1218-324 Inflammation is Associated with Endothelial 
Dysfunction Among Individuals with Treated and 
Suppressed HIV Infection
Priscilla Y. Hsue, Peter W. Hunt, Amanda Schnell, Jennifer Ho, 
Yuaner Wu, Rebecca Hoh, Jeffrey N. Martin, Steven G. Deeks, Peter 
Ganz, University of California, San Francisco, San Francisco, CA
Learning Objective: understand the mechanism underlying 
accelerated atherosclerosis in HIV infected individuals
1218-325 CD28 null T Lymphocytes are expanded in Young 
Women with Polycystic Ovary Syndrome
Giampaolo Niccoli, Rosanna Apa, Giovanna Liuzzo, Cristina Spaziani, 
Francesca Sagnella, Andrea Silenzi, Rocco A. Montone, Giuseppe 
Ferrante, Antonio Lanzone, Filippo Crea, Institute of Cardiology, 
Catholic University of Sacred Heart, Rome, Italy
Learning Objective: demonstrates the presence of an abnormal 
expansion of CD4+CD28null T lymphocytes in young women with 
polycystic ovary syndrome, providing a potential mechanism of 
increased cardiovascular risk.
1218-327 First Demonstration by Immuno-Electron 
Microscopy that Both Hepatic and Intestinal 
Lipoproteins Contribute to Human Atherosclerosis
Jesus Gustavo Vazquez Figueroa, Sarah Rinehart, Laura Murrieta, 
Patrick Battey, Tamio Teramoto, Teruhiko Matsushima, Zhen Qian, 
Idean B Marvasty, Szilard Voros, Piedmont Heart Institute, Atlanta, GA
Learning Objective: Demonstrate by Immunohistochemistry 
and Immunofluorescence the presence of ApoB48 in human 
atherosclerotic plaques.
1218-328 Oxidative Stress In Response To High Glucose Levels 
In Endothelial Cells And In Endothelial Progenitor 
Cells. Evidence For Differential Responses
Alberto Balbarini, Francesca Felice, Maria Chiara Barsotti, Laura 
Pucci, Daniela Lucchesi, Giuseppe Penno, Stefano Del Prato, 
Rossella Di Stefano, Cardiac, Vascular and Thoracic Department 
, University of Pisa, Pisa, Italy, Department of Endocrinology 
and Metabolism, Section of Metabolic Diseases and Diabetes, 
University o, Pisa, Italy
Learning Objective: identify the differential responses of the 
endothelial progenitor cells to oxidative stress
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1218-329 Nebivolol Stimulates Endothelial Nitric Oxide 
Release in White and Black Americans Through 
an ATP Autocrine Pathway and Beta3-Receptor 
Activation
Richard Preston Mason, Ruslan Kubant, Adam M. Jacoby, Robert 
F. Jacob, Yoshiko Mizuno, Tadeusz Malinski, Brigham and Women’s 
Hospital, Harvard Medical School, Boston, MA
Learning Objective: understand the pharmacologic basis for 
endothelial-dependent nitric oxide release with nebivolol
1218-330 Establishing the Links Between the Soluble 
Receptor for Advanced Glycation End Products, 
Asymmetric Dimethylarginine and Low-Grade 
Inflammation in Essential Hypertension
Konstantinos P. Tsiouﬁs, Kyriakos Dimitriadis, Costas Thomopoulos, 
Dimitris Syrseloudis, Antigoni Miliou, Kostas Toutouzas, Elli 
Stefanadi, Dimitris Tousoulis, Christodoulos Stefanadis, First 
Cardiology Clinic, University of Athens, Hippokration Hospital, 
Athens, Greece
Learning Objective: describe the relationships of the soluble 
receptor for advanced glycation end products with C-reactive protein 
and asymmetric dimethylarginine in hypertension
1218-331 Genetic Polymorphism on Adiponectin Gene 
Regulates Arterial Superoxide Generation, by 
Affecting Adiponectin Biosynthesis in Adipose 
Tissue from Patients with Atherosclerosis
Alexis S. Antonopoulos, Charalambos Antoniades, Dimitris 
Tousoulis, Constantinos Bakogiannis, Antigoni Miliou, Nikolaos 
Sfyras, Michael Dimosthenous, Costas Psarros, Kyriakoula Marinou, 
George Ekonomopoulos, Christodoulos Stefanadis, Hippokration 
Hospital, Athens, Greece
Learning Objective: Evaluate the effects of adiponectin gene 
variability on adiponectin synthesis in human adipose tissue and 
vascular redox state
1219 VASCULAR FUNCTION AND 
PROATHEROSCLEROTIC FACTORS
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 
CME/CE Hours: 1
1219-333 Clustering of Metabolic Syndrome Components 
Attenuates Coronary Plaque Regression with 
Intensive Statin Therapy in Acute Coronary 
Syndrome: Serial Intravascular Ultrasound Analysis 
from the JAPAN-ACS Study
Hiroaki Takashima, Yukio Ozaki, Kenji Asai, Yoshinori Wakita, 
Yasuo Kuroda, Takashi Kousaka, Yasushi Kuhara, Tomofumi 
Mizuno, Akiyoshi Kurita, Kazuyuki Maeda, Yasushi Wakida, Takayuki 
Ito, Takeshi Kimura, Takeshi Morimoto, Takafumi Hiro, Katsumi 
Miyauchi, Yoshihisa Nakagawa, Masakazu Yamagishi, Kazuo 
Kimura, Satoshi Saito, Tetsu Yamaguchi, Hiroyuki Daida, Masunori 
Matsuzaki, Department of Cardiology, Aichi Medical University, 
Nagakute, Japan
1219-334 Arterial Stiffness is Associated With Left Ventricular 
Systolic and Diastolic Function in Never-treated 
Hypertensives
Dimitrios Terentes-Printzios, Charalambos Vlachopoulos, Athanasios 
Bratsas, Konstantinos Aznaouridis, Nikolaos Alexopoulos, Katerina 
Baou, Nikolaos Ioakeimidis, Aikaterini Siama, Panagiota Pietri, 
Christodoulos Stefanadis, 1st Cardiology Department, Athens 
Medical School, Hippokration Hospital, Athens, Greece
Learning Objective: Identify the connection between arterial 
stiffness and left ventricular function.
1219-335 Prenatal Stress Alters Atherosclerotic Lesion 
Vulnerability in Adult Offspring
Nima Aghili, Amir Najaﬁ, XinZhi Peng, Ken Abe, Zoﬁa Zukowska, 
Stephen E. Epstein, Mary Susan Burnett, Medstar Research 
Institute, Washington, DC, Georgetown University, Washington, DC
Learning Objective: To demonstrate the effect of prenatal stress on 
atherosclerotic lesion vulnerability
1219-336 Is there a gender disparity in risk Association of 
Inflammatory Biomarkers with New Onset Diabetes 
in Healthy Adult Population?
Sandip K. Zalawadiya, Ashutosh Niraj, Vikas Veerana, Jyotiranjan 
Pradahan, Sidakpal Panaich, Jacob Sony, Luis Afonso, Wayne State 
University/Detroit Medical Center, Detroit, MI
Learning Objective: hypothesize possible pathophysiological 
mechanisms behind gender differences in NOD risk prediction for 
these bimarkers and thereby, possibly insulin resistance and related 
cardiovascular outcomes.
1219-337 Preventive Effect Of Exenatide To Endothelial 
Dysfunction Induced By Ischemia-reperfusion Injury 
Via Adp K Channels
Sang Jin Ha, Weon Kim, Jong Shin Woo, Tae-kyung Yu, Soo Joong 
Kim, Woo-Shik Kim, Myeong Kon Kim, Kwon Sam Kim, Kyunghee 
University Medical Center, Seoul, South Korea
Learning Objective: demonstrate that subcutaneous exenatide 
induces potent protection against IR-induced endothelial 
dysfunction through of KATP channel.
1219-339 Association of Plasma Matrix Metalloproteinase-9 
Levels with Subclinical Atherosclerosis and Vascular 
Stiffness in Healthy Subjects
Jonathan R. Murrow, Ibhar Al Mheid, Nino Kavtaradze, Sarfraz 
Ali, Konstantinos Aznaouridis, Muhiddin Ozkor, Jesse Jorgensen, 
Saurabh Dhawan, Hamid Syed, Riyaz Patel, W. Craig Hooper, 
Christine DeStareck, R. Wayne Alexander, Arshed Quyyumi, Emory 
University, Atlanta, GA, Centers for Disease Control, Atlanta, GA
Learning Objective: To describe the relationship between MMP-9 
and vascular health.
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1219-340 Effects of an Intensive Glycemic Control with Insulin 
on Platelet Aggregation Profile in Patients with 
Acute Coronary Syndrome: the CHIPS (Control de 
la Hiperglucemia y Función Plaquetaria en los 
Síndromes Coronarios Agudos) Study
David Vivas, Esther Bernardo, Juan Carlos Garcia-Rubira, Dominick 
J. Angiolillo, Patricia Martin Rojas-Marco, Alfonso Calle, Carlos 
Macaya, Antonio Fernandez-Ortiz, Cardiovascular Institute, San 
Carlos University Hospital, Madrid, Spain, University of Florida 
College of Medicine-Jacksonville, Jacksonville, FL
Learning Objective: Evaluate how an intensive glycemic control 
results in a reduction of platelet aggregation profile
1220 VASCULAR BIOLOGY/ATHEROSCLEROSIS/
THROMBOSIS/ENDOTHELIUM
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1220-341 Usefulness of an Abnormal Aortic/penile Index to 
Predict the Presence of Coronary Artery Disease in 
Erectile Dysfunction Patients
Nikolaos Ioakeimidis, Charalambos Vlachopoulos, Athanasios 
Aggelis, Nikolaos Alexopoulos, Dimitrios Terentes-Printzios, 
Athanasios Bratsas, Panagiotis Xaplanteris, Katerina Baou, 
Konstantinos Rokkas, Christodoulos Stefanadis, Cardiovascular 
Diseases and Sexual Health Unit, 1st Department of Cardiology, 
Athens Medical School, Athens, Greece
1220-342 Gap Junction Modulation Prevents Endothelial 
Dysfunction Induced by Ischemia-Reperfusion Injury 
in Man
Christian M. Pedersen, Ninian Lang, Gareth D. Barnes, Michael R. 
Schmidt, Hans Erik Botker, Rajesh K. Kharbanda, Nick L. Cruden, 
David E. Newby, University of Edinburgh, Centre for Cardiovascular 
Science, Edinburgh, United Kingdom, Aarhus University Hospital 
Skejby, Aarhus, Denmark
Learning Objective: demonstrate that enhanced gap junction 
communication afford protection against ischemia- reperfusion 
injury induced endothelial dysfunction.
1220-344 Progression Of Atherosclerosis In An Asymptomatic 
Population - Effect Of Lipid Subclass
Ankit D. Rathod, Apurva Badheka, Palaniappan Manickam, Vikas 
Veeranna, Rajeev Sudhakar, Tamam Mohamad, Sony Jacob, Luis 
Afonso, Wayne State Univeristy, Detroit, MI
Learning Objective: Identify Lipid subclasses associated with 
progression of atherosclerosis in asymptomatic patients.
1220-345 Glitazones and the Endothelium (GATE) Study: 
Effect of Rosiglitazone on Endothelial Function in 
Type 2 Diabetes Mellitus
Jaroslav Hubacek, Subodh Verma, S. J. Ross, A. Edwards, Lana 
Shewchuk, Todd J. Anderson, University of Calgary, Calgary, AB, Canada
Learning Objective: describe the effect of rosiglitazone on endothelial 
function in DM2 patients with sub-optimal glycemic control
1220-346 Flow Mediated Dilation Causes A Transient 
Impairment Of Endothelial Function Which Is 
Abolished By L-arginine
Gaetano A. Lanza, Roberto Nerla, Antonio Di Monaco, Pierpaolo 
Tarzia, Giulia Careri, Alfonso Sestito, Filippo Crea, Università 
Cattolica del Sacro Cuore, Rome, Italy
Learning Objective: To describe the reduction of NO bioavailability 
observed early after FMD assessment
1220-347 The Contribution of Nitric Oxide and Endothelium-
Derived Hyperpolarizing Factor to Resting and 
Stimulated Vasodilator Tone in African American 
and Whites
Muhiddin A. Ozkor, Jonathan R. Murrow, Ayaz Rahman, Nino 
Kavtaradze, Shawn Arshad, Hamid Syed, Ji Lin, Amita Manatunga, 
Arshed A. Quyyumi, Emory University, Atlanta, GA
Learning Objective: Demonstrate the differential contribution of 
endothelial-derived vasodilators in the healthy vasculature of 
different races.
1220-348 Association between Advanced Endothelial 
Dysfunction and Vulnerable Coronary Plaques in 
High Risk Patients with Suspected Coronary Artery 
Disease
Yasushi Matsuzawa, Seigo Sugiyama, Kazuo Kimura, Hisao Ogawa, 
Department of Cardiovascular Medicine, Graduate School of 
Medical Sciences, Kumamoto University, Kumamoto, Japan, Division 
of Cardiology, Yokohama City University Medical Center, Yokohama, 
Japan
Learning Objective: This study demonstrates the utility of 
endothelial dysfunction assessed by RH-PAT to identify vulnerable 
patients with vulnerable plaques requiring aggressive and intensive 
treatment.
1221 VASCULAR BIOLOGY/ATHEROSCLEROSIS/
THROMBOSIS/ENDOTHELIUM
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1221-350 Local Intracoronary Rosiglitazone Treatment 
Induces a Vasoprotective Gene Expression Profile 
and Complete Reendothelialization in A Porcine In 
Stent-restenosis Model
Stefanie I. Utchil, Chantip Dang-Heine, Jens Klinowski, Diana Bösel, 
Carolin Deiner, Heinz-Peter Schultheiss, Klaus Pels, Department of 
Cardiology and Pneumology, Charité – Campus Benjamin Franklin, 
Berlin, Germany
Learning Objective: evaluate the effects of local rosiglitazone 
treatment on different gene expression
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1221-351 Platelet Reactivity after Thienopyridine Treatment: 
Assessment with Screen Filtration Pressure Method 
and Drug-Eluting Stent Thrombosis
Shuichi Oshima, Katuso Noda, Hironobu Fukushima, Shinichi 
Nakamura, Izumi Taniguchi, Fumihito Kugimiya, Kenichiro Higa, 
Tsunenori Nishijima, Shinsuke Hanatani, Division of Cardiorogy, 
Kumamoto Central Hospital, Kumamoto City, Japan
Learning Objective: evaluate whether thienopyridine low 
responsiveness can predict adverse clinical events after drug-
eluting stent implantation.
1221-352 The Effect of St. John’s Wort on the 
Pharmacodynamic Efficacy of Clopidogrel in 
Hyporesponsive Volunteers and Patients
Wei C. Lau, Terrence D. Welch, Theresa A. Shields, Melvyn 
Rubenﬁre, Paul A. Gurbel, University of Michigan, Ann Arbor, MI
Learning Objective: understand the pharmacodynamic mechanism 
of how St. John’s wort enhances clopidogrel in clopidogrel 
hyporesponsive volunteers and patients.
1221-353 Assessment of Dual Antiplatelet Responsiveness 
with the Point-Of-Care Device VerifyNow after 
Percutaneous Coronary Intervention in Elderly 
Patients (≥75 years)
A M Tidjane, R. Ghenim, V. Bongard, N. Boudou, N. Dumonteil, N. 
Hammami, A. Ziani, J. Roncalli, Th Lhermusier, P. Sié, D. Carrié, 
Cardiovascular and Metabolic Pole, Toulouse, France, Hematology 
Laboratory, Toulouse, France
1221-354 In-stent Restenosis is Associated With Neointimal 
Angiogenesis and Macrophage Infiltrates
Nathaniel B. Cresswell, Wei-Sing Chu, Erik Mont, Allen Burke, Armed 
Forces Institute of Pathology, Washington, DC, Nova Scotia Medical 
Examiners Ofﬁce, Halifax, NS, Canada
Learning Objective: To identify the role of angiogenesis in in-stent 
restenosis
1221-356 Clinical and Genetic Determinants of Clopidogrel 
Non-responsiveness in Koreans
Jin Joo Park, Kyung-Woo Park, Ki-Hyun Joen, Si-Hyuck Kang, Hae-
Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Byung-Hee Oh, Young-
Bae Park, Hyo-Soo Kim, Department of Internal Medicine and 
Cardiovascular Center, Seoul National University Hospital, Seoul, 
South Korea
Learning Objective: The participants wll learn that clopidogrel non-
responsiveness is a multifactorial phenomenon contributed by 
genetic and and clinical factors.
1221-357 Downstream Coronary Effects of Drug Eluting 
Stents: Unintended Therapeutic Target?
George Cater, Ganesh P. Devendra, Mehdi Shishehbor, Steven E. 
Nissen, Stephen G. Ellis, Richard A. Krasuski, The Cleveland Clinic, 
Cleveland, OH
Learning Objective: Interpret the downstream effects of drug-eluting 
stents on de-novo atheroma development.
1222 ACUTE AND CHRONIC PULMONARY EMBOLISM
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1222-358 Heightened Platelet Reactivity defines Chronic 
Thromboembolic Pulmonary Hypertension from 
other Subtypes of Pulmonary Hypertension
Ronan J. Margey, Sean Gaine, Aaron Peace, Tony Tedesco, Dermot 
Kenny, Mater Misericordiae University Hospital, Dublin, Ireland, 
University College Dublin, Dublin, Ireland
Learning Objective: Identify a new potential explanation for disease 
progression in patients with thromboembolic related pulmonary 
hypertension
1222-359 Association of Alleles From Inflammatory, Vaso-
architecture, and Coagulation Pathways With 
Clinical Characteristics of a Deep Vein Thrombosis
Deanna S. Cross, Mark Craven, Steven Yale, Marshﬁeld Clinic 
Research Foundation, Marshﬁeld, WI, University of Wisconsin-
Madison School of Medicine and Public Health, Madison, WI
Learning Objective: Evaluate the utility of utilizing multiple 
alleles from a number of pathways for determining the clinical 
characteristics of DVT.
1222-360 Regional Right Ventricular Strain Pattern in Patients 
with Pulmonary Embolism
Elke Platz, Amira Hassanein, Samuel Z. Goldhaber, Frank Rybicki, 
Scott D. Solomon, Brigham and Women’s Hospital, Boston, MA
Learning Objective: Understand the role of strain imaging in 
pulmonary embolism
1222-361 Preoperative Partitioning Of Pulmonary Vascular 
Impedance: A Novel Hemodynamic Index For 
Operable And Inoperable Chronic Thromboembolic 
Pulmonary Hypertension
Maria J. Ruiz-Cano, Juan C. Grignola, Pilar Escribano, José Cortina, 
Teresa Velázquez, Miguel A. Gómez Sánchez, Juan F. Delgado, 
Carlos Sáenz de la Calzada, Unidad de HTPulmonar y Tx Cardíaco, 
Servicio de Cardiología, Hospital Universitario “12 de Octubre”, 
Madrid, Spain, Depto Fisiopatología, Hospital de Clínicas, Facultad 
de Medicina, Universidad de la República, Montevideo, Uruguay
Learning Objective: consider a novel hemodynamic index to evaluate 
proximal vs distal disease in chronic thromboembolic pulmonary 
hypertension.
1222-362 The Efficacy and Therapeutic Role of Balloon 
Pulmonary Angioplasty in Patients with Chronic 
Thromboembolic Pulmonary Hypertension
Hiroki Mizoguchi, Hiromi Matsubara, Mitsuru Munemasa, National 
Hospital Organization, Okayama Medical center, Okayama, Japan
A172 ABSTRACTS: Vascular Disease JACC    March 9, 2010
Va
sc
ul
ar
 D
is
ea
se
1223 VENOUS THROMBOSIS/PULMONARY 
EMBOLISM/PULMONARY HYPERTENSION
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1223-364 Long Term Effect Of Bosentan Therapy On Cardiac 
Function And Symptomatic Benefits In Patients 
With Eisenmenger Syndrome
Mehmet Kaya, Yat Yin Lam, Betul Erer, Selim Ayhan, Mehmet A. 
Vatankulu, Zekeriya Nurkalem, Mehmet Eren, Namik K. Eryol, 
ERCIYES UNIVERSITY, KAYSERI, Turkey
Learning Objective: Bosentan therapy results in long term 
improvement of pulmonary hypertension and RV function in ES 
patients. These hemodynamic improvements should provide 
insights on the symptomatic benefits gained in
1223-365 Oxidative Stress And Its Relation With Peripheral 
Endothelial Function And Pulmonary Vascular 
Response To Vasodilators In Pulmonary Artery 
Hypertension
Luigi Gabrielli, Pablo F. Castro, Douglas Greig, Ivan Godoy, Hugo 
Verdejo, Mario Chiong, Pablo Sepulveda, Lorena Garcia, Sergio 
Lavandero, Robert C. Bourge, Pontiﬁcia Universidad Catolica, 
Santiago, Chile, Universidad de Chile, Chile
Learning Objective: To evaluate the role of oxidative stress and its 
relation with peripheral endothelial function and pulmonary vascular 
response to vasodilators.
1223-366 Echocardiographic Predictors of Declining Exercise 
Performance in Children with Sickle Cell Disease
Niti Dham, Gregory Ensing, Mehdi Nouraie, Lori Luchtman-Jones, 
Andrew D. Campbell, Manuel Arteta, Sohail R. Rana, Caterina 
Minniti, Gregory J. Kato, Mark Gladwin, Oswaldo L. Castro, Victor 
R. Gordeuk, Craig A. Sable, Children’s National Medical Center, 
Washington, DC, Howard University, Washington, DC
Learning Objective: Identify the association of tricuspid regurgitation 
and left ventricular size with a 6-minute walk test in children with 
sickle cell disease
1223-367 Local Pulmonary Artery Stiffness Indexes Are 
Correlated With Steady And Pulsatile Components 
Of Right Ventricular Afterload In Pulmonary Arterial 
Hypertension
Juan C. Grignola, Enric Domingo, Carlos Bravo, Rio Aguilar, Manuel 
Lopez-Messeguer, Manuel Vazquez, Antonio Roman, Area del Cor 
and Servei de Pneumologia i CIBERES, Hospital Universitari Vall 
Hebron, Barcelona, Spain, Dept Physiology, Universitat Autonoma 
Barcelona, Barcelona, Spain
Learning Objective: understand the importance of local pulmonary 
artery stiffness indexes in pulmonary arterial hypertension and its 
relationship with steady and pulsatile afterload
1223-368 How Treatment Changes Sleep Apnea Syndrome In 
Patients With Pulmonary Arterial Hypertension
Seiichi Taniai, Toru Satoh, Masaharu Kataoka, Takashi Kawakami, 
Yuichi Tamura, Takanori Ikeda, Konomi Sakata, Hideaki Yoshino, 
Kyorin University School of Medicine, Mitaka, Japan, Keio University 
School of Medicine, Tokyo, Japan
Learning Objective: identify a change of sleep apnea after drug 
treatment of pulmonary arterial hypertensionof
1224 VENOUS THROMBOSIS-PROPHYLAXIS
Monday, March 15, 2010, 1:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
1224-370 Three-Month Cumulative Incidence of 
Thromboembolism and Bleeding After 
Periprocedural Anticoagulation Management of 
Patients with Venous Thromboembolism
Robert D. McBane, II, Waldemar E. Wysokinski, Paul R. Daniels, 
Scott Litin, Joshua Slusser, David Hodge, John A. Heit, Mayo Clinic, 
Rochester, MN
Learning Objective: Define the incidence of thromboembolism (TE) 
and bleeding related to peri-procedural anticoagulation management 
in patients with venous thromboembolism.
1224-371 Does Rivaroxaban Provide a Clinically Relevant 
Favorable Benefit-Risk Profile Compared with 
Enoxaparin After Hip or Knee Arthroplasty?
Sanjay Kaul, George A. Diamond, Cedars-Sinai Medical Center, Los 
Angeles, CA
Learning Objective: Critically evaluate the benefit-risk assessment 
of Rivaroxaban compared to enoxaparin in preventing venous 
thromboembolism after hip or knee arthroplasty
1224-372 Pharmacologic Prophylaxis for Venous 
Thromboembolism: The Most Frequent Reason for 
Omitting Ordered Doses Is Patient Refusal
John Fanikos, Leslie-Ann Stevens, Gregory Piazza, Mathew Labreche, 
Elaine Catapane, Lena Novack, Samuel Z. Goldhaber, Brigham and 
Women’s Hospital, Boston, MA
Learning Objective: Identify barriers to VTE prophylaxis.
1224-373 Subcutaneous FIXa Inhibitor Provides Prolonged 
Anticoagulation: The First Successful Subcutaneous 
Application of an Aptamer
Christopher P. Rusconi, Doug Kornbrust, Steven L. Zelenkofske, 
Regado Biosciences, Inc, Durham, NC
Learning Objective: Describe the PK/PD properties of anticoagulant 
aptamers following subcutaneous administration and the ability 
to control their anticoagulant effects using IV administered active 
control agents.
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1224-374 A Novel Three-Screen Computer Alert to Increase 
the Rate of Venous Thromboembolism Prophylaxis
Karen Fiumara, Chiara Piovella, Shelley Hurwitz, Gregory Piazza, 
Clyde Niles, John Fanikos, Marilyn Paterno, Matthew Labreche, 
Leslie-Ann Stevens, Steven Baroletti, Samuel Z. Goldhaber, Brigham 
and Women’s Hospital, Boston, MA, Boston, MA
Learning Objective: Identify barriers to VTE prophylaxis
1271 EXERCISE AND VASCULAR MODULATION
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1271-324 Atrial Fibrillation Is Not Associated With Increased 
Progression of Coronary Atherosclerosis: Insights 
From Intravascular Ultrasound Atherosclerosis Trials
Ozgur Bayturan, E Murat Tuzcu, Mingyuan Shao, Andrea J. Lavoei, 
Kiyoko Uno, Kathy Wolski, Paul Schoenhagen, Samir R. Kapadia, 
Steven E. Nissen, Stephen J. Nicholls, Cleveland Clinic, Cleveland, 
OH
Learning Objective: To describe the relationship of atrial fibrillation 
and atheroma burden in coronary artery patients
1271-325 Aerobic Fitness Strongly Associated With 
Thrombotic Risk Markers Than Fatness In 
Firefighters
RADHIKA R. GADESAM, Catherine Skrifvars, Brenda Garrett, 
Lakshmana Pendyala, Andrew Huang, Kathryn Momary, Stephen 
C. Frohwein, Melissa Clay, David Dusik, Bill Myers, Steve Rolader, 
Robert H. Superko, Saint Joseph Hospital, Atlanta, GA, Gwinnett 
County Fire and Emergency Services, Lawrenceville, GA
Learning Objective: Improving aerobic fitness in firefighters may be 
more effective in decreasing thrombotic risk than weight loss
1271-328 The Impact of Early Compared to Late Morning 
Hours on Brachial Endothelial Function and Long-
Term Cardiovascular Events in Healthy Subjects 
With no Apparent Coronary Heart Disease
Michael Shechter, Liran Hirsh, Nira Koren-Morag, Micha S. Feinberg, 
Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel, 
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Learning Objective: To find out the impact of early morning hours 
on brachial flow-mediated dilation and long-term cardiovascular 
outcome.
1271-329 Effect of Candesartan with Pioglitazone on Coronary 
Endothelial Function and Vascular Inflammation in 
Porcine Coronary Arteries Implanted with Sirolimus-
eluting Stents
Tomotaka Dohi, Katsumi Miyauchi, Ryo Tsuruta, Naozumi Kubota, 
Takatoshi Kasai, Takhumi Iesaki, Hiroyuki Daida, Juntendo 
University, Department of Cardiology, Tokyo, Japan
Learning Objective: demonstrate that candesartan and pioglitazone 
protected against endothelial dysfunction and vascular inflammation 
following sirolimus-eluting stent implantation.
1271-330 Does Longterm Endurance Running Enhance 
or Inhibit Coronary Artery Plaque Formation? 
A Prospective Multidetector CTA Study of Men 
Completing Marathons for least 25 Consecutive 
Years
Jonathan G. Schwartz, Stacia Merkel-Kraus, Sue Duval, Kevin 
Harris, Gretchen Peichel, John R. Lesser, Thomas Knickelbine, Bjorn 
Flygenring, Terry R. Longe, Catherine Pastorius, William R. Roberts, 
Stephen C. Oesterle, Robert S. Schwartz, University of Colorado, 
Denver, CO, Minneapolis Heart Institute Foundation, Minneapolis, MN
Learning Objective: Understand the role of chronic exercise on 
coronary artery plaque formation
1271-331 Galectin-2 Expression Is Dependent on the 
3279C>T Polymorphism and Is Associated with 
Arteriogenesis in Patients with Coronary Artery 
Disease
Anja M. Van Der Laan, Stephan Schirmer, Oscar Volger, Margreet de 
Vries, Jasper de Koning, Joost Fledderus, Joseﬁen Baggen, Reina 
Mebius, Tineke van der Pouw-Kraan, Paul Quax, Jan Piek, Anton 
Horrevoets, Niels van Royen, Academic Medical Center, University 
of Amsterdam, Amsterdam, The Netherlands, VU University Medical 
Center, Amsterdam, The Netherlands
Learning Objective: identify the relation between Galectin-2 
expression in monocytes and the arteriogenic response in patients 
with coronary artery disease.
1272 BIOMARKERS AND VASCULAR DISEASE 3
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1272-333 Microparticles Shedding after Percutaneous 
Coronary Intervention in Unstable Angina Is 
modulated by Myocardial Necrosis and Systemic 
Inflammation
Luigi M. Biasucci, Luca Di Vito, Italo Porto, Giovanni L. De Maria, 
Giuliana Di Rocco, Alessandra Tritarelli, Alessandra Paglia, 
Margherita Marcantoni, Maurizio C. Capogrossi, Filippo Crea, 
Catholic University, rome, Italy, IDI, Rome
Learning Objective: descibe mechnism of endothelial damage
1272-334 Relationship Between Coronary Artery Plaque 
Composition And Brachial-ankle Pulse Wave 
Velocity In Patients With Coronary Artery Disease: A 
Virtual Histology Intravascular Ultrasound Analysis
Sang-Wook Kim, Jee-Eun Kwon, Gary S. Mintz, Min-Suk Oh, Wang-
Soo Lee, Kwang-Je Lee, Tae-Ho Kim, Chee-Jeong Kim, Neil J. 
Weissman, Wang-Seong Ryu, Chung-Ang University Hospital, Seoul, 
South Korea, Cardiovascular Research Foundation, New York, NY
Learning Objective: interpretate that high baPWV indicates more 
severe CAD (smaller MLA) and greater atherosclerosis disease 
complexity (more calcified coronary plaque).
A174 ABSTRACTS: Vascular Disease JACC    March 9, 2010
Va
sc
ul
ar
 D
is
ea
se
1272-335 Prediction of Cardiovascular Events in Statin-
Treated Stable Coronary Patients by C-Reactive 
Protein
John Kastelein, on behalf of the TNT Steering Committee, Academic 
Medical Center, Amsterdam, The Netherlands
Learning Objective: Evaluate the ability of CRP to predict major 
CV events in statin-treated coronary patients, and the effect of 
intensive lipid lowering therapy on this relationship
1272-336 Angiotensinogen M235T Gene Variants Affect 
Endothelial Function And Arterial Stiffness In 
Patients With Essential Hypertension
Emmanouil Androulakis, Dimitris Tousoulis, Evaggelos 
Chatzistamatiou, Nikolaos Papageorgiou, George Moustakas, 
Antigoni Miliou, Evaggelos Oikonomou, Gerasimos Siasos, 
Anastasios Giolis, Ioannis Kallikazaros, Christodoulos Stefanadis, 
1st Cardiology Unit, Hippokration Hospital, Athens, Greece
Learning Objective: Investigate the impact of this polymorphism 
on the prevalence of essential hypertension (EH) and on vascular 
properties, such as arterial stiffness and endothelial function.
1272-337 Effect of Phosphodiesterase Type 5 (PDE-5) 
Inhibition on Coronary Microvascular Dysfunction 
in Women: An Ancillary Study From the NHLBI-
Sponsored Women’s Ischemia Syndrome Evaluation 
(WISE)
Scott J. Denardo, Sheron Wen, Eileen M. Handberg, Anthony A. 
Bavry, R. David Anderson, Karen M. Smith, C. Noel Bairey-Merz, 
George Sopko, Rhonda M. Cooper-DeHoff, Carl J. Pepine, University 
of Florida, Gainesville, FL
Learning Objective: have an understanding of the potential effect of 
Sildenafil on microvascular dysfunction in women.
1272-339 Prediction of Cardiovascular Events in Statin-treated 
Stable Coronary Patients with Metabolic Syndrome 
by 18 Novel Biomarkers: The Treating to New 
Targets (TNT) Trial
Prakash C. Deedwania, on behalf of the TNT Investigators, 
VACCHCS/UCSF School of Medicine, Fresno, CA
Learning Objective: Evaluate the ability of 18 novel biomarkers to 
predict the risk of major cardiovascular events among stable CHD 
patients with metabolic syndrome
1272-340 Genome-wide association of Coronary Artery 
Disease
David Seo, Pascal J. Goldschmidt-Clermont, Kara Hamilton, 
Margaret Pericak-Vance, Gary Beecham, University of Miami School 
of Medicine, Miami, FL
Learning Objective: identify gene variants associated with coronary 
artery disease
1273 BIOMARKERS AND VASCULAR DISEASE
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1273-341 Protective Effect of Ischemic Preconditioning on 
Ischemia/Reperfusion Induced Microvascular 
Obstruction Determined by On-line Measurements 
of Coronary Pressure and Blood Flow in Pigs
Mariann Gyongyosi, Aniko Posa, Rayyan Hemetsberger, Zsolt Petrasi, 
Ors Petnehazy, Kurt Huber, Dietmar Glogar, Medical University of 
Vienna, Vienna, Austria, University of Kaposvar, Kaposvar, Hungary
Learning Objective: identify microvascular obstruction after 
reopening of the infarct-related artery
1273-342 Carriers of LCAT Gene Mutations Exhibit Increased 
Atherosclerosis: A 3.0 Tesla MRI Study
Raphael Duivenvoorden, Adriaan G. Holleboom, Bas van den 
Bogaard, Eric de Groot, Aart J. Nederveen, Johan S. Lameris, John 
JP Kastelein, Jan A. Kuivenhoven, Erik SG Stroes, Academic Medical 
Center, Amsterdam, The Netherlands
Learning Objective: recognize that LCAT is a key regulator of HDL 
metabolism and this enzyme plays a crucial role in protecting the 
human vasculature from atherogenesis.
1273-344 WITHDRAWN
1273-345 Viral Anti-inflammatory Proteins Reduce 
Accelerated Atherosclerosis in ApoEnull mice with 
Periodontal Bacterial Infection and Angioplasty 
Injury
Alexandra R. Lucas, Raj K. Verma, Liying Liu, Erbin Dai, Ganesh 
Munuswamy-Ramanujam, Jennifer Kim, Sheela Pola, Sheela Pola, 
Lakshmyya Kesavalu, University of Florida, Gainesville, FL
Learning Objective: evaluate a potential role for periodonatl 
infection in atherosclerotic plaque growth
1273-346 Effects of Telmisartan and Resveratrol on Monocyte 
Adhesion to the Endothelium Exposed to Disturbed 
Flow and Inflammation
Christoph D. Garlichs, Katharina Urschel, Werner Daniel, Iwona 
Cicha, University Hospital Erlangen, Department of Cardiology and 
Angiology, Erlangen, Germany
Learning Objective: Describe that telmisartan and resveratrol 
decrease the inflammation-induced recruitment of monocytic cells 
and the endothelial expression of adhesion molecules in regions of 
non-uniform shear stress
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1273-347 Immune-modulation by Polyclonal IgM Treatment 
Reduced Atherosclerosis in Hypercholesterolemic 
Apolipoprotein E-/- Mice
Paul C. Dimayuga, Fernando HY Cesena, Juliana Yano, Jonathan 
Kirzner, Xiaoning Zhao, Xiaojun Li, Portia Trinidad, Bojan Cercek, 
Prediman K. Shah, Kuang-Yuh Chyu, Cedars-Sinai Heart Institute, 
Los Angeles, CA
Learning Objective: identify immune parameters in atherosclerotic 
disease that are modulated by polyclonal IgM treatment
1273-348 Dipeptidyl Peptidase-4 Inhibitor, Saxagliptin, Enhances 
Nitric Oxide Bioavailability in Aortic and Renal 
Endothelium From Obese, Insulin-Resistant Rats
Richard Preston Mason, Ruslan Kubant, Adam M. Jacoby, Robert F. 
Jacob, Aouatef Bellamine, Yoshiko Mizuno, Tadeusz Malinski, Brigham 
and Women’s Hospital, Harvard Medical School, Boston, MA
Learning Objective: understand the effect of DPP4 inhibition with 
saxagliptin on reversing endothelial dysfunction in animals with 
diabetes
1274 BIOMAKERS AND VASCULAR DISEASE 2
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1274-350 Decreased Plasma Adiponectine Levels in 
Asymptomatic Diabetic Patients with Obstructive 
Coronary Disease
Roxana Djaberi, Joanne D. Schuijf, Cornelis J. Roos, Alberto M. 
Pereira, Jan W. Smit, Arthur J. Scholte, Johannes A. Romijn, Ernst 
E. van der Wall, Jeroen J. Bax, J. Wouter Jukema, Leiden University 
Medical Center, Leiden, The Netherlands
Learning Objective: Interpret the the Value of Plasma Adiponectine 
in Predisposing Coronary Artery Disease in Asymptomatic Patients 
with Type 2 Diabetes
1274-351 Nitric Oxide Donation From The Cinod Naproxcinod 
Counteracts Cyclooxygenase Inhibition-dependent 
Contraction In Human Mammary Arteries
Manlio Bolla, Alessandra Poggi, Barbara Vergani, Guido Gelpi, Julio 
Padron, Daniela Miglietta, NicOx Research, Milan, Italy, NicOx SA, 
Sophia Antipolis, France
Learning Objective: Understand the role of NO donation from 
naproxcinod in the control of vascular tone in arteries with 
endothelial dysfunction
1274-352 Association of Serum Concentration of Bilirubin 
with Coronary Endothelial Function; the 
Relationship between Bilirubin and Oxidative 
Stress, Inflammatory Mediator and Lipid/Glucose 
Metabolism
Satoshi Yoshino, Shuichi Hamasaki, Sanemasa Ishida, Tetsuro 
Kataoka, Akiko Yoshikawa, Naoya Oketani, Keishi Saihara, Takuro 
Takumi, Chuwa Tei, Department of Cardiovascular, Respiratory and 
Metabolic Medicine, Kagoshima University, Kagoshima, Japan
Learning Objective: describe the association of serum concentration 
of bilirubin with coronary endothelial function
1274-353 The Levels and Cellular Origins of Procoagulant 
Microparticles within the Culprit Coronary Artery of 
Patients with Acute Myocardial Infarction
Pil-Ki Min, Sung-Yu Hong, Hee-Sun Mun, Sung-Joo Lee, Jong Kwan 
Park, Jong-Youn Kim, Byoung Kwon Lee, Bum-Kee Hong, Se-
Joong Rim, Kwang-Hoe Chung, Hyuck Moon Kwon, Hyun Seung 
Kim, Gangnam Severance Hospital, Yonsei University College of 
Medicine, Seoul, South Korea
Learning Objective: evaluate the levels and cellular origins of 
microparticles within the culprit coronary artery of patients with 
acute myocardial infarction
1274-354 Increased Cysteine level is associated with 
Recurrent Atherothrombotic Events after Acute 
Coronary Syndromes
Jeroen Jaspers Focks, Nick Clappers, Marc A. Brouwer, Etiënne G. 
Cramer, Eveline G. van Dijk, Martijn G. van Oijen, Jan B. Jansen, 
Wilbert HM Peters, Freek W. Verheugt, Radboud University Nijmegen 
Medical Centre, Nijmegen, The Netherlands
Learning Objective: Describe the predictive effect of cysteine on 
recurrent atherothrombotic events.
1274-356 Behavior of Biomarkers Linking Inflammation 
and Thrombosis in the Infarct-related Coronary 
Artery and Systemic Circulation after Primary 
Percutaneous Coronary Intervention for the 
Treatment of ST-segment Elevation Myocardial 
Infarction
Tomomi Koizumi, Tetsuo Yamasaki, Shinichiro Iida, Toshihiko 
Kikutani, Shigeyuki Nishimura, Nobuyuki Komiyama, Saitama 
International Medical Center, Saitama, Japan
Learning Objective: identify time course of biomarkers of thrombus 
and inflammation after acute myocardial infarction
1274-357 The LDL To HDL Cholesterol Ratio As A Valuable 
Parameter To Evaluate The Development Of CKD
Takaaki Sakai, Keijiro Saku, Koichi Ide, College of Healthcare 
Management, Miyama, Japan, St.Mary’s Hospital, Kurume, Japan
1275 ANGIOGENEIS
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1275-358 Intravenous Endothelial-like Cells Differentiated 
From Mesenchymal Stem Cells Accelerate Re-
endothelization In Balloon-injured Rat
Ki-Chul Hwang, Min-Ji Cha, Heesang Song, Byeong-Wook Song, 
Eunju Choi, Onji Ham, Namsik Chung, Yangsoo Jang, Ki-Chul Hwang, 
Cardiovascular Research Institute, Division of Cardiology, Yonsei 
University College of Medicine, Seoul, South Korea
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1276-365 Self Assembling Peptide Amphiphile Nanofibers As 
A Scaffold For Endothelial Progenitor Cells
Alberto Balbarini, Angela Magera, Maria Chiara Barsotti, Hossein 
Hosseinkhani, Federica Chiellini, Roberto Solaro, Rossella Di 
Stefano, Cardiac, Vascular and Thoracic Department, University of 
Pisa, Pisa, Italy, Department of Chemistry and Industrial Chemistry, 
University of Pisa, Pisa, Italy
Learning Objective: identify new possibilities in ischemic tissue 
regeneration
1276-366 Potential Role of Pentraxin 3 (PTX3) in Advanced 
Coronary Atherosclerosis: Coronary Rotational 
Atherectomy Study
Hironobu Akao, Michihiko Kitayama, Yasuyuki Kawai, Ryoko Sato, 
Atsushi Motoyama, Minoru Wakasa, Hirofumi Aoki, Ryuhei Saito, 
Kosuke Fujibayashi, Kouji Kajinami, Kanazawa Medical University, 
Uchinada, Japan
Learning Objective: atherosclerosis
1276-367 Dual CT and MRI In vivo Tracking of Stem Cell 
Therapy in Peripheral Artery Disease
Yibin Xie, Yingli Fu, Ronald Ouwerkerk, Steven M. Shea, Tina 
Ehtiati, Dorota Kedziorek, Gary Huang, Wesley D. Gilson, Meiyappan 
Solaiyappan, Robert Krieg, Dara L. Kraitchman, Johns Hopkins 
University, Baltimore, MD
Learning Objective: demonstrate that APA microcapsules containing 
PFOB provide a reliable method for tracking therapeutic stem cells 
in vivo by both CT and MRI
1276-368 Significant Down-regulation of the Anti-
inflammatory Cytokine Interleukin-10 is Genotype 
Dependent in Atherosclerotic Plaques with Intra-
plaque Hemorrhage
Pedro R. Moreno, K-Raman Purushothaman, Meerarani 
Purushothaman, Prakash Krishnan, Patrick A. Lento, John T. Fallon, 
Annapoorna S. Kini, Samin K. Sharma, Andrew P. Levy, Valentin 
Fuster, Mount Sinai Medical Center, New York, NY, New York, NY
Learning Objective: Identify the anti-inflammatory cytokine IL10 
significance in Haptoglobin Genotypes.
1277 ATHEROSCLEROTIC RISK FACTORS -- 
PATHOPHYSIOLOGY—CLINICAL
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1277-370 Posttraumatic Stress Disorder is Associated with 
Higher C-Reactive Protein Levels
Viola Vaccarino, J. Douglas Bremner, Nadeem Afzal, Emir Veledar, 
Jack Goldberg, Emory University, Atlanta, GA
Learning Objective: Demonstrate understanding that the link 
between posttraumatic stress disorder and CVD may occur through 
inflammatiory processes.
1275-359 CD271 Identifies Human Bone Marrow Stem/
Progenitor Cells with a Proangiogenic Potential and 
Circulating Progenitor Cells Mobilized after Acute 
Myocardial Infarction
Yoshitaka Iso, Jeffrey L. Spees, Takatoshi Sato, Shinji Koba, Youichi 
Kobayashi, Yoichi Takeyama, Hiroshi Suzuki, Division of Cardiology, 
Showa University Fujigaoaka Hospital, Yokohama, Japan
Learning Objective: identify that CD271(+) MSCs are recruited into 
peripheral blood after acute MI in response to myocardial damage 
and are one of the promising cell sources in angiogenic cell 
therapies.
1275-360 Differential Expression of the Hypoxia Target 
Genes in Porcine Marrow Stromal Cells After 
Transplantation into Ischemic Myocardium
Yifu Zhou, Suna Wang, Caleb N. Seavey, Robert F. Hoyt, Jr, Timothy 
Hunt, Keith A. Horvath, National Institutes of Health, Bethesda, MD
Learning Objective: The roles of ischemic target genes in the 
myocardial ischemic tissues after stem cell treatment
1275-361 Determinants of Collateral Circulation in Patients 
with Documented Coronary Occlusion: The Case for 
Gender and Smoking
Eric Van Belle, Sophie Susen, François J. Cuilleret, Frédéric 
Mouquet, Pierre V. Ennezat, Thierry Letourneau, Pieter A. 
Doevendans, Jean Dallongeville, Michel E. Bertrand, Brigitte Jude, 
CHRU, Lille, France, UMC, Utrecht, The Netherlands
Learning Objective: identidy that in patients with coronary occlusion, 
collateral circulation is impaired in women and in smokers
1275-362 Overexpressing Cellular repressor of E1A-stimulated 
genes Protects Mesenchymal Stem Cells Against 
Hypoxia- and Serum Deprivation-Induced Apoptosis 
by Activation of PI3K/Akt
Yaling Han, Jie Deng, Chenhui Yan, Xiaoxiang Tian, Jie Tao, Jian 
Kang, Shaohua Li, Shenyang Northern Hospital, Shenyang, People’s 
Republic of China
Learning Objective: Demonstrate
1276 VASCULAR--PATHOPHYSIOLOGY AND BIOLOGY
Tuesday, March 16, 2010, 9:30 a.m. - 12:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
1276-364 Difference In Neuregulin Levels And The Severity Of 
Coronary Artery Disease
Carrie Anna Geisberg, Brian Veerkamp, Guisong Wang, Radwan 
Safa, Holly Smith, Yenya Hu, David Zhao, Douglas Sawyer, Vanderbilt 
Medical University, Nashville, TN, Peking University Third Hospital, 
Beijing, People’s Republic of China
Learning Objective: Interpret the relationship between neuregulin 
and severity of coronary artery disease
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1277-371 Biomarkers of coronary atherosclerosis versus 
peripheral arterial disease in type 2 Diabetes 
Mellitus
Luis H. Eraso, Naeema Ginwala, Atif N. Qasim, Nehal N. Mehta, 
Muredach P. Reilly, Unniversity of Pennsylvania, Cardiovascular 
Institute, Philadelphia, PA
Learning Objective: Understand risk factor differences between 
coronary artery disease and peripheral arterial disease in diabetes 
type-2
1277-372 Heavy Metals And Cardiovascular Disease: Results 
From Nhanes 1999-2006
Shikhar Agarwal, E. Murat Tuzcu, Samir R. Kapadia, Cleveland Clinic, 
Cleveland, OH
Learning Objective: Evaluate association between heavy metal 
exposure and cardiovascular and cerebrovascular disease
1277-373 Vitamin D Levels Are Not Related to Myalgias 
in Statin-Treated Patients with Stable Coronary 
Disease
Vera Bittner, Nanette K. Wenger, David D. Waters, David A. DeMicco, 
Michael Messig, John C. LaRosa, University of Alabama at 
Birmingham, Birmingham, AL, Emory University, Atlanta, GA
Learning Objective: Evaluate the effect of serum vitamin D levels 
on myalgia incidence in statin-treated patients with stable coronary 
heart disease
1277-374 Cardiovascular Risk in Type 2 Diabetes Mellitus: 
The Role of an Unusual T-Cell Population
simona giubilato, Salvatore Brugaletta, Costantino Smaldone, 
Vincenzo Pazzano, Dario Pitocco, Giovanni Ghirlanda, Luigi M. 
Biasucci, Giovanna Liuzzo, Filippo Crea, Catholic University of the 
Sacred Heart, Rome, Italy
Learning Objective: evaluate the correlation between CD4CD28null 
T cells and cardiovascular risk in patients with type 2 diabetes 
mellitus
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2901 VALVULAR INTERVENTIONS
Sunday, March 14, 2010, 8:00 a.m. - 9:30 a.m.
Georgia World Congress Center, Room B308
CME/CE Hours: 1.5
8:00 MSCT Derived Preprocedural Parameters to Predict 
Clinical Outcome of Percutaneous Aortic Valve 
Replacement
Alexander Leber, Markus Kasel, Diethmar Antoni, Ellen Hoffmann, 
Thomas Ischinger, Heart Center Munich Bogenhausen, aff. with 
University of Munich, Munich, Germany
Learning Objective: learn about percutaneous valve implantation 
and Cardiac Ct
8:12 Pulmonary Hypertension in Patients with Severe 
Aortic Stenosis: Clinical Profile, Prognostic 
Implication and Response to Transcatheter Aortic 
Implantation
Itsik Ben-Dor, Steven A. Goldstein, Augusto D. Pichard, Lowell F. Satler, 
Rebecca Torguson, Petros Okubagzi, Zhenyi Xue, Yanlin Li, Asmir I. 
Syed, Zuyue Wang, Manuel A. Gonzalez, Michael A. Gaglia, Gabriel 
Maluenda, Kohei Wakabayashi, Cedric Delhaye, Nicholas N. Hanna, 
Sara D. Collins, William O. Suddath, Kenneth M. Kent, Joseph Lindsay, 
Ron Waksman, Washington Hospital Center, Washington, DC, DC
Learning Objective: To investigate incidence, predictors and 
prognostic implication and the impact of Trans catheter aortic valve 
implantation on pulmonary hypertension in patients with severe 
aortic stenosis
8:24 Mechanisms of Early Improvement of Secondary 
Mitral Regurgitation After Transcatheter Aortic Valve 
Replacement
Claudiu Stoicescu, Mariuca Vasa Nicotera, Derek Chin, Dragos 
Vinereanu, Jan Kovac, University Of Medicine and Pharmacy Carol 
Davila, Bucharest, Romania, University Hospitals of Leicester, 
Leicester, United Kingdom
Learning Objective: evaluate effects of transcatheter aortic 
replacement on functional mitral regurgitation associated with 
aortic stenosis
8:36 Transcatheter Aortic Valve Implantation Preserves 
Mitral Valve 3D Geometry Better than Standard AVR
Mathieu Vergnat, Joseph Bavaria, Benjamin M. Jackson, Albert T. 
Cheung, Stuart J. Weiss, Joseph H. Gorman III, Robert C. Gorman, 
University of Pennsylvania, Philadelphia, PA
Learning Objective: demonstrates effect of aortic procedure on 
mitral annulus geometry
8:48 Complications and Outcomes of Balloon Aortic 
Valvuloplasty in High-Risk or Inoperable Patients
Itsik Ben-Dor, Augusto D. Pichard, Lowell F. Satler, Yanlin Li, Asmir I. Syed, 
Gabriel Maluenda, Manuel A. Gonzalez, Sara D. Collins, Cedric Delhaye, 
Michael A. Gaglia, Kohei Wakabayashi, Nicholas N. Hanna, Rebecca 
Torguson, Okubagzi Petros, Zhenyi Xue, William O. Suddath, Kenneth M. 
Kent, Ron Waksman, Washington Hospital Center, Washington DC, DC
Learning Objective: To determine the success, complication and 
survival of patients after balloon aortic valvuloplasty
9:00 Percutaneous Mitral Valvuloplasty During Pregnancy
Hung Manh Pham, Oanh T.N. Pham, Vietnam Heart Insitute, Hanoi, 
Viet Nam, Ducgiang Hospital, Hanoi, Viet Nam
Learning Objective: Describes the experience in pregnant mitral 
stenosis patients undergoing valvuloplasty using the Inoue balloon 
with echo online
2902 IMAGING AND VULNERABLE PLAQUE
Sunday, March 14, 2010, 8:00 a.m. - 9:30 a.m.
Georgia World Congress Center, Room B310 
CME/CE Hours: 1.5
8:00 Relationship Between Coronary Calcium Score 
by Cardiac Computed Tomography Angiography 
and Plaque Components by Virtual Histology-
Intravascular Ultrasound
Young Joon Hong, Yun Ha Choi, Myung Ho Jeong, Eun Hye Ma, 
Keun Ho Park, Doo Sun Sim, Jum Suk Ko, Min Goo Lee, Ju Han 
Kim, Youngkeun Ahn, Jung Chaee Kang, Heart Center of Chonnam 
National University Hospital, Gwangju, South Korea
Learning Objective: to evaluate the relationship between coronary 
calcium score and plaque components
8:12 Lesion-Specific Measurements on Non-Contrast-
Enhanced Coronary CT Strongly Correlate with 
Plaque Burden and Luminal Size by Intravascular 
Ultrasound
Jesus Gustavo Vazquez Figueroa, Parag H. Joshi, Eric Krivitsky, 
Sarah Rinehart, Zhen Quian, Ayesha Shaukat, Idean B. Marvasty, 
Szilard Voros, Piedmont Heart Institute, Atlanta, GA
Learning Objective: Demonstrate the correlation between lesion 
specific calcium score and geometrical parameters by intravascular 
ultrasound.
8:24 Are Vulnerable Plaques Widely Disseminated or 
Focal? A Baseline 3-Vessel IVUS Analysis from the 
PROSPECT Trial
John A. McPherson, Akiko Maehara, Gary S. Mintz, Alexandra J. 
Lansky, Ecaterina Cristea, Barry Templin, Roxana Mehran, George 
Dangas, Zhen Zhang, Bertil Wennerblom, Andres Iniguez, Jean 
Fajadet, Michael Foster, Bernard de Bruyne, Patrick W. Serruys, 
Gregg W. Stone, Vanderbilt Heart and Vascular Institute, Nashville, 
TN, Columbia University Medical Center and the Cardiovascular 
Research Foundation, New York, NY
Learning Objective: Describe the prevalence and distribution of 
vulnerable plaques identified by intravascular ultrasound in patients 
presenting with acute coronary syndromes.
8:36 Micro-channel Structure Identified by Optical 
Coherence Tomography Is Related to Plaque 
Vulnerability in Patients with Coronary Artery Disease
Hironori Kitabata, Kohei Ishibashi, Kenichi Komukai, Takashi 
Tanimoto, Yasushi Ino, Shigeho Takarada, Takashi Kubo, Keizo 
kimura, Masato Mizukoshi, Toshio Imanishi, Takashi Akasaka, 
Wakayama medical university, Wakayama, Japan
Learning Objective: identify the imaging marker of plaque 
vulnerability to improve patient risk stratification.
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8:48 Vulnerability of Left Main Plaques by Virtual 
Histology Intravascular Ultrasound
Steven P. Marso, Tabitha G. Moe, John A. House, William J. Dolla, 
Lindsey Seifert, Jason B. Lindsey, Kevin F. Kennedy, Michel Pieper, 
Mid America Heart Institute, Kansas City, MO, AKH / Vienna General 
Hospital, Vienna, Austria
Learning Objective: Describe differences in plaque burden and 
composition between the left main and proximal coronary arteries
9:00 Association of Large Lipid Core Plaque Detected by 
Near Infrared Spectroscopy with Post Percutaneous 
Coronary Intervention Myocardial Infarction
Brijeshwar Maini, Emmanouil S. Brilakis, Michael Kim, Michael J. 
Hendricks, Stephen T. Sum, Sean P. Madden, James E. Muller, David 
Rizik, Simon R. Dixon, Mofﬁtt Heart & Vascular Group, Harrisburg, 
PA, Dallas VARC, Dallas, TX
Learning Objective: identify patients with a lipid core plaque who 
may be at risk for a post-PCI AMI.
2903 INTERVENTIONAL PHARMACOLOGY
Sunday, March 14, 2010, 2:00 p.m. - 3:30 p.m.
Georgia World Congress Center, Room B315
CME/CE Hours: 1.5
2:00 Impact of Platelet Reactivity on Clinical Outcomes: 
A Patient Level Meta-Analysis
Somjot Brar, Giuseppe Patti, Matthew J. Price, Rossella Marcucci, 
Thomas Cuisset, George Dangas, Kaiser Permanente, Los Angeles, 
CA, Columbia University Medical Center, New York, NY
Learning Objective: Demonstrate the impact of platelet reactivity on 
clinical outcomes
2:12 Impact of Clopidogrel Pretreatment on Ischemic 
Complications of PCI Among Bivalirudin-Treated 
Patients: Results from the EVENT Registry
Amit P. Amin, Kevin Kennedy, Michael Pencina, Peter Berger, Robert 
N. Piana, John Lopez, Neil Kleiman, David J. Cohen, St. Luke’s Mid-
America Heart Institute, University of Missouri, Kansas City, MO
Learning Objective: To recognize the impact of clopidogrel 
pretreatment on ischemic complications of PCI among bivalirudin-
treated elective PCI patients
2:24 Six-Month Outcomes with or without Proton-Pump 
Inhibitors after Successful PCI: Insights from the 
Guthrie PCI Registry
Kishore J. Harjai, Chetan Shenoy, Pam Orshaw, Judy Boura, Guy 
Rogers, Guthrie Health System, Sayre, PA
Learning Objective: Describe impact of use of PPI on outcomes after PCI
2:36 Impact of Chronic Kidney Disease on Platelet 
Function Profiles in Diabetes Mellitus Patients 
with Coronary Artery Disease on Dual Antiplatelet 
Therapy
Davide Capodanno, Esther Bernardo, David Vivas, Jose’ Luis 
Ferreiro, Manel Sabate’, Pilar-Jimenez Quevedo, Masafumi Ueno, 
Kodlipet Dharmashankar, Fernando Alfonso, Theodore Bass, Carlos 
Macaya, Antonio Fernandez-Ortiz, Dominick J. Angiolillo, University of 
Florida College of Medicine, Jacksonville, FL
Learning Objective: Demonstrate the impact of renal function on 
platelet function
2:48 Safety and Outcomes of Bivalirudin in Dialysis 
Patients Undergoing Percutaneous Coronary 
Intervention
Cedric Delhaye, Gabriel Maluenda, Kohei Wakabayashi, Itsik Ben-
Dor, Sara D. Collins, Asmir I. Syed, Manuel A. Gonzalez, Michael A. 
Gaglia, Rebecca Torguson, Zhenyi Xue, William O. Suddath, Lowell F. 
Satler, Kenneth M. Kent, Joseph Lindsay, Augusto D. Pichard, Ron 
Waksman, Washington, DC
Learning Objective: A dose adjusted BIV anticoagulation regimen in 
CDP undergoing PCI seems to be as safe and as effective as UFH 
use alone.
3:00 Impact of Antithrombotic Regimen and Troponin 
Status on Outcomes of Percutaneous Coronary 
Intervention in Acute Coronary Syndromes: The 
Acuity Trial
So-Yeon Choi, Eugenia Nikolsky, Alexandra J. Lansky, Roxana 
Mehran, Akiko Maehara, Brent T. McLaurin, David A. Cox, Frederick 
Feit, Gregg W. Stone, Columbia University Medical Center and the 
Cardiovascular Research Foundation, New York, NY
Learning Objective: evaluate
2904 NEW TECHNOLOGIES
Sunday, March 14, 2010, 4:30 p.m. - 6:00 p.m.
Georgia World Congress Center, Room B315
CME/CE Hours: 1.5
4:30 Very Long-term Results (> 2 Year) of the Vestasync 
I Trial with a Novel, Third-generation, Hydroxyapatite 
Polymer-free Sirolimus-eluting Stent
Jose de Ribamar Costa, Jr., Alexandre Abizaid, Ricardo Costa, 
Fausto Feres, Andrea Abizaid, Luiz Fernando Tanajura, Dimytri 
Siqueira, Rodolfo Staico, Galo Maldonado, Amanda Sousa, J 
Eduardo Sousa, Instituto Dante Pazzanese de Cardiologia, São 
Paulo, Brazil
Learning Objective: Demonstrate the very long term results of the 
first-in-man evaluation of the novel non-polymeric MIV-sirolimus-
eluting stent
A180 ABSTRACTS: i2 Summit (Interventional Cardiology) JACC    March 9, 2010
i2
 S
um
m
it 
 
(I
nt
er
ve
nt
io
na
l C
ar
di
ol
og
y)
4:42 Final Results of the INSPIRE trial with the Novel 
MGuard Stent System Containing a Protection Net 
to Prevent Distal Embolization
Jose de Ribamar Costa, Jr., Alexandre Abizaid, Ricardo Costa, 
Felipe Maia, Fausto Feres, Rodolfo Staico, Dimytri Siqueira, Galo 
Maldonado, Luiz Fernando Tanajura, Renata Viana, Juliana Castro, 
Amanda Sousa, J Eduardo Sousa, Instituto Dante Pazzanese de 
Cardiologia, São Paulo, Brazil, Cardiovascular Research Center, São 
Paulo, Brazil
Learning Objective: Demonstrate the feasibility of a novel net-
containing BMS stent dedicated to the treatment of thrombus 
containing lesions
4:54 Mitral Annular Reduction with Subablative High 
Intensity Focused Ultrasound: Safety, Efficacy and 
Dose Response in an Animal Model
Hasan Jilaihawi, Renu Virmani, Hiroshi Nakagawa, Anique 
Ducharme, Yan Fen Shi, Yong Zou, Atsushi Ikeda, Anita Asgar, Raoul 
Bonan, Montreal Heart Institute, Montreal, Canada
Learning Objective: Describe the novel technique of HIFU mitral 
annular reduction and interpret its effects from animal model data.
5:06 Prevalence and Clinical Impact of Coronary 
Artery Aneurysm after Sirolimus-eluting Stent 
Implantation: Long-term Clinical and Angiographic 
Follow-up
Masao Imai, Kazushige Kadota, Suguru Otsuru, Yoji Okamoto, 
Hiroshi Tasaka, Daiji Hasegawa, Seiji Habara, Hiroyuki Tanaka, 
Takeshi Maruo, Akitoshi Hirono, Yoshiharu Nishibori, Shingo Hosogi, 
Yasushi Fuku, Naoki Oka, Harumi Katoh, Hiroyuki Yamamoto, Satoki 
Fujii, Tsuyoshi Goto, Katsumi Inoue, Kazuaki Mitsudo, Kurashiki 
Central Hospital, Kurashiki, Japan
Learning Objective: Coronary artery aneurysm after sirolimus-eluting 
stent tend to increase the size
5:18 Long-Term Clinical Outcome of a Real World 
Experience in Patients Treated with a GenousTM EPC 
Capturing Stent
Margo Klomp, Marcel A. Beijk, Karel T. Koch, Jose P. Henriques, 
Jan Baan, Marije M. Vis, Jan G. Tijssen, Jan J. Piek, Robbert J. 
de Winter, Academic Medical Center-University of Amsterdam, 
Amsterdam, The Netherlands
Learning Objective: interpret the value of the EPC capturing stent in 
an unselected patient population
5:30 Impact of Tandem Heart Percutaneous Left 
Ventricular Assist Device on Invasive Hemodynamics
Inder M. Singh, David R. Holmes, Jr., Charanjit S. Rihal, Mayo Clinic 
(Cardiac Catheterization Laboratory), Rochester, MN
Learning Objective: Evaluate the impact of Tandem Heart 
percutaneous left ventricular assist device on invasive 
hemodynamics in inoperable patients undergoing high risk PCI.
2905 ENDOVASCULAR INTERVENTIONS
Monday, March 15, 2010, 8:00 a.m. - 9:30 a.m.
Georgia World Congress Center, Room B315
CME/CE Hours: 1.5
8:00 Influence of Lesions Characteristics on Thirty-day 
Outcomes after Carotid Artery Stenting from the 
SAPPHIRE Worldwide Registry
Christopher Metzger, Farrell Mendelsohn, Maurice Solis, Donald 
Heck, William Bachinsky, Greg Schultz, Holston Valley Medical 
Center, Kingsport, TN, Baptist Medical Center, Birmingham, AL
Learning Objective: identify lesion characteristics associated with a 
higher degree of adverse events after carotid stenting
8:15 Percutaneous Endovenous Intervention Reduces 
Post Thrombotic Syndrome and Recurrent Venous 
Thromboembolic Disease in Acute Deep Venous 
Thrombosis
Mohsen Shariﬁ, Mahshid Mehdipour, Adam Berkovits, Gary Smith, 
Arizona Cardiovascular Consultants, Mesa, AZ, A.T.Still University, 
Mesa, AZ
Learning Objective: Recognize that early percutaneous endovenous 
intervention significantly reduces the incidence of post-thrombotic 
syndrome
8:30 Renal Artery Plaque Composition Is Associated with 
Change In Renal Perfusion Following Renal Artery 
Stenting
Anand Prasad, Patrick Hu, Nayab M. Zafar, Anita N. Majabo, Kelly 
A. Enright, Vachaspathi Palakodeti, Sotirios Tsimikas, Ehtisham 
Mahmud, University of California San Diego, San Diego, CA
Learning Objective: Describe the relationship between renal artery 
plaque compostion and its relationship to renal perfusion following 
renal artery stenting.
8:45 Stent Fracture, TASC II CD Lesion as Restenosis 
Factors, and Cilostazol as a Negative-restenosis 
Factor within a Year Following Nitinol Stent 
Implantation in the Superficial Femoral Artery
Osamu Iida, Msaaki Uematsu, Seiki Nagata, Yoshimitsu Soga, 
Hiroyoshi Yokoi, Masakiyo Nobuyoshi, Keisuke Hirano, Toshiya 
Muramatsu, Shinsuke Nanto, Kansai Rosai Hospital, Amagasaki, 
Japan
Learning Objective: demonstrate the factors associated with 
restenosis occurring within a year following nitinol stent 
implantation in the superficial femoral artery.
9:00 Does Location Matter? Improvement in Quality of 
Life for Patients Undergoing Percutaneous Vascular 
Interventions, Insights from the Blue Cross Blue 
Shield of Michigan Cardiovascular Consortium
Paul Michael Grossman, Samuel R. Kaufman, David Share, Herbert 
D. Aronow, Stanley J. Chetcuti, Paul Bove, Timothy J. Nypaver, James 
M. Fox, M. Ashraf Mansour, Hitinder S. Gurm, University of Michigan 
Hospitals and Health Center, Ann Arbor, MI
Learning Objective: describe the singnificant impairment in quality 
of life of patients with severe lower extremity PAD, and understand 
the sustained improvement after percutaneous intervention.
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3:00 Feasiblity and Safety of Hybrid Revascularization for 
Left Main Coronary Artery Stenosis
S. Tanveer Rab, John S. Douglas,Jr., Ellen Lyons, Thomas A. 
Vassiliades, Jr., Emory University School of Medicine, Atlanta, GA
Learning Objective: Learn a new approach in treating Left Main 
Coronary artery stenosis.
2907 STRUCTURAL HEART DISEASE INTERVENTIONS
Monday, March 15, 2010, 4:30 p.m. - 6:00 p.m.
Georgia World Congress Center, Room B308
CME/CE Hours: 1.5
4:30 A Novel Method for Septal Ablation: Glue 
(Cyanoacrylate) Septal Ablation
Ali Oto, Kudret Aytemir, Sercan Okutucu, Ergün B. Kaya, Barbaros 
Çil, Bora PeynircioŒlu, Ali Deniz, Hikmet Yorgun, Onur S. Deveci, 
Hakan Aksoy, Lale TokgözoŒlu, Giray Kabakçı, Nasıh Nazlı, Hilmi 
Özkutlu, Hacettepe University, Ankara, Turkey
Learning Objective: We describe a successful technique for 
septal ablation with cyanoacrylate in hypertrophic obstructive 
cardiomyopathy which decrease the complications related to alcohol 
instillation
4:42 Sustained Long-term Migraine Reduction after PFO 
Closure
Daniela Trabattoni, Franco Fabbiocchi, Stefano Galli, Piero Montorsi, 
Giovanni Teruzzi, Alessandro Lualdi, Paolo Ravagnani, Pamela Gatto, 
Antonio L. Bartorelli, Centro Cardiologico Monzino, IRCCS, Milan, IL, 
Italy
Learning Objective: Interpret migraine score; evaluate beneficial 
effects of PFO closure in patients with a previous TIA and 
symptomatics for headache
4:54 PROTECT AF Trial - Intermediate-Term Outcome
David R. Holmes, Jr., Mayo Clinic, Rochester, MN
Learning Objective: To compare the outcome of left atrial 
appendage occlusion versus Warfarin in patients with nonvalvular 
atrial fibrillation (PROTECT AF) at 1200 patient years versus the 
initial 600 patient year data.
5:06 Maximum Diameter of Atrial Septal Defect 
Measured by Live 3 Dimensional Transesophageal 
Echocardiography Contributes for Appropriate 
Device Selection in Patients with Large Defect: 
Balloon Sizing Technique Should be Avoided in 
Patients with Large ASD
Teiji Akagi, Manabu Taniguchi, Koji Nakagawa, Yasufumi Kijima, 
Hiroshi Ito, Shunji Sano, Okayama University, Okayama, Japan
Learning Objective: Adult patients with ASD and significant TR are 
not rare, and the majority of these patients suffered from significant 
congestive heart failure.
2906 LEFT MAIN DISEASE
Monday, March 15, 2010, 2:00 p.m. - 3:30 p.m.
Georgia World Congress Center, Room B315
CME/CE Hours: 1.5
2:00 Drug-Eluting Stents for the Treatment of Left Main 
Coronary Artery Disease with Sirolimus, Paclitaxel, 
Zotarolimus, BiolimusA9, EPC Capture and 
Everolimus-Eluting Stent: Multicenter Registry in Asia
Sunao Nakamura, Shotaro Nakamura, Hisao Ogawa, Jang-Ho Bae, 
Yeo Hans Cahyadi, Wasan Udayachalerm, Damras Tresukosol, 
Sudaratana Tansuphaswadikul, New Tokyo Hospital, Chiba, Japan
Learning Objective: Describe the clinical efficacy of SES, PES, ZES, 
BES, ECS and EES implantation in patients with left main trunk 
disease which is safe, low restenosis rate and low incidence of 
complication.
2:12 Ten-Year Outcomes after Stent Implantation versus 
Coronary-Artery Bypass Grafting for Unprotected 
Left Main Coronary Artery Disease
Duk Woo Park, Jung-Min Ahn, Won-Jang Kim, Jong-Young Lee, 
Sung-Cheol Yun, Soo-Jin Kang, Seung-Whan Lee, Young-Hak Kim, 
Cheol Whan Lee, Seong-Wook Park, Seung-Jung Park, Asan Medical 
Center, Seoul, South Korea
Learning Objective: identify the left main coronary artery stenosis
2:24 Pathology of Drug Eluting Stents and Bare Metal 
Stents in the Left Main Coronary Artery
Marc M. Vorpahl, Masataka Nakano, Gaku Nakazawa, Robert Kutys, 
Elena Ladich, CV Path Institute, Gaithersburg, MD
Learning Objective: to understand pathological differences of DES 
and BMS in left main coronary stenting
2:36 Long-Term Clinical Outcomes of Unprotected Left Main 
Stenting with Sirolimus Eluting Stents: Correlation 
Between the SYNTAX Score and Clinical Outcomes
Hiroki Shiomi, Toshihiro Tamura, Yoshihiro Kato, Tomohisa Tada, 
Junichi Tazaki, Toshikazu Jinnai, Koh Ono, Takeshi Kimura, 
Department of cardiology, Kyoto university, Kyoto, Japan
Learning Objective: interpret the efficacy of unprotected left main 
stenting with sirolimus eluting stents and evaluate correlation 
between the SYNTAX score and clinical outcomes in unprotected 
left main stenting
2:48 Five-Year Outcomes after Drug-Eluting Stents versus 
Coronary-Artery Bypass Grafting in Unprotected Left 
Main Coronary Artery Disease
Duk Woo Park, Jong-Young Lee, Won-Jang Kim, Junhyok Oh, Jung-
Min Ahn, Haegeun Song, Soo-Jin Kang, Seung-Whan Lee, Young-Hak 
Kim, Cheol Whan Lee, Seong-Wook Park, Seung-Jung Park, Asan 
Medical Center, Seoul, South Korea
Learning Objective: to identify long-term ouctomes of left main 
coronary artery disdease
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5:06 Impact of Uncovered Stent Struts on Optical 
Coherence Tomography (OCT) Detected Thrombus 
Formation at 10-Month Follow-up of Sirolimus-
Eluting Stents (SES)
Yukio Ozaki, Masanori Okumura, Tevﬁk F. Ismail, Kousuke Hattori, 
Hiroyuki Naruse, Shino C. Kan, Makoto Ishikawa, Tomoko Kawai, 
Junichi Ishii, Hitoshi Hishida, Fujita Health University Hospital, 
Toyoake, Japan, Charing Cross Hospital, London, United Kingdom
Learning Objective: This study indicated that uncovered struts could 
play a role in the thrombus formation, furthermore, fibrin deposit 
over the strut and incomplete stent apposition would also relate to 
LST/VLST.
5:18 Prospective Application of Predefined Intravascular 
Ultrasound Criteria for Revascularization of 
Intermediate Left Main Coronary Artery Lesions: 
Results from the Multicentered LITRO Study
Jose M. de la Torre Hernandez, Felipe Hernandez, Fernando Alfonso, 
Ramon Lopez Palop, Jose R. Rumoroso, Iñigo Lozano, Juan M. 
Ruiz Nodar, Jose A. Baz, Fina Mauri, Federico Gimeno, Jose Moreu, 
Antonio Dominguez, Jose G. Galache, Vicki Martin, Ramon Calviño, 
Francisco Bosa, Armando Perez de Prado, Luis Martinez Elbal, Javier 
Botas, Jesus Jimenez Mazuecos, Cristobal Urbano, Javier Goicolea, 
Grupo de Trabajo Español de Diagnostico Intracoronario, Spain, 
Spain
Learning Objective: Demonstrate the definite value of intracoronary 
ultrasound evaluation of intermediate left main coronary artery 
stenosis in decision of revascularization
5:30 Temporal Changes of Neointimal Coverage 
and Thrombogenicity after Drug-Eluting Stent 
Implantation; Angioscopic Comparison Between 
Sirolimus-eluting and Paclitaxel-eluting Stent
Masahiko Hara, Masami Nishino, Takeshi Masaki, Naoki Mori, 
Takahiro Yoshimura, Yasuharu Lee, Daisuke Nakamura, Shinpei 
Nakatani, Masayuki Taniike, Nobuhiko Makino, Hiroyasu Kato, 
Yasuyuki Egami, Ryu Shutta, Hitoshi Yamaguchi, Jun Tanouchi, 
Yoshio Yamada, Osaka Rosai Hospital, Sakai, Japan
Learning Objective: understand that the temporal changes of 
neointimal coverage and thrombogenicity are different between 
sirolimus- and paclitaxel-eluting stent.
2909 ACUTE MYOCARDIAL INFARCTION
Monday, March 15, 2010, 4:30 p.m. - 6:00 p.m.
Georgia World Congress Center, Room B315 
CME/CE Hours: 1.5
4:30 Impact of Paclitaxel-Eluting Stents in Diabetic 
Patients with Acute Myocardial Infarction 
Undergoing Primary Angioplasty: Analysis from the 
HORIZONS AMI trial
Bernhard Witzenbichler, Jochen Woehrle, Giulio Guagliumi, Jan 
Peruga, Bruce Brodie, Dariusz Dudek, Ran Kornowski, Franz 
Hartmann, Helen Parise, Alexandra Lansky, Eugenia Nikolsky, 
Roxana Mehran, Gregg Stone, Charite - Campus Benjamin Franklin, 
Berlin, Germany
Learning Objective: describe the impact of paclitaxel-eluting stents 
on outcome in the treatment of STEMI patients
5:18 Trans-Catheter Closure of Multi-Fenestrated Atrial 
Septal Defects: Comparison study of Helex vs 
Cribriform Devices
Mohammed T. Numan, Muhammad Dilawar, Howaida Elsaeed, Amal 
ElSisi, University of Texas, Houston, TX, Hamad Hospital, Doha, Qatar
Learning Objective: Evaluate the difference between the Helex(Gore) 
and Cribriform(AGA) devices in closing Multi Fenestrated Atrial 
Septal Defects.
5:30 Long Term Follow-up of Intravascular Stent 
Placement for Atrial Baffle Stenosis after Mustard 
Repair for Transposition of the Great Arteries
Sheetal Patel, Daniel Turner, Thomas Forbes, Peter P. Karpawich, 
Children’s Hospital of Michigan, Detroit, MI
Learning Objective: know the immidiet and long term success of 
catheter based treatment of Mustard baffle obstruction
2908 IMAGING AND STENTS
Monday, March 15, 2010, 4:30 p.m. - 6:00 p.m.
Georgia World Congress Center, Room B310
CME/CE Hours: 1.5
4:30 Late and Very Late Drug-Eluting Stent 
Malapposition: A Serial Two Year Quantitative IVUS 
Analysis
Kang Soo-Jin, Gary S. Mintz, Duk-Woo Park, Seung-Whan Lee, Young-
Hak Kim, Cheol Whan Lee, Ki-Hoon Han, Jae-Joong Kim, Seong-Wook 
Park, Seung-Jung Park, Asan medical center, Seoul, South Korea
Learning Objective: malapposition
4:42 IVUS Predictors of Early Stent Thrombosis after 
Primary Percutaneous Intervention in Acute 
Myocardial Infarction: A HORIZONS-AMI Substudy
So-Yeon Choi, Bernhard Witzenbichler, Akiko Maehara, Gary S. 
Mintz, Alexandra J. Lansky, Giulio Guagliumi, Bruce Brodie, Mirle 
A. Kellett, Jr, Helen Parise, Roxana Mehran, George D. Dangas, 
Gregg W. Stone, Cardiovascular Research Foundation / Columbia 
University Medical Center, New York, NY
Learning Objective: evaluate 
4:54 Serial Changes of Tiny Stent Malapposition Not 
Detected by Intravascular Ultrasound: Follow-up 
Optical Coherence Tomography Study
Won Ho Kim, Myeong-Ki Hong, Jaemin Shim, Jung-Sun Kim, Young-
Guk Ko, Donghoon Choi, Yangsoo Jang, Division of Cardiology, 
Yonsei Cardiovascular Center, Yonsei University College of Medicine, 
Seoul, SC, South Korea
Learning Objective: This study demonstrates that tiny stent 
malapposition which is not detectable by IVUS may disappear or 
decrease in follow up OCT evaluation. It may be stable and likely 
represent a benign phenomenon.
JACC    March 9, 2010 ABSTRACTS: i2 Summit (Interventional Cardiology) A183
i2 Sum
m
it  
(Interventional Cardiology)
2910 DES
Tuesday, March 16, 2010, 8:00 a.m. - 9:30 a.m.
Georgia World Congress Center, Room B315 
CME/CE Hours: 1.5
8:00 Two-Year Graft Occlusion and Stent Thrombosis 
in Patients with De Novo Left Main and/or Three 
Vessel Disease: Analysis from the SYNTAX Trial
Ted Feldman, Michael J. Mack, Antonio Colombo, Friedrich W. Mohr, 
Patrick W. Serruys, A. Pieter Kappetein, Thomas McGarry, Scott 
K. Lucas, Andrea D’Armini, Ezio Bramucci, Katrin Leadley, Keith D. 
Dawkins, Evanston Northwestern Healthcare, Evanston, IL, Boston 
Scientiﬁc Corporation, Natick, MA
Learning Objective: explain the incidence of very late stent 
thrombosis or graft occlusion through 2 years in a high-risk 
population of patients with LM and/or 3VD disease who were 
revascularized with either PCI or CABG
8:12 Long-term Outcomes of Drug-Eluting Stents for Off-
label Indications: A Report from the NHLBI Dynamic 
Registry
Oscar C. Marroquin, Faith Selzer, Suresh R. Mulukutla, Joon S. Lee, 
Conrad Smith, William D. Anderson, Catalin Toma, David O. Williams, 
Sheryl F. Kelsey, Kevin E. Kip, University of Pittsburgh, Pittsburgh, PA
Learning Objective: Describe the long-term outcomes of off-label 
use of DES
8:24 The PERSEUS Workhorse Randomized Trial of 
the Novel Platinum-Chromium Thin-Strut TAXUS 
Element Paclitaxel-Eluting Stent versus the TAXUS 
Express Stent in de novo Coronary Stenoses
Louis A. Cannon, Dean J. Kereiakes, Ira M. Dauber, Michael W. 
Ball, Ameer Kabour, Manu Sondhi, Keith D. Dawkins, Cardiac and 
Vascular Research Center of Northern Michigan, Northern Michigan 
Regional Hospital, Petoskey, MI, Boston Scientiﬁc Corporation, 
Natick, MA
Learning Objective: Describe the clinical and angiographic outcomes 
of the PERSEUS WH trial, and evaluate the safety, efficacy, and 
technical performance of the TAXUS Element stent relative to the 
TAXUS Express stent.
8:36 Everolimus-Eluting (Xience V) Stents versus 
Sirolimus-Eluting (Cypher) Stents in Patients 
with Coronary Artery Disease: Results from a 
Randomized Controlled Trial
Robert A. Byrne, Julinda Mehilli, Klaus Tiroch, Stefanie Schulz, 
Jürgen Pache, Heidrun Holle, Steffen Massberg, Melchior Seyfarth, 
Katrin A. Birkmeier, Karl-Ludwig Laugwitz, Albert Schömig, 
Adnan Kastrati, Deutsches Herzzentrum, Technische Universität, 
Munich, Germany, 1. Medizinische Klinik, Klinikum rechts der Isar, 
Technische Universität, Munich, Germany
Learning Objective: Evaluate the comparative efficacy of Xience V 
and Cypher stents
4:42 Four Year Survival after Percutaneous Coronary 
Intervention with Drug Eluting Stents and Bare 
Metal Stents in Patients with Acute Myocardial 
Infarction. A New Jersey Statewide Database Study.
Tudor Dumitru Vagaonescu, Abel E. Moreyra, Alan C. Wilson, Nora 
M. Cosgove, John B. Kostis, UMDNJ Robert Wood Johnson Med 
Sch, New Brunswick, NJ
Learning Objective: Use of DES versus BMS in the setting of AMI PCI
4:54 Safety and Efficacy of Transradial versus 
Transfemoral Coronary Intervention in Acute 
Myocardial Infarction: A Meta-Analysis of 
Randomized Trials
Param P. Singh, Updesh S. Bedi, Mukesh Singh, Sasikanth 
Adigopula, Vamsi Kodumuri, Amol Bahekar, Ankur Sethi, Janos 
Molnar, Rohit Arora, Sandeep Khosla, Chicago Medical School/
RFUMS, North Chicago, IL
Learning Objective: Demonstrate safety and efficacy of transradial 
coronary intervention in acute myocardial infarction.
5:06 Impact of Paclitaxel-Eluting Stents in Patients with 
Anterior Myocardial Infarction Undergoing Primary 
Angioplasty Compared with Bare Metal Stents: 
Analysis from the HORIZONS AMI trial
Jochen Wöhrle, Bernhard Witzenbichler, Giulio Gualiumi, Bruce R. 
Brodie, Dariusz Dudek, Ran Kornowski, Franz Hartmann, Helen 
Paris, Alexandra J. Lansky, Carol Moore, Roxana Mehran, Gregg 
W. Stone, Clinic of Internal Medicine II, University of Ulm, Ulm, 
Germany, Cardiovascular Research Foundation and Columbia 
University Medical Center, New York, NY
Learning Objective: describe the results of paclitaxel eluting stents 
for primary PCI in patients with anterior myocardial infarction 
compared ot bare-metal stents.
5:18 ST Elevation Myocardial Infarction Due to Left Main 
Culprit Lesions: Percutaneous Coronary Intervention 
Outcomes
Gilbert J. Zoghbi, Vijay K. Misra, Brigitta C. Brott, Silvio E. 
Papapietro, David Dai, Fang-Shu Ou, Tracy Y. Wang, Lloyd W. 
Klein, John C. Messenger, William B. Hillegass, on behalf of the 
ACC NCDR Cath PCI Registry Participating Centers, University of 
Alabama at Birmingham, Brimingham, AL, Duke University Medical 
Center, Durham, NC
Learning Objective: Describe well powered multicenter outcomes of 
left main STEMI PCI.
5:30 Drug-Eluting Stents Are Associated with Decreased 
Mortality Among Medicare Beneficiaries Admitted 
with Acute Coronary Syndromes.
Joseph Rossi, Laura P. D’Arcy, Jerome J. Federspeil, Timothy S. 
Carey, Sally C. Stearns, Brett C. Sheridan, University of North 
Carolina, Chapel Hill, NC
Learning Objective: Interpret the results of a comparative 
effectiveness analysis of DES and BMS using observational data 
from Medicare beneficiaries.
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10:54 Prevalence and Impact of Renal Failure in 
Octogenarians Undergoing Percutaneous Coronary 
Intervention
Jean-Pierre Dery, Helena Tizon-Marcos, Pierre-Louis Bernard, 
Julie Plaisance, Cindy Boulanger-Gobeil, Josep Rodés-Cabau, 
Gerald Barbeau, Eric Larose, Stephane Rinfret, Can M. Nguyen, 
Onil Gleeton, Guy Proulx, Bernard Noël, Louis Roy, Robert 
Delarochellière, Olivier F. Bertrand, Institut universitaire de 
cardiologie et de pneumologie de Quebec, Quebec City, QC, Canada
Learning Objective: determine the prevalence and impact of renal 
failure in octogenarians undergoing PCi
11:06 Impact of Diabetes Mellitus on Clinical and 
Angiographic Outcomes after Treatment of 
Bifurcation Lesion Using by Single Drug-Eluting 
Stent with Final Kissing Inflation: A Subgroup 
Analysis of the SINGLE KISS Trial
Kenya Nasu, Yuji Oikawa, Tadanori Aizawa, Takahiko Suzuki, Single 
Kiss Trial Investigators, Toyohashi Heart Center, Toyohashi, AL, 
Japan, The Cardiovascular Hospital, Tokyo, AL, Japan
Learning Objective: understand efficacy of SES and PES for 
bifurcation lesions in patients with diabetes mellitus
11:18 The Impact of Renal Insufficiency on 2-Year 
Outcomes Following PCI or CABG in the SYNTAX 
Trial
David R. Holmes, Jr., Friedrich W. Mohr, Patrick W. Serruys, Michael 
J. Mack, Paul Vermeersch, Philip Van Cauwelaert, Kari Virtanen, 
Ari Lasse Harjula, Katrin Leadley, Keith D. Dawkins, Mayo Clinic, 
Rochester, MN, Boston Scientiﬁc Corporation, Natick, MA
Learning Objective: describe the effect of baseline renal 
insufficiency on 2-year outcomes in patients with de novo 3VD and/
or LM disease who were revascularized with either CABG or PCI.
11:30 Infarct Size and Left Ventricular Function in The 
PRoximal Embolic Protection in Acute Myocardial 
Infarction and Resolution of ST-segment Elevation 
(PREPARE) Trial: Ancillary Cardiovascular Magnetic 
Resonance Study
Joost D. Haeck, Wichert J. Kuijt, Karel T. Koch, Luc Bilodeau, José 
P. Henriques, Wim J. Rohling, Jan Baan, Jr., Marije M. Vis, Robin 
Nijveldt, Nan Van Geloven, Maarten Groenink, Jan J. Piek, Jan G. 
Tijssen, Mitchell W. Krucoff, Robbert J. De Winter, Academic Medical 
Center – University of Amsterdam, Amsterdam, The Netherlands
Learning Objective: This study evaluate the effect of combined 
proximal embolic protection and thrombus aspiration on final 
infarct size and left ventricular function at 4-6 months after index 
procedure.
8:48 Post-Discharge Bleeding is Associated with Early 
Myocardial Infarction and Death after Drug-
Eluting Stent Implantation: Insights from the HMO 
Research Network- Stent Registry (HMORN-Stent)
Thomas Tehsin Tsai, P. Michael Ho, Thomas M. Maddox, Nikki M. 
Carroll, Susan M. Shetterly, Stanley Xu, J. David Powers, Karen 
Margolis, John S. Rumsfeld, Alan S. Go, David J. Magid, MD, MPH, 
Denver VA Medical Center, Denver, CO, Kaiser Permanente of 
Colorado, Denver, CO
Learning Objective: Identify the risk of early events after post-
discharge bleeding in patients s/p DES implantation
9:00 Randomized Trial of a Polymer-Free Dual Drug-
Eluting Stent versus Polymer-Based Drug-Eluting 
Stents - Two-year Clinical and Angiographic 
Outcomes
Robert A. Byrne, Adnan Kastrati, Klaus Tiroch, Stefanie Schulz, 
Jürgen Pache, Susanne Pinieck, Steffen Massberg, Melchior 
Seyfarth, Katrin A. Birkmeier, Karl-Ludwig Laugwitz, Albert Schömig, 
Julinda Mehilli, Deutsches Herzzentrum, Technische Universität, 
Munich, Germany, 1. Medizinische Klinik, Klinikum rechts der Isar, 
Technische Universität, Munich, Germany
Learning Objective: To evaluate whether a polymer-free Dual-DES is 
associated with safety advantages and more durable angiographic 
antirestenotic efficacy compared with permanent-polymer DES at 
2 years.
2911 COMPLEX PATIENTS
Tuesday, March 16, 2010, 10:30 a.m. - 12:00 p.m.
Georgia World Congress Center, Room B315 
CME/CE Hours: 1.5
10:30 Long-term Clinical Outcome after Implantation of 
Sirolimus-Eluting and Paclitaxel-Eluting Stents in 
Patients with and without Diabetes Mellitus - A 
Predefined SORT OUT II Substudy
Michael Maeng, Niels Bligaard, Lisette O. Jensen, Henning Kelbaek, 
Jens F. Lassen, Peter R. Hansen, Per Thayssen, Leif Thuesen, Jan 
S. Jensen, Steen Z. Abildstrøm, Anders M. Galloe, The SORT OUT II 
Investigators, Aarhus University Hospital, Skejby, Aarhus, Denmark
Learning Objective: evalutate the impact of diabetes on the long-
term outcome after sirolimus-eluting and paclitaxel-eluting stent 
implantation
10:42 Multivessel Coronary Revascularization in Patients 
with and without Diabetes Mellitus 5-Year Follow-
Up of the ARTS-II trial (Arterial Revascularization 
Therapies Study-Part II)
Yoshinobu Onuma, Joanna Wykrzykowska, Pascal Vranckx, Patrick 
W. Serruys, the ARTS-II Investigators, Thorax Center, Erasmus MC, 
Rotterdam, The Netherlands
Learning Objective: demonstrate a comparative long-term outcome 
of coronary intervention with Sirolimus-eluting stents with coronary 
artery bypass in patients who have multivessel disease with and 
without diabetes
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2501-422 Pre-hospital Reduced-dose Fibrinolytic Therapy 
Followed by Emergent Percutaneous Intervention 
Reduces Infarct Size and Limits Microvascular 
Obstruction in Patients Treated Within Six Hours of 
STEMI Onset Without a Bleeding Penalty
Troy Weirick, Colin Barker, John LeDoux, Daniel Maland, Eugene 
Stautberg, Ali Denktas, Stephano Sdringola, Vernon Anderson, 
Catalin Loghin, Jamie McCarthy, David Persse, Mary Vooletich, 
Richard Smalling, University of Texas at Houston Health Science 
Center, Houston, TX
Learning Objective: Describe infarct size and microvascular 
obstruction in pre-hospital fibrinolytic treated STEMI patients.
2501-429 The Incidence And Predictors Of In-hospital Death 
In Patients With ST-segment Elevation Myocardial 
Infarct Who Underwent Primary Percutaneous 
Coronary Intervention
Young Jin Youn, Seung Hwan Lee, Sang Woo Han, Jun Won Lee, 
Joong Kyung Sung, Nam Seok Lee, Jang-Young Kim, Junghan Yoon, 
Kyung-Hoon Choe, Wonju Christian Hospital, Wonju, South Korea
Learning Objective: identify the patient with high risk who undergo 
PPCI due to STEMI
2501-430 In-Hospital Mortality For Paramedic Identified ST 
Elevation Myocardial Infarction Patients With Pre-
Hospital Cath Lab Activation Compares Favorably 
With Emergency Department Activations And With 
The ACTION Registry
Paul S. Rostykus, Brian W. Gross, Kent W. Dauterman, Stephen J. 
Schnugg, Todd S. Kotler, Mark G. Moran, Karen A. Bales, Mary E. 
Barnum, Rogue Valley Medical Center, Medford, OR, Jackson County 
EMS, Medford, OR
Learning Objective: Describe how pre-hospital paramedic identified 
STEMI patients have mortality results at least as good those 
patients identified in the ED.
2501-431 A Novel Strategy To Reduce “ Off-Hours “ Door to 
Balloon Time in ST Elevation Myocardial Infarction
Syed Tanveer Rab, John S. Douglas, Jr., Leeann Bauch, Jane Wilson, 
Samuel Shartar, Matthew Keadey, Leslie Stigaard, M. Rizwan Khalid, 
Douglas C. Morris, Emory University School of Medicine, Atlanta, GA
Learning Objective: Identify methods to reduce Door to Balloon 
time.
2501-432 Multivessel Versus Culprit-Only Primary 
Percutaneous Coronary Intervention in Patients with 
Multivessel Disease and ST-Elevation Myocardial 
Infarction Complicated with Cardiogenic Shock
Bimmer Claessen, Marije M. Vis, Karel T. Koch, Jan Baan, Jr, Martijn 
Meuwissen, Rob J. de Winter, Jan G. Tijssen, Jan J. Piek, Jose P. 
Henriques, Academic Medical Center - University of Amsterdam, 
Amsterdam, FL, The Netherlands
Learning Objective: Evaluate the value of multivessel primary pci in 
the setting of primary PCI for cardiogenic shock
2501 DES I AND ACUTE CORONARY SYNDROMES
Sunday, March 14, 2010, 9:30 a.m. - 10:30 a.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m. 
CME/CE Hours: 1
2501-418 Contemporary Clinical Characteristics, Treatment, 
and Outcomes of Coronary Stent Thrombosis
Khung Keong Yeo, William E. Bennett, Ehtisham Mahmud, Reginald 
I. Low, Jason H. Rogers, University of California, Davis Medical 
Center, Sacramento, CA, University of California, San Diego Medical 
Center, San Diego, CA
Learning Objective: Describe the clinical and procedural 
characteristics, and outcomes of patients who present with stent 
thrombosis in the United States
2501-419 Impact of Pre-Operative Clopidogrel Use in Patients 
With Non-ST Segment Elevation Acute Coronary 
Syndrome Requiring Coronary Artery Bypass 
Grafting: A Meta-Analysis
Rohit Bhuriya, Pawan Patel, Dhara Chaudhari, Amol Bahekar, Ankur 
Sethi, Bassel Artin, Janos Molnar, Sandeep Khosla, The Chicago 
Medical School, North Chicago, IL
Learning Objective: Identify the impact of clopidogrel in the setting 
of non-ST elevation acute coronary syndrome requiring coronary 
artery bypass grafting.
2501-420 Compliance with Dual Antiplatelet Therapy and 
Subsequent Adverse Events in Patients with STEMI 
Undergoing Stent Implantation: Analysis from the 
HORIZONS-AMI Trial
Roxana Mehran, Eugenia Nikolsky, Bernhard Witzenbichler, Giulio 
Guagliumi, Jan Z. Peruga, Bruce R. Brodie, Dariusz Dudek, Ran 
Kornowski, Franz Hartmann, Adriano Caixeta, Nicole Haratani, 
George D. Dangas, Alexandra J. Lansky, and Gregg W. Stone, 
Columbia University Medical Center and The Cardiovascular 
Research Foundation, New York, NY
Learning Objective: To defined the rates of and reasons for 
premature cessation of aspirin and/or thienopyridine therapy in pts 
with ST-elevation myocardial infarction underwent to PCI
2501-421 Impact of Intravenous Heparin Administered Prior 
to Primary Percutaneous Coronary Intervention: 
Analysis from the HORIZONS-AMI Trial
Eugenia Nikolsky, Roxana Mehran, George D. Dangas, Alexandra 
Lansky, LeRoy Rabbani, Giulio Guagliumi, Ran Kornowski, Franz 
Hartmann, Martin Fahy, Bernard Witzenbichler, Jan Z. Peruga, Louise 
Gambone, Helen Parise, Gregg W. Stone, Cardiovascular Research 
Foundation, New York, NY
Learning Objective: To assess impact of early administration of 
heparin in patients with STEMI treated with primary PCI
POSTER CONTRIBUTIONS
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2501-439 Impact of Left Ventricular Function on Mortality 
in Patients with Acute Coronary Syndromes: 
Analysis of the Acute Catheterization and Urgent 
Intervention Triage Strategy (ACUITY) Trial
Alexandra J. Lansky, Vivian Ng, Kenji Goto, Martin Fahy, Roxana 
Mehran, Ramin Ebrahimian, Marial Hamond, E Magnus Ohman, 
Fred Feit, Steven Manoukian, Michael Lincoff, Gregg W. Stone, 
Cardiovascular Research Foundation, New York, NY
Learning Objective: The impact of LVEF on outcomes in ACS pts
2501-443 The Impact of Left Ventricular Function on Mortality 
in Patients with ST-segment Elevation Acute 
Myocardial Infarction: Analysis of the Harmonizing 
Outcomes with Revascularization and Stents in 
Acute Myocardial Infarction (HORIZONS-AMI) Study
Alexandra J. Lansky, Vivian Ng, Bernhard Witzenbichler, Giulio 
Guagliumi, Jan Z. Peruga, Kenji Goto, Helen Parise, Roxana Mehran, 
Gregg W. Stone, Cardiovascular Research Foundation, New York, NY
Learning Objective: To assess the impact of LVEF on outdcomes in 
STEMI pts undergoing PCI.
2501-444 Effect of Body Mass Index on Long-Term Mortality 
After Primary Percutaneous Coronary Intervention 
in Patients With Acute ST-Segment Elevation 
Myocardial Infarction
M. Fuad Jan, Abdul-Moiz Haﬁz, Naoyo Mori, Angela Schlemm, Anjan 
Gupta, Tanvir Bajwa, Anthony C. DeFranco, Suhail Allaqaband, 
Aurora Cardiovasc Svcs, Aurora Sinai/St. Luke’s Med Ctrs, Univ 
Wisconsin Sch Med & Public Health-MCC, Milwaukee, WI, Center 
for Urban Population Health, University of Wisconsin-Milwaukee, 
Milwaukee, WI
Learning Objective: demonstrate that body mass index significantly 
impacts the long-term mortality rate of STEMI patients undergoing 
primary percutaneous coronary intervention.
2501-445 Impact of Smoking and Alternative Antithrombotic 
Strategies on Outcomes of Patients with ST-
Segment Elevation Myocardial Infarction: 
Analysis from the Harmonizing Outcomes with 
Revascularization and Stents in Acute Myocardial 
Infarction (HORIZONS-AMI) Trial
Kenji Goto, Eugenia Nikolsky, Alexandra J. Lansky, Adriano Caixeta, 
Martin Fahy, George D. Dangas, Bernhard Witzenbichler, Giulio 
Guagliumi, Roxana Mehran, Gregg W. Stone, Cardiovascular 
Research Foundation, New York, NY
Learning Objective: demonstrate impact of smoking on outcomes 
of patients with STEMI treated with primary PCI using alternative 
antithrombotic strategies.
2501-446 Characteristics And Long-term Outcomes Of 
Elderly Patients With Acute Myocardial Infarction 
Complicated By Cardiogenic Shock Undergoing 
Percutaneous Coronary Interventions.
Francesco Tomassini, Andrea Gagnor, Emanuele Tizzani, Maria 
Cristina Marocco, Vincenzo Infantino, Maria Rosa Conte, Ferdinando 
Varbella, Rivoli, Italy
Learning Objective: to demonstrate the importance of 
revascularization in acute myocardial infarction complicated by 
cardiogenic shock
2501-433 Transradial vs. Transfemoral Approach for Primary 
Angioplasty in Acute Myocardial Infarction: Analysis 
from the HORIZONS-AMI Trial.
Adriano M. Caixeta, Philippe Généreux, Eugenia Nikolsky, Roxana 
Mehran, Alexandra J. Lansky, Bernhard Witzenbichler, Giulio 
Guagliumi, Jan Z. Peruga, Bruce R. Brodie, Dariusz Dudek, Ran 
Kornowski, Franz Hartmann, LeRoy Rabbani, Ecaterina Cristea, 
Shing-Chiu Wong, George D. Dangas, Martin Fahy, and Gregg W. 
Stone, Columbia University Medical Center and The Cardiovascular 
Research Foundation, New York, NY
Learning Objective: Toassess outcomes of pts who underwent PCI 
for STEMI using radial vs. femoral access
2501-435 Gender differences in Cardiac Pain Perception 
during Myocardial Ischemia
Harald Rittger, Johannes Rieber, Martin Schmidt, Anil-Martin Sinha, 
Ole-Alexander Breithardt, Manfred Duecker, Axel Jakob, Johannes 
Brachmann, Med. Klin. II, Klinikum Coburg, Coburg, Germany, 
Universitätsklinik Muenchen, Campus Innenstadt, Muenchen, 
Germany
Learning Objective: To know about different pain cardiac pain 
perception between men and women
2501-436 ST-Elevation Myocardial Infarction in the Modern 
Era: Have We Reduced the Gender Disparity?
Sara DeReath Collins, Itsik Ben-Dor, Gabriel Maluenda, Manuel 
Gonzalez, Michael A. Gaglia, Jr, Asmir I. Syed, Kohei Wakabayashi, 
Rebecca Torguson, Zhenyi Xue, Adrian D. Margulies, Nicholas 
Hanna, Cedric Delhaye, Kenneth M. Kent, Nelson Bernardo, Augusto 
D. Pichard, William O. Suddath, Lowell F. Satler, Ron Waksman, 
Washington Hospital Center, Washington, DC
Learning Objective: Identify causes for gender disparities in 
outcomes after Primary PCI for treatment of STEMI
2501-437 Impact of Gender on the Extent of Coronary 
Atherosclerosis and Plaque Characterization in 
Acute Coronary Syndromes: Insights from the 
PROSPECT Trial
Alexandra J. Lansky, Akiko Maehara, Gary Mintz, Vivian Ng, Susan 
Veldhof, Bernard de Bruyne, John McPherson, Ecaterina Cristea, 
Barry Templin, Helen Parise, Martin Fahy, Patrick W. Serruys, Gregg 
W. Stone, Cardiovascular Research Foundation, New York, NY
Learning Objective: To characterize sex differences in plaque 
vulnerability and composition in acute coronary syndromes
2501-438 Myocardial Perfusion Imaging Performance In 
The Predict Multi-center Trial; Gender Specific 
Analysis And Comparison With The Corus Cad Gene 
Expression Score
Alexandra J. Lansky, Michael R. Elashoff, Amy J. Sehnert, Hsiao 
D. Lieu, James A. Wingrove, Susan E. Daniels, Steven Rosenberg, 
Szilard Voros, Robert S. Schwartz, William E. Kraus, Eric J. Topol, 
Cardiovascular Research Foundation, New York, NY
Learning Objective: To understand that positive myocardial perfusion 
imaging results were not predictive of obstructive CAD in women 
and that the Corus CAD gene expression score added diagnostic 
value on a gender basis
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2501-453 Sustained Ventricular Arrhythmias add Prognostic 
value Independent of Underlying Risk in STEMI 
Patients Undergoing Primary Percutaneous 
Coronary Intervention
Rajendra H. Mehta, Aijing Z. Starr, Renato D. Lopes, Jonathan P. 
Piccini, Paul W. Armstrong, Christopher B. Granger, Duke Clinical 
Research Institute and Duke University Medical Center, Durham, NC, 
University of Alberta, Alberta, Canada
Learning Objective: To Demonstrate that the Association of 
Ventricular Arrhythmias with Outcomes in Patients Undergoing 
Primary PCI is Independent of Their Underlying Risk
2501-455 Increased Levels Of Circulating Endothelial 
Progenitor Cells In Intracoronary Blood Of ST-
Elevation Myocardial Infarction Patients Correlate 
With Microvascular Damage.
Italo Porto, Luigi M Biasucci, Giovanni Luigi De Maria, Luca Di Vito, 
Antonio M Leone, Giampaolo Niccoli, Alessandra Tritarelli, Giuliana 
Di Rocco, Maurizio Capogrossi, Filippo Crea, Catholic University of 
the Sacred Heart, Rome, Italy
Learning Objective: demonstrate the immediate recruitment 
of of endothelial progenitor cells in the culprit coronary artery, 
proportional to the amount of damaged microvasculature
2501-456 Mobilization of Endothelial Progenitor Cells and 
Neointima Formation after Implantation of EPC-
Capture Stents in NSTE-ACS (JACK-EPC randomized 
trial)
Wojciech Wojakowski, Andrzej Pyrlik, Marek Krol, Maciej Kazmierski, 
Andrzej Ochala, Pawel Buszman, Damian Kawecki, Andrzej Rudnik, 
Grzegorz Smolka, Krzysztof Milewski, Aleksander Zurakowski, 
Wieslaw Cybulski, Marek Kondys, Iwona Mroz, Michal Tendera, 
Medical University of Silesia, Katowice, Poland, American Heart of 
Poland, Ustron, Poland
Learning Objective: identify the mobilization of endothelial 
progenitor cells as one of the factors that influence the neointima 
formation
2501-457 Predictors Of Lipoprotein-associated Phospholipase 
A2 Mass And Activity Levels Among Patients With 
Stable And Acute Coronary Syndromes: A CREDO 
Biomarker Substudy
Herbert D. Aronow, W. H. Wilson Tang, Steven Steinhubl, Danielle 
Brennan, Robert Wilensky, Steven Marso, Peter Berger, Michael 
Wegner, Eric Topol, Michigan Heart & Vascular Institute, Ann 
Arbor, MI
Learning Objective: Describe predictors of Lp-PLA2 mass and 
activity levels among patients undergoing PCI.
2501-458 The Effect Of Platelet Reactivity On Infarct Related 
Artery Patency In Patients With ST-elevation 
Myocardial Infarction
Nicoline J. Breet, Carina ACM Pittens, Heleen J. Bouman, Jochem W. 
van Werkum, Jurrien M. ten Berg, Christian M. Hackeng, St.Antonius 
Ziekenhuis, Nieuwegein, The Netherlands, St.Antonius Center for 
Platelet Function Research, Nieuwegein, The Netherlands
Learning Objective: desrcibe the relationship between infarct-related 
artery patency and platelet reactivity
2501-447 Age and One-Year Mortality After ST Elevation 
Myocardial Infarction Treated With Primary 
Percutaneous Intervention
Bimmer Claessen, Wouter J. Kikkert, Karel T. Koch, Marije M. Vis, 
Jan Baan, Jr., Martijn Meuwissen, Robbert J. de Winter, Jan GP 
Tijssen, Jan J. Piek, José PS Henriques, Academic Medical Center, 
Amsterdam, The Netherlands
Learning Objective: Identify the importance of older age as a 
predictor for one-year mortality after primary PCI
2501-449 Patients Admitted with ST-segment Elevation 
Myocardial Infarction and a Normal or Near Normal 
Coronary Angiogram Have a Favorable Prognosis: 
Analysis from Horizons-AMI trial
Alf-Ing Larsen, Dennis WT Nilsen, Eugenia Nikolsky, Alexandra 
J. Lansky, Adriano Caixeta, Helen Parise, Martin Fahy, Ecaterina 
Criatea, Bernhard Witzenbichler, Giulio Guagliumi, Jan Z. Peruga, 
Bruce R. Brodie, Dariusz Dudek, Roxana Mehran, Gregg W. Stone, 
Stavanger University Hospital and The University of Bergen, Bergen, 
Norway
Learning Objective: To assess outcomes of patients with non-
obstructive CAD admitted for STEMI
2501-450 Diagnostic Uncertainty of 12-lead ECG for 
Diagnosing Posterior Wall Myocardial Infarction
SungSoo Kim, Myung Ho Jeong, Young Keun Ahn, Jeong Gwan Cho, 
Jong Hyun Kim, Shung Chull Chae, Young Jo Kim, Seung Ho Hur, 
In Whan Seong, Taek Jong Hong, Dong Hoon Choi, Myeong Chan 
Cho, Chong Jin Kim, Ki Bae Seung, Wook Sung Chung, Yang Soo 
Jang, Seung Woon Rha, Jang Ho Bae, Seung Jung Park, Chonnam 
National University Hospital, Gwang Ju, South Korea
Learning Objective: 12 lead ECG was not suitable for evaluate 
posterior wall myocardial infarction associated with left circumflex 
artery territory
2501-451 Mitral Regurgitation Predicts Long-Term Mortality 
Risk After Primary Percutaneous Coronary 
Intervention for Acute ST-Elevation Myocardial 
Infarction
Ahmed M. Uddin, Timothy D. Henry, James S. Hodges, Wesley R. 
Pedersen, Kevin M. Harris, Minneapolis Heart Institute Foundation 
at Abbott Northwestern Hospital, Minneapolis, MN
Learning Objective: Understand importance of mitral regurgitation in 
acute myocardial infarction 2501-452 
Impact of Peri-procedural Atrial Fibrillation on Short-term Clinical 
Outcomes Following Percutaneous Coronary Intervention
2501-452 Impact of Peri-procedural Atrial Fibrillation 
on Short-term Clinical Outcomes Following 
Percutaneous Coronary Intervention” above author 
block 
William Chan, Andrew E. Ajani, David J. Clark, Nick Andrianopoulos, 
Angela L. Brennan, Christopher M. Reid, Gishel New, Peter M. 
Kistler, Anthony M. Dart, Stephen J. Duffy, The Alfred Hospital, 
Melbourne, Australia
Learning Objective: evaluate the impact of peri-procedural atrial 
fibrillation on short-term clinical outcomes following percutaneous 
coronary intervention
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2501-464 Procedural Myocardial Protection by Short-term 
Atorvastatin Load is Related to Lower Levels of 
Adhesion Molecules After Percutaneous Coronary 
Intervention in Patients With Acute Coronary 
Syndromes. Results From the ARMYDA-ACS CAMs 
(Atorvastatin for Reduction of MYocardial Damage 
During Angioplasty-Cell Adhesion Molecules) 
Substudy
Laura Gatto, Giuseppe Patti, Massimo Chello, Elisabetta Ricottini, 
Diego Colonna, Elvio Covino, Marco Miglionico, Fabio Mangiacapra, 
Annunziata Nusca, Germano Di Sciascio, Campus Bio-Medico 
University, Rome, Italy, Second University of Naples, Naples, Italy
Learning Objective: to demonstrate that short-term atorvastatin 
load is associated with attenuation of endothelial inflammatory 
response in patients with ACS undergoing PCI
2501-489 Five-year Prognostic Value of No-reflow 
Phenomenon After Percutaneous Coronary 
Intervention in Patients with Acute Myocardial 
Infarction
Katrin A. Birkmeier, Gjin Ndrepepa, Klaus Tiroch, Julinda Mehilli, 
Melanie Nordmann, Patricia Alger, Isabell Bernlochner, Rene 
Vollenbroich, Julia Goedel, Julia Ellert, Adnan Kastrati, Albert 
Schömig, Deutsches Herzzentrum, Technische Universität, 
Munich, Germany, 1. Medizinische Klinik, Klinikum rechts der Isar, 
Technische Universität, Munich, Germany
Learning Objective: interpret the impact of no-reflow phenomenon 
on five-year mortality in patients with STEMI
2501-490 Distal Protection Can Preserve Index of 
Microcirculatory Resistance in Patients With 
ST-Segment Elevation Anterior Wall Myocardial 
Infarction
Noritoshi Ito, Shinsuke Nanto, Yasuji Doi, Hirotaka Sawano, Daisaku 
Masuda, Shizuya Yamashita, Mai Hatano, Daisuke Tonomura, Yuma 
Kurozumi, Tomoaki Natsukawa, Yusuke Ito, Kazuyuki Oka, Jiro Ooba, 
Taizo Hasegawa, Makoto Kobayashi, Hiroshi Ichiyanagi, Koji Akashi, 
Koichi Otsuya, Shoji Kaibe, Ken-ichiro Okada, Yasuyuki Hayashi, 
Tatsuro Kai, Toru Hayashi, Osaka Saiseikai Senri Hospital, Suita, 
Japan, Osaka University Graduate School of Medicine, Suita, Japan
Learning Objective: identify that distal protection can preserve index 
of microcirculatory resistance (IMR) after primary PCI in patients 
with anterior STEMI.
2501-491 Impact Of Thrombectomy With Export Catheter 
In Infarct Related Artery During Primary Pci On 
Procedural Outcome In Patients With Ami (EXPIRA 
Trial).The Importance Of Thrombectomy On Des 
Implantation Clinical Outcome Substudy.
Gennaro Sardella, Massimo Mancone, Emanuele Canali, Luigi 
Lucisano, Rocco Stio, Giulia Benedetti, Angelo Di Roma, Luciano 
Agati, Francesco Fedele, Dept.Cardiovascular Sciences,Policlinico 
Umberto I, Rome, MD, Italy
Learning Objective: To show the manual thrombectomy impact on 
primary PCI procedural and long term outcome in particular after 
DES implantation.
2501-459 Platelet-Derived Microparticles And C-Reactive 
Protein In Intracoronary And Peripheral Blood Of 
ST-Elevation Myocardial Infarction Patients.
Italo Porto, Luigi M Biasucci, Giovanni Luigi De Maria, Luca Di Vito, 
Francesco Burzotta, Antonio M Leone, Alessandra Tritarelli, Giuliana 
Di Rocco, Maurizio Capogrossi, Filippo Crea, Catholic University of 
the Sacred Heart, Rome, Italy
Learning Objective: evaluate the role of microparticles in the 
intracoronary thrombus formation
2501-460 The Use Of Bare-Metals Stents In Primary 
Percutaneous Coronary Intervention For Acute 
Myocardial Infarction: Is There A Difference In 
Clinical Outcome Between Cobalt Chromium Versus 
Stainless Steel Stents?
Angela Koh, Lok Man Choi, Lay Wai Khin, Ling Ling Sim, Terrance 
SJ Chua, Tian Hai Koh, Jack WC Tan, Stanley Chia, National Heart 
Centre, Singapore, Singapore
Learning Objective: Evaluate differences in clinical outcome 
between cobalt chromium versus stainless steel bare metal stents 
after PCI for Acute STEMI
2501-461 Everolimus-eluting Stent Shows Equivalency To 
First And Second Generation Drug-eluting Stents 
In Terms Of Major Cardiac Adverse Events At 
Short-term Follow-up After Primary Percutaneous 
Coronary Intervention In St-elevation Myocardial 
Infarction
kyounghoon Lee, Tae Hoon Ahn, Woong Chol Kang, Seung Hwan 
Han, In Suck Choi, Eak Kyun Shin, Gil Hospital, Gachon University, 
Incheon, South Korea, Gil Hospital, Gachon University, Incheon, 
South Korea
Learning Objective: evaluate
2501-462 Everolimus-Eluting Stents Suppress In Vivo Plaque 
Inflammatory Protease Activity As Detected By 
Intravascular Fluorescence Molecular Imaging
Marcella A. Calfon, Georgios Mallas, Amir Rosenthal, Alexander 
J. Sheehy, Igor Polyakov, R. Nika Razansky, Luis Guerrero, Adam 
Mauskapf, Frank Kolodgie, Renu Virmani, Ntziachristos Vasilis, 
Farouc Jaffer, Massachusetts General Hospital, Boston, MA
Learning Objective: To evaluate, using a novel in vivo intravascular 
catheter and NIRF molecular imaging, the anti-inflammatory effects 
of everolimus-eluting versus bare metal stents in rabbit atheromata.
2501-463 Microvascular Dysfunction Assessed by Coronary 
Flow Velocity Pattern as a Predictor of Left 
Ventricular Remodeling and Thrombus Formation in 
Patients with Anterior Acute Myocardial Infarction
Yoshimori An, Atsushi Yamamuro, Shuichiro Kaji, Makoto Kinoshita, 
Natsuhiko Ehara, Atsushi Kobori, Takeshi Kitai, Kitae Kim, Tomoko 
Tani, Toru Kita, Yutaka Furukawa, Kobe City Medical Center General 
Hospital, Kobe, CA, Japan
Learning Objective: demonstrate the efficacy of coronary flow 
velocity
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2501-497 Spatial Coronary Arterial Distribution of Non-Culprit 
Lesion Atherosclerotic Events: Analysis from the 
PROSPECT Trial.
Adriano M. Caixeta, Alexandra J. Lansky, Ecaterina Cristea, Bernard 
de Bruyne, John McPherson, Akiko Maehara, Gary S. Mintz, Roxana 
Mehran, Eugenia Nikolsky, Barry Templin, Patrick W. Serruys, and 
Gregg W. Stone, Columbia University Medical Center and the 
Cardiovascular Research Foundation, New York, NY
Learning Objective: To assess the incidence and angiographic 
location of major adverse cardiovascular events in a natural history 
study of atherosclerosis
2501-498 In Vivo Assessment of Vulnerable Plaque by 
Multislice Computed Tomography Comparison With 
Optical Coherence Tomography
Ito Tsuyoshi, Mitsuyasu Terashima, Mariko Ehara, Hitoshi Matsuo, 
Masashi Kimura, Kenya Nasu, Nobuyoshi Tanaka, Maoto Habara, 
Etsuo Tsuchikane, Yoshihisa Kinoshita, Yasushi Asakura, Osamu 
Kato, Takahiko Suzuki, Toyohashi Heart Center, Toyohashi, AL, Japan
Learning Objective: interpret
2501-500 Coronary Plaque Characteristics According to the 
Renal Function in Patients with Acute Myocardial 
Infarction: An Intravascular Ultrasound Analysis
Young Joon Hong, Gary S. Mintz, Myung Ho Jeong, Jum Suk Ko, 
Min Goo Lee, Keun Ho Park, Doo Sun Sim, Ju Han Kim, Youngkeun 
Ahn, Jeong Gwan Cho, Jong Chun Park, Neil J. Weissman, Jung 
Chaee Kang, Heart Center of Chonnam National University Hospital, 
Gwangju, South Korea, Cardiovascular Research Institute/Medstar 
Research Institute, Washington Hospital Center, Washington, DC
Learning Objective: to assess plaque characteristics in acute 
myocardial infarction patients with varying degrees of renal 
dysfunction.
2501-501 In Vivo Morphologic Analysis of Plaque Rupture in 
Culprit Lesions of Patients With Acute Coronary 
Syndromes. An Optical Coherence Tomography 
Study
Antonios Karanasos, Konstantinos Toutouzas, Andreas Synetos, 
Elefterios Tsiamis, Maria Drakopoulou, John Karambelas, Costas 
Tsiouﬁs, Dimitrios Tousoulis, Elli Stefanadi, Christodoulos 
Stefanadis, 1st Department of Cardiology, Hippokration Hospital, 
Athens, Greece
Learning Objective: distinguish the in vivo morphology of ruptured 
plaque
2501-502 Thinner Fibrous Cap and Greater Incidence of 
Plaque Rupture Characterize Culprit Lesions 
in Proximal Segments of Coronary Arteries as 
Assessed by Optical Coherence Tomography
Maria Riga, Konstantinos Toutouzas, Maria Drakopoulou, John 
Karampelas, Antonis Karanasos, Eleftherios Tsiamis, Dimitrios 
Tousoulis, Elli Stefanadi, Christodoulos Stefanadis, Hippokration 
Hospital, Athens, Greece
Learning Objective: Interpret the higher frequency of acute coronary 
syndromes in the proximal segments of coronary arteries
2501-492 Percutaneous Intervention of Acutely Occluded 
Saphenous Vein Grafts: Contemporary Techniques 
and Outcomes
Abdul_rahman R. Abdel-karim, Subhash Banerjee, Emmanouil S. 
Brilakis, Veteran Affairs North Texas Healthcare System, Dallas, TX, 
University of Texas Southwestern Medical Center, Dallas, TX
Learning Objective: Describe outcomes in patients with acutely 
occluded saphenous vein grafts undergoing percutanuous 
interventions
2501-493 Clinical Benefits of Thrombus Aspiration During 
Primary Percutaneous Coronary Intervention for 
Acute Myocardial Infarction
Ju Han Kim, Doo Sun Sim, Myeong Chan Cho, Hyo Soo Kim, 
Dong Ju Choi, Tae Jin Youn, Myung Ho Jeong, Chonnam National 
University Hospital, Gwangju, South Korea
Learning Objective: appreciate the need to revisit the effect of 
thrombus aspiration in patients with acute myocardial infarction 
undergoing primary percutaneous coronary intervention
2501-494 Association of Admission Hyperglycemia with 
Impaired Coronary Flow Velocity Pattern and Left 
Ventricular Remodeling in Patients with Acute 
Anterior Myocardial Infarction
Yoshimori An, Atsushi Yamamuro, Shuichiro Kaji, Makoto Kinoshita, 
Natsuhiko Ehara, Atsushi Kobori, Takeshi Kitai, Kitae Kim, Tomoko 
Tani, Toru Kita, Yutaka Furukawa, Kobe City Medical Center General 
Hospital, Kobe, CA, Japan
Learning Objective: To demonstrate the association between 
admission hyperglycemia and microvascular dysfunction
2501-495 Which Virtual Histology Intravascular Ultrasound 
Properties Discriminate Better Between Stable 
Angina Pectoris and Troponin Positive Acute 
Coronary Syndrome - Assessment of Plaques or 
Analysis of the Whole Coronary Artery Vasculature?
Patrick A. Calvert, Daniel Obaid, Nick E. West, Leonard M. Shapiro, 
Duncan McNab, Cameron G. Densem, Peter M. Schoﬁeld, Denise 
Braganza, Sarah C. Clarke, Michael O’Sullivan, Kausik K. Ray, 
Martin R. Bennett, Division of Cardiovascular Medicine, University of 
Cambridge, Cambridge, United Kingdom, Papworth NHS Foundation 
Trust Hospital, Cambridge, United Kingdom
Learning Objective: Describe the virtual histology intravascular 
ultrasound appears of coronary artery plaques that distinguish 
stable from vulnerable plaques which result in myocardial infarction
2501-496 Virtual Histology Intravascular Ultrasound 
Demonstrates Not Only Vessel Size But Also 
Dense Calcium Component Is Associated With 
Underexpansion Of Drug Eluting Stents In Patients 
With Acute Myocardial Infarction
Wang-Soo Lee, Sang-Wook Kim, Hak-Jin Kim, Jung-Eun Kim, Eun-
Jeong Cho, Kwang-Je Lee, Tae-Ho Kim, Chee-Jeong Kim, Wang-Seong 
Ryu, Chung-Ang University Hospital, Seoul, South Korea
Learning Objective: This demonstrates an impact of plaque 
composition on underexpansion, possible cause of stent 
thrombosis, coronary stenting in patients with acute myocardial 
infarction treated with drug eluting stent.
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2501-509 Safety And Efficacy Of Drug Eluting Stents And 
Bare Metal Stents For Saphenous Vein Graft 
Interventions- Comprehensive Meta-analysis Of 
Randomized Trials And Observational Studies 
Comprising 7994 Patients
Abdul Hakeem, Siddharth Munsif, Sabha Bhatti, Mohamed Effat, 
Massoud Leesar, Tarek Helmy, Imran Arif, University of Cincinnati, 
College of Medicine, Cincinnati, OH
Learning Objective: understand the safety and efficacy of drug 
sluting stent for saphenous vein graft lesions
2501-510 Risk Factor for Coronary Artery Aneurysm 
Formation as a Complication of Drug-Eluting 
Stent Implantation: The results of 3 year serial 
angiographic follow-up
Ung Kim, Dong-Kie Kim, Sang-Hoon Seol, Tae-Hyun Yang, Dae-
Kyeong Kim, Doo-Il Kim, Dong-Soo Kim, Inje University Busan Paik 
Hospital, Busan, South Korea
Learning Objective: This study identify risk factors for coronary 
artery aneurysm as a complication of drug-eluting stent
2501-511 What Is The Optimal Rate Of Drug-eluting Stent 
Use? Insights From Temporal Analysis Of The 
Multicenter Event Registry
Lakshmi VENKITACHALAM, Yang Lei, Joshua M. Stolker, Amit P. Amin, 
Jason B. Lindsey, Kevin F. Kennedy, Michael Pencina, John J. Lopez, 
Neil S. Kleiman, David J. Cohen, Saint Luke’s Mid America Heart 
Institute, Kansas City, MO
Learning Objective: Understand the temporal trend in prevalence of 
DES use and its impact on clinical outcomes at one year after PCI
2501-512 Cost-Effectiveness of “Off-Label” Drug Eluting Stent 
versus Bare Metal Stent Use
Pascha Schafer, Matthew Sacrinty, Michael A. Kutcher, Renato 
Santos, Sanjay K. Gandhi, William C. Little, Robert J. Applegate, 
Wake Forest University School of Medicine, Winston-Salem, NC
Learning Objective: To understand cost effectiveness analysis with 
the use of drug eluting stent and bare metal stent.
2501-514 Angiographic Features Related to Incomplete Stent 
Apposition in SPIRIT III Trial. A Quantitative Analysis 
of Vessel Curvature
Moyses Oliveira Lima-Filho, Alexandra J. Lansky, Masao Yamasaki, 
Junya Ako, Andreas Wahle, Ping Yu, Takao Shimohama, Katsuhisa 
Waseda, Bon-Kwon Koo, Daysaku Nakatami, Hiromasa Otake, 
Yasuhiro Honda, Krishnankutty Sudhir, Gregg W. Stone, Peter 
J. Fitzgerald, Center for Cardiovascular Technology - Stanford 
University, Stanford, CA, Columbia University Medical Center, New 
York, NY
Learning Objective: Evaluate the importance of coronary anatomy 
on the ocurrence of incomplete stent apposition
2501-503 In Vivo Comparison of Morphological Characteristics 
of Culprit Lesions Between Patients With ST 
Elevation Myocardial Infarction and Non ST 
Elevation Acute Coronary Syndrome. An Optical 
Coherence Tomography Study.
Maria Riga, Konstantinos Toutouzas, Antonis Karanasos, Maria 
Drakopoulou, John Karampelas, Eleftherios Tsiamis, Archontoula 
Michelongona, Costas Tsiouﬁs, Christodoulos Stefanadis, 
Hippokration Hospital, Athens, Greece
Learning Objective: Understand a part of the pathophysiological 
mechanisms responsible for the clinical onset of acute coronary 
syndromes, which are related to the morphological characteristics 
of vulnerable plaques.
2501-504 Incomplete Three-vessel Intravascular Imaging in 
the PROSPECT Trial: Implications for Pre-emptive 
Vulnerable Plaque Detection
Akiko Maehara, Gary S. Mintz, Alexandra J. Lansky, Ecaterina 
Cristea, Roxana Mehran, George Dangas, Barry Templin, John 
McPherson, Bernard de Bruyne, Naim Farhat, Bertil Wennerblom, 
Andrés Iñiguez, Steven Marso, Patrick W. Serruys, Gregg W. Stone, 
Cardiovascular Research Foundation and Columbia University 
Medical Center, New York City, NY
Learning Objective: To understand the limitations of intravascular 
imaging in VP detection
2501-506 Safety And Efficacy of Early Versus Delayed 
Intervention in Acute Coronary Syndromes 
Without ST-Segment Elevation: A Meta-Analysis of 
Randomized Trials
Param P. Singh, Rohit Bhuriya, Updesh S. Bedi, Janos Molnar, Rohit 
Arora, Chicago Medical School/RFUMS, North Chicago, IL
Learning Objective: Demonstrate safety and efficacy of early 
percutaneous coronary intervention in patients with acute coronary 
syndromes without ST-segment elevation
2501-507 Outcomes Of Patients With Acute Coronary 
Syndromes And Prior Coronary Artery Bypass 
Grafting: Analysis From The Acuity Trial
Eugenia Nikolsky, Roxana Mehran, E. Magnus Ohman, Michel E. 
Bertrand, A. Michael Lincoff, Jeffrey W. Moses, Ecaterina Cristea, 
Harvey D. White, Martin Fahy, Alexandra J. Lansky, Gregg W. Stone, 
Cardiovascular Research Foundation, New York, NY
Learning Objective: To assess outcomes of patients with ACS and 
prior CABG and impact of different antithrombotic therapies on 
prognosis in this high-risk population
2501-508 Pathology of Drug-Eluting Stents in Saphenous Vein 
Graft Lesions
Saami K. Yazdani, Fank D. Kolodgie, Renu Virmani, CVPath Institute, 
Gaithersburg, MD
Learning Objective: Demonstrate the pathologic response of 
saphenous vein grafts to drug eluting stents and bare metal stents.
JACC    March 9, 2010 ABSTRACTS: i2 Summit (Interventional Cardiology) A191
i2 Sum
m
it  
(Interventional Cardiology)
2501-521 Drug-Eluting Stent Use Continues to Decline, 
Especially in Acute Myocardial Infarction, Despite 
Resolution of the Controversy over Late Thrombosis
Leo Marcoff, Claudine T. Jurkovitz, Daniel Murphy, Paul Kolm, James 
R. Bowen, William S. Weintraub, Ehsanur Rahman, Christiana Care 
Health System, Newark, DE
Learning Objective: Describe temporal trends in the use of drug-
eluting stents
2501-522 Incidence and Predictors of Stent Thrombosis Up 
to 7 Years Follow-up Following Drug-Eluting Stent 
Implantation in Unselected Patients with Complex 
Coronary Lesions Treated in the Real-World Clinical 
Practice - A Subanalysis from the Drug-Eluting Stent 
In the REal World “DESIRE” Registry
Ricardo A. Costa, Amanda Sousa, Adriana Moreira, J. Ribamar 
Costa, Jr, Galo Maldonado, Manuel Cano, Fausto Feres, Luiz A. 
Mattos, Rodolfo Staico, Alexandre Abizaid, Cantídio Campos, 
Mariana T. Carballo, Otávio Berwanger, J. Eduardo Sousa, Hospital 
do Coração - Associação do Sanatório Sírio, Sao Paulo, NY, Brazil
Learning Objective: Demonstrate the late incidence and 
independent predictors of stent thrombosis following drug-eluting 
stent implantation in the real-world clinical practice
2501-523 Evaluation of Thienopyridine Compliance and Stent 
Thrombosis Rates after Everolimus-Eluting and 
Paclitaxel-Eluting Stent Implantation: 3-Year Results 
from the SPIRIT III Analysis
David Alan Cox, Krishnankutty Sudhir, James B. Hermiller, Robert 
J. Applegate, Paul C. Gordon, Julie Doostzadeh, Lalitha K. 
Jonnavithula, Kai Koo, Thomas H. Maloney, Alexandra J. Lansky, 
Charles A. Simonton, Gregg W. Stone, Lehigh Valley Hospital, 
Allentown, PA
Learning Objective: Evaluate differences in DES stent thrombosis 
rates in the SPIRIT-III Trial
2501-524 Impact of Bleeding on the Long-term Outcomes 
after Drug -Eluting Stent Implantation in the Real-
World Practice
Young-Hak Kim, Jong-Young Lee, Won-Jang Kim, Sung-Cheol Yun, 
Jung-Min Ahn, Junhyok Oh, Haegeun Song, Duk-Woo Park, Soo-Jin 
Kang, Seung-Whan Lee, Cheol Whan Lee, Seong-Wook Park, Seung-
Jung Park, Asan Medical Center, Seoul, South Korea
Learning Objective: identify clinical impact of bleeding
2501-531 Six Years Optical Coherence Tomography, 
Intravascular Ultrasound, and Quantitative Coronary 
Angiography Follow-up of Patients with Coronary 
Lesions Treated with the Biolimus A9-Eluting Stents 
with a Bioabsorbable Polymer
Ricardo A. Costa, Alexandre Abizaid, J. Ribamar Costa, Rodolfo 
Staico, Fausto Feres, Marinella Centermero, Vinicius Esteves, 
Dimytri Siqueira, Daniel Chamié, Luiz A. Mattos, Amanda Sousa, 
J. Eduardo Sousa, Eberhard Grube, Instituto Dante Pazzanese de 
Cardiologia, Sao Paulo, NY, Brazil
Learning Objective: Demonstrate the the very late (6 years) stent 
coverage pattern by OCT and angiograhpic and IVUS results in the 
biolimus A9-coated stent with a biodegradable polymer compared to 
bare metal stents
2501-515 Angiographic Patterns of Late Restenosis after 
Sirolimus-Eluting Stent Implantation: Serial 
(8-month and 2-year) Angiographic Follow-up
Nehiro Kuriyama, Yoshio Kobayashi, Tatsuya Nakama, Daigo 
Mine, Mitsuhiro Shimomura, Kensaku Nishihira, Katsumasa 
Nomura, Keiichi Ashikaga, Akihiko Matsuyama, Yoshisato Shibata, 
Department of Cardiology, Miyazaki Medical Association Hospital, 
Miyazaki, Japan, Department of Cardiovascular Science and 
Medicine, Chiba University Graduate School of Medicine, Chiba, 
Japan
Learning Objective: describe angiographic pattern of late restenosis 
after sirolimus-eluting stent implantation.
2501-516 Higher Baseline Inflammatory Burden is Associated 
with Worse Prognosis in Patients with Stable 
Coronary Artery Disease Undergoing Coronary 
Stenting
Nima Ghasemzadeh, Zohreh Forghani, Konstantinos Aznaouridis, 
Paddi K. Reddy, Christine DeStareck, Craig Hooper, Arshed A. 
Quyyumi, Kreton Mavromatis, Emory University, Atlanta, GA, Atlanta 
VA Medical Center, Decatur, GA
Learning Objective: Demonstrates predictors of prognosis in 
patients with stable coronary artery disease undergoing coronary 
stenting
2501-517 Long-term Survival Following Multivessel Versus 
Single-Vessel Percutaneous Coronary Interventions 
in the Contemporary Drug-Eluting Stent Era
Joseph M. Lee, S. Chiu Wong, Robert M. Minutello, Geoffrey 
Bergman, Issam Moussa, Dmitriy N. Feldman, New York 
Presbyterian Hospital - Weill Cornell Medical College, New York, NY
Learning Objective: evaluate long-term outcomes in patients 
undergoing multivessel versus single-vessel PCI
2501-518 Value Of The Syntax Score (SX) For Risk 
Assessment In The “All-comers” Population Of The 
Randomized Multicenter Leaders Trial.
Joanna J. Wykrzykowska, Scot Garg, Chrystaﬁos Girasis, Ton 
de Vries, Marie-angele Morel, Marie-angele Morel, Gerrit-Anne 
van Es, Pawel Buszman, Axel Linke, Thomas Ischinger, Volker 
Klauss, Roberto Corti, Franz Eberli, William Wijns, Marie-Claude 
Morice, Carlo di Mario, Robert Jan van Geuns, Peter Juni, Stephan 
Windecker, Patrick W. Serruys, Thoraxcenter, Erasmus MC, 
Rotterdam, The Netherlands
Learning Objective: Appreciate the need for new risk assessment 
tools in patients undergoing PCI.
2501-520 Differences in Coronary Intravascular Ultrasound 
Findings in Early, Late, and Very Late Stent 
Thrombosis After Sirolimus-eluting Stent 
Implantation.
Masashi Kimura, Soichiro Ebisawa, Nobuyoshi Tanaka, Kenya Nasu, 
Mariko Ehara, Tatsuya Ito, Yoshihisa Kinoshita, Etsuo Tsuchikae, 
Mitsuyasu Terashima, Yasushi Asaskura, Osamu Katoh, Takahiko 
Suzuki, Toyohashi Heart Center, Toyohashi, NY, Japan
Learning Objective: evaluate acute and long-term intravascular 
ultrasound (IVUS) findings in pts with ST.
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2502 DES II, RESTENOSIS, LEFT MAIN AND OUTCOMES
Sunday, March 14, 2010, 3:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m.
CME/CE Hours: 1
2502-418 Comparison Of Vascular Inflammation And 
Endothelial Function In Response To A New Nobori 
And Cypher Drug Eluting Stents In Pig Coronary 
Arteries
Jin-Shen Li, Lakshmana K. Pendyala, Daisuke Matsumoto, Sarah 
Geva, Toshiro Shinke, Dongming Hou, Jack P. Chen, Jaipal Singh, 
Nicolas Chronos, Saint Joseph’s Translational Research Institute/ 
Saint Joseph’s Hospital of Atlanta, Atlanta, GA
Learning Objective: evaluate endothelial function in DESs
2502-419 Is There A Difference In Vascular Response Between 
Biodegradable Polymer-based Versus Nonpolymer-
based Biolimus-eluting Stent? Short-term 
Intravascular Ultrasound Results From STEALTH And 
BioFreedom Trial
Byoung-Keuk Kim, Hiromasa Otake, Katsuhisa Waseda, Daisaku 
Nakatani, Kenji Sakata, Yoshihisa Shimada, Tomomi Koizumi, 
Yasuhiro Honda, Eberhard Grube, Peter J. Fitzgerald, Stanford 
university, Stanford, CA, Helios Heart Center, Siegburg, Germany
Learning Objective: The aim of this study was to evaluate potential 
impact of the different carrier systems such as nonpolymer or 
biodegradable polymer on vascular response to the Biolimus A9-
eluting stents.
2502-420 A Randomized Comparison Of Nobori Biolimus 
A9 Eluting Stent With Cypher Sirolimus Eluting 
Stent For Coronary Revascularization In Japanese 
Population
Toshiya Muramatsu, Masashi Iwabuchi, Shigeru Saito, Yasuhiko 
Hayashi, Yuji Ikari, Kenshi Fujii, Shinsuke Nanto, Naoto Inoue, 
Takeshi Kimura, Atsuo Namiki, Haruo Hirayama, Osamu Doi, Mitsuo 
Kashida, Junji Yajima, Kazuaki Mitsudo, Saiseikai Yokohama-city 
Eastern Hospital, Yokohama, Japan
Learning Objective: This is the world first RCT report of Nobori 
Biolimus Eluting stent compared to SES (Cypher) to know the level 
of efficacy and safety in a Japanese population.
2502-421 Preliminary Angiographic Results of the Novel 
Polymer-Free Biolimus-A9 Coated Stents for the 
Treatment of Coronary Artery Lesions - Four-
Month Angiographic Follow-Up of the Prospective, 
Randomized, Multicenter BIOFREEDOM Trial
Ricardo A. Costa, Alexandre Abizaid, Roxana Mehran, Alexandra 
J. Lansky, Marco A. Magalhaes, Louise Gambone, Helen Parise, 
Gerhard Schuler, Karl E. Hauptmann, Joachim Schofer, Eberhard 
Grube, Cardiovascular Research Center / Cardiovascular Research 
Foundation, Sao Paulo, NY, Brazil, Helios Heart Center, Siegburg, 
Germany
Learning Objective: Demonstrate the efficacy of a novel (third 
generation) polymer-free DES for inhibiting neointimal proliferation 
in non-complex de novo coronary lesions
2501-532 Are Second-Generation Drug-Eluting Stents 
Associated with Reduction of Periprocedural 
Myocardial Infarction Post-Percutaneous Coronary 
Intervention?
Kohei Wakabayashi, Loic Belle, Itsik Ben-Dor, Cedric Delhaye, Sara D. 
Collins, Nicholas N. Hanna, Manuel A. Gonzalez, Gabriel Maluenda, 
Rebecca Torguson, Zhenyi Xue, William O. Suddath, Lowell F. Satler, 
Kenneth M. Kent, Joseph Lindsay, Augusto D. Pichard, Ron Waksman, 
Washington Hospital Center, Washington, DC
Learning Objective: Xience V stent protected CPK-MB increase post 
PCI compared with the other DES. Xience V stent might reduce MI 
after PCI because of superior stent design.
2501-533 Performance of XIENCE V Everolimus-Eluting vs. 
TAXUS Express Paclitaxel-Eluting Coronary Stents in 
Small Vessels: Pooled Results of the SPIRIT III and 
SPIRIT IV Clinical Trials
James Bernard Hermiller, Jr., Robert Applegate, Julie Dootzadeh, 
Wesley Pierson, Aakar Shah, John Peterson, Krishnankutty Sudhir, 
Gregg Stone, St Vincent Heart Center of Indiana, Indianapolis, IN
Learning Objective: Identify the relative merits of EES vs PES Drug-
Eluting Stents in small vessel coronary artery disease
2501-534 Five-Year Clinical Outcomes of Sirolimus-Eluting 
Versus Paclitaxel-Eluting Stents in High Risk Patient 
Subsets: A Pooled Analysis of 3 Randomized Trials
Katrin A. Birkmeier, Adnan Kastrati, Robert A. Byrne, Klaus Tiroch, 
Heidrun Holle, Stefanie Schulz, Sebastian Kufner, Steffen Massberg, 
Karl-Ludwig Laugwitz, Albert Schömig, Julinda Mehilli, Deutsches 
Herzzentrum, Technische Universität, Munich, Germany, 1. 
Medizinische Klinik, Klinikum rechts der Isar, Technische Universität, 
Munich, Germany
Learning Objective: evaluate the long-term efficacy and safety of 
sirolimus- and paclitaxel-eluting stents
2501-535 Comparison of Clinical Outcomes Between 
Zotarolimus- and Sirolimus- Eluting Stents 
in Patients with ST-segment Elevation Acute 
Myocardial Infarction
Hyun Kuk Kim, Myung Ho Jeong, Youngkeun Ahn, Jong Hyun Kim, 
Shung Chull Chae, Young Jo Kim, Seung Ho Hur, In Whan Seong, 
Taek Jong Hong, Dong Hoon Choi, Myeong Chan Cho, Chong Jin 
Kim, Ki Bae Seung, Yang Soo Jang, Seung Woon Rha, Jang Ho Bae, 
Jeong Gwan Cho, Seung Jung Park, The Heart Center of Chonnam 
National University Hospital, Gwangju, South Korea
Learning Objective: identify clinical outcomes of DES in real-world 
STEMI
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2502-433 Prediction of 5-year Clinical Outcomes Using the 
SYNTAX Score in Patients Undergoing Percutaneous 
Coronary Intervention from the SIRolimus-Eluting 
Stent Compared with PacliTAXel-Eluting Stent for 
Coronary Revascularization (SIRTAX) Trial
Chrysaﬁos Girasis, Scot Garg, Lorenz Räber, Giovanna Sarno, Marie-
angèle Morel, Hector Garcia-Garcia, Patrick W. Serruys, Stephan 
Windecker, Thoraxcenter, Erasmus Medical Center, Rotterdam, The 
Netherlands, Department of Cardiology, University Hospital Bern, 
Bern, Switzerland
Learning Objective: evaluate the potential of the SYNTAX score to 
risk stratify patients with the wide range of coronary artery disease 
seen in daily clinical practice
2502-435 Persistent Benefit From Paclitaxel-Eluting Stent 
Implantation in Saphenous Vein Grafts: Long-Term 
Results of the Stenting Of Saphenous Vein Grafts 
(SOS) Trial
Christopher Lichtenwalter, James A. de Lemos, Owen Obel, Abdul-
rahman Riyad Abdel-karim, Michele Roesle, Donald Haagen, Bilal 
Saeed, Joseph K. Bissett, Rajesh Sachdeva, Vassilios V. Voudris, 
Panagiotis Karyoﬁllis, Biswajit Kar, James Rossen, Panayotis 
Fasseas, Peter Berger, Subhash Banerjee, Emmanouil S. Brilakis, 
Veterans Affairs North Texas Healthcare System, Dallas, TX, 
University of Texas Southwestern Medical Center, Dallas, TX
Learning Objective: Demonstrate that major cardiac adverse events 
are frequent after SVG stenting and paclitaxol-eluting stents are 
associated with better long-term clinical outcomes than BMS in SVG 
lesions.
2502-436 Plaque Sealing with Paclitaxel-Eluting Stents for the 
Treatment of Moderate Non-Significant Saphenous 
Vein Graft Lesions. Three-Year Follow-Up of the 
VELETI (Moderate Vein Graft Lesion Stenting with 
the Taxus Stent and Intravascular Ultrasound) Trial
Josep Rodés-Cabau, Olivier F. Bertrand, Eric Larose, Jean-Pierre 
Déry, Stéphane Rinfret, Rodrigo Bagur, Guy Proulx, Can M. Nguyen, 
Mélanie Côté, Marie-Claude Landcop, Jean-Rock Boudreault, 
Jacques Rouleau, Louis Roy, Onil Gleeton, Gérald Barbeau, Bernard 
Noël, Javier Courtis, Gilles R. Dagenais, Jean-Pierre Després, Robert 
DeLarochellière, Quebec Heart and Lung Institute, Laval University, 
Quebec, QC, Canada
Learning Objective: Evaluate the role of plaque sealing in 
saphenous vein grafts.
2502-437 Comparison of a Paclitaxel Eluting Stent with 
Biodegradable Polymer and Glycolix Coating versus 
Bare Metal Stent Design: First Presentation of 9 
Months Clinical and Angiographic Outcome of the 
Randomized, Multicenter and Controlled EUCATAX 
Trial(NCT00825279).
Alfredo E. Rodriguez, Federico C. Vigo, Alejandro Delacasa, Victor 
Bernardi, Marcelo Bettinotti, Omar Santaera, Valeria Curotto, Carlos 
Fernandez-Pereira, Bibiana Rubilar, Juan Mieres, David Antoniucci, 
Igor F. Palacios, Otamendi Hospital, Buenos Aires, MA, Argentina, 
Massachusetts General Hospital, Boston, MA
Learning Objective: Biodegradable polymers and glicolix coating 
are both associated with low complications. The purpose was 
to compare this novel DES technology with BMS in a real world 
population.
2502-422 Comparative Antirestenotic Efficacy Of 
Biodegradable Polymer And Permanent Polymer 
Drug-eluting Stents: The Angiographic Follow-up 
Results Of The ISAR-TEST-4 Randomized Trial
Sebastian F. Kufner, Robert A. Byrne, Stefanie Schulz, Katrin A. 
Birkmeier, Klaus Tiroch, Susanne Pinieck, Silvia Hurt, Jürgen Pache, 
Julinda Mehilli, Deutsches Herzzentrum, Technische Universität, 
Munich, Germany, 1. Medizinische Klinik, Klinikum rechts der Isar, 
Technische Universität, Munich, Germany
Learning Objective: evaluate the antirestenotic efficacy of 
biodegradable polymer stents and permanent polymer stents
2502-429 Predictors of Late Restenosis Following Sirolimus-
Eluting Stent Implantation: Serial (8-month and 
2-year) Angiographic Follow-up
Nehiro Kuriyama, Yoshio Kobayashi, Tatsuya Nakama, Daigo 
Mine, Mitsuhiro Shimomura, Kensaku Nishihira, Katsumasa 
Nomura, Keiichi Ashikaga, Akihiko Matsuyama, Yoshisato Shibata, 
Department of Cardiology, Miyazaki Medical Association Hospital, 
Miyazaki, Japan, Department of Cardiovascular Science and 
Medicine, Chiba University Graduate School of Medicine, Chiba, 
Japan
Learning Objective: describe the incidence and predictors of late 
restenosis after sirolimus-eluting stent implantation.
2502-430 Five-Year Clinical Outcome after Implantation of 
Sirolimus-Eluting Stents versus Paclitaxel-Eluting 
Stents in Unselected Patients with Coronary artery 
Disease: KOMATE DES Registry
Young-Guk Ko, Jung-Sun Kim, Donghoon Choi, Myeong-Ki Hong, 
Yangsoo Jnag, Pil Ki Min, Young Won Yoon, Bum-Kee Hong, Byoung 
Kwon Lee, Hyuck Moon Kwon, Severance Cardiovascular Hospital, 
Seoul, South Korea, Gangnam Severance Hospital, Seoul, South 
Korea
Learning Objective: demonstrate long-term outcomes of first 
generation DES
2502-431 Late-term Safety and Efficacy Outcomes Following 
Treatment with Zotarolimus-Eluting Stents: 5-year 
Results of the Pooled Endeavor Trials Program
David E. Kandzari, Martin B. Leon, William Wijns, Ian T. Meredith, 
Jean Fajadet, Donald E. Cutlip, Laura Mauri, Scripps Clinic, La 
Jolla, CA
Learning Objective: Evaluate 5-year efficacy and safety outcomes 
from the Endeavor Pooled Clinical Trials program.
2502-432 Five Year Clinical Results from ENDEAVOR III: A 
Randomized Comparison of the Zotarolimus-Eluting 
versus Sirolimus-Eluting Stents in De Novo Native 
Coronary Lesions
David E. Kandzari, Laura Mauri, Jeffrey Popma, Mark A. Turco, 
Charles O’Shaunessy, Paul A. Gurbel, Peter J. Fitzgerald, Martin B. 
Leon, Scripps Clinic, La Jolla, CA
Learning Objective: Evaluate if disparity in early angiographic 
measures translates to clinically relevant differences over late-term 
(5 year) follow-up.
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2502-447 Impact of Total Sirolimus-Eluting Stent Length 
on Three-Year Clinical Outcomes in the j-Cypher 
Registry
Shinichi Shirai, Takeshi Kimura, Masakiyo Nobuyoshi, Takeshi 
Morimoto, Kenji Ando, Yoshimitsu Soga, Kyohei Yamaji, Katsuhiro 
Kondo, Koyu Sakai, Takeshi Arita, Masahiko Goya, Masashi 
Iwabuchi, Hiroyoshi Yokoi, Hideyuki Nosaka, Kazuaki Mitsudo, 
j-Cypher registry investigators, Kokura Memorial Hospital, 
Kiktayushu, NY, Japan
Learning Objective: interpret that full lesion cover stent implantation 
was not the risk for stent thrombosis, but multiple stent implant for 
multiple lesion was the risk for stent thrombosis.
2502-449 Influence of Non-Uniform Stent Expansion on 
Neointimal Hyperplasia after Bare-Metal and 
Zotarolimus-Eluting Stents Implantation
Daisaku Nakatani, Katsuhisa Waseda, Hiromasa Otake, Junya 
Ako, Paul G. Yock, Peter J. Fitzgerald, Yasuhiro Honda, Stanford 
University Medical Center, Palo Alto, CA
Learning Objective: We demonstrated that stent expnasion might 
affect neointimal hyperplasia
2502-450 Neointimal Coverage on the Drug-Eluting Stent 
Struts Crossing the Side-Branch Vessels : An Optical 
Coherence Tomography Study
Ae-Young Her, Myeong-Ki Hong, Jae-Min Shim, Jung-Sun Kim, Young-
Guk Ko, Donghoon Choi, Yangsoo Jang, Yonsei Cardiovascular 
Center and Cardiovascular Research Institute, Seoul, YT, South 
Korea
Learning Objective: The present OCT study showed the presence of 
neointimal coverage on the stent struts crossing the side-branch 
vessels and different pattern of neointimal coverage according to 
different DES types.
2502-451 The Impact of Hinge Motion on In-Stent Restenosis 
after Sirolimus-Eluting Stent implantation
Yasushi Ino, Hironori Kitabata, Atsushi Tanaka, Takashi Kubo, 
Shigeho Takarada, Takashi Tanimoto, Kennichi Komukai, Kouhei 
Ishibashi, Keishi Ookouchi, Akio Kuroi, Aiko Shimokado, Kumiko 
Hirata, Masato MIzukoshi, Toshio Imanishi, Takashi Akasaka, 
Wakayama Medical University, Wakayama, Japan
Learning Objective: Measuring angle in the target lesion was 
performed easily and quickly before PCI. Selection of DES types 
based on angle before PCI may be effective on more reduction of 
ISR after DES implantation.
2502-452 Two Years Clinical Outcomes after Large Coronary 
Stent (4.0mm) Placement: Comparision of Bare-
Metal Stent versus Drug-Eluting Stent
Chang-Wook Nam, Yun-Kyeong Cho, Seung-Ho Hur, Kwon-Bae Kim, 
Hyun-Tae Kim, Young-Jo Kim, Jong-Seon Park, Sang-Hee Lee, Geu-Ru 
Hong, Ung Kim, Sang-Hoon Seol, Tae-Hyun Yang, Doo-Il Kim, William 
F Fearon, Keimyung University Dongsan Hospital, Daegu, South 
Korea, Stanford University Medical Center, Palo Alto, CA
Learning Objective: This study was aimed to identify the real value 
of DES in large vessel coroanry disease, compared to BMS
2502-438 Vascular Responses to a Newly Developed Coronary 
Stent (Nobori) Coated with the Bioabsorbable 
Polymer, Polylactic Acid and Biolimus A9
Hitomi Hagiwara, Masashige Sasaki, Yoshiaki Hiraishi, Hisako Terao, 
Junji Kimura, Katsumi Inoue, TERUMO Corporation, Kanagawa, 
Japan, Kurashiki Central Hospital, Japan
Learning Objective: evaluate long-term safety and efficacy of the 
newly developed DES (Nobori) in porcine coronary arteries.
2502-439 NOBORI Female Study- Clinical Outcomes at 12 
Months
Gian Battista Danzi, Sr., Marie Claude Maurice, Fina Mauri, Marcus 
Wiemer, Dragan Sagic, Farzin Fath-Ordoubadi, Antonio Serra, David 
Hildick-Smith, René Konig, Didier Carrie, Javier Goicolea Ruigomez, 
Miodrag Ostojic, Marcus Hennersdorf, Stefan Hoffmann, Ospedale 
Maggiore Policlinico, Milan, Italy
Learning Objective: Assess the specificity in PCI in female patients 
and evaluate the new stents with biodegradable polymer.
2502-443 Endothelial Dysfunction After Sirolimus-Eluting 
Stent Implantation Is Not Persistent
Hideki Kitahara, Yoshio Kobayashi, Nakabumi Kuroda, Issei Komuro, 
Chiba University Graduate School of Medicine, Chiba, Japan
Learning Objective: demonstrate that endothelial dysfunction after 
sirolimus-eluting stent implantation is not persistent.
2502-444 Stent Fracture and Angiographic Peri-Stent 
Abnormal Finding After Sirolimus-eluting Stent 
Implantation
Kazushige Kadota, Kazuaki Mitsudo, Tsuyoshi Goto, Satoki Fujii, 
Hiroyuki Yamamoto, Harumi Katoh, Naoki Oka, Yasushi Fuku, Shingo 
Hosogi, Yoshiharu Nishibori, Akitoshi Hirono, Takeshi Maruo, Hiroyuki 
Tanaka, Seiji Habara, Yoshikazu Shigemoto, Daiji Hasegawa, Ippei 
Kosedo, Hiroshi Tasaka, Masao Imai, Mana Kusunose, Yoji Okamoto, 
Suguru Otsuru, Naoki Saito, Kentaro Shibayama, Yuki Tsujimoto, 
Kurashiki Central Hospital, Kurashiki, Japan
Learning Objective: demonstrate the prevalence of stent fracture and 
angiographic peri-stent abnormal findinds and their clinical impact
2502-445 High Pressure Post-Dilatation Procedure May Induce 
Neointimal Coverage After Silolims-Eluting Stent 
Implantation
Masayuki Taniike, Masami Nishino, Takeshi Masaki, Naoki Mori, 
Daisuke Nakamura, Takahiro Yoshimura, Yasuharu Lee, Shimpei 
Nakatani, Masahiko Hara, Nobuhiko Makino, Yasuyuki Egami, 
Hiroyasu Kato, Ryu Shutta, Hitoshi Yamaguchi, Jun Tanouchi, Yoshio 
Yamada, Division of Cardiology, Osaka Rosai Hospital, Osaka, Japan
Learning Objective: demonstrate the useful procedure of stent 
implantaion without late stent thrombosis.
2502-446 Difference in Speed of Neointimal Proliferation 
Following Sirolimus-Eluting Stent Implantation 
According to Clinical and Lesion Characteristics
Hideo Amano, Kenji Wagatsuma, Mikihito Toda, Hideo Nii, Yasuto Uchida, 
Jyunichi Yamazaki, Division of interventional Cardiology, Cardiovascular 
Center, Toho University Omori Medical Center, Tokyo, Japan
Learning Objective: Neointimal proliferation was prone to occur early 
after SES implantation in calcification of the coronary artery,thoracic 
aorta, and late was prone to occur in stent fracture.
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2502-459 Lack of Value of Traditional Predictors for Restenosis 
After a Recurrent Drug-Eluting Stent Failure
Gabriel Maluenda, Manuel A. Gonzalez, Cedric Delhaye, Itsik Ben-Dor, 
Michael A. Gaglia, Nicholas N. Hanna, Kohei Wakabayashi, Asmir I. 
Syed, Rebecca Torguson, Zhenyi Xue, William O. Suddath, Kenneth 
M. Kent, Lowell F. Satler, Joseph Lindsay, Augusto D. Pichard, Ron 
Waksman, Washington Hospital Center, Washington, DC
Learning Objective: Recognize the lack of predictors for recurrent 
DES restenosis and the complexity of treating this population
2502-460 Reintervention for Drug Eluting Stent Restenosis: Is 
There a Preferred Strategy?
Maria Alexandra Rodriguez, Aaron Giltner, Michael P. Savage, Paul 
Walinsky, David Ogilby, Babu R. Jasti, David L. Fischman, Thomas 
Jefferson University Hospital, Philadelphia, PA
Learning Objective: Identify the optimal management for patients 
who present with a drug-eluting stent (DES) restenosis. Compare the 
outcomes of patients treated with the same vs. an alternate DES.
2502-461 Thin Versus Thick Strut Stent For Percutaneous 
Coronary Intervention Using Bare Metal Stents: 
Insights from the NHLBI PCI Dynamic Registry
Sripal Bangalore, Faith Selzer, Vankeepuram S. Srinivas, David O. 
Williams, David P. Faxon, Brigham and Women’s Hospital, Boston, MA
Learning Objective: Evaluate the efficacy and safety of thin versus 
thick strut bare metal stents
2502-462 Stainless Steel Versus Non-Stainless Steel Stents For 
Percutaneous Coronary Intervention Using Bare Metal 
Stents: Findings from the NHLBI PCI Dynamic Registry
Sripal Bangalore, Faith Selzer, David O. Williams, David P. Faxon, 
Brigham and Women’s Hospital, Boston, MA
Learning Objective: Evaluate the role of stent material on the risk of 
clinical outcomes in patients treated with a bare metal stent
2502-463 Impact of Myocardial Bridge on Clinical Outcome: 
In Cases of Sirolimus-eluting-stent implantation on 
Left Anterior Descending Coronary Artery
Daiji Hasegawa, Kazushige Kadota, Yuki Tsujimoto, Kentaro 
Shibayama, Naoki Saito, Suguru Otsuru, Yoji Okamoto, Mana 
Kusunose, Masao Imai, Hiroshi Tasaka, Ippei Kosedo, Yoshikazu 
Shigemoto, Seiji Habara, Hiroyuki Tanaka, Tekeshi Maruo, Akitoshi 
Hirono, Yoshiharu Nishibori, Shingo Hosogi, Yasushi Fuku, Naoki 
Oka, Harumi Katoh, Hiroyuki Yamamoto, Satoki Fujii, Tsuyoshi Goto, 
Kazuaki Mitsudo, Kurashiki Central Hospital, Kurashiki, Japan
Learning Objective: demonstrate the prevalence of myocardial 
bridging before and after implantation sirolimus-eluting-stent on left 
anterior descending coronary and the late outcome of lesions
2502-464 Clinical Presentation Of In-stent Restenosis And 
Angiographic Confirmed Stent Thrombosis In 
Patients Treated With Bare Metal Or Drug-eluting 
Stents. From Western Denmark Heart Registry
Per Thayssen, Lisette Okkels Jensen, Anne Kaltoft, Hans Henrik 
Tilsted, Michael Maeng, Evald Hoej Christiansen, Knud N. Hansen, 
Jan Ravkilde, Jan Ravkilde, Lars Krusell, Jens F. Lassen, Leif 
Thuesen, Odense University Hospital, Odense, Denmark
Learning Objective: Target lesion revascularization and clinical 
presentation
2502-453 Impact of Optimal Stent Expansion on Outcomes of 
Drug-eluting Stent Implantation for Small Coronary 
Vessels(≤2.75mm) as Assessed with Intracoronary 
Ultrasound
Hiroshi Yamaguchi, Nobuhiko Atsuchi, Junichiro Takaoka, Akihiro 
Miyamura, Takahiro Shirasawa, Ryuma Nakao, Junko Yoshinaga, 
Yoshihiko Atsuchi, Tenyoukai Central Hospital, Kagoshima, Japan
Learning Objective: demonstrate that optimal DES stenting using 
IVUS for small coronary artery diseases might result in favorable 
long-term outcomes.
2502-455 Gender Differences In Long-Term Clinical Outcome 
After Percutaneous Revascularisation Of Multivessel 
Coronary Artery Disease: Insights From Autax 
Registry
Mariann Gyongyosi, Rosa Badr-Eslam, Susanne Winkler, Noemi 
Nyolczas, Irene Lang, Günter Christ, Gerhard Kreiner, Dietmar 
Glogar, Medical University of Vienna, Vienna, Austria
Learning Objective: distinguish the gender differences in long-
term outcome of implantation of drug-eluting stents in multivessel 
diseases
2502-456 Low-Density Lipoprotein Cholesterol Levels 
Affect Peristent Plaque Tissue Characteristics in 
Patients Treated with Drug-Eluting Stents: A Serial 
Volumetric Analysis Using Quantitative Integrated 
Backscatter Intravascular Ultrasound (IB-IVUS)
Mitsuaki Endo, Kiyoshi Hibi, Noriaki Iwahashi, Naoki Nozawa, Jun 
Okuda, Kengo Tsukahara, Masami Kosuge, Toshiaki Ebina, Tsutomu 
Endo, Satoshi Umemura, Kazuo Kimura, Saiseikai Yokohama-City 
Southern Hospital, Yokohama, Japan, Yokohama City University 
Medical Center, Yokohama, Japan
Learning Objective: characterize peristent plaque tissue changes 
and investigate the relationship between lipid profiles and peristent 
plaque compositions using quantitative integrated backscatter 
intravascular ultrasoun
2502-457 Impact of High Density Lipoprotein Levels on 
Clinical Outcomes in Patients With Drug-eluting 
Stents
Inder M. Singh, Ryan J. Lennon, Thomas G. Allison, Abhiram 
Prasad, Mandeep Singh, David R. Holmes, Jr., Amir Lerman, 
Charanjit S. Rihal, Mayo Clinic (Division of Cardiovascular 
Diseases), Rochester, MN
Learning Objective: Evaluate the impact of high-density lipoprotein 
levels on clinical outcomes in patients with drug-eluting stents
2502-458 Both Hypoglycemia and Hyperglycemia are 
Associated With Increased Incidence of in-Stent 
Restenosis in Patients Undergoing Elective Coronary 
Angioplasty
Annunziata Nusca, Giuseppe Patti, Francesco Marino, Fabio 
Mangiacapra, Laura Gatto, Marco Miglionico, Rosetta Melﬁ, Andrea 
D’Ambrosio, Germano Di Sciascio, Campus Bio-Medico University, 
Rome, Italy
Learning Objective: to demonstrate that hypoglycemia and 
hyperglycemia are associated with increased incidence of in-stent 
restenosis
A196 ABSTRACTS: i2 Summit (Interventional Cardiology) JACC    March 9, 2010
i2
 S
um
m
it 
 
(I
nt
er
ve
nt
io
na
l C
ar
di
ol
og
y)
2502-494 In-Segment Angiographic Measurement at Follow-
up after Sirolimus-Eluting Stent Implantation is 
Strongly Associated with Late Restenosis, Not with 
Stent Thrombosis
Shinichiro Miyazaki, Yoshikazu Hiasa, Koichi Kishi, Takefumi 
Takahashi, Yudai Yano, Hirotoshi Chen, Keitaro Mahara, Riyo Ogura, 
Shinobu Hosokawa, Ryuji Ohtani, Tokushima Red Cross Hospital, 
Komatsushima, Japan
Learning Objective: distinguish that the moderate progression in the in-
segment area at 9-month follow-up angiography was strongly associated 
with late restenosis, but not with stent thrombosis after 1-year.
2502-495 Optical Coherence Tomography in Unprotected Left 
Main Coronary Artery Stenting
Guido Parodi, Akiko Maehara, MD, Gabriele Giuliani, MD, Takashi 
Kubo, MD, Gary Mintz, MD, Ruben Vergara, MD, Angela Migliorini, 
MD, Renato Valenti, MD, Nazario Carrabba, MD, David Antoniucci, 
MD, Careggi Hospital, Florence, Italy, Cardiovascular Research 
Foundation, New York, NY
Learning Objective: Evaluate
2502-496 Left Main Culprit Lesion Myocardial Infarction 
in Patients with Prior Coronary Bypass Grafting: 
Percutaneous Coronary Intervention Outcomes.
William B. Hillegass, Jr., Vijay K. Misra, Brigitta C. Brott, John C. 
Messenger, LLoyd W. Klein, Tracy Y. Wang, Silvio E. Papapietro, 
David Dai, Fang-Shu Ou, Gilbert J. Zoghbi, ACC-NCDR CathPCI 
Registry Participating Centers, University of Alabama at Birmingham, 
Birmingham, AL, Duke University Medical Center, Durham, NC
Learning Objective: Describe how prior CABG modifies the risk of 
PCI in left main culprit lesion myocardial infarction.
2502-497 Real World Application of Stenting of Unprotected 
Left Main Coronary Stenosis: A Single-Center 
Experience
Calvin Leung, Timothy C. Ball, Jeremiah R. Brown, Mandeep S. 
Sidhu, James T. Devries, John F. Robb, Aaron V. Kaplan, David J. 
Malenka, Craig A. Thompson, Dartmouth-Hitchcock Medical Center, 
Lebanon, NH
Learning Objective: Identify that percutaneous coronary intervention 
stenting of left main coronary artery is a viable option to coronary 
artery bypass grafting
2502-498 Comparison of Single Versus Two Stent Techniques 
in Treatment of Unprotected Left Main Coronary 
Artery Stenosis
Won-Jang KIM, Young-Hak Kim, Duk-Woo Park, Soo-Jin Kang, Seung-
Whan Lee, Cheol Whan Lee, Jae-Joong Kim, Seong-Wook Park, 
Seung-Jung Park, Asan Medical Center, Seoul, South Korea
Learning Objective: To compare single- versus two-stent technique 
in patients with unprotected left main coroanry artery disease who 
received drug-eluting stent
2502-500 Multicentric Prospective Spanish Registry Of Left 
Main Treatment: Renacimiento Registry
Jose Antonio Baz, Sr., Agustin Albarrán, Josepa Mauri, Eduardo 
Pinar, Renacimiento Investigators, Seccion de Hemodinamica y 
cardiología intervencionista, Madrid, Spain
Learning Objective: describe
2502-489 Impact of Target Lesion Revascularization on Death, 
Myocardial Infarction and Stroke in Patients With 
Sirolimus-eluting stent Implantation : Insights From 
j-CYPHER Registry
Kazuhiro Nakao, Mitsuru Abe, Takuya Taniguchi, Takafumi Yamane, 
Yukiko Oe, Futoshi Yamanaka, Nobuhito Yagi, Nobuaki Kokubu, 
Yoichiro Kasahara, Yu Kataoka, Yoritaka Otsuka, Takeshi Morimoto, 
Kazuaki Mitsudo, Takeshi Kimura, Hiroshi Nonogi, National 
Cardiovasculer Center, Osaka, Japan
Learning Objective: We evaluate the significance of target lesion 
revascularization after sirolimus-eluting stents implantation for 
adverse outcome. SES restenosis was also relatively benign event 
in DES era.
2502-490 Impact of Cilostazol on Restenosis After Cobalt-
Chromium Alloy Stent Implantation in High-Risk 
Patients
Hiroshi Ueda, Hiroki Sakamoto, Yuichi Kawase, Shinsaku 
Shimamoto, Tomoe Murakami, Takashi Tamura, Japanese Red Cross 
Society Wakayama Medical Center, Wakayama, Japan
Learning Objective: describe the different effects of cilostazol on 
restenosis after cobalt-chromium alloy stent implantation in high-
risk compared to low-risk patients
2502-491 Coronary Plaque Components Assessed by 
Virtual Histology-Intravascular Ultrasound Are Not 
Associated With Neointimal Hyperplasia in Patients 
Who Underwent Drug-Eluting Stent Implantation
Young Joon Hong, Myung Ho Jeong, Yun Ha Choi, Eun Hye Ma, 
Jum Suk Ko, Min Goo Lee, Keun Ho Park, Doo Sun Sim, Nam Sik 
Yoon, Hyun Ju Youn, Kye Hun Kim, Hyung Wook Park, Ju Han Kim, 
Youngkeun Ahn, Jeong Gwan Cho, Jong Chun Park, Jung Chaee 
Kang, Heart Center of Chonnam National University Hospital, 
Gwangju, South Korea
Learning Objective: to evaluate the relation between neointimal 
hyperplasia and plaque components after DES implantation
2502-492 Prognostic Impact of Preprocedural Levels of 
C-Reative Protein, Lipoprotein (a) and Homocysteine 
on the Long-Term Clinical Outcomes in Patients 
with Drug-Eluting Stents Implantation
Won-Jang KIM, Duk-Woo Park, Jong-Sun Park, Jun-Hyuk Oh, Hye-Gun 
Song, Jeong-Min Ahn, Soo-Jin Kang, Seung-Whan Lee, Young-Hak 
Kim, Cheol Whan Lee, Jae-Joong Kim, Seong-Wook Park, Seung-Jung 
Park, Asan Medical Center, Seoul, South Korea
Learning Objective: To evaluate the prognotic impact of 
preprocedural levels of C-reative protein, lipoprotein (a), and 
homocystein on long-term clinical outcomes after successfu 
implantation of drug-eluting stent
2502-493 Optical Coherence Tomography Findings of Lesion 
with Very Late Restenosis after Bare Metal Stent 
Implantation
Maoto Habara, Mitsuyasu Terashima, Yoshihiro Ko, Tsuyoshi Ito, 
Soichiro Ebisawa, Tairo Kurita, Nobuyoshi Tanaka, Kenya Nasu, 
Masashi Kimura, Tatsuya Ito, Yoshihisa Kinoshita, Mariko Ehara, 
Etsuo Tsuchikane, Yasushi Asakura, Osamu Kato, Takahiko Suzuki, 
Toyohashi Heart Center, Toyohashi, AL, Japan
Learning Objective: distinguish the difference of the mechanism 
between eraly restenosis and very late restenosis of bare-metal stent
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2502-508 A Novel Approach to Screening for Sudden Cardiac 
Death in Young Adults Utilizing a Stratified Method 
With ECG and Echo
Joseph C. Marek, Sarah A. Marek, Kathleen A. Marek, Frank 
Zimmerman, Johneen Davis, Midwest Heart Foundation, Lombard, IL
Learning Objective: evaluate young adults at risk for sudden cardiac 
death more efficiently with lower false positive ECGs
2502-509 Quality performance over time in Acute Coronary 
Syndrome patients admitted to a University Hospital
Irfan Hameed, Nandu Gourineni, Sharon Van Riper, Eva-Kline Rogers, 
Jim Froehlich, Elizabeth Jackson, Kim Eagle, University of Michigan, 
Ann Arbor, MI
Learning Objective: To evaluate the trends in ACS care & outcomes. 
At the conclusion of this presentations, participants will be able to 
understand theimportance of long term care.
2502-510 Development of Two Registry-based Measures 
Suitable for Characterizing Hospital Performance on 
30-day All-Cause Mortality Rates Among Patients 
Undergoing Percutaneous Coronary Intervention
Jeptha P. Curtis, Lori Geary, Yongfei Wang, Jersey Chen, Elizabeth E. 
Drye, Laura M. Grosso, Geoffrey Schreiner, John A. Spertus, John 
Rumsfeld, William S. Weintraub, Sharon-Lise T. Normand, Harlan M. 
Krumholz, Yale University School of Medicine, New Haven, CT
Learning Objective: Understand the attributes and performance 
of two registry-based models of PCI mortality that are suitable for 
characterizing hospital performance
2502-514 A Novel Risk Score for Percutaneous Coronary 
Intervention Outcome Assessment: Weighing the 
Importance of Complications After Procedure
Gabriel Maluenda, Cedric Delhaye, Michael A. Gaglia, Manuel A. 
Gonzalez, Itsik Ben-Dor, Nicholas N. Hanna, Kohei Wakabayashi, 
Rebecca Torguson, Zehnyi Xue, William O. Suddath, Lowell F. Satler, 
Kenneth M. Kent, Joseph M. Lindsay, Augusto D. Pichard, Ron 
Waksman, Washington Hospital Center, Washington, DC
Learning Objective: To identify the significance of post-procedural 
complications in the long term outcomes
2502-515 Is it Safe to Discharge Patients on the Same Day 
after Elective Percutaneous Coronary Intervention?
Andra M. Popescu, Leo Marcoff, Gilbert A. Leidig, Dan Murphy, 
William S. Weintraub, Ehsanur Rahman, ChristianaCare Health 
Systems, Newark, DE
Learning Objective: To identify potential candidates for early 
discharge after elective PCI.
2502-516 The Changing Profile of Medicare Patients 
Receiving Drug-Eluting Stents after Myocardial 
Infarction
Jerome Federspiel, Sally C. Stearns, Laura P. D’Arcy, Kristin L. Reiter, 
Brett C. Sheridan, Joseph S. Rossi, UNC School of Public Health, 
Chapel Hill, NC, UNC School of Medicine, Chapel Hill, NC
Learning Objective: Identify how interventionalists have changed the 
profile of patients receiving DES.
2502-501 What is the Best PCI Strategy with Sirolimus-Eluting 
Stent in Unprotected Left Main Coronary Arteries?
Kensuke Takagi, Ken Kujiraoka, Jun Tanno, Yusuke Fujino, Miwako 
Tsukiji, Naoyuki Kurita, Jin Yokoyama, Sunao Nakamura, New Tokyo 
Hospital, Chiba, Japan
Learning Objective: Describe the best strategy of Sirolimus-eluting 
stent in patients with left main coronary artery disease
2502-502 Comparison of Efficacy and Four-Year Durability 
between Sirolimus-Eluting Stent and Paclitaxel-
Eluting Stent in Unprotected Left Main Coronary 
Arteries: Multicenter Registry in Asia
Sunao Nakamura, Hisao Ogawa, Jang-Ho Bae, Yeo Hans 
Cahyadi, Wasan Udayachalerm, Damras Tresukosol, Sudaratana 
Tansuphaswadikul, New Tokyo Hospital, Chiba, Japan
Learning Objective: Describe the clinical efficacy and durability of 
SES and PES implantation in patients with unprotected left main 
coronary arteries.
2502-503 In-Hospital And One Year Survival Of Patients 
Undergoing Unprotected Left Main Coronary Artery 
Stenting Who Are Not Candidates For Coronary 
Artery Bypass Surgery
William Ng, Robert Lundstrom, Edward McNulty, Kaiser-San 
Francisco Medical Center, San Francisco, CA
Learning Objective: demonstrate feasibilty of unprotected left main 
stenting in nonsurgical candidate
2502-504 Five-Year Durability of Sirolimus-Eluting Stent in 
Patients with Unprotected Left Main Coronary 
Arteries Compared with Bare Metal Stents: 
Multicenter Registry in Asia
Sunao Nakamura, Hisao Ogawa, Jang-Ho Bae, Yeo Hans 
Cahyadi, Wasan Udayachalerm, Damras Tresukosol, Sudaratana 
Tansuphaswadikul, New Tokyo Hospital, Chiba, Japan
Learning Objective: Describe the clinical efficacy and durability of 
SES implantation in patients with unprotected left main coronary 
arteries.
2502-506 Assessing PCI Outcomes at 30 Days: Are We 
Moving Too Fast? A Report from the NHLBI 
Dynamic Registry
Mark J. Ricciardi, Warren K. Laskey, Faith Selzer, Oscar Marroquin, 
Elizabeth Holper, Lakshmi Venkitachalam, Sheryl Kelsey, University 
of New Mexico, Albuquerque, NM, University of Pittsburgh, 
Pittsburgh, PA
Learning Objective: Distinguish important difference between in-
hospital and 30 day outcomes after PCI
2502-507 The Canary in the Coal Mine: Percutaneous 
Coronary Intervention Rates Mirror Decline in CABG 
Volume. Trends in Coronary Revascularization in the 
U.S. From 2001-2008
Robert F. Riley, Creighton W. Don, Wayne Powell, Larry S. Dean, 
University of Washington Medical Center, Seattle, WA, Society for 
Cardiovascular Angiography and Interventions, Washington, DC
Learning Objective: describe trends in PCI within the U.S. from 
2001-2008
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2502-523 The Impact of Body Mass Index on the One year 
Outcome of Patients treated by PCI with Biolimus- 
and Sirolimus- eluting stents from the LEADERS 
Trial.
Giovanna Sarno, Scot Garg, Yoshinobu Onuma, Pawel Buszman, 
Axel Linke, Thomas Ischinger, Volker Klauss, Franz Eberli, Roberto 
Corti, William Wijns, Marie-Claude Morice, Carlo Di Mario, Pedro 
Eerdmans, Hector M. Garcia-Garcia, Gerrit-Anne van Es, Dick 
Goedhart, Ton de Vries, Peter Jüni, Bernhard Meier, Stephan 
Windecker, Patrick Serruys, Thoraxcenter Erasmus MC, Rotterdam, 
The Netherlands
Learning Objective: appreciate that BMI has an impact on the 
cardiac events post-PCI
2502-524 Percutaneous Coronary Intervention In Patients 
Post Surgical Revascularisation
Scot Garg, Giovanna Sarno, Juan Luis Gutiérrez-Chico, Joanna 
Wykrzykowska, Chrysaﬁos Girasis, Peter de Jaegere, Arie-Peter 
Kappetein, Ron van Domburg, Patrick Serruys, Erasmus Medical 
Center, Rotterdam, The Netherlands
Learning Objective: appreciate that despite PCI, patients having 
secondary revascularisation are at high risk of mortality,reinforcing 
the importance of maintaining secondary prevention post primary 
revascularisation
2502-531 Short- and Long-term Prognostic Impacts of 
Metabolic Syndrome and Chronic Kidney Disease in 
Patients after Acute Myocardial Infarction
Nobuaki Kokubu, Yoritaka Otsuka, Yukiko Oe, Takafumi Yamane, 
Futoshi Yamanaka, Nobuhito Yagi, Yoichiro Kasahara, Yu Kataoka, 
Yoichi Goto, Hiroshi Nonogi, Sapporo Medical University, Sapporo, 
Japan, National Cardiovascular Center, Suita, Japan
Learning Objective: understand short- and long-term prognostic 
impacts of metabolic syndrome and chronic kidney disease in 
patients after acute myocardial infarction
2502-532 Use of Drug-Eluting Stents Varies According to Type 
of Health Insurance
Michael Angelo Gaglia, Jr., Rebecca Torguson, Manuel A. Gonzalez, 
Zhenyi Xue, Itsik Ben-Dor, Sara D. Collins, Asimir I. Syed, Gabriel 
Maluenda, Cedric Delhaye, Kohei Wakabayashi, Nicholas Hanna, 
William O. Suddath, Kenneth M. Kent, Lowell F. Satler, Augusto D. 
Pichard, Ron Waksman, Washington Hospital Center, Washington, DC
Learning Objective: Describe the impact of health insurance type 
upon the likelihood of receiving a drug-eluting stent.
2502-533 Long-term Bleeding in Patients on Prolonged Dual 
Oral Antiplatelet Therapy after DES Implantation: 
Prevalence, Predictors, and Prognostic Implications
Roberta Rossini, Giuseppe Musumeci, Corrado Lettieri, Giuseppe 
Biondi Zoccai, Tamar Nijaradze, Nicola Cicorella, Nikoloz 
Lortkipanidze, Michele Romano, Giuseppe Tarantini, Antonello 
Gavazzi, Dominick J. Angiolillo, Ospedali Riuniti di Bergamo, 
Bergamo, Italy, University of Florida-Shands Jacksonville, 
Jacksonville, FL
Learning Objective: Identify the predictors and the prognostic 
implications of bleeding in patients on prolonged dual antiplatelet 
therapy
2502-517 Do Patients Undergoing Elective Percutaneous 
Coronary Intervention Understand Their Risk for 
Future Myocardial Infarction?
Alexis Ann D’Elia, Abdul Moiz Haﬁz, Srihari S. Naidu, Thomas 
Chengot, Kevin P. Marzo, Winthrop University Hospital, Mineola, NY
Learning Objective: Determine if patients understand the risk 
for future myocardial infarctions after percutaneous coronary 
intervention
2502-518 Primary Percutaneous Coronary Intervention In 
a Real Life Population: Comparison With Trial 
Findings
Lars Jakobsen, Troels Niemann, Torsten Toftegaard Nielsen, 
Niels Thorsgaard Pedersen, Søren Paaske Johnsen, Department 
of Clinical epidemiology, Aarhus University Hospital, Aarhus, PE, 
Denmark, Department of Internal Medicine & Cardiology, Herning 
Hospital, Herning, Denmark
Learning Objective: describe differences in patients characteristics, 
care and patient outcomes between patients receiving primary PCI 
in routine clinical setting and patients participating in the DANAMI-2 
trial
2502-520 Twenty-Four-Hour In-Hospital Interventional 
Cardiology Team and Impact on Door-to-Balloon 
Times: Surpassing the American College of 
Cardiology Door-to-Balloon Alliance Benchmark
M. Fuad Jan, Anthony C. DeFranco, Naoyo Mori, Angela Schlemm, 
Anjan Gupta, Suhail Allaqaband, Tanvir Bajwa, Aurora Cardiovasc 
Svcs, Aurora Sinai/St. Luke’s Med Ctrs, Univ Wisconsin Sch Med 
& Public Health-MCC, Milwaukee, WI, Center for Urban Population 
Health, University of Wisconsin-Milwaukee, Milwaukee, WI
Learning Objective: demonstrate that a 24x7 in-hospital 
interventional cardiology program can effectively shorten the 
door-to-balloon time and reperfuse a greater percentage of STEMI 
patients than the current ACC goal.
2502-521 Randomized Comparison of Transradial Coronary 
Angiography via Right or Left Radial Artery 
Approaches
Yumiko Kanei, Navin C. Nakra, Michael C. Liou, Hugo Rosero, 
Ramesh Gowda, Tak W. Kwan, John T. Fox, Beth Israel Medical 
Center, New York, NY
Learning Objective: describe the difference of right radial approach 
and left radial approach in coronary angiogram.
2502-522 A New Tool For The Risk Stratification Of Patients 
With Complex Coronary Artery Disease: The Clinical 
Syntax Score
Scot Garg, Giovanna Sarno, Chrysaﬁos Girasis, Hector M. Garcia-
Garcia, Joanna Wykrzykowska, Keith D. Dawkins, Patrick W. Serruys, 
Thoraxcenter, ErasmusMC, Rotterdam, The Netherlands
Learning Objective: Appreciate the need for new risk scores 
including both angiographic and clinical variables for patients 
undergoing PCI.
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2503-422 A Randomized Comparison of Sirolimus- Versus 
Paclitaxel-Eluting Stent for Treatment of Bifurcation 
Lesions by Single Stent and Kissing Ballooning: 
Results of SINGLE KISS trial
Kenya Nasu, Yuji Oikawa, Tadanori Aizawa, Takahiko Suzuki, Single 
Kiss Trial Investigators, Toyohashi Heart Center, Toyohashi, AL, 
Japan, The Cardiovascular Hospital, Minato-ku, AL, Japan
Learning Objective: understand the efficacy of single stent strategy 
for coronary bifurcation lesions
2503-429 Three-year Clinical and Angiographic Outcomes 
after implantation of Sirolimus-Eluting Stent with 
T-stenting Technique in Coronary Bifurcation Lesions 
from j-Cypher Registry.
Toshihiro Tamura, Takeshi Kimura, Kazuaki Mitsudo, Takeshi 
Morimoto, Kazushige Kadota, Yasuhiko Hayashi, Masakiyo 
Nobuyoshi, on behalf of the j-Cypher Registry investigators, Kyoto 
University Hospital, Kyoto, Japan
Learning Objective: to clarify the safety and efficacy of T-stenting 
technique in bifurcation lesions
2503-430 First-In-Man IVUS Findings Using the Medtronic 
Bifurcation Stent in Patients with Coronary 
Bifurcation Lesions
Kenji Sakata, Bon-Kwon Koo, Daisaku Nakatani, Katsuhisa Waseda, 
Junya Ako, Paul G. Yock, Yasuhiro Honda, Robert Whitbourn, 
Stephen Worthley, Ian Meredith, Peter J. Fitzgerald, BRANCH study 
investigators, Stanford University Medical Center, Stanford, CA
Learning Objective: demonstrate Medtronic Bifurcation Stent 
appears to be feasible yielding adequate stent coverage and 
expansion at carina and side branch ostium
2503-431 Single Sirolimus Versus Paclitaxel eluting Stent 
Implantation With Kissing Balloon Technique In The 
Treatment Of Non-left Main Bifurcation.
Masahiro Yamawaki, Toshiya Muramatsu, Reiko Tsukahara, Yoshiaki 
Ito, Tsuyoshi Sakai, Hiroshi Ishimori, Keisuke Hirano, Masatsugu 
Nakano, Shinya Sasaki, Motoharu Araki, Akiyoshi Moriyama, 
Hideyuki Takimura, Yasunari Sakamoto, Ikki Komatsu, Saiseikai 
Yokohama city eastern hospital, Yokohama, Japan
Learning Objective: identify clinical outcome of single stent strategy 
with final kissing balloon technique using Paclitaxel- and Sirolimus-
eluting stent, and predictor of angiographic restenosis at side 
branch ostium
2503-432 Bifurcation Angle and T-Stenting and Small 
Protrusion (TAP) Bifurcation Percutaneous Coronary 
Intervention Technique
Young Bin Song, Joo-Yong Hahn, Jin-Ho Choi, Seung-Hyuk Choi, Sang 
Hoon Lee, Hyeon-Cheol Gwon, Samsung Medical Center, Seoul, 
South Korea
Learning Objective: know low-bifurcation angle was not associated 
with increased incidence of MACE and TLR in patients undergoing 
bifurcation PCI using TAP technique.
2502-534 Impact of Cardiac Tamponade During PCI on Short 
and Long Term Survival
Ioannis A. Stathopoulos, Gary Roubin, Georgia Panagopoulos, 
Konstandinos Kossidas, Marcelo Jimenez, Ej Kwak, Monica 
Losquadro, Howard Cohen, Kirk Garratt, New York University, Ny, Ny, 
Lenox Hill Hospital, Ny, Ny
Learning Objective: understand incidence, management, short and 
long term outcome after tamponade complicating PCI
2503 INTRAVASCULAR DIAGNOSTICS AND COMPLEX 
LESIONS
Monday, March 15, 2010, 9:30 a.m. - 10:30 a.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m.
CME/CE Hours: 1
2503-418 Systemic Double Stenting versus Simple Provisional 
T-stenting for True Bifurcation Lesions of Left Main 
Coronary Artery Disease Using Drug-Eluting Stents: 
Multicenter Registry in Asia
Sunao Nakamura, Hisao Ogawa, Jang-Ho Bae, Yeo Hans 
Cahyadi, Wasan Udayachalerm, Damras Tresukosol, Sudaratana 
Tansuphaswadikul, New Tokyo Hospital, Chiba, Japan
Learning Objective: Suggest provisional T-stenting of the side 
branch is a feasible strategy associated with low MACE and low TLR 
in patients with left main trunk disease.
2503-419 Higher Restenosis At The Main And Side Branch 
Ostium Was Explained By Both Inadequate Stent 
Expansion And Increased Neointimal Proliferation 
After Coronary Bifurcation Stenting: Serial 
Intravascular Ultrasound Study
Hyeon-Cheol Gwon, Young Bin song, Joo Yong Hahn, Jin Ho Choi, 
Seung Hyuk Choi, Sang Hoon Lee, Samsung Medical Center, 
Sungkyunkwan University School of Medicine, Seoul, South Korea
Learning Objective: Indentify the mechanism of restenosis after 
coronary bifurcation mechanism, based on the IVUS image analysis
2503-420 Predictors and Mechanism of Lesion Progression at 
the Side Branch Ostium after Main Vessel Stenting: 
Serial Intravascular Ultrasound Analysis
Hahn Joo-Yong, Young Bin Song, Jin-Ho Choi, Seung-Hyuk Choi, 
Sang Hoon Lee, Hyeon-Cheol Gwon, Samsung Medical Center, 
Sungkyunkwan University School of Medicine, Seoul, South Korea
Learning Objective: To identify predictors and mechanism of lesion 
progression at the side branch ostium after 1-stent technique
2503-421 Long Term Results For The Diverge Trial: 1 And 2 
Year Clinical Outcomes For The Axxess Bioliums A9 
Eluting Self Expanding Stent For The Treatment Of 
De Novo Bifurcation Lesions
Alexandra J. Lansky, Stefan Verheye, John Ormiston, Christophe 
Dubois, Ecaterina Cristea, Roxana Mehran, Brett Trauthen, Rachel 
Johnson, Cardiovascular Research Foundation, New York, CA, Devax, 
Irvine, CA
Learning Objective: To underdstand outcomes and performance of a 
self expandinding stent in a bifurcation
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2503-439 Long Term Safety and Prognosis of Ultra Long 
Sirolimus-Eluting Stent Implantation
Ren Kawaguchi, Hakuken Kan, Eiji Yamashita, Takuji Toyama, Hiroshi 
Hoshizaki, Shigeru Oshima, Gunma Prefectural Cardiovascular 
Center, Maebashi, Japan
Learning Objective: evaluate the long term safety and efficacy of 
sirolilus-eluting stent implantation for the ultra long lesion which is 
one of the concerned issues because of that might has frequent 
stent thrombosis
2503-443 Drug-Eluting Stents for the Treatment of Chronic 
Total Occlusion: A Comparison with Sirolimus, 
Paclitaxel, Zotarolimus, BiolimusA9, EPC Capture 
and Everolimus-Eluting Stent: Multicenter Registry 
in Asia
Sunao Nakamura, Shotaro Nakamura, Hisao Ogawa, Jang-Ho Bae, 
Yeo Hans Cahyadi, Wasan Udayachalerm, Damras Tresukosol, 
Sudaratana Tansuphaswadikul, New Tokyo Hospital, Chiba, Japan
Learning Objective: Describe the clinical efficacy of SES, PES, ZES, 
BES, ECS and EES implantation in patients with chronic total occlusion 
which is safe, low restenosis rate and low incidence of complication.
2503-444 Four-Year Durability of Sirolimus-Eluting Stent in 
Patients with Chronic Total Occlusions Compared 
with Bare Metal Stent: Multicenter Registry in Asia
Sunao Nakamura, Hisao Ogawa, Jang-Ho Bae, Yeo Hans 
Cahyadi, Wasan Udayachalerm, Damras Tresukosol, Sudaratana 
Tansuphaswadikul, New Tokyo Hospital, Chiba, Japan
Learning Objective: Describe the clinical efficacy and durability of 
SES implantation in patients with chronic total occlusion which 
is safe, low restenosis rate and low incidence of complication 
compared with BMS.
2503-445 Recanalization Pattern of Porcine Coronary Chronic 
Total Occlusions.
Paul Fefer, III, Beiping Qiang, Nigel Munce, Normand Robert, Kevan 
J. Anderson, Xui Ling Qiang, Max Weisbrod, Graham A. Wright, 
Bradley H. Strauss, Sunnybrook Health Sciences Centre, Toronto, 
ON, Canada
Learning Objective: Identify patterns of neovascularization in CTOs
2503-446 Serial Angiographic Follow-Up after Successful 
Implantation of Sirolimus-Eluting Stent and 
Paclitaxel-Eluting Stent for Chronic Total Occlusions: 
Multicenter Registry in Asia
Sunao Nakamura, Hisao Ogawa, Jang-Ho Bae, Yeo Hans 
Cahyadi, Wasan Udayachalerm, Damras Tresukosol, Sudaratana 
Tansuphaswadikul, New Tokyo Hosipital, Chiba, Japan
Learning Objective: Describe a different timing of late catch up 
phenomenon after successful implantation of SES and PES in 
patients with chronic total occlusion.
2503-447 Long-term Clinical Outcomes of Patients With 
Sirolimus-Eluting Stent Fracture
Ung Kim, Dong-Kie Kim, Sang-Hoon Seol, Tae-Hyun Yang, Dae-
Kyeong Kim, Doo-Il Kim, Dong-Soo Kim, Inje University Busan Paik 
Hospital, Busan, South Korea
Learning Objective: This study demonstrates long-term outcomes of 
patients with sirolimus-eluting stent fracture
2503-433 NOBORI Bifurcation Study
Gian Battista Danzi, Sr., Fina Mauri Ferre, Petr Kala, Marcus Wiemer, 
Farzin Fath-Ordoubadi, Rene Koning, Didier Carrie, William Wijns, 
Javier Goicolea Ruigomez, Nick West, Antonio Serra, Zoran Perisic, 
Nikola Jagic, Vladimir Miloradovic, Ospedale Maggiore Policlinico, 
Milan, Italy
Learning Objective: assess biodegradable polymer and Biolimus A9 
as a possible treatment option for bifurcation stenting
2503-435 6-months outcomes of the Placlitaxel Eluting 
Balloon for the treatment of In-stent Restenosis and 
Small Vessel Disease: Insights from the Spanish 
Multicenter Registry
beatriz vaquerizo, Antonio Serra, Faustino Miranda, Vanesa 
Martinez, Jose Antonio Gómez-Hospital, Angel Cequier, Andrés 
Iñiguez, José Antonio Baz, Guillermo Bastos, Eduardo Fernández, 
Oriol Rodríguez, Josepa Mauri, Mario Sádaba, José Ramón 
Rumoroso, Asier Subinas, Rafael Gracía-Borbolla, Antonio Gómez, 
Jesús Oneto, Antonio Martínez, Francisco Bossa, Sara Rodríguez, 
Raul Moreno, Alejandro Saez, Del Mar Hospital, Barcelone, Spain
Learning Objective: “describe” In some situations the use of BMS 
or DES may be considered inappropriate or harmful because its 
association with a high risk of restenosis and/or stent thrombosis 
the use of this new paclit
2503-436 Frequency and Predictors of Drug-Eluting 
Stent Use in Saphenous Vein Bypass Graft 
Percutaneous Coronary Interventions: A Report 
from the American College of Cardiology - National 
Cardiovascular Data Registry
Emmanouil S. Brilakis, Tracy Y. Wang, Sunil V. Rao, Subhash 
Banerjee, David Dai, Chee T. Chin, Tina M. Harding, Matthew T. Roe, 
VA North Texas Healthcare System and UT Southwestern Medical 
Center, Dallas, TX, Duke Clinical Reseach Institute, Durham, NC
Learning Objective: identify factors associated with use of drug-
eluting stents in saphenous vein graft lesions
2503-437 Drug-eluting Stents Versus Bare Metal Stents In 
Saphenous Vein Graft Lesions: A Meta-analysis Of 
22 Clinical Comparative Trials
Feng Zhang, Lili Dong, Junbo Ge, Shanghai Institute of 
Cardiovascular Diseases, Zhongshan Hospital, Fudan University, 
Shanghai, People’s Republic of China
Learning Objective: show that DES is superior to BMS in 
reducing the incidences of all-cause death, TVR and MACE, with 
nonsignificant differences in terms of non-fatal myocardial infarction 
and stent thrombosis.
2503-438 Long Term (5 Years) Outcomes in Patients with 
Unprotected Left Main Coronary Artery Stenosis 
Treated with Drug-Eluting Stent Implantation: a 
Single Center Experience.
Valeria Magni, Alaide Chieffo, Alfonso Ielasi, Matteo Montorfano, 
Azeem Latib, Cosmo Godino, Mauro Carlino, Iassen Michev, Antonio 
Colombo, San Raffaele Hospital, Milan, Italy, EMO GVM Centro 
Cuore Columbus, Milan, Italy
Learning Objective: long term follow up after percutaneous 
treatment of left main coronary artery lesions
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2503-456 Pediatric 64-channel Ct Angiography: Technical 
And Clinical Applications In 1548 Consecutive 
Examinations
Jeffrey Hellinger, Michael Poon, Monica Epelman, Stony Brook 
University, Stony Brook, NY, The Childrens Hospital of Philadelphia, 
Philadelphia, PA
Learning Objective: Understand Pediatric CTA technique and 
applications
2503-457 Clinical Efficacy and Long Term Outcomes of CT 
Guided Percutaneus Coronary Intervention
Michael C.L. Lim, Catherine G. de Larrazabal, Levinia M. Devaraj, 
June Yang, Singapore Medical Specialists Centre, Singapore, 
Singapore
Learning Objective: understand the benefits of CT guided 
percutaneous coronary intervention
2503-458 Coronary Plaque Burden by Quantitative Coronary 
Angiography Correlates with Plaque Burden by CT 
Coronary Angiography and Intravascular Ultrasound
Anna M. Kalynych, Gustavo Vazquez, Dimitri Karmpaliotis, Zhen 
Qian, Eric Krivitsky, Idean B. Marvasty, Sarah Rinehart, Szilard 
Voros, Piedmont Heart Institute, Atlanta, GA
Learning Objective: Coorelation of 3D-CTA and IVUS is stronger than 
QCA and IVUS
2503-459 Composition of Coronary Atherosclerotic Plaques 
in Diabetic and Non-diabetic Patients determined 
by 64-row Multidetector Computed Tomographic 
Angiography
Jae-Sik Jang, Yong-Seop Kwon, Chang-Won Lee, June-Hyung Kim, 
Inje University Haeundae Paik Hospital, Busan, South Korea, Busan 
St. Mary’s Hospital, Busan, South Korea
Learning Objective: identify high risk coronary atherosclerotic 
plaques in high risk diabetic patients
2503-460 The Coronary Wall by OCT in Patients with Coronary 
Spasm
Olivia Manfrini, Edoardo Verna, Jorge A. Salerno Uriarte, Antonio 
Bartorelli, Cesare Fiorentini, Raffaele Bugiardini, Univerity of 
Bologna, Bologna, Italy
Learning Objective: understand that OCT does not recognize any 
typical structural feature for coronary segments having spasm
2503-461 Long-term (>2 Years) Follow-up Results Of 
Sirolimus- And Paclitaxel-eluting Stent In Optical 
Coherence Tomography: Comparison To 9-months 
Follow-up Results
Tae Hoon Kim, Jung-Sun Kim, Young-Guk Ko, Donghoon Choi, 
Myeong-Ki Hong, Yangsoo Jang, Won Heum Shim, Seung Yun Cho, 
Severance Cardiovascular Hospital, Seoul, South Korea
Learning Objective: Our OCT data demonstrated that neointimal 
coverage 2 years after SES stent implantation is not sufficient.
2503-449 The Effects Of Combination Of Felodipine And 
Ramipril On Regression And Compositional 
Changes Of Plaque In Patients With Hypertension 
And Angina With Mild To Moderate Degree Of 
Coronary Stenosis
Young Joon Hong, Myung Ho Jeong, Yun Ha Choi, Eun Hye Ma, 
Jum Suk Ko, Min Goo Lee, Keun Ho Park, Doo Sun Sim, Nam Sik 
Yoon, Hyun Ju Youn, Kye Hun Kim, Hyung Wook Park, Ju Han Kim, 
Youngkeun Ahn, Jeong Gwan Cho, Jong Chun Park, Jung Chaee 
Kang, Heart Center of Chonnam National University Hospital, 
Gwangju, South Korea
Learning Objective: to assess the efficacy of combination therapy of 
felodipine and ramipril
2503-450 Radiation Induced Lens Opacities In The Eyes Of 
Cath Lab Staff
Kui-Hian Sim, Madan Rehani, Norman Kleiman, Olivera Ciraj-Bjelac, 
Eliseo Vano, International Atomic Energy Agency, Vienna, Austria, 
Sarawak General Hospital, Kuching, Malaysia
Learning Objective: Radiation Protection for Cardiologists
2503-451 Clinical Determinants of Radiation Skin Dose in 
Adult Percutaneous Coronary Intervention
Kenneth A. Fetterly, Ryan J. Lennon, Malcolm R. Bell, David R. 
Holmes, Jr., Charanjit S. Rihal, Mayo Clinic, Rochester, MN
Learning Objective: Identify the clinical determinants of radiation 
skin dose for adult percutaneous coronary intervention.
2503-452 Role of ECHO Doppler in Detection of Radial 
Artery Anomalies Prior to Transradial Access for 
Interventions
Anand Gnanaraj, Suma M. Victor, Vijayakumar Subban, Rajendra 
Deshmukh, Thomas George, Ezhilan Janakiraman, Ulhas 
Pandurangi, Latchumanadhas kalidoss, Mullasari Ajit sankaradoss, 
Institute of Cardiovascular diseases, Madras Medical Mission, 
Chennai, India
Learning Objective: Identify the importance of preprocedural 
verification of radial artery anomalies.
2503-453 Assessment of Common Femoral Angiograms 
during Cardiac Procedures in the Morbidly Obese
Douglas B. Bogart, Dan Sun, Mohammed Al-Amoodi, Lori Wayne, 
Martha Bogart, University of Missouri-Kansas City, Kansas City, MO, 
Truman Medical Center, Kansas City, MO
Learning Objective: Utilize the common femoral angiogram to guide 
femoral artery access the the morbidly obese patient
2503-455 Characterization of Coronary Atherosclerotic 
Plaques by Multislice Computed Tomography. 
Comparison With Optical Coherence Tomography
Ito Tsuyoshi, Mitsuyasu Terashima, Mariko Ehara, Hitoshi Matsuo, 
Masashi Kimura, Kenya Nasu, Maoto Habara, Nobuyoshi Tanaka, 
Yasushi Asakura, Yoshihisa Kinoshita, Etsuo Tsuchikane, Osamu 
Kato, Takahiko Suzuki, Toyohashi Heart Center, Toyohashi, AL, Japan
Learning Objective: evaluate
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2503-491 New Index of Microvascular Resistance Reserve for 
Evaluating Microvascular Dysfunction in Patients 
With Diabetes Mellitus
Koichi Tamita, Atsuhi Yamamuro, Syuichiro Kaji, Minako Katayama, 
Yutaka Furukawa, Nishinomiya Watanabe Cardiovascular Center, 
Nishinomiya, Japan, Kobe City Medical Center General Hospital, 
Kobe, Japan
Learning Objective: To evaluate microvascular dysfunction in 
patients with diabetes mellitus using by intracoronary Doppler and 
pressure guide wire
2503-492 Coronary Artery Remodeling and Plaque 
Composition in Non Infarct Related Coronary 
Arteries in Patients Presenting with ST Segment 
Elevation Myocardial Infarction: Where is the 
Necrotic Core?
Rasmus Egede, Lisette O. Jensen, Gary S. Mintz, Knud N. Hansen, 
Knud E. Pedersen, Anders Junker, Henrik S. Hansen, Per Thayssen, 
Department of Cardiology, Odense University Hospital, Odense, 
Denmark, Cardiovascular Research Foundation, New York, NY
Learning Objective: describe the minimum lumen area site and 
the maximum necrotic core sites in regard to the definition and 
location.
2503-493 Does The Second Generation OCT Improve Safety 
And Feasibility In Clinical Practice? A Single Center 
Experience
Takayuki Okamura, Nieves Gonzalo, Juan Luis Gutierrez Chico, 
Patrick W. Serruys, Robert J. van Geuns, Willem J. van der Giessen, 
Jurgen M. Ligthart, Gijs van Soest, Guillermo J. Tearney, Brett E. 
Bouma, Evelyn Regar, Thoraxcenter, Erasmus MC, Rotterdam, The 
Netherlands, Massachusetts General Hospital, Boston, MA
Learning Objective: appreciate the safety and feasibility of using the 
new generation optical coherence tomography.
2503-494 Reproducibility of In-vivo Coronary Fourier Domain 
Optical Coherence Tomography
Takayuki Okamura, Nieves Gonzalo, Juan Luis Gutierrez Chico, 
Patrick W. Serruys, Nico Bruining, Robert J. van Geuns, Jurgen M. 
Ligthart, Gijs van Soest, Evelyn Regar, Thoraxcenter, Erasmus MC, 
Rotterdam, The Netherlands
Learning Objective: appreciate that optical coherence tomography 
is a reliable tool for the in-vivo measurement of stent and lumen 
dimensions.
2503-495 Evaluation of Side Branch Opening Using Three 
Dimensional Visualization of New Generation 
Optical Coherence Tomography after Bioabsorbable 
Everolimus Eluting Stent Implantation
Takayuki Okamura, Yoshinobu Onuma, Juan Luis Gutierrez Chico, 
Evelyn Regar, Patrick W. Serruys, Thoraxcenter, Erasmus MC, 
Rotterdam, The Netherlands
Learning Objective: evaluate side-branch jailed by BVS struts with 
3-D FD-OCT reconstruction
2503-462 Differences Of Optical Coherence Tomographic 
Findings Between Excimer Laser And Cutting 
Balloon Angioplasty For In-Stent Restenosis Lesion
Masami Nishino, Takeshi Masaki, Naoki Mori, Takahiro Yoshimura, 
Daisuke Nakamura, Yasuharu Lee, Masahiko Hara, Shinpei 
Nakatani, Masayuki Taniike, Nobuhiko Makino, Hiroyasu Kato, 
Yasuyuki Egami, Ryu Shutta, Hitoshi Yamaguchi, Jun Tanouchi, 
Yoshio Yamada, Division of Cardiology, Osaka Rosai Hospital, Sakai, 
Osaka, Japan
Learning Objective: learn detailed findings of neointimal condition 
after excimer laser using optical coherence tomography.
2503-463 A novel classification of neointimal characteristics 
after Drug Eluting-Stent Implantation: Optical 
Coherence Tomographic Analysis
Nobuyoshi Tanaka, Mitsuyasu Terashima, Sudhir Rathore, Kenya 
Nasu, Masashi Kimura, Tatsuya Ito, Yoshihisa Kinoshita, Mariko 
Ehara, Etsuo Tsuchikane, Keiko Asakura, Yasushi Asakura, Osamu 
Kato, Takahiko Suzuki, Toyohashi Heart Center, Toyohashi, Japan
Learning Objective: demonstrate a novel classification of neointimal 
characteristics after drug eluting-stent implantation
2503-464 Analysis of In-stent Restenosis Pattern by Optical 
Coherence Tomography: Inpact of Difference in 
Stent Type and Follow-up Period
Ippei Kosedo, Shingo Hosogi, Yuki Tsujimoto, Kentaro Shibayama, 
Naoki Saito, Suguru Otsuru, Yoji Okamoto, Mana Kusunose, Masao 
Imai, Hiroshi Tasaka, Daiji Hasegawa, Yoshikazu Shigemoto, Seiji 
Habara, Hiroyuki Tanaka, Takeshi Maruo, Akitoshi Hirono, Yoshiharu 
Nishibori, Yasushi Fuku, Naoki Oka, Harumi Katoh, Hiroyuki 
Yamamoto, Satoki Fujii, Tsuyoshi Goto, Kazushige Kadota, Kazuaki 
Mitsudo, Kurashiki Central Hospital, Kurashiki, Japan
Learning Objective: identify the characteristics of ISR pattern by 
OCT
2503-489 The Axial Distribution Of Plaque Ruptures And A 
Thin-cap Fibroatheroma Within The Culprit Lesion 
In Acute Coronary Syndrome Patients: An Optical 
Coherence Tomography Study
Hyoung-Mo Yang, So-Yeon Choi, Seung-Jea Tahk, Hong-Seok Lim, 
Byoung-Joo Choi, Myeong-Ho Yoon, Jae-Hyun Moon, Jin-Sun Park, 
Gyo-Seung Hwang, Joon-Han Shin, Ajou University Medical Center, 
Suwon, South Korea
Learning Objective: to demonstrate the distribution of vulnerable 
plaques in the culprit lesion of ACS patients in vivo.
2503-490 Favorable Neointimal Coverage in Everolimus-
Eluting Stent at 9 Month after Stent Implantation: 
Comparison with Sirolimus-Eluting stent using 
Optical Coherence Tomography
Hyun-Hee Choi, Jung-Sun Kim, Young-Guk Ko, Donghoon Choi, 
Myeong-Ki Hong, Yangsoo Jang, Won-Heum Sim, Seung-Yun Cho, 
Severance Cardiovascular Hospital, Seoul, South Korea
Learning Objective: evaluate the pattern of neointimal coverage in 
everolimus-eluting stent
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2503-502 A New Set of Intravascular Ultrasound-Derived 
Anatomical Criteria for Defining Functionally 
Significant Stenoses in Small Coronary Arteries 
Results from Intravascular ultrasound Diagnostic 
Evaluation of Atherosclerosis in Singapore (IDEAS) 
study.
Chi Hang Lee, Bee-Choo Tai, Chao-Yang Soon, Adrian F. Low, Kian-
Keong Poh, Tiong-Cheng Yeo, Gek-Hsiang Lim, James Yip, Abdul 
Omar Razakjr, Swee-Guan Teo, Huay-Cheem Tan, National University 
Heart Centre, Singapore, AL, Singapore, Alexandra Hospital, 
Singapore, AL, Singapore
Learning Objective: Identify a new set of intravascular ultrasound-
derived anatomical criteria for defining functionally significant 
stenoses in small coronary arteries
2503-503 Renal Dysfunction and Coronary Plaque Morphology 
by Intravascular Ultrasound: A Report from the 
Diabetes Genome Project
Joshua Stolker, Ahmad Tuffaha, Jason B. Lindsey, John A. House, 
Lindsey Seifert, Steven P. Marso, St Luke’s Mid America Heart 
Institute, Kansas City, MO
Learning Objective: Evaluate the relationship between renal function 
and morphologic atherosclerotic changes in the coronary arteries by 
intravascular ultrasound
2503-504 Mechanism of Edge Restenosis of Sirolimus-Eluting 
Stents: Serial Intravascular Ultrasound Analysis
Eiji Ichimoto, Yoshio Kobayashi, Nakabumi Kuroda, Issei Komuro, 
Department of Cardiovascular Science and Medicine, Chiba 
University Graduate School of Medicine, Chiba, Japan
Learning Objective: evaluate that sirolimus-eluting stent edge 
restenosis occurs due to the combination of negative vessel 
remodeling and progression of plaque in the segment closest to the 
stent edge.
2503-506 Relationship Among Serial Coronary Arterial 
Remodeling, Stenosis Progression, and Plaque 
Composition: A VH-IVUS Tissue Characterization 
Analysis
So-Yeon Choi, Akiko Maehara, Gary S. Mintz, Takashi Kubo, M. 
Pauliina Margolis, Gregg W. Stone, Martin B. Leon, Columbia 
University Medical Center and the Cardiovascular Research 
Foundation, New York, NY
Learning Objective: evaluate
2503-507 Plaque Composition Change in Coronary Bifurcation 
Atherosclerosis after 1 year: a study with 
intravascular ultrasound Virtual Histology
Eun Seok Shin, Hector M. Garcia-Garcia, Patrick W. Serruys, Ulsan 
University Hospital, Ulsan, South Korea, Thoraxcenter, Erasmus MC, 
Rotterdam, The Netherlands
Learning Objective: Evaluate the change of plaque composition in 
bifurcation lesion after 1 year
2503-496 The Relationship between the Plaque Morphology 
of Culprit Lesions and Clinical Presentations of ACS 
Patients: an Optical Coherence Tomography Study
Yasushi Ino, Hironori Kitabata, Takashi Kubo, Atsushi Tanaka, 
Kenichi Komukai, Takashi Tanimoto, Kouhei Ishibashi, Tomizou 
Masuno, Shigeho Takarada, Aiko Shimokado, Akio Kuroi, Kumiko 
Hirata, Keizou Kimura, Masato Mizukoshi, Toshio Imanishi, Takashi 
Akasaka, Wakayama Medical University, Wakayama, Japan
Learning Objective: The plaque morphology of culprit lesions may 
affect obstructive thrombus formationin ACS. We investigated the 
relationship between the plaque morphology by OCT and clinical 
presentations.
2503-497 High-Risk Morphological Characteristics in Optical 
Coherence Tomography Study Are Correlated With 
Complex Angiographic Morphology
Andreas Synetos, Konstantinos Toutouzas, Antonis Karanasos, 
Elefterios Tsiamis, Maria Drakopoulou, Maria Riga, John 
Karambelas, Costas Tsiouﬁs, Christodoulos Stefanadis, 1st 
Department of Cardiology, Hippokration Hospital, Athens, Greece
Learning Objective: associate the angiographic lesion appearance 
with plaque morphology
2503-498 Homogeneous Arterial Healing Between Culprit 
and Non-Culprit Segments after Deployment of 
Zotarolimus-Eluting Stent in Patients with ST-
elevation Myocardial Infarction: Sub-analysis Of The 
OCTAMI Trial.
Satoko Tahara, Hiram G. Bezerra, Giulio Guagliumi, Hiroyuki Kyono, 
Vasile Sirbu, Orazio Valsecchi, Alessandro Aprile, Motaz Baibars, 
Giuseppe Musumeci, Marco A. Costa, University Hospitals Case 
Medical Center, Cleveland, OH, Division of Cardiology, Ospedali 
Riunti di Bergamo, Bergamo, Italy
Learning Objective: Evaluate vascular healing by OCT
2503-500 Is Spotty Calcification Revealed By Gray Scale 
Intravascular Ultrasound Really Vulnerable? A 
Virtual Histology Intravascular Ultrasound Study
Hideo Amano, Kenji Wagatsuma, Mikihito Toda, Hideo Nii, Yasuto 
Uchida, Jyunichi Yamazaki, Division of interventional Cardiology, 
Cardiovascular Center, Toho University Omori Medical Center, Tokyo, 
Japan
Learning Objective: Spotty calcification in gray scale IVUS has 
a higher NC/DC ratio in VH-IVUS compared to intermediate and 
extensive calcification, and is believed to have a higher degree of 
vulnerability.
2503-501 Intravascular Ultrasound Volumetric Analysis of 
Coronary Bifurcation Lesions: Changes in the Area 
and Volume of the Main Vessel Stent Following 
Side-Branch and Final Kissing Balloon Inflations
Massoud A. Leesar, Mehmet Cilingiroglu, Imran Arif, Mohamed Effat, 
Shahid Rahman, Tarek Helmy, University of Cincinnati, Cincinnati, 
MI, Afghanistan
Learning Objective: To evaluate impact of IVUS on the expansion of 
stent in the coronary bifurcation lesions
A204 ABSTRACTS: i2 Summit (Interventional Cardiology) JACC    March 9, 2010
i2
 S
um
m
it 
 
(I
nt
er
ve
nt
io
na
l C
ar
di
ol
og
y)
2503-516 Evaluation Of Instent Neointimal Tissue Component 
Using Integrated Backscatter Intravascular 
Ultrasound - Comparison Of Drug-eluting Stents And 
Bare-metal Stents -
Shinjo Sonoda, Yoshitaka Muraoka, Yuki Tsuda, Seiya Tanaka, 
Masahiro Okazaki, Yutaka Otsuji, University of Occupational & 
Environmental Health, Kitakyushu, Japan
Learning Objective: identify neointimal tissue characteristics of 
drug-eluting stents
2503-517 Quantitative and Compositional Differences in 
Coronary Atheroma in Patients With vs. Without 
Diabetes Mellitus (DM), Detected In Vivo Via 
Intravascular Ultrasound-Virtual Histology (IVUS-VH) 
Prior to Percutaneous Coronary Intervention (PCI)
Sandeep Nathan, Linda Lee, Falak Shah, Sandra A. Weiss, 
Shashank Sinha, Adam Goldberg, John J. Lopez, University of 
Chicago Medical Center, Chicago, IL, Loyola University Medical 
Center, Maywood, IL
Learning Objective: Understand qualitative and quantitative 
differences between diabetic and non-diabetic coronary artery 
disease
2503-518 The Impact of Pravastatin Pretreatment on 
Periprocedural Microcirculatory Damage in Patients 
Undergoing Percutaneous Coronary Intervention
Masashi Fukunaga, Kenichi Fujii, Daizo Kawasaki, Hirokuni 
Akahori, Katsumi Oka, Motomaru Masutani, Takeshi Tsujino, 
Mitsumasa Ohyanagi, Tohru Masuyama, Hyogo College of Medicine, 
Nishinomiya, Japan
Learning Objective: interpret the efficacy of statin administration 
before percutaneous coronary intervention
2503-520 A Normal Relative Coronary Flow Reserve is 
Associated with a Lower Mortality in Patients With 
Stable Coronary Artery Disease.
Martijn Meuwissen, Steven AJ Chamuleau, Karel T. Koch, Robbert 
J. de Winter, Marije M. Vis, Jan Baan, Jr, Jan GP Tijssen, Jose PS 
Henriques, Jan J. Piek, Acadeic Medical Center, Amsterdam, The 
Netherlands
Learning Objective: identify patients at risk
2503-521 Coronary Blood Flow Assessment After Successful 
Reperfusion for Acute Myocardial Infarction Predicts 
the Risk of In-Hospital and Long-Term Malignant 
Arrhythmia
Kitae Kim, Atsushi Yamamuro, Satoshi Honda, Tomohiro Nishino, 
Shunsuke Funakoshi, Noriyuki Kimura, Yoshimori An, Takeshi Kitai, 
Atsushi Kobori, Natsuhiko Ehara, Makoto Kinoshita, Shuichiro Kaji, 
Tomoko Tani, Shigefumi Morioka, Toru Kita, Yutaka Furukawa, Kobe 
City Medical Center General Hospital, Kobe, AL, Japan
Learning Objective: interpret the importance of microvascular 
dysfunction assessed by the coronary flow velocity pattern
2503-508 Target Lesion Thin-cap Fibroatheroma Detected By 
Virtual Histology Intravascular Ultrasound And Long-
term Prognosis In Patients With Angina Pectoris
Hiroyuki Okura, Takahiro Kawamoto, Ryotaro Yamada, Yoshinori 
Miyamoto, Tetsuo Tsuchiya, Akihiro Hayashida, Yoji Neishi, 
Tomoichiro Kubo, Nobuya Matsushita, Takeshi Ozaki, Hiroyuki 
Yamagishi, Iku Toda, Kiyoshi Yoshida, Kawasaki Medical School, 
Kurashiki, Japan, Bell Land General Hospital, Sakai, Japan
Learning Objective: demonstrate prognostic impact of target lesion 
TCFA
2503-509 The Utility of Routine Intra-vascular Ultrasound 
during Percutaneous Coronary Intervention of 
Saphenous Vein Grafts.
Asmir I. Syed, Gabriel Maluenda, Itsik Ben-Dor, Manuel A. Gonzalez, 
Michael A. Gaglia, Cedric Delhaye, Loic Belle, Kohei Wakabayashi, 
Nicholas Hanna, Sara D. Collins, Rebecca Torguson, Zhenyi Xue, 
Nelson Bernardo, William O. Suddath, Kenneth M. Kent, Lowell 
F. Satler, Augusto D. Pichard, Joseph Lindsay, Ron Waksman, 
Washington Hospital Center, Washington, DC
Learning Objective: IVUS is not recommended in SVG PCI
2503-510 Even After Percutaneous Coronary Intervention of 
Angiographically Significant Lesions, IVUS-defined 
High-Grade Stenoses Are Common. A Baseline IVUS 
Analysis from the PROSPECT Trial
Akiko Maehara, Gary S. Mintz, Ecaterina Cristea, Alexandra J. 
Lansky, Roxana Mehran, George Dangas, Barry Templin, Wai-Fung 
Cheong, John McPherson, Bernard de Bruyne, Naim Farhat, Steven 
Marso, Jean Fajadet, Michael Foster, Patrick W. Serruys, Gregg W. 
Stone, Cardiovascular Research Foundation and Columbia University 
Medical Center, New York City, NY
Learning Objective: To undertstand the frequency secondary 
significant non-culprit lesions in patients undergoind primary PCI
2503-514 Target Lesion Thin-cap Fibroatheroma Detected By 
Virtual Histology Intravascular Ultrasound Affects 
Microvascular Injury During Percutaneous Coronary 
Intervention In Patients With Angina Pectoris
Ryotaro Yamada, Hiroyuki Okura, Teruyoshi Kume, Yoji Neishi, 
Takahiro Kawamoto, Akihiro Hayashida, Tetsuo Tsuchiya, Ken Saito, 
Koichiro Imai, Kiyoshi Yoshida, Kawasaki Medical School, Kurashiki, 
Japan
Learning Objective: investigate the relationship between TCFA 
detected by VH-IVUS and change of IMR during PCI in patients with 
angina pectoris.
2503-515 Necrotic Core Distribution at the Coronary 
Bifurcation, and the Association Between Side 
Branch Bifurcation Angle and Vulnerability: A Virtual 
Histology Intravascular Ultrasound Study
Hideo Amano, Kenji Wagatsuma, Mikihito Toda, Hideo Nii, Yasuto 
Uchida, Jyunichi Yamazaki, Division of interventional Cardiology, 
Cardiovascular Center, Toho University Omori Medical Center, Tokyo, 
Japan
Learning Objective: Bifurcations showed high vulnerability, and 
large distribution of NC was revealed on the side branch side. The 
vulnerability of the main vessel increases with an decreasing angle 
of the side branch.
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2504-420 Comparison of Bivalirudin versus Heparin 
Plus Glycoprotein IIb/IIIa Inhibitors in Patients 
Undergoing An Invasive Strategy: A Meta-Analysis of 
Randomized Clinical Trials
Jashdeep S. Dhoot, Michael S. Lee, Hsini Liao, Tae Yang, Jonathan 
Tobis, Gregg Fonarow, Ehtisham Mahmud, David Geffen School 
of Medicine at University of California, Los Angeles (Division of 
Cardiology), Los Angeles, CA
Learning Objective: Evaluate the efficacy and safety of bivalirudin 
compared with heparin plus glycoprotein (GP) IIb/IIIa inhibitors in 
patients undergoing percutaneous coronary intervention.
2504-421 Bivalirudin vs. Unfractionated Heparin in Patients 
Undergoing Stenting of Saphenous Vein Grafts. An 
Analysis From the EVENT Registry
Radwane Kesserwane, Neal Kleiman, Michelle Keyes, Michael 
Pencina, Ali Sonel, Faisal Latif, Mazen Abu-Fadel, David Cohen, Jorge 
F. Saucedo, Oklahoma University Health Science Center, Oklahoma 
City, OK
Learning Objective: The abstract will shed the light of the safety and 
effectiveness of bivalirudin in saphenous vein graft interventions.
2504-422 Bivalirudin versus Heparin plus Glycoprotein IIb/
IIIa Inhibitors in Patients Undergoing PCI for Acute 
Coronary Syndrome: a Meta-analysis
Luke Kim, S. Chiu Wong, Hasan Ahmad, Edward Wingﬁeld, Robert 
M. Minutello, Geoffrey Bergman, Issam Moussa, Dmitriy N. Feldman, 
New York Presbyterian Hospital - Weill Cornell Medical College, New 
York, NY
Learning Objective: evaluate the efficacy of bivalirudin versus 
heparin plus GP IIb/IIIa inhibition in patients undergoing PCI for ACS
2504-429 Clinical Benefits Of Glycoprotein IIb/IIa Inhibitors 
In Patients With Acute ST-Elevation Myocardial 
Infarction Pretreated With Clopidogrel Before 
Primary Percutaneous Coronary Intervention
Doo Sun Sim, Youngkeun Ahn, Myung Ho Jeong, Young Jo Kim, 
Sung Chull Chae, Taek Jong Hong, In Whan Seong, Jei Keon Chae, 
Chong Jin Kim, Myeong Chan Cho, Ki Bae Seung, Seung Jung Park, 
Chonnam National University Hospital, Gwangju, South Korea
Learning Objective: learn that the efficacy of glycoprotein IIb/IIIa 
inhibitors should be revisited in the era of high-dose clopdiogrel 
loading before primay percutaneous coronary intervention.
2504-430 Risk Factors for Bleeding Complications in Patients 
with PCI with Adjunctive Therapy with Bivalirudin 
in Clinical Practice. Results from the IMPROVER-
Registry.
Uwe Zeymer, Steffen Schneider, Harald Darius, Dietrich Gulba, 
Herzzentrum Ludwigshafen, Ludwigshafen, Germany
Learning Objective: The identify predictors for bleeding 
complications after PCI with bivalirudin
2503-522 Recanalization Within 90 Minutes of Symptom 
Onset Critically Determines Coronary Microvascular 
Integrity in Patients with Acute Myocardial 
Infarction Achieving TIMI Grade 3 Flow
Atsushi Yamamuro, Shuichiro Kaji, Koichi Tamita, Kite Kim, 
Yoshimori An, Syunsuke Funakoshi, Noriyuki Kimura, Tomohiro 
Nishino, Satoshi Honda, Takeshi Kitai, Natsuhiko Ehara, Atsushi 
Kobori, Makoto Kinoshita, Tomoko Tani, Shigefumi Morioka, Toru 
Kita, Yutaka Furukawa, Kobe City Medical Center General Hospital, 
Kobe, Japan, Nishinomiya Watanabe Cardiovascular Center, 
Nishinomiya, Japan
Learning Objective: Early recanalization within 90 mnutes critically 
determines coronary microvascular integrity in patients with AMI 
achieving TIMI grade 3 flow.
2503-523 The Reduction In Microvascular Resistance 
Following PCI In The Adjacent Vessel Territory Is Not 
Related To Collateral Flow Index.
Billal Patel, Linda Smith, George Hart, Michael Fisher, Royal 
Liverpool University Hospital, Liverpool, United Kingdom, Liverpool 
Chest and Heart Hospital, Liverpool, United Kingdom
Learning Objective: Identify the role of collateral circulation on 
microvascular function in response to PCI.
2504 PHARMACOTHERAPIES AND COMPLEX PATIENTS
Monday, March 15, 2010, 3:30 p.m. - 4:30 p.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 3:30 p.m. - 4:30 p.m. 
CME/CE Hours: 1
2504-418 Impact of Bivalirudin Use on Body Mass Index 
and Peri-Procedural Bleeding After Percutaneous 
Coronary Intervention
Cedric Delhaye, Loic Belle, Kohei Wakabayashi, Gabriel Maluenda, 
Itsik Ben-Dor, Manuel A. Gonzalez, Michael A. Gaglia, Nicholas N. 
Hanna, Sara D. Collins, Asmir I. Syed, Rebecca Torguson, Zhenyi 
Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Joseph 
Lindsay, Augusto D. Pichard, Ron Waksman, Washington, DC
Learning Objective: The risk of PCI-related bleeding has a similar 
relationship to BMI in pts treated with bivalirudin to those receiving 
heparin.
2504-419 Bivalirudin versus Heparin plus Glycoprotein IIb/
IIIa Inhibitors in Patients Without “Adequate” 
Clopidogrel Pretreatment: a Meta-analysis
Luke Kim, S. Chiu Wong, Edward Wingﬁeld, Hasan Ahmad, Robert 
M. Minutello, Geoffrey Bergman, Issam Moussa, Dmitriy N. Feldman, 
New York Presbyterian Hospital - Weill Cornell Medical College, New 
York, NY
Learning Objective: to evaluate the efficacy of bivalirudin versus 
heparin plus glycoprotein IIb/IIIa inhibitors in patients without 
“adequate” clopidogrel pretreatment
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2504-437 Effect of Proton Pump Inhibitors on Clinical 
Outcome in Patients treated with Clopidogrel: a 
Systematic Review and Meta-Analysis
Jolanta M. Siller-Matula, Bernd Jilma, Karsten Schrör, Guenter 
Christ, Kurt Huber, Medical University of Vienna, Vienna, Austria
Learning Objective: identify whether concomitant use of proton 
pump inhibitors and clopidogrel has a negative impact on patients 
outcome.
2504-438 The Utility of Clopidogrel Re-loading for Patients 
Presenting with Acute Coronary Syndrome Who Are 
On Chronic Clopidogrel Therapy and Undergoing 
Percutaneous Coronary Intervention.
Asmir I. Syed, Itsik Ben-Dor, Rebecca Torguson, Zhenyi Xue, Manuel 
A. Gonzalez, Gabriel Maluenda, Kohei Wakabayashi, Loic Belle, 
Cedric Delhaye, Michael A. Gaglia, Sara D. Collins, Nicholas Hanna, 
Nelson Bernardo, Kenneth M. Kent, William O. Suddath, Lowell 
F. Satler, Augusto D. Pichard, Joseph Lindsay, Ron Waksman, 
Washington Hospital Center, Washington, DC
Learning Objective: Clopidogrel reloading does not improve in-
hospital outcomes
2504-439 The Effect Of Clopidogrel Low-responsiveness 
Assessed By Verifynow P2y12 Assay On Thrombotic 
Events After Implantation Of Drug-eluting Stent
Joong Kyung Sung, Young Jin Yoon, Nam Seok Lee, Jun Won Lee, 
Jang-Young Kim, Seung Hwan Lee, Junghan Yoon, Kyung-Hoon Choe, 
Wonju Christian Hospital, Wonju, South Korea
Learning Objective: Identify the relationship between stent 
thrombosis and clopidogrel resistance
2504-443 Correlation Between the VerifyNow P2Y12 Assay 
and Light Transmittance Aggregometry To Measure 
Platelet P2Y12 Receptor Inhibition in Patients on 
Clopidogrel Therapy
Masafumi Ueno, Jose Luis Ferreiro, Kodlipet Dharmashankar, Piera 
Capranzano, Davide Capodanno, Andrew Darlington, Desai Bhaloo, 
Ronald Charlton, Lyndon Box, Martin Zenni, Luis Guzman, Theodore 
Bass, Dominick J. Angiolillo, University of Florida college of Medicine 
Jacksonville, Jacksonville, FL
Learning Objective: There is a strong correlation between VerifyNow 
P2Y12 and LTA parameters, which is best with aggregation values 
obtained following addition of PGE1 to ADP stimuli.
2504-444 Platelet Reactivity Testing Following Coronary 
Percutaneous Intervention Is Independent Of The 
Initial Clinical Presentation
Firas Zahr, Rosalyn Rapsinski, Roy Semaan, Oscar C. Marroquin, 
Suresh Mulukulta, Conrad Smith, Ashley Lee, Sun Scolieri, Joon S. 
Lee, John T. Schindler, William D. Anderson, Catalin Toma, UPMC, 
Pittsburgh, PA, Firas Zahr, pittsburgh, PA
Learning Objective: Demonstrate that platelet reactivity testing after 
PCI is not effected by the clinical presentation
2504-431 Sex and ACT Following Heparin Bolus During 
Percutaneous Coronary Intervention
Claudia C. Serrano, Yoon K. Yan, Hyunseok Kang, Christopher 
Cianci, Brittany LeMonda, Mun K. Hong, David Coven, Angela 
Palazzo, Robert Leber, Claude Simon, Amy Chorzempa, Jacqueline 
Tamis-Holland, St Luke’s Roosevelt Hospital, New York, NY, Mount 
Sinai Medical Center, New York, NY
Learning Objective: determine whether there are sex related 
differences in response to a weight adjusted Heparin bolus given 
during PCI.
2504-432 Comparative Effectiveness of Bleeding Avoidance 
Therapies in PCI Patients: Analysis from the 
National Cardiovascular Data Registry®
Steven P. Marso, Amit Amin, John A. House, Kevin F. Kennedy, John 
A. Spertus, Sunil V. Rao, David J. Cohen, John C. Messenger, John 
S. Rumsfeld, Mid America Heart Institute, Kansas City, MO, Duke 
Clinical Research Institute, Durham, NC
Learning Objective: Describe use of bivalirudin and vascular closure 
devices by risk of bleeding
2504-433 Factor IXa Inhibition with REG1 Provides 
Rapid Onset, Stable and Actively Controlled 
Anticoagulation during PCI
Mauricio G. Cohen, Drew A. Purdy, Joseph S. Rossi, Liliana R. 
Grinfeld, Shelley K. Myles, Laura H. Aberle, Adam B. Greenbaum, 
Edward Fry, Mark Y. Chan, Steven Zelenkofske, John H. Alexander, 
Robert A. Harrington, Christopher P. Rusconi, Richard C. Becker, 
University of Miami Miller School of Medicine, Miami, FL, Duke 
Clinical Research Institute, Durham, NC
Learning Objective: Understand the role of aptamers as 
anticoagulants
2504-435 High-Dose Clopidogrel Loading Is Safe And Effective 
In Patients With ST-Elevation Myocardial Infarction 
Undergoing Primary Percutaneous Coronary 
Intervention
Doo Sun Sim, Myung Ho Jeong, Youngkeun Ahn, Young Jo Kim, 
Sung Chull Chae, Taek Jong Hong, In Whan Seong, Jei Keon Chae, 
Chong Jin Kim, Myeong Chan Cho, Ki Bae Seung, Seung Jung Park, 
Chonnam National University Hospital, Gwangju, South Korea
Learning Objective: feel the need to revisit the efficacy and safety of 
high-dose clopidogrel loading even in patients with acute myocardial 
infarction undergoing primary percutaneous coronary intervention.
2504-436 Can Clopidogrel Loading (600mg) Be Administered 
<2 Hours Pre-PCI in Patients Presenting with Acute 
Coronary Syndromes?
Dmitriy N. Feldman, Luke K. Kim, Robert M. Minutello, Geoffrey 
Bergman, Issam Moussa, S. Chiu Wong, New York Presbyterian 
Hospital, Weill Cornell Medical College, New York, NY
Learning Objective: demonstrate whether clopidogrel loading 
(600mg) can be administered <2 hours pre-PCI in patients 
presenting with acute coronary syndromes
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2504-451 The sPLA2 Inhibition to Decrease Enzyme Release 
after Percutaneous Coronary Intervention (SPIDER-
PCI) Trial.
Vladimir Dzavik, Warren J. Cantor, Christopher B. Overgaard, Kevin 
E. Thorpe, Shahar Lavi, Julie Lan, Eric Horlick, John R. Ross, Paul 
Daly, Alan Barolet, Douglas Ing, Sylvain Plante, Kim Robbins, 
Lorne Goldman, Rudiger von Harsdorf, Deborah Atchison, Leonard 
Schwartz, Peter H. Seidelin, Peter Munk Cardiac Centre, University 
Health Network, Toronto, ON, Canada, Southlake Regional Health 
Centre, Newmarket, ON, Canada
Learning Objective: understand the possible role of secretory 
phospholipase A2 in limiting myocardial injury associated with PCI.
2504-452 Impact of IRS-1 Genotypes on Platelet Reactivity 
and Cardiovascular Outcomes in Type 2 Diabetes 
Mellitus Patients with Coronary Artery Disease
Dominick Angiolillo, Esther Bernardo, Martina Zanoni, Piera 
Capranzano, Giovanni Malerba, Elisabetta Trabetti, Manel Sabate’, 
Pilar-Jimenez Quevedo, Paola Prandini, Davide Capodanno, 
Jose’ Luis Ferreiro, Theodore Bass, Pier Franco Pignatti, Antonio 
Fernandez-Ortiz, Carlos Macaya, University of Florida College of 
Medicine, Jacksonville, FL
Learning Objective: demonstrate
2504-453 Association of CYP2C19*2 to Altered Clopidogrel 
Reactivity as Measured by a Point-of-Care Analysis
Derek Yiu Fai So, Irena Szymanska, Alex Stewart, Michel Le May, 
Marino Labinaz, Sandro Goncalves, Olivia Assogba, Chris Glover, 
Sonny Dandona, Robert Roberts, University of Ottawa Heart 
Institute, Ottawa, ON, Canada
Learning Objective: evaluate the possible utility of point of care 
clopidogrel response testing in identifying patients with the 
CYP2C19*2 allele
2504-455 Comparison Of High-dose Bolus Tirofiban Versus 
Abciximab As Adjunctive Therapy For Primary 
Percutaneous Coronary Intervention In Patients 
With ST-elevation Myocardial Infarction: A Meta-
analysis Of Randomized Trials
Lili Dong, Feng Zhang, Xianhong Shu, Shanghai Institute of 
Cardiovascular Diseases, Zhongshan Hospital, Fudan University, 
Shanghai, People’s Republic of China
Learning Objective: demonstrate that HDB tirofiban is as effective 
as abciximab in the setting of PPCI for STEMI without an increase in 
bleeding risk.
2504-456 Low Dose Versus High Dose Aspirin After Coronary 
Stenting
Kishore J. Harjai, Chetan Shenoy, Pam Orshaw, Judy Boura, Guthrie 
Health System, Sayre, PA
Learning Objective: Evaluate the efficacy of low-dose aspirin after PCI
2504-445 WITHDRAWN
2504-446 Predictive Value Of Various Platelet Function Tests 
On St-segment Resolution And Clinical Outcome In 
STEMI Patients Randomized To Either Dual Or Triple 
Antiplatelet Therapy: The Ontime2 Platelet Function 
Substudy
Heleen J. Bouman, Jochem W. van Werkum, Jaap J. Smit, Nicoline 
J. Breet, Sonja Postma, Ton Heestermans, Jurriën M. ten Berg, 
Robbert Slingerland, Christian M. Hackeng, Christian Hamm, Arnoud 
van ‘t Hof, Ongoing in Tiroﬁban in Myocardial Infarction Evaluation 
(ON-TIME) trial investigators, St. Antonius Hospital, Nieuwegein, The 
Netherlands, Isala Klinieken, Zwolle, The Netherlands
Learning Objective: demonstrate that platelet function testing using 
the PFA-100 COL/EPI cartridge is able to identify patients who are 
at higher risk for thrombo-ischemic events
2504-447 Distribution Of Post-treatment Platelet Reactivity 
Assessed By Two Kinds Of Point-of-care Platelet 
Function Analysis In Korean Patients Who 
Underwent Drug-eluting Stent Implanation : A Single 
Center, Pilot Study
Myung-Ki Seo, Tae-Jin Youn, In-Ho Chae, Dong-Ju Choi, Jung-Won 
Suh, Seoul National University Hospital, Seoul, South Korea, Seoul 
National University Bundang Hospital, Seungnam, South Korea
Learning Objective: recognized that verifynow and multiplate assay 
are needed to evaluate further study.
2504-449 High Levels of Asymmetric Dimethyl-Arginine 
(ADMA) Increase Residual Platelet Reactivity After 
Clopidogrel Administration in Patients Undergoing 
Elective PCI
Annunziata Nusca, Giacomo Di Giovanni, Laura Gatto, Giuseppe 
Patti, Andrea D’Ambrosio, Rocco Contuzzi, Germano Di Sciascio, 
Campus Bio-Medico University, Rome, Italy
Learning Objective: to demonstrate a correlation between high 
serum ADMA levels and residual platelet reactivity after clopidogrel 
administration
2504-450 Inter-assay Agreement To Define Inadequate 
Clopidogrel Response
Kodlipet C. Dharmashankar, Jose-Luis Ferreiro, Masafumi Ueno, 
Andrew Darlington, Davide Capodanno, Bhaloo Desai, Ronald K. 
Charlton, Luis A. Guzman, Theodore A. Bass, Dominick J. Angiolillo, 
Division of Cardiology, Department of Medicine, University of Florida, 
Jacksonville, Jacksonville, FL
Learning Objective: Platelet assays
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2504-462 Does Oral Beta-Blocker Therapy Improve Long-term 
Clinical Outcomes of ST-elevation Acute Myocardial 
Infarction After Primary Angioplasty?
Neiko Ozasa, Kazuaki Mitsudo, Takeshi Morimoto, Hou Heigen, 
Toshihiro Tamura, Satoshi Shizuta, Takeshi Kimura, j-Cypher Registry 
Investigators, Graduate School of Medicine, Kyoto University, Kyoto, 
Japan, Kurashiki Central Hospital, Kurashiki, Japan
Learning Objective: evaluate optimal medication for acute 
myocardial infardtion after primary percutaneous coronary 
intervention.
2504-463 Efficacy of Statins in Patients After Percutaneous 
Coronary Interventions: Relation with Baseline CRP 
Values
Carla Auguadro, Filippo Scalise, Emilia D’Elia, Valentina Casali, 
Mariella Manfredi, Giuseppe Specchia, Dpt of Cardiology, Policlinico 
of Monza, Monza, Italy
Learning Objective: identify post-PCI pts at high risk of cardiac 
events in FU in whom the addition of statins may be useful in order 
to reduce the risk
2504-464 Effect Of Statins Pretreatment On Periprocedural 
Myocardial Infarction In Patients Undergoing 
Percutaneous Coronary Intervention: Insights From 
Randomized Clinical Trials
Feng Zhang, Lili Dong, Junbo Ge, Shanghai Institute of 
Cardiovascular Diseases, Zhongshan Hospital, Fudan University, 
Shanghai, People’s Republic of China
Learning Objective: demonstrate the beneficial effects of statins 
pretreatment on preventing periprocedural myocardial infarction in 
patients undergoing percutaneous coronary intervention.
2504-466 Supralimus™ Bioabsorbable-Polymer Sirolimus-
Eluting Stent Technology in Patients with Acute 
Coronary Syndrome: Two-Year Results of the 
Prospective, Multicenter, E-SERIES Registry.
Jose de Ribamar Costa, Jr., Alexandre Abizaid, Bruno Machado, 
Maurício Prudente, Pritesh Parikh, George Ximenes, Edmur 
Araújo, Álvaro Matheus, Ricardo Costa, Fausto Feres, Andréa 
Abizaid, Expedito Ribeiro, on behalf of E-SERIES investigators, 
Cardiovascular Research Center, São Paulo, Brazil
Learning Objective: Determine the long-term efficacy and safety of 
the Supralimus sirolimus-eluting stent with biodegradable polymer 
for the treatment of patients with acute coronary syndromes
2504-467 Mid-Term Clinical Outcome of CATANIA™ Coronary 
Stent System With Nanothin Polyzene®-F in a Real 
World Unselected Population: Preliminary Results
Alessio La Manna, Alessandra Sanﬁlippo, Sergio Monaco, Maria 
Elena Di Salvo, Irene Cascone, Daniele Giacoppo, Piera Capranzano, 
Davide Capodanno, Corrado Tamburino, Division of Cardiology - 
Ferrarotto Hospital, Catania, Italy
Learning Objective: Understand the clinical value of the 
polyphosphazene coated coronary stent in a real world population
2504-457 Cilostazol Therapy Achieves Greater P2Y
12
 Inhibitory 
Effects Compared To High Clopidogrel Maintenance 
Dosing In Suboptimal Clopidogrel Responders With 
Diabetes Mellitus
Jose Luis Ferreiro Gutierrez, Piera Capranzano, Masafumi Ueno, 
Davide Capodanno, Kodlipet Dharmashankar, Andrew Darlington, 
Bhaloo Desai, Ronald K. Charlton, Lyndon C. Box, Martin M. Zenni, 
Luis A. Guzman, MD, Theodore A. Bass, Dominick J. Angiolillo, 
University of Florida College of Medicine - Jacksonville, Jacksonville, 
FL
Learning Objective: Understand treatment options in T2DM patients 
with suboptimal response to standard clopidogrel dosing
2504-458 Initial Loading Therapy of Cilostazol Improved 
Antiplatelet Responsiveness in Patient with 
Percutaneous Coronary Intervention
Moo Hyun Kim, Long H. Yu, Jung H. Kim, Sun Y. Park, Tae H. Park, 
Kwang S. Cha, Young D. Kim, Jin Y. Han, Dept. of Cardiology, Dong-A 
Univ. Hospital, Busan, South Korea
Learning Objective: Demonstrate the role of loading effects of 
cilostzol
2504-459 The Efficacy And Safety of Triple Antiplatelet 
Therapy After Percutaneous Coronary Intervention 
(PCI) in j-Cypher Registry.
Tetsushi Nakao, Takeshi Kimura, Takeshi Morimoto, Satoshi 
Shizuta, Toshihiro Tamura, Takahiro Doi, Kazuaki Mitsudo, on behalf 
of the j-Cypher Registry Investigators, Kyoto University Hospital, 
Department of Cardiovascular Medicine, Kyoto, Japan
Learning Objective: We identify that patients received triple 
antiplatelet therapy after percutaneous coronary intervention had 
more comorbidities in j-Cypher Registry, which represent Japanese 
real clinical practice.
2504-460 Early and Late Discontinuation of Oral Antiplatelet 
Therapy after DES Implantation: Prevalence, 
Predictors, and Long-term Prognosis
Roberta Rossini, Corrado Lettieri, Giuseppe Biondi Zoccai, Giuseppe 
Musumeci, Tamar Nijaradze, Michele Romano, Nicola Cicorella, 
Nikoloz Lortkipanidze, Antonio Izzo, Vasile Sirbu, Antonello Gavazzi, 
Dominick J. Angiolillo, Ospedali Riuniti di Bergamo, Bergamo, Italy, 
University of Florida-Shands Jacksonville, Jacksonville, FL
Learning Objective: identify the predictors of oral antiplatelet 
therapy discontinuation and to evaluate its effects on long-term 
prognosis
2504-461 Efficacy of CLotinab in Acute myocardial 
infarction Trial - ST Elevation Myocardial Infarction 
(ECLAT -STEMI)
Jung-Sun Kim, Sang Min Park, Young-Guk Ko, Donghoon Choi, 
Myeong-Ki Hong, In Whah Sung, Byung Ok Kim, Hyeon-cheol Kwon, 
Bum Kee Hong, Seung-Jae Tahk, Seong-Wook Park, Myung-Ho Jeong, 
Chong Jin Kim, Junghan Yoon, Jin Won Kim, Byoung-Kuk Kim, Doo Il 
Kim, Jong-Sun Park, Sang Gon Lee, Jae Hun Jung, Byoung Eun Park, 
Myeong Gon Kim, Yangsoo Jang, Division of Cardiology, Severance 
Cardiovascular Hospital, Yonsei University, Seoul, South Korea
Learning Objective: administration of Gp IIb/IIIa receptor inhibitor in 
the setting of 600 mg clopidogrel loading might be recommended 
for only needed patients during the PCI not all patients with STEMI.
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2504-494 SPIRIT V Registry: One Year Follow-up of Complex 
Lesion and Patient Sub-Groups
Upendra Kaul, Escorts Heart Institute & Research Centre, New 
Delhi, ID, India, Fortis Flt Lt Rajan Dhall Hospital, New Delhi, India
Learning Objective: Demonstrate the safety and efficacy of the 
everolimus drug eluting stent in complex lesions in real world scenarios
2504-495 Clinical Outcomes in Different Ethnic Groups 
Undergoing Percutaneous Coronary Intervention
Domingo Tagal Addatu, Jr., Joshua P. Loh, Li-Ling Tan, Liang Shen, 
Adrian F. Low, Chi-Hang Lee, Swee Gan Teo, Huay Cheem Tan, 
National University Heart Center, Singapore, Singapore
Learning Objective: Demonstrate significant ethnic differences in 
clinical outcomes following PCI in our multiethnic population
2504-496 What is the Real Incidence of Definite Stent 
Thrombosis After Bare Metal Stent Implantation in 
the Real World Clinical Practice?
Marcelo Nakashima De Melo, Sr., Ricardo A Costa, J. Ribamar 
Costa, Jr, Fausto Feres, Alexandre Abizaid, Marcos Ortega, Erwin 
Telles, Rodolfo Staico, Luiz A. Mattos, Galo Maldonado, Luiz F. 
Tanajura, Carlos Collet, Amanda Sousa, J. Eduardo Sousa, Instituto 
Dante Pazzanese de Cardiologia, Sao Paulo, NY, Brazil
Learning Objective: Investigate the incidence and correlates of stent 
thrombosis following bare metal stent implantation in the real-world 
clinical practice
2504-497 Predictors Of Mortality And Long-term Outcomes 
Of Octogenarians Undergoing Transradial 
Percutaneous Coronary Intervention
Jean-Pierre Dery, Helena Tizon, Cindy Boulanger-Gobeil, Julie 
Plaisance, Gerald Barbeau, Josep Rodés-Cabau, Stephane Rinfret, 
Eric Larose, Bernard Noël, Can M. Nguyen, Onil Gleeton, Guy 
Proulx, Louis Roy, Robert Delarochellière, Olivier F. Bertrand, Institut 
universitaire de cardiologie et de pneumologie de Quebec, Quebec 
City, QC, Canada
Learning Objective: determine predictors of mortality in 
octogenarians undergoing PCI
2504-498 Coronary Angiographic Findings and Results 
of Percutaneous Coronary Intervention (PCI) in 
Nonagenarians: A Single Tertiary Care Center 
Experience
Ashok K. Kondur, Hari Pawan, Ramanjit Kaur, Praveen Guntipalli, Luis 
Afonso, Theodore Schreiber, Harper University Hospital, Detroit, MI
Learning Objective: PCI in nonagenarians confers a mortality benefit 
over medical management.
2504-500 Hypoglycemia is Associated With an Increased 
Incidence of Peri-Procedural Myocardial Damage 
in non-Diabetic Patients Undergoing Coronary 
Angioplasty
Annunziata Nusca, Francesco Marino, Giuseppe Patti, Fabio 
Mangiacapra, Laura Gatto, Andrea D’Ambrosio, Rosetta Melﬁ, Marco 
Miglionico, Germano Di Sciascio, Campus Bio-Medico University, 
Rome, Italy
Learning Objective: to demonstrate that a hypoglycemic status 
at the time of PCI is associated with increased incidence of peri-
procedural myocardial damage
2504-489 Short- and Long-term Clinical Outcomes in Patients 
Undergoing Rescue Percutaneous Coronary 
Intervention Compared with Primary Percutaneous 
Coronary Intervention in ST-Elevation Myocardial 
Infarction
William Chan, David J. Clark, Andrew E. Ajani, Nick Andrianopoulos, 
Angela L. Brennan, Christopher M. Reid, Thomas Yip, James A. 
Shaw, Anthony M. Dart, Stephen J. Duffy, The Alfred Hospital, 
Melbourne, Australia
Learning Objective: compare the clinical outcomes of rescue 
versus primary percutaneous coronary intervention in ST-Elevation 
Myocardial Infarction
2504-490 Physiogenomics of Thiazolidinedione Efficacy and 
Safety
Richard L. Seip, James Bernene, Steven Hanks, Andreas 
Windemuth, Detlef Wencker, Mohan Kocherla, Theodore R. Holford, 
Gualberto Ruaño, Genomas, Inc., Hartford, CT, The Hospital of 
Central Connecticut, New Britain, CT
Learning Objective: identify gene variants relevant to statin and 
thiazolidinedione side effects
2504-491 Correlation of Specific Morphological Characteristics 
of the Culprit Lesion With the Efficacy of 
Thrombolysis. An Optical Coherence Tomography 
Study
Konstantinos Toutouzas, Antonis Karanasos, Elefterios Tsiamis, 
Maria Riga, Andreas Synetos, Maria Drakopoulou, Costas Tsiouﬁs, 
Elli Stefanadi, Dimitrios Tousoulis, Christodoulos Stefanadis, 1st 
Department of Cardiology, Hippokration Hospital, Athens, Greece
Learning Objective: describe the plaque morphological 
characteristics associated with flow restoration after thrombolytic 
therapy administration
2504-492 Long-term Prognosis in Patients with Coronary 
Artery Disease Following Percutaneous Coronary 
Intervention Strictly Reducing Low Density 
Lipoprotein (LDL) Cholesterol with Statin -- 
Importance of Patients with Low LDL at Baseline --
Shigemitsu Tanaka, Yoshihiro Morino, Nobuhiko Ogata, Takashi 
Matsukage, Naoki Masuda, Gaku Nakazawa, Toshiharu Fujii, Seiji 
Tamiya, Daiki Itou, Makiyoshi Shima, Eri Toda, Yoshinari Kamiyama, 
Takayuki Iida, Takashi Ijichi, Teruhisa Tanabe, Yuji Ikari, Department 
of Cardiology, Tokai University School of Medicine, Isehara, Japan
Learning Objective: statin
2504-493 Longest Available (up To Seven Years) Experience 
With Drug-eluting Stents For Non-selected Complex 
Patients: Assessing The Independent Predictors Of 
Negative Events In The Desire Registry
Jose de Ribamar Costa, Jr., Amanda Sousa, Adriana Moreira, 
Ricardo Costa, Manuel Cano, Galo Maldonado, Cantídio Campos 
nNeto, Mariana Carballo, J Eduardo Sousa, Hospital do Coração, 
São Paulo, Brazil
Learning Objective: Determine the very long term results (up to 
seven years) of drug-eluting stents for the treatment of complex, 
unselected patients
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2504-507 Contrast Induced Nephropathy Post Percutaneous 
Coronary Intervention: What is the Right Definition?
Refat Jabara, Radhika Gadesam, Lakshmana Pendyala, Nicolas 
Chronos, Jack Chen, Steven Manoukian, Hadassah-Hebrew 
University Medical Center, Jerusalem, Israel, Saint Joseph’s 
Hospital, Atlanta, GA
Learning Objective: Learn about the practical impact of the 
definition utilized on the rate of CIN post PCI
2504-508 The Effect of Drug-Eluting Stents on Clinical and 
Angiographic Outcomes in Renal Failure Patients 
with Dialysis: Multicenter Registry in Asia
Sunao Nakamura, Hisao Ogawa, Jang-Ho Bae, Yeo Hans 
Cahyadi, Wasan Udayachalerm, Damras Tresukosol, Sudaratana 
Tansuphaswadikul, New Tokyo Hospital, Chiba, Japan
Learning Objective: Describe the clinical efficacy of SES, PES, ZES, 
BES and EES implantation in patients with chronic renal failure on 
hemodialysis which is safe, low restenosis rate and low incidence 
of complication.
2504-509 Thrombotic Profile Analysis Using 
Thromboelastography In End Stage Renal Disease 
Patients Undergoing Hemodialysis
Jose Luis Ferreiro Gutierrez, Andrew Darlington, Davide Capodanno, 
Masafumi Ueno, Piera Capranzano, Bhaloo Desai, Kodlipet 
Dharmashankar, Yoshie Suzuki, Stanley Nahman, Theodore A. Bass, 
Dominick J. Angiolillo, University of Florida College of Medicine - 
Jacksonville, Jacksonville, FL
Learning Objective: Understand thrombotic profiles in hemodialysis 
patients
2504-510 Higher Mortality Rates After Percutaneous Coronary 
Intervention in Female Patients on Hemodialysis
Luis Gruberg, Puja B. Parikh, Allen Jeremias, Srihari S. Naidu, 
Richard A. Shlofmitz, Sorin J. Brenner, Thomas Pappas, Kevin P. 
Marzo, David L. Brown, Stony Brook University, Stony Brook, NY, 
Winthrop University Hospital, Mineola, NY
Learning Objective: Assess the impact of hemodialysis on female 
patients undergoing PCI
2504-514 Efficacy of Spot Stenting with Sirolimus-Eluting 
Stents in Diffuse Lesions of Dialysis Patients
Tatsuya Ito, Masashi Kimura, Hiroshi Fujita, Mitsuyasu Terashima, 
Yoshihisa Kinoshita, Mariko Ehara, Nobuyoshi Tanaka, Kenya Nasu, 
Yasushi Asakura, Osamu Katoh, Takahiko Suzuki, Toyohashi Heart 
Center, Toyohashi, Japan
Learning Objective: demonstrate the favorable stenting strategy for 
dialysis patients to reduce the restenosis rate.
2504-501 Three-Year Clinical Outcomes with Sirolimus-Eluting 
Stents for Diabetic Patients from j-Cypher registry
Tomohisa Tada, Toshihiro Tamura, Kazuaki Mitsudo, Takeshi 
Kimura, Takeshi Morimoto, Atsushi Kawamura, Takahito Sone, 
Hideo Nishikawa, Akira Miura, Yukio Kazatani, Tomohiro Kawasaki, 
Masanori Nomura, j-Cypher Registry investigators, Kyoto University 
Hospital, Kyoto, Japan
Learning Objective: evaluate the use of Silorimus-Eluting-Stent in 
diabetic patients.
2504-502 Long-Term Mortality in Insulin Dependent Versus 
Non-Insulin Dependent Diabetic ST Elevation 
Myocardial Infarction Patients after Primary 
Percutaneous Coronary Intervention
Loes P. Hoebers, Bimmer E. Claessen, Karel T. Koch, Marije M. Vis, 
Jan Baan, jr, Jan G. Tijssen, Robbert J. de Winter, Jan J. Piek, Jose 
P. Henriques, Academic Medical Center University of Amsterdam, 
Amsterdam, The Netherlands
Learning Objective: describe the impact of insulin dependent 
diabetes mellitus on the clinical outcome of STEMI patients after 
primary percutaneous intervention.
2504-503 A Randomized Comparison of the Endeavor Drug 
(ABT-578) Eluting Stent versus TAXUS Paclitaxel-
Eluting Stent in Diabetic Patients: Three-Year 
Outcomes from ENDEAVOR IV
Ajay Kirtane, Rikesh Patel, Charles O’Shaunessy, Brent McLaurin, 
David E. Kandzari, Martin B. Leon, Columbia Medical Center and the 
Cardiovascular Research Foundation, New York, NY
Learning Objective: Evaluate the comparison of the Endeavor Drug 
Eluting Stent versus TAXUS Paclitaxel-Eluting Stent in Diabetic 
Patients
2504-504 Long-Term Clinical Outcomes of Drug-Eluting Stents 
in Diabetic Patients with Small Vessel Compared to 
Larger vessel - Up to 7 Years Clinical Follow-up.
Walid Hassan, Manzoor Memon, Adel Osman, Hani Al Sergani, 
Mohamed Mustafa, zulﬁqar Ali, Suliman Kharabsheh, Nathem 
Akhras, Mohamed Shoukri, Aly Al Sanei, Charles Canver, King Faisal 
Specialist hospital & Research Center, Riyadh, AE, Saudi Arabia
Learning Objective: Evaluate the long term outcomes of DES in 
diabetics with small vessel disease
2504-506 Validation of a Risk Score to Predict Contrast-
Induced Acute Kidney Injury after Percutaneous 
Coronary Intervention in Patients with ACS: Results 
From the ACUITY Trial
Adriano M. Caixeta, Eugenia Nikolsky, Selene Leon, Martin Fahy, 
Ecaterina Cristea, Gregg W. Stone, Alexandra J. Lansky, and Roxana 
Mehran, Columbia University Medical Center and The Cardiovascular 
Research Foundation, New York, NY
Learning Objective: To assess external validity of the proposed CIN 
risk score model using independent dataset
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2504-522 Randomized Clinical Trial To Compare The 
Nephrotoxic Effects Of Iso-osmolar Vs. Low-osmolar 
Contrast Medium In Diabetic Patients With Reduced 
Renal Function
Tobias Koppara, Rainer Wessely, Adnan Kastrati, Christian Bradaric, 
Stefanie Schulz, Marc Vorpahl, Siegmund Braun, Julinda Mehilli, 
Albert Schömig, Deutsches Herzzentrum München, Munich, 
Germany, Klinikum rechts der Isar, Munich, Germany
Learning Objective: assess the risk of contrast induced nephropathy 
in diabetic patients.
2504-523 Impact of Contrast-Induced Nephropathy in Three 
Different Definitions on Long-Term Mortality After 
Percutaneous Coronary Intervention in Patients 
With and Without Chronic Kidney Disease: Insights 
From CREDO-Kyoto Registry
Mitsuru Abe, Ryoji Taniguchi, Natsuhiko Ehara, Masaharu Akao, 
Yutaka Furukawa, Takeshi Morimoto, Toru Kita, Takeshi Kimura, for 
the CREDO-Kyoto Investigators, Kyoto Medical Center, Kyoto, Japan
Learning Objective: identify the incidence and the long-term 
prognostic implication of CIN in various definitions in patients with 
and without chronic kidney disease
2504-524 Long-term Prognosis of Hemodialysis Patients after 
Coronary Interventions in the Drug-eluting Stent Era
Koichi Sano, Sho Torii, Seiichi Fukuda, Takayoshi Sato, Yutaka 
Koyama, Yasuyuki Maruyama, Iwatsuki-Minami Hospital, Saitama-
shi, Japan, Kita-Ibaraki City Hospital, Kitaibaraki-shi, Japan
Learning Objective: interpret the long-term prognosis of 
hemodialysis patients after coronary interventions in drug-eluting 
stent era
2505 ENDOVASCULAR AND NEW TECHNOLOGIES
Tuesday, March 16, 2010, 9:30 a.m. - 10:30 a.m.
Georgia World Congress Center, Hall B5
Presentation Hour: 9:30 a.m. - 10:30 a.m. 
CME/CE Hours: 1
2505-418 Procedure Type Risk Groups for Pediatric and 
Congenital Cardiac Catheterization
Lisa T. Bergersen, Kimberlee Gauvreau, Audrey Marshall, Jacqueline 
Kreutzer, Robert Beekman, Russel Hirsch, Susan Foerster, David 
Balzer, Julie Vincent, William Hellenbrand, Ralf Holzer, John 
Cheatham, John Moore, James Lock, Kathy Jenkins, Children’s 
Hospital Boston, Boston, MA
Learning Objective: Describe types or procedures and associated 
risk rate as well as importance as a tool for outcome assessment
2505-419 Characterization of High Levels of Radiation 
Exposure in a Large Volume Pediatric Cardiac 
Catheterization Lab
George R. Verghese, Doff B. McElhinney, Lisa Bergersen, M.D., 
Children’s Hospital Boston, Boston, MA
Learning Objective: Identify variation in radiation exposure during 
pediatric cardiac catheterization
2504-515 Combined Impact of Chronic Kidney Disease and 
Anemia on Long-Term Clinical Outcomes After 
Percutaneous Coronary Intervention in the Drug-
Eluting Stent Era
Yudai Yano, Yoshikazu Hiasa, Takahashi Tatefumi, Hirotoshi Chen, 
Shin-ichiro Miyazaki, Riyo Ogura, Hitoshi Miyajima, Ken-ichiro Yuba, 
Keitaro Mahara, Shinobu Hosokawa, Kouichi Kishi, Ryuuji Ohtani, 
Tokushima Red Cross Hospital, Komatsushima, Japan
Learning Objective: demonstrate the long-term MACCE rate after PCI 
is synergistically increased in patients treated with SES when CKD 
is in association with anemia.
2504-516 Sirolimus Eluting- vs. Paclitaxel Eluting Stent in 
Patients With ST-Segment Elevation Myocardial 
Infarction and Renal Insufficiency Undergoing 
Primary Angioplasty
Sang-Ho Jo, Young-Jin Choi, Hyun-Sook Kim, Sung-Ae Kim, Chong-
Yun Rhim, Kyu Rok Han, Hallym University Sacred Heart Hospital, 
Anyang-si, Gyeonggi-do, South Korea
Learning Objective: Identify which DES is better between SES and 
PES in renal insufficiency in primary PCI
2504-517 Predictors of Contrast-induced Nephropathy After 
Percutaneous Coronary Intervention for CTO Lesions.
Masashi Kimura, Soichiro Ebisawa, Yoshihiro Ko, Nobuyoshi Tanaka, 
Kenya Nasu, Tatsuya Ito, Yoshihisa Kinoshita, Mariko Ehara, Etsuo 
Tsuchikae, Mitsuyasu Terashima, Yasushi Asaskura, Osamu Katoh, 
Takahiko Suzuki, Toyohashi Heart Center, Toyohashi, NY, Japan
Learning Objective: evaluate the impact of CTO procedures and 
contrast media use on renal function.
2504-518 Hyperglycemia and Contrast-Induced Acute Kidney 
Injury: Threshold for Injury
William B. Hillegass, Jr., Reza E. Ershadi, Marc A. Mayhew, Vijay 
K. Misra, Silvio E. Papapietro, Brigitta C. Brott, Gilbert J. Zoghbi, 
University of Alabama at Birmingham, Birmingham, AL
Learning Objective: Identify level of hyperglcemia that may be a risk 
factor for acute kidney injury with contrast administration.
2504-520 The Impact of Race on In-hospital Outcomes in 
Hemodialysis Patients Undergoing Percutaneous 
Coronary Intervention
Luis Gruberg, Puja B. Parikh, Allen Jeremias, Srihari S. Naidu, 
Richard A. Shlofmitz, Sorin J. Brenner, Thomas Pappas, Kevin P. 
Marzo, David L. Brown, Stony Brook University, Stony Brook, NY, 
Winthrop University Hospital, Mineola, NY
Learning Objective: Assess the impact of hemodialysis in African 
American patients undergoing PCI
2504-521 New Generation Drug-Eluting Stents Implantation in 
Patients With Chronic Kidney Disease
Konstantinos Toutouzas, Chrysoula Patsa, Costas Tsiouﬁs, 
Eleftherios Tsiamis, Anastasios Spanos, Costas Tentolouris, 
Dimitrios Tousoulis, Christodoulos Stefanadis, Hippokration 
Hospital, Athens, Greece
Learning Objective: to evaluated the clinical outcomes of the new 
generation DES implantation in patients with an isolated lesion in 
the proximal segment of the left anterior descending artery and 
chronic kidney disease
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2505-432 Comparison of Amplatzer® PFO Versus CardioSEAL/
STARflex® Versus Gore Helex Devices in Closure of 
Patent Foramen Ovale: A Single-Center Experience
Babak Haddadian, Alix J. Tercius, Naoyo Mori, Louie Kostopoulos, 
Satish Velagapudi, Kambiz Shetabi, Krishna Nagendran, Hani 
Hashim, Abdelazim Hashim, Andleeb Bangash, Anjan Gupta, Suhail 
Allaqaband, Tanvir Bajwa, Aurora Cardiovasc Svcs, Aurora Sinai/
St. Luke’s Med Ctrs, Univ Wisconsin Sch Med & Public Health-MCC, 
Milwaukee, WI, Center for Urban Population Health, University of 
Wisconsin-Milwaukee, Milwaukee, WI
Learning Objective: to recognize potential risks and benefits of 
different devices available in the market for percutaneous closure 
of PFO.
2505-433 Degree And Distribution Of Aortic Annulus 
Calcification As A Predictive Factor For Pacemaker 
Implantation After Corevalve Tavi. A Ct Driven, 
Prospective, Single-center Study
Georg Latsios, Seyrani Yücel, Daniel John, Ralf Mueller, Lutz 
Buellesfeld, Barthel Sauren, Ulrich Gerckens, Eberhard Grube, 
HELIOS Heart Center Siegburg, Siegburg, Germany
Learning Objective: To describe and interpret the relation of valve 
calcification and need for pacemaker implants after TAVI
2505-435 Anatomic suitability for Present and Next 
Generation Transcatheter Aortic Valve Devices
Hasan Jilaihawi, Jan Kovac, Derek Chin, Reda Ibrahim, Tomasz Spyt, 
Anita Asgar, Raoul Bonan, Montreal Heart Institute, Montreal, QC, 
Canada, Glenﬁeld Hospital, Leicester, United Kingdom
Learning Objective: interpret the anatomical suitability for different 
TAVI devices.
2505-436 Medium Term Longitudinal Follow Up of All Patients 
Referred to a Transcatheter Aortic Valve Multi-
Disciplinary Team.
Patrick A. Calvert, Isma Raﬁq, Baris A. Ozdemir, William Watson, 
Simon Hansom, Stephen T. Webb, Bushra S. Rana, Evelyn M. Lee, 
John Dunning, Rosemary A. Rusk, Catherine Sudarshan, Steven 
Tsui, Leonard M. Shapiro, Cameron G. Densem, Papworth NHS 
Foundation Trust Hospital, Cambridge, United Kingdom, Division 
of Cardiovascular Medicine, University of Cambridge, Cambridge, 
United Kingdom
Learning Objective: Evaluate the importance of a multi-disciplinary 
team in assessing high risk patients with severe aortic valvular 
stenosis and understand the importance of valve replacement 
therapy
2505-437 Transcatheter Aortic Valve Implantation Under 
Conscious Sedation Versus General Anesthesia With 
Intubation
Itsik Ben-Dor, Ron Waksman, Lowell F. Satler, Yanlin Li, Asmir I. 
Syed, Sara D. Collins, Gabriel Maluenda, Manuel A. Gonzalez, Kohei 
Wakabayashi, Cedric Delhaye, Michael A. Gaglia, Petros Okubagzi, 
Rebecca Torguson, Zhenyi Xue, William O. Suddath, Kenneth M. 
Kent, Joseph Lindsay, Augusto D. Pichard, Washington Hospital 
Center, Washington, DC, DC
Learning Objective: To examine the feasibility and safety of TAVI 
under conscious sedation and compare the clinical outcome to 
those patients who underwent general anesthesia
2505-420 Facilitating Treatment of Pulmonary Atresia with 
Radiofrequency (RF) Energy without RF Catheter 
Perforation
James Y. Coe, Prakul Chanthong, John Dyck, University of Alberta, 
Edmonton, AB, Canada
Learning Objective: Distinguish the different approaches, 
advantages and disadvantages of radiofrequency perforation of the 
atretic pulmonary valve.
2505-421 Improving Safety in the OR: An Intraoperative 
Improvement Initiative in Pediatric Cardiac Surgery
Megan Moser, Peter Manning, Traci Ashcraft, Pirooz Eghtesady, 
Cincinnati Children’s Hospital, Cincinnati, OH
Learning Objective: Identify how a systematic approach to initiate 
improvement can be effective and change outcomes.
2505-422 Most Recurrent Events After Patent Foramen Ovale 
Closure are not due to Residual Shunts
Julia T. Wallenborn, Nina Wunderlich, Horst Sievert, Cardiovascular 
Center Frankfurt, Frankfurt, Germany
Learning Objective: Identify potential causes of recurrent events 
after PFO Closure
2505-429 Catheter Closure of Atrial Septal Defect in Geriatric 
Population (> 70 years old)
Koji Nakagawa, Teiji Akagi, Yasufumi Kijima, Manabu Taniguchi, 
Kengo Kusano, Hiroshi Itoh, Shunji Sano, Department of 
Cardiovascular Medicine, Okayama University Graduate School of 
Medicine, Okayama, Japan
Learning Objective: evaluate
2505-430 Atrial Septal Defect Occlusion Using an Immediate 
ReleasePatch Method ; Early Clinical Experience
Eleftherios B. Sideris, Ali Zeinaloo, Kayhan S. Zanjani, Natalia 
Borisova, Manolis Pursanov, Athenian Institute of Pediatric 
Cardiology, Athens, Greece, Tehran University of Medical Sciences, 
Tehran, Iran (Islamic Republic of)
Learning Objective: to evaluate a new ASD occlusion method
2505-431 Markedly Elevated B-type Natriuretic Peptide 
Predicts Shock in Obstructive Cardiac Lesions on 
Systemic Side
Srikant Das, Kevin Maher, Sibley Heart Center, Children’s Healthcare 
of Atlanta, Emory University, Atlanta, GA
Learning Objective: Recognize high BNP as a marker of left side 
(systemic) obstructive lesion in infants with shock..
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2505-447 The Cardiac Benefits of Renal Artery Stenting
Osami Kawarada, Yoshiaki Yokoi, Nobuyuki Morioka, Akihiro 
Higashimori, Kishiwada Tokushukai Hospital, Kishiwada, Osaka, 
Japan
Learning Objective: evaluate cardiac benefits of renal artery 
stenting.
2505-449 Nitinol Stenting for Chronic Total Occlusion (CTO) in 
Superficial Femoral Artery (SFA), Long-Term Clinical 
Outcomes from Multicenter Registry.
Yasunari Sakamoto, Keisuke Hirano, Toshiya Muramatsu, 
Yoshimitsu Soga, Osamu Iida, Yokoi Hiroyoshi, Shinsuke Nanto, 
Saiseikai Yokohama City Eastern Hospital, Yokohama, Japan
Learning Objective: evaluate
2505-450 Long-term Mortality After Endovascular Treatment 
For Critical Limb Ischemia With Tissue Loss
Osami Kawarada, Yoshiaki Yokoi, Nobuyuki Morioka, Akihiro 
Higashimori, Shinji Shiotani, Kishiwada Tokushukai Hospital, 
Kishiwada, Osaka, Japan
Learning Objective: identify high risk patients after endovascular 
treatment for critical limb ischemia
2505-451 Effect of Time Delays on Outcomes of Acute Limb 
Ischemia
Hong H. Keo, Sue Duval, Iris Baumgartner, Niki C. Oldenburg, 
Michael R. Jaff, James M. Peacock, Alexander S. Tretinyak, Adnan 
Z. Rizvi, Timothy D. Henry, M. Darragh Flannery, Yale L. Wang, Peter 
B. Alden, Alan T. Hirsch, on behalf of the FRIENDS Investigators, 
Minneapolis Heart Institute Foundation at Abbott Northwestern 
Hospital, Minneapolis, MN
Learning Objective: Understand the importance of diagnostic delays 
and its associated shortterm outcome in patients with ALI
2505-452 Determinants of Procedural Failure in 
Contemporary Percutaneous Vascular Intervention: 
Insights from the Blue Cross Blue Shield of 
Michigan Cardiovascular Consortium
Paul Michael Grossman, Khan Munir, Stanley J. Chetcuti, Daniel 
S. Menees, Thomas P. Davis, Roberto A. Corpus, Steven K. Wang, 
Arthur Riba, David Share, Hitinder S. Gurm, University of Michigan 
Hospitals and Health Center, Ann Arbor, MI
Learning Objective: Identify patient and clinical factors that are 
associated with a failed percutaneous vascular intervention.
2505-453 Importance of Out-patient Surveillance for 
Achieving Long-term Patency After Percutaneous 
Revascularization of Long Femoral Artery Disease
Thomas M. Todoran, Gerard Connors, Brian A. Engelson, Piotr 
S. Sobieszczyk, Andrew C. Eisenhauer, Scott Kinlay, VA Boston 
Healthcare Systrm, West Roxbury, MA, Brigham and Women’s 
Hospital, Boston, MA
Learning Objective: Demonstrate a novel approach for percutaneous 
treatment of femoral artery disease.
2505-438 Mortality on the Waiting List for Transcatheter 
Aortic Valve Implantation. A Single Center 
Experience from Vancouver, Canada
Edgar Tay, Eve Aymong, Namal Wijesinghe, Fabian Nietlispach, 
Ronen Gurvitch, DA Wood, Ronald Carere, Jian Ye, Anson Cheung, 
John Webb, St. Paul’s Hospital, Vancouver, BC, Canada
Learning Objective: Risk stratify patients waiting for TAVI
2505-439 Left Atrial Stasis and VWF-ADAMTS 13 System in 
Aatrial Fibrillation
Waldemar E. Wysokinski, Ewa Konik, Robert D. McBane, II, Susan J. 
Eifert Rain, Dong Chen, Edyta Sutkowska, Thomas G. McLeod, Paul 
A. Friedman, Naser M. Ammash, Mayo Clinic, Rochester, MN
Learning Objective: To evaluate the relationship between VWF 
concentration and activity and the risk of left atrial appendage 
thrombus and stroke in atrial fibrillation.
2505-443 Optical Coherence Tomography Imaging to Evaluate 
Carotid Artery Stents: Safety, Feasibility, and 
Technique
Bernhard Reimers, Luca Favero, Eugenio Stabile, Salvatore Saccà, 
Paolo Rubino, Mirano Cardiology Dept., Mirano, Italy, Clinica 
Montevergine, Mercogliano, Italy
Learning Objective: Understand technique of intracarotid, post 
stent OCT imaging. Understand phenomenons as plaque prolaps, 
stent coverage, different appearance of open vs closed cell carotid 
stents.
2505-444 One-Year Clinical Outcomes after Treatment of 
Carotid Stenosis with Carotid Artery Stenting and 
Carotid Endarterectomy in the Medicare Population
FenWei Wang, Michael Del Core, Aryan Mooss, Thomas Lanspa, 
Stephanie Maciejewski, Dennis Esterbrooks, Creighton University, 
Omaha, NE
Learning Objective: To evaluate one-year outcomes of carotid artery 
stenting in the Medicare population
2505-445 Is Carotid Stenting A Durable Technique? Acute And 
Up To 7 Years Long-term Clinical Results From A 
Single-center Consecutive Series Of Patients
Piero Montorsi, Costanza Boiti, Stefano Galli, Paolo Ravagnani, 
Marco Agrifoglio, Franco Fabbiocchi, Daniela Trabattoni, Giovanni 
Teruzzi, Antonio Bartorelli, Gianluca Pontone, Cesare Fiorentini, 
Institute of Cardiology University of Milan, Milan, Jamaica
Learning Objective: interpretate acute and long-term results of CAS
2505-446 Completeness of Revascularization and Long 
Term Survival in Patients eligible for Percutaneous 
Coronary Intervention: A Meta-Analysis of 
Multivessel Coronary Artery Disease Studies.
Vikas Aggarwal, Manjeet Singh, Swapnil Rajpathak, Atul M. Limaye, 
Benjamin Romick, Vankeepuram S. Srinivas, Jacobi Medical Center, 
Bronx, NY, Monteﬁore Medical Center, Bronx, NY
Learning Objective: Compare clinical outcomes based on 
completeness of revascularization in patients with multivessel 
coronary artery disease undergoing percutaneous coronary 
intervention and stent implantation.
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2505-461 Efficacy and Safety of 4F New Transradial 
Diagnostic Catheter; RM and CR Catheter for 
Engaging Both Left and Right Coronary Arteries
Seung Woon Rha, Ji Young Park, Kanhaiya L. Poddar, Sureshkumar 
Ramasamy, Lin Wang, Byoung Geol Choi, Ji Bak Kim, Seung Yong 
Shin, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, 
Chang Gyu Park, Hong Seog Seo, Dong Joo Oh, Cardiovascular 
Center, Korean University Guro Hospital, Seoul, South Korea
Learning Objective: The present study aimed to investigated the 
Efficacy and Safety of 4F New Transradial Diagnostic Catheter; RM 
and CR Catheter for Engaging Both Left and Right Coronary Arteries
2505-462 The Angio-Seal Evolution Multicenter Registry: 
Multivariate Analysis of Vascular Complications in 
High Risk Patients
Robert J. Applegate, Zoltan Turi, Naveen Sachdev, Abdel Ahmed, Art 
Szyniszewski, Malcolm Foster, Antonis Pratsos, Timothy Shapiro, 
Steven J. Yakubov, David M. Shavelle, Wake Forest University School 
of Medicine, Winston-Salem, NC
Learning Objective: To identify patient and procedural factors 
associated with vascular complications after use of a closure 
device.
2505-463 The Angio-Seal Evolution Multicenter Registry: The 
Learning Curve Associated With a New Closure 
Device
Robert J. Applegate, Zoltan Turi, Naveen Sachdev, Abdel Ahmed, Art 
Szyniszewski, Malcolm Foster, Antonis Pratsos, Timothy Shapiro, 
Steven J. Yakubov, David M. Shavelle, Wake Forest University School 
of Medicine, Winston-Salem, NC
Learning Objective: To identify the learning curve associated with 
closure device use.
2505-464 Safety And Efficacy Of A Novel Metal Catheter In 
Chronic Total Occlusion Lesions. -Corsair First-In-
Man (FIM) Registry-
Masashi Kimura, Etsuo Tsuchikae, Osamu Katoh, Nobuyoshi 
Tanaka, Kenya Nasu, Tatsuya Ito, Yoshihisa Kinoshita, Mariko Ehara, 
Mitsuyasu Terashima, Yasushi Asaskura, Takahiko Suzuki, Toyohashi 
Heart Center, Toyohashi, NY, Japan
Learning Objective: evaluate the safety and feasibility of a novel 
metal catheter (CORSAIR) in the retrograde approach for CTO 
recanalization.
2505-489 Efficacy and Long Term Safety of StarClose™, an 
Extra Luminal Clip Vascular Closure System, for 
Hemostasis of Arterial Punctures Distal to Common 
Femoral Artery Bifurcation After Percutaneous 
Coronary Interventions
Payam Dehghani, Atif Mohammad, Daniel Marcuzzi, Tony Hong, 
Melma Evangelista, Howard Leong-Poi, Asim N. Cheema, St. 
Michael’s Hospital, Toronto, ON, Canada
Learning Objective: To determine immediate efficacy and long term 
safety of StarClose for hemostasis in arterial punctures distal to 
common femoral artery
2505-455 Comparison Of Transradial Coronary Intervention 
Between Right And Left Radial Approach
Young Jin Youn, Junghan Yoon, Sang Woo Han, Jun-Won Lee, Joong 
Kyung Sung, Nam Seok Lee, Jang-Young Kim, Seung Hwan Lee, 
Kyung-Hoon Choe, Wonju Christian Hospital, Wonju, South Korea
Learning Objective: Which vascular access would be helpful during 
TRI
2505-456 Transradial Percutaneous Intervention In Acute 
ST Elevation Myocardial Infarction Using A Single 
Heartrail Ikari Left Guider
Jeremy Chow, Vern Hsen Tan, Chong Hiok Tan, Sea Hing Ong, Yew 
Seong Goh, Siang Chew Chai, Changi General Hospital, Singapore, 
Singapore
Learning Objective: evaluate the feasibilty of using a single guider 
for transradial diagnostic angiography and therapeutic angioplasty 
for STEMI patients
2505-457 Comparative Effectiveness of Radial and Femoral 
Approaches to Percutaneous Coronary Intervention 
on Long-term Outcomes: A Report From The Nhlbi 
Dynamic Registry
Sunil V. Rao, Faith Selzer, Eric D. Peterson, Suresh R. Mulukutla, 
Joon S. Lee, Howard A. Cohen, David O. Williams, Alice K. Jacobs, 
Sheryl F. Kelsey, Oscar C. Marroquin, The University of Pittsburgh, 
Pittsburgh, PA, The Duke Clinical Research Institute, Durham, NC
Learning Objective: Discuss the association between radial 
approach to PCI and outcomes
2505-458 Comparative Effectiveness of Radial Access and 
Bivalirudin on PCI-Related Bleeding Events: Analysis 
from the National Cardiovascular Data Registry®
Steven P. Marso, Amit Amin, John A. House, Kevin F. Kennedy, John 
A. Spertus, Sunil V. Rao, John C. Messenger, John S. Rumsfeld, Mid 
America Heart Institute, Kansas City, MO, Duke Clinical Research 
Institute, Durham, NC
Learning Objective: Understand the comparative effectiveness of 
bivalirudin and radial access on bleeding events in PCI patients
2505-459 Incidence, Range and Clinical Impact of 
Hemoglobin Decrease after Transradial Coronary 
Stenting and Maximal Antiplatelet Therapy.
Olivier F. Bertrand, Josep Rodés-Cabau, Éric Larose, Stéphane 
Rinfret, Stéphane Rinfret, Jean-Pierre Déry, Onil Gleeton, Can M. 
Nguyen, Guy Proulx, Louis Roy, Olivier Costerousse, Paul Poirier, 
Robert De Larochellière, Quebec Heart-Lung Institute, Quebec City, 
QC, Canada
Learning Objective: evaluate the blood loss after transradial 
coronary stenting
2505-460 Transradial Approach is Associated with Lower 
Bleeding Complications in Patients Undergoing 
Percutaneous Coronary Intervention with 
Glycoprotein IIb/IIIa Inhibitors
Arthur Kerner, Eitan Abergel, Michael Berger, Majdi Halabi, Monther 
Boulus, Raphael Beyar, Ariel Roguin, Rambam Health Care Campus, 
Haifa, Israel
Learning Objective: Identify the superiority of radial access in 
preventing bleeding complications during PCI with the use of GPI
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2505-496 Conservative Versus Invasive Management Strategy 
for Retroperitoneal Hemorrhage After Percutaneous 
Coronary Intervention
Gabriel Maluenda, Cedric Delhaye, Manuel A. Gonzalez, Itsik 
Ben-Dor, Michael A. Gaglia, Sara D. Collins, Kohei Wakabayashi, 
Nicholas N. Hanna, Rebecca Torguson, Zhenyi Xue, William O. 
Suddath, Lowell F. Satler, Kenneth M. Kent, Joseph Lindsay, Augusto 
D. Pichard, Nelson L. Bernardo, Ron Waksman, Washington Hospital 
Center, Washington, DC
Learning Objective: Evaluate the role of therapeutic approach to 
manage this serious bleeding complication
2505-497 Safezone Arteriotomy Predicts Vascular 
Complications Among Men but Not Women 
Undergoing Cardiac Catheterization
Stefan Lischke, Bina Ahmed, Leigh A. Holterman, Harold L. 
Dauerman, University of Vermont, Burlington, VT
Learning Objective: identify gender specific risk factors for vascular 
complications after cardiac catheterization
2505-498 Impact of Length and Hydrophilic Coating of the 
Introducer Sheath on Radial Artery Spasm during 
Transradial Coronary Intervention: A Randomised 
Study
Sudhir Rathore, Rodney H. Stables, Maheswar Pauriah, Abdul 
Hakeem, Joseph D. Mills, Nick Palmer, Raphael A. Perry, John 
L. Morris, Liverpool Heart and Chest Hospital, Liverpool, United 
Kingdom
Learning Objective: This study evaluates the impact of hydrophilic 
coating and length of introducer sheath on radial artery spasm 
during transradial coronary procedures.
2505-500 Location of Femoral arteriotomy Site Using 
Anatomical Landmarks: Correlation with Access 
Site Complications
Sridevi Pitta, Abhiram Prasad, Gautam Kumar, Charanjit S. Rihal, 
David R. Holmes, Mayo Clinic, Rochester, MN
Learning Objective: Identify optimal versus alternative arteriotomy 
locations and its relation to vascular complications
2505-501 Mechanical Compression Devices Are Better Than 
Manual Compression Following Percutaneous 
Coronary Intervention
Abdelazim Hashim, Naoyo Mori, Satish Velagapudi, Babak 
Haddadian, Raaid Museitif, Angela Schlemm, Suhail Allaqaband, 
Tanvir Bajwa, Anjan Gupta, Aurora Cardiovasc Svcs, Aurora Sinai/
St. Luke’s Med Ctrs, Univ Wisconsin Sch Med & Public Health-MCC, 
Milwaukee, WI, Center for Urban Population Health, University of 
Wisconsin-Milwaukee, Milwaukee, WI
Learning Objective: assess differences in risk of vascular 
complications, all-cause mortality and length of hospital stay 
between manual compression and mechanical compression devices 
(Fem-Stop; C-clamp) following PCI.
2505-490 Efficacy and Safety of the Nitinol Clip-Based 
Vascular Closure Device (Starclose) for Femoral 
Arterial Cannulation at the Bifurcation: A Propensity 
Score Adjusted Analysis
Sripal Bangalore, Venkatesan Vidi, Matthew T. Galvin, Christopher B. 
Liu, Kevin P. Mullen, Kathryn M. Poulin, Holly Rand, Lisa D. Samson, 
Leigh Teittinen, Pinak B. Shah, Frederick G. Welt, Frederic Resnic, 
Brigham and Women’s Hospital, Boston, MA
Learning Objective: Demonstrate the safety of Starclose device for 
closure of femoral bifurcation cannulation
2505-491 Vascular Closure Device Versus Mechanical 
Compression for Prevention of Complications: A 
Propensity Score Adjusted Analyses of 28487 
Patients Undergoing Coronary Diagnostic and 
Interventional Procedures
Sripal Bangalore, Venkatesan Vidi, Pinak B. Shah, Federick G. Welt, 
Suwada Hinds, Frederic Resnic, Brigham and Women’s Hospital, 
Boston, MA
Learning Objective: Evaluate the efficacy of vascular closure device 
at preventing complications when compared to manual compression
2505-492 Long Term Outcomes Associated with Vascular 
Closure Device Use in Patients Undergoing 
Percutaneous Coronary Intervention Via the 
Femoral Approach: A Propensity Score Adjusted, 
Propensity Score Matched Analysis
Sripal Bangalore, Venkatesan Vidi, Frederick G. Welt, Pinak B. Shah, 
Frederic Resnic, Brigham and Women’s Hospital, Boston, MA
Learning Objective: Evaluate the long term outcomes when using 
vascular closure devices
2505-493 Learning Curve in the Use of StarClose Vascular 
Closure Device: An Analysis of the National 
Cardiovascular Data Registry
Venkatesan Vidi, Nipun Arora, Tracy Y. Wang, Fang-Shu Ou, David 
Dai, Michael Matheny, Frederic S. Resnic, Brigham and Women’s 
Hospital, Boston, MA, Duke Clinical Research Institute, Durham, NC
Learning Objective: To describe the institutional learning curve with 
the adoption of StarClose vascular closure device
2505-494 PCI-Related Bleeding Risk by Access and Non-
Access Site in the National Cardiovascular Data 
Registry®
Steven P. Marso, Amit Amin, John A. House, Kevin F. Kennedy, 
John A. Spertus, Sunil V. Rao, David J. Cohen, Mid America Heart 
Institute, Kansas City, MO, Duke Clinical Research Institute, 
Durham, NC
Learning Objective: Distinguish between risk of bleeding at PCI 
access site and non-access sites
2505-495 Access Site Management in the Cardiac Transplant 
Patient Undergoing Catheterization: Safety and 
Efficacy of Vascular Closure Devices
George V. Moukarbel, Patricia M. Campbell, Michael M. Givertz, 
Frederic S. Resnic, Brigham and Women’s Hospital, Harvard Medical 
School, Boston, MA
Learning Objective: understand the efficacy and safety of vascular 
closure devices in cardiac transplant recipients
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2505-508 Novel 19F MRI and CT Trackable Microencapsulated 
Mesenchymal Stem Cells for Treating Peripheral 
Arterial Disease
Yingli Fu, Dorota Kedziorek, Steven Shea, Ronald Ouwerkerk, 
Gary Huang, Tina Ehtiati, Robert Krieg, Jeff WM Bulte, Dara L. 
Kraitchman, Johns Hopkins University, Baltimore, MD
Learning Objective: demonstrate stem cell monitoring and non-
invasive tracking for ischemic arterial disease.
2505-509 Endovascular Cellular Paving For Vascular Repair 
Using Acoustic Radiation Force
Catalin Toma, Brion Winston, Andrew Fisher, Jianjun Wang, Xucai 
Chen, Michelle Grata, William Wagner, Flordeliza S. Villanueva, 
University of Pittsburgh Medical Center, Pittsburgh, PA, Center for 
Ultrasound Molecular Imaging and Therapeutics, Pittsburgh, PA
Learning Objective: evaluate ultrasound based application of cell 
therapy for vascular repair
2505-510 A New Method To Measure Necrotic Core And Calcium 
Content In Coronary Plaques Using Intravascular 
Ultrasound Radiofrequency-based Analysis
Eun Seok Shin, Hector M. Garcia-Garcia, Patrick W. Serruys, Ulsan 
University Hospital, Ulsan, South Korea, Thoraxcenter, Erasmus 
medical center, Rotterdam, The Netherlands
Learning Objective: evaluate for necrotic core and calcium very 
quickly in Cath. Lab.
2505-514 Outcome of Transcatheter Aortic Valve Implantation 
in Octogenarians in Comparison to Younger 
Patients: Results of the German Registry on 
Transcatheter Aortic Valve Implantations
Lutz Buellesfeld, Ulrich Gerckens, Harald Mudra, Gerhard C. Schuler, 
Ralf Zahn, Horst Sievert, Raimund Erbel, Rainer Hambrecht, Georg 
Nickenig, Karl-Eugen Hauptmann, Christoph Naber, Hans Rainer 
Figulla, Stefan Sack, Joachim Senges, Eberhard Grube, HELIOS 
Heart Center Siegburg, Siegburg, Germany
Learning Objective: To demonstrate the realtion of age and 
success/outcome after TAVI
2505-515 Comparison of Transfemoral and Transapical Aortic 
Valve Replacement: Results of the German Registry 
on Transcatheter Aortic Valve Implantations
Ulrich Gerckens, III, Harald Mudra, Gerhard C. Schuler, Ralf Zahn, 
Horst Sievert, Raimund Erbel, Rainer Hambrecht, Georg Nickenig, 
Karl-Eugen Hauptmann, Christoph Naber, Hans Rainer Figulla, 
Stefan Sack, Jochen Senges, Lutz Buellesfeld, Eberhard Grube, 
HELIOS Heart Center Siegburg, Siegburg, Germany
Learning Objective: To describe current outcome results 
of transfemoral and transapical transcatheter aortic valve 
implantations in real world practice
2505-516 TandemHeart Percutaneous Ventricular Assist 
Device for the Treatment of Refractory Cardiogenic 
Shock: A Single Center Experience
Thomas M. Todoran, Sripal Bangalore, Scott Kinlay, Andrew C. Eisenhauer, 
Piotr S. Sobieszczyk, Brigham and Women’s Hospital, Boston, MA
Learning Objective: Report clinical experience using TandemHeart 
percutaneous ventricular assist device in patients with refractory 
cardiogenic shock.
2505-502 Transluminal Retrieval of Vascular Stent Without 
Surgical Procedures: In Vitro and In Vivo Studies 
With Originally Designed Catching Device
Masayuki Tsuchida, Masa-aki Kawashiri, Hayato Tada, Chiaki 
Nakanishi, Katsuharu Uchiyama, Masakazu Yamagishi, Division of 
Cardiovascular Medicine, Kanazawa University Graduate School of 
Medicine, Kanazawa, Japan
Learning Objective: evaluate our new method to retrieve the stent.
2505-503 Safety and Efficacy of Angio-Seal™ Vascular 
Closure Device Following Percutaneous Coronary 
Intervention
Abdelazim Hashim, Naoyo Mori, Satish Velagapudi, Babak 
Haddadian, Raaid Museitif, Angela Schlemm, Suhail Allaqaband, 
Tanvir Bajwa, Anjan Gupta, Aurora Cardiovasc Svcs, Aurora Sinai/
St. Luke’s Med Ctrs, Univ Wisconsin Sch Med & Public Health-MCC, 
Milwaukee, WI, Center for Urban Population Health, University of 
Wisconsin-Milwaukee, Milwaukee, WI
Learning Objective: to compare length of hospital stay, rate of 
vascular complications, and all-cause mortality between Angio-
Seal™ VCD and manual compression or mechanical compression 
devices following PCI.
2505-504 Novel Technique of Duplex Ultrasound Guided 
Cannulation of Complete Flush Occlusion of SFA 
and Bypass Graft
Nelson L. Bernardo, Gabriel Maluenda, Manuel A. Gonzalez, 
MD, Sara D. Collins, Vishal Gupta, Marie A. Bilyeu, Raswork G. 
Gebremeskel, Stephen A. Boyd, Rebecca Torguson, Ron Waksman, 
Washington Hospital Center, Washington, DC
Learning Objective: Describe how to utilize duplex ultrasound as 
the primary imaging modality to guide recanalization of completely 
“flush” occluded vessels that show no residual “ostial stumps” 
angiographically.
2505-506 Upregulation of Hypoxia-Inducible Factor by 
Di-Methyl Oxalyl Glycine (DMOG) Increases 
Neovascularization Within Ischaemic Myocardium in 
a Porcine Coronary Occlusion Model
Damian John Kelly, Jasmin Mecinovic, Nadine Arnold, Kim Suvarna, 
Christopher J. Schoﬁeld, Julian Gunn, Anthony H. Gershlick, 
University of Leicester, Leicester, United Kingdom, University of 
Shefﬁeld, Shefﬁeld, United Kingdom
Learning Objective: Describe the effect of a novel angiogenic 
treatment for chronic total occlusion
2505-507 The First US Study to Assess the Feasibility 
and Safety of Endocardial Delivery of Allogenic 
Mesenchymal Precursor Cells in Patient With Heart 
Failure: Three-Month Interim Analysis
Nabil Dib, Tim Henry, Anthony De Maria, Silviu Itescu, Megan 
McCarthy, Susan Jaggar, Nicole Taylor, Ann Campbell, Henry Krum, 
Kendra Bartels, Donna Skerrett, Emerson Perin, Catholic Healthcare 
West, Gilbert, AZ
Learning Objective: Describe AMPC transplantation via 
endoventricular delivery to patients with heart failure.
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2505-524 Clinical Experience with a Sirolimus-eluting Nitinol 
Stent in a Biodegradable Polymer Matrix using the 
CardioMind® 0.014” Sparrow® Stent System
Roberto Botelho, Stefan Verheye, Robert J. Whitbourn, Rodolfo 
Staico, Jose R. Costa, Alexandre C. Abizaid, Instituto do Coração 
do Triângulo, Uberlandia, Brazil, Instituto Dante Pazzanese de 
Cardiologia, São Paolo, Brazil
Learning Objective: understand a novel technology that may lead 
to improved clinical outcomes for the treatment of small vessel 
disease
2505-531 The Impedance Cardiogram Is An Indicator Of CPR 
Effectiveness For Out-of-hospital Cardiac Arrest 
Victims
Rebecca C. Di Maio, NIBEC, University of Ulster, Belfast, AL, United 
Kingdom, The Heart Centre, Royal Victoria Hospital, Belfast, AL, 
United Kingdom
Learning Objective: understand the potential application of 
Impedance Cardiography in the treatment of sudden cardiac arrest
2505-532 Removal of Contrast Media from the Coronary 
Sinus Attenuates Renal Injury After Coronary 
Angiography and Intervention
David M. Kaye, Peter Ruygrok, Craig Juergens, Horst Sievert, Mark 
Richards, James Blake, Robert Whitbourn, Omar Farouque, Terry 
Pertile, Stephen Duffy, Alfred Hospital, Melbourne, MN, Australia
Learning Objective: Understand the causes and potential prevention 
of contrast-induced nephropathy
2505-533 Assessment by Optical Coherence Tomography of a 
Dedicated Drug Eluting Stent With Biodegradable 
Polymer for the Inhibition of Neovascularization and 
Neointimal Hyperplasia
Konstantinos Toutouzas, Elefterios Tsiamis, Andreas Synetos, 
Antonis Karanasos, Elli Stefanadi, Nicholas Kipshidze, 
Christodoulos Stefanadis, 1st Department of Cardiology, 
Hippokration Hospital, Athens, Greece
Learning Objective: evaluate the pre-clinical effectiveness of a 
dedicated stent for the inhibition of angiogenesis
2505-534 A Novel Method For Direct Correlation Of 
Angiography And Endovascular Diagnostic Tools In 
Human Coronary Arteries In Vivo.
Johannes Rieber, Simone Prummer, Martin Schmidt, Harald Rittger, 
Medizinische Poliklinik, University of Munich, Munich, Germany, 
Krankenhaus Coburg, Coburg, Germany 
Learning Objective: Identify the potential of a new image based 
coregistration of angiography and IVUS
2505-517 Trans-aortic Implantation Of The Medtronic 
Corevalve Prosthesis. Successful Implantation 
Through An Alternative Access Route
Ulrich Gerckens, III, Ralf Mueller, Stein Iversen, Thomas Felderhoff, 
Barthel Sauren, Bernfried Zickmann, Lutz Buellesfeld, Eberhard 
Grube, HELIOS Heart Center Siegburg, Siegburg, Germany
Learning Objective: Demonstrate a new approach for TAVI 
procedures
2505-518 Radiofrequency Energy - A New Approach to Shrink 
the Mitral Annulus: A Cross-Species Study
Richard R. Heuser, Duane Dickens, Thomas Witzell, St. Luke’s 
Hospital and Medical Center, Phoenix, AZ, University of Arizona, 
Tucson, AZ
Learning Objective: Demonstrate the ability of RF energy to modify 
collagen in a cross species study.
2505-520 Intracoronary Optical Coherence Tomography (OCT) 
and Histology 2, 3 And 4 Years After Implantation 
of Bioresorbable Everolimus-eluting Stents in a 
Porcine Coronary Model: an Attempt to Decipher 
The Human OCT Images in The Absorb Trial
Yoshinobu Onuma, Tskayuki Okamura, Nieves Gonzalo, Evelyn 
Regar, Willem van der Giessen, Laura Perkins, Jennifer Powers, 
Richard Rapoza, Renu Virmani, Thorax Center, Erasmus MC, 
Rotterdam, The Netherlands
Learning Objective: interpret alteration of bioresorbable everolimus-
eluting stent in OCT images with corresponding histology in the 
porcine coronary artery model
2505-521 Stent Degradation of Novel Fully Bioabsorbable 
Salicylate-Based Sirolimus-Eluting Stent Evaluated 
by OCT in Pig Coronary Artery
Daisuke Matsumoto, Toshiro Shinke, Sarah Geva, Nicolas Chronos, 
Refat Jabara, Saint Joseph’s Translational Research Institute, 
Atlanta, GA
Learning Objective: demonstrate stent degradation of novel fully 
bioabsorbable salicylate-based sirolimus-eluting etent evaluated by 
OCT in pig coronary artery
2505-522 A Newly Developed Rapamycin-Eluting Stent with 
a Biodegradable Polymer reduces Neointimal 
Formation while Allowing Greater Endothelialization
Marc M. Vorpahl, Gaku Nakazawa, Pinar Nebol, Frank Kolodgie, 
Renu Virmani, CV Path Institute, Gaithersburg, MD, Alvimedica 
Medical, Istanbul, Turkey
Learning Objective: understand that a biodegradable polymer is 
likely to be safer in man as compared to a non bioerodable polymer
2505-523 First-in-Man Study of Low-Dose Paclitaxel -Eluting 
Stent with a Novel Biodegradable Coating
Daisaku Nakatani, Yasuhiro Honda, Katsuhisa Waseda, Junya Ako, 
Carlos Calderas, Jose A. Condado, Peter J. Fitzgerald, Stanford 
University Medical Center, Palo Alto, CA, Institute de Clinicas 
y Urologia Tamanaco Laboratorio de Hemodinamia, Caracas, 
Venezuela
Learning Objective: We demonstrated that novel stent has similar 
neointimal suppression effect
